phenotype_id	disorder_name	phenotype_name	frequency	gene.symbol	gene.mim	disease.mim	allelic.requirement	DDD.category	mutation.consequence	organ.specificity.list	hgnc.id	name	locus_group	locus_type	status	location	location_sortable	alias_symbol	alias_name	prev_symbol	prev_name	gene_family
NA	oculoauricular syndrome	NA	NA	HMX1	142992	612109	biallelic	probable	loss of function	Eye;Ear	5017	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bardet-biedl syndrome type 14	NA	NA	CEP290	610142	209900	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition	29021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	otopalatodigital syndrome type 1	Cleft palate	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000316	otopalatodigital syndrome type 1	Hypertelorism	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000336	otopalatodigital syndrome type 1	Prominent supraorbital ridges	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000365	otopalatodigital syndrome type 1	Hearing impairment	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000431	otopalatodigital syndrome type 1	Wide nasal bridge	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000494	otopalatodigital syndrome type 1	Downslanted palpebral fissures	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000674	otopalatodigital syndrome type 1	Anodontia	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000677	otopalatodigital syndrome type 1	Oligodontia	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001163	otopalatodigital syndrome type 1	Abnormality of the metacarpal bones	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001256	otopalatodigital syndrome type 1	Intellectual disability, mild	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001376	otopalatodigital syndrome type 1	Limitation of joint mobility	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001850	otopalatodigital syndrome type 1	Abnormality of the tarsal bones	Occasional (29-5%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001852	otopalatodigital syndrome type 1	Sandal gap	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002652	otopalatodigital syndrome type 1	Skeletal dysplasia	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002684	otopalatodigital syndrome type 1	Thickened calvaria	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002738	otopalatodigital syndrome type 1	Hypoplastic frontal sinuses	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0003042	otopalatodigital syndrome type 1	Elbow dislocation	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0004279	otopalatodigital syndrome type 1	Short palm	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0005048	otopalatodigital syndrome type 1	Synostosis of carpal bones	Occasional (29-5%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0005280	otopalatodigital syndrome type 1	Depressed nasal bridge	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0005640	otopalatodigital syndrome type 1	Abnormal vertebral segmentation and fusion	Occasional (29-5%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0006487	otopalatodigital syndrome type 1	Bowing of the long bones	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0009623	otopalatodigital syndrome type 1	Proximal placement of thumb	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0009778	otopalatodigital syndrome type 1	Short thumb	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0009882	otopalatodigital syndrome type 1	Short distal phalanx of finger	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0010109	otopalatodigital syndrome type 1	Short hallux	Very frequent (99-80%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0011001	otopalatodigital syndrome type 1	Increased bone mineral density	Frequent (79-30%)	FLNA	300017	311300	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
NA	fanconi anemia complementation group p	NA	NA	SLX4	613278	613951	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Brain/Cognition	23845	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	argininemia	Behavioral abnormality	Very frequent (99-80%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	argininemia	Seizures	Frequent (79-30%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	argininemia	Global developmental delay	Very frequent (99-80%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001987	argininemia	Hyperammonemia	Frequent (79-30%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	argininemia	Neurological speech impairment	Very frequent (99-80%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	argininemia	EEG abnormality	Frequent (79-30%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002478	argininemia	Progressive spastic quadriplegia	Frequent (79-30%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	argininemia	Hemiplegia/hemiparesis	Frequent (79-30%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008339	argininemia	Diaminoaciduria	Very frequent (99-80%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010864	argininemia	Intellectual disability, severe	Very frequent (99-80%)	ARG1	608313	207800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	NA	NA	POLR3A	614258	607694	biallelic	confirmed	loss of function	Teeth & Dentitian;Brain/Cognition;Genitalia	30074	RNA polymerase III subunit A	protein-coding gene	gene with protein product	Approved	10q22.3	10q22.3	RPC1|RPC155|hRPC155			polymerase (RNA) III (DNA directed) polypeptide A, 155kDa	RNA polymerase subunits
NA	seckel syndrome type 1	NA	NA	ATR	No gene mim	210600	biallelic	probable	loss of function	Face;Skeleton;Brain/Cognition	882	ATR serine/threonine kinase	protein-coding gene	gene with protein product	Approved	3q23	03q23	FRP1|SCKL|SCKL1|MEC1	MEC1, mitosis entry checkpoint 1, homolog (S. cerevisiae)		ataxia telangiectasia and Rad3 related	
NA	fancb-related fanconi anemia	NA	NA	FANCB	300515	229139	hemizygous	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	3583	Fanconi anemia complementation group B	protein-coding gene	gene with protein product	Approved	Xp22.2	Xp22.2	FAB|FLJ34064|FAAP95				Fanconi anemia complementation groups
HP:0001250	alg9-cdg	Seizures	Very frequent (99-80%)	ALG9	606941	300153	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	15672	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	alg9-cdg	Muscular hypotonia	Very frequent (99-80%)	ALG9	606941	300153	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	15672	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001399	alg9-cdg	Hepatic failure	Very frequent (99-80%)	ALG9	606941	300153	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	15672	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	alg9-cdg	Cognitive impairment	Very frequent (99-80%)	ALG9	606941	300153	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	15672	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital insensitivity to pain with anhidrosis	NA	NA	NTRK1	191315	256800	biallelic	confirmed	loss of function	Spinal cord/Peripheral nerves	8031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness autosomal dominant type 17	NA	NA	MYH9	No gene mim	603622	monoallelic	confirmed	uncertain	Bone Marrow/Immune	7579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	NA	NA	YAP1	No gene mim	120433	monoallelic	probable	loss of function	Kidney Renal Tract;Face;Brain/Cognition;Eye;Ear	16262	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bardet-biedl syndrome type 9	NA	NA	BBS9	607968	209900	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Respiratory tract	30000	Bardet-Biedl syndrome 9	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	B1|PTHB1	parathyroid hormone responsive B1 gene			Bardet-Biedl syndrome associated|BBSome
NA	bardet-biedl syndrome type 11	NA	NA	TRIM32	602290	209900	biallelic	confirmed	uncertain	Musculature;Kidney Renal Tract;Brain/Cognition;Eye	16380	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	renal-coloboma syndrome	NA	NA	PAX2	167409	120330	monoallelic	confirmed	loss of function	Kidney Renal Tract;Eye	8616	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lacrimo-auriculo-dento-digital syndrome	NA	NA	FGFR3	134934	149730	monoallelic	confirmed	uncertain	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000023	weaver syndrome	Inguinal hernia	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	weaver syndrome	Cryptorchidism	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000098	weaver syndrome	Tall stature	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	weaver syndrome	Macrocephaly	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000278	weaver syndrome	Retrognathia	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000311	weaver syndrome	Round face	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	weaver syndrome	Hypertelorism	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	weaver syndrome	Broad forehead	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	weaver syndrome	Long philtrum	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	weaver syndrome	Micrognathia	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	weaver syndrome	Low-set, posteriorly rotated ears	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	weaver syndrome	Macrotia	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	weaver syndrome	Downslanted palpebral fissures	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	weaver syndrome	Abnormality of the metaphyses	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001176	weaver syndrome	Large hands	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001231	weaver syndrome	Abnormality of the fingernails	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	weaver syndrome	Intellectual disability	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	weaver syndrome	Spasticity	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	weaver syndrome	Global developmental delay	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001276	weaver syndrome	Hypertonia	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	weaver syndrome	Joint stiffness	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	weaver syndrome	Redundant skin	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001609	weaver syndrome	Hoarse voice	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001761	weaver syndrome	Pes cavus	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001762	weaver syndrome	Talipes equinovarus	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001769	weaver syndrome	Broad foot	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001800	weaver syndrome	Hypoplastic toenails	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001814	weaver syndrome	Deep-set nails	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001816	weaver syndrome	Thin nail	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001852	weaver syndrome	Sandal gap	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002002	weaver syndrome	Deep philtrum	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002213	weaver syndrome	Fine hair	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	weaver syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	weaver syndrome	Scoliosis	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005616	weaver syndrome	Accelerated skeletal maturation	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	weaver syndrome	Joint hyperflexibility	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	weaver syndrome	Finger syndactyly	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	weaver syndrome	Hypoplasia of penis	Occasional (29-5%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	weaver syndrome	Feeding difficulties in infancy	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010300	weaver syndrome	Abnormally low-pitched voice	Very frequent (99-80%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011304	weaver syndrome	Broad thumb	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	weaver syndrome	Camptodactyly of finger	Frequent (79-30%)	NSD1	606681	277590	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dyschromatosis symmetrica hereditaria 1	NA	NA	ADAR	146920	127400	monoallelic	confirmed	loss of function	Brain/Cognition	225	adenosine deaminase, RNA specific	protein-coding gene	gene with protein product	Approved	1q21.3	01q21.3	ADAR1		IFI4|G1P1	interferon-induced protein 4	Adenosine deaminases acting on RNA
NA	epileptic encephalopathy	NA	NA	MTOR	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	3942	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nanophthalmos 2	NA	NA	MFRP	606227	609549	biallelic	confirmed	loss of function	Eye	18121	membrane frizzled-related protein	protein-coding gene	gene with protein product	Approved	11q23.3	11q23.3	FLJ30570|rd6|NNO2|C1QTNF5	membrane-type frizzled-related protein|C1q and TNF related 5			
NA	hypogonadotropic hypogonadism with or without anosmia	NA	NA	FEZF1	No gene mim	616030	biallelic	probable	loss of function	Genitalia	22788	FEZ family zinc finger 1	protein-coding gene	gene with protein product	Approved	7q31.32	07q31.32			ZNF312B	zinc finger protein 312B	Zinc fingers C2H2-type
NA	spondylocarpotarsal synostosis syndrome	NA	NA	FLNB	603381	272460	biallelic	confirmed	loss of function	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
NA	nonpecific severe id	NA	NA	NAA10	300013	No disease mim	x-linked dominant	confirmed	all missense/in frame	Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	18704	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital disorders of glycosylation	NA	NA	MOGS	601336	612379	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	24862	mannosyl-oligosaccharide glucosidase	protein-coding gene	gene with protein product	Approved	2p13.1	02p13.1	GCS1|CWH41|DER7	glucosidase I|processing A-glucosidase I			
NA	rhizomelic chondrodysplasia punctata type 3	NA	NA	AGPS	603051	600121	biallelic	confirmed	uncertain	Skeleton;Brain/Cognition;Eye	327	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	oral-facial-digital syndrome type 1	NA	NA	OFD1	300170	311200	x-linked dominant	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	2567	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lissencephaly type 1	NA	NA	PAFAH1B1	601545	607432	monoallelic	confirmed	loss of function	Brain/Cognition	8574	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehlers-danlos syndrome type viia	NA	NA	COL1A1	120150	319158	monoallelic	confirmed	dominant negative	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehlers-danlos syndrome type viia	NA	NA	COL1A1	120150	319158	monoallelic	confirmed	dominant negative	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebellar ataxia, nonprogressive, with mental retardation	NA	NA	CAMTA1	No gene mim	614756	monoallelic	probable	loss of function	Brain/Cognition	18806	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondyloepiphyseal dysplasia with congenital joint dislocations	NA	NA	CHST3	603799	143095	biallelic	confirmed	loss of function	Skeleton	1971	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	costello syndrome	Cryptorchidism	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000158	costello syndrome	Macroglossia	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	costello syndrome	Abnormality of the teeth	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000179	costello syndrome	Thick lower lip vermilion	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000189	costello syndrome	Narrow palate	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	costello syndrome	Macrocephaly	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	costello syndrome	Coarse facial features	Occasional (29-5%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	costello syndrome	Epicanthus	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000293	costello syndrome	Full cheeks	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	costello syndrome	Low-set, posteriorly rotated ears	Occasional (29-5%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	costello syndrome	Short neck	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000474	costello syndrome	Thickened nuchal skin fold	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	costello syndrome	Strabismus	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000563	costello syndrome	Keratoconus	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	costello syndrome	Abnormality of dental enamel	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000951	costello syndrome	Abnormality of the skin	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000956	costello syndrome	Acanthosis nigricans	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000962	costello syndrome	Hyperkeratosis	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001231	costello syndrome	Abnormality of the fingernails	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	costello syndrome	Intellectual disability	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001531	costello syndrome	Failure to thrive in infancy	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	costello syndrome	Polyhydramnios	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	costello syndrome	Redundant skin	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001595	costello syndrome	Abnormality of the hair	Occasional (29-5%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001598	costello syndrome	Concave nail	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	costello syndrome	Ventricular septal defect	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001634	costello syndrome	Mitral valve prolapse	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	costello syndrome	Hypertrophic cardiomyopathy	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001642	costello syndrome	Pulmonic stenosis	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001800	costello syndrome	Hypoplastic toenails	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001814	costello syndrome	Deep-set nails	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	costello syndrome	Gastroesophageal reflux	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002033	costello syndrome	Poor suck	Occasional (29-5%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002120	costello syndrome	Cerebral cortical atrophy	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002224	costello syndrome	Woolly hair	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	costello syndrome	Delayed skeletal maturation	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	costello syndrome	Short stature	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004690	costello syndrome	Thickened Achilles tendon	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	costello syndrome	Depressed nasal bridge	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	costello syndrome	Joint hyperflexibility	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007440	costello syndrome	Generalized hyperpigmentation	Occasional (29-5%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007477	costello syndrome	Abnormal dermatoglyphics	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	costello syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009465	costello syndrome	Ulnar deviation of finger	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009748	costello syndrome	Large earlobe	Occasional (29-5%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012740	costello syndrome	Papilloma	Frequent (79-30%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100679	costello syndrome	Lack of skin elasticity	Very frequent (99-80%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100729	costello syndrome	Large face	Occasional (29-5%)	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leber congenital amaurosis 6	NA	NA	RPGRIP1	605446	613826	biallelic	confirmed	loss of function	Eye	13436	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	popliteal pterygium syndrome, lethal type	NA	NA	RIPK4	605706	263650	biallelic	confirmed	loss of function	Skeleton	496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanconi anemia, complementation group j	NA	NA	BRIP1	605882	609054	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	20473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	simpson-golabi-behmel syndrome type 2	NA	NA	OFD1	300170	300209	hemizygous	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	2567	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003063	ulnar-mammary syndrome	Abnormality of the humerus	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004050	ulnar-mammary syndrome	Absent hand	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004299	ulnar-mammary syndrome	Hernia of the abdominal wall	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004397	ulnar-mammary syndrome	Ectopic anus	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009751	ulnar-mammary syndrome	Aplasia of the pectoralis major muscle	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009882	ulnar-mammary syndrome	Short distal phalanx of finger	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	ulnar-mammary syndrome	Arrhythmia	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	ulnar-mammary syndrome	Camptodactyly of finger	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100783	ulnar-mammary syndrome	Breast aplasia	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001167	ulnar-mammary syndrome	Abnormality of finger	Very frequent (99-80%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001231	ulnar-mammary syndrome	Abnormality of the fingernails	Very frequent (99-80%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002221	ulnar-mammary syndrome	Absent axillary hair	Very frequent (99-80%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004370	ulnar-mammary syndrome	Abnormality of temperature regulation	Very frequent (99-80%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006495	ulnar-mammary syndrome	Aplasia/Hypoplasia of the ulna	Very frequent (99-80%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	ulnar-mammary syndrome	Cryptorchidism	Frequent (79-30%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000130	ulnar-mammary syndrome	Abnormality of the uterus	Frequent (79-30%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000144	ulnar-mammary syndrome	Decreased fertility	Frequent (79-30%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	ulnar-mammary syndrome	Delayed puberty	Frequent (79-30%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001513	ulnar-mammary syndrome	Obesity	Frequent (79-30%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002557	ulnar-mammary syndrome	Hypoplastic nipples	Frequent (79-30%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003019	ulnar-mammary syndrome	Abnormality of the wrist	Frequent (79-30%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	ulnar-mammary syndrome	Short stature	Frequent (79-30%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	ulnar-mammary syndrome	Hypoplasia of penis	Frequent (79-30%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000089	ulnar-mammary syndrome	Renal hypoplasia	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000668	ulnar-mammary syndrome	Hypodontia	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	ulnar-mammary syndrome	Pectus carinatum	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000889	ulnar-mammary syndrome	Abnormality of the clavicle	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000912	ulnar-mammary syndrome	Sprengel anomaly	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001162	ulnar-mammary syndrome	Postaxial hand polydactyly	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	ulnar-mammary syndrome	Abnormality of the metacarpal bones	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001601	ulnar-mammary syndrome	Laryngomalacia	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	ulnar-mammary syndrome	Ventricular septal defect	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001800	ulnar-mammary syndrome	Hypoplastic toenails	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002021	ulnar-mammary syndrome	Pyloric stenosis	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002023	ulnar-mammary syndrome	Anal atresia	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002818	ulnar-mammary syndrome	Abnormality of the radius	Occasional (29-5%)	TBX3	601621	181450	monoallelic	confirmed	loss of function	Musculature;Skeleton	11602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebellar dysplasia with cysts with or without retinal dystrophy	NA	NA	LAMA1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	6481	laminin subunit alpha 1	protein-coding gene	gene with protein product	Approved	18p11.31	18p11.31			LAMA	laminin, alpha 1	Laminin subunits
NA	autosomal recessive mental retardation	NA	NA	ERLIN2	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	1356	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	propionic acidemia	Intellectual disability	Frequent (79-30%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	propionic acidemia	Global developmental delay	Frequent (79-30%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001638	propionic acidemia	Cardiomyopathy	Occasional (29-5%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	propionic acidemia	Hypoglycemia	Very frequent (99-80%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001987	propionic acidemia	Hyperammonemia	Very frequent (99-80%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001992	propionic acidemia	Organic aciduria	Very frequent (99-80%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	propionic acidemia	Constipation	Very frequent (99-80%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	propionic acidemia	Hepatomegaly	Frequent (79-30%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003353	propionic acidemia	Propionyl-CoA carboxylase deficiency	Very frequent (99-80%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	propionic acidemia	Abnormality of immune system physiology	Frequent (79-30%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	propionic acidemia	Arrhythmia	Frequent (79-30%)	PCCA	232000	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy limb-girdle type c5	NA	NA	FKRP	606596	607155	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	17997	fukutin related protein	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	LGMD2I|MDC1C				
NA	mitochondrial complex iv deficiency	NA	NA	COX15	603646	220110	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	cog7-cdg	Muscular hypotonia	Very frequent (99-80%)	COG7	606978	300171	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	18622	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	cog7-cdg	Hypertrophic cardiomyopathy	Very frequent (99-80%)	COG7	606978	300171	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	18622	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	cog7-cdg	Abnormality of immune system physiology	Very frequent (99-80%)	COG7	606978	300171	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	18622	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nonspecific severe id	NA	NA	SCN2A	182390	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	10588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rett syndrome (rtt)[	NA	NA	MECP2	300005	312750	x-linked dominant	confirmed	loss of function	Brain/Cognition;GI tract	6990	methyl-CpG binding protein 2	protein-coding gene	gene with protein product	Approved	Xq28	Xq28			RTT|MRX16|MRX79	mental retardation, X-linked 16|mental retardation, X-linked 79|Rett syndrome|methyl CpG binding protein 2 (Rett syndrome)|methyl CpG binding protein 2	X-linked mental retardation|Methyl-CpG binding domain containing
NA	noonan syndrome type 7	NA	NA	BRAF	164757	613706	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hereditary hyperferritinemia-cataract syndrome	NA	NA	FTL	134790	600886	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Eye	3999	ferritin light chain	protein-coding gene	gene with protein product	Approved	19q13.33	19q13.33	MGC71996|NBIA3	ferritin light polypeptide-like 3|L apoferritin|ferritin L subunit|ferritin light chain|ferritin L-chain|neurodegeneration with brain iron accumulation 3		ferritin, light polypeptide	Ferritin subunits
NA	noonan syndrome-like disorder with or without juvenile meylomonocytic leukemia	NA	NA	CBL	165360	613563	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1541	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy congenital with mental retardation type b3	NA	NA	POMGNT1	606822	613151	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	19139	protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)	protein-coding gene	gene with protein product	Approved	1p34.1	01p34.1	FLJ20277|MGAT1.2|LGMD2O	protein O-mannose beta-1,2-N-acetylglucosaminyltransferase	MEB	muscle-eye-brain disease|protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase	O-linked N-acetylglucosaminyltransferases
HP:0000162	kniest dysplasia	Glossoptosis	Occasional (29-5%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	kniest dysplasia	Cleft palate	Frequent (79-30%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000311	kniest dysplasia	Round face	Frequent (79-30%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	kniest dysplasia	Micrognathia	Occasional (29-5%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	kniest dysplasia	Hearing impairment	Frequent (79-30%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000488	kniest dysplasia	Retinopathy	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	kniest dysplasia	Glaucoma	Occasional (29-5%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	kniest dysplasia	Ptosis	Occasional (29-5%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	kniest dysplasia	Cataract	Occasional (29-5%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	kniest dysplasia	Proptosis	Frequent (79-30%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000541	kniest dysplasia	Retinal detachment	Frequent (79-30%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	kniest dysplasia	Myopia	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000655	kniest dysplasia	Vitreoretinal degeneration	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000926	kniest dysplasia	Platyspondyly	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	kniest dysplasia	Abnormality of the metaphyses	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000947	kniest dysplasia	Dumbbell-shaped long bone	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001083	kniest dysplasia	Ectopia lentis	Occasional (29-5%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001373	kniest dysplasia	Joint dislocation	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	kniest dysplasia	Joint stiffness	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002098	kniest dysplasia	Respiratory distress	Occasional (29-5%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	kniest dysplasia	Scoliosis	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	kniest dysplasia	Skeletal dysplasia	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002758	kniest dysplasia	Osteoarthritis	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002777	kniest dysplasia	Tracheal stenosis	Occasional (29-5%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002779	kniest dysplasia	Tracheomalacia	Occasional (29-5%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	kniest dysplasia	Kyphosis	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002812	kniest dysplasia	Coxa vara	Frequent (79-30%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002827	kniest dysplasia	Hip dislocation	Frequent (79-30%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	kniest dysplasia	Micromelia	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003015	kniest dysplasia	Flared metaphysis	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003307	kniest dysplasia	Hyperlordosis	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003521	kniest dysplasia	Disproportionate short-trunk short stature	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	kniest dysplasia	Depressed nasal bridge	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	kniest dysplasia	Abnormality of epiphysis morphology	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006172	kniest dysplasia	Flattened, squared-off epiphyses of tubular bones	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008839	kniest dysplasia	Hypoplastic pelvis	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008905	kniest dysplasia	Rhizomelia	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010306	kniest dysplasia	Short thorax	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	kniest dysplasia	Midface retrusion	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100625	kniest dysplasia	Enlarged thorax	Very frequent (99-80%)	COL2A1	120140	156550	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000098	loeys-dietz syndrome	Tall stature	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000193	loeys-dietz syndrome	Bifid uvula	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000202	loeys-dietz syndrome	Oral cleft	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	loeys-dietz syndrome	High palate	Very frequent (99-80%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	loeys-dietz syndrome	Malar flattening	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	loeys-dietz syndrome	Hypertelorism	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	loeys-dietz syndrome	Micrognathia	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000592	loeys-dietz syndrome	Blue sclerae	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	loeys-dietz syndrome	Pectus excavatum	Occasional (29-5%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	loeys-dietz syndrome	Pectus carinatum	Occasional (29-5%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000963	loeys-dietz syndrome	Thin skin	Occasional (29-5%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000978	loeys-dietz syndrome	Bruising susceptibility	Occasional (29-5%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000987	loeys-dietz syndrome	Atypical scarring of skin	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001065	loeys-dietz syndrome	Striae distensae	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001166	loeys-dietz syndrome	Arachnodactyly	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	loeys-dietz syndrome	Craniosynostosis	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001373	loeys-dietz syndrome	Joint dislocation	Occasional (29-5%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	loeys-dietz syndrome	Patent ductus arteriosus	Very frequent (99-80%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001695	loeys-dietz syndrome	Cardiac arrest	Occasional (29-5%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	loeys-dietz syndrome	Pes planus	Very frequent (99-80%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001892	loeys-dietz syndrome	Abnormal bleeding	Occasional (29-5%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002617	loeys-dietz syndrome	Aneurysm	Very frequent (99-80%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002647	loeys-dietz syndrome	Aortic dissection	Very frequent (99-80%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	loeys-dietz syndrome	Scoliosis	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004942	loeys-dietz syndrome	Aortic aneurysm	Very frequent (99-80%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005116	loeys-dietz syndrome	Arterial tortuosity	Very frequent (99-80%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005294	loeys-dietz syndrome	Arterial dissection	Very frequent (99-80%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	loeys-dietz syndrome	Joint hyperflexibility	Occasional (29-5%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	loeys-dietz syndrome	Camptodactyly of finger	Frequent (79-30%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100718	loeys-dietz syndrome	Uterine rupture	Very frequent (99-80%)	TGFB3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperphosphatasia with mental retardation syndrome 2	NA	NA	PIGO	614730	614749	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23215	phosphatidylinositol glycan anchor biosynthesis class O	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3	DKFZp434M222|FLJ00135			phosphatidylinositol glycan, class O	Phosphatidylinositol glycan anchor biosynthesis
HP:0000028	hallermann-streiff syndrome	Cryptorchidism	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000157	hallermann-streiff syndrome	Abnormality of the tongue	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000160	hallermann-streiff syndrome	Narrow mouth	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000162	hallermann-streiff syndrome	Glossoptosis	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000164	hallermann-streiff syndrome	Abnormality of the teeth	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000235	hallermann-streiff syndrome	Abnormality of the fontanelles or cranial sutures	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000248	hallermann-streiff syndrome	Brachycephaly	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000252	hallermann-streiff syndrome	Microcephaly	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000272	hallermann-streiff syndrome	Malar flattening	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000347	hallermann-streiff syndrome	Micrognathia	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000430	hallermann-streiff syndrome	Underdeveloped nasal alae	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000444	hallermann-streiff syndrome	Convex nasal ridge	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000453	hallermann-streiff syndrome	Choanal atresia	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000486	hallermann-streiff syndrome	Strabismus	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000501	hallermann-streiff syndrome	Glaucoma	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000505	hallermann-streiff syndrome	Visual impairment	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000506	hallermann-streiff syndrome	Telecanthus	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000519	hallermann-streiff syndrome	Congenital cataract	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000535	hallermann-streiff syndrome	Sparse eyebrow	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000545	hallermann-streiff syndrome	Myopia	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000554	hallermann-streiff syndrome	Uveitis	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000568	hallermann-streiff syndrome	Microphthalmia	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000639	hallermann-streiff syndrome	Nystagmus	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000653	hallermann-streiff syndrome	Sparse eyelashes	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000695	hallermann-streiff syndrome	Natal tooth	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000773	hallermann-streiff syndrome	Short ribs	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000821	hallermann-streiff syndrome	Hypothyroidism	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000896	hallermann-streiff syndrome	Rib exostoses	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0000929	hallermann-streiff syndrome	Abnormality of the skull	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0001006	hallermann-streiff syndrome	Hypotrichosis	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0001249	hallermann-streiff syndrome	Intellectual disability	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0001321	hallermann-streiff syndrome	Cerebellar hypoplasia	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0001596	hallermann-streiff syndrome	Alopecia	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0001635	hallermann-streiff syndrome	Congestive heart failure	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0001773	hallermann-streiff syndrome	Short foot	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0002007	hallermann-streiff syndrome	Frontal bossing	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0002093	hallermann-streiff syndrome	Respiratory insufficiency	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0002231	hallermann-streiff syndrome	Sparse body hair	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0002564	hallermann-streiff syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0002705	hallermann-streiff syndrome	High, narrow palate	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0002757	hallermann-streiff syndrome	Recurrent fractures	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0002779	hallermann-streiff syndrome	Tracheomalacia	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0003363	hallermann-streiff syndrome	Abdominal situs inversus	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0003508	hallermann-streiff syndrome	Proportionate short stature	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0004209	hallermann-streiff syndrome	Clinodactyly of the 5th finger	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0004334	hallermann-streiff syndrome	Dermal atrophy	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0004349	hallermann-streiff syndrome	Reduced bone mineral density	Very frequent (99-80%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0010719	hallermann-streiff syndrome	Abnormality of hair texture	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0011069	hallermann-streiff syndrome	Increased number of teeth	Frequent (79-30%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0200055	hallermann-streiff syndrome	Small hand	Occasional (29-5%)	GJA1	121014	234100	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
NA	microcephaly, growth failure and retinopathy	NA	NA	PLK4	No gene mim	616171	biallelic	confirmed	loss of function	Brain/Cognition;Eye	11397	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	arylsulfatase a deficiency	NA	NA	ARSA	607574	250100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	713	arylsulfatase A	protein-coding gene	gene with protein product	Approved	22q13.33	22q13.33		metachromatic leucodystrophy			Sulfatases
NA	neuronal ceroid lipofuscinosis type 3	NA	NA	CLN3	607042	204200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	2074	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	high bone mass trait	NA	NA	LRP5	603506	601884	monoallelic	confirmed	activating	Skeleton;Eye	6697	LDL receptor related protein 5	protein-coding gene	gene with protein product	Approved	11q13.2	11q13.2	LR3|BMND1|HBM|OPS|OPTA1|VBCH2|EVR4		LRP7|OPPG|EVR1	osteoporosis pseudoglioma syndrome|exudative vitreoretinopathy 1|low density lipoprotein receptor-related protein 5	Low density lipoprotein receptors
NA	speech-language disorder 1	NA	NA	FOXP2	605317	602081	monoallelic	probable	loss of function	Brain/Cognition	13875	forkhead box P2	protein-coding gene	gene with protein product	Approved	7q31.1	07q31.1	CAGH44	trinucleotide repeat containing 10|forkhead/winged-helix transcription factor|speech and language disorder 1|CAG repeat protein 44	TNRC10|SPCH1		Forkhead boxes|Trinucleotide repeat containing
NA	adams-oliver syndrome 2	NA	NA	DOCK6	614194	614219	biallelic	probable	loss of function	Skin;Skeleton	19189	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	parkinsonism-dystonia, infantile	NA	NA	SLC6A3	126455	319029	biallelic	confirmed	loss of function	Brain/Cognition	11049	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract posterior polar type 4	NA	NA	PITX3	602669	610623	monoallelic	confirmed	loss of function	Eye	9006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	CHAMP1	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	20311	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	xeroderma pigmentosum, group c	NA	NA	XPC	613208	278720	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton	12816	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	congenital primary aphakia	Abnormality of vision	Frequent (79-30%)	FOXE3	601094	610256	biallelic	confirmed	loss of function	Eye	3808	forkhead box E3	protein-coding gene	gene with protein product	Approved	1p33	01p33	FREAC8		FKHL12		Forkhead boxes
HP:0000568	congenital primary aphakia	Microphthalmia	Very frequent (99-80%)	FOXE3	601094	610256	biallelic	confirmed	loss of function	Eye	3808	forkhead box E3	protein-coding gene	gene with protein product	Approved	1p33	01p33	FREAC8		FKHL12		Forkhead boxes
HP:0000647	congenital primary aphakia	Sclerocornea	Frequent (79-30%)	FOXE3	601094	610256	biallelic	confirmed	loss of function	Eye	3808	forkhead box E3	protein-coding gene	gene with protein product	Approved	1p33	01p33	FREAC8		FKHL12		Forkhead boxes
HP:0007707	congenital primary aphakia	Congenital primary aphakia	Very frequent (99-80%)	FOXE3	601094	610256	biallelic	confirmed	loss of function	Eye	3808	forkhead box E3	protein-coding gene	gene with protein product	Approved	1p33	01p33	FREAC8		FKHL12		Forkhead boxes
HP:0007973	congenital primary aphakia	Retinal dysplasia	Frequent (79-30%)	FOXE3	601094	610256	biallelic	confirmed	loss of function	Eye	3808	forkhead box E3	protein-coding gene	gene with protein product	Approved	1p33	01p33	FREAC8		FKHL12		Forkhead boxes
HP:0008062	congenital primary aphakia	Aplasia/Hypoplasia affecting the anterior segment of the eye	Very frequent (99-80%)	FOXE3	601094	610256	biallelic	confirmed	loss of function	Eye	3808	forkhead box E3	protein-coding gene	gene with protein product	Approved	1p33	01p33	FREAC8		FKHL12		Forkhead boxes
NA	cleft lip +/- cleft palate	NA	NA	SUMO1	No gene mim	608874	monoallelic	possible	loss of function	Face	12502	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	stat1 deficiency complete	NA	NA	STAT1	600555	613796	biallelic	confirmed	loss of function	Bone Marrow/Immune	11362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neuronal ceroid lipofuscinosis type 8	NA	NA	CLN8	607837	600143	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2079	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dyskeratosis congenita, autosomal recessive 5	NA	NA	RTEL1	No gene mim	615190	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	15888	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia isolated type 7	NA	NA	GDF3	No gene mim	613704	monoallelic	possible	all missense/in frame	Skeleton;Eye	4218	growth differentiation factor 3	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31					Endogenous ligands
HP:0000003	mckusick-kaufman syndrome	Multicystic kidney dysplasia	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0000028	mckusick-kaufman syndrome	Cryptorchidism	Frequent (79-30%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0000126	mckusick-kaufman syndrome	Hydronephrosis	Frequent (79-30%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0000175	mckusick-kaufman syndrome	Cleft palate	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0000218	mckusick-kaufman syndrome	High palate	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0000807	mckusick-kaufman syndrome	Glandular hypospadias	Frequent (79-30%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001156	mckusick-kaufman syndrome	Brachydactyly syndrome	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001162	mckusick-kaufman syndrome	Postaxial hand polydactyly	Frequent (79-30%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001163	mckusick-kaufman syndrome	Abnormality of the metacarpal bones	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001249	mckusick-kaufman syndrome	Intellectual disability	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001263	mckusick-kaufman syndrome	Global developmental delay	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001508	mckusick-kaufman syndrome	Failure to thrive	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001629	mckusick-kaufman syndrome	Ventricular septal defect	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001631	mckusick-kaufman syndrome	Atrial septal defect	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001636	mckusick-kaufman syndrome	Tetralogy of Fallot	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001643	mckusick-kaufman syndrome	Patent ductus arteriosus	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0001830	mckusick-kaufman syndrome	Postaxial foot polydactyly	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0002023	mckusick-kaufman syndrome	Anal atresia	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0002251	mckusick-kaufman syndrome	Aganglionic megacolon	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0004322	mckusick-kaufman syndrome	Short stature	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0004383	mckusick-kaufman syndrome	Hypoplastic left heart	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0004397	mckusick-kaufman syndrome	Ectopic anus	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0006101	mckusick-kaufman syndrome	Finger syndactyly	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0008368	mckusick-kaufman syndrome	Tarsal synostosis	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0008678	mckusick-kaufman syndrome	Renal hypoplasia/aplasia	Very rare (<4-1%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0012227	mckusick-kaufman syndrome	Urethral stricture	Occasional (29-5%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0030010	mckusick-kaufman syndrome	Hydrometrocolpos	Very frequent (99-80%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
HP:0100779	mckusick-kaufman syndrome	Urogenital sinus anomaly	Frequent (79-30%)	MKKS	604896	236700	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
NA	acute liver failure (alf) in infancy and childhood	NA	NA	NBAS	No gene mim	No disease mim	biallelic	confirmed	loss of function		15625	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephrotic syndrome type 1	NA	NA	NPHS1	602716	256300	biallelic	confirmed	loss of function	Kidney Renal Tract	7908	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondyloepiphyseal dysplasia type kimberley	NA	NA	ACAN	No gene mim	608361	monoallelic	confirmed	loss of function	Skeleton	319	aggrecan	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	CSPGCP	aggrecan proteoglycan	MSK16|CSPG1|AGC1	chondroitin sulfate proteoglycan 1|aggrecan 1	Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing
NA	cataract zonular pulverulent type 1	NA	NA	GJA8	600897	116200	monoallelic	confirmed	uncertain	Eye	4281	gap junction protein alpha 8	protein-coding gene	gene with protein product	Approved	1q21.2	01q21.2	CX50	connexin 50	CAE1|CZP1|CAE	gap junction protein, alpha 8, 50kD (connexin 50)|gap junction protein, alpha 8, 50kDa (connexin 50)|gap junction protein, alpha 8, 50kDa	Gap junction proteins
NA	extreme myopia;myopia 23, autosomal recessive	NA	NA	LRPAP1	No gene mim	615431	biallelic	possible	loss of function	Eye	6701	LDL receptor related protein associated protein 1	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	HBP44		A2MRAP|RAP	low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1)|low density lipoprotein receptor-related protein associated protein 1	
NA	epileptic encephalopathy	NA	NA	FLNA	300017	No disease mim	x-linked dominant	confirmed	all missense/in frame	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
NA	kanzaki disease	NA	NA	NAGA	104170	609242	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7631	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy, early infantile, 12	NA	NA	PLCB1	No gene mim	613722	biallelic	probable	loss of function	Brain/Cognition	15917	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hemolytic anemia due to umph1 deficiency	NA	NA	NT5C3A	606224	266120	biallelic	confirmed	loss of function	Bone Marrow/Immune	17820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	corneal dystrophy, fuchs endothelial, 4	NA	NA	SLC4A11	No gene mim	613268	biallelic	both DD and IF	loss of function	Eye	16438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked arx-related	NA	NA	ARX	300382	300419	hemizygous	confirmed	loss of function	Brain/Cognition;Genitalia	18060	aristaless related homeobox	protein-coding gene	gene with protein product	Approved	Xp21.3	Xp21.3	ISSX|CT121|EIEE1	cancer/testis antigen 121	MRXS1|PRTS|MRX76|MRX54|MRX43|MRX36|MRX29|MRX32|MRX33|MRX38|MRX87	mental retardation, X-linked 54|mental retardation, X-linked 43|mental retardation, X-linked 36|mental retardation, X-linked 29|mental retardation, X-linked 32|mental retardation, X-linked 33|mental retardation, X-linked 38|mental retardation, X-linked 87|mental retardation, X-linked 76	X-linked mental retardation|PRD class homeoboxes and pseudogenes
NA	coffin siris	NA	NA	SMARCA2	600014	135900	monoallelic	confirmed	all missense/in frame	Skin;Skeleton;Brain/Cognition	11098	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked type 1	NA	NA	IQSEC2	300522	309530	hemizygous	confirmed	all missense/in frame	Brain/Cognition	29059	IQ motif and Sec7 domain 2	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	KIAA0522		MRX1|MRX78|MRX18	mental retardation, X-linked 1 (non-dysmorphic)|mental retardation, X-linked 78|mental retardation, X-linked 18	X-linked mental retardation
NA	microphthalmia with cataracts and iris abnormalities	NA	NA	VSX2	142993	610092	biallelic	confirmed	uncertain	Eye	1975	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	senior-loken syndrome type 6	NA	NA	CEP290	610142	610189	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition	29021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ck syndrome	NA	NA	NSDHL	300275	300831	hemizygous	confirmed	loss of function	Skin;Skeleton	13398	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	myasthenic syndrome, congenital, with tubular aggregates 2	NA	NA	DPAGT1	191350	614750	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nemaline myopathy 6	NA	NA	KBTBD13	613727	609273	monoallelic	confirmed	all missense/in frame	Musculature	37227	kelch repeat and BTB domain containing 13	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	hCG_1645727|NEM6	nemaline myopathy type 6		kelch repeat and BTB (POZ) domain containing 13	BTB domain containing
NA	pierre robin sequence	NA	NA	SOX9	608160	No disease mim	monoallelic	confirmed	cis-regulatory or promotor mutation	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	osteopathia striata with cranial sclerosis	NA	NA	AMER1	No gene mim	300373	monoallelic	both DD and IF	loss of function	Face;Skeleton	26837	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	auriculocondylar syndrome	NA	NA	PLCB4	600810	602483	monoallelic	probable	all missense/in frame	Face;Ear	9059	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal dominant partial epilepsy with auditory features	NA	NA	LGI1	No gene mim	600512	monoallelic	possible	loss of function	Brain/Cognition	6572	leucine rich glioma inactivated 1	protein-coding gene	gene with protein product	Approved	10q23.33	10q23.33	IB1099|ETL1|EPITEMPIN		EPT	epilepsy, partial	
NA	nephronophthisis 9	NA	NA	NEK8	No gene mim	613824	biallelic	probable	all missense/in frame	Kidney Renal Tract;GI tract;Heart/Cardiovasculature/Lymphatic	13387	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	left ventricular non-compaction type 3	NA	NA	LDB3	No gene mim	601493	monoallelic	both DD and IF	all missense/in frame	Musculature;Heart/Cardiovasculature/Lymphatic	15710	LIM domain binding 3	protein-coding gene	gene with protein product	Approved	10q23.2	10q23.2	PDLIM6|KIAA0613|ZASP	cypher|oracle|Z-band alternatively spliced PDZ motif protein	CMD1C	cardiomyopathy, dilated 1C (autosomal dominant)	LIM domain containing|PDZ domain containing
HP:0000470	spondyloepiphyseal dysplasia tarda	Short neck	Frequent (79-30%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000926	spondyloepiphyseal dysplasia tarda	Platyspondyly	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001552	spondyloepiphyseal dysplasia tarda	Barrel-shaped chest	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	spondyloepiphyseal dysplasia tarda	Scoliosis	Frequent (79-30%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002655	spondyloepiphyseal dysplasia tarda	Spondyloepiphyseal dysplasia	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002758	spondyloepiphyseal dysplasia tarda	Osteoarthritis	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002812	spondyloepiphyseal dysplasia tarda	Coxa vara	Frequent (79-30%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002829	spondyloepiphyseal dysplasia tarda	Arthralgia	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002866	spondyloepiphyseal dysplasia tarda	Hypoplastic iliac wing	Frequent (79-30%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002938	spondyloepiphyseal dysplasia tarda	Lumbar hyperlordosis	Frequent (79-30%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002942	spondyloepiphyseal dysplasia tarda	Thoracic kyphosis	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003311	spondyloepiphyseal dysplasia tarda	Hypoplasia of the odontoid process	Frequent (79-30%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003498	spondyloepiphyseal dysplasia tarda	Disproportionate short stature	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	spondyloepiphyseal dysplasia tarda	Abnormality of epiphysis morphology	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008843	spondyloepiphyseal dysplasia tarda	Hip osteoarthritis	Frequent (79-30%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009824	spondyloepiphyseal dysplasia tarda	Upper limb undergrowth	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010306	spondyloepiphyseal dysplasia tarda	Short thorax	Very frequent (99-80%)	TRAPPC2	300202	313400	hemizygous	confirmed	loss of function	Skeleton	23068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pure hair and nail ectodermal dysplasia	NA	NA	HOXC13	142976	614931	biallelic	confirmed	loss of function	Hair/Nails	5125	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	meier-gorlin syndrome 5	NA	NA	CDC6	602627	613805	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear	1744	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mainzer-saldino syndrome	NA	NA	IFT140	614620	266920	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	29077	intraflagellar transport 140	protein-coding gene	gene with protein product	Approved	16p13.3	16p13.3	gs114|KIAA0590		WDTC2	WD and tetratricopeptide repeats 2|intraflagellar transport 140 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
NA	hyperphosphatasia with mental retardation	NA	NA	PIGV	610274	239300	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	26031	phosphatidylinositol glycan anchor biosynthesis class V	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	FLJ20477	GPI mannosyltransferase 2|dol-P-Man dependent GPI mannosyltransferase		phosphatidylinositol glycan, class V	Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis
NA	cleft lip +/- cleft palate	NA	NA	MSX1	142983	608874	monoallelic	confirmed	loss of function	Face	7391	msh homeobox 1	protein-coding gene	gene with protein product	Approved	4p16.2	04p16.2	HYD1|OFC5		HOX7	msh (Drosophila) homeo box homolog 1 (formerly homeo box 7)|msh homeobox homolog 1 (Drosophila)	NKL subclass homeoboxes and pseudogenes
NA	schaaf-yang syndrome	NA	NA	MAGEL2	No gene mim	No disease mim	imprinted	confirmed	loss of function	Brain/Cognition	6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
NA	tubular-aggregate myopathy	NA	NA	STIM1	No gene mim	160565	monoallelic	possible	activating	Musculature	11386	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glut1 deficiency syndrome type 1	NA	NA	SLC2A1	138140	606777	monoallelic	confirmed	loss of function	Brain/Cognition	11005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000055	ablepharon macrostomia syndrome	Abnormality of female external genitalia	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000062	ablepharon macrostomia syndrome	Ambiguous genitalia	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	ablepharon macrostomia syndrome	Wide mouth	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000233	ablepharon macrostomia syndrome	Thin vermilion border	Occasional (29-5%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	ablepharon macrostomia syndrome	Hypoplasia of the maxilla	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	ablepharon macrostomia syndrome	Hearing impairment	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000413	ablepharon macrostomia syndrome	Atresia of the external auditory canal	Occasional (29-5%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000430	ablepharon macrostomia syndrome	Underdeveloped nasal alae	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	ablepharon macrostomia syndrome	Anteverted nares	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	ablepharon macrostomia syndrome	Visual impairment	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	ablepharon macrostomia syndrome	Myopia	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000561	ablepharon macrostomia syndrome	Absent eyelashes	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000691	ablepharon macrostomia syndrome	Microdontia	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000750	ablepharon macrostomia syndrome	Delayed speech and language development	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000958	ablepharon macrostomia syndrome	Dry skin	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000963	ablepharon macrostomia syndrome	Thin skin	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001000	ablepharon macrostomia syndrome	Abnormality of skin pigmentation	Occasional (29-5%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001126	ablepharon macrostomia syndrome	Cryptophthalmos	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	ablepharon macrostomia syndrome	Global developmental delay	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	ablepharon macrostomia syndrome	Growth delay	Occasional (29-5%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	ablepharon macrostomia syndrome	Umbilical hernia	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001539	ablepharon macrostomia syndrome	Omphalocele	Occasional (29-5%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	ablepharon macrostomia syndrome	Redundant skin	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001770	ablepharon macrostomia syndrome	Toe syndactyly	Occasional (29-5%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002213	ablepharon macrostomia syndrome	Fine hair	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002223	ablepharon macrostomia syndrome	Absent eyebrow	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003187	ablepharon macrostomia syndrome	Breast hypoplasia	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	ablepharon macrostomia syndrome	Depressed nasal bridge	Occasional (29-5%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006709	ablepharon macrostomia syndrome	Aplasia/Hypoplasia of the nipples	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007392	ablepharon macrostomia syndrome	Excessive wrinkled skin	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007957	ablepharon macrostomia syndrome	Corneal opacity	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008070	ablepharon macrostomia syndrome	Sparse hair	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008551	ablepharon macrostomia syndrome	Microtia	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	ablepharon macrostomia syndrome	Hypoplasia of penis	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010669	ablepharon macrostomia syndrome	Cheekbone underdevelopment	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010720	ablepharon macrostomia syndrome	Abnormal hair pattern	Occasional (29-5%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011224	ablepharon macrostomia syndrome	Ablepharon	Very frequent (99-80%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	ablepharon macrostomia syndrome	Camptodactyly of finger	Frequent (79-30%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200020	ablepharon macrostomia syndrome	Corneal erosion	Occasional (29-5%)	TWIST2	607556	200110	monoallelic	confirmed	dominant negative		20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ectodermal dysplasia/short stature syndrome	NA	NA	GRHL2	No gene mim	616029	biallelic	probable	all missense/in frame	Skin;Skeleton	2799	grainyhead like transcription factor 2	protein-coding gene	gene with protein product	Approved	8q22.3	08q22.3	FLJ13782|BOM		DFNA28|TFCP2L3	deafness, autosomal dominant 28|transcription factor CP2-like 3|grainyhead-like 2 (Drosophila)	Deafness associated genes
NA	3-hydroxyacyl-coenzyme a dehydrogenase deficiency	NA	NA	HADH	No gene mim	231530	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4799	hydroxyacyl-CoA dehydrogenase	protein-coding gene	gene with protein product	Approved	4q25	04q25	HADH1|SCHAD		HADHSC	L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain|hydroxyacyl-Coenzyme A dehydrogenase	
NA	autosomal recessive mental retardation	NA	NA	PRRT2	614386	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	30500	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acromesomelic chondrodysplasia grebe type	NA	NA	GDF5	601146	200700	biallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
NA	subcortical band heterotopia	NA	NA	PAFAH1B1	601545	607432	monoallelic	confirmed	loss of function	Brain/Cognition	8574	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001399	ornithine transcarbamylase deficiency	Hepatic failure	Very frequent (99-80%)	OTC	300461	311250	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8512	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	ornithine transcarbamylase deficiency	Splenomegaly	Very frequent (99-80%)	OTC	300461	311250	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8512	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	ornithine transcarbamylase deficiency	Hypoglycemia	Very frequent (99-80%)	OTC	300461	311250	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8512	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001987	ornithine transcarbamylase deficiency	Hyperammonemia	Very frequent (99-80%)	OTC	300461	311250	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8512	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002021	ornithine transcarbamylase deficiency	Pyloric stenosis	Very frequent (99-80%)	OTC	300461	311250	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8512	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003355	ornithine transcarbamylase deficiency	Aminoaciduria	Very frequent (99-80%)	OTC	300461	311250	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8512	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	inherited skin fragility	NA	NA	EXPH5	612878	615028	biallelic	probable	loss of function	Skin	30578	exophilin 5	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	SLAC2-B	synaptotagmin-like homologue lacking C2 domains b			
NA	corneal dystrophy fuchs endothelial type 6	NA	NA	ZEB1	No gene mim	613270	monoallelic	possible	loss of function	Eye	11642	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract, coppock-like	NA	NA	CRYBB2	123620	604307	monoallelic	confirmed	loss of function	Eye	2398	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	growth hormone insensitivity with immunodeficiency	NA	NA	STAT5B	No gene mim	245590	biallelic	probable	loss of function	Endocrine/Metabolic	11367	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	townes-brocks syndrome	Cryptorchidism	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	townes-brocks syndrome	Hypospadias	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000048	townes-brocks syndrome	Bifid scrotum	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	townes-brocks syndrome	Vesicoureteral reflux	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000077	townes-brocks syndrome	Abnormality of the kidney	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000083	townes-brocks syndrome	Renal insufficiency	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000086	townes-brocks syndrome	Ectopic kidney	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000089	townes-brocks syndrome	Renal hypoplasia	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000130	townes-brocks syndrome	Abnormality of the uterus	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000142	townes-brocks syndrome	Abnormality of the vagina	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000143	townes-brocks syndrome	Rectovaginal fistula	Very frequent (99-80%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	townes-brocks syndrome	Wide mouth	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000324	townes-brocks syndrome	Facial asymmetry	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	townes-brocks syndrome	Hearing impairment	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000384	townes-brocks syndrome	Preauricular skin tag	Very frequent (99-80%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000396	townes-brocks syndrome	Overfolded helix	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	townes-brocks syndrome	Strabismus	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	townes-brocks syndrome	Abnormality of vision	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	townes-brocks syndrome	Cataract	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000567	townes-brocks syndrome	Chorioretinal coloboma	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	townes-brocks syndrome	Microphthalmia	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000581	townes-brocks syndrome	Blepharophimosis	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	townes-brocks syndrome	Iris coloboma	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	townes-brocks syndrome	Abnormality of the ribs	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000821	townes-brocks syndrome	Hypothyroidism	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	townes-brocks syndrome	Delayed puberty	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001140	townes-brocks syndrome	Epibulbar dermoid	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001177	townes-brocks syndrome	Preaxial hand polydactyly	Very frequent (99-80%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001199	townes-brocks syndrome	Triphalangeal thumb	Very frequent (99-80%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	townes-brocks syndrome	Intellectual disability	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001274	townes-brocks syndrome	Agenesis of corpus callosum	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001482	townes-brocks syndrome	Subcutaneous nodule	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	townes-brocks syndrome	Failure to thrive	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001545	townes-brocks syndrome	Anteriorly placed anus	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001631	townes-brocks syndrome	Atrial septal defect	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	townes-brocks syndrome	Tetralogy of Fallot	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001641	townes-brocks syndrome	Abnormality of the pulmonary valve	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	townes-brocks syndrome	Patent ductus arteriosus	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001671	townes-brocks syndrome	Abnormality of the cardiac septa	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001760	townes-brocks syndrome	Abnormality of the foot	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	townes-brocks syndrome	Pes planus	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001770	townes-brocks syndrome	Toe syndactyly	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001863	townes-brocks syndrome	Toe clinodactyly	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	townes-brocks syndrome	Constipation	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002023	townes-brocks syndrome	Anal atresia	Very frequent (99-80%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002308	townes-brocks syndrome	Arnold-Chiari malformation	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	townes-brocks syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002607	townes-brocks syndrome	Bowel incontinence	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003468	townes-brocks syndrome	Abnormality of the vertebrae	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	townes-brocks syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	townes-brocks syndrome	Short stature	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004792	townes-brocks syndrome	Rectoperineal fistula	Very frequent (99-80%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005562	townes-brocks syndrome	Multiple renal cysts	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006824	townes-brocks syndrome	Cranial nerve paralysis	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008551	townes-brocks syndrome	Microtia	Frequent (79-30%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008572	townes-brocks syndrome	External ear malformation	Very frequent (99-80%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	townes-brocks syndrome	Hypoplasia of penis	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009465	townes-brocks syndrome	Ulnar deviation of finger	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009912	townes-brocks syndrome	Abnormality of the tragus	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009944	townes-brocks syndrome	Partial duplication of thumb phalanx	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010059	townes-brocks syndrome	Broad hallux phalanx	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010331	townes-brocks syndrome	Aplasia/Hypoplasia of the 3rd toe	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010481	townes-brocks syndrome	Urethral valve	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010760	townes-brocks syndrome	Absent toe	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011304	townes-brocks syndrome	Broad thumb	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100559	townes-brocks syndrome	Lower limb asymmetry	Occasional (29-5%)	SALL1	602218	107480	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract;Ear	10524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	retinitis pigmentosa 57	NA	NA	PDE6G	180073	613582	biallelic	confirmed	loss of function	Eye	8789	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	renal-hepatic-pancreatic dysplasia 2	NA	NA	NEK8	No gene mim	615415	biallelic	probable	loss of function	Kidney Renal Tract;GI tract;Heart/Cardiovasculature/Lymphatic	13387	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hemorrhagic destruction of the brain, subependymal calcification, and cataracts	NA	NA	JAM3	606871	613730	biallelic	probable	loss of function	Brain/Cognition;Eye	15532	junctional adhesion molecule 3	protein-coding gene	gene with protein product	Approved	11q25	11q25	JAM-C|JAMC				V-set domain containing|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
NA	congenital contractures of the limbs and face, hypotonia, and developmental delay	NA	NA	NALCN	No gene mim	616266	monoallelic	confirmed	all missense/in frame	Skeleton;Brain/Cognition	19082	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	alopecia and t-cell immunodeficiency	NA	NA	FOXN1	600838	601705	biallelic	confirmed	loss of function	Bone Marrow/Immune;Hair/Nails	12765	forkhead box N1	protein-coding gene	gene with protein product	Approved	17q11.2	17q11.2	FKHL20		WHN|RONU	winged-helix nude|Rowett nude	Forkhead boxes
HP:0000239	occipital horn syndrome	Large fontanelles	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000270	occipital horn syndrome	Delayed cranial suture closure	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000271	occipital horn syndrome	Abnormality of the face	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000929	occipital horn syndrome	Abnormality of the skull	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000974	occipital horn syndrome	Hyperextensible skin	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001249	occipital horn syndrome	Intellectual disability	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001263	occipital horn syndrome	Global developmental delay	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001328	occipital horn syndrome	Specific learning disability	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002514	occipital horn syndrome	Cerebral calcification	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0005692	occipital horn syndrome	Joint hyperflexibility	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100777	occipital horn syndrome	Exostoses	Very frequent (99-80%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000343	occipital horn syndrome	Long philtrum	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000767	occipital horn syndrome	Pectus excavatum	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000768	occipital horn syndrome	Pectus carinatum	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000926	occipital horn syndrome	Platyspondyly	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000938	occipital horn syndrome	Osteopenia	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000939	occipital horn syndrome	Osteoporosis	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000952	occipital horn syndrome	Jaundice	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000978	occipital horn syndrome	Bruising susceptibility	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000987	occipital horn syndrome	Atypical scarring of skin	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001156	occipital horn syndrome	Brachydactyly syndrome	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001252	occipital horn syndrome	Muscular hypotonia	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001396	occipital horn syndrome	Cholestasis	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002015	occipital horn syndrome	Dysphagia	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002020	occipital horn syndrome	Gastroesophageal reflux	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002033	occipital horn syndrome	Poor suck	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002036	occipital horn syndrome	Hiatus hernia	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002045	occipital horn syndrome	Hypothermia	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002578	occipital horn syndrome	Gastroparesis	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002617	occipital horn syndrome	Aneurysm	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002705	occipital horn syndrome	High, narrow palate	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002748	occipital horn syndrome	Rickets	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002749	occipital horn syndrome	Osteomalacia	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0003019	occipital horn syndrome	Abnormality of the wrist	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0004279	occipital horn syndrome	Short palm	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0004408	occipital horn syndrome	Abnormality of the sense of smell	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0005293	occipital horn syndrome	Venous insufficiency	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0010562	occipital horn syndrome	Keloids	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0012115	occipital horn syndrome	Hepatitis	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0025270	occipital horn syndrome	Abnormality of esophagus physiology	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100240	occipital horn syndrome	Synostosis of joints	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100633	occipital horn syndrome	Esophagitis	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100699	occipital horn syndrome	Scarring	Frequent (79-30%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000010	occipital horn syndrome	Recurrent urinary tract infections	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000015	occipital horn syndrome	Bladder diverticulum	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000023	occipital horn syndrome	Inguinal hernia	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000348	occipital horn syndrome	High forehead	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000494	occipital horn syndrome	Downslanted palpebral fissures	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000774	occipital horn syndrome	Narrow chest	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001385	occipital horn syndrome	Hip dysplasia	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001763	occipital horn syndrome	Pes planus	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002208	occipital horn syndrome	Coarse hair	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002650	occipital horn syndrome	Scoliosis	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002673	occipital horn syndrome	Coxa valga	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002797	occipital horn syndrome	Osteolysis	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002808	occipital horn syndrome	Kyphosis	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002812	occipital horn syndrome	Coxa vara	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002827	occipital horn syndrome	Hip dislocation	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002857	occipital horn syndrome	Genu valgum	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002991	occipital horn syndrome	Abnormality of the fibula	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0003172	occipital horn syndrome	Abnormality of the pubic bone	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0003874	occipital horn syndrome	Humerus varus	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0005743	occipital horn syndrome	Avascular necrosis of the capital femoral epiphysis	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0006507	occipital horn syndrome	Aplasia/hypoplasia of the humerus	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0006660	occipital horn syndrome	Aplastic clavicles	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0008818	occipital horn syndrome	Large iliac wings	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0009556	occipital horn syndrome	Absent tibia	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100541	occipital horn syndrome	Femoral hernia	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100874	occipital horn syndrome	Thick hair	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0200021	occipital horn syndrome	Down-sloping shoulders	Occasional (29-5%)	ATP7A	300011	304150	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
NA	bardet-biedl syndrome type 10	NA	NA	BBS10	610148	209900	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	26291	Bardet-Biedl syndrome 10	protein-coding gene	gene with protein product	Approved	12q21.2	12q21.2	FLJ23560		C12orf58	chromosome 12 open reading frame 58	Chaperonins|Bardet-Biedl syndrome associated
NA	infantile hypertrophic cardiomyopathy and lactic acidosis	NA	NA	MTO1	614667	614702	biallelic	confirmed	loss of function	Endocrine/Metabolic;Heart/Cardiovasculature/Lymphatic	19261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	growth retardation developmental delay coarse facies and early death	NA	NA	FTO	No gene mim	612938	biallelic	possible	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Genitalia;Heart/Cardiovasculature/Lymphatic	24678	FTO, alpha-ketoglutarate dependent dioxygenase	protein-coding gene	gene with protein product	Approved	16q12.2	16q12.2	KIAA1752|MGC5149|ALKBH9	alkB homolog 9|alpha-ketoglutarate-dependent dioxygenase		fat mass and obesity associated	Alkylation repair homologs
HP:0000093	gaucher disease type 1	Proteinuria	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000225	gaucher disease type 1	Gingival bleeding	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000790	gaucher disease type 1	Hematuria	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000823	gaucher disease type 1	Delayed puberty	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000938	gaucher disease type 1	Osteopenia	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000978	gaucher disease type 1	Bruising susceptibility	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001394	gaucher disease type 1	Cirrhosis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001510	gaucher disease type 1	Growth delay	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001541	gaucher disease type 1	Ascites	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001637	gaucher disease type 1	Abnormality of the myocardium	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001698	gaucher disease type 1	Pericardial effusion	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001744	gaucher disease type 1	Splenomegaly	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001873	gaucher disease type 1	Thrombocytopenia	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001876	gaucher disease type 1	Pancytopenia	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001882	gaucher disease type 1	Leukopenia	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001903	gaucher disease type 1	Anemia	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001971	gaucher disease type 1	Hypersplenism	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002027	gaucher disease type 1	Abdominal pain	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002039	gaucher disease type 1	Anorexia	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002092	gaucher disease type 1	Pulmonary arterial hypertension	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002240	gaucher disease type 1	Hepatomegaly	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002653	gaucher disease type 1	Bone pain	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002750	gaucher disease type 1	Delayed skeletal maturation	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002756	gaucher disease type 1	Pathologic fracture	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002758	gaucher disease type 1	Osteoarthritis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002797	gaucher disease type 1	Osteolysis	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002808	gaucher disease type 1	Kyphosis	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002953	gaucher disease type 1	Vertebral compression fractures	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0005230	gaucher disease type 1	Biliary tract obstruction	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0006530	gaucher disease type 1	Interstitial pulmonary disease	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0010702	gaucher disease type 1	Increased antibody level in blood	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0010741	gaucher disease type 1	Edema of the lower limbs	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0010885	gaucher disease type 1	Aseptic necrosis	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0011001	gaucher disease type 1	Increased bone mineral density	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
NA	desbuquois dysplasia 2	NA	NA	XYLT1	No gene mim	615777	biallelic	confirmed	loss of function	Skeleton	15516	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple pterygium syndrome escobar variant	NA	NA	CHRNG	No gene mim	265000	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves	1967	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	temtamy preaxial brachydactyly syndrome	NA	NA	CHSY1	608183	605282	biallelic	confirmed	loss of function	Skeleton	17198	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy congenital with mental retardation type b2	NA	NA	POMT2	607439	613156	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	19743	protein O-mannosyltransferase 2	protein-coding gene	gene with protein product	Approved	14q24.3	14q24.3	LGMD2N	Dolichyl-phosphate-mannose--protein mannosyltransferase			Dolichyl D-mannosyl phosphate dependent mannosyltransferases
NA	symphalangism proximal syndrome	NA	NA	NOG	602991	185800	monoallelic	confirmed	loss of function	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	goldberg-shprintzen megacolon syndrome	Hypospadias	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000048	goldberg-shprintzen megacolon syndrome	Bifid scrotum	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000175	goldberg-shprintzen megacolon syndrome	Cleft palate	Very frequent (99-80%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000252	goldberg-shprintzen megacolon syndrome	Microcephaly	Very frequent (99-80%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000307	goldberg-shprintzen megacolon syndrome	Pointed chin	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000316	goldberg-shprintzen megacolon syndrome	Hypertelorism	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000340	goldberg-shprintzen megacolon syndrome	Sloping forehead	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000400	goldberg-shprintzen megacolon syndrome	Macrotia	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000431	goldberg-shprintzen megacolon syndrome	Wide nasal bridge	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000508	goldberg-shprintzen megacolon syndrome	Ptosis	Frequent (79-30%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000535	goldberg-shprintzen megacolon syndrome	Sparse eyebrow	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0000612	goldberg-shprintzen megacolon syndrome	Iris coloboma	Frequent (79-30%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0001249	goldberg-shprintzen megacolon syndrome	Intellectual disability	Very frequent (99-80%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0001250	goldberg-shprintzen megacolon syndrome	Seizures	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0001252	goldberg-shprintzen megacolon syndrome	Muscular hypotonia	Frequent (79-30%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0001302	goldberg-shprintzen megacolon syndrome	Pachygyria	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0001328	goldberg-shprintzen megacolon syndrome	Specific learning disability	Very frequent (99-80%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0002079	goldberg-shprintzen megacolon syndrome	Hypoplasia of the corpus callosum	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0002119	goldberg-shprintzen megacolon syndrome	Ventriculomegaly	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0002209	goldberg-shprintzen megacolon syndrome	Sparse scalp hair	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0002251	goldberg-shprintzen megacolon syndrome	Aganglionic megacolon	Very frequent (99-80%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0004322	goldberg-shprintzen megacolon syndrome	Short stature	Very frequent (99-80%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
HP:0006101	goldberg-shprintzen megacolon syndrome	Finger syndactyly	Occasional (29-5%)	KIF1BP	No gene mim	609460	biallelic	confirmed	loss of function	Brain/Cognition;GI tract	23419	KIF1 binding protein	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	DKFZP586B0923|TTC20|KBP	kinesin binding protein	KIAA1279	KIAA1279	Tetratricopeptide repeat domain containing
NA	mainzer-saldino syndrome	NA	NA	IFT172	No gene mim	266920	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
NA	meckel syndrome, type 6	NA	NA	CC2D2A	612013	612284	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;GI tract	29253	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation-truncal obesity-retinal dystrophy-micropenis	NA	NA	INPP5E	613037	610156	biallelic	confirmed	loss of function	Brain/Cognition;Eye;Genitalia	21474	inositol polyphosphate-5-phosphatase E	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3	PPI5PIV|CORS1|pharbin		JBTS1	Joubert syndrome 1|inositol polyphosphate-5-phosphatase, 72 kDa	Phosphoinositide phosphatases
NA	sinoatrial node dysfunction and deafness	NA	NA	CACNA1D	No gene mim	614896	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	1391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cleft palate isolated	NA	NA	SATB2	608148	119540	monoallelic	confirmed	loss of function	Face;Brain/Cognition	21637	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atrioventricular septal defect 5	NA	NA	GATA6	601656	614474	monoallelic	confirmed	all missense/in frame	Heart/Cardiovasculature/Lymphatic	4174	GATA binding protein 6	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2				GATA-binding protein 6	GATA zinc finger domain containing
NA	hyperimmunoglobulin e recurrent infection syndrome autosomal recessive	NA	NA	DOCK8	No gene mim	243700	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	19191	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000010	hereditary folate malabsorption	Recurrent urinary tract infections	Occasional (29-5%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000206	hereditary folate malabsorption	Glossitis	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	hereditary folate malabsorption	Behavioral abnormality	Frequent (79-30%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000980	hereditary folate malabsorption	Pallor	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	hereditary folate malabsorption	Seizures	Frequent (79-30%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	hereditary folate malabsorption	Global developmental delay	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001347	hereditary folate malabsorption	Hyperreflexia	Occasional (29-5%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	hereditary folate malabsorption	Failure to thrive	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	hereditary folate malabsorption	Thrombocytopenia	Occasional (29-5%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001876	hereditary folate malabsorption	Pancytopenia	Occasional (29-5%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001880	hereditary folate malabsorption	Eosinophilia	Occasional (29-5%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001889	hereditary folate malabsorption	Megaloblastic anemia	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002014	hereditary folate malabsorption	Diarrhea	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002017	hereditary folate malabsorption	Nausea and vomiting	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	hereditary folate malabsorption	Gastroesophageal reflux	Frequent (79-30%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002039	hereditary folate malabsorption	Anorexia	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	hereditary folate malabsorption	Recurrent respiratory infections	Occasional (29-5%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002514	hereditary folate malabsorption	Cerebral calcification	Occasional (29-5%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002715	hereditary folate malabsorption	Abnormality of the immune system	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002721	hereditary folate malabsorption	Immunodeficiency	Occasional (29-5%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	hereditary folate malabsorption	Skeletal muscle atrophy	Occasional (29-5%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004313	hereditary folate malabsorption	Decreased antibody level in blood	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009830	hereditary folate malabsorption	Peripheral neuropathy	Frequent (79-30%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	hereditary folate malabsorption	Abnormality of movement	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100825	hereditary folate malabsorption	Cheilitis	Very frequent (99-80%)	SLC46A1	611672	229050	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	30521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dystrophia myotonica type 1	NA	NA	DMPK	605377	160900	monoallelic	confirmed	dominant negative	Musculature;Endocrine/Metabolic;Eye	2933	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	aspartylglucosaminuria	Inguinal hernia	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000053	aspartylglucosaminuria	Macroorchidism	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000158	aspartylglucosaminuria	Macroglossia	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	aspartylglucosaminuria	Abnormality of the teeth	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000212	aspartylglucosaminuria	Gingival overgrowth	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	aspartylglucosaminuria	Coarse facial features	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	aspartylglucosaminuria	Mandibular prognathia	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	aspartylglucosaminuria	Hypertelorism	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000389	aspartylglucosaminuria	Chronic otitis media	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	aspartylglucosaminuria	Wide nasal bridge	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	aspartylglucosaminuria	Carious teeth	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	aspartylglucosaminuria	Behavioral abnormality	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000750	aspartylglucosaminuria	Delayed speech and language development	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	aspartylglucosaminuria	Pectus carinatum	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	aspartylglucosaminuria	Intellectual disability	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	aspartylglucosaminuria	Seizures	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001369	aspartylglucosaminuria	Arthritis	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	aspartylglucosaminuria	Joint stiffness	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	aspartylglucosaminuria	Umbilical hernia	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	aspartylglucosaminuria	Splenomegaly	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	aspartylglucosaminuria	Pes planus	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001999	aspartylglucosaminuria	Abnormal facial shape	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	aspartylglucosaminuria	Malabsorption	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	aspartylglucosaminuria	Neurological speech impairment	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	aspartylglucosaminuria	Recurrent respiratory infections	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	aspartylglucosaminuria	Hepatomegaly	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002360	aspartylglucosaminuria	Sleep disturbance	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	aspartylglucosaminuria	Scoliosis	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002684	aspartylglucosaminuria	Thickened calvaria	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	aspartylglucosaminuria	Delayed skeletal maturation	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002997	aspartylglucosaminuria	Abnormality of the ulna	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003103	aspartylglucosaminuria	Abnormal cortical bone morphology	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	aspartylglucosaminuria	Short nose	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003468	aspartylglucosaminuria	Abnormality of the vertebrae	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004337	aspartylglucosaminuria	Abnormality of amino acid metabolism	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004568	aspartylglucosaminuria	Beaking of vertebral bodies	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008430	aspartylglucosaminuria	Anterior beaking of lumbar vertebrae	Frequent (79-30%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008551	aspartylglucosaminuria	Microtia	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011276	aspartylglucosaminuria	Vascular skin abnormality	Occasional (29-5%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012068	aspartylglucosaminuria	Aspartylglucosaminuria	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012471	aspartylglucosaminuria	Thick vermilion border	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100660	aspartylglucosaminuria	Dyskinesia	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100729	aspartylglucosaminuria	Large face	Very frequent (99-80%)	AGA	613228	208400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of siemens-like	NA	NA	CSTA	184600	607936	biallelic	probable	loss of function	Skin	2481	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	anemia, sideroblastic, pyridoxine-refractory, autosomal recessive	NA	NA	SLC25A38	610819	205950	biallelic	confirmed	loss of function	Bone Marrow/Immune	26054	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive otospondylomegaepiphyseal dysplasia	NA	NA	COL11A2	120290	215150	biallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	split hand and foot malformation	NA	NA	DLX5	No gene mim	220600	biallelic	possible	all missense/in frame	Skeleton	2918	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	BRCA1	No gene mim	No disease mim	biallelic	both DD and IF	loss of function	Brain/Cognition	1100	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	arterial calcification, generalized, of infancy, 2	NA	NA	ABCC6	603234	614473	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	57	ATP binding cassette subfamily C member 6	protein-coding gene	gene with protein product	Approved	16p13.11	16p13.11	MRP6|EST349056|MLP1|URG7		ARA|PXE	pseudoxanthoma elasticum|ATP-binding cassette, sub-family C (CFTR/MRP), member 6	ATP binding cassette subfamily C
NA	fragile x-e mental retardation syndrome	NA	NA	AFF2	300806	309548	hemizygous	confirmed	loss of function	Brain/Cognition	3776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	boomerang dysplasia	Cryptorchidism	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0000774	boomerang dysplasia	Narrow chest	Very frequent (99-80%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0000824	boomerang dysplasia	Growth hormone deficiency	Very frequent (99-80%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0001163	boomerang dysplasia	Abnormality of the metacarpal bones	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0001539	boomerang dysplasia	Omphalocele	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0001561	boomerang dysplasia	Polyhydramnios	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0001789	boomerang dysplasia	Hydrops fetalis	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0002818	boomerang dysplasia	Abnormality of the radius	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0002823	boomerang dysplasia	Abnormality of the femur	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0002983	boomerang dysplasia	Micromelia	Very frequent (99-80%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0002992	boomerang dysplasia	Abnormality of the tibia	Very frequent (99-80%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0002997	boomerang dysplasia	Abnormality of the ulna	Occasional (29-5%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0003063	boomerang dysplasia	Abnormality of the humerus	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0006101	boomerang dysplasia	Finger syndactyly	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0006492	boomerang dysplasia	Aplasia/Hypoplasia of the fibula	Very frequent (99-80%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0006703	boomerang dysplasia	Aplasia/Hypoplasia of the lungs	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0008890	boomerang dysplasia	Severe short-limb dwarfism	Very frequent (99-80%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0010318	boomerang dysplasia	Aplasia/Hypoplasia of the abdominal wall musculature	Frequent (79-30%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0011849	boomerang dysplasia	Abnormal bone ossification	Very frequent (99-80%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0100569	boomerang dysplasia	Abnormal vertebral ossification	Very frequent (99-80%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0100856	boomerang dysplasia	Poorly ossified vertebrae	Very frequent (99-80%)	FLNB	603381	112310	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
NA	combined oxidative phosphorylation deficiency 5	NA	NA	MRPS22	No gene mim	611719	biallelic	probable	all missense/in frame	Face;Endocrine/Metabolic;Brain/Cognition	14508	mitochondrial ribosomal protein S22	protein-coding gene	gene with protein product	Approved	3q23	03q23	MRP-S22|GK002|C3orf5|GIBT				Mitochondrial ribosomal proteins
NA	bosley-salih-alorainy syndrome	NA	NA	HOXA1	142955	601536	biallelic	confirmed	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5099	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	jervell and lange-nielsen syndrome type 2	NA	NA	KCNE1	No gene mim	612347	biallelic	both DD and IF	all missense/in frame	Ear;Heart/Cardiovasculature/Lymphatic	6240	potassium voltage-gated channel subfamily E regulatory subunit 1	protein-coding gene	gene with protein product	Approved	21q22.12	21q22.12	minK|ISK|JLNS2|LQT5			potassium voltage-gated channel, Isk-related family, member 1|potassium channel, voltage gated subfamily E regulatory beta subunit 1	Potassium voltage-gated channel regulatory subunits
NA	chudley-mccullough syndrome	NA	NA	GPSM2	609245	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition;Ear	29501	G protein signaling modulator 2	protein-coding gene	gene with protein product	Approved	1p13.3	01p13.3	LGN|Pins		DFNB82	G-protein signalling modulator 2 (AGS3-like, C. elegans)|deafness, autosomal recessive 82|G-protein signaling modulator 2	Tetratricopeptide repeat domain containing|Deafness associated genes
NA	baraitser-winter syndrome	NA	NA	ACTB	102630	No disease mim	monoallelic	confirmed	all missense/in frame	Brain/Cognition;Eye	132	actin beta	protein-coding gene	gene with protein product	Approved	7p22.1	07p22.1					Actins
NA	congenital cataract, corneal opacity, and developmental glaucoma	NA	NA	PXDN	No gene mim	No disease mim	biallelic	probable	loss of function	Eye	14966	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spinocerebellar ataxia 28	NA	NA	AFG3L2	No gene mim	610246	monoallelic	child IF	loss of function	Brain/Cognition	315	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	chondrodysplasia punctata 2, x-linked	NA	NA	EBP	300205	302960	x-linked dominant	confirmed	loss of function	Skeleton;Brain/Cognition	3133	emopamil binding protein (sterol isomerase)	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	CPX|CPXD|CHO2	3-beta-hydroxysteroid-delta-8,delta-7-isomerase|Chondrodysplasia punctata-2, X-linked dominant (Happle syndrome)|sterol 8-isomerase	CDPX2	emopamil-binding protein (sterol isomerase)	
NA	primary aldosteronism, seizures, and neurologic abnormalities	NA	NA	CACNA1D	No gene mim	615474	monoallelic	probable	activating	Endocrine/Metabolic;Brain/Cognition	1391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nakajo syndrome	NA	NA	PSMB8	177046	256040	biallelic	confirmed	all missense/in frame	Bone Marrow/Immune;Skeleton	9545	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hypotonia, infantile, with psychomotor retardation and characteristic facies	NA	NA	NALCN	No gene mim	615419	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	19082	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	ASCC3	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	18697	activating signal cointegrator 1 complex subunit 3	protein-coding gene	gene with protein product	Approved	6q16.3	06q16.3	RNAH|ASC1p200|dJ121G13.4|dJ467N11.1	RNA helicase family	HELIC1	helicase, ATP binding 1	DNA helicases|RNA helicases
NA	occipital cortical malformations	NA	NA	LAMC3	No gene mim	614115	biallelic	confirmed	loss of function	Brain/Cognition	6494	laminin subunit gamma 3	protein-coding gene	gene with protein product	Approved	9q34.12	09q34.12	DKFZp434E202			laminin, gamma 3	Laminin subunits
NA	iridogoniodysgenesis type 2	NA	NA	PITX2	601542	137600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Eye;GI tract	9005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primordial dwarfism	NA	NA	XRCC4	No gene mim	615272	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	12831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	adrenoleukodystrophy neonatal	NA	NA	PEX13	601789	202370	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8855	peroxisomal biogenesis factor 13	protein-coding gene	gene with protein product	Approved	2p15	02p15				peroxisome biogenesis factor 13	Peroxins
NA	methionine adenosyltransferase deficiency	NA	NA	MAT1A	610550	250850	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	6903	methionine adenosyltransferase 1A	protein-coding gene	gene with protein product	Approved	10q22.3	10q22.3	MAT|SAMS|MATA1|SAMS1	S-adenosylmethionine synthetase		methionine adenosyltransferase I, alpha	
NA	congenital inability to experience pain	NA	NA	SCN11A	No gene mim	No disease mim	monoallelic	confirmed	activating	Spinal cord/Peripheral nerves	10583	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	stickler syndrome type 4	NA	NA	COL9A1	120210	614134	biallelic	confirmed	loss of function	Face;Skeleton;Eye	2217	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atrial septal defect with atrioventricular conduction defects	NA	NA	NKX2-5	600584	108900	monoallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	retinitis pigmentosa-12, autosomal recessive	NA	NA	CRB1	604210	600105	biallelic	confirmed	loss of function	Eye	2343	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	pitt-hopkins syndrome	Wide mouth	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000174	pitt-hopkins syndrome	Abnormality of the palate	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	pitt-hopkins syndrome	Microcephaly	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000391	pitt-hopkins syndrome	Thickened helices	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	pitt-hopkins syndrome	Anteverted nares	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	pitt-hopkins syndrome	Deeply set eye	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000692	pitt-hopkins syndrome	Misalignment of teeth	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	pitt-hopkins syndrome	Intellectual disability	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	pitt-hopkins syndrome	Ataxia	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	pitt-hopkins syndrome	Muscular hypotonia	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	pitt-hopkins syndrome	Global developmental delay	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	pitt-hopkins syndrome	Specific learning disability	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	pitt-hopkins syndrome	Failure to thrive	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	pitt-hopkins syndrome	Growth delay	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	pitt-hopkins syndrome	Constipation	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	pitt-hopkins syndrome	Gastroesophageal reflux	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002036	pitt-hopkins syndrome	Hiatus hernia	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002300	pitt-hopkins syndrome	Mutism	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002357	pitt-hopkins syndrome	Dysphasia	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002381	pitt-hopkins syndrome	Aphasia	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006352	pitt-hopkins syndrome	Failure of eruption of permanent teeth	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010529	pitt-hopkins syndrome	Echolalia	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011968	pitt-hopkins syndrome	Feeding difficulties	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012471	pitt-hopkins syndrome	Thick vermilion border	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100633	pitt-hopkins syndrome	Esophagitis	Very frequent (99-80%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	pitt-hopkins syndrome	Cryptorchidism	Frequent (79-30%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	pitt-hopkins syndrome	Myopia	Frequent (79-30%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001182	pitt-hopkins syndrome	Tapered finger	Frequent (79-30%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	pitt-hopkins syndrome	Seizures	Frequent (79-30%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002793	pitt-hopkins syndrome	Abnormal pattern of respiration	Frequent (79-30%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010535	pitt-hopkins syndrome	Sleep apnea	Frequent (79-30%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001053	pitt-hopkins syndrome	Hypopigmented skin patches	Occasional (29-5%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	pitt-hopkins syndrome	Hypoplasia of penis	Occasional (29-5%)	TCF4	602272	610954	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	combined oxidative phosphorylation deficiency 1	NA	NA	GFM1	No gene mim	609060	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	13780	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	polymicrogyria with optic nerve hypoplasia	NA	NA	TUBA8	605742	613180	biallelic	confirmed	loss of function	Brain/Cognition;Eye	12410	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	chromosome 11p15.5-related russell-silver syndrome	NA	NA	IGF2	147470	180860	imprinted	confirmed	loss of function	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
NA	osteogenesis imperfecta type i	NA	NA	COL1A1	120150	166200	monoallelic	confirmed	dominant negative	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	crouzon syndrome	NA	NA	FGFR2	176943	123500	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	bardet-biedl syndrome type 4	NA	NA	BBS4	600374	209900	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	969	Bardet-Biedl syndrome 4	protein-coding gene	gene with protein product	Approved	15q24.1	15q24.1					Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome
NA	amelogenesis imperfecta.	NA	NA	SLC24A4	609840	No disease mim	biallelic	probable	loss of function	Teeth & Dentitian	10978	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microcephalic osteodysplastic primordial dwarfism, type ii	NA	NA	PCNT	605925	210720	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	16068	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mosaic variegated aneuploidy syndrome 1	NA	NA	BUB1B	602860	257300	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	1149	BUB1 mitotic checkpoint serine/threonine kinase B	protein-coding gene	gene with protein product	Approved	15q15.1	15q15.1	BUBR1|MAD3L|Bub1A|SSK1			budding uninhibited by benzimidazoles 1 (yeast homolog), beta|budding uninhibited by benzimidazoles 1 homolog beta (yeast)	
NA	branchiootorenal syndrome type 1	NA	NA	EYA1	601653	113650	monoallelic	confirmed	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
NA	n-acetylglutamate synthase deficiency	NA	NA	NAGS	608300	237310	biallelic	confirmed	loss of function	Endocrine/Metabolic	17996	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000093	cednik syndrome	Proteinuria	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000100	cednik syndrome	Nephrotic syndrome	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	cednik syndrome	Hypogonadism	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	cednik syndrome	Abnormality of the teeth	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	cednik syndrome	Microcephaly	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000268	cednik syndrome	Dolichocephaly	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	cednik syndrome	Long face	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	cednik syndrome	Hypertelorism	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	cednik syndrome	Macrotia	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	cednik syndrome	Sensorineural hearing impairment	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	cednik syndrome	Prominent nasal bridge	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	cednik syndrome	Depressed nasal ridge	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000478	cednik syndrome	Abnormality of the eye	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	cednik syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000496	cednik syndrome	Abnormality of eye movement	Frequent (79-30%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	cednik syndrome	Abnormality of vision	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	cednik syndrome	Optic atrophy	Frequent (79-30%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	cednik syndrome	Intellectual disability	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	cednik syndrome	Seizures	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	cednik syndrome	Ataxia	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	cednik syndrome	Global developmental delay	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001273	cednik syndrome	Abnormality of the corpus callosum	Frequent (79-30%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001284	cednik syndrome	Areflexia	Frequent (79-30%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001297	cednik syndrome	Stroke	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001302	cednik syndrome	Pachygyria	Frequent (79-30%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001635	cednik syndrome	Congestive heart failure	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002126	cednik syndrome	Polymicrogyria	Frequent (79-30%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002421	cednik syndrome	Poor head control	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003134	cednik syndrome	Abnormality of peripheral nerve conduction	Frequent (79-30%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	cednik syndrome	Short stature	Occasional (29-5%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007435	cednik syndrome	Diffuse palmoplantar keratoderma	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008064	cednik syndrome	Ichthyosis	Very frequent (99-80%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009830	cednik syndrome	Peripheral neuropathy	Frequent (79-30%)	SNAP29	604202	609528	biallelic	probable	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	11133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	22q11.2 deletion syndrome	Vesicoureteral reflux	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000113	22q11.2 deletion syndrome	Polycystic kidney dysplasia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000130	22q11.2 deletion syndrome	Abnormality of the uterus	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	22q11.2 deletion syndrome	Narrow mouth	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	22q11.2 deletion syndrome	Hydrocephalus	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	22q11.2 deletion syndrome	Microcephaly	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	22q11.2 deletion syndrome	Malar flattening	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	22q11.2 deletion syndrome	Epicanthus	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	22q11.2 deletion syndrome	Long philtrum	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	22q11.2 deletion syndrome	Micrognathia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	22q11.2 deletion syndrome	Low-set ears	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000385	22q11.2 deletion syndrome	Small earlobe	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000396	22q11.2 deletion syndrome	Overfolded helix	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	22q11.2 deletion syndrome	Prominent nasal bridge	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	22q11.2 deletion syndrome	Wide nasal bridge	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	22q11.2 deletion syndrome	Short neck	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	22q11.2 deletion syndrome	Strabismus	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	22q11.2 deletion syndrome	Downslanted palpebral fissures	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	22q11.2 deletion syndrome	Ptosis	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	22q11.2 deletion syndrome	Cataract	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	22q11.2 deletion syndrome	Microphthalmia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000582	22q11.2 deletion syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000627	22q11.2 deletion syndrome	Posterior embryotoxon	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	22q11.2 deletion syndrome	Abnormality of dental enamel	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	22q11.2 deletion syndrome	Behavioral abnormality	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000717	22q11.2 deletion syndrome	Autism	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000739	22q11.2 deletion syndrome	Anxiety	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000778	22q11.2 deletion syndrome	Hypoplasia of the thymus	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000929	22q11.2 deletion syndrome	Abnormality of the skull	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001053	22q11.2 deletion syndrome	Hypopigmented skin patches	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001136	22q11.2 deletion syndrome	Retinal arteriolar tortuosity	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	22q11.2 deletion syndrome	Seizures	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001281	22q11.2 deletion syndrome	Tetany	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	22q11.2 deletion syndrome	Polyhydramnios	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001631	22q11.2 deletion syndrome	Atrial septal defect	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	22q11.2 deletion syndrome	Tetralogy of Fallot	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001641	22q11.2 deletion syndrome	Abnormality of the pulmonary valve	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	22q11.2 deletion syndrome	Patent ductus arteriosus	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001646	22q11.2 deletion syndrome	Abnormality of the aortic valve	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	22q11.2 deletion syndrome	Inguinal hernia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	22q11.2 deletion syndrome	Cryptorchidism	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	22q11.2 deletion syndrome	Hypospadias	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000089	22q11.2 deletion syndrome	Renal hypoplasia	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	22q11.2 deletion syndrome	Abnormality of the teeth	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	22q11.2 deletion syndrome	Cleft palate	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000262	22q11.2 deletion syndrome	Turricephaly	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	22q11.2 deletion syndrome	Long face	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	22q11.2 deletion syndrome	Hypertelorism	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000322	22q11.2 deletion syndrome	Short philtrum	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	22q11.2 deletion syndrome	Hearing impairment	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000389	22q11.2 deletion syndrome	Chronic otitis media	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000405	22q11.2 deletion syndrome	Conductive hearing impairment	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000414	22q11.2 deletion syndrome	Bulbous nose	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000453	22q11.2 deletion syndrome	Choanal atresia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000492	22q11.2 deletion syndrome	Abnormality of the eyelid	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	22q11.2 deletion syndrome	Glaucoma	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000506	22q11.2 deletion syndrome	Telecanthus	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000600	22q11.2 deletion syndrome	Abnormality of the pharynx	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	22q11.2 deletion syndrome	Optic atrophy	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	22q11.2 deletion syndrome	Carious teeth	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000716	22q11.2 deletion syndrome	Depression	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000765	22q11.2 deletion syndrome	Abnormality of the thorax	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000821	22q11.2 deletion syndrome	Hypothyroidism	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000829	22q11.2 deletion syndrome	Hypoparathyroidism	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000836	22q11.2 deletion syndrome	Hyperthyroidism	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000979	22q11.2 deletion syndrome	Purpura	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001051	22q11.2 deletion syndrome	Seborrheic dermatitis	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001061	22q11.2 deletion syndrome	Acne	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001081	22q11.2 deletion syndrome	Cholelithiasis	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	22q11.2 deletion syndrome	Hand polydactyly	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001166	22q11.2 deletion syndrome	Arachnodactyly	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	22q11.2 deletion syndrome	Intellectual disability	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	22q11.2 deletion syndrome	Muscular hypotonia	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001256	22q11.2 deletion syndrome	Intellectual disability, mild	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	22q11.2 deletion syndrome	Global developmental delay	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	22q11.2 deletion syndrome	Specific learning disability	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001369	22q11.2 deletion syndrome	Arthritis	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	22q11.2 deletion syndrome	Failure to thrive	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	22q11.2 deletion syndrome	Intrauterine growth retardation	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001513	22q11.2 deletion syndrome	Obesity	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	22q11.2 deletion syndrome	Umbilical hernia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001601	22q11.2 deletion syndrome	Laryngomalacia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001611	22q11.2 deletion syndrome	Nasal speech	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	22q11.2 deletion syndrome	Ventricular septal defect	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001660	22q11.2 deletion syndrome	Truncus arteriosus	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	22q11.2 deletion syndrome	Splenomegaly	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001762	22q11.2 deletion syndrome	Talipes equinovarus	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001829	22q11.2 deletion syndrome	Foot polydactyly	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001872	22q11.2 deletion syndrome	Abnormality of thrombocytes	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	22q11.2 deletion syndrome	Thrombocytopenia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001999	22q11.2 deletion syndrome	Abnormal facial shape	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	22q11.2 deletion syndrome	Constipation	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	22q11.2 deletion syndrome	Gastroesophageal reflux	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002023	22q11.2 deletion syndrome	Anal atresia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002099	22q11.2 deletion syndrome	Asthma	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002139	22q11.2 deletion syndrome	Arrhinencephaly	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002239	22q11.2 deletion syndrome	Gastrointestinal hemorrhage	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002251	22q11.2 deletion syndrome	Aganglionic megacolon	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002357	22q11.2 deletion syndrome	Dysphasia	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002414	22q11.2 deletion syndrome	Spina bifida	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002435	22q11.2 deletion syndrome	Meningocele	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	22q11.2 deletion syndrome	Malformation of the heart and great vessels	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002566	22q11.2 deletion syndrome	Intestinal malrotation	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002607	22q11.2 deletion syndrome	Bowel incontinence	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002619	22q11.2 deletion syndrome	Varicose veins	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	22q11.2 deletion syndrome	Scoliosis	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002691	22q11.2 deletion syndrome	Platybasia	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002721	22q11.2 deletion syndrome	Immunodeficiency	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002901	22q11.2 deletion syndrome	Hypocalcemia	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002960	22q11.2 deletion syndrome	Autoimmunity	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002999	22q11.2 deletion syndrome	Patellar dislocation	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003326	22q11.2 deletion syndrome	Myalgia	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	22q11.2 deletion syndrome	Short stature	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005435	22q11.2 deletion syndrome	Impaired T cell function	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005562	22q11.2 deletion syndrome	Multiple renal cysts	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	22q11.2 deletion syndrome	Joint hyperflexibility	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006510	22q11.2 deletion syndrome	Chronic obstructive pulmonary disease	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006525	22q11.2 deletion syndrome	Lung segmentation defects	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007018	22q11.2 deletion syndrome	Attention deficit hyperactivity disorder	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007271	22q11.2 deletion syndrome	Occipital myelomeningocele	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007302	22q11.2 deletion syndrome	Bipolar affective disorder	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	22q11.2 deletion syndrome	Feeding difficulties in infancy	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011324	22q11.2 deletion syndrome	Multiple suture craniosynostosis	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011496	22q11.2 deletion syndrome	Corneal neovascularization	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011662	22q11.2 deletion syndrome	Tricuspid atresia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012303	22q11.2 deletion syndrome	Abnormality of the aortic arch	Very frequent (99-80%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012732	22q11.2 deletion syndrome	Anorectal anomaly	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100735	22q11.2 deletion syndrome	Hypertensive crisis	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100750	22q11.2 deletion syndrome	Atelectasis	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100753	22q11.2 deletion syndrome	Schizophrenia	Occasional (29-5%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100765	22q11.2 deletion syndrome	Abnormality of the tonsils	Frequent (79-30%)	TBX1	602054	188400	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	coffin-lowry syndrome	Wide mouth	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000179	coffin-lowry syndrome	Thick lower lip vermilion	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000189	coffin-lowry syndrome	Narrow palate	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000194	coffin-lowry syndrome	Open mouth	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	coffin-lowry syndrome	High palate	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000232	coffin-lowry syndrome	Everted lower lip vermilion	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	coffin-lowry syndrome	Microcephaly	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	coffin-lowry syndrome	Coarse facial features	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	coffin-lowry syndrome	Epicanthus	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	coffin-lowry syndrome	Hypertelorism	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	coffin-lowry syndrome	Hypoplasia of the maxilla	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	coffin-lowry syndrome	Sensorineural hearing impairment	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000411	coffin-lowry syndrome	Protruding ear	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000445	coffin-lowry syndrome	Wide nose	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	coffin-lowry syndrome	Anteverted nares	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	coffin-lowry syndrome	Strabismus	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	coffin-lowry syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	coffin-lowry syndrome	Cataract	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	coffin-lowry syndrome	Optic atrophy	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000668	coffin-lowry syndrome	Hypodontia	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	coffin-lowry syndrome	Delayed eruption of teeth	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000687	coffin-lowry syndrome	Widely spaced teeth	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	coffin-lowry syndrome	Pectus excavatum	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	coffin-lowry syndrome	Pectus carinatum	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000940	coffin-lowry syndrome	Abnormal diaphysis morphology	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	coffin-lowry syndrome	Brachydactyly syndrome	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001176	coffin-lowry syndrome	Large hands	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001182	coffin-lowry syndrome	Tapered finger	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	coffin-lowry syndrome	Intellectual disability	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	coffin-lowry syndrome	Seizures	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	coffin-lowry syndrome	Muscular hypotonia	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001276	coffin-lowry syndrome	Hypertonia	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	coffin-lowry syndrome	Gait disturbance	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	coffin-lowry syndrome	Muscle weakness	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001500	coffin-lowry syndrome	Broad finger	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	coffin-lowry syndrome	Redundant skin	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001633	coffin-lowry syndrome	Abnormality of the mitral valve	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001646	coffin-lowry syndrome	Abnormality of the aortic valve	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001702	coffin-lowry syndrome	Abnormality of the tricuspid valve	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	coffin-lowry syndrome	Pes planus	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001804	coffin-lowry syndrome	Hypoplastic fingernail	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001812	coffin-lowry syndrome	Hyperconvex fingernails	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	coffin-lowry syndrome	Frontal bossing	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	coffin-lowry syndrome	Ventriculomegaly	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002120	coffin-lowry syndrome	Cerebral cortical atrophy	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	coffin-lowry syndrome	Neurological speech impairment	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002191	coffin-lowry syndrome	Progressive spasticity	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	coffin-lowry syndrome	Abnormality of neuronal migration	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	coffin-lowry syndrome	Scoliosis	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	coffin-lowry syndrome	Delayed skeletal maturation	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	coffin-lowry syndrome	Kyphosis	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002868	coffin-lowry syndrome	Narrow iliac wings	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	coffin-lowry syndrome	Skeletal muscle atrophy	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	coffin-lowry syndrome	Abnormal form of the vertebral bodies	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	coffin-lowry syndrome	Short stature	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004493	coffin-lowry syndrome	Craniofacial hyperostosis	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	coffin-lowry syndrome	Depressed nasal bridge	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	coffin-lowry syndrome	Joint hyperflexibility	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006288	coffin-lowry syndrome	Advanced eruption of teeth	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006482	coffin-lowry syndrome	Abnormality of dental morphology	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	coffin-lowry syndrome	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	coffin-lowry syndrome	Aplasia/Hypoplasia of the corpus callosum	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	coffin-lowry syndrome	Abnormality of retinal pigmentation	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	coffin-lowry syndrome	Feeding difficulties in infancy	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009193	coffin-lowry syndrome	Pseudoepiphyses of the metacarpals	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009882	coffin-lowry syndrome	Short distal phalanx of finger	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009928	coffin-lowry syndrome	Thick nasal alae	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010049	coffin-lowry syndrome	Short metacarpal	Frequent (79-30%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010535	coffin-lowry syndrome	Sleep apnea	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011344	coffin-lowry syndrome	Severe global developmental delay	Very frequent (99-80%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100613	coffin-lowry syndrome	Death in early adulthood	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100716	coffin-lowry syndrome	Self-injurious behavior	Occasional (29-5%)	RPS6KA3	300075	303600	hemizygous	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	coffin-lowry syndrome	Wide mouth	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000179	coffin-lowry syndrome	Thick lower lip vermilion	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000189	coffin-lowry syndrome	Narrow palate	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000194	coffin-lowry syndrome	Open mouth	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	coffin-lowry syndrome	High palate	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000232	coffin-lowry syndrome	Everted lower lip vermilion	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	coffin-lowry syndrome	Microcephaly	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	coffin-lowry syndrome	Coarse facial features	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	coffin-lowry syndrome	Epicanthus	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	coffin-lowry syndrome	Hypertelorism	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	coffin-lowry syndrome	Hypoplasia of the maxilla	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	coffin-lowry syndrome	Sensorineural hearing impairment	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000411	coffin-lowry syndrome	Protruding ear	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000445	coffin-lowry syndrome	Wide nose	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	coffin-lowry syndrome	Anteverted nares	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	coffin-lowry syndrome	Strabismus	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	coffin-lowry syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	coffin-lowry syndrome	Cataract	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	coffin-lowry syndrome	Optic atrophy	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000668	coffin-lowry syndrome	Hypodontia	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	coffin-lowry syndrome	Delayed eruption of teeth	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000687	coffin-lowry syndrome	Widely spaced teeth	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	coffin-lowry syndrome	Pectus excavatum	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	coffin-lowry syndrome	Pectus carinatum	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000940	coffin-lowry syndrome	Abnormal diaphysis morphology	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	coffin-lowry syndrome	Brachydactyly syndrome	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001176	coffin-lowry syndrome	Large hands	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001182	coffin-lowry syndrome	Tapered finger	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	coffin-lowry syndrome	Intellectual disability	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	coffin-lowry syndrome	Seizures	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	coffin-lowry syndrome	Muscular hypotonia	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001276	coffin-lowry syndrome	Hypertonia	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	coffin-lowry syndrome	Gait disturbance	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	coffin-lowry syndrome	Muscle weakness	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001500	coffin-lowry syndrome	Broad finger	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	coffin-lowry syndrome	Redundant skin	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001633	coffin-lowry syndrome	Abnormality of the mitral valve	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001646	coffin-lowry syndrome	Abnormality of the aortic valve	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001702	coffin-lowry syndrome	Abnormality of the tricuspid valve	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	coffin-lowry syndrome	Pes planus	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001804	coffin-lowry syndrome	Hypoplastic fingernail	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001812	coffin-lowry syndrome	Hyperconvex fingernails	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	coffin-lowry syndrome	Frontal bossing	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	coffin-lowry syndrome	Ventriculomegaly	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002120	coffin-lowry syndrome	Cerebral cortical atrophy	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	coffin-lowry syndrome	Neurological speech impairment	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002191	coffin-lowry syndrome	Progressive spasticity	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	coffin-lowry syndrome	Abnormality of neuronal migration	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	coffin-lowry syndrome	Scoliosis	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	coffin-lowry syndrome	Delayed skeletal maturation	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	coffin-lowry syndrome	Kyphosis	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002868	coffin-lowry syndrome	Narrow iliac wings	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	coffin-lowry syndrome	Skeletal muscle atrophy	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	coffin-lowry syndrome	Abnormal form of the vertebral bodies	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	coffin-lowry syndrome	Short stature	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004493	coffin-lowry syndrome	Craniofacial hyperostosis	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	coffin-lowry syndrome	Depressed nasal bridge	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	coffin-lowry syndrome	Joint hyperflexibility	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006288	coffin-lowry syndrome	Advanced eruption of teeth	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006482	coffin-lowry syndrome	Abnormality of dental morphology	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	coffin-lowry syndrome	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	coffin-lowry syndrome	Aplasia/Hypoplasia of the corpus callosum	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	coffin-lowry syndrome	Abnormality of retinal pigmentation	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	coffin-lowry syndrome	Feeding difficulties in infancy	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009193	coffin-lowry syndrome	Pseudoepiphyses of the metacarpals	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009882	coffin-lowry syndrome	Short distal phalanx of finger	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009928	coffin-lowry syndrome	Thick nasal alae	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010049	coffin-lowry syndrome	Short metacarpal	Frequent (79-30%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010535	coffin-lowry syndrome	Sleep apnea	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011344	coffin-lowry syndrome	Severe global developmental delay	Very frequent (99-80%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100613	coffin-lowry syndrome	Death in early adulthood	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100716	coffin-lowry syndrome	Self-injurious behavior	Occasional (29-5%)	RPS6KA3	300075	303600	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition	10432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	NA	NA	SLC25A15	603861	238970	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10985	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glycogen storage disease type vi	NA	NA	PYGL	613741	232700	biallelic	confirmed	loss of function	GI tract	9725	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lethal neonatal rigidity and seizure syndrome	NA	NA	BRAT1	614506	614498	biallelic	probable	loss of function	Brain/Cognition	21701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spinal muscular atrophy, distal, x-linked 3	NA	NA	ATP7A	300011	300489	hemizygous	confirmed	all missense/in frame	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
NA	congenital disorder of glycosylation type 1n	NA	NA	RFT1	611908	612015	biallelic	probable	loss of function	Endocrine/Metabolic	30220	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spastic paraplegia 9, autosomal dominant	NA	NA	ALDH18A1	138250	601162	monoallelic	confirmed	dominant negative	Skin;Skeleton;Brain/Cognition	9722	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cutis laxa, autosomal recessive, type iib	NA	NA	PYCR1	179035	612940	biallelic	confirmed	loss of function	Skin	9721	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked type 41	NA	NA	GDI1	300104	300104	hemizygous	confirmed	loss of function	Brain/Cognition	4226	GDP dissociation inhibitor 1	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	RABGDIA|XAP-4|OPHN2|FLJ41411	mental retardation, X-linked 41|mental retardation, X-linked 48|rab GDP-dissociation inhibitor, alpha	MRX48|MRX41|GDIL		X-linked mental retardation
HP:0000518	coenzyme q10 deficiency	Cataract	Very frequent (99-80%)	COQ2	609825	607426	biallelic	confirmed	loss of function	Endocrine/Metabolic	25223	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000974	coenzyme q10 deficiency	Hyperextensible skin	Very frequent (99-80%)	COQ2	609825	607426	biallelic	confirmed	loss of function	Endocrine/Metabolic	25223	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	coenzyme q10 deficiency	Intellectual disability	Very frequent (99-80%)	COQ2	609825	607426	biallelic	confirmed	loss of function	Endocrine/Metabolic	25223	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	coenzyme q10 deficiency	Joint hyperflexibility	Very frequent (99-80%)	COQ2	609825	607426	biallelic	confirmed	loss of function	Endocrine/Metabolic	25223	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gldc-related glycine encephalopathy	NA	NA	GLDC	238300	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4313	glycine decarboxylase	protein-coding gene	gene with protein product	Approved	9p24.1	09p24.1	GCSP|NKH	glycine cleavage system protein P|glycine dehydrogenase		glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)|glycine dehydrogenase (decarboxylating)	
NA	autism	NA	NA	TBL1XR1	No gene mim	209850	monoallelic	probable	loss of function	Brain/Cognition	29529	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation-aphasia-shuffling gait-adducted thumbs syndrome	NA	NA	L1CAM	308840	303350	hemizygous	confirmed	loss of function	Brain/Cognition	6470	L1 cell adhesion molecule	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	CD171	neural cell adhesion molecule L1	HSAS1|SPG1|HSAS|MASA|MIC5|S10	antigen identified by monoclonal antibody R1	CD molecules|Fibronectin type III domain containing|I-set domain containing|Ig-like cell adhesion molecule family
NA	dyskeratosis congenita, autosomal recessive 1	NA	NA	NOP10	No gene mim	224230	biallelic	possible	all missense/in frame	Bone Marrow/Immune;Skin	14378	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital disorders of glycosylation	NA	NA	MPDU1	604041	612379	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7207	mannose-P-dolichol utilization defect 1	protein-coding gene	gene with protein product	Approved	17p13.1	17p13.1	SL15|Lec35|PQLC5|CDGIf				
NA	joubert syndrome and related disorders	NA	NA	TCTN2	613846	194263	biallelic	probable	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	25774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	achondrogenesis type 2	Macrocephaly	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	achondrogenesis type 2	Long philtrum	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	achondrogenesis type 2	Micrognathia	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	achondrogenesis type 2	Anteverted nares	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	achondrogenesis type 2	Short neck	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000474	achondrogenesis type 2	Thickened nuchal skin fold	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000476	achondrogenesis type 2	Cystic hygroma	Occasional (29-5%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	achondrogenesis type 2	Narrow chest	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001162	achondrogenesis type 2	Postaxial hand polydactyly	Occasional (29-5%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	achondrogenesis type 2	Umbilical hernia	Frequent (79-30%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	achondrogenesis type 2	Polyhydramnios	Frequent (79-30%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001789	achondrogenesis type 2	Hydrops fetalis	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	achondrogenesis type 2	Frontal bossing	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	achondrogenesis type 2	Malformation of the heart and great vessels	Occasional (29-5%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	achondrogenesis type 2	Micromelia	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	achondrogenesis type 2	Short nose	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003270	achondrogenesis type 2	Abdominal distention	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003336	achondrogenesis type 2	Abnormal enchondral ossification	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005257	achondrogenesis type 2	Thoracic hypoplasia	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005716	achondrogenesis type 2	Lethal skeletal dysplasia	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006703	achondrogenesis type 2	Aplasia/Hypoplasia of the lungs	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008873	achondrogenesis type 2	Disproportionate short-limb short stature	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012368	achondrogenesis type 2	Flat face	Very frequent (99-80%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100541	achondrogenesis type 2	Femoral hernia	Frequent (79-30%)	COL2A1	120140	200610	monoallelic	confirmed	dominant negative	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy, limb-girdle, type 2q	NA	NA	PLEC	601282	613723	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	joubert syndrome and related disorders	NA	NA	TCTN1	609863	194263	biallelic	probable	loss of function	Brain/Cognition	26113	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	renal tubular acidosis, distal, ad	NA	NA	SLC4A1	No gene mim	179800	monoallelic	both DD and IF	all missense/in frame	Kidney Renal Tract;Endocrine/Metabolic	11027	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanconi anemia, complementation group c	NA	NA	FANCC	613899	227645	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	3584	Fanconi anemia complementation group C	protein-coding gene	gene with protein product	Approved	9q22.32	09q22.32	FAC|FA3		FACC		Fanconi anemia complementation groups
NA	cortical dysplasia-focal epilepsy syndrome	NA	NA	CNTNAP2	604569	610042	biallelic	confirmed	loss of function	Brain/Cognition	13830	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	coffin siris	NA	NA	SMARCE1	603111	135900	monoallelic	probable	all missense/in frame	Skeleton;Brain/Cognition	11109	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ataxia telangiectasia-like disorder	NA	NA	MRE11	No gene mim	604391	biallelic	confirmed	loss of function	Brain/Cognition	7230	MRE11 homolog, double strand break repair nuclease	protein-coding gene	gene with protein product	Approved	11q21	11q21	ATLD	AT-like disease	MRE11A	MRE11 meiotic recombination 11 homolog A (S. cerevisiae)|MRE11 homolog A, double strand break repair nuclease	BRCA1 C complex|MRN complex
NA	autosomal recessive mental retardation	NA	NA	RABL6	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	24703	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	xeroderma pigmentosum, group e, ddb-negative subtype	NA	NA	DDB2	600811	278740	biallelic	confirmed	loss of function	Skin;Skeleton	2718	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	periventricular neuronal heterotopia	NA	NA	FAT4	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	23109	FAT atypical cadherin 4	protein-coding gene	gene with protein product	Approved	4q28.1	04q28.1	CDHF14|FAT-J|CDHR11	cadherin-related family member 11		FAT tumor suppressor homolog 4 (Drosophila)	Cadherin related
NA	sebastian syndrome	NA	NA	MYH9	No gene mim	605249	monoallelic	confirmed	loss of function	Bone Marrow/Immune	7579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	muenke syndrome	Hydrocephalus	Occasional (29-5%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000248	muenke syndrome	Brachycephaly	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000256	muenke syndrome	Macrocephaly	Occasional (29-5%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000272	muenke syndrome	Malar flattening	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000316	muenke syndrome	Hypertelorism	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000407	muenke syndrome	Sensorineural hearing impairment	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000508	muenke syndrome	Ptosis	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000520	muenke syndrome	Proptosis	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001034	muenke syndrome	Hypermelanotic macule	Occasional (29-5%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001053	muenke syndrome	Hypopigmented skin patches	Occasional (29-5%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001263	muenke syndrome	Global developmental delay	Occasional (29-5%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001357	muenke syndrome	Plagiocephaly	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001773	muenke syndrome	Short foot	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002516	muenke syndrome	Increased intracranial pressure	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002705	muenke syndrome	High, narrow palate	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004279	muenke syndrome	Short palm	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004440	muenke syndrome	Coronal craniosynostosis	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005599	muenke syndrome	Hypopigmentation of hair	Occasional (29-5%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0008368	muenke syndrome	Tarsal synostosis	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0009702	muenke syndrome	Carpal synostosis	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010579	muenke syndrome	Cone-shaped epiphysis	Frequent (79-30%)	FGFR3	134934	602849	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000023	short syndrome	Inguinal hernia	Very frequent (99-80%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000407	short syndrome	Sensorineural hearing impairment	Very frequent (99-80%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000490	short syndrome	Deeply set eye	Very frequent (99-80%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0003510	short syndrome	Severe short stature	Very frequent (99-80%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0005692	short syndrome	Joint hyperflexibility	Very frequent (99-80%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0007676	short syndrome	Hypoplasia of the iris	Very frequent (99-80%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000164	short syndrome	Abnormality of the teeth	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000271	short syndrome	Abnormality of the face	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000485	short syndrome	Megalocornea	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000501	short syndrome	Glaucoma	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000615	short syndrome	Abnormality of the pupil	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000682	short syndrome	Abnormality of dental enamel	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000691	short syndrome	Microdontia	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000819	short syndrome	Diabetes mellitus	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000855	short syndrome	Insulin resistance	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0001006	short syndrome	Hypotrichosis	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0001596	short syndrome	Alopecia	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0001824	short syndrome	Weight loss	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0002167	short syndrome	Neurological speech impairment	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0004396	short syndrome	Poor appetite	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0007392	short syndrome	Excessive wrinkled skin	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0009125	short syndrome	Lipodystrophy	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0011800	short syndrome	Midface retrusion	Frequent (79-30%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000272	short syndrome	Malar flattening	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000277	short syndrome	Abnormality of the mandible	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000316	short syndrome	Hypertelorism	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000325	short syndrome	Triangular face	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000336	short syndrome	Prominent supraorbital ridges	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000431	short syndrome	Wide nasal bridge	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000506	short syndrome	Telecanthus	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000593	short syndrome	Abnormality of the anterior chamber	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0000627	short syndrome	Posterior embryotoxon	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0001156	short syndrome	Brachydactyly syndrome	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0004279	short syndrome	Short palm	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0007957	short syndrome	Corneal opacity	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0010668	short syndrome	Abnormality of the zygomatic bone	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
HP:0011220	short syndrome	Prominent forehead	Occasional (29-5%)	PIK3R1	No gene mim	269880	monoallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
NA	microphthalmia isolated with coloboma type 3	NA	NA	VSX2	142993	610092	biallelic	confirmed	loss of function	Eye	1975	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	cohen syndrome	Cryptorchidism	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	cohen syndrome	Abnormality of the teeth	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000194	cohen syndrome	Open mouth	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000212	cohen syndrome	Gingival overgrowth	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	cohen syndrome	Microcephaly	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000294	cohen syndrome	Low anterior hairline	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000322	cohen syndrome	Short philtrum	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	cohen syndrome	Hypoplasia of the maxilla	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	cohen syndrome	Micrognathia	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000384	cohen syndrome	Preauricular skin tag	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	cohen syndrome	Sensorineural hearing impairment	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	cohen syndrome	Prominent nasal bridge	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	cohen syndrome	Strabismus	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000492	cohen syndrome	Abnormality of the eyelid	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	cohen syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000499	cohen syndrome	Abnormality of the eyelashes	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000527	cohen syndrome	Long eyelashes	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	cohen syndrome	Myopia	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	cohen syndrome	Microphthalmia	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000574	cohen syndrome	Thick eyebrow	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	cohen syndrome	Iris coloboma	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	cohen syndrome	Nystagmus	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	cohen syndrome	Optic atrophy	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	cohen syndrome	Pectus excavatum	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	cohen syndrome	Delayed puberty	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001000	cohen syndrome	Abnormality of skin pigmentation	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001135	cohen syndrome	Chorioretinal dystrophy	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001166	cohen syndrome	Arachnodactyly	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001182	cohen syndrome	Tapered finger	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	cohen syndrome	Intellectual disability	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	cohen syndrome	Seizures	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	cohen syndrome	Muscular hypotonia	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	cohen syndrome	Global developmental delay	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	cohen syndrome	Intrauterine growth retardation	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001513	cohen syndrome	Obesity	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001531	cohen syndrome	Failure to thrive in infancy	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001558	cohen syndrome	Decreased fetal movement	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001572	cohen syndrome	Macrodontia	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001612	cohen syndrome	Weak cry	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	cohen syndrome	Ventricular septal defect	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001634	cohen syndrome	Mitral valve prolapse	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001852	cohen syndrome	Sandal gap	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001875	cohen syndrome	Neutropenia	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	cohen syndrome	Neurological speech impairment	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	cohen syndrome	Scoliosis	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002705	cohen syndrome	High, narrow palate	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	cohen syndrome	Kyphosis	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	cohen syndrome	Genu valgum	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002967	cohen syndrome	Cubitus valgus	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003272	cohen syndrome	Abnormality of the hip bone	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	cohen syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004283	cohen syndrome	Narrow palm	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	cohen syndrome	Short stature	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	cohen syndrome	Joint hyperflexibility	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	cohen syndrome	Finger syndactyly	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	cohen syndrome	Abnormality of retinal pigmentation	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	cohen syndrome	Feeding difficulties in infancy	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	cohen syndrome	Reduced number of teeth	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009906	cohen syndrome	Aplasia/Hypoplasia of the earlobes	Occasional (29-5%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010295	cohen syndrome	Aplasia/Hypoplasia of the tongue	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010669	cohen syndrome	Cheekbone underdevelopment	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011308	cohen syndrome	Slender toe	Very frequent (99-80%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100874	cohen syndrome	Thick hair	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200046	cohen syndrome	Cat cry	Frequent (79-30%)	VPS13B	607817	193538	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	2183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	xeroderma pigmentosum complementation group b	NA	NA	ERCC3	133510	610651	biallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition;Eye;Ear	3435	ERCC excision repair 3, TFIIH core complex helicase subunit	protein-coding gene	gene with protein product	Approved	2q14.3	02q14.3	XPB|BTF2|RAD25|TFIIH|GTF2H	xeroderma pigmentosum group B complementing		excision repair cross-complementing rodent repair deficiency, complementation group 3|excision repair cross-complementation group 3	General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated
NA	niemann-pick disease type a	NA	NA	SMPD1	607608	257200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	11120	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000104	serkal syndrome	Renal agenesis	Obligate (100%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	serkal syndrome	Growth delay	Obligate (100%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001562	serkal syndrome	Oligohydramnios	Obligate (100%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002089	serkal syndrome	Pulmonary hypoplasia	Obligate (100%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012245	serkal syndrome	Sex reversal	Obligate (100%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000036	serkal syndrome	Abnormality of the penis	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	serkal syndrome	Hypospadias	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000202	serkal syndrome	Oral cleft	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000776	serkal syndrome	Congenital diaphragmatic hernia	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000834	serkal syndrome	Abnormality of the adrenal glands	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	serkal syndrome	Ventricular septal defect	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001642	serkal syndrome	Pulmonic stenosis	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004794	serkal syndrome	Malrotation of small bowel	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005343	serkal syndrome	Hypoplasia of the bladder	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030680	serkal syndrome	Abnormality of cardiovascular system morphology	Frequent (79-30%)	WNT4	No gene mim	611812	biallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperinsulinism-hyperammonemia syndrome	NA	NA	GLUD1	138130	606762	monoallelic	confirmed	activating	Endocrine/Metabolic	4335	glutamate dehydrogenase 1	protein-coding gene	gene with protein product	Approved	10q23.2	10q23.2	GDH		GLUD		
NA	renal tubular acidosis, distal, ar	NA	NA	SLC4A1	No gene mim	611590	biallelic	both DD and IF	all missense/in frame	Kidney Renal Tract;Endocrine/Metabolic	11027	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehlers-danlos syndrome	NA	NA	B3GALT6	No gene mim	130070	biallelic	confirmed	loss of function	Skin;Skeleton	17978	beta-1,3-galactosyltransferase 6	protein-coding gene	gene with protein product	Approved	1p36.33	01p36.33	beta3GalT6	beta-1,3-galactosyltransferase-6		UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 6|UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6|UDP-Gal:betaGal beta 1,3-galactosyltransferase 6	Beta 3-glycosyltransferases
NA	long chain 3-hydroxyacyl-coa dehydrogenase deficiency	NA	NA	HADHA	No gene mim	609016	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4801	hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	GBP|LCEH|LCHAD|MTPA	gastrin-binding protein|long-chain-3-hydroxyacyl-CoA dehydrogenase|long-chain 2-enoyl-CoA hydratase|mitochondrial trifunctional protein, alpha subunit		hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit|hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit	
NA	terminal osseous dysplasia	NA	NA	FLNA	300017	300244	hemizygous	confirmed	loss of function	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001251	hereditary spastic paraplegia	Ataxia	Frequent (79-30%)	DDHD1	614603	615030	biallelic	confirmed	loss of function	Brain/Cognition	19714	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	hereditary spastic paraplegia	Spasticity	Very frequent (99-80%)	DDHD1	614603	615030	biallelic	confirmed	loss of function	Brain/Cognition	19714	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	hereditary spastic paraplegia	Gait disturbance	Very frequent (99-80%)	DDHD1	614603	615030	biallelic	confirmed	loss of function	Brain/Cognition	19714	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	hereditary spastic paraplegia	Finger syndactyly	Occasional (29-5%)	DDHD1	614603	615030	biallelic	confirmed	loss of function	Brain/Cognition	19714	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007328	hereditary spastic paraplegia	Impaired pain sensation	Very frequent (99-80%)	DDHD1	614603	615030	biallelic	confirmed	loss of function	Brain/Cognition	19714	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010550	hereditary spastic paraplegia	Paraplegia	Very frequent (99-80%)	DDHD1	614603	615030	biallelic	confirmed	loss of function	Brain/Cognition	19714	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	brown-vialetto-van laere syndrome	NA	NA	SLC52A3	613350	211530	biallelic	confirmed	loss of function	Brain/Cognition;Ear	16187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	FRY	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	20367	FRY microtubule binding protein	protein-coding gene	gene with protein product	Approved	13q13.1	13q13.1	bA37E23.1|13CDNA73|CG003		C13orf14	chromosome 13 open reading frame 14|furry homolog (Drosophila)	
NA	mental retardation syndromic x-linked turner type	NA	NA	HUWE1	300697	300706	hemizygous	confirmed	all missense/in frame	Skeleton;Brain/Cognition	30892	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spinal muscular atrophy, lower extremity-predominant, ad	NA	NA	DYNC1H1	No gene mim	158600	monoallelic	confirmed	all missense/in frame	Brain/Cognition	2961	dynein cytoplasmic 1 heavy chain 1	protein-coding gene	gene with protein product	Approved	14q32.31	14q32.31	Dnchc1|HL-3|p22|DHC1|CMT2O		DNECL|DNCL|DNCH1	dynein, cytoplasmic, heavy polypeptide 1	Dyneins, cytoplasmic
NA	myopathy, early-onset, areflexia, respiratory distress, and dysphagia	NA	NA	MEGF10	612453	614399	biallelic	confirmed	loss of function	Musculature	29634	multiple EGF like domains 10	protein-coding gene	gene with protein product	Approved	5q23.2	05q23.2	KIAA1780			multiple EGF-like-domains 10	Scavenger receptors
NA	autosomal recessive mental retardation	NA	NA	ARL14EP	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	26798	ADP ribosylation factor like GTPase 14 effector protein	protein-coding gene	gene with protein product	Approved	11p14.1	11p14.1	FLJ38968|ARF7EP		C11orf46	chromosome 11 open reading frame 46|ADP-ribosylation factor like GTPase 14 effector protein	
NA	polymicrogyria	NA	NA	ADGRG1	No gene mim	606854	biallelic	confirmed	loss of function	Brain/Cognition	4512	adhesion G protein-coupled receptor G1	protein-coding gene	gene with protein product	Approved	16q21	16q21	TM7LN4|TM7XN1		GPR56	G protein-coupled receptor 56	Adhesion G protein-coupled receptors, subfamily G
NA	trichothiodystrophy non-photosensitive type 1	NA	NA	MPLKIP	609188	234050	biallelic	confirmed	loss of function	Skin;Brain/Cognition	16002	M-phase specific PLK1 interacting protein	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	ORF20|TTDN1		C7orf11	chromosome 7 open reading frame 11	
NA	hydrocephalus due to stenosis of the aqueduct of sylvius	NA	NA	L1CAM	308840	307000	hemizygous	confirmed	loss of function	Brain/Cognition	6470	L1 cell adhesion molecule	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	CD171	neural cell adhesion molecule L1	HSAS1|SPG1|HSAS|MASA|MIC5|S10	antigen identified by monoclonal antibody R1	CD molecules|Fibronectin type III domain containing|I-set domain containing|Ig-like cell adhesion molecule family
HP:0000037	denys-drash syndrome	Male pseudohermaphroditism	Very frequent (99-80%)	WT1	607102	194080	monoallelic	confirmed	dominant negative	Kidney Renal Tract;Genitalia;Heart/Cardiovasculature/Lymphatic	12796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000093	denys-drash syndrome	Proteinuria	Very frequent (99-80%)	WT1	607102	194080	monoallelic	confirmed	dominant negative	Kidney Renal Tract;Genitalia;Heart/Cardiovasculature/Lymphatic	12796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000100	denys-drash syndrome	Nephrotic syndrome	Very frequent (99-80%)	WT1	607102	194080	monoallelic	confirmed	dominant negative	Kidney Renal Tract;Genitalia;Heart/Cardiovasculature/Lymphatic	12796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000112	denys-drash syndrome	Nephropathy	Very frequent (99-80%)	WT1	607102	194080	monoallelic	confirmed	dominant negative	Kidney Renal Tract;Genitalia;Heart/Cardiovasculature/Lymphatic	12796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002667	denys-drash syndrome	Nephroblastoma	Very frequent (99-80%)	WT1	607102	194080	monoallelic	confirmed	dominant negative	Kidney Renal Tract;Genitalia;Heart/Cardiovasculature/Lymphatic	12796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000822	denys-drash syndrome	Hypertension	Frequent (79-30%)	WT1	607102	194080	monoallelic	confirmed	dominant negative	Kidney Renal Tract;Genitalia;Heart/Cardiovasculature/Lymphatic	12796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000133	denys-drash syndrome	Gonadal dysgenesis	Occasional (29-5%)	WT1	607102	194080	monoallelic	confirmed	dominant negative	Kidney Renal Tract;Genitalia;Heart/Cardiovasculature/Lymphatic	12796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rapadilino syndrome	NA	NA	RECQL4	603780	266280	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cardiomyopathy dilated type 1c	NA	NA	LDB3	No gene mim	601493	monoallelic	both DD and IF	all missense/in frame	Musculature;Heart/Cardiovasculature/Lymphatic	15710	LIM domain binding 3	protein-coding gene	gene with protein product	Approved	10q23.2	10q23.2	PDLIM6|KIAA0613|ZASP	cypher|oracle|Z-band alternatively spliced PDZ motif protein	CMD1C	cardiomyopathy, dilated 1C (autosomal dominant)	LIM domain containing|PDZ domain containing
NA	spondyloepimetaphyseal dysplasia with joint laxity type 1	NA	NA	B3GALT6	No gene mim	271640	biallelic	confirmed	loss of function	Skin;Skeleton	17978	beta-1,3-galactosyltransferase 6	protein-coding gene	gene with protein product	Approved	1p36.33	01p36.33	beta3GalT6	beta-1,3-galactosyltransferase-6		UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 6|UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6|UDP-Gal:betaGal beta 1,3-galactosyltransferase 6	Beta 3-glycosyltransferases
NA	megalocornea, x-linked	NA	NA	CHRDL1	300350	309300	hemizygous	confirmed	loss of function	Eye	29861	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal-dominant robinow syndrome	NA	NA	DVL1	No gene mim	No disease mim	monoallelic	confirmed	activating	Face;Skeleton;Genitalia	3084	dishevelled segment polarity protein 1	protein-coding gene	gene with protein product	Approved	1p36.33	01p36.33				dishevelled 1 (homologous to Drosophila dsh)|dishevelled, dsh homolog 1 (Drosophila)	Dishevelled segment polarity proteins|PDZ domain containing
NA	autosomal recessive mental retardation	NA	NA	CNKSR1	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	19700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital anomalies of kidney and urinary tract, cakut1	NA	NA	DSTYK	No gene mim	610805	monoallelic	confirmed	loss of function	Kidney Renal Tract	29043	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital and juvenile cataract	NA	NA	TMEM114	No gene mim	611579	monoallelic	possible	loss of function	Eye	33227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000091	alg8-cdg	Abnormality of the renal tubule	Very frequent (99-80%)	ALG8	608103	237145	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23161	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	alg8-cdg	Cataract	Frequent (79-30%)	ALG8	608103	237145	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23161	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001004	alg8-cdg	Lymphedema	Very frequent (99-80%)	ALG8	608103	237145	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23161	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001399	alg8-cdg	Hepatic failure	Very frequent (99-80%)	ALG8	608103	237145	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23161	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	3mc syndrome 1	NA	NA	MASP1	600521	257920	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	6901	mannan binding lectin serine peptidase 1	protein-coding gene	gene with protein product	Approved	3q27.3	03q27.3	MASP	C4/C2 activating component of Ra-reactive factor	CRARF|PRSS5	mannan-binding lectin serine protease 1 (C4/C2 activating component of Ra-reactive factor)|mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)	Proteases, serine|Sushi domain containing
NA	ror2-related disorders ar	NA	NA	ROR2	602337	268310	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Genitalia	10257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spinocerebellar ataxia type 13	NA	NA	KCNC3	No gene mim	605259	monoallelic	both DD and IF	uncertain	Brain/Cognition	6235	potassium voltage-gated channel subfamily C member 3	protein-coding gene	gene with protein product	Approved	19q13.33	19q13.33	Kv3.3		SCA13	spinocerebellar ataxia 13|potassium voltage-gated channel, Shaw-related subfamily, member 3|potassium channel, voltage gated Shaw related subfamily C, member 3	Potassium voltage-gated channels
HP:0000028	norrie disease	Cryptorchidism	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000233	norrie disease	Thin vermilion border	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	norrie disease	Microcephaly	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	norrie disease	Malar flattening	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000375	norrie disease	Abnormality of cochlea	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	norrie disease	Macrotia	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	norrie disease	Sensorineural hearing impairment	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000411	norrie disease	Protruding ear	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000446	norrie disease	Narrow nasal bridge	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	norrie disease	Deeply set eye	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	norrie disease	Glaucoma	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	norrie disease	Cataract	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000532	norrie disease	Chorioretinal abnormality	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000541	norrie disease	Retinal detachment	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	norrie disease	Microphthalmia	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000601	norrie disease	Hypotelorism	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000615	norrie disease	Abnormality of the pupil	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000618	norrie disease	Blindness	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	norrie disease	Nystagmus	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000647	norrie disease	Sclerocornea	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	norrie disease	Optic atrophy	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	norrie disease	Behavioral abnormality	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000709	norrie disease	Psychosis	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000717	norrie disease	Autism	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000733	norrie disease	Stereotypy	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000737	norrie disease	Irritability	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000738	norrie disease	Hallucinations	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000739	norrie disease	Anxiety	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000819	norrie disease	Diabetes mellitus	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	norrie disease	Delayed puberty	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001083	norrie disease	Ectopia lentis	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	norrie disease	Seizures	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	norrie disease	Muscular hypotonia	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001276	norrie disease	Hypertonia	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	norrie disease	Muscle weakness	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001347	norrie disease	Hyperreflexia	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	norrie disease	Failure to thrive	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002076	norrie disease	Migraine	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002120	norrie disease	Cerebral cortical atrophy	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002169	norrie disease	Clonus	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	norrie disease	EEG abnormality	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002360	norrie disease	Sleep disturbance	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002376	norrie disease	Developmental regression	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	norrie disease	Scoliosis	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004326	norrie disease	Cachexia	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004327	norrie disease	Abnormality of the vitreous humor	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005293	norrie disease	Venous insufficiency	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006887	norrie disease	Intellectual disability, progressive	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007018	norrie disease	Attention deficit hyperactivity disorder	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	norrie disease	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007676	norrie disease	Hypoplasia of the iris	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007833	norrie disease	Anterior chamber synechiae	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007957	norrie disease	Corneal opacity	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007968	norrie disease	Persistent hyperplastic primary vitreous	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008046	norrie disease	Abnormality of the retinal vasculature	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008063	norrie disease	Aplasia/Hypoplasia of the lens	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010662	norrie disease	Abnormality of the diencephalon	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	norrie disease	Abnormality of immune system physiology	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011039	norrie disease	Abnormality of the helix	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100012	norrie disease	Neoplasm of the eye	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100639	norrie disease	Erectile abnormalities	Frequent (79-30%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100716	norrie disease	Self-injurious behavior	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100718	norrie disease	Uterine rupture	Occasional (29-5%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100742	norrie disease	Vascular neoplasm	Very frequent (99-80%)	NDP	300658	310600	hemizygous	confirmed	loss of function	Brain/Cognition;Eye	7678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, autosomal dominant 32	NA	NA	KAT6A	No gene mim	616268	monoallelic	confirmed	loss of function	Brain/Cognition	13013	lysine acetyltransferase 6A	protein-coding gene	gene with protein product	Approved	8p11.21	08p11.21	MOZ|ZC2HC6A	Monocytic leukemia zinc finger protein	ZNF220|RUNXBP2|MYST3	runt-related transcription factor binding protein 2|MYST histone acetyltransferase (monocytic leukemia) 3|K(lysine) acetyltransferase 6A	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
NA	microphthalmia syndromic type 2	NA	NA	BCOR	300485	300166	x-linked dominant	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	20893	BCL6 corepressor	protein-coding gene	gene with protein product	Approved	Xp11.4	Xp11.4	FLJ20285|KIAA1575			BCL6 co-repressor	Ankyrin repeat domain containing
NA	knobloch syndrome 2	NA	NA	ADAMTS18	No gene mim	608454	biallelic	possible	all missense/in frame	Skin;Skeleton;Eye	17110	ADAM metallopeptidase with thrombospondin type 1 motif 18	protein-coding gene	gene with protein product	Approved	16q23.1	16q23.1			ADAMTS21	a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 18	ADAM metallopeptidases with thrombospondin type 1 motif
NA	cornelia de lange-like syndrome	NA	NA	HDAC8	300269	No disease mim	hemizygous	confirmed	loss of function	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
NA	cornelia de lange-like syndrome	NA	NA	HDAC8	300269	No disease mim	x-linked dominant	confirmed	loss of function	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
NA	coenzyme q10 deficiency, primary, 2	NA	NA	PDSS1	607429	614651	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	17759	decaprenyl diphosphate synthase subunit 1	protein-coding gene	gene with protein product	Approved	10p12.1	10p12.1	TPT|COQ1	coenzyme Q1 homolog (yeast)	TPRT	trans-prenyltransferase|prenyl (decaprenyl) diphosphate synthase, subunit 1	
HP:0000003	fraser syndrome	Multicystic kidney dysplasia	Very frequent (99-80%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000028	fraser syndrome	Cryptorchidism	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000046	fraser syndrome	Scrotal hypoplasia	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000047	fraser syndrome	Hypospadias	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000062	fraser syndrome	Ambiguous genitalia	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000068	fraser syndrome	Urethral atresia	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000089	fraser syndrome	Renal hypoplasia	Very frequent (99-80%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000142	fraser syndrome	Abnormality of the vagina	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000148	fraser syndrome	Vaginal atresia	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000202	fraser syndrome	Oral cleft	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000204	fraser syndrome	Cleft upper lip	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000218	fraser syndrome	High palate	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000252	fraser syndrome	Microcephaly	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000316	fraser syndrome	Hypertelorism	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000368	fraser syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000370	fraser syndrome	Abnormality of the middle ear	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000405	fraser syndrome	Conductive hearing impairment	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000413	fraser syndrome	Atresia of the external auditory canal	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000430	fraser syndrome	Underdeveloped nasal alae	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000431	fraser syndrome	Wide nasal bridge	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000528	fraser syndrome	Anophthalmia	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000568	fraser syndrome	Microphthalmia	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000618	fraser syndrome	Blindness	Very frequent (99-80%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000678	fraser syndrome	Dental crowding	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000689	fraser syndrome	Dental malocclusion	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000813	fraser syndrome	Bicornuate uterus	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0001126	fraser syndrome	Cryptophthalmos	Very frequent (99-80%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0001249	fraser syndrome	Intellectual disability	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0001362	fraser syndrome	Skull defect	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0001522	fraser syndrome	Death in infancy	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0001537	fraser syndrome	Umbilical hernia	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0001539	fraser syndrome	Omphalocele	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0001602	fraser syndrome	Laryngeal stenosis	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0001607	fraser syndrome	Subglottic stenosis	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0001770	fraser syndrome	Toe syndactyly	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0002023	fraser syndrome	Anal atresia	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0002025	fraser syndrome	Anal stenosis	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0002084	fraser syndrome	Encephalocele	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0002089	fraser syndrome	Pulmonary hypoplasia	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0002101	fraser syndrome	Abnormal lung lobation	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0002475	fraser syndrome	Myelomeningocele	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0002564	fraser syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0002777	fraser syndrome	Tracheal stenosis	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0003183	fraser syndrome	Wide pubic symphysis	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0003191	fraser syndrome	Cleft ala nasi	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0003422	fraser syndrome	Vertebral segmentation defect	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0004112	fraser syndrome	Midline nasal groove	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0004397	fraser syndrome	Ectopic anus	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0005280	fraser syndrome	Depressed nasal bridge	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0006101	fraser syndrome	Finger syndactyly	Very frequent (99-80%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0006610	fraser syndrome	Wide intermamillary distance	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0007925	fraser syndrome	Lacrimal duct aplasia	Very frequent (99-80%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0007993	fraser syndrome	Malformed lacrimal ducts	Very frequent (99-80%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0008572	fraser syndrome	External ear malformation	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0008736	fraser syndrome	Hypoplasia of penis	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0010297	fraser syndrome	Bifid tongue	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0010458	fraser syndrome	Female pseudohermaphroditism	Frequent (79-30%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0010720	fraser syndrome	Abnormal hair pattern	Occasional (29-5%)	FREM2	608945	219000	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Eye;Heart/Cardiovasculature/Lymphatic	25396	FRAS1 related extracellular matrix protein 2	protein-coding gene	gene with protein product	Approved	13q13.3	13q13.3	DKFZp686J0811				
HP:0000023	schwartz-jampel syndrome	Inguinal hernia	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000069	schwartz-jampel syndrome	Abnormality of the ureter	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000079	schwartz-jampel syndrome	Abnormality of the urinary system	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	schwartz-jampel syndrome	Narrow mouth	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	schwartz-jampel syndrome	Cleft palate	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000205	schwartz-jampel syndrome	Pursed lips	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000211	schwartz-jampel syndrome	Trismus	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	schwartz-jampel syndrome	High palate	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000232	schwartz-jampel syndrome	Everted lower lip vermilion	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	schwartz-jampel syndrome	Microcephaly	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000293	schwartz-jampel syndrome	Full cheeks	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000294	schwartz-jampel syndrome	Low anterior hairline	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000298	schwartz-jampel syndrome	Mask-like facies	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	schwartz-jampel syndrome	Hypertelorism	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	schwartz-jampel syndrome	Long philtrum	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	schwartz-jampel syndrome	Micrognathia	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	schwartz-jampel syndrome	Low-set, posteriorly rotated ears	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000396	schwartz-jampel syndrome	Overfolded helix	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	schwartz-jampel syndrome	Prominent nasal bridge	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	schwartz-jampel syndrome	Short neck	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000482	schwartz-jampel syndrome	Microcornea	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	schwartz-jampel syndrome	Strabismus	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	schwartz-jampel syndrome	Visual impairment	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	schwartz-jampel syndrome	Ptosis	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	schwartz-jampel syndrome	Cataract	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000534	schwartz-jampel syndrome	Abnormality of the eyebrow	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	schwartz-jampel syndrome	Myopia	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000581	schwartz-jampel syndrome	Blepharophimosis	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000600	schwartz-jampel syndrome	Abnormality of the pharynx	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000643	schwartz-jampel syndrome	Blepharospasm	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000689	schwartz-jampel syndrome	Dental malocclusion	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000737	schwartz-jampel syndrome	Irritability	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000739	schwartz-jampel syndrome	Anxiety	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	schwartz-jampel syndrome	Pectus excavatum	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	schwartz-jampel syndrome	Pectus carinatum	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	schwartz-jampel syndrome	Abnormality of the ribs	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000787	schwartz-jampel syndrome	Nephrolithiasis	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000912	schwartz-jampel syndrome	Sprengel anomaly	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000926	schwartz-jampel syndrome	Platyspondyly	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000939	schwartz-jampel syndrome	Osteoporosis	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	schwartz-jampel syndrome	Abnormality of the metaphyses	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001083	schwartz-jampel syndrome	Ectopia lentis	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001239	schwartz-jampel syndrome	Wrist flexion contracture	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	schwartz-jampel syndrome	Intellectual disability	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001265	schwartz-jampel syndrome	Hyporeflexia	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001276	schwartz-jampel syndrome	Hypertonia	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	schwartz-jampel syndrome	Gait disturbance	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	schwartz-jampel syndrome	Muscle weakness	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001385	schwartz-jampel syndrome	Hip dysplasia	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	schwartz-jampel syndrome	Joint stiffness	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001522	schwartz-jampel syndrome	Death in infancy	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	schwartz-jampel syndrome	Umbilical hernia	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001557	schwartz-jampel syndrome	Prenatal movement abnormality	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	schwartz-jampel syndrome	Polyhydramnios	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001601	schwartz-jampel syndrome	Laryngomalacia	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001618	schwartz-jampel syndrome	Dysphonia	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001620	schwartz-jampel syndrome	High pitched voice	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001621	schwartz-jampel syndrome	Weak voice	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001762	schwartz-jampel syndrome	Talipes equinovarus	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	schwartz-jampel syndrome	Pes planus	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002047	schwartz-jampel syndrome	Malignant hyperthermia	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002092	schwartz-jampel syndrome	Pulmonary arterial hypertension	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	schwartz-jampel syndrome	Respiratory insufficiency	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002104	schwartz-jampel syndrome	Apnea	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	schwartz-jampel syndrome	Neurological speech impairment	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002230	schwartz-jampel syndrome	Generalized hirsutism	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002486	schwartz-jampel syndrome	Myotonia	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002645	schwartz-jampel syndrome	Wormian bones	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	schwartz-jampel syndrome	Scoliosis	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	schwartz-jampel syndrome	Skeletal dysplasia	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002673	schwartz-jampel syndrome	Coxa valga	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	schwartz-jampel syndrome	Delayed skeletal maturation	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002804	schwartz-jampel syndrome	Arthrogryposis multiplex congenita	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	schwartz-jampel syndrome	Kyphosis	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002812	schwartz-jampel syndrome	Coxa vara	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	schwartz-jampel syndrome	Genu valgum	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	schwartz-jampel syndrome	Micromelia	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003042	schwartz-jampel syndrome	Elbow dislocation	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003044	schwartz-jampel syndrome	Shoulder flexion contracture	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003179	schwartz-jampel syndrome	Protrusio acetabuli	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003198	schwartz-jampel syndrome	Myopathy	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	schwartz-jampel syndrome	Skeletal muscle atrophy	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003236	schwartz-jampel syndrome	Elevated serum creatine phosphokinase	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003273	schwartz-jampel syndrome	Hip contracture	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003306	schwartz-jampel syndrome	Spinal rigidity	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003307	schwartz-jampel syndrome	Hyperlordosis	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003326	schwartz-jampel syndrome	Myalgia	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003457	schwartz-jampel syndrome	EMG abnormality	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003712	schwartz-jampel syndrome	Skeletal muscle hypertrophy	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	schwartz-jampel syndrome	Short stature	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004325	schwartz-jampel syndrome	Decreased body weight	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004326	schwartz-jampel syndrome	Cachexia	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005830	schwartz-jampel syndrome	Flexion contracture of toe	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	schwartz-jampel syndrome	Abnormality of epiphysis morphology	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	schwartz-jampel syndrome	Bowing of the long bones	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007018	schwartz-jampel syndrome	Attention deficit hyperactivity disorder	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007740	schwartz-jampel syndrome	Long eyelashes in irregular rows	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008056	schwartz-jampel syndrome	Aplasia/Hypoplasia affecting the eye	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008734	schwartz-jampel syndrome	Decreased testicular size	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	schwartz-jampel syndrome	Feeding difficulties in infancy	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009743	schwartz-jampel syndrome	Distichiasis	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010508	schwartz-jampel syndrome	Metatarsus valgus	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	schwartz-jampel syndrome	Abnormality of immune system physiology	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011001	schwartz-jampel syndrome	Increased bone mineral density	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011069	schwartz-jampel syndrome	Increased number of teeth	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	schwartz-jampel syndrome	Arrhythmia	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012368	schwartz-jampel syndrome	Flat face	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012544	schwartz-jampel syndrome	Elevated aldolase level	Very frequent (99-80%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100569	schwartz-jampel syndrome	Abnormal vertebral ossification	Frequent (79-30%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100612	schwartz-jampel syndrome	Odontogenic neoplasm	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100795	schwartz-jampel syndrome	Abnormally straight spine	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100813	schwartz-jampel syndrome	Testicular torsion	Occasional (29-5%)	HSPG2	142461	255800	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000112	alg1-cdg	Nephropathy	Frequent (79-30%)	ALG1	605907	300141	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	18294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	alg1-cdg	Hypogonadism	Frequent (79-30%)	ALG1	605907	300141	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	18294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	alg1-cdg	Microcephaly	Very frequent (99-80%)	ALG1	605907	300141	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	18294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	alg1-cdg	Seizures	Very frequent (99-80%)	ALG1	605907	300141	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	18294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	alg1-cdg	Global developmental delay	Very frequent (99-80%)	ALG1	605907	300141	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	18294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001399	alg1-cdg	Hepatic failure	Frequent (79-30%)	ALG1	605907	300141	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	18294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	alg1-cdg	Hypertrophic cardiomyopathy	Frequent (79-30%)	ALG1	605907	300141	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	18294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	alg1-cdg	Abnormality of immune system physiology	Frequent (79-30%)	ALG1	605907	300141	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	18294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	syndromic intellectual disability	NA	NA	AUTS2	No gene mim	612100	monoallelic	confirmed	loss of function	Brain/Cognition	14262	AUTS2, activator of transcription and developmental regulator	protein-coding gene	gene with protein product	Approved	7q11.22	07q11.22	KIAA0442|FBRSL2			autism susceptibility candidate 2	
NA	may-hegglin anomaly	NA	NA	MYH9	No gene mim	155100	monoallelic	confirmed	loss of function	Bone Marrow/Immune	7579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pontocerebellar hypoplasia type 6	NA	NA	RARS2	611524	318922	biallelic	confirmed	loss of function	Brain/Cognition	21406	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	subcutaneous lipodystrophy, deafness, mandibular hypoplasia and hypogonadism in males	NA	NA	POLD1	No gene mim	615381	monoallelic	both DD and IF	all missense/in frame	Skin;Ear;Genitalia	9175	DNA polymerase delta 1, catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.3	19q13.3	CDC2	CDC2 homolog (S. cerevisiae)	POLD	polymerase (DNA directed), delta 1, catalytic subunit (125kD)|polymerase (DNA) delta 1, catalytic subunit	DNA polymerases
HP:0000365	leber congenital amaurosis	Hearing impairment	Occasional (29-5%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0000512	leber congenital amaurosis	Abnormal electroretinogram	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0000518	leber congenital amaurosis	Cataract	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0000563	leber congenital amaurosis	Keratoconus	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0000639	leber congenital amaurosis	Nystagmus	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0001141	leber congenital amaurosis	Severe visual impairment	Very frequent (99-80%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0001249	leber congenital amaurosis	Intellectual disability	Occasional (29-5%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0001250	leber congenital amaurosis	Seizures	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0001252	leber congenital amaurosis	Muscular hypotonia	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0001263	leber congenital amaurosis	Global developmental delay	Occasional (29-5%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0002084	leber congenital amaurosis	Encephalocele	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0002269	leber congenital amaurosis	Abnormality of neuronal migration	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0004374	leber congenital amaurosis	Hemiplegia/hemiparesis	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0006817	leber congenital amaurosis	Aplasia/Hypoplasia of the cerebellar vermis	Frequent (79-30%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0007703	leber congenital amaurosis	Abnormality of retinal pigmentation	Very frequent (99-80%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
HP:0012795	leber congenital amaurosis	Abnormality of the optic disc	Very frequent (99-80%)	LRAT	No gene mim	608553	biallelic	probable	loss of function	Brain/Cognition;Eye	6685	lecithin retinol acyltransferase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	LCA14	phosphatidylcholine--retinol O-acyltransferase		lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)	
NA	charcot-marie-tooth disease, recessive intermediate, b	NA	NA	KARS	No gene mim	613641	biallelic	both DD and IF	loss of function	Spinal cord/Peripheral nerves;Ear	6215	lysyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	16q23.1	16q23.1	KARS2|KARS1	lysine tRNA ligase	DFNB89	deafness, autosomal recessive 89	Aminoacyl tRNA synthetases, Class II|Deafness associated genes
HP:0000187	mucolipidosis type ii	Broad alveolar ridges	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0000280	mucolipidosis type ii	Coarse facial features	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0000286	mucolipidosis type ii	Epicanthus	Frequent (79-30%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0000343	mucolipidosis type ii	Long philtrum	Frequent (79-30%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0000463	mucolipidosis type ii	Anteverted nares	Frequent (79-30%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0000485	mucolipidosis type ii	Megalocornea	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0000765	mucolipidosis type ii	Abnormality of the thorax	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0000963	mucolipidosis type ii	Thin skin	Frequent (79-30%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0001048	mucolipidosis type ii	Cavernous hemangioma	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0001131	mucolipidosis type ii	Corneal dystrophy	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0001498	mucolipidosis type ii	Carpal bone hypoplasia	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0001508	mucolipidosis type ii	Failure to thrive	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0001635	mucolipidosis type ii	Congestive heart failure	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0001654	mucolipidosis type ii	Abnormality of the heart valves	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0001744	mucolipidosis type ii	Splenomegaly	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0001824	mucolipidosis type ii	Weight loss	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0002205	mucolipidosis type ii	Recurrent respiratory infections	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0002230	mucolipidosis type ii	Generalized hirsutism	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0002240	mucolipidosis type ii	Hepatomegaly	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0002808	mucolipidosis type ii	Kyphosis	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0003026	mucolipidosis type ii	Short long bone	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0004322	mucolipidosis type ii	Short stature	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0005280	mucolipidosis type ii	Depressed nasal bridge	Frequent (79-30%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0007759	mucolipidosis type ii	Opacification of the corneal stroma	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0008155	mucolipidosis type ii	Mucopolysacchariduria	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0009092	mucolipidosis type ii	Progressive alveolar ridge hypertropy	Occasional (29-5%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0011344	mucolipidosis type ii	Severe global developmental delay	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0012639	mucolipidosis type ii	Abnormality of nervous system morphology	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0100679	mucolipidosis type ii	Lack of skin elasticity	Frequent (79-30%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0100790	mucolipidosis type ii	Hernia	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
HP:0200020	mucolipidosis type ii	Corneal erosion	Very frequent (99-80%)	GNPTAB	607840	252500	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
NA	congenital disorder of glycosylation type 2c	NA	NA	SLC35C1	605881	266265	biallelic	confirmed	loss of function	Bone Marrow/Immune;Face;Brain/Cognition	20197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	syndromal pierre robin sequence	NA	NA	SATB2	608148	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	21637	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia syndromic type 8	NA	NA	SNX3	No gene mim	601349	monoallelic	possible	loss of function	Face;Brain/Cognition;Eye	11174	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial respiratory chain complex i deficiency	NA	NA	NDUFS8	602141	252010	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	7715	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary microcephaly	NA	NA	PHC1	No gene mim	615414	biallelic	possible	all missense/in frame	Brain/Cognition	3182	polyhomeotic homolog 1	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	HPH1|RAE28		EDR1	early development regulator 1 (homolog of polyhomeotic 1)|polyhomeotic-like 1 (Drosophila)|polyhomeotic homolog 1 (Drosophila)	Sterile alpha motif domain containing
HP:0008153	hypokalemic periodic paralysis	Periodic hypokalemic paresis	Obligate (100%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012726	hypokalemic periodic paralysis	Episodic hypokalemia	Obligate (100%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003457	hypokalemic periodic paralysis	EMG abnormality	Very frequent (99-80%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003470	hypokalemic periodic paralysis	Paralysis	Very frequent (99-80%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003752	hypokalemic periodic paralysis	Episodic flaccid weakness	Very frequent (99-80%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004303	hypokalemic periodic paralysis	Abnormality of muscle fibers	Very frequent (99-80%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008180	hypokalemic periodic paralysis	Mildly elevated creatine phosphokinase	Very frequent (99-80%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012240	hypokalemic periodic paralysis	Increased intramyocellular lipid droplets	Very frequent (99-80%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009020	hypokalemic periodic paralysis	Exercise-induced muscle fatigue	Frequent (79-30%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011998	hypokalemic periodic paralysis	Postprandial hyperglycemia	Frequent (79-30%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003694	hypokalemic periodic paralysis	Late-onset proximal muscle weakness	Occasional (29-5%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002203	hypokalemic periodic paralysis	Respiratory paralysis	Very rare (<4-1%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008256	hypokalemic periodic paralysis	Adrenocortical adenoma	Very rare (<4-1%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030196	hypokalemic periodic paralysis	Fatigable weakness of respiratory muscles	Very rare (<4-1%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002486	hypokalemic periodic paralysis	Myotonia	Excluded (0%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006670	hypokalemic periodic paralysis	Impaired myocardial contractility	Excluded (0%)	SCN4A	603967	613345	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebral cavernous malformations type 1	NA	NA	KRIT1	No gene mim	116860	monoallelic	both DD and IF	loss of function	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1573	KRIT1, ankyrin repeat containing	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2	CAM		CCM1	cerebral cavernous malformations 1	Ankyrin repeat domain containing|FERM domain containing
NA	alg11-cdg	NA	NA	ALG11	613666	319490	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	32456	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	adrenoleukodystrophy neonatal	NA	NA	PEX5	600414	202370	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000028	tetralogy of fallot	Cryptorchidism	Frequent (79-30%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0000233	tetralogy of fallot	Thin vermilion border	Frequent (79-30%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0000268	tetralogy of fallot	Dolichocephaly	Frequent (79-30%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0000337	tetralogy of fallot	Broad forehead	Very frequent (99-80%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0000520	tetralogy of fallot	Proptosis	Frequent (79-30%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0001156	tetralogy of fallot	Brachydactyly syndrome	Very frequent (99-80%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0001511	tetralogy of fallot	Intrauterine growth retardation	Very frequent (99-80%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0001636	tetralogy of fallot	Tetralogy of Fallot	Frequent (79-30%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0004209	tetralogy of fallot	Clinodactyly of the 5th finger	Very frequent (99-80%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0004467	tetralogy of fallot	Preauricular pit	Frequent (79-30%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0005105	tetralogy of fallot	Abnormal nasal morphology	Very frequent (99-80%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0009891	tetralogy of fallot	Underdeveloped supraorbital ridges	Frequent (79-30%)	GDF1	No gene mim	187500	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
NA	septooptic dysplasia	NA	NA	HESX1	601802	256657	biallelic	probable	loss of function	Endocrine;Brain/Cognition	4877	HESX homeobox 1	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	RPX|ANF			homeobox, ES cell expressed 1	PRD class homeoboxes and pseudogenes
NA	autosomal recessive mental retardation	NA	NA	TRMT1	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	25980	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	jeune syndromes	NA	NA	WDR60	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	21862	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	immunodeficiency nemo-related without anhidrotic ectodermal dysplasia	NA	NA	IKBKG	300248	300584	hemizygous	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
NA	spondylocostal dysostosis type 1	NA	NA	DLL3	602768	277300	biallelic	confirmed	loss of function	Skeleton	2909	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	parkes weber syndrome	Glaucoma	Occasional (29-5%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001052	parkes weber syndrome	Nevus flammeus	Very frequent (99-80%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001269	parkes weber syndrome	Hemiparesis	Occasional (29-5%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001635	parkes weber syndrome	Congestive heart failure	Occasional (29-5%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001892	parkes weber syndrome	Abnormal bleeding	Very frequent (99-80%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002315	parkes weber syndrome	Headache	Occasional (29-5%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002619	parkes weber syndrome	Varicose veins	Frequent (79-30%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010484	parkes weber syndrome	Hypertrophy of the upper limb	Very frequent (99-80%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010496	parkes weber syndrome	Hypertrophy of the lower limb	Very frequent (99-80%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011276	parkes weber syndrome	Vascular skin abnormality	Occasional (29-5%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100585	parkes weber syndrome	Telangiectasia of the skin	Very frequent (99-80%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100784	parkes weber syndrome	Peripheral arteriovenous fistula	Very frequent (99-80%)	RASA1	139150	608355	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanconi anemia, complementation group f	NA	NA	FANCF	613897	603467	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	3587	Fanconi anemia complementation group F	protein-coding gene	gene with protein product	Approved	11p14.3	11p14.3	FAF				Fanconi anemia complementation groups
NA	fumarase deficiency	NA	NA	FH	No gene mim	606812	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	3700	fumarate hydratase	protein-coding gene	gene with protein product	Approved	1q43	01q43	fumarase				
NA	muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type a3 (mddga3	NA	NA	POMGNT1	606822	253280	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	19139	protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)	protein-coding gene	gene with protein product	Approved	1p34.1	01p34.1	FLJ20277|MGAT1.2|LGMD2O	protein O-mannose beta-1,2-N-acetylglucosaminyltransferase	MEB	muscle-eye-brain disease|protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase	O-linked N-acetylglucosaminyltransferases
NA	deafness autosomal recessive type 2	NA	NA	MYO7A	No gene mim	600060	biallelic	both DD and IF	loss of function	Eye;Ear	7606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000162	cleidocranial dysplasia	Glossoptosis	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	cleidocranial dysplasia	Abnormality of the teeth	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	cleidocranial dysplasia	Cleft palate	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000239	cleidocranial dysplasia	Large fontanelles	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000246	cleidocranial dysplasia	Sinusitis	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	cleidocranial dysplasia	Brachycephaly	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	cleidocranial dysplasia	Macrocephaly	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	cleidocranial dysplasia	Mandibular prognathia	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	cleidocranial dysplasia	Hypertelorism	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	cleidocranial dysplasia	Broad forehead	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000340	cleidocranial dysplasia	Sloping forehead	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	cleidocranial dysplasia	Micrognathia	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000364	cleidocranial dysplasia	Hearing abnormality	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	cleidocranial dysplasia	Hearing impairment	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000389	cleidocranial dysplasia	Chronic otitis media	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	cleidocranial dysplasia	Carious teeth	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	cleidocranial dysplasia	Abnormality of dental enamel	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	cleidocranial dysplasia	Delayed eruption of teeth	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	cleidocranial dysplasia	Abnormality of the ribs	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	cleidocranial dysplasia	Narrow chest	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000882	cleidocranial dysplasia	Hypoplastic scapulae	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000894	cleidocranial dysplasia	Short clavicles	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000939	cleidocranial dysplasia	Osteoporosis	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	cleidocranial dysplasia	Brachydactyly syndrome	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	cleidocranial dysplasia	Abnormality of the metacarpal bones	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001172	cleidocranial dysplasia	Abnormality of the thumb	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001182	cleidocranial dysplasia	Tapered finger	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001810	cleidocranial dysplasia	Dystrophic toenail	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	cleidocranial dysplasia	Frontal bossing	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	cleidocranial dysplasia	Recurrent respiratory infections	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002644	cleidocranial dysplasia	Abnormality of pelvic girdle bone morphology	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002645	cleidocranial dysplasia	Wormian bones	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	cleidocranial dysplasia	Scoliosis	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	cleidocranial dysplasia	Skeletal dysplasia	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002705	cleidocranial dysplasia	High, narrow palate	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	cleidocranial dysplasia	Recurrent fractures	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002812	cleidocranial dysplasia	Coxa vara	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	cleidocranial dysplasia	Genu valgum	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003298	cleidocranial dysplasia	Spina bifida occulta	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	cleidocranial dysplasia	Clinodactyly of the 5th finger	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	cleidocranial dysplasia	Short stature	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004331	cleidocranial dysplasia	Decreased skull ossification	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005107	cleidocranial dysplasia	Abnormality of the sacrum	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	cleidocranial dysplasia	Depressed nasal bridge	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	cleidocranial dysplasia	Abnormality of epiphysis morphology	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008391	cleidocranial dysplasia	Dystrophic fingernails	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008821	cleidocranial dysplasia	Hypoplastic inferior ilia	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010535	cleidocranial dysplasia	Sleep apnea	Occasional (29-5%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010669	cleidocranial dysplasia	Cheekbone underdevelopment	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010751	cleidocranial dysplasia	Chin dimple	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010807	cleidocranial dysplasia	Open bite	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011069	cleidocranial dysplasia	Increased number of teeth	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011219	cleidocranial dysplasia	Short face	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	cleidocranial dysplasia	Midface retrusion	Frequent (79-30%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200021	cleidocranial dysplasia	Down-sloping shoulders	Very frequent (99-80%)	RUNX2	600211	119600	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	10472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract autosomal dominant	NA	NA	CRYGC	123680	604219	monoallelic	confirmed	loss of function	Eye	2410	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lowe oculocerebrorenal syndrome	NA	NA	OCRL	300535	309000	hemizygous	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	8108	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	martinez-frias syndrome	NA	NA	RFX6	612659	601346	biallelic	confirmed	loss of function	Endocrine/Metabolic;GI tract	21478	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leigh syndrome, french-canadian type	NA	NA	LRPPRC	607544	220111	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	15714	leucine rich pentatricopeptide repeat containing	protein-coding gene	gene with protein product	Approved	2p21	02p21	GP130|LRP130		LSFC	Leigh syndrome, French-Canadian type (cytochrome oxidase deficiency)	
NA	infantile striatonigral degeneration	NA	NA	NUP62	605815	271930	biallelic	probable	uncertain	Brain/Cognition	8066	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acromesomelic dysplasia maroteaux type	NA	NA	NPR2	108961	602875	biallelic	confirmed	loss of function	Skeleton	7944	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial complex iv deficiency	NA	NA	PET100	No gene mim	220110	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	40038	PET100 homolog	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2			C19orf79	chromosome 19 open reading frame 79|PET100 homolog (S. cerevisiae)	
HP:0000154	floating-harbor syndrome	Wide mouth	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000233	floating-harbor syndrome	Thin vermilion border	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000243	floating-harbor syndrome	Trigonocephaly	Occasional (29-5%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000322	floating-harbor syndrome	Short philtrum	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000325	floating-harbor syndrome	Triangular face	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000358	floating-harbor syndrome	Posteriorly rotated ears	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000403	floating-harbor syndrome	Recurrent otitis media	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000414	floating-harbor syndrome	Bulbous nose	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000430	floating-harbor syndrome	Underdeveloped nasal alae	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	floating-harbor syndrome	Wide nasal bridge	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000448	floating-harbor syndrome	Prominent nose	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	floating-harbor syndrome	Short neck	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	floating-harbor syndrome	Strabismus	Occasional (29-5%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	floating-harbor syndrome	Deeply set eye	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000506	floating-harbor syndrome	Telecanthus	Occasional (29-5%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000527	floating-harbor syndrome	Long eyelashes	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000889	floating-harbor syndrome	Abnormality of the clavicle	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000894	floating-harbor syndrome	Short clavicles	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	floating-harbor syndrome	Brachydactyly syndrome	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001231	floating-harbor syndrome	Abnormality of the fingernails	Occasional (29-5%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	floating-harbor syndrome	Intellectual disability	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	floating-harbor syndrome	Global developmental delay	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	floating-harbor syndrome	Joint stiffness	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	floating-harbor syndrome	Intrauterine growth retardation	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001608	floating-harbor syndrome	Abnormality of the voice	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001611	floating-harbor syndrome	Nasal speech	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001620	floating-harbor syndrome	High pitched voice	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	floating-harbor syndrome	Constipation	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	floating-harbor syndrome	Malabsorption	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	floating-harbor syndrome	Neurological speech impairment	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002230	floating-harbor syndrome	Generalized hirsutism	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002474	floating-harbor syndrome	Expressive language delay	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	floating-harbor syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	floating-harbor syndrome	Delayed skeletal maturation	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003037	floating-harbor syndrome	Enlarged joints	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	floating-harbor syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	floating-harbor syndrome	Short stature	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	floating-harbor syndrome	Joint hyperflexibility	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006585	floating-harbor syndrome	Congenital pseudoarthrosis of the clavicle	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007058	floating-harbor syndrome	Generalized cerebral atrophy/hypoplasia	Occasional (29-5%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	floating-harbor syndrome	Hypoplasia of penis	Occasional (29-5%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	floating-harbor syndrome	Feeding difficulties in infancy	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010761	floating-harbor syndrome	Broad columella	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010957	floating-harbor syndrome	Congenital posterior urethral valve	Occasional (29-5%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011304	floating-harbor syndrome	Broad thumb	Very frequent (99-80%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	floating-harbor syndrome	Camptodactyly of finger	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100736	floating-harbor syndrome	Abnormality of the soft palate	Frequent (79-30%)	SRCAP	611421	136140	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition	16974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000488	neurodegeneration with brain iron accumulation	Retinopathy	Frequent (79-30%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	neurodegeneration with brain iron accumulation	Optic atrophy	Frequent (79-30%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	neurodegeneration with brain iron accumulation	Spasticity	Frequent (79-30%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001260	neurodegeneration with brain iron accumulation	Dysarthria	Frequent (79-30%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001272	neurodegeneration with brain iron accumulation	Cerebellar atrophy	Frequent (79-30%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001332	neurodegeneration with brain iron accumulation	Dystonia	Very frequent (99-80%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002063	neurodegeneration with brain iron accumulation	Rigidity	Frequent (79-30%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002071	neurodegeneration with brain iron accumulation	Abnormality of extrapyramidal motor function	Frequent (79-30%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002072	neurodegeneration with brain iron accumulation	Chorea	Frequent (79-30%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012675	neurodegeneration with brain iron accumulation	Iron accumulation in brain	Very frequent (99-80%)	COASY	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	29932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephronophthisis type 4	NA	NA	NPHP4	607215	606966	biallelic	confirmed	loss of function	Kidney Renal Tract	19104	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	agnathia-otocephaly complex	NA	NA	PRRX1	No gene mim	202650	monoallelic	possible	all missense/in frame	Face;Ear	9142	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	agnathia-otocephaly complex	NA	NA	PRRX1	No gene mim	202650	biallelic	possible	all missense/in frame	Face;Ear	9142	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acrofacial dysostosis weyers type	NA	NA	EVC	604831	193530	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Heart/Cardiovasculature/Lymphatic	3497	EvC ciliary complex subunit 1	protein-coding gene	gene with protein product	Approved	4p16.2	04p16.2	DWF-1			Ellis van Creveld syndrome|Ellis van Creveld protein	
NA	scn1a-related seizure disorders	NA	NA	SCN1A	182389	607208	monoallelic	confirmed	loss of function	Brain/Cognition	10585	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple epiphyseal dysplasia type 6	NA	NA	COL9A1	120210	614135	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye	2217	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spastic paraplegia autosomal recessive type 15	NA	NA	ZFYVE26	612012	270700	biallelic	confirmed	loss of function	Brain/Cognition;Eye	20761	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	PARP1	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	270	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, autosomal dominant 24	NA	NA	DEAF1	No gene mim	615828	monoallelic	confirmed	loss of function	Brain/Cognition	14677	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000070	epidermolysis bullosa simplex with pyloric atresia	Ureterocele	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000096	epidermolysis bullosa simplex with pyloric atresia	Glomerulosclerosis	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000110	epidermolysis bullosa simplex with pyloric atresia	Renal dysplasia	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000126	epidermolysis bullosa simplex with pyloric atresia	Hydronephrosis	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001057	epidermolysis bullosa simplex with pyloric atresia	Aplasia cutis congenita	Very frequent (99-80%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001376	epidermolysis bullosa simplex with pyloric atresia	Limitation of joint mobility	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	epidermolysis bullosa simplex with pyloric atresia	Failure to thrive	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	epidermolysis bullosa simplex with pyloric atresia	Polyhydramnios	Very frequent (99-80%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001622	epidermolysis bullosa simplex with pyloric atresia	Premature birth	Very frequent (99-80%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	epidermolysis bullosa simplex with pyloric atresia	Anemia	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001944	epidermolysis bullosa simplex with pyloric atresia	Dehydration	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002015	epidermolysis bullosa simplex with pyloric atresia	Dysphagia	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002577	epidermolysis bullosa simplex with pyloric atresia	Abnormality of the stomach	Very frequent (99-80%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008066	epidermolysis bullosa simplex with pyloric atresia	Abnormal blistering of the skin	Very frequent (99-80%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010477	epidermolysis bullosa simplex with pyloric atresia	Aplasia of the bladder	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100806	epidermolysis bullosa simplex with pyloric atresia	Sepsis	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200041	epidermolysis bullosa simplex with pyloric atresia	Skin erosion	Very frequent (99-80%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200097	epidermolysis bullosa simplex with pyloric atresia	Oral mucosal blisters	Frequent (79-30%)	PLEC	601282	612138	biallelic	possible	loss of function	Musculature;Skin	9069	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cranioectodermal dysplasia 2	NA	NA	WDR35	613602	613610	biallelic	confirmed	loss of function	Skeleton	29250	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	SCAPER	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	13081	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	eln-related cutis laxa	NA	NA	ELN	130160	314088	monoallelic	confirmed	loss of function	Skin;Heart/Cardiovasculature/Lymphatic	3327	elastin	protein-coding gene	gene with protein product	Approved	7q11.23	07q11.23	WBS|WS|SVAS	tropoelastin|supravalvular aortic stenosis|Williams-Beuren syndrome			
NA	aicardi-goutieres syndrome 4	NA	NA	RNASEH2A	606034	610333	biallelic	confirmed	loss of function	Skin;Brain/Cognition	18518	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	erythrokeratodermia variabilis et progressiva	NA	NA	GJB3	No gene mim	133200	monoallelic	both DD and IF	all missense/in frame	Skin;Ear	4285	gap junction protein beta 3	protein-coding gene	gene with protein product	Approved	1p34.3	01p34.3	CX31	connexin 31	DFNA2|EKV	gap junction protein, beta 3, 31kD (connexin 31)|gap junction protein, beta 3, 31kDa (connexin 31)|erythrokeratodermia variabilis|gap junction protein, beta 3, 31kDa	Gap junction proteins|Deafness associated genes
NA	cerebral palsy spastic quadriplegic type 3	NA	NA	AP4M1	No gene mim	612936	biallelic	probable	loss of function	Brain/Cognition	574	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital heart defects, multiple types, 4	NA	NA	NR2F2	No gene mim	615779	monoallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	7976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	temtamy syndrome; coloboma, hypoplastic corpus callosum and intellectual disability	NA	NA	C12orf57	No gene mim	218340	biallelic	probable	all missense/in frame	Brain/Cognition	29521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rhabdoid predisposition syndrome 1	NA	NA	SMARCB1	601607	609322	monoallelic	confirmed	loss of function	Musculature;Skeleton;Brain/Cognition;Cancer predisposition	11103	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	molybdenum cofactor deficiency	NA	NA	MOCS1	603707	603707	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7190	molybdenum cofactor synthesis 1	protein-coding gene	gene with protein product	Approved	6p21.2	06p21.2	MOCOD				
NA	keratitis hereditary	NA	NA	PAX6	607108	148190	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pyruvate dehydrogenase e2 deficiency	NA	NA	DLAT	608770	245348	biallelic	confirmed	loss of function	Endocrine/Metabolic	2896	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	frank-ter haar syndrome	Wide mouth	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	frank-ter haar syndrome	Coarse facial features	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	frank-ter haar syndrome	Hypertelorism	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000322	frank-ter haar syndrome	Short philtrum	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	frank-ter haar syndrome	Wide nasal bridge	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	frank-ter haar syndrome	Deeply set eye	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001061	frank-ter haar syndrome	Acne	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001072	frank-ter haar syndrome	Thickened skin	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	frank-ter haar syndrome	Brachydactyly syndrome	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001634	frank-ter haar syndrome	Mitral valve prolapse	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002797	frank-ter haar syndrome	Osteolysis	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	frank-ter haar syndrome	Depressed nasal bridge	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010885	frank-ter haar syndrome	Aseptic necrosis	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012471	frank-ter haar syndrome	Thick vermilion border	Very frequent (99-80%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000212	frank-ter haar syndrome	Gingival overgrowth	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	frank-ter haar syndrome	Mandibular prognathia	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	frank-ter haar syndrome	Broad forehead	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	frank-ter haar syndrome	High forehead	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000411	frank-ter haar syndrome	Protruding ear	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	frank-ter haar syndrome	Downslanted palpebral fissures	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	frank-ter haar syndrome	Delayed eruption of teeth	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	frank-ter haar syndrome	Abnormality of the metacarpal bones	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	frank-ter haar syndrome	Joint stiffness	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	frank-ter haar syndrome	Scoliosis	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	frank-ter haar syndrome	Kyphosis	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002816	frank-ter haar syndrome	Genu recurvatum	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	frank-ter haar syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004568	frank-ter haar syndrome	Beaking of vertebral bodies	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006480	frank-ter haar syndrome	Premature loss of teeth	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	frank-ter haar syndrome	Camptodactyly of finger	Frequent (79-30%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	frank-ter haar syndrome	Inguinal hernia	Occasional (29-5%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000771	frank-ter haar syndrome	Gynecomastia	Occasional (29-5%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	frank-ter haar syndrome	Umbilical hernia	Occasional (29-5%)	SH3PXD2B	613293	249420	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	29242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	melnick-needles syndrome	NA	NA	FLNA	300017	309350	x-linked dominant	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
NA	bosch-boonstra optic atrophy syndrome	NA	NA	NR2F1	No gene mim	615722	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	7975	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rolandic epilepsy with speech dyspraxia and mental retardation x-linked	NA	NA	SRPX2	300642	300643	hemizygous	probable	uncertain	Brain/Cognition	30668	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	blepharophimosis/intellectual disability phenotype which is noonan-like	NA	NA	KAT6B	605880	No disease mim	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000238	greig cephalopolysyndactyly syndrome	Hydrocephalus	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0000256	greig cephalopolysyndactyly syndrome	Macrocephaly	Very frequent (99-80%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0000316	greig cephalopolysyndactyly syndrome	Hypertelorism	Frequent (79-30%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0000348	greig cephalopolysyndactyly syndrome	High forehead	Frequent (79-30%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0000431	greig cephalopolysyndactyly syndrome	Wide nasal bridge	Frequent (79-30%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0000506	greig cephalopolysyndactyly syndrome	Telecanthus	Frequent (79-30%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0000776	greig cephalopolysyndactyly syndrome	Congenital diaphragmatic hernia	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001162	greig cephalopolysyndactyly syndrome	Postaxial hand polydactyly	Very frequent (99-80%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001177	greig cephalopolysyndactyly syndrome	Preaxial hand polydactyly	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001250	greig cephalopolysyndactyly syndrome	Seizures	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001256	greig cephalopolysyndactyly syndrome	Intellectual disability, mild	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001274	greig cephalopolysyndactyly syndrome	Agenesis of corpus callosum	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001363	greig cephalopolysyndactyly syndrome	Craniosynostosis	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001537	greig cephalopolysyndactyly syndrome	Umbilical hernia	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001770	greig cephalopolysyndactyly syndrome	Toe syndactyly	Frequent (79-30%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001830	greig cephalopolysyndactyly syndrome	Postaxial foot polydactyly	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0001841	greig cephalopolysyndactyly syndrome	Preaxial foot polydactyly	Very frequent (99-80%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0002007	greig cephalopolysyndactyly syndrome	Frontal bossing	Frequent (79-30%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0005616	greig cephalopolysyndactyly syndrome	Accelerated skeletal maturation	Frequent (79-30%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0006101	greig cephalopolysyndactyly syndrome	Finger syndactyly	Frequent (79-30%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0010059	greig cephalopolysyndactyly syndrome	Broad hallux phalanx	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
HP:0011304	greig cephalopolysyndactyly syndrome	Broad thumb	Occasional (29-5%)	GLI3	165240	175700	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
NA	neuropathy, hereditary sensory and autonomic, type iib	NA	NA	RETREG1	No gene mim	613115	biallelic	confirmed	loss of function	Spinal cord/Peripheral nerves	25964	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lethal congenital contracture syndrome type 3	NA	NA	PIP5K1C	No gene mim	611369	biallelic	possible	all missense/in frame	Skeleton;Spinal cord/Peripheral nerves	8996	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	non-phenylketonuria hyperphenylalaninemia	NA	NA	PAH	612349	261600	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	8582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	loeys-dietz syndrome type 2a	NA	NA	TGFBR1	190181	608967	monoallelic	confirmed	uncertain	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11772	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy congenital without mental retardation type b4	NA	NA	FKTN	607440	613152	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	3622	fukutin	protein-coding gene	gene with protein product	Approved	9q31.2	09q31.2	LGMD2M		FCMD	Fukuyama type congenital muscular dystrophy (fukutin)	
NA	cardiomyopathy dilated type 1a	NA	NA	LMNA	No gene mim	115200	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
NA	pituitary dwarfism ii	NA	NA	GHR	600946	262500	biallelic	confirmed	loss of function	Endocrine/Metabolic	4263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	coenzyme q10 deficiency, primary, 7	NA	NA	COQ4	No gene mim	616276	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	19693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	tooth agenesis, selective, 3	NA	NA	PAX9	167416	318869	monoallelic	confirmed	loss of function	Teeth & Dentitian	8623	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	emery-dreifuss muscular dystrophy 6, x-linked	NA	NA	FHL1	300163	300696	hemizygous	confirmed	loss of function	Musculature	3702	four and a half LIM domains 1	protein-coding gene	gene with protein product	Approved	Xq26.3	Xq26.3	SLIM1|KYO-T|bA535K18.1|FHL1B|XMPMA|FLH1A|MGC111107	Four-and-a-half LIM domains 1|LIM protein SLIMMER			LIM domain containing
NA	deafness autosomal recessive type 12	NA	NA	CDH23	605516	601386	biallelic	confirmed	all missense/in frame	Eye;Ear	13733	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	night blindness, congenital stationary, type 1c	NA	NA	TRPM1	603576	613216	biallelic	confirmed	loss of function	Eye	7146	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peroxisome biogenesis disorder complementation group 13	NA	NA	PEX13	601789	601789	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8855	peroxisomal biogenesis factor 13	protein-coding gene	gene with protein product	Approved	2p15	02p15				peroxisome biogenesis factor 13	Peroxins
NA	mental retardation x-linked type 59	NA	NA	AP1S2	300629	300630	hemizygous	confirmed	loss of function	Brain/Cognition	560	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ichthyosis, x-linked	NA	NA	STS	300747	308100	hemizygous	confirmed	loss of function	Skin;Eye	11425	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	hypophosphatasia	Abnormality of the teeth	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000239	hypophosphatasia	Large fontanelles	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000737	hypophosphatasia	Irritability	Frequent (79-30%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	hypophosphatasia	Abnormality of the ribs	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	hypophosphatasia	Narrow chest	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	hypophosphatasia	Abnormality of the metaphyses	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001024	hypophosphatasia	Skin dimple over apex of long bone angulation	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	hypophosphatasia	Seizures	Frequent (79-30%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	hypophosphatasia	Muscular hypotonia	Frequent (79-30%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	hypophosphatasia	Craniosynostosis	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001531	hypophosphatasia	Failure to thrive in infancy	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	hypophosphatasia	Anemia	Frequent (79-30%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	hypophosphatasia	Respiratory insufficiency	Frequent (79-30%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002097	hypophosphatasia	Emphysema	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	hypophosphatasia	Recurrent fractures	Frequent (79-30%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003072	hypophosphatasia	Hypercalcemia	Frequent (79-30%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	hypophosphatasia	Short stature	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	hypophosphatasia	Bowing of the long bones	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	hypophosphatasia	Feeding difficulties in infancy	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010781	hypophosphatasia	Skin dimples	Very frequent (99-80%)	ALPL	No gene mim	241500	biallelic	confirmed	all missense/in frame	Skeleton	438	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gli2-related holoprosencephaly	NA	NA	GLI2	165230	261768	monoallelic	confirmed	loss of function	Brain/Cognition	4318	GLI family zinc finger 2	protein-coding gene	gene with protein product	Approved	2q14.2	02q14.2	THP2|HPE9|THP1	tax-responsive element-2 holding protein|tax helper protein 1|tax helper protein 2		GLI-Kruppel family member GLI2|glioma-associated oncogene family zinc finger 2	Zinc fingers C2H2-type
NA	farber lipogranulomatosis	NA	NA	ASAH1	613468	228000	biallelic	confirmed	all missense/in frame	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	735	N-acylsphingosine amidohydrolase 1	protein-coding gene	gene with protein product	Approved	8p22	08p22	AC|PHP32|FLJ21558|ACDase	acylsphingosine deacylase|acid ceramidase	ASAH	N-acylsphingosine amidohydrolase (acid ceramidase)	
NA	methylmalonic aciduria type cbla	NA	NA	MMAA	607481	251100	biallelic	confirmed	loss of function	Multisystem;Brain/Cognition	18871	methylmalonic aciduria (cobalamin deficiency) cblA type	protein-coding gene	gene with protein product	Approved	4q31.21	04q31.21	cblA			methylmalonic aciduria (cobalamin deficiency) type A	
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX14	601791	214100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
HP:0000028	autosomal dominant larsen syndrome	Cryptorchidism	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0000175	autosomal dominant larsen syndrome	Cleft palate	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0000272	autosomal dominant larsen syndrome	Malar flattening	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0000316	autosomal dominant larsen syndrome	Hypertelorism	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0000405	autosomal dominant larsen syndrome	Conductive hearing impairment	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0001156	autosomal dominant larsen syndrome	Brachydactyly syndrome	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0001249	autosomal dominant larsen syndrome	Intellectual disability	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0001363	autosomal dominant larsen syndrome	Craniosynostosis	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0001626	autosomal dominant larsen syndrome	Abnormality of the cardiovascular system	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0001799	autosomal dominant larsen syndrome	Short nail	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0002093	autosomal dominant larsen syndrome	Respiratory insufficiency	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0002650	autosomal dominant larsen syndrome	Scoliosis	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0003319	autosomal dominant larsen syndrome	Abnormality of the cervical spine	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0003422	autosomal dominant larsen syndrome	Vertebral segmentation defect	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0004232	autosomal dominant larsen syndrome	Accessory carpal bones	Frequent (79-30%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0004322	autosomal dominant larsen syndrome	Short stature	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0005008	autosomal dominant larsen syndrome	Large joint dislocations	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0005280	autosomal dominant larsen syndrome	Depressed nasal bridge	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0005692	autosomal dominant larsen syndrome	Joint hyperflexibility	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0005930	autosomal dominant larsen syndrome	Abnormality of epiphysis morphology	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0006101	autosomal dominant larsen syndrome	Finger syndactyly	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0008755	autosomal dominant larsen syndrome	Laryngotracheomalacia	Occasional (29-5%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0009836	autosomal dominant larsen syndrome	Broad distal phalanx of finger	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0009882	autosomal dominant larsen syndrome	Short distal phalanx of finger	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0011220	autosomal dominant larsen syndrome	Prominent forehead	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0011304	autosomal dominant larsen syndrome	Broad thumb	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
HP:0012368	autosomal dominant larsen syndrome	Flat face	Very frequent (99-80%)	FLNB	603381	150250	monoallelic	confirmed	uncertain	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
NA	intellectual disability	NA	NA	PGAP2	615187	No disease mim	biallelic	confirmed	all missense/in frame	Skeleton;Brain/Cognition	17893	post-GPI attachment to proteins 2	protein-coding gene	gene with protein product	Approved	11p15.4	11p15.4	FRAG1|CWH43-N	FGF receptor activating protein 1|cell wall biogenesis 43 N-terminal homolog (S. cerevisiae)	MRT21	mental retardation, non-syndromic, autosomal recessive, 21	
NA	microphthalmia syndromic type 9	NA	NA	STRA6	610745	601186	biallelic	confirmed	loss of function	Brain/Cognition;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	30650	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked znf711-related	NA	NA	ZNF711	314990	300803	hemizygous	confirmed	loss of function	Brain/Cognition	13128	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation autosomal recessive type 1	NA	NA	PRSS12	606709	249500	biallelic	confirmed	loss of function	Brain/Cognition	9477	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	distal arthrogryposis type 2b	NA	NA	MYH3	160720	601680	monoallelic	confirmed	uncertain	Musculature;Skeleton	7573	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type a5	NA	NA	FKRP	606596	613153	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	17997	fukutin related protein	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	LGMD2I|MDC1C				
NA	microphthalmia syndromic type 7	NA	NA	HCCS	300056	309801	x-linked dominant	confirmed	loss of function	Skin;Eye	4837	holocytochrome c synthase	protein-coding gene	gene with protein product	Approved	Xp22.2	Xp22.2	CCHL	cytochrome c heme-lyase	MLS	holocytochrome c synthase (cytochrome c heme-lyase)|microphthalamia with linear skin defects	
NA	microcephalycapillary malformation (mic-cap) syndrome	NA	NA	STAMBP	606247	No disease mim	biallelic	confirmed	loss of function	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	16950	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondylo-megaepiphyseal-metaphyseal dysplasia	NA	NA	NKX3-2	602183	613330	biallelic	confirmed	loss of function	Skeleton	951	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal- recessive intellectual disability mrt5	NA	NA	NSUN2	610916	611091	biallelic	probable	all missense/in frame	Brain/Cognition	25994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000098	loeys-dietz syndrome	Tall stature	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000193	loeys-dietz syndrome	Bifid uvula	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000202	loeys-dietz syndrome	Oral cleft	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	loeys-dietz syndrome	High palate	Very frequent (99-80%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	loeys-dietz syndrome	Malar flattening	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	loeys-dietz syndrome	Hypertelorism	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	loeys-dietz syndrome	Micrognathia	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000592	loeys-dietz syndrome	Blue sclerae	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	loeys-dietz syndrome	Pectus excavatum	Occasional (29-5%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	loeys-dietz syndrome	Pectus carinatum	Occasional (29-5%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000963	loeys-dietz syndrome	Thin skin	Occasional (29-5%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000978	loeys-dietz syndrome	Bruising susceptibility	Occasional (29-5%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000987	loeys-dietz syndrome	Atypical scarring of skin	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001065	loeys-dietz syndrome	Striae distensae	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001166	loeys-dietz syndrome	Arachnodactyly	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	loeys-dietz syndrome	Craniosynostosis	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001373	loeys-dietz syndrome	Joint dislocation	Occasional (29-5%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	loeys-dietz syndrome	Patent ductus arteriosus	Very frequent (99-80%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001695	loeys-dietz syndrome	Cardiac arrest	Occasional (29-5%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	loeys-dietz syndrome	Pes planus	Very frequent (99-80%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001892	loeys-dietz syndrome	Abnormal bleeding	Occasional (29-5%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002617	loeys-dietz syndrome	Aneurysm	Very frequent (99-80%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002647	loeys-dietz syndrome	Aortic dissection	Very frequent (99-80%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	loeys-dietz syndrome	Scoliosis	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004942	loeys-dietz syndrome	Aortic aneurysm	Very frequent (99-80%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005116	loeys-dietz syndrome	Arterial tortuosity	Very frequent (99-80%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005294	loeys-dietz syndrome	Arterial dissection	Very frequent (99-80%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	loeys-dietz syndrome	Joint hyperflexibility	Occasional (29-5%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	loeys-dietz syndrome	Camptodactyly of finger	Frequent (79-30%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100718	loeys-dietz syndrome	Uterine rupture	Very frequent (99-80%)	TGFBR2	190182	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peroxisome biogenesis disorder complementation group 9	NA	NA	PEX16	603360	603360	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
NA	autoimmune disease, syndromic multisystem	NA	NA	ITCH	606409	613385	biallelic	probable	loss of function	Bone Marrow/Immune	13890	itchy E3 ubiquitin protein ligase	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	AIP4			itchy (mouse homolog) E3 ubiquitin protein ligase|itchy E3 ubiquitin protein ligase homolog (mouse)	C2 domain containing
NA	congenital disorder of glycosylation type 1o	NA	NA	DPM3	605951	612937	biallelic	probable	loss of function	Face;Endocrine/Metabolic;Brain/Cognition	3007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	aromatic l-amino-acid decarboxylase deficiency	NA	NA	DDC	107930	608643	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	2719	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple mitochondrial dysfunctions syndrome 1	NA	NA	NFU1	608100	605711	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	16287	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	familial focal epilepsy with variable foci	NA	NA	DEPDC5	614191	604364	monoallelic	confirmed	loss of function	Brain/Cognition	18423	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	SYT1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	11509	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cloves: congenital lipomatous overgrowth, vascular malformations, and epidermal nevi	NA	NA	PIK3CA	171834	612918	mosaic	confirmed	activating	Skeleton;Endocrine/Metabolic	8975	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	protein-coding gene	gene with protein product	Approved	3q26.32	03q26.32	PI3K			phosphoinositide-3-kinase, catalytic, alpha polypeptide|phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	Phosphatidylinositol 3-kinase subunits
NA	joubert syndrome type 1	NA	NA	INPP5E	613037	213300	biallelic	confirmed	uncertain	Brain/Cognition;Eye;Genitalia	21474	inositol polyphosphate-5-phosphatase E	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3	PPI5PIV|CORS1|pharbin		JBTS1	Joubert syndrome 1|inositol polyphosphate-5-phosphatase, 72 kDa	Phosphoinositide phosphatases
HP:0000175	postaxial acrofacial dysostosis	Cleft palate	Frequent (79-30%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	postaxial acrofacial dysostosis	Malar flattening	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	postaxial acrofacial dysostosis	Micrognathia	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	postaxial acrofacial dysostosis	Low-set, posteriorly rotated ears	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000370	postaxial acrofacial dysostosis	Abnormality of the middle ear	Frequent (79-30%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000378	postaxial acrofacial dysostosis	Cupped ear	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000405	postaxial acrofacial dysostosis	Conductive hearing impairment	Frequent (79-30%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	postaxial acrofacial dysostosis	Strabismus	Occasional (29-5%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	postaxial acrofacial dysostosis	Downslanted palpebral fissures	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000625	postaxial acrofacial dysostosis	Cleft eyelid	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002558	postaxial acrofacial dysostosis	Supernumerary nipple	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	postaxial acrofacial dysostosis	Malformation of the heart and great vessels	Frequent (79-30%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002984	postaxial acrofacial dysostosis	Hypoplasia of the radius	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003022	postaxial acrofacial dysostosis	Hypoplasia of the ulna	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	postaxial acrofacial dysostosis	Finger syndactyly	Frequent (79-30%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007477	postaxial acrofacial dysostosis	Abnormal dermatoglyphics	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007651	postaxial acrofacial dysostosis	Ectropion of lower eyelids	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008551	postaxial acrofacial dysostosis	Microtia	Very frequent (99-80%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100335	postaxial acrofacial dysostosis	Non-midline cleft lip	Frequent (79-30%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	postaxial acrofacial dysostosis	Camptodactyly of finger	Frequent (79-30%)	DHODH	126064	263750	biallelic	confirmed	loss of function	Face;Skeleton	2867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	charcot-marie-tooth disease x-linked recessive type 5	NA	NA	PRPS1	311850	311070	hemizygous	confirmed	loss of function	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001231	brachydactyly type c	Abnormality of the fingernails	Frequent (79-30%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0004209	brachydactyly type c	Clinodactyly of the 5th finger	Occasional (29-5%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0004322	brachydactyly type c	Short stature	Occasional (29-5%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0005819	brachydactyly type c	Short middle phalanx of finger	Very frequent (99-80%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0009373	brachydactyly type c	Type C brachydactyly	Very frequent (99-80%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0009465	brachydactyly type c	Ulnar deviation of finger	Very frequent (99-80%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0009495	brachydactyly type c	Pseudoepiphyses of the 2nd finger	Very frequent (99-80%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0009606	brachydactyly type c	Complete duplication of distal phalanx of the thumb	Frequent (79-30%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0009684	brachydactyly type c	Stippling of the epiphysis of the distal phalanx of the thumb	Frequent (79-30%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0009773	brachydactyly type c	Symphalangism affecting the phalanges of the hand	Occasional (29-5%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0010026	brachydactyly type c	Aplasia/Hypoplasia of the 1st metacarpal	Very frequent (99-80%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0010508	brachydactyly type c	Metatarsus valgus	Occasional (29-5%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0010579	brachydactyly type c	Cone-shaped epiphysis	Frequent (79-30%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0010743	brachydactyly type c	Short metatarsal	Frequent (79-30%)	GDF5	601146	113100	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
NA	mucopolysaccharidosis type 4b	NA	NA	GLB1	611458	253010	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4298	galactosidase beta 1	protein-coding gene	gene with protein product	Approved	3p22.3	03p22.3	EBP		ELNR1	elastin receptor 1, 67kDa|elastin receptor 1 (67kD)|galactosidase, beta 1	
NA	hypophosphatemic rickets, ar	NA	NA	DMP1	600980	241520	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	2932	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia isolated type 3	NA	NA	RAX	601881	611038	biallelic	confirmed	loss of function	Brain/Cognition;Eye	18662	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000185	amish lethal microcephaly	Cleft soft palate	Occasional (29-5%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	amish lethal microcephaly	Microcephaly	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000340	amish lethal microcephaly	Sloping forehead	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	amish lethal microcephaly	Micrognathia	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	amish lethal microcephaly	Optic atrophy	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000737	amish lethal microcephaly	Irritability	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000939	amish lethal microcephaly	Osteoporosis	Frequent (79-30%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	amish lethal microcephaly	Muscular hypotonia	Frequent (79-30%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001274	amish lethal microcephaly	Agenesis of corpus callosum	Frequent (79-30%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001320	amish lethal microcephaly	Cerebellar vermis hypoplasia	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001339	amish lethal microcephaly	Lissencephaly	Frequent (79-30%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001376	amish lethal microcephaly	Limitation of joint mobility	Occasional (29-5%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001522	amish lethal microcephaly	Death in infancy	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001558	amish lethal microcephaly	Decreased fetal movement	Occasional (29-5%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001942	amish lethal microcephaly	Metabolic acidosis	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001992	amish lethal microcephaly	Organic aciduria	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002069	amish lethal microcephaly	Generalized tonic-clonic seizures	Occasional (29-5%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	amish lethal microcephaly	Ventriculomegaly	Frequent (79-30%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	amish lethal microcephaly	Hepatomegaly	Occasional (29-5%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002414	amish lethal microcephaly	Spina bifida	Frequent (79-30%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002509	amish lethal microcephaly	Limb hypertonia	Frequent (79-30%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004331	amish lethal microcephaly	Decreased skull ossification	Occasional (29-5%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005968	amish lethal microcephaly	Temperature instability	Frequent (79-30%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011344	amish lethal microcephaly	Severe global developmental delay	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011968	amish lethal microcephaly	Feeding difficulties	Very frequent (99-80%)	SLC25A19	No gene mim	216535	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	14409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	NA	NA	B3GALNT2	610194	615181	biallelic	probable	loss of function	Musculature;Brain/Cognition;Eye	28596	beta-1,3-N-acetylgalactosaminyltransferase 2	protein-coding gene	gene with protein product	Approved	1q42.3	01q42.3	MGC39558			UDP-GalNAc:betaGlcNAc beta-1,3-galactosaminyltransferase, polypeptide 2	Beta 3-glycosyltransferases
NA	adams-oliver syndrome 1	NA	NA	ARHGAP31	610911	100300	monoallelic	probable	loss of function	Skin;Skeleton	29216	Rho GTPase activating protein 31	protein-coding gene	gene with protein product	Approved	3q13.32-q13.33	03q13.32-q13.33	CDGAP				Rho GTPase activating proteins
NA	bardet-biedl syndrome type 5	NA	NA	BBS5	603650	209900	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	970	Bardet-Biedl syndrome 5	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	DKFZp762I194				Bardet-Biedl syndrome associated|BBSome
NA	autosomal recessive mental retardation	NA	NA	PECR	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	18281	peroxisomal trans-2-enoyl-CoA reductase	protein-coding gene	gene with protein product	Approved	2q35	02q35	HSA250303|TERP|SDR29C1	short chain dehydrogenase/reductase family 29C, member 1			Short chain dehydrogenase/reductase superfamily
NA	hydrocephalus, nonsyndromic, autosomal recessive 2	NA	NA	MPDZ	No gene mim	615219	biallelic	possible	loss of function	Brain/Cognition	7208	multiple PDZ domain crumbs cell polarity complex component	protein-coding gene	gene with protein product	Approved	9p23	09p23	MUPP1			multiple PDZ domain protein	PDZ domain containing|Crumbs complex
NA	2-aminoadipic and 2-oxoadipic aciduria	NA	NA	DHTKD1	614984	204750	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	23537	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia, isolated, with coloboma 7	NA	NA	ABCB6	No gene mim	614497	monoallelic	possible	all missense/in frame	Eye	47	ATP binding cassette subfamily B member 6 (Langereis blood group)	protein-coding gene	gene with protein product	Approved	2q35	02q35	EST45597|umat|MTABC3	ATP-binding cassette half-transporter		ATP-binding cassette, sub-family B (MDR/TAP), member 6|ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)	Blood group antigens|ATP binding cassette subfamily B
NA	epilepsy with myoclonic-atonic seizures	NA	NA	SLC6A1	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	11042	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leukodystrophy hypomyelinating type 4	NA	NA	HSPD1	No gene mim	612233	biallelic	both DD and IF	loss of function	Brain/Cognition	5261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	miyoshi muscular dystrophy type 3	NA	NA	ANO5	No gene mim	613319	biallelic	both DD and IF	loss of function	Musculature;Skeleton	27337	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	guanidinoacetate methyltransferase deficiency	NA	NA	GAMT	601240	612736	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4136	guanidinoacetate N-methyltransferase	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PIG2|TP53I2				Seven-beta-strand methyltransferase motif containing
HP:0001635	arterial tortuosity syndrome	Congestive heart failure	Very frequent (99-80%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002616	arterial tortuosity syndrome	Aortic root dilatation	Very frequent (99-80%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002617	arterial tortuosity syndrome	Aneurysm	Very frequent (99-80%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004942	arterial tortuosity syndrome	Aortic aneurysm	Very frequent (99-80%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005344	arterial tortuosity syndrome	Abnormality of the carotid arteries	Very frequent (99-80%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100545	arterial tortuosity syndrome	Arterial stenosis	Very frequent (99-80%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100585	arterial tortuosity syndrome	Telangiectasia of the skin	Very frequent (99-80%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	arterial tortuosity syndrome	Inguinal hernia	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	arterial tortuosity syndrome	Long face	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	arterial tortuosity syndrome	Hypertelorism	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	arterial tortuosity syndrome	Macrotia	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000963	arterial tortuosity syndrome	Thin skin	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000974	arterial tortuosity syndrome	Hyperextensible skin	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	arterial tortuosity syndrome	Craniosynostosis	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002647	arterial tortuosity syndrome	Aortic dissection	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004415	arterial tortuosity syndrome	Pulmonary artery stenosis	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	arterial tortuosity syndrome	Joint hyperflexibility	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008501	arterial tortuosity syndrome	Median cleft lip and palate	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010668	arterial tortuosity syndrome	Abnormality of the zygomatic bone	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012378	arterial tortuosity syndrome	Fatigue	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100541	arterial tortuosity syndrome	Femoral hernia	Frequent (79-30%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	arterial tortuosity syndrome	Macrocephaly	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	arterial tortuosity syndrome	Malar flattening	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	arterial tortuosity syndrome	Strabismus	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	arterial tortuosity syndrome	Myopia	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000563	arterial tortuosity syndrome	Keratoconus	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000581	arterial tortuosity syndrome	Blepharophimosis	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000822	arterial tortuosity syndrome	Hypertension	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001119	arterial tortuosity syndrome	Keratoglobus	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001166	arterial tortuosity syndrome	Arachnodactyly	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	arterial tortuosity syndrome	Intellectual disability	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	arterial tortuosity syndrome	Muscular hypotonia	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	arterial tortuosity syndrome	Global developmental delay	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	arterial tortuosity syndrome	Specific learning disability	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001385	arterial tortuosity syndrome	Hip dysplasia	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	arterial tortuosity syndrome	Redundant skin	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001637	arterial tortuosity syndrome	Abnormality of the myocardium	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	arterial tortuosity syndrome	Hypertrophic cardiomyopathy	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001644	arterial tortuosity syndrome	Dilated cardiomyopathy	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001658	arterial tortuosity syndrome	Myocardial infarction	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001695	arterial tortuosity syndrome	Cardiac arrest	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001838	arterial tortuosity syndrome	Rocker bottom foot	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	arterial tortuosity syndrome	Gastroesophageal reflux	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002021	arterial tortuosity syndrome	Pyloric stenosis	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002036	arterial tortuosity syndrome	Hiatus hernia	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002094	arterial tortuosity syndrome	Dyspnea	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002098	arterial tortuosity syndrome	Respiratory distress	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	arterial tortuosity syndrome	Scoliosis	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002673	arterial tortuosity syndrome	Coxa valga	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002812	arterial tortuosity syndrome	Coxa vara	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002827	arterial tortuosity syndrome	Hip dislocation	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002878	arterial tortuosity syndrome	Respiratory failure	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	arterial tortuosity syndrome	Short nose	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	arterial tortuosity syndrome	Clinodactyly of the 5th finger	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005743	arterial tortuosity syndrome	Avascular necrosis of the capital femoral epiphysis	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006543	arterial tortuosity syndrome	Cardiorespiratory arrest	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007495	arterial tortuosity syndrome	Prematurely aged appearance	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011302	arterial tortuosity syndrome	Long palm	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012745	arterial tortuosity syndrome	Short palpebral fissure	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012819	arterial tortuosity syndrome	Myocarditis	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100633	arterial tortuosity syndrome	Esophagitis	Occasional (29-5%)	SLC2A10	606145	208050	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	13444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	x-linked congenital idiopathic intestinal pseudoobstruction	NA	NA	FLNA	300017	300048	hemizygous	confirmed	loss of function	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
NA	cfc1-related conotruncal heart malformations	NA	NA	CFC1	605194	319372	monoallelic	probable	loss of function	Heart/Cardiovasculature/Lymphatic	18292	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lysyl hydroxylase 3 deficiency	NA	NA	PLOD3	No gene mim	612394	biallelic	possible	loss of function	Skin;Face;Skeleton;Heart/Cardiovasculature/Lymphatic	9083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	coffin siris syndrome	NA	NA	ARID1B	614556	No disease mim	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	18040	AT-rich interaction domain 1B	protein-coding gene	gene with protein product	Approved	6q25.3	06q25.3	KIAA1235|ELD/OSA1|p250R|BAF250b|DAN15|6A3-5			AT rich interactive domain 1B (SWI1-like)	AT-rich interaction domain containing
HP:0000044	moebius syndrome	Hypogonadotrophic hypogonadism	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	moebius syndrome	Cleft palate	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000194	moebius syndrome	Open mouth	Very frequent (99-80%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	moebius syndrome	High palate	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000232	moebius syndrome	Everted lower lip vermilion	Frequent (79-30%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	moebius syndrome	Epicanthus	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000298	moebius syndrome	Mask-like facies	Very frequent (99-80%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	moebius syndrome	Micrognathia	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	moebius syndrome	Hearing impairment	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	moebius syndrome	Strabismus	Very frequent (99-80%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000498	moebius syndrome	Blepharitis	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	moebius syndrome	Visual impairment	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	moebius syndrome	Ptosis	Very frequent (99-80%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000602	moebius syndrome	Ophthalmoplegia	Very frequent (99-80%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000691	moebius syndrome	Microdontia	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000717	moebius syndrome	Autism	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	moebius syndrome	Brachydactyly syndrome	Frequent (79-30%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	moebius syndrome	Muscular hypotonia	Frequent (79-30%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001270	moebius syndrome	Motor delay	Frequent (79-30%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001522	moebius syndrome	Death in infancy	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001608	moebius syndrome	Abnormality of the voice	Very frequent (99-80%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001762	moebius syndrome	Talipes equinovarus	Frequent (79-30%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002015	moebius syndrome	Dysphagia	Frequent (79-30%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002804	moebius syndrome	Arthrogryposis multiplex congenita	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002997	moebius syndrome	Abnormality of the ulna	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	moebius syndrome	Skeletal muscle atrophy	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004050	moebius syndrome	Absent hand	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	moebius syndrome	Clinodactyly of the 5th finger	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004408	moebius syndrome	Abnormality of the sense of smell	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005914	moebius syndrome	Aplasia/Hypoplasia involving the metacarpal bones	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	moebius syndrome	Finger syndactyly	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006501	moebius syndrome	Aplasia/Hypoplasia of the radius	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006824	moebius syndrome	Cranial nerve paralysis	Very frequent (99-80%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007565	moebius syndrome	Multiple cafe-au-lait spots	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007957	moebius syndrome	Corneal opacity	Frequent (79-30%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	moebius syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009601	moebius syndrome	Aplasia/Hypoplasia of the thumb	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009751	moebius syndrome	Aplasia of the pectoralis major muscle	Frequent (79-30%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	moebius syndrome	Reduced number of teeth	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010295	moebius syndrome	Aplasia/Hypoplasia of the tongue	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010628	moebius syndrome	Facial palsy	Very frequent (99-80%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100783	moebius syndrome	Breast aplasia	Occasional (29-5%)	PLXND1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autoinflammation, antibody deficiency, and immune dysregulation, plcg2-associated	NA	NA	PLCG2	No gene mim	614878	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Skin	9066	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neural tube defect	NA	NA	SHROOM3	No gene mim	No disease mim	monoallelic	probable	loss of function	Skeleton;Spinal cord/Peripheral nerves	30422	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pontocerebellar hypoplasia type 1	NA	NA	VRK1	602168	607596	biallelic	probable	loss of function	Brain/Cognition	12718	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	apert syndrome	Cleft palate	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000189	apert syndrome	Narrow palate	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000193	apert syndrome	Bifid uvula	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000238	apert syndrome	Hydrocephalus	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000239	apert syndrome	Large fontanelles	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000244	apert syndrome	Brachyturricephaly	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000303	apert syndrome	Mandibular prognathia	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000316	apert syndrome	Hypertelorism	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000324	apert syndrome	Facial asymmetry	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000327	apert syndrome	Hypoplasia of the maxilla	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000337	apert syndrome	Broad forehead	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000405	apert syndrome	Conductive hearing impairment	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000407	apert syndrome	Sensorineural hearing impairment	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000444	apert syndrome	Convex nasal ridge	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000453	apert syndrome	Choanal atresia	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000486	apert syndrome	Strabismus	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000494	apert syndrome	Downslanted palpebral fissures	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000505	apert syndrome	Visual impairment	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000520	apert syndrome	Proptosis	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000648	apert syndrome	Optic atrophy	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000684	apert syndrome	Delayed eruption of teeth	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000822	apert syndrome	Hypertension	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001249	apert syndrome	Intellectual disability	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001274	apert syndrome	Agenesis of corpus callosum	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001331	apert syndrome	Absent septum pellucidum	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001770	apert syndrome	Toe syndactyly	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002007	apert syndrome	Frontal bossing	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002032	apert syndrome	Esophageal atresia	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002093	apert syndrome	Respiratory insufficiency	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002119	apert syndrome	Ventriculomegaly	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002308	apert syndrome	Arnold-Chiari malformation	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002564	apert syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002676	apert syndrome	Cloverleaf skull	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002983	apert syndrome	Micromelia	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003422	apert syndrome	Vertebral segmentation defect	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004397	apert syndrome	Ectopic anus	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004487	apert syndrome	Acrobrachycephaly	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004635	apert syndrome	Cervical vertebrae fusion (C5/C6)	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005280	apert syndrome	Depressed nasal bridge	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0006101	apert syndrome	Finger syndactyly	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0008872	apert syndrome	Feeding difficulties in infancy	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0009601	apert syndrome	Aplasia/Hypoplasia of the thumb	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0011304	apert syndrome	Broad thumb	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0011380	apert syndrome	Morphological abnormality of the semicircular canal	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0011800	apert syndrome	Midface retrusion	Frequent (79-30%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0012368	apert syndrome	Flat face	Very frequent (99-80%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0100615	apert syndrome	Ovarian neoplasm	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0200020	apert syndrome	Corneal erosion	Occasional (29-5%)	FGFR2	176943	101200	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	spinocerebellar ataxia, autosomal recessive 12	NA	NA	WWOX	No gene mim	614322	biallelic	probable	all missense/in frame	Spinal cord/Peripheral nerves;Brain/Cognition	12799	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leopard syndrome type 3	NA	NA	BRAF	164757	613707	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glycogen storage disease type iii	NA	NA	AGL	610860	232400	biallelic	confirmed	loss of function	Endocrine/Metabolic	321	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	tricho-rhino-phalangeal syndrome type 1	NA	NA	TRPS1	604386	190350	monoallelic	confirmed	loss of function	Skin;Face;Skeleton	12340	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	orofacial cleft 11	NA	NA	BMP4	112262	600625	monoallelic	confirmed	loss of function	Face;Skeleton;Eye	1071	bone morphogenetic protein 4	protein-coding gene	gene with protein product	Approved	14q22.2	14q22.2			BMP2B		Bone morphogenetic proteins|Endogenous ligands
NA	nemaline myopathy 8, autosomal recessive	NA	NA	KLHL40	No gene mim	615348	biallelic	confirmed	loss of function	Musculature	30372	kelch like family member 40	protein-coding gene	gene with protein product	Approved	3p22.1	03p22.1	SRYP|NEM8	sarcosynapsin|nemaline myopathy type 8	KBTBD5	kelch repeat and BTB (POZ) domain containing 5|kelch-like 40 (Drosophila)	Kelch like|BTB domain containing
NA	intellectual disability	NA	NA	LRP2	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
NA	congenital disorder of glycosylation type 2a	NA	NA	MGAT2	602616	212066	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	7045	mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	GNT-II				Mannosyl-glycoprotein N-acetylglucosaminyltransferases
NA	mental retardation, autosomal dominant, 27	NA	NA	SOX11	No gene mim	615866	monoallelic	probable	all missense/in frame	Brain/Cognition	11191	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	parkinson disease 9	NA	NA	ATP13A2	No gene mim	606693	biallelic	both DD and IF	loss of function	Brain/Cognition	30213	ATPase 13A2	protein-coding gene	gene with protein product	Approved	1p36.13	01p36.13	HSA9947|CLN12		PARK9	Parkinson disease (autosomal recessive) 9 (Kufor-Rakeb syndrome)|ATPase type 13A2	Parkinson disease associated genes|ATPase orphan transporters
NA	lissencephaly 2	NA	NA	RELN	600514	319306	biallelic	confirmed	loss of function	Brain/Cognition	9957	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000044	galactosemia	Hypogonadotrophic hypogonadism	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0000083	galactosemia	Renal insufficiency	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0000252	galactosemia	Microcephaly	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0000505	galactosemia	Visual impairment	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0000518	galactosemia	Cataract	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0000939	galactosemia	Osteoporosis	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0000952	galactosemia	Jaundice	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001249	galactosemia	Intellectual disability	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001250	galactosemia	Seizures	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001251	galactosemia	Ataxia	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001252	galactosemia	Muscular hypotonia	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001254	galactosemia	Lethargy	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001260	galactosemia	Dysarthria	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001263	galactosemia	Global developmental delay	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001337	galactosemia	Tremor	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001399	galactosemia	Hepatic failure	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001510	galactosemia	Growth delay	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001531	galactosemia	Failure to thrive in infancy	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001541	galactosemia	Ascites	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001608	galactosemia	Abnormality of the voice	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001878	galactosemia	Hemolytic anemia	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001928	galactosemia	Abnormality of coagulation	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001939	galactosemia	Abnormality of metabolism/homeostasis	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0001943	galactosemia	Hypoglycemia	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0002017	galactosemia	Nausea and vomiting	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0002167	galactosemia	Neurological speech impairment	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0002240	galactosemia	Hepatomegaly	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0008872	galactosemia	Feeding difficulties in infancy	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0010741	galactosemia	Edema of the lower limbs	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0011098	galactosemia	Speech apraxia	Occasional (29-5%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0100543	galactosemia	Cognitive impairment	Very frequent (99-80%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
HP:0100806	galactosemia	Sepsis	Frequent (79-30%)	GALT	606999	230400	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	4135	galactose-1-phosphate uridylyltransferase	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3					
NA	crigler-najjar syndrome, type i	NA	NA	UGT1A1	191740	218800	biallelic	confirmed	loss of function	Endocrine/Metabolic;GI tract	12530	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	chediak-higashi syndrome	NA	NA	LYST	606897	214500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Kidney Renal Tract	1968	lysosomal trafficking regulator	protein-coding gene	gene with protein product	Approved	1q42.3	01q42.3	CHS		CHS1	Chediak-Higashi syndrome 1	WD repeat domain containing|BEACH domain containing 
HP:0000028	mowat-wilson syndrome	Cryptorchidism	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	mowat-wilson syndrome	Hypospadias	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000048	mowat-wilson syndrome	Bifid scrotum	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	mowat-wilson syndrome	Vesicoureteral reflux	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000086	mowat-wilson syndrome	Ectopic kidney	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000126	mowat-wilson syndrome	Hydronephrosis	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	mowat-wilson syndrome	Cleft palate	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000194	mowat-wilson syndrome	Open mouth	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000204	mowat-wilson syndrome	Cleft upper lip	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	mowat-wilson syndrome	High palate	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000232	mowat-wilson syndrome	Everted lower lip vermilion	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	mowat-wilson syndrome	Microcephaly	Very frequent (99-80%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	mowat-wilson syndrome	Epicanthus	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000307	mowat-wilson syndrome	Pointed chin	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	mowat-wilson syndrome	Hypertelorism	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	mowat-wilson syndrome	High forehead	Very frequent (99-80%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000358	mowat-wilson syndrome	Posteriorly rotated ears	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	mowat-wilson syndrome	Wide nasal bridge	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	mowat-wilson syndrome	Strabismus	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	mowat-wilson syndrome	Deeply set eye	Very frequent (99-80%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000534	mowat-wilson syndrome	Abnormality of the eyebrow	Very frequent (99-80%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	mowat-wilson syndrome	Microphthalmia	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	mowat-wilson syndrome	Iris coloboma	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	mowat-wilson syndrome	Nystagmus	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001182	mowat-wilson syndrome	Tapered finger	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	mowat-wilson syndrome	Seizures	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	mowat-wilson syndrome	Muscular hypotonia	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	mowat-wilson syndrome	Ventricular septal defect	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	mowat-wilson syndrome	Tetralogy of Fallot	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	mowat-wilson syndrome	Patent ductus arteriosus	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001822	mowat-wilson syndrome	Hallux valgus	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001869	mowat-wilson syndrome	Deep plantar creases	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	mowat-wilson syndrome	Frontal bossing	Very frequent (99-80%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	mowat-wilson syndrome	Constipation	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	mowat-wilson syndrome	Ventriculomegaly	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002120	mowat-wilson syndrome	Cerebral cortical atrophy	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002213	mowat-wilson syndrome	Fine hair	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002251	mowat-wilson syndrome	Aganglionic megacolon	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002558	mowat-wilson syndrome	Supernumerary nipple	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	mowat-wilson syndrome	Malformation of the heart and great vessels	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	mowat-wilson syndrome	Short stature	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	mowat-wilson syndrome	Finger syndactyly	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	mowat-wilson syndrome	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	mowat-wilson syndrome	Aplasia/Hypoplasia of the corpus callosum	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008572	mowat-wilson syndrome	External ear malformation	Very frequent (99-80%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009748	mowat-wilson syndrome	Large earlobe	Very frequent (99-80%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009909	mowat-wilson syndrome	Uplifted earlobe	Very frequent (99-80%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010059	mowat-wilson syndrome	Broad hallux phalanx	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010761	mowat-wilson syndrome	Broad columella	Frequent (79-30%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	mowat-wilson syndrome	Camptodactyly of finger	Occasional (29-5%)	ZEB2	605802	235730	monoallelic	confirmed	loss of function	Face;Brain/Cognition;GI tract	14881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	retinitis pigmentosa type 51	NA	NA	TTC8	608132	613464	biallelic	confirmed	uncertain	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Heart/Cardiovasculature/Lymphatic	20087	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	acrodysostosis	Cryptorchidism	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000055	acrodysostosis	Abnormality of female external genitalia	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000135	acrodysostosis	Hypogonadism	Occasional (29-5%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000194	acrodysostosis	Open mouth	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000248	acrodysostosis	Brachycephaly	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000286	acrodysostosis	Epicanthus	Occasional (29-5%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000303	acrodysostosis	Mandibular prognathia	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000316	acrodysostosis	Hypertelorism	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000327	acrodysostosis	Hypoplasia of the maxilla	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000365	acrodysostosis	Hearing impairment	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000431	acrodysostosis	Wide nasal bridge	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000457	acrodysostosis	Depressed nasal ridge	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000463	acrodysostosis	Anteverted nares	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000684	acrodysostosis	Delayed eruption of teeth	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000858	acrodysostosis	Menstrual irregularities	Occasional (29-5%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0000995	acrodysostosis	Melanocytic nevus	Occasional (29-5%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0001156	acrodysostosis	Brachydactyly syndrome	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0001163	acrodysostosis	Abnormality of the metacarpal bones	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0001249	acrodysostosis	Intellectual disability	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0001597	acrodysostosis	Abnormality of the nail	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0001831	acrodysostosis	Short toe	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0002818	acrodysostosis	Abnormality of the radius	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0002983	acrodysostosis	Micromelia	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0002984	acrodysostosis	Hypoplasia of the radius	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0002997	acrodysostosis	Abnormality of the ulna	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0003022	acrodysostosis	Hypoplasia of the ulna	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0003196	acrodysostosis	Short nose	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0003312	acrodysostosis	Abnormal form of the vertebral bodies	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0003416	acrodysostosis	Spinal canal stenosis	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0004322	acrodysostosis	Short stature	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0005280	acrodysostosis	Depressed nasal bridge	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0005616	acrodysostosis	Accelerated skeletal maturation	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0009830	acrodysostosis	Peripheral neuropathy	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0010049	acrodysostosis	Short metacarpal	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0010579	acrodysostosis	Cone-shaped epiphysis	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0010655	acrodysostosis	Epiphyseal stippling	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0010743	acrodysostosis	Short metatarsal	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0010807	acrodysostosis	Open bite	Occasional (29-5%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0010978	acrodysostosis	Abnormality of immune system physiology	Frequent (79-30%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
HP:0011800	acrodysostosis	Midface retrusion	Very frequent (99-80%)	PRKAR1A	188830	101800	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9388	protein kinase cAMP-dependent type I regulatory subunit alpha	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	CNC1	Carney complex type 1	PRKAR1|TSE1	tissue specific extinguisher 1|protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory subunit type I alpha	
NA	cranioectodermal dysplasia type 3	NA	NA	IFT43	614068	614099	biallelic	confirmed	all missense/in frame	Skin;Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	29669	intraflagellar transport 43	protein-coding gene	gene with protein product	Approved	14q24.3	14q24.3	FLJ32173|MGC16028		C14orf179	chromosome 14 open reading frame 179|intraflagellar transport 43 homolog (Chlamydomonas)	Intraflagellar transport proteins
NA	proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome	NA	NA	FLVCR2	610865	225790	biallelic	confirmed	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	20105	feline leukemia virus subgroup C cellular receptor family member 2	protein-coding gene	gene with protein product	Approved	14q24.3	14q24.3	FLJ20371|MFSD7C		C14orf58	chromosome 14 open reading frame 58|feline leukemia virus subgroup C cellular receptor 2|feline leukemia virus subgroup C cellular receptor family, member 2	Solute carriers
HP:0001251	hereditary spastic paraplegia	Ataxia	Frequent (79-30%)	CYP2U1	610670	615030	biallelic	confirmed	loss of function	Brain/Cognition	20582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	hereditary spastic paraplegia	Spasticity	Very frequent (99-80%)	CYP2U1	610670	615030	biallelic	confirmed	loss of function	Brain/Cognition	20582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	hereditary spastic paraplegia	Gait disturbance	Very frequent (99-80%)	CYP2U1	610670	615030	biallelic	confirmed	loss of function	Brain/Cognition	20582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	hereditary spastic paraplegia	Finger syndactyly	Occasional (29-5%)	CYP2U1	610670	615030	biallelic	confirmed	loss of function	Brain/Cognition	20582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007328	hereditary spastic paraplegia	Impaired pain sensation	Very frequent (99-80%)	CYP2U1	610670	615030	biallelic	confirmed	loss of function	Brain/Cognition	20582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010550	hereditary spastic paraplegia	Paraplegia	Very frequent (99-80%)	CYP2U1	610670	615030	biallelic	confirmed	loss of function	Brain/Cognition	20582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000232	gapo syndrome	Everted lower lip vermilion	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	gapo syndrome	Hypertelorism	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	gapo syndrome	Broad forehead	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	gapo syndrome	Long philtrum	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	gapo syndrome	Micrognathia	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	gapo syndrome	High forehead	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	gapo syndrome	Low-set ears	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	gapo syndrome	Anteverted nares	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000535	gapo syndrome	Sparse eyebrow	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000653	gapo syndrome	Sparse eyelashes	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	gapo syndrome	Delayed eruption of teeth	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000974	gapo syndrome	Hyperextensible skin	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001596	gapo syndrome	Alopecia	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	gapo syndrome	Frontal bossing	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002234	gapo syndrome	Early balding	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	gapo syndrome	Delayed skeletal maturation	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	gapo syndrome	Short stature	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	gapo syndrome	Depressed nasal bridge	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	gapo syndrome	Joint hyperflexibility	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007495	gapo syndrome	Prematurely aged appearance	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009891	gapo syndrome	Underdeveloped supraorbital ridges	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009928	gapo syndrome	Thick nasal alae	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	gapo syndrome	Midface retrusion	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100540	gapo syndrome	Palpebral edema	Very frequent (99-80%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000174	gapo syndrome	Abnormality of the palate	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	gapo syndrome	Mandibular prognathia	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	gapo syndrome	Glaucoma	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	gapo syndrome	Visual impairment	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000563	gapo syndrome	Keratoconus	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000765	gapo syndrome	Abnormality of the thorax	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000889	gapo syndrome	Abnormality of the clavicle	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	gapo syndrome	Abnormality of the metaphyses	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	gapo syndrome	Umbilical hernia	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002644	gapo syndrome	Abnormality of pelvic girdle bone morphology	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	gapo syndrome	Abnormal form of the vertebral bodies	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010609	gapo syndrome	Skin tags	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100659	gapo syndrome	Abnormality of the cerebral vasculature	Frequent (79-30%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	gapo syndrome	Hypogonadism	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000141	gapo syndrome	Amenorrhea	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	gapo syndrome	Hearing impairment	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000453	gapo syndrome	Choanal atresia	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	gapo syndrome	Myopia	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	gapo syndrome	Nystagmus	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	gapo syndrome	Optic atrophy	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000787	gapo syndrome	Nephrolithiasis	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000798	gapo syndrome	Oligospermia	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001028	gapo syndrome	Hemangioma	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001053	gapo syndrome	Hypopigmented skin patches	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	gapo syndrome	Growth delay	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001555	gapo syndrome	Asymmetry of the thorax	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002516	gapo syndrome	Increased intracranial pressure	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002621	gapo syndrome	Atherosclerosis	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004331	gapo syndrome	Decreased skull ossification	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100607	gapo syndrome	Dysmenorrhea	Occasional (29-5%)	ANTXR1	606410	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Endocrine/Metabolic	21014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dent disease type 2	NA	NA	OCRL	300535	300555	hemizygous	confirmed	uncertain	Skin;Endocrine/Metabolic;Brain/Cognition	8108	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephrotic syndrome, type 2	NA	NA	NPHS2	604766	600995	biallelic	confirmed	loss of function	Kidney Renal Tract	13394	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	vacterl association	NA	NA	HOXD13	142989	192350	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	9q subtelomeric deletion syndrome	NA	NA	EHMT1	607001	610253	monoallelic	confirmed	loss of function	Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	24650	euchromatic histone lysine methyltransferase 1	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3	Eu-HMTase1|FLJ12879|KIAA1876|bA188C12.1|KMT1D|FLJ40292		EHMT1-IT1	euchromatic histone methyltransferase 1|EHMT1 intronic transcript 1	Ankyrin repeat domain containing|Lysine methyltransferases|SET domain containing
NA	meier-gorlin syndrome 4	NA	NA	CDT1	605525	613804	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear	24576	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cause of early-onset myopathy with fatal cardiomyopathy	NA	NA	TTN	188840	611705	biallelic	possible	loss of function	Musculature;Heart/Cardiovasculature/Lymphatic	12403	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	synpolydactyly, 3/3-prime/4, associated with metacarpal and metatarsal synostoses	NA	NA	FBLN1	No gene mim	608180	biallelic	possible	all missense/in frame	Skeleton	3600	fibulin 1	protein-coding gene	gene with protein product	Approved	22q13.31	22q13.31	FBLN				Fibulins
NA	athelia	NA	NA	PTPRF	No gene mim	No disease mim	biallelic	possible	loss of function	Skin	9670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy with seizure onset in the first days of life	NA	NA	SLC13A5	No gene mim	No disease mim	biallelic	confirmed	loss of function	Teeth & Dentitian;Brain/Cognition	23089	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	de sanctis-cacchione syndrome	NA	NA	ERCC6	609413	278800	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	3438	ERCC excision repair 6, chromatin remodeling factor	protein-coding gene	gene with protein product	Approved	10q11.23	10q11.23	CSB|RAD26|ARMD5	Cockayne syndrome B protein	CKN2	excision repair cross-complementing rodent repair deficiency, complementation group 6|excision repair cross-complementation group 6	ERCC excision repair associated
NA	lysosomal beta-mannosidosis	NA	NA	MANBA	609489	248510	biallelic	confirmed	loss of function	Spinal cord/Peripheral nerves;Endocrine/Metabolic;Brain/Cognition	6831	mannosidase beta	protein-coding gene	gene with protein product	Approved	4q24	04q24		beta-mannosidase A		mannosidase, beta A, lysosomal	Mannosidases type beta
HP:0000239	lenz-majewski hyperostotic dwarfism	Large fontanelles	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	lenz-majewski hyperostotic dwarfism	Macrocephaly	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000270	lenz-majewski hyperostotic dwarfism	Delayed cranial suture closure	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	lenz-majewski hyperostotic dwarfism	Mandibular prognathia	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	lenz-majewski hyperostotic dwarfism	Hypertelorism	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	lenz-majewski hyperostotic dwarfism	Broad forehead	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	lenz-majewski hyperostotic dwarfism	Macrotia	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000453	lenz-majewski hyperostotic dwarfism	Choanal atresia	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	lenz-majewski hyperostotic dwarfism	Abnormality of dental enamel	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	lenz-majewski hyperostotic dwarfism	Abnormality of the metaphyses	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	lenz-majewski hyperostotic dwarfism	Brachydactyly syndrome	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	lenz-majewski hyperostotic dwarfism	Intellectual disability	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	lenz-majewski hyperostotic dwarfism	Global developmental delay	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	lenz-majewski hyperostotic dwarfism	Specific learning disability	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	lenz-majewski hyperostotic dwarfism	Redundant skin	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002684	lenz-majewski hyperostotic dwarfism	Thickened calvaria	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	lenz-majewski hyperostotic dwarfism	Delayed skeletal maturation	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003103	lenz-majewski hyperostotic dwarfism	Abnormal cortical bone morphology	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003510	lenz-majewski hyperostotic dwarfism	Severe short stature	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004279	lenz-majewski hyperostotic dwarfism	Short palm	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004437	lenz-majewski hyperostotic dwarfism	Cranial hyperostosis	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005465	lenz-majewski hyperostotic dwarfism	Facial hyperostosis	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	lenz-majewski hyperostotic dwarfism	Joint hyperflexibility	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	lenz-majewski hyperostotic dwarfism	Finger syndactyly	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006660	lenz-majewski hyperostotic dwarfism	Aplastic clavicles	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007495	lenz-majewski hyperostotic dwarfism	Prematurely aged appearance	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008065	lenz-majewski hyperostotic dwarfism	Aplasia/Hypoplasia of the skin	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009773	lenz-majewski hyperostotic dwarfism	Symphalangism affecting the phalanges of the hand	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011001	lenz-majewski hyperostotic dwarfism	Increased bone mineral density	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011002	lenz-majewski hyperostotic dwarfism	Osteopetrosis	Very frequent (99-80%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	lenz-majewski hyperostotic dwarfism	Inguinal hernia	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	lenz-majewski hyperostotic dwarfism	Cryptorchidism	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000036	lenz-majewski hyperostotic dwarfism	Abnormality of the penis	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000039	lenz-majewski hyperostotic dwarfism	Epispadias	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	lenz-majewski hyperostotic dwarfism	Hypospadias	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	lenz-majewski hyperostotic dwarfism	Wide mouth	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000614	lenz-majewski hyperostotic dwarfism	Abnormality of the nasolacrimal system	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	lenz-majewski hyperostotic dwarfism	Abnormality of the metacarpal bones	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001167	lenz-majewski hyperostotic dwarfism	Abnormality of finger	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003070	lenz-majewski hyperostotic dwarfism	Elbow ankylosis	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010628	lenz-majewski hyperostotic dwarfism	Facial palsy	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012471	lenz-majewski hyperostotic dwarfism	Thick vermilion border	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100541	lenz-majewski hyperostotic dwarfism	Femoral hernia	Frequent (79-30%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	lenz-majewski hyperostotic dwarfism	Hypogonadism	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	lenz-majewski hyperostotic dwarfism	Cleft palate	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000176	lenz-majewski hyperostotic dwarfism	Submucous cleft hard palate	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000193	lenz-majewski hyperostotic dwarfism	Bifid uvula	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	lenz-majewski hyperostotic dwarfism	Hydrocephalus	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	lenz-majewski hyperostotic dwarfism	Muscular hypotonia	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001274	lenz-majewski hyperostotic dwarfism	Agenesis of corpus callosum	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001331	lenz-majewski hyperostotic dwarfism	Absent septum pellucidum	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001376	lenz-majewski hyperostotic dwarfism	Limitation of joint mobility	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001804	lenz-majewski hyperostotic dwarfism	Hypoplastic fingernail	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001812	lenz-majewski hyperostotic dwarfism	Hyperconvex fingernails	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	lenz-majewski hyperostotic dwarfism	Scoliosis	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002705	lenz-majewski hyperostotic dwarfism	High, narrow palate	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	lenz-majewski hyperostotic dwarfism	Kyphosis	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003241	lenz-majewski hyperostotic dwarfism	External genital hypoplasia	Occasional (29-5%)	PTDSS1	No gene mim	151050	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	9587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy, early infantile, 8	NA	NA	ARHGEF9	No gene mim	300607	hemizygous	possible	loss of function	Brain/Cognition	14561	Cdc42 guanine nucleotide exchange factor 9	protein-coding gene	gene with protein product	Approved	Xq11.1	Xq11.1	KIAA0424|PEM-2	collybistin		Cdc42 guanine nucleotide exchange factor (GEF) 9	Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
NA	anonychia congenita	NA	NA	RSPO4	610573	206800	biallelic	confirmed	loss of function	Skin	16175	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000737	carnitine-acylcarnitine translocase deficiency	Irritability	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001254	carnitine-acylcarnitine translocase deficiency	Lethargy	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	carnitine-acylcarnitine translocase deficiency	Global developmental delay	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001298	carnitine-acylcarnitine translocase deficiency	Encephalopathy	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	carnitine-acylcarnitine translocase deficiency	Muscle weakness	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001638	carnitine-acylcarnitine translocase deficiency	Cardiomyopathy	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001985	carnitine-acylcarnitine translocase deficiency	Hypoketotic hypoglycemia	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001987	carnitine-acylcarnitine translocase deficiency	Hyperammonemia	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	carnitine-acylcarnitine translocase deficiency	Respiratory insufficiency	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	carnitine-acylcarnitine translocase deficiency	Hepatomegaly	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002615	carnitine-acylcarnitine translocase deficiency	Hypotension	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002910	carnitine-acylcarnitine translocase deficiency	Elevated hepatic transaminases	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003162	carnitine-acylcarnitine translocase deficiency	Fasting hypoglycemia	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003201	carnitine-acylcarnitine translocase deficiency	Rhabdomyolysis	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003215	carnitine-acylcarnitine translocase deficiency	Dicarboxylic aciduria	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003234	carnitine-acylcarnitine translocase deficiency	Decreased plasma carnitine	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004756	carnitine-acylcarnitine translocase deficiency	Ventricular tachycardia	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008331	carnitine-acylcarnitine translocase deficiency	Elevated creatine kinase after exercise	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	carnitine-acylcarnitine translocase deficiency	Arrhythmia	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0040290	carnitine-acylcarnitine translocase deficiency	Abnormality of skeletal muscles	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0045045	carnitine-acylcarnitine translocase deficiency	Elevated plasma acylcarnitine levels	Very frequent (99-80%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	carnitine-acylcarnitine translocase deficiency	Microcephaly	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	carnitine-acylcarnitine translocase deficiency	Nystagmus	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000961	carnitine-acylcarnitine translocase deficiency	Cyanosis	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	carnitine-acylcarnitine translocase deficiency	Seizures	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001259	carnitine-acylcarnitine translocase deficiency	Coma	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001399	carnitine-acylcarnitine translocase deficiency	Hepatic failure	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002045	carnitine-acylcarnitine translocase deficiency	Hypothermia	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002882	carnitine-acylcarnitine translocase deficiency	Sudden episodic apnea	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100520	carnitine-acylcarnitine translocase deficiency	Oliguria	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100602	carnitine-acylcarnitine translocase deficiency	Preeclampsia	Occasional (29-5%)	SLC25A20	613698	212138	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	1421	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	split-hand/foot malformation type 6	NA	NA	WNT10B	601906	225300	biallelic	confirmed	loss of function	Skeleton	12775	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gaucher disease type 3c	NA	NA	GBA	No gene mim	231005	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
NA	peroxisome biogenesis disorder complementation group 1	NA	NA	PEX1	602136	602136	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
NA	aicardi-goutieres syndrome 1, dominant and recessive	NA	NA	TREX1	606609	225750	biallelic	confirmed	loss of function	Skin;Brain/Cognition	12269	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy.	NA	NA	KCNA2	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	6220	potassium voltage-gated channel subfamily A member 2	protein-coding gene	gene with protein product	Approved	1p13.3	01p13.3	Kv1.2|HK4			potassium voltage-gated channel, shaker-related subfamily, member 2	Potassium voltage-gated channels
NA	epileptic encephalopathy.	NA	NA	KCNA2	No gene mim	No disease mim	monoallelic	confirmed	activating	Brain/Cognition	6220	potassium voltage-gated channel subfamily A member 2	protein-coding gene	gene with protein product	Approved	1p13.3	01p13.3	Kv1.2|HK4			potassium voltage-gated channel, shaker-related subfamily, member 2	Potassium voltage-gated channels
NA	cohesinopathy	NA	NA	RAD21	606462	614701	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9811	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infantile encephalopathy with epilepsy and dysmorphic corpus callosum	NA	NA	SZT2	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	29040	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000821	hawkinsinuria	Hypothyroidism	Occasional (29-5%)	HPD	No gene mim	140350	monoallelic	probable	dominant negative	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	hawkinsinuria	Muscular hypotonia	Frequent (79-30%)	HPD	No gene mim	140350	monoallelic	probable	dominant negative	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	hawkinsinuria	Failure to thrive	Very frequent (99-80%)	HPD	No gene mim	140350	monoallelic	probable	dominant negative	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001942	hawkinsinuria	Metabolic acidosis	Very frequent (99-80%)	HPD	No gene mim	140350	monoallelic	probable	dominant negative	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002213	hawkinsinuria	Fine hair	Very frequent (99-80%)	HPD	No gene mim	140350	monoallelic	probable	dominant negative	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003161	hawkinsinuria	4-Hydroxyphenylpyruvic aciduria	Very frequent (99-80%)	HPD	No gene mim	140350	monoallelic	probable	dominant negative	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003607	hawkinsinuria	4-Hydroxyphenylacetic aciduria	Very frequent (99-80%)	HPD	No gene mim	140350	monoallelic	probable	dominant negative	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008070	hawkinsinuria	Sparse hair	Very frequent (99-80%)	HPD	No gene mim	140350	monoallelic	probable	dominant negative	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010917	hawkinsinuria	Abnormality of tyrosine metabolism	Very frequent (99-80%)	HPD	No gene mim	140350	monoallelic	probable	dominant negative	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rhizomelic chondrodysplasia punctata type 2	NA	NA	GNPAT	602744	222765	biallelic	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye	4416	glyceronephosphate O-acyltransferase	protein-coding gene	gene with protein product	Approved	1q42.2	01q42.2	DHAPAT|DAPAT|DAP-AT	glycerone-phosphate O-acyltransferase|dihydroxyacetone phosphate acyltransferase			
NA	epileptic encephalopathy	NA	NA	DNM1	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Brain/Cognition	2972	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cog5-cdg	NA	NA	COG5	606821	319494	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	14857	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gm2-gangliosidosis type 2	NA	NA	HEXB	606873	268800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	4879	hexosaminidase subunit beta	protein-coding gene	gene with protein product	Approved	5q13.3	05q13.3		beta-hexosaminidase subunit beta		hexosaminidase B (beta polypeptide)	
HP:0000218	otofaciocervical syndrome	High palate	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0000293	otofaciocervical syndrome	Full cheeks	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0000324	otofaciocervical syndrome	Facial asymmetry	Occasional (29-5%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0000400	otofaciocervical syndrome	Macrotia	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0000405	otofaciocervical syndrome	Conductive hearing impairment	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0000411	otofaciocervical syndrome	Protruding ear	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0000413	otofaciocervical syndrome	Atresia of the external auditory canal	Occasional (29-5%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0000463	otofaciocervical syndrome	Anteverted nares	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0000889	otofaciocervical syndrome	Abnormality of the clavicle	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0001249	otofaciocervical syndrome	Intellectual disability	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0001263	otofaciocervical syndrome	Global developmental delay	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0001276	otofaciocervical syndrome	Hypertonia	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0001347	otofaciocervical syndrome	Hyperreflexia	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0002167	otofaciocervical syndrome	Neurological speech impairment	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0002750	otofaciocervical syndrome	Delayed skeletal maturation	Frequent (79-30%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0003691	otofaciocervical syndrome	Scapular winging	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0004322	otofaciocervical syndrome	Short stature	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0004467	otofaciocervical syndrome	Preauricular pit	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0005280	otofaciocervical syndrome	Depressed nasal bridge	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0007477	otofaciocervical syndrome	Abnormal dermatoglyphics	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0008678	otofaciocervical syndrome	Renal hypoplasia/aplasia	Occasional (29-5%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0009738	otofaciocervical syndrome	Abnormality of the antihelix	Frequent (79-30%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
HP:0200021	otofaciocervical syndrome	Down-sloping shoulders	Very frequent (99-80%)	EYA1	601653	166780	monoallelic	possible	loss of function	Kidney Renal Tract;Eye;Ear	3519	EYA transcriptional coactivator and phosphatase 1	protein-coding gene	gene with protein product	Approved	8q13.3	08q13.3			BOR	eyes absent (Drosophila) homolog 1|eyes absent homolog 1 (Drosophila)	EYA transcriptional coactivator and phosphatases
NA	intellectual disability	NA	NA	MED13L	No gene mim	No disease mim	monoallelic	probable	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	22962	mediator complex subunit 13 like	protein-coding gene	gene with protein product	Approved	12q24.21	12q24.21	KIAA1025|TRAP240L		THRAP2	thyroid hormone receptor associated protein 2|mediator complex subunit 13-like	Mediator complex
NA	spondylocostal dysostosis type 2	NA	NA	MESP2	605195	608681	biallelic	confirmed	loss of function	Skeleton	29659	mesoderm posterior bHLH transcription factor 2	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	SCDO2|bHLHc6			mesoderm posterior 2 homolog (mouse)|mesoderm posterior basic helix-loop-helix transcription factor 2	Basic helix-loop-helix proteins
NA	primary autosomal recessive microcephaly	NA	NA	CDK5RAP2	608201	279936	biallelic	probable	loss of function	Brain/Cognition	18672	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cystinosis adult non-nephropathic type	NA	NA	CTNS	606272	219750	biallelic	confirmed	loss of function	Kidney Renal Tract	2518	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperphenylalaninemia, bh4-deficient, d	NA	NA	PCBD1	126090	264070	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8646	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	venous malformations, multiple cutaneous and mucosal	NA	NA	TEK	600221	600195	monoallelic	confirmed	all missense/in frame	Skin;Heart/Cardiovasculature/Lymphatic	11724	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness, dystonia, and central hypomyelination with disorganization of the golgi apparatus	NA	NA	BCAP31	No gene mim	No disease mim	hemizygous	confirmed	loss of function	Brain/Cognition;Ear	16695	B-cell receptor associated protein 31	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	DXS1357E|BAP31|6C6-Ag|CDM				
NA	atrial septal defect type 3	NA	NA	MYH6	No gene mim	160710	monoallelic	both DD and IF	uncertain	Heart/Cardiovasculature/Lymphatic	7576	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	perrault syndrome	NA	NA	HSD17B4	601860	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition;Ear;Genitalia	5213	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebral palsy spastic quadriplegic type 2	NA	NA	KANK1	No gene mim	612900	imprinted	possible	loss of function	Brain/Cognition	19309	KN motif and ankyrin repeat domains 1	protein-coding gene	gene with protein product	Approved	9p24.3	09p24.3	KIAA0172|KANK		ANKRD15	ankyrin repeat domain 15	Ankyrin repeat domain containing|KN motif and ankyrin repeat domain containing
NA	kbg syndrome	NA	NA	ANKRD11	611192	148050	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Brain/Cognition	21316	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	synpolydactyly 1	NA	NA	HOXD13	142989	186000	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000054	potocki-shaffer syndrome	Micropenis	Frequent (79-30%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000248	potocki-shaffer syndrome	Brachycephaly	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000286	potocki-shaffer syndrome	Epicanthus	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000322	potocki-shaffer syndrome	Short philtrum	Frequent (79-30%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000347	potocki-shaffer syndrome	Micrognathia	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000426	potocki-shaffer syndrome	Prominent nasal bridge	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000430	potocki-shaffer syndrome	Underdeveloped nasal alae	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000437	potocki-shaffer syndrome	Depressed nasal tip	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000455	potocki-shaffer syndrome	Broad nasal tip	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000486	potocki-shaffer syndrome	Strabismus	Frequent (79-30%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000639	potocki-shaffer syndrome	Nystagmus	Frequent (79-30%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000821	potocki-shaffer syndrome	Hypothyroidism	Occasional (29-5%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000822	potocki-shaffer syndrome	Hypertension	Occasional (29-5%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0000823	potocki-shaffer syndrome	Delayed puberty	Occasional (29-5%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0001249	potocki-shaffer syndrome	Intellectual disability	Occasional (29-5%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0001250	potocki-shaffer syndrome	Seizures	Frequent (79-30%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0001263	potocki-shaffer syndrome	Global developmental delay	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0001903	potocki-shaffer syndrome	Anemia	Occasional (29-5%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0002667	potocki-shaffer syndrome	Nephroblastoma	Occasional (29-5%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0002697	potocki-shaffer syndrome	Parietal foramina	Frequent (79-30%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0002714	potocki-shaffer syndrome	Downturned corners of mouth	Frequent (79-30%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0004331	potocki-shaffer syndrome	Decreased skull ossification	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
HP:0100777	potocki-shaffer syndrome	Exostoses	Very frequent (99-80%)	PHF21A	No gene mim	601224	monoallelic	probable	loss of function	Brain/Cognition	24156	PHD finger protein 21A	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	BHC80|KIAA1696|BM-006				PHD finger proteins
NA	posterior polymorphous corneal dystrophy type 3	NA	NA	ZEB1	No gene mim	609141	monoallelic	possible	loss of function	Eye	11642	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neural tube defects	NA	NA	VANGL1	No gene mim	182940	monoallelic	possible	all missense/in frame	Skeleton;Spinal cord/Peripheral nerves	15512	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	neurofibromatosis-noonan syndrome	Cryptorchidism	Frequent (79-30%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000271	neurofibromatosis-noonan syndrome	Abnormality of the face	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	neurofibromatosis-noonan syndrome	Hypertelorism	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	neurofibromatosis-noonan syndrome	Low-set, posteriorly rotated ears	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000465	neurofibromatosis-noonan syndrome	Webbed neck	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	neurofibromatosis-noonan syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	neurofibromatosis-noonan syndrome	Ptosis	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000765	neurofibromatosis-noonan syndrome	Abnormality of the thorax	Frequent (79-30%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	neurofibromatosis-noonan syndrome	Specific learning disability	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	neurofibromatosis-noonan syndrome	Hypertrophic cardiomyopathy	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001642	neurofibromatosis-noonan syndrome	Pulmonic stenosis	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002015	neurofibromatosis-noonan syndrome	Dysphagia	Frequent (79-30%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003010	neurofibromatosis-noonan syndrome	Prolonged bleeding time	Frequent (79-30%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	neurofibromatosis-noonan syndrome	Short stature	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007565	neurofibromatosis-noonan syndrome	Multiple cafe-au-lait spots	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009023	neurofibromatosis-noonan syndrome	Abdominal wall muscle weakness	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011039	neurofibromatosis-noonan syndrome	Abnormality of the helix	Very frequent (99-80%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100763	neurofibromatosis-noonan syndrome	Abnormality of the lymphatic system	Frequent (79-30%)	NF1	613113	601321	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	joubert syndrome type 10	NA	NA	OFD1	300170	300804	hemizygous	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	2567	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bactericidal permeability-increasing protein-like 3	NA	NA	BPIFB6	No gene mim	614110	monoallelic	possible	uncertain	Brain/Cognition	16504	BPI fold containing family B member 6	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	LPLUNC6		BPIL3	bactericidal/permeability-increasing protein-like 3	BPI fold containing
HP:0000202	incontinentia pigmenti	Oral cleft	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000364	incontinentia pigmenti	Hearing abnormality	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000486	incontinentia pigmenti	Strabismus	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000491	incontinentia pigmenti	Keratitis	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000505	incontinentia pigmenti	Visual impairment	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000518	incontinentia pigmenti	Cataract	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000532	incontinentia pigmenti	Chorioretinal abnormality	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000541	incontinentia pigmenti	Retinal detachment	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000554	incontinentia pigmenti	Uveitis	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000568	incontinentia pigmenti	Microphthalmia	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000573	incontinentia pigmenti	Retinal hemorrhage	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000592	incontinentia pigmenti	Blue sclerae	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000668	incontinentia pigmenti	Hypodontia	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000682	incontinentia pigmenti	Abnormality of dental enamel	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000684	incontinentia pigmenti	Delayed eruption of teeth	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000962	incontinentia pigmenti	Hyperkeratosis	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000975	incontinentia pigmenti	Hyperhidrosis	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0000988	incontinentia pigmenti	Skin rash	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001000	incontinentia pigmenti	Abnormality of skin pigmentation	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001053	incontinentia pigmenti	Hypopigmented skin patches	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001231	incontinentia pigmenti	Abnormality of the fingernails	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001249	incontinentia pigmenti	Intellectual disability	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001250	incontinentia pigmenti	Seizures	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001252	incontinentia pigmenti	Muscular hypotonia	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001257	incontinentia pigmenti	Spasticity	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001263	incontinentia pigmenti	Global developmental delay	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001288	incontinentia pigmenti	Gait disturbance	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001537	incontinentia pigmenti	Umbilical hernia	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001595	incontinentia pigmenti	Abnormality of the hair	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001596	incontinentia pigmenti	Alopecia	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001597	incontinentia pigmenti	Abnormality of the nail	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001635	incontinentia pigmenti	Congestive heart failure	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001804	incontinentia pigmenti	Hypoplastic fingernail	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001810	incontinentia pigmenti	Dystrophic toenail	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001821	incontinentia pigmenti	Broad nail	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0001880	incontinentia pigmenti	Eosinophilia	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0002092	incontinentia pigmenti	Pulmonary arterial hypertension	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0002120	incontinentia pigmenti	Cerebral cortical atrophy	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0002383	incontinentia pigmenti	Encephalitis	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0002558	incontinentia pigmenti	Supernumerary nipple	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0002637	incontinentia pigmenti	Cerebral ischemia	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0002650	incontinentia pigmenti	Scoliosis	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0002797	incontinentia pigmenti	Osteolysis	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0003298	incontinentia pigmenti	Spina bifida occulta	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0004050	incontinentia pigmenti	Absent hand	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0004097	incontinentia pigmenti	Deviation of finger	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0004322	incontinentia pigmenti	Short stature	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0004374	incontinentia pigmenti	Hemiplegia/hemiparesis	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0005815	incontinentia pigmenti	Supernumerary ribs	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0005922	incontinentia pigmenti	Abnormal hand morphology	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0006101	incontinentia pigmenti	Finger syndactyly	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0006482	incontinentia pigmenti	Abnormality of dental morphology	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0007018	incontinentia pigmenti	Attention deficit hyperactivity disorder	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0007400	incontinentia pigmenti	Irregular hyperpigmentation	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0007850	incontinentia pigmenti	Retinal vascular proliferation	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0007957	incontinentia pigmenti	Corneal opacity	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0008066	incontinentia pigmenti	Abnormal blistering of the skin	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0008388	incontinentia pigmenti	Abnormality of the toenails	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0008402	incontinentia pigmenti	Ridged fingernail	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0010783	incontinentia pigmenti	Erythema	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0010978	incontinentia pigmenti	Abnormality of immune system physiology	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0100490	incontinentia pigmenti	Camptodactyly of finger	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0100543	incontinentia pigmenti	Cognitive impairment	Occasional (29-5%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0100555	incontinentia pigmenti	Asymmetric growth	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0100585	incontinentia pigmenti	Telangiectasia of the skin	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0200042	incontinentia pigmenti	Skin ulcer	Frequent (79-30%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
HP:0200043	incontinentia pigmenti	Verrucae	Very frequent (99-80%)	IKBKG	300248	308300	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
NA	diabetes mellitus, permanent neonatal, with cerebellar agenesis	NA	NA	PTF1A	607194	609069	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23734	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	ASCL1	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	738	achaete-scute family bHLH transcription factor 1	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	ASH1|HASH1|bHLHa46			achaete-scute complex (Drosophila) homolog-like 1|achaete-scute complex-like 1 (Drosophila)|achaete-scute complex homolog 1 (Drosophila)	Basic helix-loop-helix proteins
NA	ichthyosis vulgaris	NA	NA	FLG	135940	146700	biallelic	possible	loss of function	Skin	3748	filaggrin	protein-coding gene	gene with protein product	Approved	1q21.3	01q21.3					EF-hand domain containing|S100 fused type protein family
NA	severe early-onset epilepsy	NA	NA	PIGQ	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	14135	phosphatidylinositol glycan anchor biosynthesis class Q	protein-coding gene	gene with protein product	Approved	16p13.3	16p13.3	hGPI1|GPI1			phosphatidylinositol glycan, class Q	Phosphatidylinositol glycan anchor biosynthesis
NA	mental retardation-joint hypermobility-skin laxity with or without metabolic abnormalities	NA	NA	ALDH18A1	138250	612652	biallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9722	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fuhrmann syndrome	NA	NA	WNT7A	601570	228930	biallelic	confirmed	uncertain	Skeleton	12786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperkalemic periodic paralysis type 1	NA	NA	SCN4A	603967	170500	monoallelic	confirmed	activating	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	blepharophimosis, ptosis, and epicanthus inversus syndrome	NA	NA	FOXL2	605597	110100	monoallelic	probable	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	1092	forkhead box L2	protein-coding gene	gene with protein product	Approved	3q22.3	03q22.3	BPES1		BPES		Forkhead boxes
NA	nemaline myopathy 7	NA	NA	CFL2	601443	610687	biallelic	probable	all missense/in frame	Musculature	1875	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microcephaly, postnatal progressive, with seizures and brain atrophy	NA	NA	MED17	603810	613668	biallelic	probable	all missense/in frame	Brain/Cognition	2375	mediator complex subunit 17	protein-coding gene	gene with protein product	Approved	11q21	11q21	CRSP77|TRAP80|DRIP80|SRB4		CRSP6	cofactor required for Sp1 transcriptional activation, subunit 6 (77kD)|cofactor required for Sp1 transcriptional activation, subunit 6, 77kDa	Mediator complex
NA	coffin siris	NA	NA	SMARCA4	603254	135900	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Cancer predisposition	11100	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	thyroid hormonogenesis defect i	NA	NA	SLC5A5	601843	274400	biallelic	confirmed	loss of function	Endocrine/Metabolic	11040	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	moyamoya disease 5	NA	NA	ACTA2	No gene mim	614042	monoallelic	both DD and IF	all missense/in frame	Heart/Cardiovasculature/Lymphatic	130	actin, alpha 2, smooth muscle, aorta	protein-coding gene	gene with protein product	Approved	10q23.31	10q23.31	ACTSA				Actins
NA	fanconi anemia, complementation group g	NA	NA	FANCG	602956	614082	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	3588	Fanconi anemia complementation group G	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3	FAG	DNA repair protein XRCC9|X-ray repair, complementing defective, in Chinese hamster, 9|X-ray repair complementing defective repair in Chinese hamster cells 9	XRCC9		Fanconi anemia complementation groups
NA	split-hand/foot malformation type 3	NA	NA	FBXW4	No gene mim	246560	monoallelic	possible	part of contiguous gene duplication	Skeleton	10847	F-box and WD repeat domain containing 4	protein-coding gene	gene with protein product	Approved	10q24.32	10q24.32	Fbw4|dactylin		SHFM3	split hand/foot malformation (ectrodactyly) type 3|F-box and WD-40 domain protein 4	WD repeat domain containing|F-box and WD repeat domain containing
NA	facial dysmorphism, lens dislocation, anterior segment abnormalities, and spontaneous filtering blebs	NA	NA	ASPH	No gene mim	No disease mim	biallelic	probable	loss of function	Face;Eye	757	aspartate beta-hydroxylase	protein-coding gene	gene with protein product	Approved	8q12.3	08q12.3	CASQ2BP1|BAH|JCTN|HAAH	junctin|humbug|junctate			
NA	cortical dysplasia, complex, with other brain malformations 5	NA	NA	TUBB2A	No gene mim	615763	monoallelic	confirmed	all missense/in frame	Brain/Cognition	12412	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	sulfatidosis, juvenile, austin type	NA	NA	SUMF1	607939	272200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20376	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX6	601498	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
NA	usher syndrome type 1j	NA	NA	CIB2	605564	614869	biallelic	confirmed	loss of function	Eye;Ear	24579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	macrocephaly, macrosomia, facial dysmorphism syndrome	NA	NA	RNF135	611358	614192	monoallelic	confirmed	loss of function	Skeleton	21158	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebral cavernous malformations type 3	NA	NA	PDCD10	No gene mim	603285	monoallelic	both DD and IF	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	8761	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	orofaciodigital syndrome xiv	NA	NA	C2CD3	No gene mim	615948	biallelic	probable	loss of function	Face;Brain/Cognition	24564	C2 calcium dependent domain containing 3	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	DKFZP586P0123				C2 domain containing
NA	joubert syndrome 15	NA	NA	CEP41	610523	614464	biallelic	confirmed	loss of function	Brain/Cognition	12370	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness autosomal dominant type 2b	NA	NA	GJB3	No gene mim	612644	monoallelic	both DD and IF	loss of function	Skin;Ear	4285	gap junction protein beta 3	protein-coding gene	gene with protein product	Approved	1p34.3	01p34.3	CX31	connexin 31	DFNA2|EKV	gap junction protein, beta 3, 31kD (connexin 31)|gap junction protein, beta 3, 31kDa (connexin 31)|erythrokeratodermia variabilis|gap junction protein, beta 3, 31kDa	Gap junction proteins|Deafness associated genes
HP:0000028	neurofibromatosis type 1	Cryptorchidism	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000098	neurofibromatosis type 1	Tall stature	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000364	neurofibromatosis type 1	Hearing abnormality	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	neurofibromatosis type 1	Hearing impairment	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000478	neurofibromatosis type 1	Abnormality of the eye	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	neurofibromatosis type 1	Abnormality of vision	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	neurofibromatosis type 1	Proptosis	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001100	neurofibromatosis type 1	Heterochromia iridis	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	neurofibromatosis type 1	Ataxia	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001480	neurofibromatosis type 1	Freckling	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	neurofibromatosis type 1	Neurological speech impairment	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002315	neurofibromatosis type 1	Headache	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002354	neurofibromatosis type 1	Memory impairment	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	neurofibromatosis type 1	Skeletal dysplasia	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	neurofibromatosis type 1	Recurrent fractures	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	neurofibromatosis type 1	Genu valgum	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003100	neurofibromatosis type 1	Slender long bone	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003401	neurofibromatosis type 1	Paresthesia	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000707	neurofibromatosis type 1	Abnormality of the nervous system	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	neurofibromatosis type 1	Delayed puberty	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000995	neurofibromatosis type 1	Melanocytic nevus	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001012	neurofibromatosis type 1	Multiple lipomas	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001256	neurofibromatosis type 1	Intellectual disability, mild	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	neurofibromatosis type 1	Specific learning disability	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001482	neurofibromatosis type 1	Subcutaneous nodule	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	neurofibromatosis type 1	Kyphosis	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002858	neurofibromatosis type 1	Meningioma	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007440	neurofibromatosis type 1	Generalized hyperpigmentation	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007565	neurofibromatosis type 1	Multiple cafe-au-lait spots	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008069	neurofibromatosis type 1	Neoplasm of the skin	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009592	neurofibromatosis type 1	Astrocytoma	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009732	neurofibromatosis type 1	Plexiform neurofibroma	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009737	neurofibromatosis type 1	Lisch nodules	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012733	neurofibromatosis type 1	Macule	Very frequent (99-80%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007018	neurofibromatosis type 1	Attention deficit hyperactivity disorder	Frequent (79-30%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	neurofibromatosis type 1	Hydrocephalus	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	neurofibromatosis type 1	Macrocephaly	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000492	neurofibromatosis type 1	Abnormality of the eyelid	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	neurofibromatosis type 1	Glaucoma	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	neurofibromatosis type 1	Visual impairment	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000512	neurofibromatosis type 1	Abnormal electroretinogram	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	neurofibromatosis type 1	Cataract	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	neurofibromatosis type 1	Myopia	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000567	neurofibromatosis type 1	Chorioretinal coloboma	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000818	neurofibromatosis type 1	Abnormality of the endocrine system	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000822	neurofibromatosis type 1	Hypertension	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000826	neurofibromatosis type 1	Precocious puberty	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000924	neurofibromatosis type 1	Abnormality of the skeletal system	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001053	neurofibromatosis type 1	Hypopigmented skin patches	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	neurofibromatosis type 1	Seizures	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	neurofibromatosis type 1	Joint stiffness	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001909	neurofibromatosis type 1	Leukemia	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002086	neurofibromatosis type 1	Abnormality of the respiratory system	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	neurofibromatosis type 1	Scoliosis	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002664	neurofibromatosis type 1	Neoplasm	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002666	neurofibromatosis type 1	Pheochromocytoma	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002970	neurofibromatosis type 1	Genu varum	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003272	neurofibromatosis type 1	Abnormality of the hip bone	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	neurofibromatosis type 1	Short stature	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005506	neurofibromatosis type 1	Chronic myelogenous leukemia	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007378	neurofibromatosis type 1	Neoplasm of the gastrointestinal tract	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	neurofibromatosis type 1	Abnormality of retinal pigmentation	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007957	neurofibromatosis type 1	Corneal opacity	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009735	neurofibromatosis type 1	Spinal neurofibromas	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010786	neurofibromatosis type 1	Urinary tract neoplasm	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010935	neurofibromatosis type 1	Abnormality of the upper urinary tract	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011362	neurofibromatosis type 1	Abnormal hair quantity	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100242	neurofibromatosis type 1	Sarcoma	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100545	neurofibromatosis type 1	Arterial stenosis	Occasional (29-5%)	NF1	613113	162200	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy, early infantile, 24	NA	NA	HCN1	No gene mim	615871	monoallelic	confirmed	all missense/in frame	Brain/Cognition	4845	hyperpolarization activated cyclic nucleotide gated potassium channel 1	protein-coding gene	gene with protein product	Approved	5p12	05p12	BCNG-1|HAC-2		BCNG1	hyperpolarization activated cyclic nucleotide-gated potassium channel 1	Cyclic nucleotide gated channels
HP:0000016	camurati-engelmann disease	Urinary retention	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	camurati-engelmann disease	Hypogonadism	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	camurati-engelmann disease	Hearing impairment	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	camurati-engelmann disease	Glaucoma	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	camurati-engelmann disease	Proptosis	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	camurati-engelmann disease	Optic atrophy	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	camurati-engelmann disease	Carious teeth	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	camurati-engelmann disease	Delayed eruption of teeth	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000763	camurati-engelmann disease	Sensory neuropathy	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	camurati-engelmann disease	Delayed puberty	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000925	camurati-engelmann disease	Abnormality of the vertebral column	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000929	camurati-engelmann disease	Abnormality of the skull	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000940	camurati-engelmann disease	Abnormal diaphysis morphology	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	camurati-engelmann disease	Ataxia	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	camurati-engelmann disease	Muscle weakness	Frequent (79-30%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001376	camurati-engelmann disease	Limitation of joint mobility	Frequent (79-30%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001533	camurati-engelmann disease	Slender build	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	camurati-engelmann disease	Hypertrophic cardiomyopathy	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	camurati-engelmann disease	Splenomegaly	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	camurati-engelmann disease	Pes planus	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001882	camurati-engelmann disease	Leukopenia	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	camurati-engelmann disease	Anemia	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001999	camurati-engelmann disease	Abnormal facial shape	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	camurati-engelmann disease	Frontal bossing	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002039	camurati-engelmann disease	Anorexia	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	camurati-engelmann disease	Neurological speech impairment	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	camurati-engelmann disease	Hepatomegaly	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002515	camurati-engelmann disease	Waddling gait	Frequent (79-30%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002644	camurati-engelmann disease	Abnormality of pelvic girdle bone morphology	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	camurati-engelmann disease	Scoliosis	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	camurati-engelmann disease	Skeletal dysplasia	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002653	camurati-engelmann disease	Bone pain	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002673	camurati-engelmann disease	Coxa valga	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	camurati-engelmann disease	Kyphosis	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002818	camurati-engelmann disease	Abnormality of the radius	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002823	camurati-engelmann disease	Abnormality of the femur	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	camurati-engelmann disease	Genu valgum	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002992	camurati-engelmann disease	Abnormality of the tibia	Frequent (79-30%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002997	camurati-engelmann disease	Abnormality of the ulna	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003063	camurati-engelmann disease	Abnormality of the humerus	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	camurati-engelmann disease	Skeletal muscle atrophy	Frequent (79-30%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003307	camurati-engelmann disease	Hyperlordosis	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003565	camurati-engelmann disease	Elevated erythrocyte sedimentation rate	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004326	camurati-engelmann disease	Cachexia	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005464	camurati-engelmann disease	Craniofacial osteosclerosis	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005791	camurati-engelmann disease	Cortical thickening of long bone diaphyses	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006501	camurati-engelmann disease	Aplasia/Hypoplasia of the radius	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007552	camurati-engelmann disease	Abnormal subcutaneous fat tissue distribution	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007807	camurati-engelmann disease	Optic nerve compression	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	camurati-engelmann disease	Feeding difficulties in infancy	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010628	camurati-engelmann disease	Facial palsy	Occasional (29-5%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012544	camurati-engelmann disease	Elevated aldolase level	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100255	camurati-engelmann disease	Metaphyseal dysplasia	Frequent (79-30%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100774	camurati-engelmann disease	Hyperostosis	Very frequent (99-80%)	TGFB1	190180	131300	monoallelic	confirmed	all missense/in frame	Skeleton	11766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bannayan-zonana syndrome	NA	NA	PTEN	601728	153480	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	osteoglophonic dysplasia	NA	NA	FGFR1	136350	166250	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	mucopolysaccharidosis type 3a	NA	NA	SGSH	605270	252900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	10818	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atrial septal defect type 6	NA	NA	TLL1	No gene mim	613087	monoallelic	possible	uncertain	Heart/Cardiovasculature/Lymphatic	11843	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nonspecific severe id	NA	NA	SATB2	608148	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	21637	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation autosomal recessive type 6	NA	NA	GRIK2	138244	611092	biallelic	confirmed	loss of function	Brain/Cognition	4580	glutamate ionotropic receptor kainate type subunit 2	protein-coding gene	gene with protein product	Approved	6q16.3	06q16.3	GluK2|MRT6		GLUR6	glutamate receptor, ionotropic, kainate 2	Glutamate ionotropic receptor kainate type subunits
NA	meier-gorlin syndrome 1	NA	NA	ORC1	601902	224690	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear	8487	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanconi anemia, complementation group e	NA	NA	FANCE	613976	600901	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	3586	Fanconi anemia complementation group E	protein-coding gene	gene with protein product	Approved	6p21.31	06p21.31	FAE		FACE		Fanconi anemia complementation groups
NA	emery-dreifuss muscular dystrophy 4, autosomal recessive	NA	NA	SYNE1	No gene mim	612998	biallelic	both DD and IF	loss of function	Brain/Cognition	17089	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bardet-biedl syndrome type 3	NA	NA	ARL6	608845	209900	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye	13210	ADP ribosylation factor like GTPase 6	protein-coding gene	gene with protein product	Approved	3q11.2	03q11.2	RP55		BBS3	ADP-ribosylation factor-like 6	ARF GTPase family|Bardet-Biedl syndrome associated
NA	cowden disease	NA	NA	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	QKI	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	21100	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mucopolysaccharidosis type 1s	NA	NA	IDUA	252800	607016	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	angelman/pitt hopkins syndrome-like disorder	NA	NA	STXBP1	602926	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	11444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	overgrowth syndrome with intellectual disability	NA	NA	DNMT3A	No gene mim	615879	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2978	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	uv-sensitive syndrome	NA	NA	UVSSA	614632	609413	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	29304	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	choanal atresia and lymphedema	NA	NA	PTPN14	603155	613611	biallelic	probable	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	9647	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	familial horizontal gaze palsy with progressive scoliosis	NA	NA	ROBO3	608630	607313	biallelic	confirmed	loss of function	Skeleton;Eye	13433	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bardet-biedl syndrome type 1	NA	NA	BBS1	209901	209900	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	966	Bardet-Biedl syndrome 1	protein-coding gene	gene with protein product	Approved	11q13.2	11q13.2	FLJ23590				Bardet-Biedl syndrome associated|BBSome
NA	mucopolysaccharidosis type 1h/s	NA	NA	IDUA	252800	607015	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	frontonasal dysplasia type 3	NA	NA	ALX1	601527	136760	biallelic	confirmed	loss of function	Face	1494	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001540	beckwith-wiedemann syndrome	Diastasis recti	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	beckwith-wiedemann syndrome	Hypertrophic cardiomyopathy	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001640	beckwith-wiedemann syndrome	Cardiomegaly	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	beckwith-wiedemann syndrome	Splenomegaly	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001901	beckwith-wiedemann syndrome	Polycythemia	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	beckwith-wiedemann syndrome	Neurological speech impairment	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	beckwith-wiedemann syndrome	Hepatomegaly	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	beckwith-wiedemann syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002667	beckwith-wiedemann syndrome	Nephroblastoma	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002859	beckwith-wiedemann syndrome	Rhabdomyosarcoma	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002884	beckwith-wiedemann syndrome	Hepatoblastoma	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003006	beckwith-wiedemann syndrome	Neuroblastoma	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005487	beckwith-wiedemann syndrome	Prominent metopic ridge	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005562	beckwith-wiedemann syndrome	Multiple renal cysts	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006254	beckwith-wiedemann syndrome	Elevated alpha-fetoprotein	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006744	beckwith-wiedemann syndrome	Adrenocortical carcinoma	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008186	beckwith-wiedemann syndrome	Adrenocortical cytomegaly	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008676	beckwith-wiedemann syndrome	Congenital megaureter	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	beckwith-wiedemann syndrome	Feeding difficulties in infancy	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010535	beckwith-wiedemann syndrome	Sleep apnea	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012090	beckwith-wiedemann syndrome	Abnormality of pancreas morphology	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012758	beckwith-wiedemann syndrome	Neurodevelopmental delay	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030255	beckwith-wiedemann syndrome	Large intestinal polyposis	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100243	beckwith-wiedemann syndrome	Leiomyosarcoma	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100589	beckwith-wiedemann syndrome	Urogenital fistula	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000852	beckwith-wiedemann syndrome	Pseudohypoparathyroidism	Very rare (<4-1%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002308	beckwith-wiedemann syndrome	Arnold-Chiari malformation	Very rare (<4-1%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000098	beckwith-wiedemann syndrome	Tall stature	Very frequent (99-80%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001520	beckwith-wiedemann syndrome	Large for gestational age	Very frequent (99-80%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002664	beckwith-wiedemann syndrome	Neoplasm	Very frequent (99-80%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000105	beckwith-wiedemann syndrome	Enlarged kidney	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000112	beckwith-wiedemann syndrome	Nephropathy	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	beckwith-wiedemann syndrome	Wide mouth	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000158	beckwith-wiedemann syndrome	Macroglossia	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000269	beckwith-wiedemann syndrome	Prominent occiput	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	beckwith-wiedemann syndrome	Coarse facial features	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	beckwith-wiedemann syndrome	Mandibular prognathia	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000363	beckwith-wiedemann syndrome	Abnormality of earlobe	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	beckwith-wiedemann syndrome	Proptosis	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000776	beckwith-wiedemann syndrome	Congenital diaphragmatic hernia	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000995	beckwith-wiedemann syndrome	Melanocytic nevus	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001052	beckwith-wiedemann syndrome	Nevus flammeus	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001139	beckwith-wiedemann syndrome	Choroideremia	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001513	beckwith-wiedemann syndrome	Obesity	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001528	beckwith-wiedemann syndrome	Hemihypertrophy	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	beckwith-wiedemann syndrome	Umbilical hernia	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001539	beckwith-wiedemann syndrome	Omphalocele	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	beckwith-wiedemann syndrome	Polyhydramnios	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	beckwith-wiedemann syndrome	Redundant skin	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001622	beckwith-wiedemann syndrome	Premature birth	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001738	beckwith-wiedemann syndrome	Exocrine pancreatic insufficiency	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	beckwith-wiedemann syndrome	Hypoglycemia	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001998	beckwith-wiedemann syndrome	Neonatal hypoglycemia	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002150	beckwith-wiedemann syndrome	Hypercalciuria	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003271	beckwith-wiedemann syndrome	Visceromegaly	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005616	beckwith-wiedemann syndrome	Accelerated skeletal maturation	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006267	beckwith-wiedemann syndrome	Large placenta	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008523	beckwith-wiedemann syndrome	Posterior helix pit	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009796	beckwith-wiedemann syndrome	Branchial cyst	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009908	beckwith-wiedemann syndrome	Anterior creases of earlobe	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	beckwith-wiedemann syndrome	Midface retrusion	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030720	beckwith-wiedemann syndrome	Subchorionic septal cyst	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100555	beckwith-wiedemann syndrome	Asymmetric growth	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100876	beckwith-wiedemann syndrome	Infra-orbital crease	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0430026	beckwith-wiedemann syndrome	Abnormality of the shape of the midface	Frequent (79-30%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	beckwith-wiedemann syndrome	Inguinal hernia	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	beckwith-wiedemann syndrome	Cryptorchidism	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000073	beckwith-wiedemann syndrome	Ureteral duplication	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	beckwith-wiedemann syndrome	Vesicoureteral reflux	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000150	beckwith-wiedemann syndrome	Gonadoblastoma	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	beckwith-wiedemann syndrome	Cleft palate	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000239	beckwith-wiedemann syndrome	Large fontanelles	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000260	beckwith-wiedemann syndrome	Wide anterior fontanel	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000329	beckwith-wiedemann syndrome	Facial hemangioma	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000362	beckwith-wiedemann syndrome	Otosclerosis	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000787	beckwith-wiedemann syndrome	Nephrolithiasis	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000821	beckwith-wiedemann syndrome	Hypothyroidism	Occasional (29-5%)	NSD1	606681	130650	monoallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia, syndromic 6	NA	NA	BMP4	112262	607932	monoallelic	confirmed	loss of function	Face;Skeleton;Eye	1071	bone morphogenetic protein 4	protein-coding gene	gene with protein product	Approved	14q22.2	14q22.2			BMP2B		Bone morphogenetic proteins|Endogenous ligands
NA	tetra-amelia syndrome	NA	NA	WNT3	165330	276069	biallelic	confirmed	loss of function	Skeleton	12782	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	merrf	Sensorineural hearing impairment	Very frequent (99-80%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0000648	merrf	Optic atrophy	Frequent (79-30%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0001012	merrf	Multiple lipomas	Frequent (79-30%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0001251	merrf	Ataxia	Very frequent (99-80%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0002123	merrf	Generalized myoclonic seizures	Very frequent (99-80%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0003198	merrf	Myopathy	Very frequent (99-80%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0003200	merrf	Ragged-red muscle fibers	Very frequent (99-80%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0003457	merrf	EMG abnormality	Very frequent (99-80%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0004322	merrf	Short stature	Frequent (79-30%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0100022	merrf	Abnormality of movement	Very frequent (99-80%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
HP:0100543	merrf	Cognitive impairment	Frequent (79-30%)	MT-TP	No gene mim	545000	mitochondrial	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	7494	mitochondrially encoded tRNA proline	non-coding RNA	RNA, transfer	Approved	mitochondria	mitochondria	trnP		MTTP	tRNA proline	Mitochondrially encoded tRNAs
NA	congenital disorder of glycosylation type 1g	NA	NA	ALG12	607144	607143	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	19358	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	succinyl-coa-3-ketoacid-coa transferase deficiency	NA	NA	OXCT1	601424	245050	biallelic	confirmed	loss of function	Endocrine/Metabolic	8527	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	osteopetrosis autosomal dominant type 1	NA	NA	LRP5	603506	607634	monoallelic	confirmed	uncertain	Skeleton;Eye	6697	LDL receptor related protein 5	protein-coding gene	gene with protein product	Approved	11q13.2	11q13.2	LR3|BMND1|HBM|OPS|OPTA1|VBCH2|EVR4		LRP7|OPPG|EVR1	osteoporosis pseudoglioma syndrome|exudative vitreoretinopathy 1|low density lipoprotein receptor-related protein 5	Low density lipoprotein receptors
NA	sotos-like syndrome	NA	NA	NFIX	164005	614753	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Respiratory tract	7788	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mfsd8-related neuronal ceroid-lipofuscinosis	NA	NA	MFSD8	No gene mim	610951	biallelic	confirmed	loss of function	Brain/Cognition;Eye	28486	major facilitator superfamily domain containing 8	protein-coding gene	gene with protein product	Approved	4q28.2	04q28.2	MGC33302		CLN7	ceroid-lipofuscinosis, neuronal 7, late infantile, variant	
NA	cerebro-oculo-facio-skeletal syndrome type 2	NA	NA	ERCC2	126340	610756	biallelic	confirmed	loss of function	Skin;Skeleton;Spinal cord/Peripheral nerves;Brain/Cognition	3434	ERCC excision repair 2, TFIIH core complex helicase subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	MAG|EM9|MGC102762|MGC126218|MGC126219|TFIIH	excision repair cross-complementing rodent repair deficiency, complementation group 2 protein|TFIIH basal transcription factor complex helicase XPB subunit	XPD	xeroderma pigmentosum complementary group D|excision repair cross-complementing rodent repair deficiency, complementation group 2|excision repair cross-complementation group 2	General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated
NA	coenzyme q10 deficiency, primary, 3	NA	NA	PDSS2	610564	614652	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition	23041	decaprenyl diphosphate synthase subunit 2	protein-coding gene	gene with protein product	Approved	6q21	06q21	bA59I9.3		C6orf210	chromosome 6 open reading frame 210|prenyl (decaprenyl) diphosphate synthase, subunit 2	
HP:0000023	mucopolysaccharidosis type 7	Inguinal hernia	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0000280	mucopolysaccharidosis type 7	Coarse facial features	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0000470	mucopolysaccharidosis type 7	Short neck	Occasional (29-5%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0001004	mucopolysaccharidosis type 7	Lymphedema	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0001249	mucopolysaccharidosis type 7	Intellectual disability	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0001252	mucopolysaccharidosis type 7	Muscular hypotonia	Frequent (79-30%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0001387	mucopolysaccharidosis type 7	Joint stiffness	Frequent (79-30%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0001537	mucopolysaccharidosis type 7	Umbilical hernia	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0001541	mucopolysaccharidosis type 7	Ascites	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0001744	mucopolysaccharidosis type 7	Splenomegaly	Frequent (79-30%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0001789	mucopolysaccharidosis type 7	Hydrops fetalis	Frequent (79-30%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0001840	mucopolysaccharidosis type 7	Metatarsus adductus	Frequent (79-30%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0002103	mucopolysaccharidosis type 7	Abnormality of the pleura	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0002205	mucopolysaccharidosis type 7	Recurrent respiratory infections	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0002650	mucopolysaccharidosis type 7	Scoliosis	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0003272	mucopolysaccharidosis type 7	Abnormality of the hip bone	Frequent (79-30%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0004607	mucopolysaccharidosis type 7	Anterior beaking of lower thoracic vertebrae	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0005019	mucopolysaccharidosis type 7	Diaphyseal thickening	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0007957	mucopolysaccharidosis type 7	Corneal opacity	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0008155	mucopolysaccharidosis type 7	Mucopolysacchariduria	Frequent (79-30%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0008430	mucopolysaccharidosis type 7	Anterior beaking of lumbar vertebrae	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0010655	mucopolysaccharidosis type 7	Epiphyseal stippling	Frequent (79-30%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0012115	mucopolysaccharidosis type 7	Hepatitis	Frequent (79-30%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0012368	mucopolysaccharidosis type 7	Flat face	Very frequent (99-80%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0100026	mucopolysaccharidosis type 7	Arteriovenous malformation	Occasional (29-5%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
HP:0100625	mucopolysaccharidosis type 7	Enlarged thorax	Occasional (29-5%)	GUSB	611499	253220	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	4696	glucuronidase beta	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21				glucuronidase, beta	
NA	2-methyl-3-hydroxybutyryl-coa dehydrogenase deficiency	NA	NA	HSD17B10	300256	300438	hemizygous	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	4800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	renal agenesis	NA	NA	RET	No gene mim	191830	biallelic	both DD and IF	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Cancer predisposition	9967	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	noonan syndrome 8	NA	NA	RIT1	No gene mim	615355	monoallelic	confirmed	activating	Face;Skeleton	10023	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	diabetes mellitus, 6q24-related transient neonatal	NA	NA	ZFP57	612192	601410	biallelic	confirmed	loss of function	Endocrine/Metabolic	18791	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lethal restrictive dermopathy, zmpste24-related	NA	NA	ZMPSTE24	No gene mim	319186	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanconi anemia, complementation group q	NA	NA	ERCC4	133520	615272	biallelic	probable	loss of function	Bone Marrow/Immune;Skin;Skeleton	3436	ERCC excision repair 4, endonuclease catalytic subunit	protein-coding gene	gene with protein product	Approved	16p13.12	16p13.12	RAD1|FANCQ	xeroderma pigmentosum, complementation group F	XPF	excision repair cross-complementing rodent repair deficiency, complementation group 4|excision repair cross-complementation group 4	Fanconi anemia complementation groups|Xeroderma pigmentosum complementation groups|ERCC excision repair associated
NA	hypogonadotropic hypogonadism	NA	NA	TAC3	No gene mim	146110	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Genitalia	11521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dyskeratosis congenita, autosomal dominant 4	NA	NA	RTEL1	No gene mim	615190	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	15888	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	du pan syndrome	NA	NA	GDF5	601146	228900	biallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0000271	infantile refsum disease	Abnormality of the face	Occasional (29-5%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000365	infantile refsum disease	Hearing impairment	Frequent (79-30%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000407	infantile refsum disease	Sensorineural hearing impairment	Frequent (79-30%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000505	infantile refsum disease	Visual impairment	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000510	infantile refsum disease	Rod-cone dystrophy	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000518	infantile refsum disease	Cataract	Occasional (29-5%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000639	infantile refsum disease	Nystagmus	Frequent (79-30%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000648	infantile refsum disease	Optic atrophy	Occasional (29-5%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000662	infantile refsum disease	Nyctalopia	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000708	infantile refsum disease	Behavioral abnormality	Frequent (79-30%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001250	infantile refsum disease	Seizures	Occasional (29-5%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001251	infantile refsum disease	Ataxia	Frequent (79-30%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001252	infantile refsum disease	Muscular hypotonia	Frequent (79-30%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001257	infantile refsum disease	Spasticity	Frequent (79-30%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001263	infantile refsum disease	Global developmental delay	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001508	infantile refsum disease	Failure to thrive	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001638	infantile refsum disease	Cardiomyopathy	Occasional (29-5%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0002240	infantile refsum disease	Hepatomegaly	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0003323	infantile refsum disease	Progressive muscle weakness	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0004322	infantile refsum disease	Short stature	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0005930	infantile refsum disease	Abnormality of epiphysis morphology	Occasional (29-5%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0007981	infantile refsum disease	Concentric narrowing of visual fields	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0008064	infantile refsum disease	Ichthyosis	Occasional (29-5%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0008167	infantile refsum disease	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0010571	infantile refsum disease	Elevated levels of phytanic acid	Very frequent (99-80%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0010628	infantile refsum disease	Facial palsy	Occasional (29-5%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0011675	infantile refsum disease	Arrhythmia	Occasional (29-5%)	PEX26	608666	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
NA	leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation	NA	NA	DARS2	No gene mim	611105	biallelic	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition	25538	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	malonyl-coa decarboxylase deficiency	NA	NA	MLYCD	606761	167676	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7150	malonyl-CoA decarboxylase	protein-coding gene	gene with protein product	Approved	16q23.3	16q23.3	MCD|hMCD				
NA	human piebaldism	NA	NA	KIT	No gene mim	172800	monoallelic	both DD and IF	loss of function	GI tract;Cancer predisposition	6342	KIT proto-oncogene receptor tyrosine kinase	protein-coding gene	gene with protein product	Approved	4q12	04q12	CD117|SCFR|C-Kit		PBT	piebald trait|v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	Receptor Tyrosine Kinases|CD molecules|Immunoglobulin like domain containing
HP:0001540	beckwith-wiedemann syndrome	Diastasis recti	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001639	beckwith-wiedemann syndrome	Hypertrophic cardiomyopathy	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001640	beckwith-wiedemann syndrome	Cardiomegaly	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001744	beckwith-wiedemann syndrome	Splenomegaly	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001901	beckwith-wiedemann syndrome	Polycythemia	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0002167	beckwith-wiedemann syndrome	Neurological speech impairment	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0002240	beckwith-wiedemann syndrome	Hepatomegaly	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0002564	beckwith-wiedemann syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0002667	beckwith-wiedemann syndrome	Nephroblastoma	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0002859	beckwith-wiedemann syndrome	Rhabdomyosarcoma	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0002884	beckwith-wiedemann syndrome	Hepatoblastoma	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0003006	beckwith-wiedemann syndrome	Neuroblastoma	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0005487	beckwith-wiedemann syndrome	Prominent metopic ridge	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0005562	beckwith-wiedemann syndrome	Multiple renal cysts	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0006254	beckwith-wiedemann syndrome	Elevated alpha-fetoprotein	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0006744	beckwith-wiedemann syndrome	Adrenocortical carcinoma	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0008186	beckwith-wiedemann syndrome	Adrenocortical cytomegaly	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0008676	beckwith-wiedemann syndrome	Congenital megaureter	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0008872	beckwith-wiedemann syndrome	Feeding difficulties in infancy	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0010535	beckwith-wiedemann syndrome	Sleep apnea	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0012090	beckwith-wiedemann syndrome	Abnormality of pancreas morphology	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0012758	beckwith-wiedemann syndrome	Neurodevelopmental delay	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0030255	beckwith-wiedemann syndrome	Large intestinal polyposis	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0100243	beckwith-wiedemann syndrome	Leiomyosarcoma	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0100589	beckwith-wiedemann syndrome	Urogenital fistula	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000852	beckwith-wiedemann syndrome	Pseudohypoparathyroidism	Very rare (<4-1%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0002308	beckwith-wiedemann syndrome	Arnold-Chiari malformation	Very rare (<4-1%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000098	beckwith-wiedemann syndrome	Tall stature	Very frequent (99-80%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001520	beckwith-wiedemann syndrome	Large for gestational age	Very frequent (99-80%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0002664	beckwith-wiedemann syndrome	Neoplasm	Very frequent (99-80%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000105	beckwith-wiedemann syndrome	Enlarged kidney	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000112	beckwith-wiedemann syndrome	Nephropathy	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000154	beckwith-wiedemann syndrome	Wide mouth	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000158	beckwith-wiedemann syndrome	Macroglossia	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000269	beckwith-wiedemann syndrome	Prominent occiput	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000280	beckwith-wiedemann syndrome	Coarse facial features	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000303	beckwith-wiedemann syndrome	Mandibular prognathia	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000363	beckwith-wiedemann syndrome	Abnormality of earlobe	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000520	beckwith-wiedemann syndrome	Proptosis	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000776	beckwith-wiedemann syndrome	Congenital diaphragmatic hernia	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000995	beckwith-wiedemann syndrome	Melanocytic nevus	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001052	beckwith-wiedemann syndrome	Nevus flammeus	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001139	beckwith-wiedemann syndrome	Choroideremia	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001513	beckwith-wiedemann syndrome	Obesity	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001528	beckwith-wiedemann syndrome	Hemihypertrophy	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001537	beckwith-wiedemann syndrome	Umbilical hernia	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001539	beckwith-wiedemann syndrome	Omphalocele	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001561	beckwith-wiedemann syndrome	Polyhydramnios	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001582	beckwith-wiedemann syndrome	Redundant skin	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001622	beckwith-wiedemann syndrome	Premature birth	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001738	beckwith-wiedemann syndrome	Exocrine pancreatic insufficiency	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001943	beckwith-wiedemann syndrome	Hypoglycemia	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0001998	beckwith-wiedemann syndrome	Neonatal hypoglycemia	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0002150	beckwith-wiedemann syndrome	Hypercalciuria	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0003271	beckwith-wiedemann syndrome	Visceromegaly	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0005616	beckwith-wiedemann syndrome	Accelerated skeletal maturation	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0006267	beckwith-wiedemann syndrome	Large placenta	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0008523	beckwith-wiedemann syndrome	Posterior helix pit	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0009796	beckwith-wiedemann syndrome	Branchial cyst	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0009908	beckwith-wiedemann syndrome	Anterior creases of earlobe	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0011800	beckwith-wiedemann syndrome	Midface retrusion	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0030720	beckwith-wiedemann syndrome	Subchorionic septal cyst	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0100555	beckwith-wiedemann syndrome	Asymmetric growth	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0100876	beckwith-wiedemann syndrome	Infra-orbital crease	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0430026	beckwith-wiedemann syndrome	Abnormality of the shape of the midface	Frequent (79-30%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000023	beckwith-wiedemann syndrome	Inguinal hernia	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000028	beckwith-wiedemann syndrome	Cryptorchidism	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000073	beckwith-wiedemann syndrome	Ureteral duplication	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000076	beckwith-wiedemann syndrome	Vesicoureteral reflux	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000150	beckwith-wiedemann syndrome	Gonadoblastoma	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000175	beckwith-wiedemann syndrome	Cleft palate	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000239	beckwith-wiedemann syndrome	Large fontanelles	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000260	beckwith-wiedemann syndrome	Wide anterior fontanel	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000329	beckwith-wiedemann syndrome	Facial hemangioma	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000362	beckwith-wiedemann syndrome	Otosclerosis	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000787	beckwith-wiedemann syndrome	Nephrolithiasis	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
HP:0000821	beckwith-wiedemann syndrome	Hypothyroidism	Occasional (29-5%)	IGF2	147470	130650	imprinted	confirmed	activating	Endocrine	5466	insulin like growth factor 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	FLJ44734|IGF-II	somatomedin A|preptin	C11orf43	chromosome 11 open reading frame 43|insulin-like growth factor 2	
NA	alopecia neurologic defects and endocrinopathy syndrome	NA	NA	RBM28	No gene mim	612079	biallelic	possible	uncertain	Skin;Endocrine/Metabolic;Brain/Cognition	21863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mucopolysaccharidosis type 3c	NA	NA	HGSNAT	610453	252930	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	26527	heparan-alpha-glucosaminide N-acetyltransferase	protein-coding gene	gene with protein product	Approved	8p11.21-p11.1	08p11.21-p11.1	FLJ32731|HGNAT		TMEM76	transmembrane protein 76	
NA	glutaricacidemia type 1	NA	NA	GCDH	608801	231670	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	4189	glutaryl-CoA dehydrogenase	protein-coding gene	gene with protein product	Approved	19p13.13	19p13.13	ACAD5			glutaryl-Coenzyme A dehydrogenase	Acyl-CoA dehydrogenase family
NA	zunich neuroectodermal syndrome	NA	NA	PIGL	605947	280000	biallelic	confirmed	loss of function	Multisystem;Brain/Cognition;Eye	8966	phosphatidylinositol glycan anchor biosynthesis class L	protein-coding gene	gene with protein product	Approved	17p11.2	17p11.2		N-acetylglucosaminylphosphatidylinositol deacetylase		phosphatidylinositol glycan, class L	Phosphatidylinositol glycan anchor biosynthesis
NA	46,xy gonadal dysgenesis	NA	NA	ZFPM2	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary ciliary dysplasia	NA	NA	DNAAF4	No gene mim	No disease mim	biallelic	confirmed	loss of function	Respiratory tract	21493	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pontocerebellar hypoplasia	NA	NA	AMPD2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	469	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cantu syndrome hypertrichotic osteochondrodysplasia	NA	NA	ABCC9	No gene mim	239850	monoallelic	confirmed	activating	Skin;Heart/Cardiovasculature/Lymphatic	60	ATP binding cassette subfamily C member 9	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	SUR2|CMD1O	sulfonylurea receptor 2		ATP-binding cassette, sub-family C (CFTR/MRP), member 9	ATP binding cassette subfamily C
NA	perrault syndrome	NA	NA	CLPP	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Ear;Genitalia	2084	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	kabuki syndrome 2	NA	NA	KDM6A	300128	300867	x-linked dominant	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	12637	lysine demethylase 6A	protein-coding gene	gene with protein product	Approved	Xp11.3	Xp11.3			UTX	ubiquitously transcribed tetratricopeptide repeat, X chromosome|lysine (K)-specific demethylase 6A	Lysine demethylases|Tetratricopeptide repeat domain containing
NA	primary autosomal recessive microcephaly	NA	NA	ASPM	No gene mim	279936	biallelic	confirmed	loss of function	Brain/Cognition	19048	abnormal spindle microtubule assembly	protein-coding gene	gene with protein product	Approved	1q31.3	01q31.3	Calmbp1|ASP|FLJ10517|FLJ10549		MCPH5	microcephaly, primary autosomal recessive 5|asp (abnormal spindle)-like, microcephaly associated (Drosophila)|asp (abnormal spindle) homolog, microcephaly associated (Drosophila)	
HP:0000218	langer mesomelic dysplasia	High palate	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001191	langer mesomelic dysplasia	Abnormality of the carpal bones	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	langer mesomelic dysplasia	Micromelia	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002997	langer mesomelic dysplasia	Abnormality of the ulna	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003067	langer mesomelic dysplasia	Madelung deformity	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003510	langer mesomelic dysplasia	Severe short stature	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005026	langer mesomelic dysplasia	Mesomelic/rhizomelic limb shortening	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	langer mesomelic dysplasia	Abnormality of epiphysis morphology	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	langer mesomelic dysplasia	Bowing of the long bones	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006492	langer mesomelic dysplasia	Aplasia/Hypoplasia of the fibula	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008873	langer mesomelic dysplasia	Disproportionate short-limb short stature	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009465	langer mesomelic dysplasia	Ulnar deviation of finger	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100864	langer mesomelic dysplasia	Short femoral neck	Very frequent (99-80%)	SHOX	312865	249700	biallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome	NA	NA	PRRT2	614386	602066	monoallelic	confirmed	loss of function	Brain/Cognition	30500	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	klippel-feil syndrome type 1	NA	NA	GDF6	601147	118100	monoallelic	confirmed	uncertain	Skeleton;Eye	4221	growth differentiation factor 6	protein-coding gene	gene with protein product	Approved	8q22.1	08q22.1	BMP13|KFS|KFS1		SGM1	segmentation syndrome 1	
NA	coach syndrom	NA	NA	TMEM67	609884	216360	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;GI tract	28396	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	vacterl association, x-linked, with or without hydrocephalus	NA	NA	ZIC3	300265	319683	hemizygous	confirmed	all missense/in frame	Skeleton;Heart/Cardiovasculature/Lymphatic	12874	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	heterotaxy syndrome	NA	NA	ACVR2B	No gene mim	207574	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	174	activin A receptor type 2B	protein-coding gene	gene with protein product	Approved	3p22.2	03p22.2	ActR-IIB			activin A receptor, type IIB	Type 2 receptor serine/threonine kinases
NA	congenital myopathy with excess of muscle spindles	NA	NA	HRAS	190020	218040	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5173	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epilepsy, progressive myoclonic 7	NA	NA	KCNC1	No gene mim	616187	monoallelic	confirmed	activating	Brain/Cognition	6233	potassium voltage-gated channel subfamily C member 1	protein-coding gene	gene with protein product	Approved	11p15.1	11p15.1	Kv3.1			potassium voltage-gated channel, Shaw-related subfamily, member 1|potassium channel, voltage gated Shaw related subfamily C, member 1	Potassium voltage-gated channels
NA	chrnb2-related nocturnal frontal lobe epilepsy, autosomal dominant	NA	NA	CHRNB2	No gene mim	605375	monoallelic	probable	activating	Brain/Cognition	1962	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	waardenburg syndrome type 2 with ocular albinism	NA	NA	MITF	156845	103470	monoallelic	confirmed	loss of function	Skin;Ear	7105	melanogenesis associated transcription factor	protein-coding gene	gene with protein product	Approved	3p13	03p13	MI|bHLHe32	homolog of mouse microphthalmia	WS2A|WS2	Waardenburg syndrome, type 2A|microphthalmia-associated transcription factor	Basic helix-loop-helix proteins
NA	methylmalonic aciduria and homocystinuria type cbld	NA	NA	MMADHC	611935	277410	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	25221	methylmalonic aciduria and homocystinuria, cblD type	protein-coding gene	gene with protein product	Approved	2q23.2	02q23.2	CL25022|cblD		C2orf25	chromosome 2 open reading frame 25|methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria	
NA	galactosemia ii	NA	NA	GALK1	604313	230200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Eye	4118	galactokinase 1	protein-coding gene	gene with protein product	Approved	17q25.1	17q25.1			GALK		
NA	night blindness, congenital stationary, type 1a	NA	NA	NYX	300278	310500	hemizygous	confirmed	loss of function	Eye	8082	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ventriculomegaly with cystic kidney disease	NA	NA	CRB2	No gene mim	219730	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition	18688	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pyruvate carboxylase deficiency	NA	NA	PC	608786	266150	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8636	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	joubert syndrome 14	NA	NA	TMEM237	614423	614424	biallelic	confirmed	loss of function	Brain/Cognition	14432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX12	601758	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
NA	congenital myopathy with prominent internal nuclei and atypical cores	NA	NA	CCDC78	614666	614807	monoallelic	probable	loss of function	Musculature	14153	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atrial septal defect type 2	NA	NA	GATA4	600576	607941	monoallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	4173	GATA binding protein 4	protein-coding gene	gene with protein product	Approved	8p23.1	08p23.1				GATA-binding protein 4	GATA zinc finger domain containing
NA	cognitive impairment with or without cerebellar ataxia	NA	NA	SCN8A	600702	614306	monoallelic	confirmed	loss of function	Brain/Cognition	10596	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe cobblestone lissencephaly	NA	NA	TMEM5	605862	615041	biallelic	confirmed	loss of function	Brain/Cognition;Genitalia	13530	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ring dermoid of cornea	NA	NA	PITX2	601542	180550	monoallelic	confirmed	uncertain	Teeth & Dentitian;Eye;GI tract	9005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	childhood absence epilepsy type 5	NA	NA	GABRB3	No gene mim	612269	monoallelic	confirmed	all missense/in frame	Brain/Cognition	4083	gamma-aminobutyric acid type A receptor beta3 subunit	protein-coding gene	gene with protein product	Approved	15q12	15q12		GABA(A) receptor, beta 3		gamma-aminobutyric acid (GABA) A receptor, beta 3	Gamma-aminobutyric acid type A receptor subunits
NA	benign familial neonatal infantile seizures	NA	NA	SCN2A	182390	248968	monoallelic	confirmed	loss of function	Brain/Cognition	10588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract posterior polar type 2	NA	NA	CRYAB	No gene mim	613763	monoallelic	possible	loss of function	Musculature;Eye	2389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	alveolar capillary dysplasia with misalignment of pulmonary veins	NA	NA	FOXF1	601089	265380	monoallelic	confirmed	loss of function	Respiratory tract;Genitalia;Heart/Cardiovasculature/Lymphatic	3809	forkhead box F1	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	FREAC1		FKHL5		Forkhead boxes
NA	aeg syndrome	NA	NA	SOX2	184429	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	11195	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	agenesis of the corpus callosum with abnormal genitalia	NA	NA	ARX	300382	300004	hemizygous	confirmed	loss of function	Brain/Cognition;Genitalia	18060	aristaless related homeobox	protein-coding gene	gene with protein product	Approved	Xp21.3	Xp21.3	ISSX|CT121|EIEE1	cancer/testis antigen 121	MRXS1|PRTS|MRX76|MRX54|MRX43|MRX36|MRX29|MRX32|MRX33|MRX38|MRX87	mental retardation, X-linked 54|mental retardation, X-linked 43|mental retardation, X-linked 36|mental retardation, X-linked 29|mental retardation, X-linked 32|mental retardation, X-linked 33|mental retardation, X-linked 38|mental retardation, X-linked 87|mental retardation, X-linked 76	X-linked mental retardation|PRD class homeoboxes and pseudogenes
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX26	608666	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
HP:0000486	leigh syndrome	Strabismus	Very frequent (99-80%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leigh syndrome	Nystagmus	Very frequent (99-80%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	leigh syndrome	Optic atrophy	Frequent (79-30%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leigh syndrome	Seizures	Frequent (79-30%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	leigh syndrome	Ataxia	Very frequent (99-80%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leigh syndrome	Muscular hypotonia	Very frequent (99-80%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	leigh syndrome	Respiratory insufficiency	Very frequent (99-80%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leigh syndrome	Hemiplegia/hemiparesis	Frequent (79-30%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007020	leigh syndrome	Progressive spastic paraplegia	Frequent (79-30%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007650	leigh syndrome	Progressive ophthalmoplegia	Frequent (79-30%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008972	leigh syndrome	Decreased activity of mitochondrial respiratory chain	Very frequent (99-80%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	leigh syndrome	Abnormality of movement	Very frequent (99-80%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	leigh syndrome	Cognitive impairment	Very frequent (99-80%)	SURF1	185620	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autism	NA	NA	GRIN2B	138252	209850	monoallelic	confirmed	loss of function	Brain/Cognition	4586	glutamate ionotropic receptor NMDA type subunit 2B	protein-coding gene	gene with protein product	Approved	12p13.1	12p13.1	GluN2B		NMDAR2B	glutamate receptor, ionotropic, N-methyl D-aspartate 2B	Glutamate ionotropic receptor NMDA type subunits
NA	autosomal-dominant microcephaly associated with lymphedema and/or chorioretinopathy	NA	NA	KIF11	148760	152950	monoallelic	confirmed	loss of function	Brain/Cognition;Eye;Heart/Cardiovasculature/Lymphatic	6388	kinesin family member 11	protein-coding gene	gene with protein product	Approved	10q23.33	10q23.33	Eg5|HKSP|TRIP5		KNSL1	kinesin-like 1	Kinesins
NA	intellectual disability	NA	NA	CTCF	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	13723	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	exostoses, multiple, type 2	NA	NA	EXT2	608210	133701	monoallelic	confirmed	loss of function	Skeleton	3513	exostosin glycosyltransferase 2	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	SOTV	Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N- acetylglucosaminyltransferase|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase		exostoses (multiple) 2|exostosin 2	Exostosin glycosyltransferase family
NA	pontocerebellar hypoplasia type 2 and type 4	NA	NA	TSEN34	608754	316970	biallelic	probable	all missense/in frame	Brain/Cognition	15506	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	coach syndrome	NA	NA	RPGRIP1L	610937	216360	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;GI tract	29168	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	osteogenesis imperfecta type iii	NA	NA	COL1A1	120150	259420	monoallelic	confirmed	dominant negative	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	methylmalonic aciduria and homocystinuria, cblj type	NA	NA	ABCD4	603214	614857	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	68	ATP binding cassette subfamily D member 4	protein-coding gene	gene with protein product	Approved	14q24.3	14q24.3	PMP69|P70R|EST352188		PXMP1L	ATP-binding cassette, sub-family D (ALD), member 4	ATP binding cassette subfamily D
NA	mental retardation x-linked ophn1-related	NA	NA	OPHN1	300127	300486	hemizygous	confirmed	loss of function	Face;Brain/Cognition	8148	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness autosomal recessive type 1a	NA	NA	GJB2	121011	220290	biallelic	confirmed	loss of function	Skin;Ear	4284	gap junction protein beta 2	protein-coding gene	gene with protein product	Approved	13q12.11	13q12.11	CX26|NSRD1	connexin 26	DFNB1|DFNA3	gap junction protein, beta 2, 26kD (connexin 26)|gap junction protein, beta 2, 26kDa (connexin 26)|gap junction protein, beta 2, 26kDa	Gap junction proteins|Deafness associated genes
NA	mental retardation x-linked type 91	NA	NA	ZDHHC15	No gene mim	300577	x-linked dominant	possible	loss of function	Brain/Cognition	20342	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	medium chain acyl-coenzyme a dehydrogenase deficiency	NA	NA	ACADM	607008	201450	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	89	acyl-CoA dehydrogenase medium chain	protein-coding gene	gene with protein product	Approved	1p31.1	01p31.1	MCAD|MCADH|ACAD1	medium-chain acyl-CoA dehydrogenase		acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain	Acyl-CoA dehydrogenase family
NA	elejalde syndrome	NA	NA	MYO5A	160777	256710	biallelic	confirmed	loss of function	Skin	7602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	smad3-related loeys-dietz syndrome	NA	NA	SMAD3	No gene mim	319643	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	6769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hypogonadotropic hypogonadism	NA	NA	TACR3	No gene mim	146110	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Genitalia	11528	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary ciliary diskinesia	NA	NA	LRRC6	614930	614935	biallelic	confirmed	loss of function	Respiratory tract	16725	leucine rich repeat containing 6	protein-coding gene	gene with protein product	Approved	8q24.22	08q24.22	TSLRP|LRTP|CILD19	leucine rich testes protein			
NA	mental retardation x-linked cask-related	NA	NA	CASK	300172	300749	x-linked dominant	confirmed	loss of function	Face;Brain/Cognition;GI tract	1497	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glutaric aciduria type 2c	NA	NA	ETFDH	231675	231680	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	3483	electron transfer flavoprotein dehydrogenase	protein-coding gene	gene with protein product	Approved	4q32.1	04q32.1	ETFQO			electron-transferring-flavoprotein dehydrogenase	
HP:0000207	char syndrome	Triangular mouth	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000232	char syndrome	Everted lower lip vermilion	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	char syndrome	Malar flattening	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	char syndrome	Hypertelorism	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000322	char syndrome	Short philtrum	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	char syndrome	Depressed nasal ridge	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	char syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	char syndrome	Ptosis	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	char syndrome	Patent ductus arteriosus	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	char syndrome	Depressed nasal bridge	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012471	char syndrome	Thick vermilion border	Very frequent (99-80%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	char syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004220	char syndrome	Short middle phalanx of the 5th finger	Frequent (79-30%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006159	char syndrome	Mesoaxial hand polydactyly	Frequent (79-30%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000269	char syndrome	Prominent occiput	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	char syndrome	Hearing impairment	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	char syndrome	Strabismus	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	char syndrome	Myopia	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	char syndrome	Hand polydactyly	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	char syndrome	Global developmental delay	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	char syndrome	Ventricular septal defect	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001770	char syndrome	Toe syndactyly	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002360	char syndrome	Sleep disturbance	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002558	char syndrome	Supernumerary nipple	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004218	char syndrome	Symphalangism of the 5th finger	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006335	char syndrome	Persistence of primary teeth	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008498	char syndrome	No permanent dentition	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010112	char syndrome	Mesoaxial foot polydactyly	Occasional (29-5%)	TFAP2B	601601	169100	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	11743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual diability	NA	NA	DDX3X	No gene mim	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	2745	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual diability	NA	NA	DDX3X	No gene mim	No disease mim	hemizygous	confirmed	all missense/in frame	Brain/Cognition	2745	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spinal and bulbar muscular atrophy	NA	NA	AR	No gene mim	313200	hemizygous	both DD and IF	dominant negative	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	olmsted syndrome	NA	NA	TRPV3	607066	614594	monoallelic	probable	all missense/in frame	Skin	18084	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000015	acro-renal-ocular syndrome	Bladder diverticulum	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	acro-renal-ocular syndrome	Vesicoureteral reflux	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000085	acro-renal-ocular syndrome	Horseshoe kidney	Very frequent (99-80%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	acro-renal-ocular syndrome	Epicanthus	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	acro-renal-ocular syndrome	Hypertelorism	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000405	acro-renal-ocular syndrome	Conductive hearing impairment	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	acro-renal-ocular syndrome	Sensorineural hearing impairment	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000482	acro-renal-ocular syndrome	Microcornea	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	acro-renal-ocular syndrome	Strabismus	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	acro-renal-ocular syndrome	Visual impairment	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	acro-renal-ocular syndrome	Ptosis	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	acro-renal-ocular syndrome	Cataract	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000567	acro-renal-ocular syndrome	Chorioretinal coloboma	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	acro-renal-ocular syndrome	Microphthalmia	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000588	acro-renal-ocular syndrome	Optic nerve coloboma	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000589	acro-renal-ocular syndrome	Coloboma	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	acro-renal-ocular syndrome	Iris coloboma	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	acro-renal-ocular syndrome	Nystagmus	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001172	acro-renal-ocular syndrome	Abnormality of the thumb	Very frequent (99-80%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001177	acro-renal-ocular syndrome	Preaxial hand polydactyly	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001199	acro-renal-ocular syndrome	Triphalangeal thumb	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	acro-renal-ocular syndrome	Tetralogy of Fallot	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001770	acro-renal-ocular syndrome	Toe syndactyly	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001852	acro-renal-ocular syndrome	Sandal gap	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001883	acro-renal-ocular syndrome	Talipes	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002251	acro-renal-ocular syndrome	Aganglionic megacolon	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002818	acro-renal-ocular syndrome	Abnormality of the radius	Very frequent (99-80%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002948	acro-renal-ocular syndrome	Vertebral fusion	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003022	acro-renal-ocular syndrome	Hypoplasia of the ulna	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003422	acro-renal-ocular syndrome	Vertebral segmentation defect	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004059	acro-renal-ocular syndrome	Radial club hand	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004712	acro-renal-ocular syndrome	Renal malrotation	Very frequent (99-80%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004736	acro-renal-ocular syndrome	Crossed fused renal ectopia	Very frequent (99-80%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005792	acro-renal-ocular syndrome	Short humerus	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	acro-renal-ocular syndrome	Finger syndactyly	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006501	acro-renal-ocular syndrome	Aplasia/Hypoplasia of the radius	Very frequent (99-80%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007766	acro-renal-ocular syndrome	Optic disc hypoplasia	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008678	acro-renal-ocular syndrome	Renal hypoplasia/aplasia	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008897	acro-renal-ocular syndrome	Postnatal growth retardation	Occasional (29-5%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009650	acro-renal-ocular syndrome	Short distal phalanx of the thumb	Very frequent (99-80%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009778	acro-renal-ocular syndrome	Short thumb	Very frequent (99-80%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010059	acro-renal-ocular syndrome	Broad hallux phalanx	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010109	acro-renal-ocular syndrome	Short hallux	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012745	acro-renal-ocular syndrome	Short palpebral fissure	Frequent (79-30%)	SALL4	607343	217001	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	van der woude syndrome	Cleft palate	Frequent (79-30%)	GRHL3	No gene mim	119300	monoallelic	confirmed	loss of function	Face;GI tract	25839	grainyhead like transcription factor 3	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	SOM		TFCP2L4	transcription factor CP2-like 4|grainyhead-like 3 (Drosophila)	
HP:0000196	van der woude syndrome	Lower lip pit	Frequent (79-30%)	GRHL3	No gene mim	119300	monoallelic	confirmed	loss of function	Face;GI tract	25839	grainyhead like transcription factor 3	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	SOM		TFCP2L4	transcription factor CP2-like 4|grainyhead-like 3 (Drosophila)	
HP:0000204	van der woude syndrome	Cleft upper lip	Occasional (29-5%)	GRHL3	No gene mim	119300	monoallelic	confirmed	loss of function	Face;GI tract	25839	grainyhead like transcription factor 3	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	SOM		TFCP2L4	transcription factor CP2-like 4|grainyhead-like 3 (Drosophila)	
HP:0000668	van der woude syndrome	Hypodontia	Occasional (29-5%)	GRHL3	No gene mim	119300	monoallelic	confirmed	loss of function	Face;GI tract	25839	grainyhead like transcription factor 3	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	SOM		TFCP2L4	transcription factor CP2-like 4|grainyhead-like 3 (Drosophila)	
HP:0010286	van der woude syndrome	Abnormality of the salivary glands	Occasional (29-5%)	GRHL3	No gene mim	119300	monoallelic	confirmed	loss of function	Face;GI tract	25839	grainyhead like transcription factor 3	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	SOM		TFCP2L4	transcription factor CP2-like 4|grainyhead-like 3 (Drosophila)	
HP:0100267	van der woude syndrome	Lip pit	Very frequent (99-80%)	GRHL3	No gene mim	119300	monoallelic	confirmed	loss of function	Face;GI tract	25839	grainyhead like transcription factor 3	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	SOM		TFCP2L4	transcription factor CP2-like 4|grainyhead-like 3 (Drosophila)	
HP:0000175	van der woude syndrome	Cleft palate	Frequent (79-30%)	IRF6	607199	119300	monoallelic	confirmed	loss of function	Face;Skeleton	6121	interferon regulatory factor 6	protein-coding gene	gene with protein product	Approved	1q32.2	01q32.2	OFC6|VWS1		VWS|LPS	Van der Woude syndrome	
HP:0000196	van der woude syndrome	Lower lip pit	Frequent (79-30%)	IRF6	607199	119300	monoallelic	confirmed	loss of function	Face;Skeleton	6121	interferon regulatory factor 6	protein-coding gene	gene with protein product	Approved	1q32.2	01q32.2	OFC6|VWS1		VWS|LPS	Van der Woude syndrome	
HP:0000204	van der woude syndrome	Cleft upper lip	Occasional (29-5%)	IRF6	607199	119300	monoallelic	confirmed	loss of function	Face;Skeleton	6121	interferon regulatory factor 6	protein-coding gene	gene with protein product	Approved	1q32.2	01q32.2	OFC6|VWS1		VWS|LPS	Van der Woude syndrome	
HP:0000668	van der woude syndrome	Hypodontia	Occasional (29-5%)	IRF6	607199	119300	monoallelic	confirmed	loss of function	Face;Skeleton	6121	interferon regulatory factor 6	protein-coding gene	gene with protein product	Approved	1q32.2	01q32.2	OFC6|VWS1		VWS|LPS	Van der Woude syndrome	
HP:0010286	van der woude syndrome	Abnormality of the salivary glands	Occasional (29-5%)	IRF6	607199	119300	monoallelic	confirmed	loss of function	Face;Skeleton	6121	interferon regulatory factor 6	protein-coding gene	gene with protein product	Approved	1q32.2	01q32.2	OFC6|VWS1		VWS|LPS	Van der Woude syndrome	
HP:0100267	van der woude syndrome	Lip pit	Very frequent (99-80%)	IRF6	607199	119300	monoallelic	confirmed	loss of function	Face;Skeleton	6121	interferon regulatory factor 6	protein-coding gene	gene with protein product	Approved	1q32.2	01q32.2	OFC6|VWS1		VWS|LPS	Van der Woude syndrome	
NA	periventricular heterotopia with microcephaly	NA	NA	ARFGEF2	605371	608097	biallelic	probable	loss of function	Brain/Cognition	15853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hydrolethalus syndrome type 1	NA	NA	HYLS1	610693	236680	biallelic	confirmed	uncertain	Face;Skeleton;Brain/Cognition	26558	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spastic ataxia, charlevoix-saguenay type	NA	NA	SACS	No gene mim	270550	biallelic	probable	loss of function	Brain/Cognition	10519	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nestor-guillermo progeria syndrome	NA	NA	BANF1	603811	614008	biallelic	probable	all missense/in frame	Skin;Skeleton;Endocrine/Metabolic;Heart/Cardiovasculature/Lymphatic	17397	barrier to autointegration factor 1	protein-coding gene	gene with protein product	Approved	11q13.1	11q13.1	BAF				
HP:0000008	androgen insensitivity syndrome	Abnormality of female internal genitalia	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	androgen insensitivity syndrome	Inguinal hernia	Frequent (79-30%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	androgen insensitivity syndrome	Cryptorchidism	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000033	androgen insensitivity syndrome	Ambiguous genitalia, male	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000037	androgen insensitivity syndrome	Male pseudohermaphroditism	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000130	androgen insensitivity syndrome	Abnormality of the uterus	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	androgen insensitivity syndrome	Delayed puberty	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002215	androgen insensitivity syndrome	Sparse axillary hair	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002221	androgen insensitivity syndrome	Absent axillary hair	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002225	androgen insensitivity syndrome	Sparse pubic hair	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002555	androgen insensitivity syndrome	Absent pubic hair	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003251	androgen insensitivity syndrome	Male infertility	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008655	androgen insensitivity syndrome	Aplasia/Hypoplasia of the fallopian tube	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008684	androgen insensitivity syndrome	Aplasia/hypoplasia of the uterus	Very frequent (99-80%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010788	androgen insensitivity syndrome	Testicular neoplasm	Occasional (29-5%)	AR	No gene mim	300068	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;Genitalia	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehmt1-like intellectual disability	NA	NA	NR1I3	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	7969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation syndromic x-linked zdhhc9-related	NA	NA	ZDHHC9	300646	300799	hemizygous	confirmed	loss of function	Brain/Cognition	18475	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	smith-mccort dysplasia	NA	NA	DYM	607461	607326	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	21317	dymeclin	protein-coding gene	gene with protein product	Approved	18q21.1	18q21.1	FLJ20071|DMC|SMC				
NA	axenfeld-rieger syndrome type 3	NA	NA	FOXC1	601090	602482	monoallelic	confirmed	loss of function	Eye	3800	forkhead box C1	protein-coding gene	gene with protein product	Approved	6p25.3	06p25.3	FREAC3|ARA|IGDA|IHG1		FKHL7|IRID1		Forkhead boxes
NA	generalized epilepsy and paroxysmal dyskinesia	NA	NA	KCNMA1	No gene mim	609446	monoallelic	possible	activating	Brain/Cognition	6284	potassium calcium-activated channel subfamily M alpha 1	protein-coding gene	gene with protein product	Approved	10q22.3	10q22.3	KCa1.1|mSLO1	BK channel alpha subunit|maxiK channel|big potassium channel alpha subunit	SLO	potassium large conductance calcium-activated channel, subfamily M, alpha member 1|potassium channel, calcium activated large conductance subfamily M alpha, member 1	Potassium calcium-activated channels
NA	mitochondrial complex i deficiency	NA	NA	NDUFV1	161015	252010	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	7716	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital disorders of glycosylation	NA	NA	DOLK	610746	612379	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	23406	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation syndromic x-linked with hypotonic facies syndrome type 1	NA	NA	ATRX	300032	309580	hemizygous	confirmed	loss of function	Face;Brain/Cognition;Genitalia	886	ATRX, chromatin remodeler	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1	XH2|XNP	RAD54 homolog (S. cerevisiae)	RAD54|JMS|MRX52	alpha thalassemia/mental retardation syndrome X-linked (RAD54 (S. cerevisiae) homolog)|Juberg-Marsidi syndrome|mental retardation, X-linked 52|alpha thalassemia/mental retardation syndrome X-linked	X-linked mental retardation|RNA helicases
HP:0000164	cranioectodermal dysplasia	Abnormality of the teeth	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000232	cranioectodermal dysplasia	Everted lower lip vermilion	Frequent (79-30%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000268	cranioectodermal dysplasia	Dolichocephaly	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000269	cranioectodermal dysplasia	Prominent occiput	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000286	cranioectodermal dysplasia	Epicanthus	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000463	cranioectodermal dysplasia	Anteverted nares	Frequent (79-30%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000545	cranioectodermal dysplasia	Myopia	Occasional (29-5%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000601	cranioectodermal dysplasia	Hypotelorism	Frequent (79-30%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000639	cranioectodermal dysplasia	Nystagmus	Occasional (29-5%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000668	cranioectodermal dysplasia	Hypodontia	Frequent (79-30%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000679	cranioectodermal dysplasia	Taurodontia	Occasional (29-5%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000682	cranioectodermal dysplasia	Abnormality of dental enamel	Occasional (29-5%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000691	cranioectodermal dysplasia	Microdontia	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000767	cranioectodermal dysplasia	Pectus excavatum	Frequent (79-30%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000774	cranioectodermal dysplasia	Narrow chest	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000939	cranioectodermal dysplasia	Osteoporosis	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000940	cranioectodermal dysplasia	Abnormal diaphysis morphology	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000944	cranioectodermal dysplasia	Abnormality of the metaphyses	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0001156	cranioectodermal dysplasia	Brachydactyly syndrome	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0001231	cranioectodermal dysplasia	Abnormality of the fingernails	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0001363	cranioectodermal dysplasia	Craniosynostosis	Frequent (79-30%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0002007	cranioectodermal dysplasia	Frontal bossing	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0004209	cranioectodermal dysplasia	Clinodactyly of the 5th finger	Occasional (29-5%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0005692	cranioectodermal dysplasia	Joint hyperflexibility	Frequent (79-30%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0006101	cranioectodermal dysplasia	Finger syndactyly	Frequent (79-30%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0008070	cranioectodermal dysplasia	Sparse hair	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0008388	cranioectodermal dysplasia	Abnormality of the toenails	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0008499	cranioectodermal dysplasia	High-grade hypermetropia	Occasional (29-5%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0008905	cranioectodermal dysplasia	Rhizomelia	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0009882	cranioectodermal dysplasia	Short distal phalanx of finger	Very frequent (99-80%)	IFT122	606045	218330	biallelic	confirmed	all missense/in frame	Skin;Face;Skeleton	13556	intraflagellar transport 122	protein-coding gene	gene with protein product	Approved	3q21.3-q22.1	03q21.3-q22.1	WDR140|WDR10p|SPG		WDR10	WD repeat domain 10|intraflagellar transport 122 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
HP:0000028	tetralogy of fallot	Cryptorchidism	Frequent (79-30%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000233	tetralogy of fallot	Thin vermilion border	Frequent (79-30%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000268	tetralogy of fallot	Dolichocephaly	Frequent (79-30%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	tetralogy of fallot	Broad forehead	Very frequent (99-80%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	tetralogy of fallot	Proptosis	Frequent (79-30%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	tetralogy of fallot	Brachydactyly syndrome	Very frequent (99-80%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	tetralogy of fallot	Intrauterine growth retardation	Very frequent (99-80%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	tetralogy of fallot	Tetralogy of Fallot	Frequent (79-30%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	tetralogy of fallot	Clinodactyly of the 5th finger	Very frequent (99-80%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004467	tetralogy of fallot	Preauricular pit	Frequent (79-30%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005105	tetralogy of fallot	Abnormal nasal morphology	Very frequent (99-80%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009891	tetralogy of fallot	Underdeveloped supraorbital ridges	Frequent (79-30%)	NKX2-5	600584	187500	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperekplexia	NA	NA	SLC6A5	604159	149400	biallelic	confirmed	loss of function	Brain/Cognition	11051	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cranioectodermal dysplasia 4	NA	NA	WDR19	608151	614378	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton	18340	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	aortic aneurysm, familial thoracic 6	NA	NA	ACTA2	No gene mim	611788	monoallelic	both DD and IF	all missense/in frame	Heart/Cardiovasculature/Lymphatic	130	actin, alpha 2, smooth muscle, aorta	protein-coding gene	gene with protein product	Approved	10q23.31	10q23.31	ACTSA				Actins
NA	microcephaly primary type 4	NA	NA	CEP152	613529	604321	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	29298	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness autosomal dominant type 39 with dentinogenesis imperfecta 1	NA	NA	DSPP	125485	605594	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Ear	3054	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness autosomal dominant type 39 with dentinogenesis imperfecta 1	NA	NA	DSPP	125485	605594	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Ear	3054	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	clcn7-related osteopetrosis	NA	NA	CLCN7	602727	611490	biallelic	confirmed	loss of function	Skeleton	2025	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	moderate sensorineural hearing loss	NA	NA	OTOGL	614925	614944	biallelic	confirmed	loss of function	Ear	26901	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	clubbing with skeletal dysplasia inc acroosteolysis	NA	NA	PTHLH	168470	No disease mim	monoallelic	confirmed	increased gene dosage	Skeleton	9607	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	palmoplantar keratoderma with deafness	NA	NA	GJB2	121011	148350	monoallelic	confirmed	all missense/in frame	Skin;Ear	4284	gap junction protein beta 2	protein-coding gene	gene with protein product	Approved	13q12.11	13q12.11	CX26|NSRD1	connexin 26	DFNB1|DFNA3	gap junction protein, beta 2, 26kD (connexin 26)|gap junction protein, beta 2, 26kDa (connexin 26)|gap junction protein, beta 2, 26kDa	Gap junction proteins|Deafness associated genes
NA	non syndromal hearing loss	NA	NA	TBC1D24	613577	614617	biallelic	confirmed	all missense/in frame	Skeleton;Brain/Cognition;Ear	29203	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cardiomyopathy dilated type 1ee	NA	NA	MYH6	No gene mim	613252	monoallelic	both DD and IF	uncertain	Heart/Cardiovasculature/Lymphatic	7576	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multicentric carpotarsal osteolysis syndrome	NA	NA	MAFB	608968	166300	monoallelic	confirmed	activating	Skeleton	6408	MAF bZIP transcription factor B	protein-coding gene	gene with protein product	Approved	20q12	20q12			KRML	Kreisler (mouse) maf-related leucine zipper homolog|v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B	Basic leucine zipper proteins
NA	combined oxidative phosphorylation deficiency 7	NA	NA	C12orf65	613541	613559	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	26784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	polycystic kidney disease, autosomal recessive	NA	NA	PKHD1	606702	263200	biallelic	confirmed	loss of function	Kidney Renal Tract	9016	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	subcortical band heterotopia x-linked	NA	NA	DCX	300121	300067	x-linked dominant	confirmed	loss of function	Brain/Cognition	2714	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	kenny-caffey syndrome	NA	NA	FAM111A	No gene mim	127000	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic;Brain/Cognition	24725	family with sequence similarity 111 member A	protein-coding gene	gene with protein product	Approved	11q12.1	11q12.1	FLJ22794|KIAA1895			family with sequence similarity 111, member A	
NA	congenital disorders of glycosylation	NA	NA	MPI	154550	612379	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7216	mannose phosphate isomerase	protein-coding gene	gene with protein product	Approved	15q24.1	15q24.1		mannose-6-phosphate isomerase			
NA	autosomal-recessive cone-rod dystrophy	NA	NA	POC1B	No gene mim	No disease mim	biallelic	confirmed	loss of function	Eye	30836	POC1 centriolar protein B	protein-coding gene	gene with protein product	Approved	12q21.33	12q21.33	TUWD12|FLJ14923		WDR51B	WD repeat domain 51B|POC1 centriolar protein homolog B (Chlamydomonas)	WD repeat domain containing
NA	3-methylcrotonyl-coa carboxylase 2 deficiency	NA	NA	MCCC2	No gene mim	210210	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6937	methylcrotonoyl-CoA carboxylase 2	protein-coding gene	gene with protein product	Approved	5q13.2	05q13.2	MCCB	methylcrotonoyl-CoA carboxylase beta		methylcrotonoyl-Coenzyme A carboxylase 2 (beta)	
NA	x-linked leigh syndrome	NA	NA	PDHA1	300502	312170	hemizygous	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	8806	pyruvate dehydrogenase E1 alpha 1 subunit	protein-coding gene	gene with protein product	Approved	Xp22.12	Xp22.12		pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	PDHA	pyruvate dehydrogenase (lipoamide) alpha 1|pyruvate dehydrogenase alpha 1	Pyruvate dehydrogenase complex
NA	kallmann syndrome type 2	NA	NA	FGFR1	136350	147950	monoallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	crx-related leber congenital amaurosis leber congenital amaurosis 7	NA	NA	CRX	No gene mim	613829	monoallelic	confirmed	loss of function	Eye	2383	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract, autosomal recessive congenital 1	NA	NA	CRYAA	123580	123580	biallelic	confirmed	loss of function	Eye	2388	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lymphedema, hereditary, ic	NA	NA	GJC2	608803	613480	monoallelic	confirmed	all missense/in frame	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	17494	gap junction protein gamma 2	protein-coding gene	gene with protein product	Approved	1q42.13	01q42.13	CX47|CX46.6|SPG44	connexin 47	GJA12	gap junction protein, alpha 12, 47kDa|gap junction protein, gamma 2, 47kDa	Gap junction proteins
NA	autism	NA	NA	NRXN2	No gene mim	209850	monoallelic	probable	loss of function	Brain/Cognition	8009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe congenital neutropenia	NA	NA	JAGN1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Bone Marrow/Immune	26926	jagunal homolog 1	protein-coding gene	gene with protein product	Approved	3p25.3	03p25.3	GL009|FLJ14602			jagunal homolog 1 (Drosophila)	
NA	congenital disorders of glycosylation	NA	NA	PMM2	601785	612379	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	9115	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, waardenburg syndrome, and hirschsprung disease	NA	NA	SOX10	602229	609136	monoallelic	confirmed	dominant negative	Skin;Face;Spinal cord/Peripheral nerves;Ear	11190	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	orotic aciduria type 1	NA	NA	UMPS	613891	258900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	12563	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia isolated type 2	NA	NA	VSX2	142993	610093	biallelic	confirmed	loss of function	Eye	1975	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX19	600279	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
NA	proximal renal tubular acidosis with ocular abnormalities	NA	NA	SLC4A4	603345	604278	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye	11030	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	bamforth-lazarus syndrome	Cleft palate	Very frequent (99-80%)	FOXE1	No gene mim	241850	biallelic	confirmed	all missense/in frame	Face	3806	forkhead box E1	protein-coding gene	gene with protein product	Approved	9q22.33	09q22.33	TTF-2|HFKH4	thyroid transcription factor 2	FKHL15|TITF2|FOXE2	forkhead box E2|forkhead box E1 (thyroid transcription factor 2)	Forkhead boxes
HP:0000278	bamforth-lazarus syndrome	Retrognathia	Very frequent (99-80%)	FOXE1	No gene mim	241850	biallelic	confirmed	all missense/in frame	Face	3806	forkhead box E1	protein-coding gene	gene with protein product	Approved	9q22.33	09q22.33	TTF-2|HFKH4	thyroid transcription factor 2	FKHL15|TITF2|FOXE2	forkhead box E2|forkhead box E1 (thyroid transcription factor 2)	Forkhead boxes
HP:0000453	bamforth-lazarus syndrome	Choanal atresia	Very frequent (99-80%)	FOXE1	No gene mim	241850	biallelic	confirmed	all missense/in frame	Face	3806	forkhead box E1	protein-coding gene	gene with protein product	Approved	9q22.33	09q22.33	TTF-2|HFKH4	thyroid transcription factor 2	FKHL15|TITF2|FOXE2	forkhead box E2|forkhead box E1 (thyroid transcription factor 2)	Forkhead boxes
HP:0000851	bamforth-lazarus syndrome	Congenital hypothyroidism	Very frequent (99-80%)	FOXE1	No gene mim	241850	biallelic	confirmed	all missense/in frame	Face	3806	forkhead box E1	protein-coding gene	gene with protein product	Approved	9q22.33	09q22.33	TTF-2|HFKH4	thyroid transcription factor 2	FKHL15|TITF2|FOXE2	forkhead box E2|forkhead box E1 (thyroid transcription factor 2)	Forkhead boxes
HP:0001249	bamforth-lazarus syndrome	Intellectual disability	Very frequent (99-80%)	FOXE1	No gene mim	241850	biallelic	confirmed	all missense/in frame	Face	3806	forkhead box E1	protein-coding gene	gene with protein product	Approved	9q22.33	09q22.33	TTF-2|HFKH4	thyroid transcription factor 2	FKHL15|TITF2|FOXE2	forkhead box E2|forkhead box E1 (thyroid transcription factor 2)	Forkhead boxes
HP:0001561	bamforth-lazarus syndrome	Polyhydramnios	Very frequent (99-80%)	FOXE1	No gene mim	241850	biallelic	confirmed	all missense/in frame	Face	3806	forkhead box E1	protein-coding gene	gene with protein product	Approved	9q22.33	09q22.33	TTF-2|HFKH4	thyroid transcription factor 2	FKHL15|TITF2|FOXE2	forkhead box E2|forkhead box E1 (thyroid transcription factor 2)	Forkhead boxes
HP:0008191	bamforth-lazarus syndrome	Thyroid agenesis	Very frequent (99-80%)	FOXE1	No gene mim	241850	biallelic	confirmed	all missense/in frame	Face	3806	forkhead box E1	protein-coding gene	gene with protein product	Approved	9q22.33	09q22.33	TTF-2|HFKH4	thyroid transcription factor 2	FKHL15|TITF2|FOXE2	forkhead box E2|forkhead box E1 (thyroid transcription factor 2)	Forkhead boxes
HP:0011362	bamforth-lazarus syndrome	Abnormal hair quantity	Very frequent (99-80%)	FOXE1	No gene mim	241850	biallelic	confirmed	all missense/in frame	Face	3806	forkhead box E1	protein-coding gene	gene with protein product	Approved	9q22.33	09q22.33	TTF-2|HFKH4	thyroid transcription factor 2	FKHL15|TITF2|FOXE2	forkhead box E2|forkhead box E1 (thyroid transcription factor 2)	Forkhead boxes
NA	hermansky-pudlak syndrome 9	NA	NA	BLOC1S6	604310	614171	biallelic	probable	loss of function	Skin	8549	biogenesis of lysosomal organelles complex 1 subunit 6	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	HPS9		PA|PLDN	pallid (mouse) homolog, pallidin|pallidin homolog (mouse)	Biogenesis of lysosomal organelles complex 1 
NA	myopathy myofibrillar type 4	NA	NA	LDB3	No gene mim	609452	monoallelic	both DD and IF	all missense/in frame	Musculature;Heart/Cardiovasculature/Lymphatic	15710	LIM domain binding 3	protein-coding gene	gene with protein product	Approved	10q23.2	10q23.2	PDLIM6|KIAA0613|ZASP	cypher|oracle|Z-band alternatively spliced PDZ motif protein	CMD1C	cardiomyopathy, dilated 1C (autosomal dominant)	LIM domain containing|PDZ domain containing
NA	severe dermatitis, multiple allergies and metabolic wasting	NA	NA	DSG1	No gene mim	No disease mim	biallelic	probable	loss of function	Bone Marrow/Immune;Skin;Endocrine/Metabolic	3048	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	retinitis pigmentosa type 55	NA	NA	ARL6	608845	613575	biallelic	confirmed	uncertain	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye	13210	ADP ribosylation factor like GTPase 6	protein-coding gene	gene with protein product	Approved	3q11.2	03q11.2	RP55		BBS3	ADP-ribosylation factor-like 6	ARF GTPase family|Bardet-Biedl syndrome associated
NA	epileptic encephalopathy early infantile type 5	NA	NA	SPTAN1	182810	613477	monoallelic	probable	dominant negative	Brain/Cognition	11273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	abcb11-related intrahepatic cholestasis	NA	NA	ABCB11	603201	601847	biallelic	confirmed	loss of function	GI tract	42	ATP binding cassette subfamily B member 11	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	ABC16|SPGP|PFIC-2|PGY4	ABC member 16, MDR/TAP subfamily	BSEP|PFIC2	progressive familial intrahepatic cholestasis 2|bile salt export pump|ATP-binding cassette, sub-family B (MDR/TAP), member 11	ATP binding cassette subfamily B
NA	epileptic encephalopathy	NA	NA	GNAO1	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	4389	G protein subunit alpha o1	protein-coding gene	gene with protein product	Approved	16q13	16q13	G-ALPHA-o			guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O	G protein subunits alpha, group i
NA	acute hepatic porphyria	NA	NA	ALAD	No gene mim	612740	biallelic	both DD and IF	all missense/in frame	Endocrine/Metabolic	395	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010739	buschke-ollendorff syndrome	Osteopoikilosis	Obligate (100%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0100898	buschke-ollendorff syndrome	Connective tissue nevi	Obligate (100%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0000944	buschke-ollendorff syndrome	Abnormality of the metaphyses	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0001482	buschke-ollendorff syndrome	Subcutaneous nodule	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0002652	buschke-ollendorff syndrome	Skeletal dysplasia	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0002653	buschke-ollendorff syndrome	Bone pain	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0003330	buschke-ollendorff syndrome	Abnormal bone structure	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0004322	buschke-ollendorff syndrome	Short stature	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0005469	buschke-ollendorff syndrome	Flat occiput	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0005789	buschke-ollendorff syndrome	Generalized osteosclerosis	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0005930	buschke-ollendorff syndrome	Abnormality of epiphysis morphology	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0007513	buschke-ollendorff syndrome	Generalized hypopigmentation	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0100774	buschke-ollendorff syndrome	Hyperostosis	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0200034	buschke-ollendorff syndrome	Papule	Very frequent (99-80%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0001371	buschke-ollendorff syndrome	Flexion contracture	Frequent (79-30%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0001387	buschke-ollendorff syndrome	Joint stiffness	Frequent (79-30%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0100324	buschke-ollendorff syndrome	Scleroderma	Frequent (79-30%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0000083	buschke-ollendorff syndrome	Renal insufficiency	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0000164	buschke-ollendorff syndrome	Abnormality of the teeth	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0000365	buschke-ollendorff syndrome	Hearing impairment	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0000486	buschke-ollendorff syndrome	Strabismus	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0000505	buschke-ollendorff syndrome	Visual impairment	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0000822	buschke-ollendorff syndrome	Hypertension	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0000982	buschke-ollendorff syndrome	Palmoplantar keratoderma	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0000987	buschke-ollendorff syndrome	Atypical scarring of skin	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0001004	buschke-ollendorff syndrome	Lymphedema	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0001028	buschke-ollendorff syndrome	Hemangioma	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0001369	buschke-ollendorff syndrome	Arthritis	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0001609	buschke-ollendorff syndrome	Hoarse voice	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0001679	buschke-ollendorff syndrome	Abnormality of the aorta	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0002757	buschke-ollendorff syndrome	Recurrent fractures	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0002829	buschke-ollendorff syndrome	Arthralgia	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0003326	buschke-ollendorff syndrome	Myalgia	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0007488	buschke-ollendorff syndrome	Diffuse skin atrophy	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0009055	buschke-ollendorff syndrome	Generalized limb muscle atrophy	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0009121	buschke-ollendorff syndrome	Abnormal axial skeleton morphology	Occasional (29-5%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0001363	buschke-ollendorff syndrome	Craniosynostosis	Very rare (<4-1%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
HP:0010554	buschke-ollendorff syndrome	Cutaneous finger syndactyly	Very rare (<4-1%)	LEMD3	607844	166700	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
NA	meckel syndrome type 3	NA	NA	TMEM67	609884	607361	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;GI tract	28396	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ataxia, posterior column, with retinitis pigmentosa	NA	NA	FLVCR1	609144	609033	biallelic	confirmed	all missense/in frame	Brain/Cognition;Eye	24682	feline leukemia virus subgroup C cellular receptor 1	protein-coding gene	gene with protein product	Approved	1q32.3	01q32.3	FLVCR|MFSD7B|PCA		AXPC1	ataxia, posterior column 1, with retinitis pigmentosa	Solute carriers
NA	platyspondylic lethal skeletal dysplasia torrance type	NA	NA	COL2A1	120140	151210	monoallelic	confirmed	loss of function	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	joubert syndrome 2	NA	NA	TMEM216	613277	608091	biallelic	probable	all missense/in frame	Brain/Cognition	25018	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hypothyroidism, congenital, nongoitrous, 6	NA	NA	THRA	190120	614450	monoallelic	confirmed	loss of function	Endocrine;Brain/Cognition	11796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bartter syndrome type 4b	NA	NA	CLCNKB	602023	613090	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic	2027	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract autosomal dominant bfsp2-related	NA	NA	BFSP2	603212	611597	monoallelic	confirmed	uncertain	Eye	1041	beaded filament structural protein 2	protein-coding gene	gene with protein product	Approved	3q22.1	03q22.1	CP47|CP49|LIFL-L|phakinin			beaded filament structural protein 2, phakinin	Beaded filament structural proteins
NA	microcephaly and chorioretinopathy with or without mental retardation	NA	NA	TUBGCP6	No gene mim	251270	biallelic	confirmed	loss of function	Brain/Cognition;Eye	18127	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atypical noonan syndrome	NA	NA	RRAS	No gene mim	No disease mim	monoallelic	probable	activating	Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10447	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	otopalatodigital syndrome type 2	Hypospadias	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000126	otopalatodigital syndrome type 2	Hydronephrosis	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000160	otopalatodigital syndrome type 2	Narrow mouth	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000162	otopalatodigital syndrome type 2	Glossoptosis	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000175	otopalatodigital syndrome type 2	Cleft palate	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000201	otopalatodigital syndrome type 2	Pierre-Robin sequence	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000238	otopalatodigital syndrome type 2	Hydrocephalus	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000239	otopalatodigital syndrome type 2	Large fontanelles	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000272	otopalatodigital syndrome type 2	Malar flattening	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000316	otopalatodigital syndrome type 2	Hypertelorism	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000336	otopalatodigital syndrome type 2	Prominent supraorbital ridges	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000337	otopalatodigital syndrome type 2	Broad forehead	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000347	otopalatodigital syndrome type 2	Micrognathia	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000365	otopalatodigital syndrome type 2	Hearing impairment	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000369	otopalatodigital syndrome type 2	Low-set ears	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000377	otopalatodigital syndrome type 2	Abnormality of the pinna	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000494	otopalatodigital syndrome type 2	Downslanted palpebral fissures	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000518	otopalatodigital syndrome type 2	Cataract	Occasional (29-5%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000674	otopalatodigital syndrome type 2	Anodontia	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000677	otopalatodigital syndrome type 2	Oligodontia	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000772	otopalatodigital syndrome type 2	Abnormality of the ribs	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000774	otopalatodigital syndrome type 2	Narrow chest	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001087	otopalatodigital syndrome type 2	Congenital glaucoma	Occasional (29-5%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001163	otopalatodigital syndrome type 2	Abnormality of the metacarpal bones	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001249	otopalatodigital syndrome type 2	Intellectual disability	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001263	otopalatodigital syndrome type 2	Global developmental delay	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001321	otopalatodigital syndrome type 2	Cerebellar hypoplasia	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001508	otopalatodigital syndrome type 2	Failure to thrive	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001539	otopalatodigital syndrome type 2	Omphalocele	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001654	otopalatodigital syndrome type 2	Abnormality of the heart valves	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001671	otopalatodigital syndrome type 2	Abnormality of the cardiac septa	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002084	otopalatodigital syndrome type 2	Encephalocele	Occasional (29-5%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002475	otopalatodigital syndrome type 2	Myelomeningocele	Occasional (29-5%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002652	otopalatodigital syndrome type 2	Skeletal dysplasia	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002684	otopalatodigital syndrome type 2	Thickened calvaria	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002990	otopalatodigital syndrome type 2	Fibular aplasia	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0003042	otopalatodigital syndrome type 2	Elbow dislocation	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0003196	otopalatodigital syndrome type 2	Short nose	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0004279	otopalatodigital syndrome type 2	Short palm	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0005048	otopalatodigital syndrome type 2	Synostosis of carpal bones	Occasional (29-5%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0005280	otopalatodigital syndrome type 2	Depressed nasal bridge	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0005640	otopalatodigital syndrome type 2	Abnormal vertebral segmentation and fusion	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0006000	otopalatodigital syndrome type 2	Ureteral obstruction	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0006487	otopalatodigital syndrome type 2	Bowing of the long bones	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0008368	otopalatodigital syndrome type 2	Tarsal synostosis	Occasional (29-5%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0009702	otopalatodigital syndrome type 2	Carpal synostosis	Occasional (29-5%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0009778	otopalatodigital syndrome type 2	Short thumb	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0010109	otopalatodigital syndrome type 2	Short hallux	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0011001	otopalatodigital syndrome type 2	Increased bone mineral density	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0100258	otopalatodigital syndrome type 2	Preaxial polydactyly	Occasional (29-5%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0100490	otopalatodigital syndrome type 2	Camptodactyly of finger	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002089	otopalatodigital syndrome type 2	Pulmonary hypoplasia	Very frequent (99-80%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002650	otopalatodigital syndrome type 2	Scoliosis	Occasional (29-5%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002738	otopalatodigital syndrome type 2	Hypoplastic frontal sinuses	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002869	otopalatodigital syndrome type 2	Flared iliac wings	Frequent (79-30%)	FLNA	300017	304120	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
NA	ectodermal dysplasia-syndactyly syndrome 1	NA	NA	NECTIN4	No gene mim	613573	biallelic	confirmed	loss of function	Skin;Skeleton	19688	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nystagmus 1, congenital, x-linked	NA	NA	FRMD7	300628	310700	hemizygous	confirmed	loss of function	Brain/Cognition	8079	FERM domain containing 7	protein-coding gene	gene with protein product	Approved	Xq26.2	Xq26.2	FLJ43346		NYS|NYS1	nystagmus 1, congenital	FERM domain containing
NA	ehlers-danlos syndrome, classic type, col1a1-related	NA	NA	COL1A1	120150	130060	monoallelic	confirmed	dominant negative	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital systemic glutamine deficiency	NA	NA	GLUL	138290	610015	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition	4341	glutamate-ammonia ligase	protein-coding gene	gene with protein product	Approved	1q25.3	01q25.3		glutamine synthetase	GLNS	glutamate-ammonia ligase (glutamine synthase)	
NA	meier-gorlin syndrome 2	NA	NA	ORC4	603056	613800	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear	8490	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	3mc syndrome 2	NA	NA	COLEC11	612502	265050	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	17213	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract crystalline aculeiform	NA	NA	CRYGD	123690	115700	monoallelic	possible	loss of function	Eye	2411	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	kallmann syndrome type 5	NA	NA	CHD7	608892	612370	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy	NA	NA	NEDD4L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	7728	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leber congenital amaurosis type 10	NA	NA	CEP290	610142	611755	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition	29021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	holoprosencephaly	Cryptorchidism	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000079	holoprosencephaly	Abnormality of the urinary system	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000093	holoprosencephaly	Proteinuria	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000161	holoprosencephaly	Median cleft lip	Very frequent (99-80%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	holoprosencephaly	Hydrocephalus	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	holoprosencephaly	Microcephaly	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	holoprosencephaly	Macrocephaly	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	holoprosencephaly	Epicanthus	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000289	holoprosencephaly	Broad philtrum	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	holoprosencephaly	Hypertelorism	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	holoprosencephaly	Macrotia	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000437	holoprosencephaly	Depressed nasal tip	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000453	holoprosencephaly	Choanal atresia	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	holoprosencephaly	Depressed nasal ridge	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000458	holoprosencephaly	Anosmia	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	holoprosencephaly	Anteverted nares	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	holoprosencephaly	Short neck	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000488	holoprosencephaly	Retinopathy	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	holoprosencephaly	Deeply set eye	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	holoprosencephaly	Ptosis	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000528	holoprosencephaly	Anophthalmia	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000567	holoprosencephaly	Chorioretinal coloboma	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	holoprosencephaly	Microphthalmia	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000574	holoprosencephaly	Thick eyebrow	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000581	holoprosencephaly	Blepharophimosis	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000582	holoprosencephaly	Upslanted palpebral fissure	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000601	holoprosencephaly	Hypotelorism	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	holoprosencephaly	Iris coloboma	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	holoprosencephaly	Optic atrophy	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000664	holoprosencephaly	Synophrys	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000776	holoprosencephaly	Congenital diaphragmatic hernia	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000819	holoprosencephaly	Diabetes mellitus	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000830	holoprosencephaly	Anterior hypopituitarism	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000871	holoprosencephaly	Panhypopituitarism	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000873	holoprosencephaly	Diabetes insipidus	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000929	holoprosencephaly	Abnormality of the skull	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	holoprosencephaly	Brachydactyly syndrome	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	holoprosencephaly	Hand polydactyly	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	holoprosencephaly	Seizures	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	holoprosencephaly	Muscular hypotonia	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	holoprosencephaly	Spasticity	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	holoprosencephaly	Global developmental delay	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001305	holoprosencephaly	Dandy-Walker malformation	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	holoprosencephaly	Muscle weakness	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001332	holoprosencephaly	Dystonia	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001360	holoprosencephaly	Holoprosencephaly	Very frequent (99-80%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001531	holoprosencephaly	Failure to thrive in infancy	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001539	holoprosencephaly	Omphalocele	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	holoprosencephaly	Ventricular septal defect	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	holoprosencephaly	Tetralogy of Fallot	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001641	holoprosencephaly	Abnormality of the pulmonary valve	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001679	holoprosencephaly	Abnormality of the aorta	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001743	holoprosencephaly	Abnormality of the spleen	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001883	holoprosencephaly	Talipes	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	holoprosencephaly	Hypoglycemia	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001999	holoprosencephaly	Abnormal facial shape	Very frequent (99-80%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002002	holoprosencephaly	Deep philtrum	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	holoprosencephaly	Frontal bossing	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	holoprosencephaly	Constipation	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	holoprosencephaly	Gastroesophageal reflux	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002072	holoprosencephaly	Chorea	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002084	holoprosencephaly	Encephalocele	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	holoprosencephaly	Respiratory insufficiency	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	holoprosencephaly	Abnormality of neuronal migration	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002553	holoprosencephaly	Highly arched eyebrow	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	holoprosencephaly	Scoliosis	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002902	holoprosencephaly	Hyponatremia	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	holoprosencephaly	Abnormal form of the vertebral bodies	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004409	holoprosencephaly	Hyposmia	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005469	holoprosencephaly	Flat occiput	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	holoprosencephaly	Joint hyperflexibility	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006315	holoprosencephaly	Single median maxillary incisor	Very frequent (99-80%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006703	holoprosencephaly	Aplasia/Hypoplasia of the lungs	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	holoprosencephaly	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	holoprosencephaly	Aplasia/Hypoplasia of the corpus callosum	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008501	holoprosencephaly	Median cleft lip and palate	Very frequent (99-80%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008572	holoprosencephaly	External ear malformation	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	holoprosencephaly	Hypoplasia of penis	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	holoprosencephaly	Feeding difficulties in infancy	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009738	holoprosencephaly	Abnormality of the antihelix	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009794	holoprosencephaly	Branchial anomaly	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	holoprosencephaly	Reduced number of teeth	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009914	holoprosencephaly	Cyclopia	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009924	holoprosencephaly	Aplasia/Hypoplasia involving the nose	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010301	holoprosencephaly	Spinal dysraphism	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010302	holoprosencephaly	Spinal cord tumor	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010669	holoprosencephaly	Cheekbone underdevelopment	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011100	holoprosencephaly	Intestinal atresia	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	holoprosencephaly	Arrhythmia	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012639	holoprosencephaly	Abnormality of nervous system morphology	Very frequent (99-80%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100336	holoprosencephaly	Bilateral cleft lip	Very frequent (99-80%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	holoprosencephaly	Cognitive impairment	Frequent (79-30%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100596	holoprosencephaly	Absent nares	Occasional (29-5%)	ZIC2	603073	609637	monoallelic	confirmed	loss of function	Brain/Cognition	12873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epilepsy with neurodevelopmental defects	NA	NA	GRIN2A	138253	613971	monoallelic	confirmed	loss of function	Brain/Cognition	4585	glutamate ionotropic receptor NMDA type subunit 2A	protein-coding gene	gene with protein product	Approved	16p13.2	16p13.2	GluN2A		NMDAR2A	glutamate receptor, ionotropic, N-methyl D-aspartate 2A	Glutamate ionotropic receptor NMDA type subunits
NA	fragile x tremor/ataxia syndrome	NA	NA	FMR1	No gene mim	300623	hemizygous	both DD and IF	activating	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
NA	myoclonic epilepsy, infantile, familial	NA	NA	TBC1D24	613577	605021	biallelic	confirmed	all missense/in frame	Brain/Cognition	29203	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	chromosome 1p32-p31 deletion syndrome	NA	NA	NFIA	No gene mim	613735	monoallelic	possible	loss of function	Kidney Renal Tract;Brain/Cognition	7784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000488	neurodegeneration with brain iron accumulation	Retinopathy	Frequent (79-30%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	neurodegeneration with brain iron accumulation	Optic atrophy	Frequent (79-30%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	neurodegeneration with brain iron accumulation	Spasticity	Frequent (79-30%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001260	neurodegeneration with brain iron accumulation	Dysarthria	Frequent (79-30%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001272	neurodegeneration with brain iron accumulation	Cerebellar atrophy	Frequent (79-30%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001332	neurodegeneration with brain iron accumulation	Dystonia	Very frequent (99-80%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002063	neurodegeneration with brain iron accumulation	Rigidity	Frequent (79-30%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002071	neurodegeneration with brain iron accumulation	Abnormality of extrapyramidal motor function	Frequent (79-30%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002072	neurodegeneration with brain iron accumulation	Chorea	Frequent (79-30%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012675	neurodegeneration with brain iron accumulation	Iron accumulation in brain	Very frequent (99-80%)	WDR45	300526	No disease mim	x-linked dominant	confirmed	loss of function	Brain/Cognition	28912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hereditary spastic paraparesis	NA	NA	TECPR2	615000	615031	biallelic	probable	loss of function	Brain/Cognition	19957	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	brachydactyly, type b1	NA	NA	ROR2	602337	113000	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Genitalia	10257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	sialidosis	NA	NA	NEU1	608272	256550	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye	7758	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cardiomyopathy dilated with hypergonadotropic hypogonadism	NA	NA	LMNA	No gene mim	212112	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
NA	microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	NA	NA	QARS	No gene mim	615760	biallelic	probable	all missense/in frame	Brain/Cognition	9751	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000324	caffey disease	Facial asymmetry	Occasional (29-5%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	caffey disease	Proptosis	Occasional (29-5%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	caffey disease	Behavioral abnormality	Frequent (79-30%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001945	caffey disease	Fever	Frequent (79-30%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	caffey disease	Respiratory insufficiency	Occasional (29-5%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	caffey disease	Scoliosis	Occasional (29-5%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004490	caffey disease	Calvarial hyperostosis	Occasional (29-5%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005731	caffey disease	Cortical irregularity	Very frequent (99-80%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005791	caffey disease	Cortical thickening of long bone diaphyses	Occasional (29-5%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006465	caffey disease	Periosteal thickening of long tubular bones	Frequent (79-30%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	caffey disease	Feeding difficulties in infancy	Occasional (29-5%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010702	caffey disease	Increased antibody level in blood	Occasional (29-5%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100658	caffey disease	Cellulitis	Very frequent (99-80%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100963	caffey disease	Hyperesthesia	Frequent (79-30%)	COL1A1	120150	114000	monoallelic	confirmed	uncertain	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	eem syndrome	Strabismus	Occasional (29-5%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000488	eem syndrome	Retinopathy	Very frequent (99-80%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	eem syndrome	Abnormality of vision	Frequent (79-30%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	eem syndrome	Carious teeth	Frequent (79-30%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000687	eem syndrome	Widely spaced teeth	Frequent (79-30%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001592	eem syndrome	Selective tooth agenesis	Frequent (79-30%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002223	eem syndrome	Absent eyebrow	Frequent (79-30%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002231	eem syndrome	Sparse body hair	Very frequent (99-80%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	eem syndrome	Finger syndactyly	Frequent (79-30%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006482	eem syndrome	Abnormality of dental morphology	Very frequent (99-80%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	eem syndrome	Abnormality of retinal pigmentation	Very frequent (99-80%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007754	eem syndrome	Macular dystrophy	Very frequent (99-80%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100257	eem syndrome	Ectrodactyly	Very frequent (99-80%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000478	eem syndrome	Abnormality of the eye	Frequent (79-30%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000691	eem syndrome	Microdontia	Frequent (79-30%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002209	eem syndrome	Sparse scalp hair	Very frequent (99-80%)	CDH3	114021	280238	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	osteogenesis imperfecta type iia	NA	NA	COL1A1	120150	166210	monoallelic	confirmed	dominant negative	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	waardenburg syndrome, type 1	NA	NA	PAX3	606597	193500	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	benign hereditary chorea	NA	NA	NKX2-1	No gene mim	118700	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Respiratory tract	11825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebro-costo-mandibular syndrome	NA	NA	SNRPB	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	11153	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	galactosialidosis	Coarse facial features	Very frequent (99-80%)	CTSA	613111	256540	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9251	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	galactosialidosis	Hearing impairment	Very frequent (99-80%)	CTSA	613111	256540	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9251	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000925	galactosialidosis	Abnormality of the vertebral column	Very frequent (99-80%)	CTSA	613111	256540	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9251	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	galactosialidosis	Intellectual disability	Very frequent (99-80%)	CTSA	613111	256540	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9251	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	galactosialidosis	Seizures	Very frequent (99-80%)	CTSA	613111	256540	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9251	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	galactosialidosis	Skeletal dysplasia	Very frequent (99-80%)	CTSA	613111	256540	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9251	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003468	galactosialidosis	Abnormality of the vertebrae	Very frequent (99-80%)	CTSA	613111	256540	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9251	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007957	galactosialidosis	Corneal opacity	Very frequent (99-80%)	CTSA	613111	256540	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9251	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010729	galactosialidosis	Cherry red spot of the macula	Very frequent (99-80%)	CTSA	613111	256540	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9251	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	athabaskan brainstem dysgenesis syndrome	NA	NA	HOXA1	142955	601536	biallelic	confirmed	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	5099	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	GON4L	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	25973	gon-4 like	protein-coding gene	gene with protein product	Approved	1q22	01q22	FLJ20203|GON-4|YARP	YY1AP related protein	GON4	gon-4 homolog (C.elegans)|gon-4-like (C. elegans)	Myb/SANT domain containing
HP:0000175	diaphanospondylodysostosis	Cleft palate	Occasional (29-5%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0000470	diaphanospondylodysostosis	Short neck	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0000921	diaphanospondylodysostosis	Missing ribs	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0002098	diaphanospondylodysostosis	Respiratory distress	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0002475	diaphanospondylodysostosis	Myelomeningocele	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0003275	diaphanospondylodysostosis	Narrow pelvis bone	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0004599	diaphanospondylodysostosis	Absent or minimally ossified vertebral bodies	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0005562	diaphanospondylodysostosis	Multiple renal cysts	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0005640	diaphanospondylodysostosis	Abnormal vertebral segmentation and fusion	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0010306	diaphanospondylodysostosis	Short thorax	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0100625	diaphanospondylodysostosis	Enlarged thorax	Very frequent (99-80%)	BMPER	608699	608022	biallelic	confirmed	loss of function	Skeleton	24154	BMP binding endothelial regulator	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	Cv2|CRIM3	crossveinless-2			
HP:0001643	hypoplastic left heart syndrome	Patent ductus arteriosus	Occasional (29-5%)	GJA1	121014	241550	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0001718	hypoplastic left heart syndrome	Mitral stenosis	Occasional (29-5%)	GJA1	121014	241550	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0009800	hypoplastic left heart syndrome	Maternal diabetes	Occasional (29-5%)	GJA1	121014	241550	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0012304	hypoplastic left heart syndrome	Hypoplastic aortic arch	Frequent (79-30%)	GJA1	121014	241550	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0001631	hypoplastic left heart syndrome	Atrial septal defect	Occasional (29-5%)	GJA1	121014	241550	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0002916	hypoplastic left heart syndrome	Abnormality of chromosome segregation	Occasional (29-5%)	GJA1	121014	241550	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0004383	hypoplastic left heart syndrome	Hypoplastic left heart	Very frequent (99-80%)	GJA1	121014	241550	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0011560	hypoplastic left heart syndrome	Mitral atresia	Occasional (29-5%)	GJA1	121014	241550	monoallelic	confirmed	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
NA	thiamine metabolism dysfunction syndrome 2	NA	NA	SLC19A3	606152	607483	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	16266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	diaphragmatic hernia 3	NA	NA	ZFPM2	No gene mim	610187	monoallelic	possible	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	vesicoureteral reflux type 3	NA	NA	SOX17	610928	613674	monoallelic	confirmed	all missense/in frame	Kidney Renal Tract	18122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, autosomal dominant 6	NA	NA	GRIN2B	138252	613970	monoallelic	confirmed	loss of function	Brain/Cognition	4586	glutamate ionotropic receptor NMDA type subunit 2B	protein-coding gene	gene with protein product	Approved	12p13.1	12p13.1	GluN2B		NMDAR2B	glutamate receptor, ionotropic, N-methyl D-aspartate 2B	Glutamate ionotropic receptor NMDA type subunits
NA	sengers syndrome	NA	NA	AGK	610345	212350	biallelic	confirmed	loss of function		21869	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	myopathy, myofibrillar, fatal infantile hypertonic, alpha-b crystallin-related	NA	NA	CRYAB	No gene mim	613869	biallelic	possible	loss of function	Musculature;Eye	2389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked type 46	NA	NA	ARHGEF6	No gene mim	300436	hemizygous	possible	loss of function	Brain/Cognition	685	Rac/Cdc42 guanine nucleotide exchange factor 6	protein-coding gene	gene with protein product	Approved	Xq26.3	Xq26.3	alphaPIX|Cool-2|KIAA0006|alpha-PIX|Cool2	Rac/Cdc42 guanine exchange factor (GEF) 6|PAK-interacting exchange factor, alpha|rho guanine nucleotide exchange factor 6	MRX46	mental retardation, X-linked 46|Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6	X-linked mental retardation|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
NA	intellectual disability	NA	NA	BCL11A	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	13221	B-cell CLL/lymphoma 11A	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	BCL11A-XL|BCL11A-L|BCL11A-S|CTIP1|HBFQTL5|ZNF856		EVI9	ecotropic viral integration site 9|B-cell CLL/lymphoma 11A (zinc finger protein)	Zinc fingers C2H2-type
HP:0000852	pseudohypoparathyroidism type 1b	Pseudohypoparathyroidism	Obligate (100%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0002901	pseudohypoparathyroidism type 1b	Hypocalcemia	Very frequent (99-80%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0002905	pseudohypoparathyroidism type 1b	Hyperphosphatemia	Very frequent (99-80%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0003165	pseudohypoparathyroidism type 1b	Elevated circulating parathyroid hormone level	Very frequent (99-80%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0003456	pseudohypoparathyroidism type 1b	Low urinary cyclic AMP response to PTH administration	Very frequent (99-80%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000293	pseudohypoparathyroidism type 1b	Full cheeks	Frequent (79-30%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000311	pseudohypoparathyroidism type 1b	Round face	Frequent (79-30%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000470	pseudohypoparathyroidism type 1b	Short neck	Frequent (79-30%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000518	pseudohypoparathyroidism type 1b	Cataract	Frequent (79-30%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000639	pseudohypoparathyroidism type 1b	Nystagmus	Frequent (79-30%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000684	pseudohypoparathyroidism type 1b	Delayed eruption of teeth	Frequent (79-30%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0004322	pseudohypoparathyroidism type 1b	Short stature	Frequent (79-30%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0005280	pseudohypoparathyroidism type 1b	Depressed nasal bridge	Frequent (79-30%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0006297	pseudohypoparathyroidism type 1b	Hypoplasia of dental enamel	Frequent (79-30%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000509	pseudohypoparathyroidism type 1b	Conjunctivitis	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000716	pseudohypoparathyroidism type 1b	Depression	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000737	pseudohypoparathyroidism type 1b	Irritability	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000739	pseudohypoparathyroidism type 1b	Anxiety	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0001265	pseudohypoparathyroidism type 1b	Hyporeflexia	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0001657	pseudohypoparathyroidism type 1b	Prolonged QT interval	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0002094	pseudohypoparathyroidism type 1b	Dyspnea	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0003034	pseudohypoparathyroidism type 1b	Diaphyseal sclerosis	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0003394	pseudohypoparathyroidism type 1b	Muscle cramps	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0003401	pseudohypoparathyroidism type 1b	Paresthesia	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0003472	pseudohypoparathyroidism type 1b	Hypocalcemic tetany	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0003739	pseudohypoparathyroidism type 1b	Myoclonic spasms	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0003909	pseudohypoparathyroidism type 1b	Cortical subperiosteal resorption of humeral metaphyses	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0005700	pseudohypoparathyroidism type 1b	Increased bone density with cystic changes	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0011001	pseudohypoparathyroidism type 1b	Increased bone mineral density	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0011458	pseudohypoparathyroidism type 1b	Abdominal symptom	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0012049	pseudohypoparathyroidism type 1b	Laryngeal dystonia	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0100660	pseudohypoparathyroidism type 1b	Dyskinesia	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0100749	pseudohypoparathyroidism type 1b	Chest pain	Occasional (29-5%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000824	pseudohypoparathyroidism type 1b	Growth hormone deficiency	Very rare (<4-1%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0002199	pseudohypoparathyroidism type 1b	Hypocalcemic seizures	Very rare (<4-1%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0008227	pseudohypoparathyroidism type 1b	Pituitary resistance to thyroid hormone	Very rare (<4-1%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0003761	pseudohypoparathyroidism type 1b	Calcinosis	Excluded (0%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0010766	pseudohypoparathyroidism type 1b	Ectopic calcification	Excluded (0%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0030057	pseudohypoparathyroidism type 1b	Autoimmune antibody positivity	Excluded (0%)	GNAS	139320	603233	imprinted	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
NA	mucopolysaccharidosis type 3d	NA	NA	GNS	607664	252940	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4422	glucosamine (N-acetyl)-6-sulfatase	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3		Sanfilippo disease IIID|N-acetylglucosamine-6-sulfatase			Sulfatases
NA	short-rib polydactyly	NA	NA	WDR60	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	21862	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peters anomaly	NA	NA	FOXC1	601090	604229	monoallelic	confirmed	loss of function	Eye	3800	forkhead box C1	protein-coding gene	gene with protein product	Approved	6p25.3	06p25.3	FREAC3|ARA|IGDA|IHG1		FKHL7|IRID1		Forkhead boxes
NA	epileptic encephalopathy, early infantile, 28	NA	NA	WWOX	No gene mim	616211	biallelic	probable	loss of function	Brain/Cognition	12799	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	partington syndrome	NA	NA	ARX	300382	309510	hemizygous	confirmed	uncertain	Brain/Cognition;Genitalia	18060	aristaless related homeobox	protein-coding gene	gene with protein product	Approved	Xp21.3	Xp21.3	ISSX|CT121|EIEE1	cancer/testis antigen 121	MRXS1|PRTS|MRX76|MRX54|MRX43|MRX36|MRX29|MRX32|MRX33|MRX38|MRX87	mental retardation, X-linked 54|mental retardation, X-linked 43|mental retardation, X-linked 36|mental retardation, X-linked 29|mental retardation, X-linked 32|mental retardation, X-linked 33|mental retardation, X-linked 38|mental retardation, X-linked 87|mental retardation, X-linked 76	X-linked mental retardation|PRD class homeoboxes and pseudogenes
NA	cataract, congenital nuclear, autosomal recessive 3	NA	NA	CRYBB1	600929	611544	biallelic	confirmed	loss of function	Eye	2397	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract, congenital nuclear, autosomal recessive 3	NA	NA	CRYBB1	600929	611544	monoallelic	confirmed	loss of function	Eye	2397	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	x-linked creatine deficiency syndrome	NA	NA	SLC6A8	300036	300352	hemizygous	confirmed	loss of function	Face;Skeleton;Brain/Cognition	11055	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	neu-laxova syndrome	Microcephaly	Very frequent (99-80%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000340	neu-laxova syndrome	Sloping forehead	Very frequent (99-80%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001511	neu-laxova syndrome	Intrauterine growth retardation	Very frequent (99-80%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0008064	neu-laxova syndrome	Ichthyosis	Very frequent (99-80%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0012471	neu-laxova syndrome	Thick vermilion border	Very frequent (99-80%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0012639	neu-laxova syndrome	Abnormality of nervous system morphology	Very frequent (99-80%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0100679	neu-laxova syndrome	Lack of skin elasticity	Very frequent (99-80%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000062	neu-laxova syndrome	Ambiguous genitalia	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000135	neu-laxova syndrome	Hypogonadism	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000153	neu-laxova syndrome	Abnormality of the mouth	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000211	neu-laxova syndrome	Trismus	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000232	neu-laxova syndrome	Everted lower lip vermilion	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000288	neu-laxova syndrome	Abnormality of the philtrum	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000316	neu-laxova syndrome	Hypertelorism	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000400	neu-laxova syndrome	Macrotia	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000457	neu-laxova syndrome	Depressed nasal ridge	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000520	neu-laxova syndrome	Proptosis	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000951	neu-laxova syndrome	Abnormality of the skin	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001176	neu-laxova syndrome	Large hands	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001302	neu-laxova syndrome	Pachygyria	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001305	neu-laxova syndrome	Dandy-Walker malformation	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001321	neu-laxova syndrome	Cerebellar hypoplasia	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001331	neu-laxova syndrome	Absent septum pellucidum	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001339	neu-laxova syndrome	Lissencephaly	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001371	neu-laxova syndrome	Flexion contracture	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001460	neu-laxova syndrome	Aplasia/Hypoplasia involving the skeletal musculature	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001558	neu-laxova syndrome	Decreased fetal movement	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001561	neu-laxova syndrome	Polyhydramnios	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001769	neu-laxova syndrome	Broad foot	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002126	neu-laxova syndrome	Polymicrogyria	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002179	neu-laxova syndrome	Opisthotonus	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002269	neu-laxova syndrome	Abnormality of neuronal migration	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002334	neu-laxova syndrome	Abnormality of the cerebellar vermis	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002536	neu-laxova syndrome	Abnormal cortical gyration	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0003202	neu-laxova syndrome	Skeletal muscle atrophy	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0003241	neu-laxova syndrome	External genital hypoplasia	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0003394	neu-laxova syndrome	Muscle cramps	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0003560	neu-laxova syndrome	Muscular dystrophy	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0007227	neu-laxova syndrome	Macrogyria	Frequent (79-30%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000175	neu-laxova syndrome	Cleft palate	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000176	neu-laxova syndrome	Submucous cleft hard palate	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000193	neu-laxova syndrome	Bifid uvula	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000269	neu-laxova syndrome	Prominent occiput	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000278	neu-laxova syndrome	Retrognathia	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000347	neu-laxova syndrome	Micrognathia	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000492	neu-laxova syndrome	Abnormality of the eyelid	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000499	neu-laxova syndrome	Abnormality of the eyelashes	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000518	neu-laxova syndrome	Cataract	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000614	neu-laxova syndrome	Abnormality of the nasolacrimal system	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000938	neu-laxova syndrome	Osteopenia	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0000939	neu-laxova syndrome	Osteoporosis	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001059	neu-laxova syndrome	Pterygium	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0001595	neu-laxova syndrome	Abnormality of the hair	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002089	neu-laxova syndrome	Pulmonary hypoplasia	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002119	neu-laxova syndrome	Ventriculomegaly	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002414	neu-laxova syndrome	Spina bifida	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002514	neu-laxova syndrome	Cerebral calcification	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002650	neu-laxova syndrome	Scoliosis	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002748	neu-laxova syndrome	Rickets	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002749	neu-laxova syndrome	Osteomalacia	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002804	neu-laxova syndrome	Arthrogryposis multiplex congenita	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0002983	neu-laxova syndrome	Micromelia	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
HP:0030680	neu-laxova syndrome	Abnormality of cardiovascular system morphology	Occasional (29-5%)	PHGDH	606879	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
NA	adrenoleukodystrophy neonatal	NA	NA	PEX26	608666	202370	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
NA	intellectual disability	NA	NA	MTF1	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	7428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	familial partial lipodystrophy type 2	NA	NA	LMNA	No gene mim	151660	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
NA	succinate semialdehyde dehydrogenase deficiency	NA	NA	ALDH5A1	610045	271980	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	408	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000083	refsum disease	Renal insufficiency	Occasional (29-5%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000458	refsum disease	Anosmia	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000478	refsum disease	Abnormality of the eye	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000488	refsum disease	Retinopathy	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000496	refsum disease	Abnormality of eye movement	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000504	refsum disease	Abnormality of vision	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000505	refsum disease	Visual impairment	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000508	refsum disease	Ptosis	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000518	refsum disease	Cataract	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000529	refsum disease	Progressive visual loss	Occasional (29-5%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000568	refsum disease	Microphthalmia	Occasional (29-5%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000639	refsum disease	Nystagmus	Occasional (29-5%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000662	refsum disease	Nyctalopia	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000958	refsum disease	Dry skin	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0001251	refsum disease	Ataxia	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0001638	refsum disease	Cardiomyopathy	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0001744	refsum disease	Splenomegaly	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000407	refsum disease	Sensorineural hearing impairment	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000616	refsum disease	Miosis	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0001252	refsum disease	Muscular hypotonia	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0001760	refsum disease	Abnormality of the foot	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0001761	refsum disease	Pes cavus	Occasional (29-5%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0001765	refsum disease	Hammertoe	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0001939	refsum disease	Abnormality of metabolism/homeostasis	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0002093	refsum disease	Respiratory insufficiency	Occasional (29-5%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0002164	refsum disease	Nail dysplasia	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0002376	refsum disease	Developmental regression	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0002652	refsum disease	Skeletal dysplasia	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0003202	refsum disease	Skeletal muscle atrophy	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0004374	refsum disease	Hemiplegia/hemiparesis	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0005930	refsum disease	Abnormality of epiphysis morphology	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0007256	refsum disease	Abnormal pyramidal signs	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0007703	refsum disease	Abnormality of retinal pigmentation	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0008064	refsum disease	Ichthyosis	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0009830	refsum disease	Peripheral neuropathy	Very frequent (99-80%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0010049	refsum disease	Short metacarpal	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0010864	refsum disease	Intellectual disability, severe	Frequent (79-30%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0012722	refsum disease	Heart block	Occasional (29-5%)	PEX7	601757	266500	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
NA	mitochondrial respiratory chain complex i deficiency	NA	NA	NDUFS4	602694	252010	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	porencephaly 1	NA	NA	COL4A1	No gene mim	175780	monoallelic	both DD and IF	dominant negative	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2202	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type a1	NA	NA	POMT1	607423	236670	biallelic	confirmed	loss of function	Musculature;Brain/Cognition	9202	protein O-mannosyltransferase 1	protein-coding gene	gene with protein product	Approved	9q34.13	09q34.13	LGMD2K	dolichyl-phosphate-mannose-protein mannosyltransferase			Dolichyl D-mannosyl phosphate dependent mannosyltransferases
NA	autism	NA	NA	NRXN3	No gene mim	209850	monoallelic	possible	loss of function	Brain/Cognition	8010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	brachydactyly, type e2	NA	NA	PTHLH	168470	613382	monoallelic	confirmed	loss of function	Skeleton	9607	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cone-rod dystrophy 16	NA	NA	C8orf37	614477	614500	biallelic	confirmed	loss of function	Eye	27232	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gm1-gangliosidosis type 2	NA	NA	GLB1	611458	230600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4298	galactosidase beta 1	protein-coding gene	gene with protein product	Approved	3p22.3	03p22.3	EBP		ELNR1	elastin receptor 1, 67kDa|elastin receptor 1 (67kD)|galactosidase, beta 1	
NA	epileptic encephalopathy early infantile type 1	NA	NA	ARX	300382	308350	hemizygous	confirmed	loss of function	Brain/Cognition;Genitalia	18060	aristaless related homeobox	protein-coding gene	gene with protein product	Approved	Xp21.3	Xp21.3	ISSX|CT121|EIEE1	cancer/testis antigen 121	MRXS1|PRTS|MRX76|MRX54|MRX43|MRX36|MRX29|MRX32|MRX33|MRX38|MRX87	mental retardation, X-linked 54|mental retardation, X-linked 43|mental retardation, X-linked 36|mental retardation, X-linked 29|mental retardation, X-linked 32|mental retardation, X-linked 33|mental retardation, X-linked 38|mental retardation, X-linked 87|mental retardation, X-linked 76	X-linked mental retardation|PRD class homeoboxes and pseudogenes
NA	congenital generalized lipodystrophy type 3	NA	NA	CAV1	No gene mim	612526	biallelic	possible	loss of function	Skin	1527	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondyloepimetaphyseal dysplasia with abnormal dentition	NA	NA	SLC39A13	608735	601668	biallelic	confirmed	loss of function	Skin;Skeleton	20859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	seckel syndrome 6	NA	NA	CEP63	614724	614728	biallelic	probable	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	25815	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	proximal spinal muscular atrophy with autosomal-dominant inheritance	NA	NA	BICD2	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame	Spinal cord/Peripheral nerves	17208	BICD cargo adaptor 2	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31	KIAA0699			bicaudal D homolog 2 (Drosophila)	
NA	hypotrichosis simplex of the scalp 2	NA	NA	KRT74	608248	613981	monoallelic	probable	all missense/in frame	Skin	28929	keratin 74	protein-coding gene	gene with protein product	Approved	12q13.13	12q13.13	K6IRS4|KRT5C|KRT6IRS4			keratin 74, type II	Keratins, type II
NA	ehlers-danlos syndrome progeroid type	NA	NA	B4GALT7	604327	130070	biallelic	confirmed	loss of function	Skeleton	930	beta-1,4-galactosyltransferase 7	protein-coding gene	gene with protein product	Approved	5q35.3	05q35.3	XGALT-1|beta4Gal-T7	galactosyltransferase I		xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7	Beta 4-glycosyltransferases
NA	autosomal recessive mental retardation	NA	NA	EEF1B2	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	3208	eukaryotic translation elongation factor 1 beta 2	protein-coding gene	gene with protein product	Approved	2q33.3	02q33.3					
NA	syndromic mr with ataxia, dysarthria and epilepsy	NA	NA	RUBCN	No gene mim	No disease mim	biallelic	possible	uncertain	Brain/Cognition	28991	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	megaloblastic anemia due to dihydrofolate reductase deficiency	NA	NA	DHFR	126060	613839	biallelic	confirmed	all missense/in frame	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	2861	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000144	usher syndrome	Decreased fertility	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000360	usher syndrome	Tinnitus	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000407	usher syndrome	Sensorineural hearing impairment	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000483	usher syndrome	Astigmatism	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000505	usher syndrome	Visual impairment	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000512	usher syndrome	Abnormal electroretinogram	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000518	usher syndrome	Cataract	Frequent (79-30%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000529	usher syndrome	Progressive visual loss	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000545	usher syndrome	Myopia	Frequent (79-30%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000618	usher syndrome	Blindness	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000639	usher syndrome	Nystagmus	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000662	usher syndrome	Nyctalopia	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000670	usher syndrome	Carious teeth	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000682	usher syndrome	Abnormality of dental enamel	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000691	usher syndrome	Microdontia	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000709	usher syndrome	Psychosis	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000716	usher syndrome	Depression	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000738	usher syndrome	Hallucinations	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0000739	usher syndrome	Anxiety	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0001123	usher syndrome	Visual field defect	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0001251	usher syndrome	Ataxia	Frequent (79-30%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0001639	usher syndrome	Hypertrophic cardiomyopathy	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0001751	usher syndrome	Vestibular dysfunction	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0002120	usher syndrome	Cerebral cortical atrophy	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0003198	usher syndrome	Myopathy	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0003457	usher syndrome	EMG abnormality	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0007360	usher syndrome	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0007703	usher syndrome	Abnormality of retinal pigmentation	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0008499	usher syndrome	High-grade hypermetropia	Frequent (79-30%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0008568	usher syndrome	Vestibular areflexia	Very frequent (99-80%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0010780	usher syndrome	Hyperacusis	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0011025	usher syndrome	Abnormality of cardiovascular system physiology	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0011073	usher syndrome	Abnormality of dental color	Occasional (29-5%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
HP:0100543	usher syndrome	Cognitive impairment	Frequent (79-30%)	HARS	No gene mim	614504	biallelic	possible	all missense/in frame	Eye;Ear	4816	histidyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	5q31.3	05q31.3		histidine tRNA ligase 1, cytoplasmic	USH3B	Usher syndrome 3B	Aminoacyl tRNA synthetases, Class II
NA	osteopetrosis autosomal recessive type 3	NA	NA	CA2	611492	259730	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	1373	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	glycine encephalopathy	Seizures	Very frequent (99-80%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0002079	glycine encephalopathy	Hypoplasia of the corpus callosum	Very frequent (99-80%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0002154	glycine encephalopathy	Hyperglycinemia	Very frequent (99-80%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0002353	glycine encephalopathy	EEG abnormality	Very frequent (99-80%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0010851	glycine encephalopathy	EEG with burst suppression	Very frequent (99-80%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0011398	glycine encephalopathy	Central hypotonia	Very frequent (99-80%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0012705	glycine encephalopathy	Abnormal metabolic brain imaging by MRS	Very frequent (99-80%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0100247	glycine encephalopathy	Recurrent singultus	Very frequent (99-80%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0001254	glycine encephalopathy	Lethargy	Frequent (79-30%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0002033	glycine encephalopathy	Poor suck	Frequent (79-30%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0002123	glycine encephalopathy	Generalized myoclonic seizures	Frequent (79-30%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0005957	glycine encephalopathy	Breathing dysregulation	Frequent (79-30%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
HP:0005972	glycine encephalopathy	Respiratory acidosis	Frequent (79-30%)	GCSH	No gene mim	605899	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	4208	glycine cleavage system protein H	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2		lipoic acid-containing protein		glycine cleavage system protein H (aminomethyl carrier)	
NA	cocoon syndrome	NA	NA	CHUK	600664	613630	biallelic	confirmed	loss of function	Skin;Face	1974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract marner type	NA	NA	HSF4	602438	116800	monoallelic	confirmed	uncertain	Eye	5227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mirror movements 2	NA	NA	RAD51	179617	614508	monoallelic	probable	loss of function	Brain/Cognition	9817	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	mandibuloacral dysplasia with type b lipodystrophy	Narrow mouth	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	mandibuloacral dysplasia with type b lipodystrophy	Abnormality of the teeth	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000239	mandibuloacral dysplasia with type b lipodystrophy	Large fontanelles	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	mandibuloacral dysplasia with type b lipodystrophy	Micrognathia	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000444	mandibuloacral dysplasia with type b lipodystrophy	Convex nasal ridge	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	mandibuloacral dysplasia with type b lipodystrophy	Proptosis	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	mandibuloacral dysplasia with type b lipodystrophy	Delayed puberty	Occasional (29-5%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000855	mandibuloacral dysplasia with type b lipodystrophy	Insulin resistance	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000924	mandibuloacral dysplasia with type b lipodystrophy	Abnormality of the skeletal system	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000953	mandibuloacral dysplasia with type b lipodystrophy	Hyperpigmentation of the skin	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000963	mandibuloacral dysplasia with type b lipodystrophy	Thin skin	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001211	mandibuloacral dysplasia with type b lipodystrophy	Abnormality of the fingertips	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001595	mandibuloacral dysplasia with type b lipodystrophy	Abnormality of the hair	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001596	mandibuloacral dysplasia with type b lipodystrophy	Alopecia	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001870	mandibuloacral dysplasia with type b lipodystrophy	Acroosteolysis of distal phalanges (feet)	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002797	mandibuloacral dysplasia with type b lipodystrophy	Osteolysis	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003077	mandibuloacral dysplasia with type b lipodystrophy	Hyperlipidemia	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	mandibuloacral dysplasia with type b lipodystrophy	Short nose	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003761	mandibuloacral dysplasia with type b lipodystrophy	Calcinosis	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	mandibuloacral dysplasia with type b lipodystrophy	Short stature	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004334	mandibuloacral dysplasia with type b lipodystrophy	Dermal atrophy	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005328	mandibuloacral dysplasia with type b lipodystrophy	Progeroid facial appearance	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006710	mandibuloacral dysplasia with type b lipodystrophy	Aplasia/Hypoplasia of the clavicles	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007495	mandibuloacral dysplasia with type b lipodystrophy	Prematurely aged appearance	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008404	mandibuloacral dysplasia with type b lipodystrophy	Nail dystrophy	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009064	mandibuloacral dysplasia with type b lipodystrophy	Generalized lipodystrophy	Frequent (79-30%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009839	mandibuloacral dysplasia with type b lipodystrophy	Osteolytic defects of the distal phalanges of the hand	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009882	mandibuloacral dysplasia with type b lipodystrophy	Short distal phalanx of finger	Very frequent (99-80%)	ZMPSTE24	No gene mim	608612	biallelic	confirmed	loss of function	Skin;Face;Skeleton;Endocrine/Metabolic	12877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lacrimo-auriculo-dento-digital syndrome	NA	NA	FGFR2	176943	149730	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000194	pfeiffer syndrome	Open mouth	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000218	pfeiffer syndrome	High palate	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000262	pfeiffer syndrome	Turricephaly	Frequent (79-30%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000303	pfeiffer syndrome	Mandibular prognathia	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000316	pfeiffer syndrome	Hypertelorism	Frequent (79-30%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000322	pfeiffer syndrome	Short philtrum	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000324	pfeiffer syndrome	Facial asymmetry	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000348	pfeiffer syndrome	High forehead	Frequent (79-30%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000431	pfeiffer syndrome	Wide nasal bridge	Frequent (79-30%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000470	pfeiffer syndrome	Short neck	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000508	pfeiffer syndrome	Ptosis	Very frequent (99-80%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001156	pfeiffer syndrome	Brachydactyly syndrome	Frequent (79-30%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001385	pfeiffer syndrome	Hip dysplasia	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003307	pfeiffer syndrome	Hyperlordosis	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004209	pfeiffer syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004322	pfeiffer syndrome	Short stature	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005048	pfeiffer syndrome	Synostosis of carpal bones	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0006101	pfeiffer syndrome	Finger syndactyly	Frequent (79-30%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0009773	pfeiffer syndrome	Symphalangism affecting the phalanges of the hand	Frequent (79-30%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010669	pfeiffer syndrome	Cheekbone underdevelopment	Very frequent (99-80%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0011304	pfeiffer syndrome	Broad thumb	Very frequent (99-80%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0012368	pfeiffer syndrome	Flat face	Occasional (29-5%)	FGFR1	136350	101600	monoallelic	confirmed	activating	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000407	krabbe disease	Sensorineural hearing impairment	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0000505	krabbe disease	Visual impairment	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0000708	krabbe disease	Behavioral abnormality	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0000737	krabbe disease	Irritability	Frequent (79-30%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0000763	krabbe disease	Sensory neuropathy	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0001172	krabbe disease	Abnormality of the thumb	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0001250	krabbe disease	Seizures	Frequent (79-30%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0001251	krabbe disease	Ataxia	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0001257	krabbe disease	Spasticity	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0001263	krabbe disease	Global developmental delay	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0001288	krabbe disease	Gait disturbance	Frequent (79-30%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0001824	krabbe disease	Weight loss	Occasional (29-5%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0001939	krabbe disease	Abnormality of metabolism/homeostasis	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0001945	krabbe disease	Fever	Frequent (79-30%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0002123	krabbe disease	Generalized myoclonic seizures	Frequent (79-30%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0002205	krabbe disease	Recurrent respiratory infections	Frequent (79-30%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0002676	krabbe disease	Cloverleaf skull	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0003457	krabbe disease	EMG abnormality	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0004374	krabbe disease	Hemiplegia/hemiparesis	Frequent (79-30%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0009830	krabbe disease	Peripheral neuropathy	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0010318	krabbe disease	Aplasia/Hypoplasia of the abdominal wall musculature	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0011968	krabbe disease	Feeding difficulties	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
HP:0000365	krabbe disease	Hearing impairment	Very frequent (99-80%)	GALC	606890	245200	biallelic	confirmed	loss of function	Brain/Cognition	4115	galactosylceramidase	protein-coding gene	gene with protein product	Approved	14q31.3	14q31.3		Krabbe disease		galactosylceramidase (Krabbe disease)	
NA	aicardi-goutieres syndrome 2	NA	NA	RNASEH2B	610326	610181	biallelic	confirmed	loss of function	Skin;Brain/Cognition	25671	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	adrenoleukodystrophy pseudoneonatal	NA	NA	ACOX1	609751	264470	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract;Respiratory tract	119	acyl-CoA oxidase 1	protein-coding gene	gene with protein product	Approved	17q25.1	17q25.1	PALMCOX	palmitoyl-CoA oxidase		acyl-Coenzyme A oxidase 1, palmitoyl|acyl-CoA oxidase 1, palmitoyl	
NA	epileptic encephalopathy	NA	NA	CACNA1A	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1388	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation autosomal dominant type 3	NA	NA	CDH15	114019	612580	monoallelic	possible	loss of function	Brain/Cognition	1754	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000202	feingold syndrome	Oral cleft	Occasional (29-5%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0000252	feingold syndrome	Microcephaly	Very frequent (99-80%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0000347	feingold syndrome	Micrognathia	Frequent (79-30%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0000407	feingold syndrome	Sensorineural hearing impairment	Occasional (29-5%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0000463	feingold syndrome	Anteverted nares	Frequent (79-30%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0001156	feingold syndrome	Brachydactyly syndrome	Very frequent (99-80%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0001249	feingold syndrome	Intellectual disability	Frequent (79-30%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0001643	feingold syndrome	Patent ductus arteriosus	Occasional (29-5%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0001734	feingold syndrome	Annular pancreas	Occasional (29-5%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0001743	feingold syndrome	Abnormality of the spleen	Occasional (29-5%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0001770	feingold syndrome	Toe syndactyly	Frequent (79-30%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0001822	feingold syndrome	Hallux valgus	Frequent (79-30%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0002032	feingold syndrome	Esophageal atresia	Occasional (29-5%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0002247	feingold syndrome	Duodenal atresia	Occasional (29-5%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0003312	feingold syndrome	Abnormal form of the vertebral bodies	Occasional (29-5%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0004209	feingold syndrome	Clinodactyly of the 5th finger	Very frequent (99-80%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0004322	feingold syndrome	Short stature	Frequent (79-30%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0005280	feingold syndrome	Depressed nasal bridge	Frequent (79-30%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0008572	feingold syndrome	External ear malformation	Frequent (79-30%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0009468	feingold syndrome	Deviation of the 2nd finger	Very frequent (99-80%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0012745	feingold syndrome	Short palpebral fissure	Very frequent (99-80%)	MIR17HG	No gene mim	614326	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	23564	miR-17-92a-1 cluster host gene	non-coding RNA	RNA, long non-coding	Approved	13q31.3	13q31.3	FLJ14178|MIRH1|MIHG1|NCRNA00048|miR-17-92|LINC00048	non-protein coding RNA 48|long intergenic non-protein coding RNA 48	C13orf25|MIRHG1	chromosome 13 open reading frame 25|microRNA host gene 1 (non-protein coding)|MIR17 host gene (non-protein coding)|miR-17-92 cluster host gene	Long non-coding RNAs (published)
HP:0000175	desmosterolosis	Cleft palate	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000176	desmosterolosis	Submucous cleft hard palate	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000193	desmosterolosis	Bifid uvula	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	desmosterolosis	Microcephaly	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000278	desmosterolosis	Retrognathia	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	desmosterolosis	Micrognathia	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	desmosterolosis	Intellectual disability	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	desmosterolosis	Spasticity	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001274	desmosterolosis	Agenesis of corpus callosum	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001276	desmosterolosis	Hypertonia	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001331	desmosterolosis	Absent septum pellucidum	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	desmosterolosis	Failure to thrive	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	desmosterolosis	Growth delay	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	desmosterolosis	Intrauterine growth retardation	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002063	desmosterolosis	Rigidity	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003510	desmosterolosis	Severe short stature	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003552	desmosterolosis	Muscle stiffness	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011968	desmosterolosis	Feeding difficulties	Very frequent (99-80%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	desmosterolosis	Narrow mouth	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000363	desmosterolosis	Abnormality of earlobe	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000366	desmosterolosis	Abnormality of the nose	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	desmosterolosis	Low-set, posteriorly rotated ears	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	desmosterolosis	Low-set ears	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	desmosterolosis	Strabismus	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	desmosterolosis	Nystagmus	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	desmosterolosis	Seizures	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	desmosterolosis	Ventriculomegaly	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002133	desmosterolosis	Status epilepticus	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	desmosterolosis	Short nose	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	desmosterolosis	Depressed nasal bridge	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009748	desmosterolosis	Large earlobe	Frequent (79-30%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000062	desmosterolosis	Ambiguous genitalia	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000104	desmosterolosis	Renal agenesis	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	desmosterolosis	Hydrocephalus	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	desmosterolosis	Macrocephaly	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	desmosterolosis	Epicanthus	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	desmosterolosis	Downslanted palpebral fissures	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001302	desmosterolosis	Pachygyria	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001339	desmosterolosis	Lissencephaly	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	desmosterolosis	Patent ductus arteriosus	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	desmosterolosis	Splenomegaly	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001840	desmosterolosis	Metatarsus adductus	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001883	desmosterolosis	Talipes	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	desmosterolosis	Frontal bossing	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002126	desmosterolosis	Polymicrogyria	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	desmosterolosis	Abnormality of neuronal migration	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002536	desmosterolosis	Abnormal cortical gyration	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002566	desmosterolosis	Intestinal malrotation	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	desmosterolosis	Micromelia	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004334	desmosterolosis	Dermal atrophy	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007227	desmosterolosis	Macrogyria	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008065	desmosterolosis	Aplasia/Hypoplasia of the skin	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008678	desmosterolosis	Renal hypoplasia/aplasia	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010772	desmosterolosis	Anomalous pulmonary venous return	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011001	desmosterolosis	Increased bone mineral density	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011002	desmosterolosis	Osteopetrosis	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011220	desmosterolosis	Prominent forehead	Occasional (29-5%)	DHCR24	606418	238860	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	2859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	skeletal defects genital hypoplasia and mental retardation	NA	NA	ZBTB16	No gene mim	612447	biallelic	possible	uncertain	Skeleton;Brain/Cognition;Genitalia	12930	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	alexander disease	High palate	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	alexander disease	Hydrocephalus	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	alexander disease	Macrocephaly	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	alexander disease	Short neck	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000496	alexander disease	Abnormality of eye movement	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	alexander disease	Ptosis	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	alexander disease	Nystagmus	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000651	alexander disease	Diplopia	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000712	alexander disease	Emotional lability	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000716	alexander disease	Depression	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000819	alexander disease	Diabetes mellitus	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000821	alexander disease	Hypothyroidism	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000822	alexander disease	Hypertension	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000826	alexander disease	Precocious puberty	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000938	alexander disease	Osteopenia	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000975	alexander disease	Hyperhidrosis	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	alexander disease	Intellectual disability	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	alexander disease	Seizures	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	alexander disease	Ataxia	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	alexander disease	Muscular hypotonia	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	alexander disease	Spasticity	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001260	alexander disease	Dysarthria	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001274	alexander disease	Agenesis of corpus callosum	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	alexander disease	Gait disturbance	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	alexander disease	Muscle weakness	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001337	alexander disease	Tremor	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001347	alexander disease	Hyperreflexia	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001355	alexander disease	Megalencephaly	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	alexander disease	Failure to thrive	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001618	alexander disease	Dysphonia	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001645	alexander disease	Sudden cardiac death	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	alexander disease	Frontal bossing	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002015	alexander disease	Dysphagia	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002017	alexander disease	Nausea and vomiting	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	alexander disease	Constipation	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002045	alexander disease	Hypothermia	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002072	alexander disease	Chorea	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	alexander disease	Respiratory insufficiency	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	alexander disease	Neurological speech impairment	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002169	alexander disease	Clonus	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	alexander disease	EEG abnormality	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002357	alexander disease	Dysphasia	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002360	alexander disease	Sleep disturbance	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002376	alexander disease	Developmental regression	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002383	alexander disease	Encephalitis	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002410	alexander disease	Aqueductal stenosis	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002445	alexander disease	Tetraplegia	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002459	alexander disease	Dysautonomia	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002514	alexander disease	Cerebral calcification	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002607	alexander disease	Bowel incontinence	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002615	alexander disease	Hypotension	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	alexander disease	Scoliosis	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	alexander disease	Kyphosis	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003307	alexander disease	Hyperlordosis	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007256	alexander disease	Abnormal pyramidal signs	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007481	alexander disease	Hyperpigmented nevi	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010535	alexander disease	Sleep apnea	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010628	alexander disease	Facial palsy	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100247	alexander disease	Recurrent singultus	Frequent (79-30%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100716	alexander disease	Self-injurious behavior	Occasional (29-5%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100729	alexander disease	Large face	Very frequent (99-80%)	GFAP	137780	203450	monoallelic	confirmed	dominant negative	Brain/Cognition	4235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hesx1-related combined pituitary hormone deficiency	NA	NA	HESX1	601802	319358	monoallelic	probable	loss of function	Endocrine;Brain/Cognition	4877	HESX homeobox 1	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	RPX|ANF			homeobox, ES cell expressed 1	PRD class homeoboxes and pseudogenes
HP:0000028	cardiofaciocutaneous syndrome	Cryptorchidism	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000126	cardiofaciocutaneous syndrome	Hydronephrosis	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000176	cardiofaciocutaneous syndrome	Submucous cleft hard palate	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000218	cardiofaciocutaneous syndrome	High palate	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000238	cardiofaciocutaneous syndrome	Hydrocephalus	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000256	cardiofaciocutaneous syndrome	Macrocephaly	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000276	cardiofaciocutaneous syndrome	Long face	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000280	cardiofaciocutaneous syndrome	Coarse facial features	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000286	cardiofaciocutaneous syndrome	Epicanthus	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000293	cardiofaciocutaneous syndrome	Full cheeks	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000316	cardiofaciocutaneous syndrome	Hypertelorism	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000343	cardiofaciocutaneous syndrome	Long philtrum	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000348	cardiofaciocutaneous syndrome	High forehead	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000368	cardiofaciocutaneous syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000391	cardiofaciocutaneous syndrome	Thickened helices	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000400	cardiofaciocutaneous syndrome	Macrotia	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000463	cardiofaciocutaneous syndrome	Anteverted nares	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000465	cardiofaciocutaneous syndrome	Webbed neck	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000470	cardiofaciocutaneous syndrome	Short neck	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000478	cardiofaciocutaneous syndrome	Abnormality of the eye	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000486	cardiofaciocutaneous syndrome	Strabismus	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000494	cardiofaciocutaneous syndrome	Downslanted palpebral fissures	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000499	cardiofaciocutaneous syndrome	Abnormality of the eyelashes	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000504	cardiofaciocutaneous syndrome	Abnormality of vision	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000508	cardiofaciocutaneous syndrome	Ptosis	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000545	cardiofaciocutaneous syndrome	Myopia	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000637	cardiofaciocutaneous syndrome	Long palpebral fissure	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000639	cardiofaciocutaneous syndrome	Nystagmus	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000648	cardiofaciocutaneous syndrome	Optic atrophy	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000767	cardiofaciocutaneous syndrome	Pectus excavatum	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000958	cardiofaciocutaneous syndrome	Dry skin	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000962	cardiofaciocutaneous syndrome	Hyperkeratosis	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000974	cardiofaciocutaneous syndrome	Hyperextensible skin	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0000982	cardiofaciocutaneous syndrome	Palmoplantar keratoderma	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001003	cardiofaciocutaneous syndrome	Multiple lentigines	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001004	cardiofaciocutaneous syndrome	Lymphedema	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001048	cardiofaciocutaneous syndrome	Cavernous hemangioma	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001249	cardiofaciocutaneous syndrome	Intellectual disability	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001252	cardiofaciocutaneous syndrome	Muscular hypotonia	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001260	cardiofaciocutaneous syndrome	Dysarthria	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001263	cardiofaciocutaneous syndrome	Global developmental delay	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001531	cardiofaciocutaneous syndrome	Failure to thrive in infancy	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001582	cardiofaciocutaneous syndrome	Redundant skin	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001622	cardiofaciocutaneous syndrome	Premature birth	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001631	cardiofaciocutaneous syndrome	Atrial septal defect	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001639	cardiofaciocutaneous syndrome	Hypertrophic cardiomyopathy	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001642	cardiofaciocutaneous syndrome	Pulmonic stenosis	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0001654	cardiofaciocutaneous syndrome	Abnormality of the heart valves	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002007	cardiofaciocutaneous syndrome	Frontal bossing	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002120	cardiofaciocutaneous syndrome	Cerebral cortical atrophy	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002162	cardiofaciocutaneous syndrome	Low posterior hairline	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002167	cardiofaciocutaneous syndrome	Neurological speech impairment	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002213	cardiofaciocutaneous syndrome	Fine hair	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002217	cardiofaciocutaneous syndrome	Slow-growing hair	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002299	cardiofaciocutaneous syndrome	Brittle hair	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002353	cardiofaciocutaneous syndrome	EEG abnormality	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002564	cardiofaciocutaneous syndrome	Malformation of the heart and great vessels	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002650	cardiofaciocutaneous syndrome	Scoliosis	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002857	cardiofaciocutaneous syndrome	Genu valgum	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002967	cardiofaciocutaneous syndrome	Cubitus valgus	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0002997	cardiofaciocutaneous syndrome	Abnormality of the ulna	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0003196	cardiofaciocutaneous syndrome	Short nose	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0004322	cardiofaciocutaneous syndrome	Short stature	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0004422	cardiofaciocutaneous syndrome	Biparietal narrowing	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0005280	cardiofaciocutaneous syndrome	Depressed nasal bridge	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0006191	cardiofaciocutaneous syndrome	Deep palmar crease	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0007392	cardiofaciocutaneous syndrome	Excessive wrinkled skin	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0007440	cardiofaciocutaneous syndrome	Generalized hyperpigmentation	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0007565	cardiofaciocutaneous syndrome	Multiple cafe-au-lait spots	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0008064	cardiofaciocutaneous syndrome	Ichthyosis	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0008070	cardiofaciocutaneous syndrome	Sparse hair	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0008391	cardiofaciocutaneous syndrome	Dystrophic fingernails	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0008872	cardiofaciocutaneous syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0009891	cardiofaciocutaneous syndrome	Underdeveloped supraorbital ridges	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0010669	cardiofaciocutaneous syndrome	Cheekbone underdevelopment	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0011024	cardiofaciocutaneous syndrome	Abnormality of the gastrointestinal tract	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0012719	cardiofaciocutaneous syndrome	Functional abnormality of the gastrointestinal tract	Occasional (29-5%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0100840	cardiofaciocutaneous syndrome	Aplasia/Hypoplasia of the eyebrow	Very frequent (99-80%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
HP:0200102	cardiofaciocutaneous syndrome	Sparse or absent eyelashes	Frequent (79-30%)	MAP2K1	176872	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6840	mitogen-activated protein kinase kinase 1	protein-coding gene	gene with protein product	Approved	15q22.31	15q22.31	MEK1|MAPKK1		PRKMK1		Mitogen-activated protein kinase kinases
NA	partial agenesis of the corpus callosum	NA	NA	L1CAM	308840	304100	hemizygous	confirmed	loss of function	Brain/Cognition	6470	L1 cell adhesion molecule	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	CD171	neural cell adhesion molecule L1	HSAS1|SPG1|HSAS|MASA|MIC5|S10	antigen identified by monoclonal antibody R1	CD molecules|Fibronectin type III domain containing|I-set domain containing|Ig-like cell adhesion molecule family
NA	kenny-caffey syndrome type 1	NA	NA	TBCE	604934	244460	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Brain/Cognition	11582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy, early infantile, 3	NA	NA	SLC25A22	609302	319213	biallelic	probable	all missense/in frame	Brain/Cognition	19954	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autism	NA	NA	NRXN1	600565	209850	monoallelic	probable	loss of function	Brain/Cognition	8008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	alagille syndrome	Cryptorchidism	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000069	alagille syndrome	Abnormality of the ureter	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000100	alagille syndrome	Nephrotic syndrome	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000248	alagille syndrome	Brachycephaly	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000280	alagille syndrome	Coarse facial features	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000307	alagille syndrome	Pointed chin	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000311	alagille syndrome	Round face	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000316	alagille syndrome	Hypertelorism	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000322	alagille syndrome	Short philtrum	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000347	alagille syndrome	Micrognathia	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000411	alagille syndrome	Protruding ear	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000486	alagille syndrome	Strabismus	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000490	alagille syndrome	Deeply set eye	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000494	alagille syndrome	Downslanted palpebral fissures	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000563	alagille syndrome	Keratoconus	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000615	alagille syndrome	Abnormality of the pupil	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000772	alagille syndrome	Abnormality of the ribs	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000822	alagille syndrome	Hypertension	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0000823	alagille syndrome	Delayed puberty	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0001131	alagille syndrome	Corneal dystrophy	Very frequent (99-80%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0001256	alagille syndrome	Intellectual disability, mild	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0001328	alagille syndrome	Specific learning disability	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0001396	alagille syndrome	Cholestasis	Very frequent (99-80%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0001508	alagille syndrome	Failure to thrive	Very frequent (99-80%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0001511	alagille syndrome	Intrauterine growth retardation	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0001629	alagille syndrome	Ventricular septal defect	Very frequent (99-80%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0001631	alagille syndrome	Atrial septal defect	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0002007	alagille syndrome	Frontal bossing	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0002240	alagille syndrome	Hepatomegaly	Very frequent (99-80%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0002750	alagille syndrome	Delayed skeletal maturation	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0003022	alagille syndrome	Hypoplasia of the ulna	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0003189	alagille syndrome	Long nose	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0003298	alagille syndrome	Spina bifida occulta	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0003312	alagille syndrome	Abnormal form of the vertebral bodies	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0003422	alagille syndrome	Vertebral segmentation defect	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0004209	alagille syndrome	Clinodactyly of the 5th finger	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0004617	alagille syndrome	Butterfly vertebral arch	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0004969	alagille syndrome	Peripheral pulmonary artery stenosis	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0006571	alagille syndrome	Reduced number of intrahepatic bile ducts	Very frequent (99-80%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0008678	alagille syndrome	Renal hypoplasia/aplasia	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0009882	alagille syndrome	Short distal phalanx of finger	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0012368	alagille syndrome	Flat face	Occasional (29-5%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
HP:0100585	alagille syndrome	Telangiectasia of the skin	Frequent (79-30%)	JAG1	601920	279357	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	6188	jagged 1	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2	AHD|AWS|HJ1|CD339		AGS|JAGL1	Alagille syndrome	CD molecules
NA	sex reversal type 3	NA	NA	SOX3	313430	300833	x-linked dominant	confirmed	cis-regulatory or promotor mutation	Endocrine/Metabolic;Brain/Cognition	11199	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	jensen syndrome	NA	NA	TIMM8A	No gene mim	311150	hemizygous	both DD and IF	loss of function	Musculature;Brain/Cognition;Ear	11817	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	van den ende-gupta syndrome	NA	NA	SCARF2	613619	600920	biallelic	confirmed	loss of function	Skin;Skeleton	19869	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000013	woodhouse-sakati syndrome	Hypoplasia of the uterus	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000054	woodhouse-sakati syndrome	Micropenis	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	woodhouse-sakati syndrome	Hypogonadism	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000411	woodhouse-sakati syndrome	Protruding ear	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000815	woodhouse-sakati syndrome	Hypergonadotropic hypogonadism	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000821	woodhouse-sakati syndrome	Hypothyroidism	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000831	woodhouse-sakati syndrome	Insulin-resistant diabetes mellitus	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	woodhouse-sakati syndrome	Intellectual disability	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001260	woodhouse-sakati syndrome	Dysarthria	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001266	woodhouse-sakati syndrome	Choreoathetosis	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001268	woodhouse-sakati syndrome	Mental deterioration	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001332	woodhouse-sakati syndrome	Dystonia	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001587	woodhouse-sakati syndrome	Primary ovarian failure	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001596	woodhouse-sakati syndrome	Alopecia	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003077	woodhouse-sakati syndrome	Hyperlipidemia	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005135	woodhouse-sakati syndrome	Abnormal T-wave	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008214	woodhouse-sakati syndrome	Decreased serum estradiol	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008619	woodhouse-sakati syndrome	Bilateral sensorineural hearing impairment	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008669	woodhouse-sakati syndrome	Abnormal spermatogenesis	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008697	woodhouse-sakati syndrome	Hypoplasia of the fallopian tube	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008734	woodhouse-sakati syndrome	Decreased testicular size	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010464	woodhouse-sakati syndrome	Streak ovary	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0040171	woodhouse-sakati syndrome	Decreased serum testosterone level	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100840	woodhouse-sakati syndrome	Aplasia/Hypoplasia of the eyebrow	Very frequent (99-80%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000325	woodhouse-sakati syndrome	Triangular face	Occasional (29-5%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000448	woodhouse-sakati syndrome	Prominent nose	Occasional (29-5%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000674	woodhouse-sakati syndrome	Anodontia	Occasional (29-5%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000709	woodhouse-sakati syndrome	Psychosis	Occasional (29-5%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000738	woodhouse-sakati syndrome	Hallucinations	Occasional (29-5%)	DCAF17	No gene mim	241080	biallelic	possible	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	25784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	homocystinuria-megaloblastic anemia, cbl e type	NA	NA	MTRR	602568	236270	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	7473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3	NA	NA	TP63	603273	604292	monoallelic	confirmed	loss of function	Skin;Face;Skeleton	15979	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	RALGDS	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	9842	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathies.	NA	NA	ALG13	No gene mim	No disease mim	hemizygous	probable	all missense/in frame	Brain/Cognition	30881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathies.	NA	NA	ALG13	No gene mim	No disease mim	x-linked dominant	probable	all missense/in frame	Brain/Cognition	30881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bardet-biedl syndrome type 8	NA	NA	TTC8	608132	209900	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Heart/Cardiovasculature/Lymphatic	20087	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital muscular dystrophy	NA	NA	LAMA2	156225	607855	biallelic	confirmed	loss of function	Musculature;Brain/Cognition	6482	laminin subunit alpha 2	protein-coding gene	gene with protein product	Approved	6q22.33	06q22.33		merosin|congenital muscular dystrophy	LAMM	laminin, alpha 2	Laminin subunits
NA	leukodystrophy hypomyelinating type 1	NA	NA	PLP1	300401	312080	hemizygous	confirmed	loss of function	Brain/Cognition	9086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	6-pyruvoyltetrahydropterin synthase deficiency	NA	NA	PTS	612719	261640	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	9689	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	schmid type metaphyseal chondrodysplasia	NA	NA	COL10A1	120110	156500	monoallelic	confirmed	dominant negative	Skeleton	2185	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	congenital contractural arachnodactyly	High palate	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0001083	congenital contractural arachnodactyly	Ectopia lentis	Occasional (29-5%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0001166	congenital contractural arachnodactyly	Arachnodactyly	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0001371	congenital contractural arachnodactyly	Flexion contracture	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0001387	congenital contractural arachnodactyly	Joint stiffness	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0001519	congenital contractural arachnodactyly	Disproportionate tall stature	Frequent (79-30%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0001533	congenital contractural arachnodactyly	Slender build	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0001634	congenital contractural arachnodactyly	Mitral valve prolapse	Occasional (29-5%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0001724	congenital contractural arachnodactyly	Aortic dilatation	Occasional (29-5%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0002247	congenital contractural arachnodactyly	Duodenal atresia	Occasional (29-5%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0002564	congenital contractural arachnodactyly	Malformation of the heart and great vessels	Occasional (29-5%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0002566	congenital contractural arachnodactyly	Intestinal malrotation	Occasional (29-5%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0002575	congenital contractural arachnodactyly	Tracheoesophageal fistula	Occasional (29-5%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0002650	congenital contractural arachnodactyly	Scoliosis	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0002803	congenital contractural arachnodactyly	Congenital contracture	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0002804	congenital contractural arachnodactyly	Arthrogryposis multiplex congenita	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0003011	congenital contractural arachnodactyly	Abnormality of the musculature	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0008453	congenital contractural arachnodactyly	Congenital kyphoscoliosis	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0008544	congenital contractural arachnodactyly	Abnormally folded helix	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0009901	congenital contractural arachnodactyly	Crumpled ear	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
HP:0100490	congenital contractural arachnodactyly	Camptodactyly of finger	Very frequent (99-80%)	FBN2	612570	121050	monoallelic	confirmed	dominant negative	Skeleton;Ear	3604	fibrillin 2	protein-coding gene	gene with protein product	Approved	5q23.3	05q23.3	DA9	fibrillin 5	CCA	congenital contractural arachnodactyly	
NA	achalasia-addisonianism-alacrima syndrome	NA	NA	AAAS	605378	231550	biallelic	confirmed	loss of function	Face;Endocrine/Metabolic;Eye	13666	aladin WD repeat nucleoporin	protein-coding gene	gene with protein product	Approved	12q13.13	12q13.13		aladin|Allgrove, triple-A|adracalin		achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple-A)|achalasia, adrenocortical insufficiency, alacrimia	WD repeat domain containing|Nucleoporins
NA	nonsyndromic mental retardation	NA	NA	KLF8	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	6351	Kruppel like factor 8	protein-coding gene	gene with protein product	Approved	Xp11.21	Xp11.21	BKLF3|ZNF741|DXS741				Zinc fingers C2H2-type|Kruppel like factors
NA	chondrodysplasia with joint dislocations, grapp type	NA	NA	IMPAD1	614010	614078	biallelic	confirmed	loss of function	Skeleton	26019	inositol monophosphatase domain containing 1	protein-coding gene	gene with protein product	Approved	8q12.1	08q12.1	FLJ20421|IMPA3|gPAPP	golgi-resident nucleotide phosphatase			
NA	mental retardation, x-linked 99	NA	NA	USP9X	No gene mim	300919	hemizygous	probable	loss of function	Skeleton;GI tract;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	12632	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, x-linked 99	NA	NA	USP9X	No gene mim	300919	x-linked dominant	probable	loss of function	Skeleton;GI tract;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	12632	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	tyrosinemia type 3	NA	NA	HPD	No gene mim	276710	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	5147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary ciliary dyskineasia	NA	NA	DNAAF3	614566	606763	biallelic	confirmed	loss of function	Respiratory tract;Genitalia	30492	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, autosomal recessive 48	NA	NA	SLC6A17	No gene mim	616269	biallelic	probable	all missense/in frame	Brain/Cognition	31399	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	immunodeficiency-centromeric instability-facial anomalies syndrome 1	NA	NA	DNMT3B	602900	242860	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	2979	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000053	fragile x syndrome	Macroorchidism	Very frequent (99-80%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000246	fragile x syndrome	Sinusitis	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000256	fragile x syndrome	Macrocephaly	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000275	fragile x syndrome	Narrow face	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000276	fragile x syndrome	Long face	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000303	fragile x syndrome	Mandibular prognathia	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000388	fragile x syndrome	Otitis media	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000389	fragile x syndrome	Chronic otitis media	Very frequent (99-80%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000411	fragile x syndrome	Protruding ear	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000486	fragile x syndrome	Strabismus	Occasional (29-5%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000717	fragile x syndrome	Autism	Occasional (29-5%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0000739	fragile x syndrome	Anxiety	Occasional (29-5%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0001250	fragile x syndrome	Seizures	Occasional (29-5%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0001252	fragile x syndrome	Muscular hypotonia	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0001388	fragile x syndrome	Joint laxity	Very frequent (99-80%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0001634	fragile x syndrome	Mitral valve prolapse	Occasional (29-5%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0001763	fragile x syndrome	Pes planus	Very frequent (99-80%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0002003	fragile x syndrome	Large forehead	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0002007	fragile x syndrome	Frontal bossing	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0002020	fragile x syndrome	Gastroesophageal reflux	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0002120	fragile x syndrome	Cerebral cortical atrophy	Occasional (29-5%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0002167	fragile x syndrome	Neurological speech impairment	Very frequent (99-80%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0002342	fragile x syndrome	Intellectual disability, moderate	Very frequent (99-80%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0003564	fragile x syndrome	Folate-dependent fragile site at Xq28	Very frequent (99-80%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0005111	fragile x syndrome	Dilatation of the ascending aorta	Occasional (29-5%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0007018	fragile x syndrome	Attention deficit hyperactivity disorder	Frequent (79-30%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
HP:0100716	fragile x syndrome	Self-injurious behavior	Occasional (29-5%)	FMR1	No gene mim	300624	hemizygous	confirmed	loss of function	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
NA	cornelia de lange syndrome type 3	NA	NA	SMC3	No gene mim	610759	monoallelic	confirmed	uncertain	Skeleton;Brain/Cognition	2468	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spastic paraplegia, 44	NA	NA	GJC2	608803	613206	monoallelic	confirmed	all missense/in frame	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	17494	gap junction protein gamma 2	protein-coding gene	gene with protein product	Approved	1q42.13	01q42.13	CX47|CX46.6|SPG44	connexin 47	GJA12	gap junction protein, alpha 12, 47kDa|gap junction protein, gamma 2, 47kDa	Gap junction proteins
NA	ophthalmoacromelic syndrome	NA	NA	SMOC1	608488	206920	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition;Eye	20318	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked type 48	NA	NA	GDI1	300104	300104	hemizygous	confirmed	loss of function	Brain/Cognition	4226	GDP dissociation inhibitor 1	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	RABGDIA|XAP-4|OPHN2|FLJ41411	mental retardation, X-linked 41|mental retardation, X-linked 48|rab GDP-dissociation inhibitor, alpha	MRX48|MRX41|GDIL		X-linked mental retardation
NA	fanconi-bickel syndrome	NA	NA	SLC2A2	No gene mim	269871	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;GI tract	11006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primordial dwarfism seckel syndrome 8	NA	NA	DNA2	No gene mim	615807	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	2939	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cystinosis nephropathic type	NA	NA	CTNS	606272	219800	biallelic	confirmed	loss of function	Kidney Renal Tract	2518	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000093	donnai-barrow syndrome	Proteinuria	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000130	donnai-barrow syndrome	Abnormality of the uterus	Occasional (29-5%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000256	donnai-barrow syndrome	Macrocephaly	Frequent (79-30%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000260	donnai-barrow syndrome	Wide anterior fontanel	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000316	donnai-barrow syndrome	Hypertelorism	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000337	donnai-barrow syndrome	Broad forehead	Frequent (79-30%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000349	donnai-barrow syndrome	Widows peak	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000358	donnai-barrow syndrome	Posteriorly rotated ears	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000407	donnai-barrow syndrome	Sensorineural hearing impairment	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000494	donnai-barrow syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000520	donnai-barrow syndrome	Proptosis	Frequent (79-30%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000529	donnai-barrow syndrome	Progressive visual loss	Frequent (79-30%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000541	donnai-barrow syndrome	Retinal detachment	Frequent (79-30%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000545	donnai-barrow syndrome	Myopia	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000556	donnai-barrow syndrome	Retinal dystrophy	Occasional (29-5%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000612	donnai-barrow syndrome	Iris coloboma	Occasional (29-5%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000776	donnai-barrow syndrome	Congenital diaphragmatic hernia	Frequent (79-30%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0000813	donnai-barrow syndrome	Bicornuate uterus	Occasional (29-5%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0001249	donnai-barrow syndrome	Intellectual disability	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0001250	donnai-barrow syndrome	Seizures	Occasional (29-5%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0001263	donnai-barrow syndrome	Global developmental delay	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0001537	donnai-barrow syndrome	Umbilical hernia	Frequent (79-30%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0001539	donnai-barrow syndrome	Omphalocele	Frequent (79-30%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0001629	donnai-barrow syndrome	Ventricular septal defect	Occasional (29-5%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0002566	donnai-barrow syndrome	Intestinal malrotation	Occasional (29-5%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0003196	donnai-barrow syndrome	Short nose	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0005280	donnai-barrow syndrome	Depressed nasal bridge	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
HP:0007370	donnai-barrow syndrome	Aplasia/Hypoplasia of the corpus callosum	Very frequent (99-80%)	LRP2	No gene mim	222448	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;Ear	6694	LDL receptor related protein 2	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	gp330|DBS	megalin		low density lipoprotein receptor-related protein 2	Low density lipoprotein receptors
NA	autosomal recessive mental retardation	NA	NA	ZNF526	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	29415	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	sc phocomelia syndrome	NA	NA	ESCO2	609353	269000	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hennekam lymphangiectasia-lymphedema syndrome	NA	NA	CCBE1	612753	235510	biallelic	confirmed	loss of function	Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	29426	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	asphyxiating thoracic dystrophy type 3	NA	NA	DYNC2H1	603297	613091	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract	2962	dynein cytoplasmic 2 heavy chain 1	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	hdhc11|DHC2|DHC1b|DYH1B		DNCH2	dynein, cytoplasmic, heavy polypeptide 2	Dyneins, cytoplasmic
NA	microcephalic osteodysplastic primordial dwarfism, type i	NA	NA	RNU4ATAC	601428	210710	biallelic	confirmed	uncertain	Skeleton;Heart/Cardiovasculature/Lymphatic	34016	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital myasthenic syndrome with acetylcholine receptor deficiency	NA	NA	RAPSN	No gene mim	608931	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	POGZ	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	18801	pogo transposable element derived with ZNF domain	protein-coding gene	gene with protein product	Approved	1q21.3	01q21.3	KIAA0461|ZNF635m|ZNF280E	zinc finger protein 280E|putative protein product of Nbla00003		pogo transposable element with ZNF domain	Helix-turn-helix CENPB type domain containing|DNA transposon derived genes
NA	limb/pelvis-hypoplasia/aplasia syndrome	NA	NA	WNT7A	601570	276820	biallelic	confirmed	uncertain	Skeleton	12786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephropathy with pretibial epidermolysis bullosa and deafness	NA	NA	CD151	602243	609057	biallelic	probable	loss of function	Skin;Kidney Renal Tract;Ear	1630	CD151 molecule (Raph blood group)	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	SFA-1|PETA-3|TSPAN24|RAPH			CD151 antigen|CD151 antigen (Raph blood group)	Blood group antigens|CD molecules|Tetraspanins
NA	intellectual disability	NA	NA	TUBA1A	602529	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	20766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	short chain acyl-coa dehydrogenase deficiency	NA	NA	ACADS	No gene mim	201470	biallelic	both DD and IF	all missense/in frame	Endocrine/Metabolic	90	acyl-CoA dehydrogenase short chain	protein-coding gene	gene with protein product	Approved	12q24.31	12q24.31	SCAD|ACAD3			acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain	Acyl-CoA dehydrogenase family
NA	adenylosuccinase deficiency	NA	NA	ADSL	608222	103050	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	291	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	46xy sex reversal 3	NA	NA	NR5A1	No gene mim	612965	monoallelic	both DD and IF	all missense/in frame	Genitalia	7983	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	charcot-marie-tooth disease type 2b1	NA	NA	LMNA	No gene mim	605588	biallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
NA	cog1-cdg	NA	NA	COG1	606973	300197	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6545	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acth-independent macronodular adrenal hyperplasia	NA	NA	GNAS	139320	219080	mosaic	confirmed	activating	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
NA	ichthyosis, spastic quadriplegia, and mental retardation	NA	NA	ELOVL4	No gene mim	614457	biallelic	confirmed	loss of function	Skin;Brain/Cognition;Eye	14415	ELOVL fatty acid elongase 4	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1	CT118	cancer/testis antigen 118	STGD2|STGD3|SCA34	elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4|spinocerebellar ataxia 34	
NA	autosomal recessive mental retardation	NA	NA	NDST1	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	7680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nonsyndromic autosomal-recessive intellectual disability	NA	NA	FMN2	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	14074	formin 2	protein-coding gene	gene with protein product	Approved	1q43	01q43					
NA	cortical dysplasia, complex, with other brain malformations 6	NA	NA	TUBB	No gene mim	615771	monoallelic	confirmed	all missense/in frame	Brain/Cognition	20778	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001440	syndactyly type 5	Synostosis involving metatarsal bones	Very frequent (99-80%)	HOXD13	142989	186300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	syndactyly type 5	Clinodactyly of the 5th finger	Occasional (29-5%)	HOXD13	142989	186300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004691	syndactyly type 5	2-3 toe syndactyly	Frequent (79-30%)	HOXD13	142989	186300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006097	syndactyly type 5	3-4 finger syndactyly	Frequent (79-30%)	HOXD13	142989	186300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009465	syndactyly type 5	Ulnar deviation of finger	Very frequent (99-80%)	HOXD13	142989	186300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009701	syndactyly type 5	Metacarpal synostosis	Very frequent (99-80%)	HOXD13	142989	186300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009882	syndactyly type 5	Short distal phalanx of finger	Very frequent (99-80%)	HOXD13	142989	186300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	syndactyly type 5	Camptodactyly of finger	Frequent (79-30%)	HOXD13	142989	186300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple endocrine neoplasia iib	NA	NA	RET	No gene mim	162300	monoallelic	both DD and IF	activating	Kidney Renal Tract;Endocrine/Metabolic;Cancer predisposition	9967	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	arthrogryposis multiplex congenita and intellectual disability	NA	NA	ZC4H2	300897	314580	hemizygous	confirmed	loss of function	Musculature;Skeleton;Brain/Cognition	24931	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	arthrogryposis multiplex congenita and intellectual disability	NA	NA	ZC4H2	300897	314580	x-linked dominant	confirmed	loss of function	Musculature;Skeleton;Brain/Cognition	24931	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ceroid lipofuscinosis, neuronal, 6	NA	NA	CLN6	No gene mim	601780	biallelic	both DD and IF	loss of function	Brain/Cognition	2077	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	phelan-mcdermid syndrome	NA	NA	SHANK3	606230	606232	monoallelic	probable	loss of function	Brain/Cognition	14294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pyruvate dehydrogenase e1-alpha deficiency in females	NA	NA	PDHA1	300502	312170	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8806	pyruvate dehydrogenase E1 alpha 1 subunit	protein-coding gene	gene with protein product	Approved	Xp22.12	Xp22.12		pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	PDHA	pyruvate dehydrogenase (lipoamide) alpha 1|pyruvate dehydrogenase alpha 1	Pyruvate dehydrogenase complex
NA	hypomagnesemia 5, renal, with ocular involvement	NA	NA	CLDN19	610036	248190	biallelic	confirmed	uncertain	Endocrine/Metabolic;Eye	2040	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	usher syndrome type 1b	NA	NA	MYO7A	No gene mim	276900	biallelic	both DD and IF	loss of function	Eye;Ear	7606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	als2-related disorders	NA	NA	ALS2	No gene mim	240656	biallelic	confirmed	loss of function	Spinal cord/Peripheral nerves;Brain/Cognition	443	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cockayne syndrome type b	NA	NA	ERCC6	609413	133540	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	3438	ERCC excision repair 6, chromatin remodeling factor	protein-coding gene	gene with protein product	Approved	10q11.23	10q11.23	CSB|RAD26|ARMD5	Cockayne syndrome B protein	CKN2	excision repair cross-complementing rodent repair deficiency, complementation group 6|excision repair cross-complementation group 6	ERCC excision repair associated
NA	triphalangeal thumb-polysyndactyly syndrome	NA	NA	SHH	600725	174500	monoallelic	confirmed	cis-regulatory or promotor mutation	Teeth & Dentitian;Face;Brain/Cognition;Eye	10848	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lissencephaly x-linked type 2	NA	NA	ARX	300382	300215	hemizygous	confirmed	loss of function	Brain/Cognition;Genitalia	18060	aristaless related homeobox	protein-coding gene	gene with protein product	Approved	Xp21.3	Xp21.3	ISSX|CT121|EIEE1	cancer/testis antigen 121	MRXS1|PRTS|MRX76|MRX54|MRX43|MRX36|MRX29|MRX32|MRX33|MRX38|MRX87	mental retardation, X-linked 54|mental retardation, X-linked 43|mental retardation, X-linked 36|mental retardation, X-linked 29|mental retardation, X-linked 32|mental retardation, X-linked 33|mental retardation, X-linked 38|mental retardation, X-linked 87|mental retardation, X-linked 76	X-linked mental retardation|PRD class homeoboxes and pseudogenes
NA	joubert syndrome type 6	NA	NA	TMEM67	609884	610688	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;GI tract	28396	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	ADRA2B	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	282	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple mitochondrial dysfunctions syndrome 2	NA	NA	BOLA3	613183	614299	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	24415	bolA family member 3	protein-coding gene	gene with protein product	Approved	2p13.1	02p13.1				bolA-like 3 (E. coli)|bolA homolog 3 (E. coli)	
NA	coronal craniosynostosis	NA	NA	TCF12	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton	11623	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	tyrosinemia type 2	NA	NA	TAT	613018	276600	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	11573	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial complex iii deficiency	NA	NA	TTC19	613814	124000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	26006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	yemenite deaf-blind hypopigmentation syndrome	NA	NA	SOX10	602229	601706	monoallelic	confirmed	uncertain	Skin;Face;Spinal cord/Peripheral nerves;Ear	11190	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	PURA	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	9701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leukodystrophy, hypomyelinating, 2	NA	NA	GJC2	608803	608804	biallelic	confirmed	all missense/in frame	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	17494	gap junction protein gamma 2	protein-coding gene	gene with protein product	Approved	1q42.13	01q42.13	CX47|CX46.6|SPG44	connexin 47	GJA12	gap junction protein, alpha 12, 47kDa|gap junction protein, gamma 2, 47kDa	Gap junction proteins
NA	febrile seizures	NA	NA	SLC12A5	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	13818	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	currarino syndrome	NA	NA	MNX1	142994	176450	monoallelic	confirmed	loss of function	Skeleton;Spinal cord/Peripheral nerves;GI tract	4979	motor neuron and pancreas homeobox 1	protein-coding gene	gene with protein product	Approved	7q36.3	07q36.3	HB9|HOXHB9|SCRA1		HLXB9	homeo box HB9|homeobox HB9	HOXL subclass homeoboxes
NA	adenosine deaminase deficiency	NA	NA	ADA	608958	102700	biallelic	confirmed	loss of function	Bone Marrow/Immune	186	adenosine deaminase	protein-coding gene	gene with protein product	Approved	20q13.12	20q13.12					Adenosine deaminase family
NA	epileptic encephalopathy	NA	NA	GRIN2B	138252	No disease mim	monoallelic	confirmed	all missense/in frame	Brain/Cognition	4586	glutamate ionotropic receptor NMDA type subunit 2B	protein-coding gene	gene with protein product	Approved	12p13.1	12p13.1	GluN2B		NMDAR2B	glutamate receptor, ionotropic, N-methyl D-aspartate 2B	Glutamate ionotropic receptor NMDA type subunits
HP:0000015	menkes disease	Bladder diverticulum	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000023	menkes disease	Inguinal hernia	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000174	menkes disease	Abnormality of the palate	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000252	menkes disease	Microcephaly	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000269	menkes disease	Prominent occiput	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000293	menkes disease	Full cheeks	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000298	menkes disease	Mask-like facies	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000347	menkes disease	Micrognathia	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000708	menkes disease	Behavioral abnormality	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000767	menkes disease	Pectus excavatum	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000774	menkes disease	Narrow chest	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000934	menkes disease	Chondrocalcinosis	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000939	menkes disease	Osteoporosis	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000944	menkes disease	Abnormality of the metaphyses	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000958	menkes disease	Dry skin	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000974	menkes disease	Hyperextensible skin	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0000987	menkes disease	Atypical scarring of skin	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001072	menkes disease	Thickened skin	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001249	menkes disease	Intellectual disability	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001250	menkes disease	Seizures	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001252	menkes disease	Muscular hypotonia	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001257	menkes disease	Spasticity	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001276	menkes disease	Hypertonia	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001324	menkes disease	Muscle weakness	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001511	menkes disease	Intrauterine growth retardation	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001537	menkes disease	Umbilical hernia	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0001943	menkes disease	Hypoglycemia	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002017	menkes disease	Nausea and vomiting	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002024	menkes disease	Malabsorption	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002045	menkes disease	Hypothermia	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002072	menkes disease	Chorea	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002170	menkes disease	Intracranial hemorrhage	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002224	menkes disease	Woolly hair	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002239	menkes disease	Gastrointestinal hemorrhage	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002376	menkes disease	Developmental regression	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002617	menkes disease	Aneurysm	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002645	menkes disease	Wormian bones	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002754	menkes disease	Osteomyelitis	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0002757	menkes disease	Recurrent fractures	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0005293	menkes disease	Venous insufficiency	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0005344	menkes disease	Abnormality of the carotid arteries	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0005599	menkes disease	Hypopigmentation of hair	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0005692	menkes disease	Joint hyperflexibility	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0006487	menkes disease	Bowing of the long bones	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0006579	menkes disease	Prolonged neonatal jaundice	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0007420	menkes disease	Spontaneous hematomas	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0008070	menkes disease	Sparse hair	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0008368	menkes disease	Tarsal synostosis	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0008872	menkes disease	Feeding difficulties in infancy	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0010318	menkes disease	Aplasia/Hypoplasia of the abdominal wall musculature	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0012378	menkes disease	Fatigue	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100545	menkes disease	Arterial stenosis	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100777	menkes disease	Exostoses	Frequent (79-30%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100790	menkes disease	Hernia	Very frequent (99-80%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
HP:0100806	menkes disease	Sepsis	Occasional (29-5%)	ATP7A	300011	309400	hemizygous	confirmed	loss of function	Skin;Skeleton;Endocrine/Metabolic;Brain/Cognition	869	ATPase copper transporting alpha	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1		copper pump 1|copper-transporting ATPase 1	MNK	Menkes syndrome|ATPase, Cu++ transporting, alpha polypeptide	ATPase copper transporting
NA	hyperlysinemia	NA	NA	AASS	605113	238700	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	17366	aminoadipate-semialdehyde synthase	protein-coding gene	gene with protein product	Approved	7q31.32	07q31.32	LORSDH|LKRSDH				
NA	pancreatic agenesis, diaphragmatic hernia and congenital heart defects	NA	NA	GATA6	601656	600001	monoallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	4174	GATA binding protein 6	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2				GATA-binding protein 6	GATA zinc finger domain containing
NA	branchiooculofacial syndrome	NA	NA	TFAP2A	No gene mim	113620	monoallelic	confirmed	all missense/in frame	Skin;Face;Eye	11742	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ghosal hematodiaphyseal syndrome	NA	NA	TBXAS1	No gene mim	231095	biallelic	confirmed	all missense/in frame	Bone Marrow/Immune;Skeleton	11609	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lhx4-related combined pituitary hormone deficiency	NA	NA	LHX4	602146	290135	monoallelic	confirmed	loss of function	Endocrine/Metabolic	21734	LIM homeobox 4	protein-coding gene	gene with protein product	Approved	1q25.2	01q25.2	Gsh4				LIM class homeoboxes
NA	fancl-related fanconi anemia	NA	NA	FANCL	608111	234480	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
NA	ectodermal dysplasia type 1	NA	NA	EDA	300451	305100	hemizygous	confirmed	loss of function	Teeth & Dentitian;Skin	3157	ectodysplasin A	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	EDA1|XLHED|HED|XHED|ED1-A1|ED1-A2|EDA-A1|EDA-A2		ED1|EDA2|ODT1	ectodermal dysplasia 1, anhidrotic|oligodontia 1	Tumor necrosis factor superfamily
NA	mental retardation autosomal recessive type 18	NA	NA	MED23	No gene mim	614249	biallelic	possible	all missense/in frame	Brain/Cognition	2372	mediator complex subunit 23	protein-coding gene	gene with protein product	Approved	6q23.2	06q23.2	CRSP130|DRIP130|Sur2		CRSP3	cofactor required for Sp1 transcriptional activation, subunit 3, 130kDa	Mediator complex
HP:0000486	gaucher disease type 2	Strabismus	Very frequent (99-80%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000602	gaucher disease type 2	Ophthalmoplegia	Very frequent (99-80%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001257	gaucher disease type 2	Spasticity	Very frequent (99-80%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001298	gaucher disease type 2	Encephalopathy	Very frequent (99-80%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001332	gaucher disease type 2	Dystonia	Very frequent (99-80%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001371	gaucher disease type 2	Flexion contracture	Frequent (79-30%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001695	gaucher disease type 2	Cardiac arrest	Occasional (29-5%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001744	gaucher disease type 2	Splenomegaly	Very frequent (99-80%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002015	gaucher disease type 2	Dysphagia	Very frequent (99-80%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002098	gaucher disease type 2	Respiratory distress	Frequent (79-30%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002123	gaucher disease type 2	Generalized myoclonic seizures	Frequent (79-30%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002205	gaucher disease type 2	Recurrent respiratory infections	Frequent (79-30%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002240	gaucher disease type 2	Hepatomegaly	Very frequent (99-80%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002793	gaucher disease type 2	Abnormal pattern of respiration	Very frequent (99-80%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0012735	gaucher disease type 2	Cough	Frequent (79-30%)	GBA	No gene mim	230900	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000160	fibrochondrogenesis	Narrow mouth	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	fibrochondrogenesis	Cleft palate	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000260	fibrochondrogenesis	Wide anterior fontanel	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000311	fibrochondrogenesis	Round face	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	fibrochondrogenesis	Hypertelorism	Occasional (29-5%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000364	fibrochondrogenesis	Hearing abnormality	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	fibrochondrogenesis	Low-set ears	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	fibrochondrogenesis	Anteverted nares	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	fibrochondrogenesis	Short neck	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	fibrochondrogenesis	Downslanted palpebral fissures	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	fibrochondrogenesis	Proptosis	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	fibrochondrogenesis	Abnormality of the ribs	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000773	fibrochondrogenesis	Short ribs	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	fibrochondrogenesis	Narrow chest	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000882	fibrochondrogenesis	Hypoplastic scapulae	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000885	fibrochondrogenesis	Broad ribs	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000940	fibrochondrogenesis	Abnormal diaphysis morphology	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	fibrochondrogenesis	Abnormality of the metaphyses	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	fibrochondrogenesis	Brachydactyly syndrome	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001357	fibrochondrogenesis	Plagiocephaly	Occasional (29-5%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001539	fibrochondrogenesis	Omphalocele	Occasional (29-5%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001591	fibrochondrogenesis	Bell-shaped thorax	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001804	fibrochondrogenesis	Hypoplastic fingernail	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	fibrochondrogenesis	Respiratory insufficiency	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	fibrochondrogenesis	Micromelia	Occasional (29-5%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	fibrochondrogenesis	Abnormal form of the vertebral bodies	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	fibrochondrogenesis	Short stature	Very frequent (99-80%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	fibrochondrogenesis	Depressed nasal bridge	Frequent (79-30%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	fibrochondrogenesis	Camptodactyly of finger	Occasional (29-5%)	COL11A1	120280	228520	biallelic	confirmed	loss of function	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rapid-onset dystonia-parkinsonism	NA	NA	ATP1A3	No gene mim	128235	monoallelic	both DD and IF	all missense/in frame	Brain/Cognition	801	ATPase Na+/K+ transporting subunit alpha 3	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2		sodium/potassium-transporting ATPase subunit alpha-3|sodium pump subunit alpha-3|sodium-potassium ATPase catalytic subunit alpha-3	DYT12	dystonia 12|ATPase, Na+/K+ transporting, alpha 3 polypeptide	ATPase Na+/K+ transporting subunits
HP:0000467	systemic primary carnitine deficiency	Neck muscle weakness	Very frequent (99-80%)	SLC22A5	603377	212140	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001289	systemic primary carnitine deficiency	Confusion	Very frequent (99-80%)	SLC22A5	603377	212140	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	systemic primary carnitine deficiency	Muscle weakness	Very frequent (99-80%)	SLC22A5	603377	212140	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002013	systemic primary carnitine deficiency	Vomiting	Very frequent (99-80%)	SLC22A5	603377	212140	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	systemic primary carnitine deficiency	Hepatomegaly	Very frequent (99-80%)	SLC22A5	603377	212140	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002312	systemic primary carnitine deficiency	Clumsiness	Very frequent (99-80%)	SLC22A5	603377	212140	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002910	systemic primary carnitine deficiency	Elevated hepatic transaminases	Very frequent (99-80%)	SLC22A5	603377	212140	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006846	systemic primary carnitine deficiency	Acute encephalopathy	Very frequent (99-80%)	SLC22A5	603377	212140	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007334	systemic primary carnitine deficiency	Bilateral convulsive seizures	Very frequent (99-80%)	SLC22A5	603377	212140	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10969	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cowchock syndrome	NA	NA	AIFM1	300169	No disease mim	hemizygous	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	8768	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	paramyotonia congenita of von eulenburg	NA	NA	SCN4A	603967	168300	monoallelic	confirmed	all missense/in frame	Musculature	10591	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	familial hyperinsulinism	NA	NA	KCNJ11	No gene mim	3272	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6257	potassium voltage-gated channel subfamily J member 11	protein-coding gene	gene with protein product	Approved	11p15.1	11p15.1	Kir6.2|BIR			potassium inwardly-rectifying channel, subfamily J, member 11	Potassium voltage-gated channel subfamily J
NA	phosphoserine phosphatase deficiency	NA	NA	PSPH	172480	614023	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	9577	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gm1-gangliosidosis type 1	NA	NA	GLB1	611458	230500	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4298	galactosidase beta 1	protein-coding gene	gene with protein product	Approved	3p22.3	03p22.3	EBP		ELNR1	elastin receptor 1, 67kDa|elastin receptor 1 (67kD)|galactosidase, beta 1	
NA	ube2a-related x-linked syndromic mental retardation	NA	NA	UBE2A	312180	319562	hemizygous	confirmed	loss of function	Brain/Cognition	12472	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nail disorder non-syndromic congenital type 10	NA	NA	FZD6	603409	614157	biallelic	confirmed	loss of function	Skin	4044	frizzled class receptor 6	protein-coding gene	gene with protein product	Approved	8q22.3	08q22.3	Hfz6			frizzled (Drosophila) homolog 6|frizzled homolog 6 (Drosophila)|frizzled 6, seven transmembrane spanning receptor|frizzled family receptor 6	G protein-coupled receptors, Class F frizzled
NA	primary microcephaly and disturbed centrosomal function	NA	NA	CEP135	611423	614673	biallelic	probable	loss of function	Brain/Cognition	29086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness with labyrinthine aplasia, microtia and microdontia	NA	NA	FGF3	164950	610706	biallelic	confirmed	loss of function	Teeth & Dentitian;Ear	3681	fibroblast growth factor 3	protein-coding gene	gene with protein product	Approved	11q13.3	11q13.3	HBGF-3	INT-2 proto-oncogene protein|oncogene INT2|V-INT2 murine mammary tumor virus integration site oncogene homolog|murine mammary tumor virus integration site 2, mouse	INT2	fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog)	
NA	walker warburg syndrome	NA	NA	ISPD	614631	614643	biallelic	confirmed	loss of function	Brain/Cognition;Eye	37276	isoprenoid synthase domain containing	protein-coding gene	gene with protein product	Approved	7p21.2	07p21.2	hCG_1745121|IspD|Nip	notch1-induced protein|4-diphosphocytidyl-2C-methyl-D-erythritol synthase homolog (Arabidopsis)			
NA	star syndrome	NA	NA	FAM58A	300708	300707	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton	28434	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dyskeratosis congenita, autosomal recessive 3	NA	NA	WRAP53	No gene mim	613988	biallelic	confirmed	all missense/in frame	Bone Marrow/Immune;Skin	25522	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	46xy sex reversal 6	NA	NA	MAP3K1	600982	613762	monoallelic	confirmed	loss of function	Genitalia	6848	mitogen-activated protein kinase kinase kinase 1	protein-coding gene	gene with protein product	Approved	5q11.2	05q11.2	MEKK|MAPKKK1		MEKK1	mitogen-activated protein kinase kinase kinase 1|mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase	Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases
HP:0000028	cardiofaciocutaneous syndrome	Cryptorchidism	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000126	cardiofaciocutaneous syndrome	Hydronephrosis	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000176	cardiofaciocutaneous syndrome	Submucous cleft hard palate	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000218	cardiofaciocutaneous syndrome	High palate	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000238	cardiofaciocutaneous syndrome	Hydrocephalus	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000256	cardiofaciocutaneous syndrome	Macrocephaly	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000276	cardiofaciocutaneous syndrome	Long face	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000280	cardiofaciocutaneous syndrome	Coarse facial features	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000286	cardiofaciocutaneous syndrome	Epicanthus	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000293	cardiofaciocutaneous syndrome	Full cheeks	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000316	cardiofaciocutaneous syndrome	Hypertelorism	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000343	cardiofaciocutaneous syndrome	Long philtrum	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000348	cardiofaciocutaneous syndrome	High forehead	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000368	cardiofaciocutaneous syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000391	cardiofaciocutaneous syndrome	Thickened helices	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000400	cardiofaciocutaneous syndrome	Macrotia	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000463	cardiofaciocutaneous syndrome	Anteverted nares	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000465	cardiofaciocutaneous syndrome	Webbed neck	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000470	cardiofaciocutaneous syndrome	Short neck	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000478	cardiofaciocutaneous syndrome	Abnormality of the eye	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000486	cardiofaciocutaneous syndrome	Strabismus	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000494	cardiofaciocutaneous syndrome	Downslanted palpebral fissures	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000499	cardiofaciocutaneous syndrome	Abnormality of the eyelashes	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000504	cardiofaciocutaneous syndrome	Abnormality of vision	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000508	cardiofaciocutaneous syndrome	Ptosis	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000545	cardiofaciocutaneous syndrome	Myopia	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000637	cardiofaciocutaneous syndrome	Long palpebral fissure	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000639	cardiofaciocutaneous syndrome	Nystagmus	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000648	cardiofaciocutaneous syndrome	Optic atrophy	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000767	cardiofaciocutaneous syndrome	Pectus excavatum	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000958	cardiofaciocutaneous syndrome	Dry skin	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000962	cardiofaciocutaneous syndrome	Hyperkeratosis	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000974	cardiofaciocutaneous syndrome	Hyperextensible skin	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0000982	cardiofaciocutaneous syndrome	Palmoplantar keratoderma	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001003	cardiofaciocutaneous syndrome	Multiple lentigines	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001004	cardiofaciocutaneous syndrome	Lymphedema	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001048	cardiofaciocutaneous syndrome	Cavernous hemangioma	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001249	cardiofaciocutaneous syndrome	Intellectual disability	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001252	cardiofaciocutaneous syndrome	Muscular hypotonia	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001260	cardiofaciocutaneous syndrome	Dysarthria	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001263	cardiofaciocutaneous syndrome	Global developmental delay	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001531	cardiofaciocutaneous syndrome	Failure to thrive in infancy	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001582	cardiofaciocutaneous syndrome	Redundant skin	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001622	cardiofaciocutaneous syndrome	Premature birth	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001631	cardiofaciocutaneous syndrome	Atrial septal defect	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001639	cardiofaciocutaneous syndrome	Hypertrophic cardiomyopathy	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001642	cardiofaciocutaneous syndrome	Pulmonic stenosis	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0001654	cardiofaciocutaneous syndrome	Abnormality of the heart valves	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002007	cardiofaciocutaneous syndrome	Frontal bossing	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002120	cardiofaciocutaneous syndrome	Cerebral cortical atrophy	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002162	cardiofaciocutaneous syndrome	Low posterior hairline	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002167	cardiofaciocutaneous syndrome	Neurological speech impairment	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002213	cardiofaciocutaneous syndrome	Fine hair	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002217	cardiofaciocutaneous syndrome	Slow-growing hair	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002299	cardiofaciocutaneous syndrome	Brittle hair	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002353	cardiofaciocutaneous syndrome	EEG abnormality	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002564	cardiofaciocutaneous syndrome	Malformation of the heart and great vessels	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002650	cardiofaciocutaneous syndrome	Scoliosis	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002857	cardiofaciocutaneous syndrome	Genu valgum	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002967	cardiofaciocutaneous syndrome	Cubitus valgus	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0002997	cardiofaciocutaneous syndrome	Abnormality of the ulna	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0003196	cardiofaciocutaneous syndrome	Short nose	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0004322	cardiofaciocutaneous syndrome	Short stature	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0004422	cardiofaciocutaneous syndrome	Biparietal narrowing	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0005280	cardiofaciocutaneous syndrome	Depressed nasal bridge	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0006191	cardiofaciocutaneous syndrome	Deep palmar crease	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0007392	cardiofaciocutaneous syndrome	Excessive wrinkled skin	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0007440	cardiofaciocutaneous syndrome	Generalized hyperpigmentation	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0007565	cardiofaciocutaneous syndrome	Multiple cafe-au-lait spots	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0008064	cardiofaciocutaneous syndrome	Ichthyosis	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0008070	cardiofaciocutaneous syndrome	Sparse hair	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0008391	cardiofaciocutaneous syndrome	Dystrophic fingernails	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0008872	cardiofaciocutaneous syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0009891	cardiofaciocutaneous syndrome	Underdeveloped supraorbital ridges	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0010669	cardiofaciocutaneous syndrome	Cheekbone underdevelopment	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0011024	cardiofaciocutaneous syndrome	Abnormality of the gastrointestinal tract	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0012719	cardiofaciocutaneous syndrome	Functional abnormality of the gastrointestinal tract	Occasional (29-5%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0100840	cardiofaciocutaneous syndrome	Aplasia/Hypoplasia of the eyebrow	Very frequent (99-80%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
HP:0200102	cardiofaciocutaneous syndrome	Sparse or absent eyelashes	Frequent (79-30%)	KRAS	190070	115150	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
NA	juvenile myoclonic epilepsy	NA	NA	CACNB4	No gene mim	611136		child IF		Brain/Cognition	1404	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	holt-oram syndrome	Pectus excavatum	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000889	holt-oram syndrome	Abnormality of the clavicle	Very frequent (99-80%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000912	holt-oram syndrome	Sprengel anomaly	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001171	holt-oram syndrome	Split hand	Very frequent (99-80%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	holt-oram syndrome	Joint stiffness	Very frequent (99-80%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030680	holt-oram syndrome	Abnormality of cardiovascular system morphology	Very frequent (99-80%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	holt-oram syndrome	Abnormality of the metacarpal bones	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001199	holt-oram syndrome	Triphalangeal thumb	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	holt-oram syndrome	Ventricular septal defect	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001631	holt-oram syndrome	Atrial septal defect	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001678	holt-oram syndrome	Atrioventricular block	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	holt-oram syndrome	Scoliosis	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	holt-oram syndrome	Kyphosis	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004757	holt-oram syndrome	Paroxysmal atrial fibrillation	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006501	holt-oram syndrome	Aplasia/Hypoplasia of the radius	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009777	holt-oram syndrome	Absent thumb	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011705	holt-oram syndrome	First degree atrioventricular block	Frequent (79-30%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	holt-oram syndrome	Abnormality of the ribs	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	holt-oram syndrome	Patent ductus arteriosus	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001679	holt-oram syndrome	Abnormality of the aorta	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002974	holt-oram syndrome	Radioulnar synostosis	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003063	holt-oram syndrome	Abnormality of the humerus	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004383	holt-oram syndrome	Hypoplastic left heart	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	holt-oram syndrome	Finger syndactyly	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006695	holt-oram syndrome	Atrioventricular canal defect	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009829	holt-oram syndrome	Phocomelia	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010772	holt-oram syndrome	Anomalous pulmonary venous return	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011304	holt-oram syndrome	Broad thumb	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200021	holt-oram syndrome	Down-sloping shoulders	Occasional (29-5%)	TBX5	601620	142900	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	11604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	tietz syndrome	NA	NA	MITF	156845	103500	monoallelic	confirmed	uncertain	Skin;Ear	7105	melanogenesis associated transcription factor	protein-coding gene	gene with protein product	Approved	3p13	03p13	MI|bHLHe32	homolog of mouse microphthalmia	WS2A|WS2	Waardenburg syndrome, type 2A|microphthalmia-associated transcription factor	Basic helix-loop-helix proteins
NA	meckel syndrome type 1	NA	NA	MKS1	609883	249000	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye	7121	Meckel syndrome, type 1	protein-coding gene	gene with protein product	Approved	17q22	17q22	FLJ20345|POC12|BBS13	POC12 centriolar protein homolog (Chlamydomonas)	MKS		Bardet-Biedl syndrome associated|B9 domain containing|MKS complex
NA	cataract zonular type 2	NA	NA	CRYBA4	123631	610425	monoallelic	confirmed	dominant negative	Eye	2396	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atelosteogenesis type 3	NA	NA	FLNB	603381	108721	monoallelic	confirmed	activating	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
NA	stickler syndrome, type v	NA	NA	COL9A2	120260	614284	biallelic	confirmed	loss of function	Face;Skeleton;Eye;Ear	2218	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peroxisome biogenesis disorder complementation group 12	NA	NA	PEX3	603164	603164	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
NA	coloboma of optic nerve	NA	NA	PAX6	607108	120430	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract, nuclear	NA	NA	CRYAA	123580	123580	monoallelic	confirmed	all missense/in frame	Eye	2388	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	childhood-onset hypogammaglobulinemia	NA	NA	LRBA	606453	614700	biallelic	probable	loss of function	Bone Marrow/Immune	1742	LPS responsive beige-like anchor protein	protein-coding gene	gene with protein product	Approved	4q31.3	04q31.3	BGL|LAB300|LBA		CDC4L	LPS-responsive vesicle trafficking, beach and anchor containing	WD repeat domain containing|BEACH domain containing 
NA	cortical dysplasia, complex, with other brain malformations 2	NA	NA	KIF5C	No gene mim	615282	monoallelic	probable	all missense/in frame	Brain/Cognition	6325	kinesin family member 5C	protein-coding gene	gene with protein product	Approved	2q23.1-q23.2	02q23.1-q23.2					Kinesins
NA	pontocerebellar hypoplasia type 1	NA	NA	EXOSC3	606489	607596	biallelic	confirmed	all missense/in frame	Spinal cord/Peripheral nerves;Brain/Cognition	17944	exosome component 3	protein-coding gene	gene with protein product	Approved	9p13.2	09p13.2	hRrp40p|Rrp40p|RRP40|CGI-102|p10|hRrp-40	exosome component Rrp40|CGI-102 protein			Exosome complex
NA	fanconi anemia, complementation group d2	NA	NA	FANCD2	613984	227646	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	3585	Fanconi anemia complementation group D2	protein-coding gene	gene with protein product	Approved	3p25.3	03p25.3	FAD|FA-D2		FACD|FANCD		Fanconi anemia complementation groups
HP:0000252	3-methylglutaconic aciduria type 1	Microcephaly	Occasional (29-5%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0000750	3-methylglutaconic aciduria type 1	Delayed speech and language development	Frequent (79-30%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0001250	3-methylglutaconic aciduria type 1	Seizures	Occasional (29-5%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0001259	3-methylglutaconic aciduria type 1	Coma	Occasional (29-5%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0001263	3-methylglutaconic aciduria type 1	Global developmental delay	Frequent (79-30%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0001285	3-methylglutaconic aciduria type 1	Spastic tetraparesis	Occasional (29-5%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0001332	3-methylglutaconic aciduria type 1	Dystonia	Occasional (29-5%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0001508	3-methylglutaconic aciduria type 1	Failure to thrive	Very frequent (99-80%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0001943	3-methylglutaconic aciduria type 1	Hypoglycemia	Occasional (29-5%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0002073	3-methylglutaconic aciduria type 1	Progressive cerebellar ataxia	Occasional (29-5%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0002134	3-methylglutaconic aciduria type 1	Abnormality of the basal ganglia	Occasional (29-5%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0002240	3-methylglutaconic aciduria type 1	Hepatomegaly	Occasional (29-5%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0003535	3-methylglutaconic aciduria type 1	3-Methylglutaconic aciduria	Very frequent (99-80%)	AUH	600529	250950	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	890	AU RNA binding methylglutaconyl-CoA hydratase	protein-coding gene	gene with protein product	Approved	9q22.31	09q22.31				AU RNA-binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-Coenzyme A hydratase|AU RNA binding protein/enoyl-CoA hydratase	
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX2	170993	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
NA	hereditary multiple exostoses type 1	NA	NA	EXT1	608177	133700	monoallelic	confirmed	loss of function	Skin;Face;Skeleton	3512	exostosin glycosyltransferase 1	protein-coding gene	gene with protein product	Approved	8q24.11	08q24.11	ttv	Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N- acetylglucosaminyltransferase|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase	LGCR|LGS	Langer-Giedion syndrome chromosome region|exostoses (multiple) 1|exostosin 1	Exostosin glycosyltransferase family
NA	maple syrup urine diseaseq	NA	NA	DBT	248610	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2698	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000600	maple syrup urine disease	Abnormality of the pharynx	Very frequent (99-80%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0001249	maple syrup urine disease	Intellectual disability	Very frequent (99-80%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0001250	maple syrup urine disease	Seizures	Very frequent (99-80%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0001251	maple syrup urine disease	Ataxia	Frequent (79-30%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0001252	maple syrup urine disease	Muscular hypotonia	Very frequent (99-80%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0001263	maple syrup urine disease	Global developmental delay	Very frequent (99-80%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0001315	maple syrup urine disease	Reduced tendon reflexes	Very frequent (99-80%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0001608	maple syrup urine disease	Abnormality of the voice	Very frequent (99-80%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0002093	maple syrup urine disease	Respiratory insufficiency	Very frequent (99-80%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0004374	maple syrup urine disease	Hemiplegia/hemiparesis	Frequent (79-30%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
HP:0008344	maple syrup urine disease	Elevated plasma branched chain amino acids	Very frequent (99-80%)	BCKDHA	608348	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	986	branched chain keto acid dehydrogenase E1, alpha polypeptide	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	MSU	maple syrup urine disease	OVD1A	branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)|2-oxoisovalerate dehydrogenase (lipoamide)	
NA	congenital disorders of glycosylation	NA	NA	SLC35A1	605634	612379	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	11021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bh4-deficient hyperphenylalaninemia c	NA	NA	QDPR	612676	261630	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	9752	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	kabuki syndrome	Cryptorchidism	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000047	kabuki syndrome	Hypospadias	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000074	kabuki syndrome	Ureteropelvic junction obstruction	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000081	kabuki syndrome	Duplicated collecting system	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000126	kabuki syndrome	Hydronephrosis	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000164	kabuki syndrome	Abnormality of the teeth	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000175	kabuki syndrome	Cleft palate	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000202	kabuki syndrome	Oral cleft	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000218	kabuki syndrome	High palate	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000238	kabuki syndrome	Hydrocephalus	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000252	kabuki syndrome	Microcephaly	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000298	kabuki syndrome	Mask-like facies	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000384	kabuki syndrome	Preauricular skin tag	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000400	kabuki syndrome	Macrotia	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000405	kabuki syndrome	Conductive hearing impairment	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000407	kabuki syndrome	Sensorineural hearing impairment	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000411	kabuki syndrome	Protruding ear	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000482	kabuki syndrome	Microcornea	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000486	kabuki syndrome	Strabismus	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000508	kabuki syndrome	Ptosis	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000527	kabuki syndrome	Long eyelashes	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000589	kabuki syndrome	Coloboma	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000592	kabuki syndrome	Blue sclerae	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000639	kabuki syndrome	Nystagmus	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000668	kabuki syndrome	Hypodontia	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000687	kabuki syndrome	Widely spaced teeth	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000691	kabuki syndrome	Microdontia	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000776	kabuki syndrome	Congenital diaphragmatic hernia	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0000826	kabuki syndrome	Precocious puberty	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0001250	kabuki syndrome	Seizures	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0001252	kabuki syndrome	Muscular hypotonia	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0001508	kabuki syndrome	Failure to thrive	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0001513	kabuki syndrome	Obesity	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0001671	kabuki syndrome	Abnormality of the cardiac septa	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0001680	kabuki syndrome	Coarctation of aorta	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0002000	kabuki syndrome	Short columella	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0002119	kabuki syndrome	Ventriculomegaly	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0002120	kabuki syndrome	Cerebral cortical atrophy	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0002353	kabuki syndrome	EEG abnormality	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0002553	kabuki syndrome	Highly arched eyebrow	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0002650	kabuki syndrome	Scoliosis	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0002719	kabuki syndrome	Recurrent infections	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0002827	kabuki syndrome	Hip dislocation	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0002937	kabuki syndrome	Hemivertebrae	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0003312	kabuki syndrome	Abnormal form of the vertebral bodies	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0003316	kabuki syndrome	Butterfly vertebrae	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0004322	kabuki syndrome	Short stature	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0004736	kabuki syndrome	Crossed fused renal ectopia	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0005338	kabuki syndrome	Sparse lateral eyebrow	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0005692	kabuki syndrome	Joint hyperflexibility	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0005819	kabuki syndrome	Short middle phalanx of finger	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0006482	kabuki syndrome	Abnormality of dental morphology	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0007477	kabuki syndrome	Abnormal dermatoglyphics	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0007655	kabuki syndrome	Eversion of lateral third of lower eyelids	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0008428	kabuki syndrome	Vertebral clefting	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0008678	kabuki syndrome	Renal hypoplasia/aplasia	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0008736	kabuki syndrome	Hypoplasia of penis	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0009237	kabuki syndrome	Short 5th finger	Very frequent (99-80%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0010978	kabuki syndrome	Abnormality of immune system physiology	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0011968	kabuki syndrome	Feeding difficulties	Frequent (79-30%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0100267	kabuki syndrome	Lip pit	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0100542	kabuki syndrome	Abnormal localization of kidney	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
HP:0200055	kabuki syndrome	Small hand	Occasional (29-5%)	KMT2D	No gene mim	147920	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Skeleton;Brain/Cognition	7133	lysine methyltransferase 2D	protein-coding gene	gene with protein product	Approved	12q13.12	12q13.12	ALR|MLL4|CAGL114		TNRC21|MLL2	trinucleotide repeat containing 21|myeloid/lymphoid or mixed-lineage leukemia 2|lysine (K)-specific methyltransferase 2D	PHD finger proteins|Lysine methyltransferases|Trinucleotide repeat containing|SET domain containing
NA	neuromyotonia and axonal neuropathy, autosomal recessive	NA	NA	HINT1	601314	137200	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves	4912	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	johanson-blizzard syndrome	Hypospadias	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000126	johanson-blizzard syndrome	Hydronephrosis	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000142	johanson-blizzard syndrome	Abnormality of the vagina	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	johanson-blizzard syndrome	Abnormality of the teeth	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	johanson-blizzard syndrome	Microcephaly	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	johanson-blizzard syndrome	Sensorineural hearing impairment	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000430	johanson-blizzard syndrome	Underdeveloped nasal alae	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000632	johanson-blizzard syndrome	Lacrimation abnormality	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000677	johanson-blizzard syndrome	Oligodontia	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	johanson-blizzard syndrome	Delayed eruption of teeth	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000691	johanson-blizzard syndrome	Microdontia	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000819	johanson-blizzard syndrome	Diabetes mellitus	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000969	johanson-blizzard syndrome	Edema	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001092	johanson-blizzard syndrome	Absent lacrimal punctum	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	johanson-blizzard syndrome	Intellectual disability	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	johanson-blizzard syndrome	Muscular hypotonia	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	johanson-blizzard syndrome	Failure to thrive	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	johanson-blizzard syndrome	Intrauterine growth retardation	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001522	johanson-blizzard syndrome	Death in infancy	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001545	johanson-blizzard syndrome	Anteriorly placed anus	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001596	johanson-blizzard syndrome	Alopecia	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001651	johanson-blizzard syndrome	Dextrocardia	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001671	johanson-blizzard syndrome	Abnormality of the cardiac septa	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001732	johanson-blizzard syndrome	Abnormality of the pancreas	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001738	johanson-blizzard syndrome	Exocrine pancreatic insufficiency	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	johanson-blizzard syndrome	Anemia	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002023	johanson-blizzard syndrome	Anal atresia	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	johanson-blizzard syndrome	Malabsorption	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	johanson-blizzard syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	johanson-blizzard syndrome	Delayed skeletal maturation	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003075	johanson-blizzard syndrome	Hypoproteinemia	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	johanson-blizzard syndrome	Short nose	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	johanson-blizzard syndrome	Short stature	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005288	johanson-blizzard syndrome	Abnormality of the nares	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	johanson-blizzard syndrome	Hypoplasia of penis	Occasional (29-5%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010460	johanson-blizzard syndrome	Abnormality of the female genitalia	Frequent (79-30%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010720	johanson-blizzard syndrome	Abnormal hair pattern	Very frequent (99-80%)	UBR1	605981	243800	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition	16808	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	preaxial polydactyly type iv	NA	NA	GLI3	165240	269157	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
NA	autoimmune polyendocrinopathy syndrome type 1	NA	NA	AIRE	No gene mim	240300	biallelic	both DD and IF	loss of function	Endocrine/Metabolic	360	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract congenital non-nuclear polymorphic autosomal dominant	NA	NA	CRYGD	123690	123690	monoallelic	possible	loss of function	Eye	2411	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	alg6-cdg	Muscular hypotonia	Very frequent (99-80%)	ALG6	604566	237124	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	alg6-cdg	Global developmental delay	Very frequent (99-80%)	ALG6	604566	237124	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001399	alg6-cdg	Hepatic failure	Frequent (79-30%)	ALG6	604566	237124	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	wilson-turner syndrome	Cryptorchidism	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000219	wilson-turner syndrome	Thin upper lip vermilion	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000336	wilson-turner syndrome	Prominent supraorbital ridges	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000347	wilson-turner syndrome	Micrognathia	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000455	wilson-turner syndrome	Broad nasal tip	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000490	wilson-turner syndrome	Deeply set eye	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000574	wilson-turner syndrome	Thick eyebrow	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000712	wilson-turner syndrome	Emotional lability	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000771	wilson-turner syndrome	Gynecomastia	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001182	wilson-turner syndrome	Tapered finger	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001249	wilson-turner syndrome	Intellectual disability	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001263	wilson-turner syndrome	Global developmental delay	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001761	wilson-turner syndrome	Pes cavus	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001763	wilson-turner syndrome	Pes planus	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001773	wilson-turner syndrome	Short foot	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001956	wilson-turner syndrome	Truncal obesity	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001999	wilson-turner syndrome	Abnormal facial shape	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0002465	wilson-turner syndrome	Poor speech	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0004322	wilson-turner syndrome	Short stature	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0008551	wilson-turner syndrome	Microtia	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0010620	wilson-turner syndrome	Malar prominence	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0200055	wilson-turner syndrome	Small hand	Very frequent (99-80%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000044	wilson-turner syndrome	Hypogonadotrophic hypogonadism	Frequent (79-30%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001250	wilson-turner syndrome	Seizures	Occasional (29-5%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0001328	wilson-turner syndrome	Specific learning disability	Occasional (29-5%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000518	wilson-turner syndrome	Cataract	Excluded (0%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0000540	wilson-turner syndrome	Hypermetropia	Excluded (0%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
HP:0009909	wilson-turner syndrome	Uplifted earlobe	Excluded (0%)	HDAC8	300269	309585	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition	13315	histone deacetylase 8	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	RPD3		HDACL1|WTS|MRXS6	histone deacetylase-like 1|Wilson-Turner X-linked mental retardation syndrome	X-linked mental retardation|Histone deacetylases, class I
NA	intellectual disability	NA	NA	YY1	No gene mim	No disease mim	monoallelic	confirmed	uncertain	Brain/Cognition	12856	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	salla disease	NA	NA	SLC17A5	604322	604369	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10933	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primordial dwarfism	NA	NA	ERCC4	133520	615272	biallelic	probable	loss of function	Bone Marrow/Immune;Skin;Skeleton	3436	ERCC excision repair 4, endonuclease catalytic subunit	protein-coding gene	gene with protein product	Approved	16p13.12	16p13.12	RAD1|FANCQ	xeroderma pigmentosum, complementation group F	XPF	excision repair cross-complementing rodent repair deficiency, complementation group 4|excision repair cross-complementation group 4	Fanconi anemia complementation groups|Xeroderma pigmentosum complementation groups|ERCC excision repair associated
HP:0000028	coffin-siris syndrome	Cryptorchidism	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000086	coffin-siris syndrome	Ectopic kidney	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000126	coffin-siris syndrome	Hydronephrosis	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000154	coffin-siris syndrome	Wide mouth	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000164	coffin-siris syndrome	Abnormality of the teeth	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000175	coffin-siris syndrome	Cleft palate	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000179	coffin-siris syndrome	Thick lower lip vermilion	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000252	coffin-siris syndrome	Microcephaly	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000280	coffin-siris syndrome	Coarse facial features	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000286	coffin-siris syndrome	Epicanthus	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000322	coffin-siris syndrome	Short philtrum	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000365	coffin-siris syndrome	Hearing impairment	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000431	coffin-siris syndrome	Wide nasal bridge	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000457	coffin-siris syndrome	Depressed nasal ridge	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000486	coffin-siris syndrome	Strabismus	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000508	coffin-siris syndrome	Ptosis	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000518	coffin-siris syndrome	Cataract	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000527	coffin-siris syndrome	Long eyelashes	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000574	coffin-siris syndrome	Thick eyebrow	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000632	coffin-siris syndrome	Lacrimation abnormality	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000639	coffin-siris syndrome	Nystagmus	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000776	coffin-siris syndrome	Congenital diaphragmatic hernia	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000889	coffin-siris syndrome	Abnormality of the clavicle	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0000965	coffin-siris syndrome	Cutis marmorata	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0001249	coffin-siris syndrome	Intellectual disability	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0001250	coffin-siris syndrome	Seizures	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0001252	coffin-siris syndrome	Muscular hypotonia	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0001263	coffin-siris syndrome	Global developmental delay	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0001305	coffin-siris syndrome	Dandy-Walker malformation	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0001338	coffin-siris syndrome	Partial agenesis of the corpus callosum	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0001511	coffin-siris syndrome	Intrauterine growth retardation	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0002079	coffin-siris syndrome	Hypoplasia of the corpus callosum	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0002119	coffin-siris syndrome	Ventriculomegaly	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0002205	coffin-siris syndrome	Recurrent respiratory infections	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0002217	coffin-siris syndrome	Slow-growing hair	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0002230	coffin-siris syndrome	Generalized hirsutism	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0002564	coffin-siris syndrome	Malformation of the heart and great vessels	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0002650	coffin-siris syndrome	Scoliosis	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0002673	coffin-siris syndrome	Coxa valga	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0002808	coffin-siris syndrome	Kyphosis	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0003042	coffin-siris syndrome	Elbow dislocation	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0003272	coffin-siris syndrome	Abnormality of the hip bone	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0003298	coffin-siris syndrome	Spina bifida occulta	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0004322	coffin-siris syndrome	Short stature	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0005108	coffin-siris syndrome	Abnormality of the intervertebral disk	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0005280	coffin-siris syndrome	Depressed nasal bridge	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0005692	coffin-siris syndrome	Joint hyperflexibility	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0006498	coffin-siris syndrome	Aplasia/Hypoplasia of the patella	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0007360	coffin-siris syndrome	Aplasia/Hypoplasia of the cerebellum	Frequent (79-30%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0007598	coffin-siris syndrome	Bilateral single transverse palmar creases	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0008398	coffin-siris syndrome	Hypoplastic fifth fingernail	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0008678	coffin-siris syndrome	Renal hypoplasia/aplasia	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0008872	coffin-siris syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0009239	coffin-siris syndrome	Aplasia/Hypoplasia of the distal phalanx of the 5th finger	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0009882	coffin-siris syndrome	Short distal phalanx of finger	Very frequent (99-80%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0011937	coffin-siris syndrome	Hypoplastic fifth toenail	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0100371	coffin-siris syndrome	Aplasia/Hypoplasia of the distal phalanx of the 5th toe	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
HP:0100790	coffin-siris syndrome	Hernia	Occasional (29-5%)	ARID1A	603024	135900	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	11110	AT-rich interaction domain 1A	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	B120|P270|C10rf4|BAF250|BAF250a		C1orf4|SMARCF1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily f, member 1|AT rich interactive domain 1A (SWI- like)|AT rich interactive domain 1A (SWI-like)	AT-rich interaction domain containing
NA	opitz-kaveggia syndrome	NA	NA	MED12	300188	305450	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition;GI tract;Genitalia	11957	mediator complex subunit 12	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	CAGH45|HOPA|OPA1|TRAP230|KIAA0192|OKS		TNRC11|FGS1	trinucleotide repeat containing 11 (THR-associated protein, 230kDa subunit)|mediator of RNA polymerase II transcription, subunit 12 homolog (S. cerevisiae)|FG syndrome 1	Trinucleotide repeat containing|Mediator complex
NA	autosomal recessive mental retardation	NA	NA	ACBD6	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	23339	acyl-CoA binding domain containing 6	protein-coding gene	gene with protein product	Approved	1q25.2-q25.3	01q25.2-q25.3	MGC2404			acyl-Coenzyme A binding domain containing 6	Ankyrin repeat domain containing
NA	46xy sex reversal 1	NA	NA	SRY	480000	400044	hemizygous	confirmed	loss of function	Genitalia	11311	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract congenital zonular with sutural opacities	NA	NA	CRYBA1	123610	600881	monoallelic	confirmed	loss of function	Eye	2394	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	split-hand/foot malformation type 4	NA	NA	TP63	603273	605289	monoallelic	confirmed	uncertain	Skin;Face;Skeleton	15979	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	transposition of the great arteries dextro-looped type 3	NA	NA	GDF1	No gene mim	613854	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
NA	epilepsy, generalized, with febrile seizures plus, type 1	NA	NA	SCN1B	No gene mim	604233	monoallelic	confirmed	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10586	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	HIST3H3	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	4778	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000069	smith-magenis syndrome	Abnormality of the ureter	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	smith-magenis syndrome	Cleft palate	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000194	smith-magenis syndrome	Open mouth	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000204	smith-magenis syndrome	Cleft upper lip	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	smith-magenis syndrome	Brachycephaly	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	smith-magenis syndrome	Microcephaly	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	smith-magenis syndrome	Mandibular prognathia	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	smith-magenis syndrome	Hypertelorism	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000322	smith-magenis syndrome	Short philtrum	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	smith-magenis syndrome	Broad forehead	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	smith-magenis syndrome	Micrognathia	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000389	smith-magenis syndrome	Chronic otitis media	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000405	smith-magenis syndrome	Conductive hearing impairment	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	smith-magenis syndrome	Wide nasal bridge	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	smith-magenis syndrome	Anteverted nares	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000482	smith-magenis syndrome	Microcornea	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	smith-magenis syndrome	Strabismus	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	smith-magenis syndrome	Deeply set eye	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000541	smith-magenis syndrome	Retinal detachment	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	smith-magenis syndrome	Myopia	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000582	smith-magenis syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000664	smith-magenis syndrome	Synophrys	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000679	smith-magenis syndrome	Taurodontia	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000680	smith-magenis syndrome	Delayed eruption of primary teeth	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000733	smith-magenis syndrome	Stereotypy	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000739	smith-magenis syndrome	Anxiety	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000750	smith-magenis syndrome	Delayed speech and language development	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000821	smith-magenis syndrome	Hypothyroidism	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	smith-magenis syndrome	Delayed puberty	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000826	smith-magenis syndrome	Precocious puberty	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	smith-magenis syndrome	Brachydactyly syndrome	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	smith-magenis syndrome	Hand polydactyly	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	smith-magenis syndrome	Intellectual disability	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	smith-magenis syndrome	Seizures	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	smith-magenis syndrome	Muscular hypotonia	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	smith-magenis syndrome	Global developmental delay	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001265	smith-magenis syndrome	Hyporeflexia	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	smith-magenis syndrome	Gait disturbance	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	smith-magenis syndrome	Joint stiffness	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001513	smith-magenis syndrome	Obesity	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001531	smith-magenis syndrome	Failure to thrive in infancy	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001558	smith-magenis syndrome	Decreased fetal movement	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001609	smith-magenis syndrome	Hoarse voice	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	smith-magenis syndrome	Pes planus	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001770	smith-magenis syndrome	Toe syndactyly	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	smith-magenis syndrome	Frontal bossing	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	smith-magenis syndrome	Constipation	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	smith-magenis syndrome	Gastroesophageal reflux	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	smith-magenis syndrome	Ventriculomegaly	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002155	smith-magenis syndrome	Hypertriglyceridemia	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	smith-magenis syndrome	Neurological speech impairment	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	smith-magenis syndrome	EEG abnormality	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002360	smith-magenis syndrome	Sleep disturbance	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	smith-magenis syndrome	Malformation of the heart and great vessels	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	smith-magenis syndrome	Scoliosis	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003124	smith-magenis syndrome	Hypercholesterolemia	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	smith-magenis syndrome	Short nose	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	smith-magenis syndrome	Abnormal form of the vertebral bodies	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	smith-magenis syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	smith-magenis syndrome	Short stature	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	smith-magenis syndrome	Depressed nasal bridge	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005607	smith-magenis syndrome	Abnormality of the tracheobronchial system	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007016	smith-magenis syndrome	Corticospinal tract hypoplasia	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007018	smith-magenis syndrome	Attention deficit hyperactivity disorder	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007328	smith-magenis syndrome	Impaired pain sensation	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	smith-magenis syndrome	Aplasia/Hypoplasia of the corpus callosum	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008678	smith-magenis syndrome	Renal hypoplasia/aplasia	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	smith-magenis syndrome	Feeding difficulties in infancy	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009830	smith-magenis syndrome	Peripheral neuropathy	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010780	smith-magenis syndrome	Hyperacusis	Frequent (79-30%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010804	smith-magenis syndrome	Tented upper lip vermilion	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	smith-magenis syndrome	Midface retrusion	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100542	smith-magenis syndrome	Abnormal localization of kidney	Occasional (29-5%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100716	smith-magenis syndrome	Self-injurious behavior	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100729	smith-magenis syndrome	Large face	Very frequent (99-80%)	RAI1	607642	182290	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	9834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	c syndrome	Multicystic kidney dysplasia	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000028	c syndrome	Cryptorchidism	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000085	c syndrome	Horseshoe kidney	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000175	c syndrome	Cleft palate	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000191	c syndrome	Accessory oral frenulum	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000212	c syndrome	Gingival overgrowth	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000218	c syndrome	High palate	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000233	c syndrome	Thin vermilion border	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000243	c syndrome	Trigonocephaly	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000252	c syndrome	Microcephaly	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000286	c syndrome	Epicanthus	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000319	c syndrome	Smooth philtrum	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000343	c syndrome	Long philtrum	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000347	c syndrome	Micrognathia	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000368	c syndrome	Low-set, posteriorly rotated ears	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000463	c syndrome	Anteverted nares	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000470	c syndrome	Short neck	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000486	c syndrome	Strabismus	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000582	c syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000767	c syndrome	Pectus excavatum	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000776	c syndrome	Congenital diaphragmatic hernia	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0000960	c syndrome	Sacral dimple	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001161	c syndrome	Hand polydactyly	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001249	c syndrome	Intellectual disability	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001250	c syndrome	Seizures	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001252	c syndrome	Muscular hypotonia	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001373	c syndrome	Joint dislocation	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001376	c syndrome	Limitation of joint mobility	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001522	c syndrome	Death in infancy	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001531	c syndrome	Failure to thrive in infancy	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001539	c syndrome	Omphalocele	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001561	c syndrome	Polyhydramnios	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001582	c syndrome	Redundant skin	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001770	c syndrome	Toe syndactyly	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0001883	c syndrome	Talipes	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0002019	c syndrome	Constipation	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0002564	c syndrome	Malformation of the heart and great vessels	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0002983	c syndrome	Micromelia	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0003083	c syndrome	Dislocated radial head	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0003196	c syndrome	Short nose	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0004209	c syndrome	Clinodactyly of the 5th finger	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0004322	c syndrome	Short stature	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0004378	c syndrome	Abnormality of the anus	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0004422	c syndrome	Biparietal narrowing	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0005280	c syndrome	Depressed nasal bridge	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0007370	c syndrome	Aplasia/Hypoplasia of the corpus callosum	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0007598	c syndrome	Bilateral single transverse palmar creases	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0007601	c syndrome	Midline facial capillary hemangioma	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0008678	c syndrome	Renal hypoplasia/aplasia	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0010318	c syndrome	Aplasia/Hypoplasia of the abdominal wall musculature	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0010458	c syndrome	Female pseudohermaphroditism	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0010720	c syndrome	Abnormal hair pattern	Occasional (29-5%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0010978	c syndrome	Abnormality of immune system physiology	Frequent (79-30%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
HP:0100720	c syndrome	Hypoplasia of the ear cartilage	Very frequent (99-80%)	CD96	606037	211750	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	16892	CD96 molecule	protein-coding gene	gene with protein product	Approved	3q13.13-q13.2	03q13.13-q13.2	TACTILE			CD96 antigen	CD molecules|Immunoglobulin like domain containing|Ig-like cell adhesion molecule family
NA	early infantile epileptic encephalopathy and microcephaly	NA	NA	CSNK1G1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	2454	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital fibrosis of the extraocular muscles	NA	NA	TUBB3	No gene mim	600638	monoallelic	probable	all missense/in frame	Brain/Cognition;Eye	20772	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, autosomal dominant 23	NA	NA	SETD5	No gene mim	615761	monoallelic	confirmed	loss of function	Brain/Cognition	25566	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	complex hereditary spastic paraplegia	NA	NA	DDHD2	615003	615033	biallelic	confirmed	loss of function	Brain/Cognition	29106	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary cillary dyskineasia	NA	NA	CCDC151	No gene mim	616037	biallelic	probable	loss of function	GI tract;Respiratory tract	28303	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005328	keppen-lubinsky syndrome	Progeroid facial appearance	Obligate (100%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0009059	keppen-lubinsky syndrome	Congenital generalized lipodystrophy	Obligate (100%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000194	keppen-lubinsky syndrome	Open mouth	Very frequent (99-80%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000252	keppen-lubinsky syndrome	Microcephaly	Very frequent (99-80%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000322	keppen-lubinsky syndrome	Short philtrum	Very frequent (99-80%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000347	keppen-lubinsky syndrome	Micrognathia	Very frequent (99-80%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0001249	keppen-lubinsky syndrome	Intellectual disability	Very frequent (99-80%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0001347	keppen-lubinsky syndrome	Hyperreflexia	Very frequent (99-80%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0100678	keppen-lubinsky syndrome	Premature skin wrinkling	Very frequent (99-80%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000212	keppen-lubinsky syndrome	Gingival overgrowth	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000218	keppen-lubinsky syndrome	High palate	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000290	keppen-lubinsky syndrome	Abnormality of the forehead	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000292	keppen-lubinsky syndrome	Loss of facial adipose tissue	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000298	keppen-lubinsky syndrome	Mask-like facies	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000430	keppen-lubinsky syndrome	Underdeveloped nasal alae	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000446	keppen-lubinsky syndrome	Narrow nasal bridge	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000496	keppen-lubinsky syndrome	Abnormality of eye movement	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000520	keppen-lubinsky syndrome	Proptosis	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0000586	keppen-lubinsky syndrome	Shallow orbits	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0001090	keppen-lubinsky syndrome	Large eyes	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0001276	keppen-lubinsky syndrome	Hypertonia	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0001285	keppen-lubinsky syndrome	Spastic tetraparesis	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0001371	keppen-lubinsky syndrome	Flexion contracture	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0001508	keppen-lubinsky syndrome	Failure to thrive	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0001561	keppen-lubinsky syndrome	Polyhydramnios	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0002093	keppen-lubinsky syndrome	Respiratory insufficiency	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0002094	keppen-lubinsky syndrome	Dyspnea	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0002179	keppen-lubinsky syndrome	Opisthotonus	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0002187	keppen-lubinsky syndrome	Intellectual disability, profound	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0002650	keppen-lubinsky syndrome	Scoliosis	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0002781	keppen-lubinsky syndrome	Upper airway obstruction	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0005274	keppen-lubinsky syndrome	Prominent nasal tip	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0006532	keppen-lubinsky syndrome	Recurrent pneumonia	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0008734	keppen-lubinsky syndrome	Decreased testicular size	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0008897	keppen-lubinsky syndrome	Postnatal growth retardation	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0009125	keppen-lubinsky syndrome	Lipodystrophy	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0009933	keppen-lubinsky syndrome	Narrow naris	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0010751	keppen-lubinsky syndrome	Chin dimple	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0010804	keppen-lubinsky syndrome	Tented upper lip vermilion	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0011344	keppen-lubinsky syndrome	Severe global developmental delay	Frequent (79-30%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0001250	keppen-lubinsky syndrome	Seizures	Occasional (29-5%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
HP:0002659	keppen-lubinsky syndrome	Increased susceptibility to fractures	Occasional (29-5%)	KCNJ6	No gene mim	614098	monoallelic	probable	all missense/in frame	Skin;Brain/Cognition	6267	potassium voltage-gated channel subfamily J member 6	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13	Kir3.2|GIRK2|KATP2|BIR1|hiGIRK2		KCNJ7	potassium inwardly-rectifying channel, subfamily J, member 6	Potassium voltage-gated channel subfamily J
NA	autosomal-recessive microcephaly with chorioretinopathy.	NA	NA	TUBGCP4	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition;Eye	16691	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ankyloblepharon-ectodermal defects-cleft lip/palate	NA	NA	TP63	603273	106260	monoallelic	confirmed	uncertain	Skin;Face;Skeleton	15979	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondyloepimetaphyseal dysplasia missouri type	NA	NA	MMP13	600108	602111	monoallelic	confirmed	all missense/in frame	Skeleton	7159	matrix metallopeptidase 13	protein-coding gene	gene with protein product	Approved	11q22.2	11q22.2	CLG3	collagenase 3		matrix metalloproteinase 13 (collagenase 3)	Endogenous ligands|M10 matrix metallopeptidases
NA	rps19-related diamond-blackfan anemia	NA	NA	RPS19	603474	220176	monoallelic	confirmed	loss of function	Bone Marrow/Immune	10402	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glycogen storage disease type ii	NA	NA	GAA	606800	232300	biallelic	confirmed	loss of function	Endocrine/Metabolic;Heart/Cardiovasculature/Lymphatic	4065	glucosidase alpha, acid	protein-coding gene	gene with protein product	Approved	17q25.3	17q25.3		Pompe disease|glycogen storage disease type II		glucosidase, alpha; acid	
NA	mental retardation autosomal dominant type 4	NA	NA	KIRREL3	607761	612581	monoallelic	possible	all missense/in frame	Brain/Cognition	23204	kirre like nephrin family adhesion molecule 3	protein-coding gene	gene with protein product	Approved	11q24.2	11q24.2	NEPH2|KIAA1867|KIRRE			kin of IRRE like 3 (Drosophila)	C2-set domain containing|I-set domain containing|Immunoglobulin like domain containing
NA	chrna2-related nocturnal frontal lobe epilepsy, autosomal dominant	NA	NA	CHRNA2	No gene mim	291607	monoallelic	child IF	all missense/in frame	Brain/Cognition	1956	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary failure of tooth eruption	NA	NA	PTH1R	168468	125350	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9608	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	NA	NA	PIK3R2	603157	603387	monoallelic	confirmed	activating	Brain/Cognition	8980	phosphoinositide-3-kinase regulatory subunit 2	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11	P85B|p85	phosphoinositide-3-kinase regulatory subunit beta		phosphoinositide-3-kinase, regulatory subunit 2 (beta)	SH2 domain containing
NA	cacnb4-related episodic ataxia type 2	NA	NA	CACNB4	No gene mim	279386	monoallelic	possible	loss of function	Brain/Cognition	1404	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000385	scalp-ear-nipple syndrome	Small earlobe	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000951	scalp-ear-nipple syndrome	Abnormality of the skin	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0001965	scalp-ear-nipple syndrome	Abnormality of the scalp	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0006709	scalp-ear-nipple syndrome	Aplasia/Hypoplasia of the nipples	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0008070	scalp-ear-nipple syndrome	Sparse hair	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0008551	scalp-ear-nipple syndrome	Microtia	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0009738	scalp-ear-nipple syndrome	Abnormality of the antihelix	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0011251	scalp-ear-nipple syndrome	Underdeveloped antitragus	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0011272	scalp-ear-nipple syndrome	Underdeveloped tragus	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0100783	scalp-ear-nipple syndrome	Breast aplasia	Very frequent (99-80%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000010	scalp-ear-nipple syndrome	Recurrent urinary tract infections	Frequent (79-30%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000164	scalp-ear-nipple syndrome	Abnormality of the teeth	Frequent (79-30%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000506	scalp-ear-nipple syndrome	Telecanthus	Frequent (79-30%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000518	scalp-ear-nipple syndrome	Cataract	Frequent (79-30%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000684	scalp-ear-nipple syndrome	Delayed eruption of teeth	Frequent (79-30%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000822	scalp-ear-nipple syndrome	Hypertension	Frequent (79-30%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0001231	scalp-ear-nipple syndrome	Abnormality of the fingernails	Frequent (79-30%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0100540	scalp-ear-nipple syndrome	Palpebral edema	Frequent (79-30%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0100651	scalp-ear-nipple syndrome	Type I diabetes mellitus	Frequent (79-30%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000073	scalp-ear-nipple syndrome	Ureteral duplication	Occasional (29-5%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000077	scalp-ear-nipple syndrome	Abnormality of the kidney	Occasional (29-5%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000625	scalp-ear-nipple syndrome	Cleft eyelid	Occasional (29-5%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0000966	scalp-ear-nipple syndrome	Hypohidrosis	Occasional (29-5%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0005580	scalp-ear-nipple syndrome	Duplication of renal pelvis	Occasional (29-5%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
HP:0012330	scalp-ear-nipple syndrome	Pyelonephritis	Occasional (29-5%)	KCTD1	No gene mim	No disease mim	monoallelic	confirmed	activating	Skin;Eye	18249	potassium channel tetramerization domain containing 1	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2			C18orf5	potassium channel tetramerisation domain containing 1	
NA	retinal non-attachment congenital non-syndromic	NA	NA	ATOH7	No gene mim	221900	biallelic	possible	cis-regulatory or promotor mutation	Eye	13907	atonal bHLH transcription factor 7	protein-coding gene	gene with protein product	Approved	10q21.3	10q21.3	Math5|bHLHa13			atonal homolog 7 (Drosophila)|atonal homolog bHLH transcription factor 7	Basic helix-loop-helix proteins
NA	mitochondrial progressive myopathy with congenital cataract hearing loss and developmental delay (mpmchd	NA	NA	GFER	No gene mim	613076	biallelic	possible	loss of function	Musculature;Ear	4236	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atrial septal defect type 4	NA	NA	TBX20	606061	611363	monoallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	11598	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital disorder of glycosylation, type iik	NA	NA	TMEM165	614726	614727	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;GI tract	30760	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fg syndrome type 4	NA	NA	CASK	300172	300422	hemizygous	confirmed	uncertain	Face;Brain/Cognition;GI tract	1497	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000071	frontometaphyseal dysplasia	Ureteral stenosis	Occasional (29-5%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000126	frontometaphyseal dysplasia	Hydronephrosis	Occasional (29-5%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000218	frontometaphyseal dysplasia	High palate	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000316	frontometaphyseal dysplasia	Hypertelorism	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000336	frontometaphyseal dysplasia	Prominent supraorbital ridges	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000347	frontometaphyseal dysplasia	Micrognathia	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000405	frontometaphyseal dysplasia	Conductive hearing impairment	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000407	frontometaphyseal dysplasia	Sensorineural hearing impairment	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000494	frontometaphyseal dysplasia	Downslanted palpebral fissures	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000940	frontometaphyseal dysplasia	Abnormal diaphysis morphology	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0000944	frontometaphyseal dysplasia	Abnormality of the metaphyses	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001363	frontometaphyseal dysplasia	Craniosynostosis	Occasional (29-5%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001387	frontometaphyseal dysplasia	Joint stiffness	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0001607	frontometaphyseal dysplasia	Subglottic stenosis	Occasional (29-5%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002650	frontometaphyseal dysplasia	Scoliosis	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002777	frontometaphyseal dysplasia	Tracheal stenosis	Occasional (29-5%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0002949	frontometaphyseal dysplasia	Fused cervical vertebrae	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0003042	frontometaphyseal dysplasia	Elbow dislocation	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0003312	frontometaphyseal dysplasia	Abnormal form of the vertebral bodies	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0004493	frontometaphyseal dysplasia	Craniofacial hyperostosis	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0005048	frontometaphyseal dysplasia	Synostosis of carpal bones	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0005453	frontometaphyseal dysplasia	Absent/hypoplastic paranasal sinuses	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0005616	frontometaphyseal dysplasia	Accelerated skeletal maturation	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0006160	frontometaphyseal dysplasia	Irregular metacarpals	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0006482	frontometaphyseal dysplasia	Abnormality of dental morphology	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0006487	frontometaphyseal dysplasia	Bowing of the long bones	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0006695	frontometaphyseal dysplasia	Atrioventricular canal defect	Occasional (29-5%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0008451	frontometaphyseal dysplasia	Posterior vertebral hypoplasia	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0008661	frontometaphyseal dysplasia	Urethral stenosis	Occasional (29-5%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0009004	frontometaphyseal dysplasia	Hypoplasia of the musculature	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0009465	frontometaphyseal dysplasia	Ulnar deviation of finger	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0009650	frontometaphyseal dysplasia	Short distal phalanx of the thumb	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0009804	frontometaphyseal dysplasia	Reduced number of teeth	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0010103	frontometaphyseal dysplasia	Short distal phalanx of hallux	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0010493	frontometaphyseal dysplasia	Long metacarpals	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0100490	frontometaphyseal dysplasia	Camptodactyly of finger	Very frequent (99-80%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
HP:0100807	frontometaphyseal dysplasia	Long fingers	Frequent (79-30%)	FLNA	300017	305620	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
NA	leukodystrophy hypomyelinating type 5	NA	NA	FAM126A	610531	610532	biallelic	confirmed	loss of function	Brain/Cognition;Eye	24587	family with sequence similarity 126 member A	protein-coding gene	gene with protein product	Approved	7p15.3	07p15.3	DRCTNNB1A|HCC|HYCC1|hyccin	down regulated by Ctnnb1, a		family with sequence similarity 126, member A	
HP:0000003	renal cysts and diabetes syndrome	Multicystic kidney dysplasia	Very frequent (99-80%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	renal cysts and diabetes syndrome	Hypospadias	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000083	renal cysts and diabetes syndrome	Renal insufficiency	Very frequent (99-80%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000085	renal cysts and diabetes syndrome	Horseshoe kidney	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000104	renal cysts and diabetes syndrome	Renal agenesis	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	renal cysts and diabetes syndrome	Mandibular prognathia	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	renal cysts and diabetes syndrome	Hearing impairment	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000813	renal cysts and diabetes syndrome	Bicornuate uterus	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000819	renal cysts and diabetes syndrome	Diabetes mellitus	Frequent (79-30%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000821	renal cysts and diabetes syndrome	Hypothyroidism	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000952	renal cysts and diabetes syndrome	Jaundice	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	renal cysts and diabetes syndrome	Intellectual disability	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	renal cysts and diabetes syndrome	Global developmental delay	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001369	renal cysts and diabetes syndrome	Arthritis	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001397	renal cysts and diabetes syndrome	Hepatic steatosis	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001919	renal cysts and diabetes syndrome	Acute kidney injury	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001959	renal cysts and diabetes syndrome	Polydipsia	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001994	renal cysts and diabetes syndrome	Renal Fanconi syndrome	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002021	renal cysts and diabetes syndrome	Pyloric stenosis	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002149	renal cysts and diabetes syndrome	Hyperuricemia	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002910	renal cysts and diabetes syndrome	Elevated hepatic transaminases	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005584	renal cysts and diabetes syndrome	Renal cell carcinoma	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	renal cysts and diabetes syndrome	Joint hyperflexibility	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009715	renal cysts and diabetes syndrome	Papillary cystadenoma of the epididymis	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012092	renal cysts and diabetes syndrome	Abnormality of exocrine pancreas physiology	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012093	renal cysts and diabetes syndrome	Abnormality of endocrine pancreas physiology	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012873	renal cysts and diabetes syndrome	Absent vas deferens	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100800	renal cysts and diabetes syndrome	Aplasia/Hypoplasia of the pancreas	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100820	renal cysts and diabetes syndrome	Glomerulopathy	Occasional (29-5%)	HNF1B	189907	137920	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	11630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	ELP2	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	18248	elongator acetyltransferase complex subunit 2	protein-coding gene	gene with protein product	Approved	18q12.2	18q12.2	FLJ10879|StIP		STATIP1	signal transducer and activator of transcription 3 interacting protein 1|elongation protein 2 homolog (S. cerevisiae)	WD repeat domain containing|Elongator acetyltransferase complex 
NA	molybdenum cofactor deficiency	NA	NA	MOCS2	603708	603707	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7193	molybdenum cofactor synthesis 2	protein-coding gene	gene with protein product	Approved	5q11.2	05q11.2	MOCO1				
NA	epileptic encephalopathy	NA	NA	SYNGAP1	603384	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	11497	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000561	alopecia universalis	Absent eyelashes	Very frequent (99-80%)	HR	602302	146550	biallelic	confirmed	all missense/in frame	Skin;Hair/Nails	5172	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002223	alopecia universalis	Absent eyebrow	Very frequent (99-80%)	HR	602302	146550	biallelic	confirmed	all missense/in frame	Skin;Hair/Nails	5172	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002229	alopecia universalis	Alopecia areata	Very frequent (99-80%)	HR	602302	146550	biallelic	confirmed	all missense/in frame	Skin;Hair/Nails	5172	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002289	alopecia universalis	Alopecia universalis	Very frequent (99-80%)	HR	602302	146550	biallelic	confirmed	all missense/in frame	Skin;Hair/Nails	5172	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	vacterl association with hydrocephalus	NA	NA	PTEN	601728	276950	monoallelic	confirmed	uncertain	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	thrombocytopenia 2	NA	NA	ANKRD26	610855	188000	monoallelic	probable	5_prime or 3_prime UTR mutation	Bone Marrow/Immune	29186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hereditary fructose intolerance	NA	NA	ALDOB	No gene mim	229600	biallelic	both DD and IF	loss of function	Endocrine/Metabolic	417	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	alpha-thalassemia mental retardation syndrome x-linked non-deletion type	NA	NA	ATRX	300032	301040	hemizygous	confirmed	loss of function	Face;Brain/Cognition;Genitalia	886	ATRX, chromatin remodeler	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1	XH2|XNP	RAD54 homolog (S. cerevisiae)	RAD54|JMS|MRX52	alpha thalassemia/mental retardation syndrome X-linked (RAD54 (S. cerevisiae) homolog)|Juberg-Marsidi syndrome|mental retardation, X-linked 52|alpha thalassemia/mental retardation syndrome X-linked	X-linked mental retardation|RNA helicases
NA	ectodermal dysplasia anhidrotic with immunodeficiency-osteopetrosis-lymphedema	NA	NA	IKBKG	300248	300301	hemizygous	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
NA	popliteal pterygium syndrome	NA	NA	IRF6	607199	119500	monoallelic	confirmed	activating	Face;Skeleton	6121	interferon regulatory factor 6	protein-coding gene	gene with protein product	Approved	1q32.2	01q32.2	OFC6|VWS1		VWS|LPS	Van der Woude syndrome	
NA	agenesis of the corpus callosum with peripheral neuropathy	NA	NA	SLC12A6	604878	218000	biallelic	confirmed	loss of function	Face;Spinal cord/Peripheral nerves;Brain/Cognition	10914	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	non-syndromic orofacial cleft type 8	NA	NA	TP63	603273	129400	monoallelic	confirmed	uncertain	Skin;Face;Skeleton	15979	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000112	congenital disorder of glycosylation	Nephropathy	Occasional (29-5%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	congenital disorder of glycosylation	Broad forehead	Frequent (79-30%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000478	congenital disorder of glycosylation	Abnormality of the eye	Frequent (79-30%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	congenital disorder of glycosylation	Strabismus	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	congenital disorder of glycosylation	Abnormality of vision	Frequent (79-30%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000815	congenital disorder of glycosylation	Hypergonadotropic hypogonadism	Frequent (79-30%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	congenital disorder of glycosylation	Seizures	Frequent (79-30%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	congenital disorder of glycosylation	Global developmental delay	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001410	congenital disorder of glycosylation	Decreased liver function	Occasional (29-5%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	congenital disorder of glycosylation	Failure to thrive	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001541	congenital disorder of glycosylation	Ascites	Occasional (29-5%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001638	congenital disorder of glycosylation	Cardiomyopathy	Frequent (79-30%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001697	congenital disorder of glycosylation	Abnormality of the pericardium	Frequent (79-30%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001928	congenital disorder of glycosylation	Abnormality of coagulation	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	congenital disorder of glycosylation	Hypoglycemia	Frequent (79-30%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002120	congenital disorder of glycosylation	Cerebral cortical atrophy	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002242	congenital disorder of glycosylation	Abnormality of the intestine	Occasional (29-5%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002910	congenital disorder of glycosylation	Elevated hepatic transaminases	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006610	congenital disorder of glycosylation	Wide intermamillary distance	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006709	congenital disorder of glycosylation	Aplasia/Hypoplasia of the nipples	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	congenital disorder of glycosylation	Aplasia/Hypoplasia of the cerebellum	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007552	congenital disorder of glycosylation	Abnormal subcutaneous fat tissue distribution	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	congenital disorder of glycosylation	Abnormality of retinal pigmentation	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009830	congenital disorder of glycosylation	Peripheral neuropathy	Occasional (29-5%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	congenital disorder of glycosylation	Abnormality of immune system physiology	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011013	congenital disorder of glycosylation	Abnormality of carbohydrate metabolism/homeostasis	Very frequent (99-80%)	SLC35A2	314375	No disease mim	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	adrenoleukodystrophy, x-linked	NA	NA	ABCD1	No gene mim	300100	hemizygous	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition	61	ATP binding cassette subfamily D member 1	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	AMN|ALDP|adrenoleukodystrophy		ALD	ATP-binding cassette, sub-family D (ALD), member 1	ATP binding cassette subfamily D
NA	snyder-robinson syndrome	NA	NA	SMS	300105	309583	hemizygous	probable	loss of function	Face;Skeleton;Brain/Cognition	11123	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glutamate formiminotransferase deficiency	NA	NA	FTCD	606806	229100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	3974	formimidoyltransferase cyclodeaminase	protein-coding gene	gene with protein product	Approved	21q22.3	21q22.3				formiminotransferase cyclodeaminase	
NA	benign neonatal epilepsy type 1	NA	NA	KCNQ2	602235	121200	monoallelic	confirmed	loss of function	Musculature;Brain/Cognition	6296	potassium voltage-gated channel subfamily Q member 2	protein-coding gene	gene with protein product	Approved	20q13.33	20q13.33	Kv7.2|ENB1|BFNC|KCNA11|HNSPC		EBN|EBN1	potassium voltage-gated channel, KQT-like subfamily, member 2|potassium channel, voltage gated KQT-like subfamily Q, member 2	Potassium voltage-gated channels
HP:0000256	canavan disease	Macrocephaly	Frequent (79-30%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0000365	canavan disease	Hearing impairment	Frequent (79-30%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0000505	canavan disease	Visual impairment	Frequent (79-30%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0000618	canavan disease	Blindness	Frequent (79-30%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0000648	canavan disease	Optic atrophy	Very frequent (99-80%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0000649	canavan disease	Abnormality of visual evoked potentials	Frequent (79-30%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0001250	canavan disease	Seizures	Occasional (29-5%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0001252	canavan disease	Muscular hypotonia	Frequent (79-30%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0001263	canavan disease	Global developmental delay	Very frequent (99-80%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0001276	canavan disease	Hypertonia	Frequent (79-30%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0001371	canavan disease	Flexion contracture	Occasional (29-5%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0002020	canavan disease	Gastroesophageal reflux	Frequent (79-30%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0002353	canavan disease	EEG abnormality	Very frequent (99-80%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0002376	canavan disease	Developmental regression	Occasional (29-5%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0004372	canavan disease	Reduced consciousness/confusion	Very frequent (99-80%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0007703	canavan disease	Abnormality of retinal pigmentation	Occasional (29-5%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0008872	canavan disease	Feeding difficulties in infancy	Very frequent (99-80%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
HP:0100543	canavan disease	Cognitive impairment	Very frequent (99-80%)	ASPA	608034	271900	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	756	aspartoacylase	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2	ASP|ACY2	aminoacylase 2|Canavan disease		aspartoacylase (aminoacylase 2, Canavan disease)	
NA	seborrhea-like dermatitis with psoriasiform elements	NA	NA	ZNF750	610226	610227	monoallelic	probable	loss of function	Skin	25843	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rubinstein-taybi syndrome type 2	NA	NA	EP300	602700	613684	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	3373	E1A binding protein p300	protein-coding gene	gene with protein product	Approved	22q13.2	22q13.2	p300|KAT3B	histone acetyltransferase p300			Zinc fingers ZZ-type|Lysine acetyltransferases
NA	mental retardation syndromic x-linked type 14	NA	NA	UPF3B	300298	300676	hemizygous	confirmed	loss of function	Skeleton;Brain/Cognition	20439	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	aicardi-goutieres syndrome	NA	NA	SAMHD1	606754	239588	biallelic	confirmed	loss of function	Skin;Brain/Cognition	15925	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	argininosuccinate lyase deficiency	NA	NA	ASL	608310	207900	biallelic	confirmed	loss of function	Endocrine/Metabolic	746	argininosuccinate lyase	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21					
HP:0000256	brachydactyly type e	Macrocephaly	Occasional (29-5%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	brachydactyly type e	Frontal bossing	Occasional (29-5%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	brachydactyly type e	Short stature	Frequent (79-30%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	brachydactyly type e	Joint hyperflexibility	Frequent (79-30%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005863	brachydactyly type e	Type E brachydactyly	Very frequent (99-80%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009882	brachydactyly type e	Short distal phalanx of finger	Frequent (79-30%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010049	brachydactyly type e	Short metacarpal	Very frequent (99-80%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010076	brachydactyly type e	Aplasia/Hypoplasia of the distal phalanx of the hallux	Occasional (29-5%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010743	brachydactyly type e	Short metatarsal	Occasional (29-5%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100560	brachydactyly type e	Upper limb asymmetry	Occasional (29-5%)	HOXD13	142989	113300	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	generalized epilepsy with febrile seizures plus, type 9	NA	NA	STX1B	No gene mim	616172	monoallelic	probable	loss of function	Brain/Cognition	18539	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX3	603164	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	8858	peroxisomal biogenesis factor 3	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2					Peroxins
NA	stickler syndrome type 1 non-syndromic ocular	NA	NA	COL2A1	120140	609508	monoallelic	confirmed	loss of function	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	achondrogenesis type 1b	Macrocephaly	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	achondrogenesis type 1b	Long philtrum	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	achondrogenesis type 1b	Micrognathia	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	achondrogenesis type 1b	Anteverted nares	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	achondrogenesis type 1b	Short neck	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000474	achondrogenesis type 1b	Thickened nuchal skin fold	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000476	achondrogenesis type 1b	Cystic hygroma	Occasional (29-5%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	achondrogenesis type 1b	Abnormality of the ribs	Frequent (79-30%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	achondrogenesis type 1b	Narrow chest	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	achondrogenesis type 1b	Umbilical hernia	Frequent (79-30%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	achondrogenesis type 1b	Polyhydramnios	Frequent (79-30%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001762	achondrogenesis type 1b	Talipes equinovarus	Frequent (79-30%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001773	achondrogenesis type 1b	Short foot	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001789	achondrogenesis type 1b	Hydrops fetalis	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	achondrogenesis type 1b	Frontal bossing	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	achondrogenesis type 1b	Malformation of the heart and great vessels	Occasional (29-5%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	achondrogenesis type 1b	Micromelia	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	achondrogenesis type 1b	Short nose	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003336	achondrogenesis type 1b	Abnormal enchondral ossification	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003498	achondrogenesis type 1b	Disproportionate short stature	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003510	achondrogenesis type 1b	Severe short stature	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005716	achondrogenesis type 1b	Lethal skeletal dysplasia	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006703	achondrogenesis type 1b	Aplasia/Hypoplasia of the lungs	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010306	achondrogenesis type 1b	Short thorax	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012368	achondrogenesis type 1b	Flat face	Very frequent (99-80%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100541	achondrogenesis type 1b	Femoral hernia	Frequent (79-30%)	SLC26A2	606718	600972	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	juvenile myoclonic epilepsy	NA	NA	GABRA1	No gene mim	611136	monoallelic	probable	loss of function	Brain/Cognition	4075	gamma-aminobutyric acid type A receptor alpha1 subunit	protein-coding gene	gene with protein product	Approved	5q34	05q34	EJM5	GABA(A) receptor, alpha 1		gamma-aminobutyric acid (GABA) A receptor, alpha 1	Gamma-aminobutyric acid type A receptor subunits
NA	carney complex variant	NA	NA	MYH8	No gene mim	608837	monoallelic	both DD and IF	all missense/in frame	Skin;Skeleton;Cancer predisposition	7578	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	hutchinson-gilford progeria syndrome	Narrow mouth	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000320	hutchinson-gilford progeria syndrome	Bird-like facies	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000347	hutchinson-gilford progeria syndrome	Micrognathia	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000407	hutchinson-gilford progeria syndrome	Sensorineural hearing impairment	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000520	hutchinson-gilford progeria syndrome	Proptosis	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000684	hutchinson-gilford progeria syndrome	Delayed eruption of teeth	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000765	hutchinson-gilford progeria syndrome	Abnormality of the thorax	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000789	hutchinson-gilford progeria syndrome	Infertility	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000842	hutchinson-gilford progeria syndrome	Hyperinsulinemia	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000894	hutchinson-gilford progeria syndrome	Short clavicles	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000939	hutchinson-gilford progeria syndrome	Osteoporosis	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001043	hutchinson-gilford progeria syndrome	Prominent scalp veins	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001387	hutchinson-gilford progeria syndrome	Joint stiffness	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001508	hutchinson-gilford progeria syndrome	Failure to thrive	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001510	hutchinson-gilford progeria syndrome	Growth delay	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001596	hutchinson-gilford progeria syndrome	Alopecia	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001611	hutchinson-gilford progeria syndrome	Nasal speech	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001620	hutchinson-gilford progeria syndrome	High pitched voice	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001894	hutchinson-gilford progeria syndrome	Thrombocytosis	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002692	hutchinson-gilford progeria syndrome	Hypoplastic facial bones	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002753	hutchinson-gilford progeria syndrome	Thin bony cortex	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002828	hutchinson-gilford progeria syndrome	Multiple joint contractures	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0003335	hutchinson-gilford progeria syndrome	Low gonadotropins (secondary hypogonadism)	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0004322	hutchinson-gilford progeria syndrome	Short stature	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0004325	hutchinson-gilford progeria syndrome	Decreased body weight	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0005461	hutchinson-gilford progeria syndrome	Craniofacial disproportion	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0006660	hutchinson-gilford progeria syndrome	Aplastic clavicles	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0008070	hutchinson-gilford progeria syndrome	Sparse hair	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0008197	hutchinson-gilford progeria syndrome	Absence of pubertal development	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0008214	hutchinson-gilford progeria syndrome	Decreased serum estradiol	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0008230	hutchinson-gilford progeria syndrome	Decreased testosterone in males	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0010665	hutchinson-gilford progeria syndrome	Bilateral coxa valga	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0011220	hutchinson-gilford progeria syndrome	Prominent forehead	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0100578	hutchinson-gilford progeria syndrome	Lipoatrophy	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0100671	hutchinson-gilford progeria syndrome	Abnormal trabecular bone morphology	Very frequent (99-80%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000233	hutchinson-gilford progeria syndrome	Thin vermilion border	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000400	hutchinson-gilford progeria syndrome	Macrotia	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000535	hutchinson-gilford progeria syndrome	Sparse eyebrow	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000540	hutchinson-gilford progeria syndrome	Hypermetropia	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000561	hutchinson-gilford progeria syndrome	Absent eyelashes	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000668	hutchinson-gilford progeria syndrome	Hypodontia	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000822	hutchinson-gilford progeria syndrome	Hypertension	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000883	hutchinson-gilford progeria syndrome	Thin ribs	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000961	hutchinson-gilford progeria syndrome	Cyanosis	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000963	hutchinson-gilford progeria syndrome	Thin skin	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000966	hutchinson-gilford progeria syndrome	Hypohidrosis	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001006	hutchinson-gilford progeria syndrome	Hypotrichosis	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001097	hutchinson-gilford progeria syndrome	Keratoconjunctivitis sicca	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001397	hutchinson-gilford progeria syndrome	Hepatic steatosis	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001681	hutchinson-gilford progeria syndrome	Angina pectoris	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001816	hutchinson-gilford progeria syndrome	Thin nail	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002136	hutchinson-gilford progeria syndrome	Broad-based gait	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002164	hutchinson-gilford progeria syndrome	Nail dysplasia	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002216	hutchinson-gilford progeria syndrome	Premature graying of hair	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002557	hutchinson-gilford progeria syndrome	Hypoplastic nipples	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002758	hutchinson-gilford progeria syndrome	Osteoarthritis	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002808	hutchinson-gilford progeria syndrome	Kyphosis	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002905	hutchinson-gilford progeria syndrome	Hyperphosphatemia	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0003016	hutchinson-gilford progeria syndrome	Metaphyseal widening	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0003300	hutchinson-gilford progeria syndrome	Ovoid vertebral bodies	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0003355	hutchinson-gilford progeria syndrome	Aminoaciduria	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0004417	hutchinson-gilford progeria syndrome	Intermittent claudication	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0004492	hutchinson-gilford progeria syndrome	Widely patent fontanelles and sutures	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0004931	hutchinson-gilford progeria syndrome	Arteriosclerosis of small cerebral arteries	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0005181	hutchinson-gilford progeria syndrome	Premature coronary artery disease	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0006224	hutchinson-gilford progeria syndrome	Tapering pointed ends of distal finger phalanges	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0007427	hutchinson-gilford progeria syndrome	Reticulated skin pigmentation	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0008151	hutchinson-gilford progeria syndrome	Prolonged prothrombin time	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0009906	hutchinson-gilford progeria syndrome	Aplasia/Hypoplasia of the earlobes	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0011832	hutchinson-gilford progeria syndrome	Narrow nasal tip	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0100679	hutchinson-gilford progeria syndrome	Lack of skin elasticity	Frequent (79-30%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000678	hutchinson-gilford progeria syndrome	Dental crowding	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000877	hutchinson-gilford progeria syndrome	Insulin-resistant diabetes mellitus at puberty	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000938	hutchinson-gilford progeria syndrome	Osteopenia	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000956	hutchinson-gilford progeria syndrome	Acanthosis nigricans	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001297	hutchinson-gilford progeria syndrome	Stroke	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001657	hutchinson-gilford progeria syndrome	Prolonged QT interval	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002155	hutchinson-gilford progeria syndrome	Hypertriglyceridemia	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002326	hutchinson-gilford progeria syndrome	Transient ischemic attack	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002827	hutchinson-gilford progeria syndrome	Hip dislocation	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0003115	hutchinson-gilford progeria syndrome	Abnormal EKG	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0011356	hutchinson-gilford progeria syndrome	Regional abnormality of skin	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0011703	hutchinson-gilford progeria syndrome	Sinus tachycardia	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0100546	hutchinson-gilford progeria syndrome	Carotid artery stenosis	Occasional (29-5%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000823	hutchinson-gilford progeria syndrome	Delayed puberty	Very rare (<4-1%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001712	hutchinson-gilford progeria syndrome	Left ventricular hypertrophy	Very rare (<4-1%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000518	hutchinson-gilford progeria syndrome	Cataract	Excluded (0%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000726	hutchinson-gilford progeria syndrome	Dementia	Excluded (0%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001084	hutchinson-gilford progeria syndrome	Corneal arcus	Excluded (0%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001249	hutchinson-gilford progeria syndrome	Intellectual disability	Excluded (0%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002664	hutchinson-gilford progeria syndrome	Neoplasm	Excluded (0%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0040113	hutchinson-gilford progeria syndrome	Old-aged sensorineural hearing impairment	Excluded (0%)	LMNA	No gene mim	176670	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
NA	branchiootorenal syndrome type 2	NA	NA	SIX5	No gene mim	610896	monoallelic	confirmed	all missense/in frame	Skin;Face;Eye	10891	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	coenzyme q10 deficiency	Cataract	Very frequent (99-80%)	COQ9	612837	607426	biallelic	confirmed	loss of function	Endocrine/Metabolic	25302	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000974	coenzyme q10 deficiency	Hyperextensible skin	Very frequent (99-80%)	COQ9	612837	607426	biallelic	confirmed	loss of function	Endocrine/Metabolic	25302	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	coenzyme q10 deficiency	Intellectual disability	Very frequent (99-80%)	COQ9	612837	607426	biallelic	confirmed	loss of function	Endocrine/Metabolic	25302	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	coenzyme q10 deficiency	Joint hyperflexibility	Very frequent (99-80%)	COQ9	612837	607426	biallelic	confirmed	loss of function	Endocrine/Metabolic	25302	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	axenfeld-rieger syndrome type 1	NA	NA	PITX2	601542	180500	monoallelic	confirmed	loss of function	Teeth & Dentitian;Eye;GI tract	9005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neuronal ceroid lipofuscinosis type 1	NA	NA	PPT1	600722	256730	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	9325	palmitoyl-protein thioesterase 1	protein-coding gene	gene with protein product	Approved	1p34.2	01p34.2	CLN1|INCL	ceroid-lipofuscinosis, neuronal 1, infantile	PPT		
NA	mental retardation syndromic x-linked christianson type	NA	NA	SLC9A6	300231	300243	hemizygous	confirmed	loss of function	Brain/Cognition	11079	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanconi anemia complementation group d type 1	NA	NA	BRCA2	No gene mim	605724	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	1101	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microcephaly primary type 6	NA	NA	CENPJ	609279	608393	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	17272	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ogden syndrome	NA	NA	NAA10	300013	300855	hemizygous	confirmed	all missense/in frame	Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	18704	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	myopathy with extrapyramidal signs	NA	NA	MICU1	No gene mim	615673	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition	1530	mitochondrial calcium uptake 1	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	CALC|EFHA3|FLJ12684		CBARA1	calcium binding atopy-related autoantigen 1	EF-hand domain containing
HP:0000486	leigh syndrome	Strabismus	Very frequent (99-80%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leigh syndrome	Nystagmus	Very frequent (99-80%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	leigh syndrome	Optic atrophy	Frequent (79-30%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leigh syndrome	Seizures	Frequent (79-30%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	leigh syndrome	Ataxia	Very frequent (99-80%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leigh syndrome	Muscular hypotonia	Very frequent (99-80%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	leigh syndrome	Respiratory insufficiency	Very frequent (99-80%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leigh syndrome	Hemiplegia/hemiparesis	Frequent (79-30%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007020	leigh syndrome	Progressive spastic paraplegia	Frequent (79-30%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007650	leigh syndrome	Progressive ophthalmoplegia	Frequent (79-30%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008972	leigh syndrome	Decreased activity of mitochondrial respiratory chain	Very frequent (99-80%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	leigh syndrome	Abnormality of movement	Very frequent (99-80%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	leigh syndrome	Cognitive impairment	Very frequent (99-80%)	NDUFS1	157655	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	early-onset epileptic encephalopathy with persistent myelination defect.	NA	NA	AARS	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	20	alanyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	16q22.1	16q22.1	CMT2N|AlaRS	alanine tRNA ligase 1, cytoplasmic			Aminoacyl tRNA synthetases, Class II
NA	immunodeficiency with cleft lip/palate, cataract, hypopigmentation, and absent corpus callosum	NA	NA	EPG5	615068	242840	biallelic	confirmed	loss of function	Musculature;Skin;Brain/Cognition;Eye	29331	ectopic P-granules autophagy protein 5 homolog	protein-coding gene	gene with protein product	Approved	18q12.3-q21.1	18q12.3-q21.1	hEPG5		KIAA1632	KIAA1632|ectopic P-granules autophagy protein 5 homolog (C. elegans)	
NA	autosomal recessive mental retardation	NA	NA	ADK	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	257	adenosine kinase	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	AK	"adenosine 5-phosphotransferase					1986-01-01			2016-11-01	132	ENSG00000156110	OTTHUMG00000018506	uc001jwi.4	U50196	NM_006721	""CCDS7343|CCDS7344|CCDS55716|CCDS55717""	P55263	8577746	MGI:87930	RGD:2046		ADK	102750					289298					objectId:1231					2.7.1.20		
HGNC:259	ADM	adrenomedullin	protein-coding gene	gene with protein product	Approved	11p15.4	11p15.4	AM				Endogenous ligands	542	1994-12-15			2015-08-24	133	ENSG00000148926	OTTHUMG00000165907	uc001mil.2	D14874	NM_001124	CCDS7801	P35318	7688224	MGI:108058	RGD:2047		ADM	103275										ligandId:683							
HGNC:28898	ADM2	adrenomedullin 2	protein-coding gene	gene with protein product	Approved	22q13.33	22q13.33	""AM2|FLJ21135""				Endogenous ligands	542	2004-02-04			2014-11-19	79924	ENSG00000128165	OTTHUMG00000150202	uc003blj.4	AF529213	NM_024866	CCDS33682	Q7Z4H4	14706825	MGI:2675256	RGD:1302971		ADM2	608682										ligandId:684							
HGNC:27293	ADM5	adrenomedullin 5 (putative)	protein-coding gene	gene with protein product	Approved	19q13.33	19q13.33	AM5		C19orf76	""chromosome 19 open reading frame 76|adrenomedullin 5 homolog (pig)""			2009-09-22	2012-10-29	2012-12-07	2016-11-16	199800	ENSG00000224420	OTTHUMG00000183240	uc002pph.3	BC032764	NM_001101340	CCDS46146	C9JUS6	18434369																						
HGNC:15766	ADNP	activity dependent neuroprotector homeobox	protein-coding gene	gene with protein product	Approved	20q13.13	20q13.13	""KIAA0784|ADNP1""	ADNP homeobox 1		activity-dependent neuroprotector	ZF class homeoboxes and pseudogenes	529	2001-05-31		2016-06-08	2016-06-08	23394	ENSG00000101126	OTTHUMG00000032737	uc002xvt.3	AF250860	NM_181442	CCDS13433	Q9H2P0	""9872452|11013255""	MGI:1338758	RGD:71030		ADNP	611386		8666			406010												
HGNC:51227	ADNP-AS1	ADNP antisense RNA 1	non-coding RNA	RNA, long non-coding	Approved	20q13.13	20q13.13							2014-08-08			2014-08-08	101927631	ENSG00000259456	OTTHUMG00000172534			NR_110009																									URS000075E7BC
HGNC:23803	ADNP2	ADNP homeobox 2	protein-coding gene	gene with protein product	Approved	18q23	18q23	KIAA0863		ZNF508	zinc finger protein 508	""Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes""	""28|529""	2006-06-30	2007-07-17	2007-07-17	2014-11-19	22850	ENSG00000101544	OTTHUMG00000172535	uc032hie.2	AB020670	NM_014913	CCDS32853	Q6IQ32		MGI:2448562	RGD:1308279		ADNP2	617422		8560															
HGNC:23506	ADO	2-aminoethanethiol dioxygenase	protein-coding gene	gene with protein product	Approved	10q21.3	10q21.3	FLJ14547	cysteamine dioxygenase	C10orf22	""chromosome 10 open reading frame 22|2-aminoethanethiol (cysteamine) dioxygenase""			2003-11-21	2007-08-28	2016-06-03	2016-06-03	84890	ENSG00000181915	OTTHUMG00000018306	uc001jmg.4	BC028589	NM_032804	CCDS7266	Q96SZ5	17581819	MGI:2685083	RGD:1308233		ADO	611392															1.13.11.19		
HGNC:262	ADORA1	adenosine A1 receptor	protein-coding gene	gene with protein product	Approved	1q32.1	01q32.1	RDC7				Adenosine receptors	211	1991-03-11			2014-11-19	134	ENSG00000163485	OTTHUMG00000042125	uc057onx.1	BC026340	NM_000674	CCDS1434	P30542	""1662665|2541503""	MGI:99401	RGD:2048		ADORA1	102775										objectId:18							
HGNC:263	ADORA2A	adenosine A2a receptor	protein-coding gene	gene with protein product	Approved	22q11.23	22q11.23	RDC8		ADORA2		Adenosine receptors	211	1991-03-11			2014-11-19	135	ENSG00000128271	OTTHUMG00000150761	uc002zzy.6	X68486	NM_000675	CCDS13826	P29274	""1662665|2541503""	MGI:99402	RGD:2049		ADORA2A	102776					365126					objectId:19							
HGNC:37122	ADORA2A-AS1	ADORA2A antisense RNA 1	non-coding RNA	RNA, long non-coding	Approved	22q11.23	22q11.23	FLJ34651		C22orf45	chromosome 22 open reading frame 45			2009-08-15	2012-10-11	2012-10-11	2016-11-09	646023	ENSG00000178803	OTTHUMG00000150735	uc062cjs.1	AK091970	NR_028483		P86434	19726446				ADORA2A-AS1																		URS00008E39D5
HGNC:264	ADORA2B	adenosine A2b receptor	protein-coding gene	gene with protein product	Approved	17p12	17p12					Adenosine receptors	211	1993-01-19			2015-08-24	136	ENSG00000170425	OTTHUMG00000059140	uc002gpd.2	M97759	NM_000676	CCDS11173	P29275	7558011	MGI:99403	RGD:2050		ADORA2B	600446										objectId:20							
HGNC:265	ADORA2BP1	adenosine A2b receptor pseudogene 1	pseudogene	pseudogene	Approved	1q32.2	01q32.2			ADORA2BP	adenosine A2b receptor pseudogene			1995-08-29	2010-01-12	2010-01-12	2014-02-13	137	ENSG00000236136	OTTHUMG00000036482			NG_000843			7558011											PGOHUM00000245194											
HGNC:266	ADORA2L1	entry withdrawn	withdrawn	withdrawn	Entry Withdrawn												2005-09-06																															
HGNC:267	ADORA2L2	entry withdrawn	withdrawn	withdrawn	Entry Withdrawn												2005-09-06																															
HGNC:268	ADORA3	adenosine A3 receptor	protein-coding gene	gene with protein product	Approved	1p13.2	01p13.2	AD026				""Adenosine receptors|V-set domain containing""	""211|590""	1993-12-13			2017-03-24	140	ENSG00000282608	OTTHUMG00000011957	uc001ebh.5	BC029831	""NM_000677|NM_020683""	""CCDS838|CCDS839|CCDS41369|CCDS81358""	P0DMS8	7607699	MGI:104847	RGD:2051	LRG_424|http://www.lrg-sequence.org/LRG/LRG_424	ADORA3	600445										objectId:21							
HGNC:25250	ADPGK	ADP dependent glucokinase	protein-coding gene	gene with protein product	Approved	15q24.1	15q24.1	""DKFZp434B195|ADP-GK""						2004-09-29		2016-06-08	2016-06-08	83440	ENSG00000159322	OTTHUMG00000172777	uc002avf.5	AL136873	NM_031284	CCDS42057	Q9BRR6	11230166	MGI:1919391	RGD:1306103		ADPGK	611861																	
HGNC:44144	ADPGK-AS1	ADPGK antisense RNA 1	non-coding RNA	RNA, long non-coding	Approved	15q24.1	15q24.1				ADPGK antisense RNA 1 (non-protein coding)			2012-06-30		2012-08-15	2012-10-12	100287559	ENSG00000260898	OTTHUMG00000173100	uc002avk.1	AK127877	NR_040107																									URS00004A7F77
HGNC:269	ADPRH	ADP-ribosylarginine hydrolase	protein-coding gene	gene with protein product	Approved	3q13.33	03q13.33	ARH1	[Protein ADP-ribosylarginine] hydrolase					1997-06-20			2016-10-05	141	ENSG00000144843	OTTHUMG00000159420	uc062mux.1	L13291	NM_001125	CCDS2990	P54922	""8349667|12070318""	MGI:1098234	RGD:2052		ADPRH	603081															3.2.2.19		
HGNC:21303	ADPRHL1	ADP-ribosylhydrolase like 1	protein-coding gene	gene with protein product	Approved	13q34	13q34	ARH2	ADP-ribosylarginine hydrolase like 1					2003-06-19			2016-06-02	113622	ENSG00000153531	OTTHUMG00000017386	uc001vtq.3	AJ313429	NM_138430	""CCDS9535|CCDS9536""	Q8NDY3	""12070318|27217161""	MGI:2442168	RGD:1305641		ADPRHL1	610620																	
HGNC:21304	ADPRHL2	ADP-ribosylhydrolase like 2	protein-coding gene	gene with protein product	Approved	1p34.3	01p34.3	""ARH3|FLJ20446""	ADP-ribosylarginine hydrolase like 2					2003-06-19			2016-06-02	54936	ENSG00000116863	OTTHUMG00000007628	uc001bzt.4	AJ427295	NM_017825	CCDS402	Q9NX46	""12070318|16278211""	MGI:2140364	RGD:1309068		ADPRHL2	610624																	
HGNC:30925	ADPRM	ADP-ribose/CDP-alcohol diphosphatase, manganese dependent	protein-coding gene	gene with protein product	Approved	17p13.1	17p13.1	MDS006		C17orf48	""chromosome 17 open reading frame 48|ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent""	Sugar phosphatases	1073	2005-12-13	2012-07-20	2016-03-24	2016-03-24	56985	ENSG00000170222	OTTHUMG00000130366	uc002gmt.4	BC070155	NM_020233	CCDS11159	Q3LIE5	18352857	MGI:1913608	RGD:1309906																		""3.6.1.13|3.6.1.16|3.6.1.53""		
HGNC:277	ADRA1A	adrenoceptor alpha 1A	protein-coding gene	gene with protein product	Approved	8p21.2	08p21.2	ADRA1L1		ADRA1C	adrenergic, alpha-1A-, receptor	Adrenoceptors	169	1991-08-19		2012-05-09	2014-11-19	148	ENSG00000120907	OTTHUMG00000099459	uc010lun.2	L31774	NM_033303	""CCDS6052|CCDS6053|CCDS6054|CCDS34869|CCDS83269""	P35348		MGI:104773	RGD:2055		ADRA1A	104221										objectId:22							
HGNC:278	ADRA1B	adrenoceptor alpha 1B	protein-coding gene	gene with protein product	Approved	5q33.3	05q33.3				adrenergic, alpha-1B-, receptor	Adrenoceptors	169	1991-06-04		2012-05-09	2015-08-24	147	ENSG00000170214	OTTHUMG00000130327	uc003lxt.2	L31773	NM_000679	CCDS4347	P35368		MGI:104774	RGD:2054		ADRA1B	104220										objectId:23							
HGNC:280	ADRA1D	adrenoceptor alpha 1D	protein-coding gene	gene with protein product	Approved	20p13	20p13	""ADRA1R|ADRA1A|ADRA1""			adrenergic, alpha-1D-, receptor	Adrenoceptors	169	1990-09-10		2012-05-09	2014-11-19	146	ENSG00000171873	OTTHUMG00000031779	uc002wkr.3	U03864	NM_000678	CCDS13079	P25100	8039425	MGI:106673	RGD:62064		ADRA1D	104219										objectId:24							
HGNC:281	ADRA2A	adrenoceptor alpha 2A	protein-coding gene	gene with protein product	Approved	10q25.2	10q25.2	ADRAR	""alpha-2AAR subtype C10| alpha-2A-adrenergic receptor""	""ADRA2|ADRA2R""	adrenergic, alpha-2A-, receptor	Adrenoceptors	169	1990-09-10		2012-05-09	2015-08-24	150	ENSG00000150594	OTTHUMG00000019050	uc001kzo.4	AF284095	NM_000681	CCDS7569	P08913		MGI:87934	RGD:2056		ADRA2A	104210										objectId:25							
HGNC:282	ADRA2B	adrenoceptor alpha 2B	protein-coding gene	gene with protein product	Approved	2q11.2	02q11.2	ADRARL1		""ADRA2L1|ADRA2RL1""	adrenergic, alpha-2B-, receptor	Adrenoceptors	169	1990-09-10		2012-05-09	2015-08-27	151	ENSG00000274286	OTTHUMG00000188276	uc032nvj.2	M34041	NM_000682	CCDS56129	P18089	2164221	MGI:87935	RGD:2057		ADRA2B	104260					395886					objectId:26							
HGNC:283	ADRA2C	adrenoceptor alpha 2C	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	ADRARL2		""ADRA2L2|ADRA2RL2""	adrenergic, alpha-2C-, receptor	Adrenoceptors	169	1986-01-01		2012-05-09	2014-11-19	152	ENSG00000184160	OTTHUMG00000159830	uc003ghm.4	AY455666	NM_000683	CCDS47004	P18825	1849485	MGI:87936	RGD:2058		ADRA2C	104250										objectId:27							
HGNC:285	ADRB1	adrenoceptor beta 1	protein-coding gene	gene with protein product	Approved	10q25.3	10q25.3			ADRB1R	adrenergic, beta-1-, receptor	Adrenoceptors	169	1990-09-10		2012-05-09	2015-08-24	153	ENSG00000043591	OTTHUMG00000019079	uc001lba.4	J03019	NM_000684	CCDS7586	P08588		MGI:87937	RGD:2059		ADRB1	109630										objectId:28							
HGNC:286	ADRB2	adrenoceptor beta 2	protein-coding gene	gene with protein product	Approved	5q32	05q32	""ADRBR|BAR|B2AR""		ADRB2R	""adrenergic, beta-2-, receptor, surface|adrenoceptor beta 2, surface""	Adrenoceptors	169	1990-09-10		2015-11-26	2016-10-05	154	ENSG00000169252	OTTHUMG00000129933	uc003lpr.3	AF022953	NM_000024	CCDS4292	P07550		MGI:87938	RGD:2060		ADRB2	109690										objectId:29							
HGNC:288	ADRB3	adrenoceptor beta 3	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23				adrenergic, beta-3-, receptor	Adrenoceptors	169	1993-10-04		2012-05-09	2015-10-15	155	ENSG00000188778	OTTHUMG00000164028	uc003xkr.3	AY487247	NM_000025	CCDS6099	P13945	""7898940|15123695""	MGI:87939	RGD:2061		ADRB3	109691										objectId:30							
HGNC:15759	ADRM1	adhesion regulating molecule 1	protein-coding gene	gene with protein product	Approved	20q13.33	20q13.33	""GP110|Rpn13|ARM1""						2001-09-17			2015-09-11	11047	ENSG00000130706	OTTHUMG00000032904	uc002ycn.5	D64154	NM_001281437	""CCDS13496|CCDS74747""	Q16186	8033103	MGI:1929289	RGD:69248		ADRM1	610650																	
HGNC:291	ADSL	adenylosuccinate lyase	protein-coding gene	gene with protein product	Approved	22q13.1	22q13.1							1986-01-01			2014-11-18	158	ENSG00000239900	OTTHUMG00000166425	uc003ayp.5	X65867	NM_000026	""CCDS14001|CCDS46714""	P30566	8404037	MGI:103202	RGD:1307617	Adenylosuccinate Lyase Mutations Database Home Page|http://www.icp.ucl.ac.be/adsldb/	ADSL	608222					119507										4.3.2.2		
HGNC:292	ADSS	adenylosuccinate synthase	protein-coding gene	gene with protein product	Approved	1q44	01q44							1989-05-19			2015-09-11	159	ENSG00000035687	OTTHUMG00000040102	uc001iaj.4	BC012356	NM_001126	CCDS1624	P30520	""2004783|1592113""	MGI:87948	RGD:1310508		ADSS	103060															6.3.4.4		
HGNC:20093	ADSSL1	adenylosuccinate synthase like 1	protein-coding gene	gene with protein product	Approved	14q32.33	14q32.33	FLJ38602						2002-12-17			2016-11-10	122622	ENSG00000185100	OTTHUMG00000170818	uc001ypd.5	AK095921	NM_001320424	""CCDS9990|CCDS9991""	Q8N142		MGI:87947	RGD:1590342		ADSSL1	612498					469928												
HGNC:293	ADT	entry withdrawn	withdrawn	withdrawn	Entry Withdrawn												2005-09-06																															
HGNC:21214	ADTRP	androgen dependent TFPI regulating protein	protein-coding gene	gene with protein product	Approved	6p24.1	06p24.1	""dJ413H6.1|AIG1L""	androgen-induced 1-like	C6orf105	""chromosome 6 open reading frame 105|androgen-dependent TFPI-regulating protein""			2003-11-25	2012-01-27	2016-02-24	2016-02-24	84830	ENSG00000111863	OTTHUMG00000014260	uc003nab.4	AJ420520	NM_032744	""CCDS4521|CCDS47374""	Q96IZ2	21868574	MGI:1924596	RGD:1305679		ADTRP	614348																	
HGNC:303	AEBP1	AE binding protein 1	protein-coding gene	gene with protein product	Approved	7p13	07p13	ACLP	""aortic carboxypeptidase-like protein|adipocyte enhancer binding protein 1""		AE-binding protein 1	M14 carboxypeptidases	1321	1998-03-06		2001-11-28	2016-10-05	165	ENSG00000106624	OTTHUMG00000023362	uc003tkb.5	D86479	NM_001129	CCDS5476	Q8IUX7	8920928	MGI:1197012	RGD:1306922		AEBP1	602981								M14.951		objectId:1586							
HGNC:24051	AEBP2	AE binding protein 2	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3	MGC17922						2004-03-18			2012-10-02	121536	ENSG00000139154	OTTHUMG00000168906	uc001ref.2		NM_153207	""CCDS44841|CCDS44842|CCDS58215""	Q6ZN18	10329662	MGI:1338038	RGD:1307233		AEBP2																		
HGNC:25722	AEN	apoptosis enhancing nuclease	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	""FLJ12484|FLJ12562""		ISG20L1	interferon stimulated exonuclease gene 20kDa-like 1	Exonucleases	544	2005-06-30	2008-07-15	2008-07-15	2014-11-19	64782	ENSG00000181026	OTTHUMG00000148681	uc002bmt.3	BC020988	NM_022767	CCDS10344	Q8WTP8	""18264133|16171785""	MGI:1915298	RGD:1305051		AEN	610177																	
HGNC:307	AES	amino-terminal enhancer of split	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	""GRG5|TLE5""						1993-12-13			2015-10-15	166	ENSG00000104964	OTTHUMG00000180567	uc002lwy.2	AK094591	NM_198969	""CCDS12101|CCDS12102""	Q08117	8365415	MGI:95806	RGD:2731		AES	600188																	
HGNC:309	AF8T	AF8 temperature sensitivity complementing	phenotype	phenotype only	Approved	3	03							2001-06-22			2012-10-02	169								180537					116950																	
HGNC:310	AFA	ankyloblepharon filiforme adnatum	phenotype	phenotype only	Approved	reserved	reserved							1994-01-05			2012-03-30	170								8135297					106250																	
HGNC:24017	AFAP1	actin filament associated protein 1	protein-coding gene	gene with protein product	Approved	4p16.1	04p16.1	""AFAP-110|AFAP""				Pleckstrin homology domain containing	682	2007-02-07		2007-02-07	2016-10-05	60312	ENSG00000196526	OTTHUMG00000125515	uc003gkg.2	AB209676	NM_021638	""CCDS3397|CCDS47010""	Q8N556	""14755689|11641786|11607843""	MGI:1917542	RGD:619959		AFAP1	608252																	
HGNC:28141	AFAP1-AS1	AFAP1 antisense RNA 1	non-coding RNA	RNA, long non-coding	Approved	4p16.1	04p16.1	MGC10981		""AFAP1AS|AFAP1-AS""	""AFAP1 antisense RNA (non-protein coding)|AFAP1 antisense RNA 1 (non-protein coding)""	Long non-coding RNAs (published)	788	2010-07-08	2010-11-25	2012-08-15	2016-11-24	84740	ENSG00000272620	OTTHUMG00000186238	uc003gkd.5	BC004397	NR_026892			""23333711|26892468""																			AFAP1AS			URS000075E0F9
HGNC:26714	AFAP1L1	actin filament associated protein 1 like 1	protein-coding gene	gene with protein product	Approved	5q32	05q32	FLJ36748			actin filament associated protein 1-like 1	Pleckstrin homology domain containing	682	2007-02-07		2015-11-26	2016-10-05	134265	ENSG00000157510	OTTHUMG00000163441	uc003lqh.4	AK094067	NM_152406	""CCDS34274|CCDS54932""	Q8TED9		MGI:2147199	RGD:1311580		AFAP1L1	614410																	
HGNC:25901	AFAP1L2	actin filament associated protein 1 like 2	protein-coding gene	gene with protein product	Approved	10q25.3	10q25.3	""FLJ14564|Em:AC005383.4|XB130""		KIAA1914	""KIAA1914|actin filament associated protein 1-like 2""	Pleckstrin homology domain containing	682	2004-02-18	2007-02-07	2015-11-26	2016-10-05	84632	ENSG00000169129	OTTHUMG00000019086	uc001lbn.5	BC024314	NM_032550	""CCDS31286|CCDS31287""	Q8N4X5	""11572484|17412687""	MGI:2147658	RGD:1310668		AFAP1L2	612420																	
HGNC:312	AFD1	acrofacial dysostosis 1, Nager type	phenotype	phenotype only	Approved	9q32	09q32							1994-01-05			2014-02-12	171								9585434																						
HGNC:7137	AFDN	afadin, adherens junction formation factor	protein-coding gene	gene with protein product	Approved	6q27	06q27	""AF-6|AF6""		MLLT4	myeloid/lymphoid or mixed-lineage leukemia; translocated to, 4	PDZ domain containing	1220	1994-09-06	2016-06-28	2016-06-28	2016-06-28	4301	ENSG00000130396	OTTHUMG00000016031	uc063sxr.1	AB011399	NM_005936	""CCDS47517|CCDS75553|CCDS78199""	P55196	8242616	MGI:1314653	RGD:708561			159559																	
HGNC:21236	AFDN-DT	AFDN divergent transcript	non-coding RNA	RNA, long non-coding	Approved	6q27	06q27	""HGC6.4|dJ431P23.3""		""C6orf124|MLLT4-AS1|AFDN-AS1""	""chromosome 6 open reading frame 124|MLLT4 antisense RNA 1 (non-protein coding)|MLLT4 antisense RNA 1 (head to head)|AFDN antisense RNA 1 (head to head)""			2003-05-29	2017-09-21	2017-09-21	2017-09-21	653483	ENSG00000198221	OTTHUMG00000016029	uc003qwa.3		NR_027906		Q9Y6Z5	10382971																						URS000075BCEE
HGNC:7135	AFF1	AF4/FMR2 family member 1	protein-coding gene	gene with protein product	Approved	4q21.3-q22.1	04q21.3-q22.1	""AF-4|AF4""		""PBM1|MLLT2""	""myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); translocated to, 2|pre-B-cell monocytic leukemia partner 1|AF4/FMR2 family, member 1""	""AF4/FMR2 family|Super elongation complex""	""1145|1280""	2005-06-27		2015-11-18	2017-06-08	4299	ENSG00000172493	OTTHUMG00000130603	uc003hqj.5	L22179	NM_005935	""CCDS3616|CCDS54775""	P51825	""7689231|1423625|8353274""	MGI:1100819	RGD:1307940		AFF1	159557					171634												
HGNC:53447	AFF1-AS1	AFF1 antisense RNA 1	non-coding RNA	RNA, long non-coding	Approved	4q21.3	04q21.3							2017-04-19			2017-04-19	100506746					NR_038841					RGD:1564576																				URS000075D11F
HGNC:3776	AFF2	AF4/FMR2 family member 2	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	FRAXE		FMR2	""fragile X mental retardation 2|AF4/FMR2 family, member 2""	""AF4/FMR2 family|Super elongation complex""	""1145|1280""	2005-06-27		2015-11-18	2017-03-10	2334	ENSG00000155966	OTTHUMG00000022613	uc004fcp.3	U48436	NM_002025	""CCDS14684|CCDS55521|CCDS76040|CCDS78510""	P51816		MGI:1202294	RGD:1565592	Mental Retardation database|http://grenada.lumc.nl/LOVD2/MR/home.php?select_db=AFF2	AFF2	300806					119509												
HGNC:41334	AFF2-IT1	AFF2 intronic transcript 1	non-coding RNA	RNA, long non-coding	Approved	Xq28	Xq28				AFF2 intronic transcript 1 (non-protein coding)			2011-05-20		2015-02-25	2015-02-25	100874269	ENSG00000223516	OTTHUMG00000022611	uc065bmd.1																											URS00001F0F1B
HGNC:6473	AFF3	AF4/FMR2 family member 3	protein-coding gene	gene with protein product	Approved	2q11.2	02q11.2	MLLT2-like		LAF4	""lymphoid nuclear protein related to AF4|AF4/FMR2 family, member 3""	""AF4/FMR2 family|Super elongation complex""	""1145|1280""	1998-03-27	2005-06-27	2015-11-18	2016-10-05	3899	ENSG00000144218	OTTHUMG00000153011	uc002tah.2	U34360	NM_002285	""CCDS33258|CCDS42723""	P51826	""8662235|8555498""	MGI:106927	RGD:1308527		AFF3	601464																	
HGNC:17869	AFF4	AF4/FMR2 family member 4	protein-coding gene	gene with protein product	Approved	5q31.1	05q31.1	""AF5Q31|MCEF""	ALL1 fused gene from 5q31		AF4/FMR2 family, member 4	""AF4/FMR2 family|Super elongation complex""	""1145|1280""	2005-06-27		2015-11-18	2016-10-05	27125	ENSG00000072364	OTTHUMG00000059838	uc003kyd.4	AF197927	NM_014423	CCDS4164	Q9UHB7	10588740	MGI:2136171	RGD:1311694		AFF4	604417					448667												
HGNC:16411	AFG1L	AFG1 like ATPase	protein-coding gene	gene with protein product	Approved	6q21	06q21	AFG1	ATPase family gene 1 homolog (S. cerevisiae)	LACE1	lactation elevated 1			2002-06-07	2017-03-09	2017-03-09	2017-03-09	246269	ENSG00000135537	OTTHUMG00000015324	uc003psj.4	AF520418	NM_145315	CCDS5067	Q8WV93	12079282	MGI:2148801	RGD:1561501			617469																	
HGNC:314	AFG3L1P	AFG3 like matrix AAA peptidase subunit 1, pseudogene	pseudogene	pseudogene	Approved	16q24.3	16q24.3			""AFG3|AFG3L1""	""AFG3 ATPase family gene 3-like 1 (S. cerevisiae), pseudogene|AFG3 like AAA ATPase 1, pseudogene""	AAA ATPases	413	1997-04-10	2010-10-28	2016-02-26	2016-02-26	172	ENSG00000223959	OTTHUMG00000138987		AJ001495	NR_003226			""9545647|11549317""	MGI:1928277				603020						PGOHUM00000249187		M41.010									
HGNC:315	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	protein-coding gene	gene with protein product	Approved	18p11.21	18p11.21	SPAX5		SCA28	""AFG3 (ATPase family gene 3, yeast)-like 2|spinocerebellar ataxia 28|AFG3 ATPase family member 3-like 2 (S. cerevisiae)|AFG3 like AAA ATPase 2""	AAA ATPases	413	1999-07-13		2016-02-26	2017-03-24	10939	ENSG00000141385	OTTHUMG00000131695	uc002kqz.3	Y18314	NM_006796	CCDS11859	Q9Y4W6	""10395799|18769991""	MGI:1916847	RGD:1305259	LRG_666|http://www.lrg-sequence.org/LRG/LRG_666	AFG3L2	604581					212604			M41.007									
HGNC:24169	AFG3L2P1	AFG3 like AAA ATPase 2 pseudogene 1	pseudogene	pseudogene	Approved	8p11.1	08p11.1			AFG3L2P	""AFG3 ATPase family gene 3-like 2 (yeast) pseudogene|AFG3 ATPase family gene 3-like 2 (yeast) pseudogene 1|AFG3 ATPase family gene 3-like 2 (S. cerevisiae) pseudogene 1|AFG3 ATPase family member 3-like 2 (S. cerevisiae) pseudogene 1|AFG3-like AAA ATPase 2 pseudogene 1""			2005-10-05	2010-01-12	2016-02-23	2016-02-23	347028	ENSG00000253606	OTTHUMG00000164107			NG_016585														PGOHUM00000249313											
HGNC:316	AFM	afamin	protein-coding gene	gene with protein product	Approved	4q13.3	04q13.3	""ALB2|ALBA""						1994-12-09			2015-08-26	173	ENSG00000079557	OTTHUMG00000130004	uc003hhb.4	L32140	NM_001133	CCDS3557	P43652	7517938	MGI:2429409	RGD:628614		AFM	104145																	
HGNC:20910	AFMID	arylformamidase	protein-coding gene	gene with protein product	Approved	17q25.3	17q25.3	""DKFZp686F03259|KF""	kynurenine formamidase					2004-01-30			2016-10-18	125061	ENSG00000183077	OTTHUMG00000153957	uc002jva.3	BX648442	NM_001145526	""CCDS32750|CCDS45801""	Q63HM1		MGI:2448704	RGD:1591143		AFMID									S09.977							3.5.1.9		
HGNC:317	AFP	alpha fetoprotein	protein-coding gene	gene with protein product	Approved	4q13.3	04q13.3	FETA		HPAFP				1996-04-01		2016-01-13	2016-01-13	174	ENSG00000081051	OTTHUMG00000130011	uc003hgz.3	V01514	NM_001134	CCDS3556	P02771		MGI:87951	RGD:2065		AFP	104150					173230												
HGNC:25951	AFTPH	aftiphilin	protein-coding gene	gene with protein product	Approved	2p14	02p14	""MGC33965|FLJ20080|FLJ23793|Nbla10388""						2006-06-19			2017-06-30	54812	ENSG00000119844	OTTHUMG00000129539	uc002sdb.5	AB073356	NM_017657	""CCDS1878|CCDS46303""	Q6ULP2	""14665628|15758025|15811338""	MGI:1923012	RGD:1311920		AFTPH																		
HGNC:318	AGA	aspartylglucosaminidase	protein-coding gene	gene with protein product	Approved	4q34.3	04q34.3	ASRG	""glycosylasparaginase|N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase""					1991-05-09			2015-08-24	175	ENSG00000038002	OTTHUMG00000160723	uc003iuu.3	X55330	NM_000027	CCDS3829	P20933		MGI:104873	RGD:1309646		AGA	613228					119513			T02.001							3.5.1.26		
HGNC:16922	AGAP1	ArfGAP with GTPase domain, ankyrin repeat and PH domain 1	protein-coding gene	gene with protein product	Approved	2q37.2	02q37.2	""KIAA1099|GGAP1""		CENTG2	centaurin, gamma 2	""ArfGAPs|Ankyrin repeat domain containing|Pleckstrin homology domain containing|BAR-PH domain containing""	""395|403|682|1291""	2001-10-29	2008-09-22	2008-09-22	2016-10-05	116987	ENSG00000157985	OTTHUMG00000133293	uc002vvt.4	AF413078	NM_014914	""CCDS2514|CCDS33408|CCDS58756""	Q9UPQ3		MGI:2653690	RGD:1309244		AGAP1	608651																	
HGNC:41427	AGAP1-IT1	AGAP1 intronic transcript 1	non-coding RNA	RNA, long non-coding	Approved	2q37.2	02q37.2				AGAP1 intronic transcript 1 (non-protein coding)			2011-05-20		2015-02-25	2015-02-25	100506749	ENSG00000235529	OTTHUMG00000153124	uc061txt.1		NR_131900																									URS00008E3A47
HGNC:16921	AGAP2	ArfGAP with GTPase domain, ankyrin repeat and PH domain 2	protein-coding gene	gene with protein product	Approved	12q14.1	12q14.1			CENTG1	centaurin, gamma 1	""ArfGAPs|Ankyrin repeat domain containing|Pleckstrin homology domain containing|BAR-PH domain containing""	""395|403|682|1291""	2001-10-29	2008-09-22	2008-09-22	2016-10-05	116986	ENSG00000135439	OTTHUMG00000170285	uc001spr.4	AF413077	NM_014770	""CCDS8951|CCDS44932""	Q99490		MGI:3580016	RGD:628844		AGAP2	605476																	
HGNC:48633	AGAP2-AS1	AGAP2 antisense RNA 1	non-coding RNA	RNA, long non-coding	Approved	12q14.1	12q14.1	""LOC100130776|PUNISHER""						2013-05-30			2016-10-03	100130776	ENSG00000255737	OTTHUMG00000170286		""BC039697|BC069024""	NR_027032			""25392693|27195672""																						URS000075E9B8
HGNC:16923	AGAP3	ArfGAP with GTPase domain, ankyrin repeat and PH domain 3	protein-coding gene	gene with protein product	Approved	7q36.1	07q36.1			CENTG3	centaurin, gamma 3	""ArfGAPs|Ankyrin repeat domain containing|Pleckstrin homology domain containing|BAR-PH domain containing""	""395|403|682|1291""	2001-10-29	2008-09-22	2008-09-22	2015-09-11	116988	ENSG00000133612	OTTHUMG00000158724	uc003wjg.3	AF413079	NM_031946	""CCDS43681|CCDS55185|CCDS64802|CCDS78287|CCDS83243""	Q96P47		MGI:2183446	RGD:1310751		AGAP3	616813																	
HGNC:23459	AGAP4	ArfGAP with GTPase domain, ankyrin repeat and PH domain 4	protein-coding gene	gene with protein product	Approved	10q11.22	10q11.22	""Em:AC012044.1|MRIP2""		""CTGLF1|AGAP8|CTGLF5""	""centaurin, gamma-like family, member 1|ArfGAP with GTPase domain, ankyrin repeat and PH domain 8|centaurin, gamma-like family, member 5""	""ArfGAPs|Ankyrin repeat domain containing|Pleckstrin homology domain containing|BAR-PH domain containing""	""395|403|682|1291""	2004-05-27	2008-09-22	2008-09-22	2016-10-05	119016	ENSG00000188234	OTTHUMG00000018088	uc057szm.1	AF411132	NM_133446	CCDS7215	Q96P64	12477932				AGAP4																		
HGNC:23467	AGAP5	ArfGAP with GTPase domain, ankyrin repeat and PH domain 5	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	Em:AC073389.1		CTGLF2	centaurin, gamma-like family, member 2	""ArfGAPs|Ankyrin repeat domain containing|Pleckstrin homology domain containing|BAR-PH domain containing""	""395|403|682|1291""	2004-05-27	2008-09-22	2008-09-22	2016-10-18	729092	ENSG00000172650	OTTHUMG00000018473	uc009xri.4		NM_001144000	CCDS44439	A6NIR3					AGAP5																		
HGNC:23466	AGAP6	ArfGAP with GTPase domain, ankyrin repeat and PH domain 6	protein-coding gene	gene with protein product	Approved	10q11.23	10q11.23	bA324H6.1		CTGLF3	centaurin, gamma-like family, member 3	""ArfGAPs|Ankyrin repeat domain containing|Pleckstrin homology domain containing|BAR-PH domain containing""	""395|403|682|1291""	2004-05-27	2008-09-22	2008-09-22	2015-08-27	414189	ENSG00000204149	OTTHUMG00000018220	uc001jix.5		NM_001077665	CCDS44397	Q5VW22					AGAP6																		
HGNC:23465	AGAP7P	ArfGAP with GTPase domain, ankyrin repeat and PH domain 7, pseudogene	pseudogene	pseudogene	Approved	10q11.22	10q11.22	bA109G10.1		""CTGLF4|AGAP7""	""centaurin, gamma-like family, member 4|ArfGAP with GTPase domain, ankyrin repeat and PH domain 7""	""ArfGAPs|Ankyrin repeat domain containing|Pleckstrin homology domain containing""	""395|403|682""	2004-05-27	2014-06-12	2014-06-12	2014-11-18	653268	ENSG00000264204	OTTHUMG00000188316			NM_001077685		Q5VUJ5																							
HGNC:23463	AGAP9	ArfGAP with GTPase domain, ankyrin repeat and PH domain 9	protein-coding gene	gene with protein product	Approved	10q11.22	10q11.22	""bA301J7.2|FLJ00312""		CTGLF6	centaurin, gamma-like family, member 6	""ArfGAPs|Ankyrin repeat domain containing|Pleckstrin homology domain containing|BAR-PH domain containing""	""395|403|682|1291""	2004-05-27	2008-09-22	2008-09-22	2016-10-18	642517	ENSG00000204172	OTTHUMG00000018115	uc031wfn.1		NM_001190810	CCDS73125	Q5VTM2					AGAP9																		
HGNC:23659	AGAP10P	ArfGAP with GTPase domain, ankyrin repeat and PH domain 10 pseudogene	pseudogene	pseudogene	Approved	10q11.22	10q11.22	""bA358L16.1|bA144G6.2""		""AGAP10|CTGLF7|CTGLF10P""	""ArfGAP with GTPase domain, ankyrin repeat and PH domain 10|centaurin, gamma-like family, member 7|centaurin, gamma-like family, member 10 pseudogene""	ArfGAPs	395	2004-05-27	2015-02-05	2015-02-05	2015-02-05	653234	ENSG00000230869	OTTHUMG00000018083			NG_005805																									
HGNC:29421	AGAP11	ArfGAP with GTPase domain, ankyrin repeat and PH domain 11	other	unknown	Approved	10q23.2	10q23.2	KIAA1975			ankyrin repeat and GTPase domain Arf GTPase activating protein 11	""ArfGAPs|Ankyrin repeat domain containing|BAR-PH domain containing""	""395|403|1291""	2008-09-22		2015-11-17	2015-11-17	119385	ENSG00000271880	OTTHUMG00000185463	uc057urd.1		NM_133447		Q8TF27	11853319																						
HGNC:23661	AGAP12P	ArfGAP with GTPase domain, ankyrin repeat and PH domain 12, pseudogene	pseudogene	pseudogene	Approved	10q11.22	10q11.22	bA164N7.2		CTGLF12P	centaurin, gamma-like family, member 12 pseudogene	ArfGAPs	395	2004-05-27	2015-11-17	2015-11-17	2015-11-17	414224	ENSG00000265018	OTTHUMG00000018164		BC127745	NR_029396														PGOHUM00000289853											
HGNC:23499	AGAP13P	ArfGAP with GTPase domain, ankyrin repeat and PH domain 13, pseudogene	pseudogene	pseudogene	Approved	10q11.22	10q11.22	bA548K23.1		CTGLF9P	centaurin, gamma-like family, member 9 pseudogene	ArfGAPs	395	2004-05-27	2015-11-17	2015-11-17	2015-11-17	728005	ENSG00000243289	OTTHUMG00000018095		AF411132	NG_005807														PGOHUM00000290147											
HGNC:23660	AGAP14P	ArfGAP with GTPase domain, ankyrin repeat and PH domain 14, pseudogene	pseudogene	pseudogene	Approved	10q11.22	10q11.22	bA145E20.1		""CTGLF11P|AGAP14""	""centaurin, gamma-like family, member 11 pseudogene|ArfGAP with GTPase domain, ankyrin repeat and PH domain 14""	ArfGAPs	395	2004-05-27	2017-08-14	2017-08-14	2017-08-14	653259	ENSG00000279058	OTTHUMG00000192004	uc057szz.1		NG_005806		A8MT82																							
HGNC:26504	AGBL1	ATP/GTP binding protein like 1	protein-coding gene	gene with protein product	Approved	15q25.3	15q25.3	""FLJ32310|CCP4""	cytosolic carboxypeptidase 4					2004-11-19		2016-06-21	2017-05-11	123624	ENSG00000273540	OTTHUMG00000149978	uc002blz.2	AK056872	NM_152336	CCDS58398	Q96MI9	""21074048|24094747""	MGI:3646469	RGD:1560280		AGBL1	615496					368101												
HGNC:48617	AGBL1-AS1	AGBL1 antisense RNA 1	non-coding RNA	RNA, long non-coding	Approved	15q25.3	15q25.3							2013-05-24			2013-05-24	727915	ENSG00000260125	OTTHUMG00000172872			NR_046012																									URS000075E9BB
HGNC:26296	AGBL2	ATP/GTP binding protein like 2	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	""FLJ23598|CCP2""	cytoplasmic carboxypeptidase 2					2005-05-26		2016-06-21	2016-06-21	79841	ENSG00000165923	OTTHUMG00000165368	uc001ngg.4		NM_024783	CCDS7944	Q5U5Z8	""12738998|21303978""	MGI:2443254	RGD:1306827		AGBL2	617345																	
HGNC:27981	AGBL3	ATP/GTP binding protein like 3	protein-coding gene	gene with protein product	Approved	7q33	07q33	""MGC32955|CCP3""				M14 carboxypeptidases	1321	2005-05-26		2016-06-21	2016-06-21	340351	ENSG00000146856	OTTHUMG00000155406	uc011kpw.2	BC030651	NM_178563	CCDS47718	Q8NEM8		MGI:1923473	RGD:1561995		AGBL3	617346								M14.026									
HGNC:25892	AGBL4	ATP/GTP binding protein like 4	protein-coding gene	gene with protein product	Approved	1p33	01p33	""FLJ14442|CCP6""	cytosolic carboxypeptidase 6			M14 carboxypeptidases	1321	2005-05-26		2016-06-21	2016-06-21	84871	ENSG00000186094	OTTHUMG00000007793	uc001cru.3	AK027348	NM_032785	CCDS44137	Q5VU57	21074048	MGI:1918244	RGD:6493177		AGBL4	616476								M14.027									
HGNC:41482	AGBL4-IT1	AGBL4 intronic transcript 1	non-coding RNA	RNA, long non-coding	Approved	1p33	01p33				AGBL4 intronic transcript 1 (non-protein coding)			2011-06-08		2015-02-25	2015-02-25	100874313	ENSG00000225623	OTTHUMG00000008155	uc031tzy.1		NR_046839																									URS00001BDE86
HGNC:26147	AGBL5	ATP/GTP binding protein like 5	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	""FLJ21839|CCP5""	cytosolic carboxypeptidase 5					2007-03-27		2016-06-21	2016-06-21	60509	ENSG00000084693	OTTHUMG00000128406	uc002rie.4	BC007415	NM_021831	""CCDS1732|CCDS42665""	Q8NDL9	24022482	MGI:2441745	RGD:1598311		AGBL5	615900					461232												
HGNC:41133	AGBL5-AS1	AGBL5 antisense RNA 1	non-coding RNA	RNA, long non-coding	Approved	2p23.3	02p23.3				AGBL5 antisense RNA 1 (non-protein coding)			2011-06-08		2012-08-15	2014-11-19	100874031	ENSG00000231636	OTTHUMG00000151996	uc061hjm.1		NR_046730																									URS00003B86EF
HGNC:41484	AGBL5-IT1	AGBL5 intronic transcript 1	non-coding RNA	RNA, long non-coding	Approved	2p23.3	02p23.3				AGBL5 intronic transcript 1 (non-protein coding)			2011-06-08		2015-02-25	2015-02-25	106481744	ENSG00000229122	OTTHUMG00000151991	uc061hjv.1																											URS0000318C7A
HGNC:320	AGER	advanced glycosylation end-product specific receptor	protein-coding gene	gene with protein product	Approved	6p21.32	06p21.32	""RAGE|SCARJ1""	receptor for advanced glycation end-products			""C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors""	""592|594|1253""	1994-10-17		2016-07-18	2016-10-05	177	ENSG00000204305	OTTHUMG00000031120	uc003oal.3	M91211	NM_001136	""CCDS4746|CCDS4747|CCDS56417|CCDS56418|CCDS75429""	Q15109	7713518	MGI:893592	RGD:69258		AGER	600214										objectId:2843							
HGNC:5175	AGFG1	ArfGAP with FG repeats 1	protein-coding gene	gene with protein product	Approved	2q36.3	02q36.3	""RIP|RAB""		HRB	HIV-1 Rev binding protein	ArfGAPs	395	1996-11-15	2008-09-22	2008-09-22	2016-10-05	3267	ENSG00000173744	OTTHUMG00000133186	uc002vpc.3		NM_004504	""CCDS2467|CCDS46533|CCDS46534|CCDS46535""	P52594	7637788	MGI:1333754	RGD:1560041		AGFG1	600862																	
HGNC:5177	AGFG2	ArfGAP with FG repeats 2	protein-coding gene	gene with protein product	Approved	7q22.1	07q22.1	RABR		HRBL	HIV-1 Rev binding protein-like	ArfGAPs	395	1998-06-03	2008-09-22	2008-09-22	2014-11-18	3268	ENSG00000106351	OTTHUMG00000156029	uc003uvf.4	AF015042	NM_006076	CCDS5697	O95081	9799793	MGI:2443267	RGD:1306590		AGFG2	604019																	
HGNC:24684	AGGF1	angiogenic factor with G-patch and FHA domains 1	protein-coding gene	gene with protein product	Approved	5q13.3	05q13.3	""VG5Q|HSU84971|FLJ10283|GPATC7|GPATCH7""				G-patch domain containing	579	2004-12-14		2015-11-13	2015-11-13	55109	ENSG00000164252	OTTHUMG00000102132	uc003ket.4	AK001145	NM_018046	CCDS4035	Q8N302	""18564129|17103452""	MGI:1913799	RGD:1310888		AGGF1	608464					119516												
HGNC:38051	AGGF1P1	angiogenic factor with G-patch and FHA domains 1 pseudogene 1	pseudogene	pseudogene	Approved	4q35.2	04q35.2							2010-03-31		2015-11-13	2015-11-13	100132380	ENSG00000214273	OTTHUMG00000160174			NG_022094														PGOHUM00000300469											
HGNC:38052	AGGF1P2	angiogenic factor with G-patch and FHA domains 1 pseudogene 2	pseudogene	pseudogene	Approved	10q26.3	10q26.3							2010-04-01		2015-11-13	2015-11-13	644435	ENSG00000233435	OTTHUMG00000019330			NG_005569														PGOHUM00000290323											
HGNC:38053	AGGF1P3	angiogenic factor with G-patch and FHA domains 1 pseudogene 3	pseudogene	pseudogene	Approved	3p12.3	03p12.3							2010-04-01		2015-11-13	2015-11-13	391552	ENSG00000241532	OTTHUMG00000158959			NG_022208														PGOHUM00000299074											
HGNC:38054	AGGF1P4	angiogenic factor with G-patch and FHA domains 1 pseudogene 4	pseudogene	pseudogene	Approved	16p11.1	16p11.1							2010-04-01		2015-11-13	2015-11-13	100129351	ENSG00000261689	OTTHUMG00000176252			NG_022503														PGOHUM00000293577											
HGNC:51741	AGGF1P5	angiogenic factor with G-patch and FHA domains 1 pseudogene 5	pseudogene	pseudogene	Approved	16p11.1	16p11.1							2015-05-18		2015-11-13	2015-11-13	100128103	ENSG00000260680	OTTHUMG00000176001			NG_022516														PGOHUM00000293837											
HGNC:51744	AGGF1P6	angiogenic factor with G-patch and FHA domains 1 pseudogene 6	pseudogene	pseudogene	Approved	16p11.1	16p11.1							2015-05-18		2015-11-13	2015-11-13	106481737	ENSG00000259836	OTTHUMG00000176006			NG_043510														PGOHUM00000293839											
HGNC:51740	AGGF1P7	angiogenic factor with G-patch and FHA domains 1 pseudogene 7	pseudogene	pseudogene	Approved	16p11.1	16p11.1							2015-05-18		2015-11-13	2015-11-13	100132606	ENSG00000260994	OTTHUMG00000176014			NG_022517														PGOHUM00000293841											
HGNC:51745	AGGF1P8	angiogenic factor with G-patch and FHA domains 1 pseudogene 8	pseudogene	pseudogene	Approved	16p11.2	16p11.2							2015-05-18		2015-11-13	2015-11-13	100128804	ENSG00000261752	OTTHUMG00000176245			NG_022514														PGOHUM00000293833											
HGNC:51746	AGGF1P9	angiogenic factor with G-patch and FHA domains 1 pseudogene 9	pseudogene	pseudogene	Approved	16p11.1	16p11.1							2015-05-18		2015-11-13	2015-11-13	100127958	ENSG00000260427	OTTHUMG00000176248			NG_022515														PGOHUM00000293835											
HGNC:51747	AGGF1P10	angiogenic factor with G-patch and FHA domains 1 pseudogene 10	pseudogene	pseudogene	Approved	20q11.1	20q11.1							2015-05-18		2015-11-13	2016-11-09	100288774	ENSG00000282968	OTTHUMG00000191526			NG_046386														PGOHUM00000297086											
HGNC:21869	AGK	acylglycerol kinase	protein-coding gene	gene with protein product	Approved	7q34	07q34	FLJ10842		MULK	multiple substrate lipid kinase			2005-02-01	2007-01-11	2007-01-11	2014-11-18	55750	ENSG00000006530	OTTHUMG00000157499	uc003vwi.3	BC022777	NM_018238	CCDS5865	Q53H12	""15252046|15939762|17135245""	MGI:1917173	RGD:1562046		AGK	610345					286552										2.7.1.94		
HGNC:37661	AGKP1	acylglycerol kinase pseudogene 1	pseudogene	pseudogene	Approved	Yq11.221	Yq11.221	AGKY1	acylglycerol kinase Y-linked pseudogene 1					2009-12-16		2009-12-16	2016-10-05	359793	ENSG00000226555	OTTHUMG00000036620			NG_002810														PGOHUM00000233964											
HGNC:321	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	protein-coding gene	gene with protein product	Approved	1p21.2	01p21.2		""glycogen debranching enzyme|glycogen storage disease type III""		amylo-1, 6-glucosidase, 4-alpha-glucanotransferase			1992-07-29		2010-04-27	2016-10-05	178	ENSG00000162688	OTTHUMG00000010803	uc001dsi.2	BC078663	NM_000028	""CCDS759|CCDS760""	P35573	1505983	MGI:1924809	RGD:1306376		AGL	610860					119523										""2.4.1.25|3.2.1.33""		
HGNC:18407	AGMAT	agmatinase	protein-coding gene	gene with protein product	Approved	1p36.21	01p36.21	FLJ23384			agmatine ureohydrolase (agmatinase)			2002-03-22		2015-11-03	2016-10-05	79814	ENSG00000116771	OTTHUMG00000002357	uc001awv.3	AY057097	NM_024758	CCDS160	Q9BSE5	""11804860|14648699|11914032""	MGI:1923236	RGD:1308424		AGMAT																3.5.3.11		
HGNC:33784	AGMO	alkylglycerol monooxygenase	protein-coding gene	gene with protein product	Approved	7p21.2	07p21.2	FLJ16237		TMEM195	transmembrane protein 195	Fatty acid hydroxylase domain containing	552	2007-11-20	2011-01-31	2011-01-31	2016-10-05	392636	ENSG00000187546	OTTHUMG00000152387	uc003stb.1		NM_001004320	CCDS34604	Q6ZNB7	20643956	MGI:2442495	RGD:1312038		AGMO	613738															1.14.16.5		
HGNC:323	AGMX2	agammaglobulinemia, X-linked 2 (with growth hormone deficiency)	phenotype	phenotype only	Approved	Xp22	Xp22							1989-11-23			2014-02-12	179								3502688					300310																	
HGNC:3262	AGO1	argonaute 1, RISC catalytic component	protein-coding gene	gene with protein product	Approved	1p34.3	01p34.3	hAGO1	argonaute 1	EIF2C1	""eukaryotic translation initiation factor 2C, 1|argonaute RISC catalytic component 1""	Argonaute/PIWI family	408	1999-12-07	2013-02-15	2015-11-27	2015-11-27	26523	ENSG00000092847	OTTHUMG00000007381	uc001bzl.5	AF093097	NM_001317122	""CCDS398|CCDS81300""	Q9UL18	""10534406|12906857""	MGI:2446630	RGD:1304619			606228					469930												
HGNC:3263	AGO2	argonaute 2, RISC catalytic component	protein-coding gene	gene with protein product	Approved	8q24.3	08q24.3	""hAGO2|Q10|LINC00980""	argonaute 2	""EIF2C2|CASC7""	""eukaryotic translation initiation factor 2C, 2|argonaute RISC catalytic component 2|cancer susceptibility candidate 7 (non-protein coding)""	Argonaute/PIWI family	408	2000-01-14	2013-02-15	2015-11-27	2017-01-19	27161	ENSG00000123908	OTTHUMG00000164232	uc003yvm.5	AF121255	NM_012154	""CCDS6380|CCDS55279""	Q9UKV8	""10534406|12906857""	MGI:2446632	RGD:621255			606229					469932												
HGNC:18421	AGO3	argonaute 3, RISC catalytic component	protein-coding gene	gene with protein product	Approved	1p34.3	01p34.3	""hAGO3|FLJ12765""	argonaute 3	EIF2C3	""eukaryotic translation initiation factor 2C, 3|argonaute RISC catalytic component 3""	Argonaute/PIWI family	408	2002-04-26	2013-02-15	2015-11-27	2016-10-05	192669	ENSG00000126070	OTTHUMG00000184172	uc001bzp.4	AB046787	NM_024852	""CCDS399|CCDS400""	Q9H9G7	12906857	MGI:2446634	RGD:1309163			607355																	
HGNC:18424	AGO4	argonaute 4, RISC catalytic component	protein-coding gene	gene with protein product	Approved	1p34.3	01p34.3	""hAGO4|KIAA1567|FLJ20033""	argonaute 4	EIF2C4	""eukaryotic translation initiation factor 2C, 4|argonaute RISC catalytic component 4""	Argonaute/PIWI family	408	2002-04-26	2013-02-15	2015-11-27	2016-10-05	192670	ENSG00000134698	OTTHUMG00000004243	uc001bzj.3	AB046787	NM_017629	CCDS397	Q9HCK5	12906857	MGI:1924100	RGD:1304583			607356																	
HGNC:324	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1	protein-coding gene	gene with protein product	Approved	6p21.32	06p21.32	LPAAT-alpha	lysophosphatidic acid acyltransferase, alpha		1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	1-acylglycerol-3-phosphate O-acyltransferases	46	1999-12-07		2013-02-05	2016-10-05	10554	ENSG00000204310	OTTHUMG00000031210	uc003oah.4	U56417	NM_006411	CCDS4744	Q99943	""9461603|9291118""	MGI:1932075	RGD:1303287		AGPAT1	603099															2.3.1.51		
HGNC:325	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3	LPAAT-beta	lysophosphatidic acid acyltransferase, beta	BSCL	""Berardinelli-Seip congenital lipodystrophy|1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)""	1-acylglycerol-3-phosphate O-acyltransferases	46	1999-12-07		2013-02-05	2015-08-24	10555	ENSG00000169692	OTTHUMG00000020936	uc004cii.2	AF000237	NM_006412	""CCDS7003|CCDS35181""	O15120	""9242711|9212163""	MGI:1914762	RGD:1309229		AGPAT2	603100					119525										2.3.1.51		
HGNC:326	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	protein-coding gene	gene with protein product	Approved	21q22.3	21q22.3	LPAAT-gamma				1-acylglycerol-3-phosphate O-acyltransferases	46	2000-05-16			2015-08-26	56894	ENSG00000160216	OTTHUMG00000086892	uc002zdv.4	AF156774	NM_020132	CCDS13703	Q9NRZ7		MGI:1336186	RGD:1305787		AGPAT3	614794															2.3.1.51		
HGNC:20885	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4	protein-coding gene	gene with protein product	Approved	6q26	06q26	""LPAAT-delta|dJ473J16.2""	lysophosphatidic acid acyltransferase, delta		1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	1-acylglycerol-3-phosphate O-acyltransferases	46	2003-11-25		2013-02-05	2016-10-05	56895	ENSG00000026652	OTTHUMG00000015966	uc003qtr.2	AF156776	NM_020133	CCDS5280	Q9NRZ5		MGI:1915512	RGD:619916		AGPAT4	614795															2.3.1.51		
HGNC:20988	AGPAT4-IT1	AGPAT4 intronic transcript 1	non-coding RNA	RNA, long non-coding	Approved	6q26	06q26	FLJ23112		""C6orf59|NCRNA00241""	""chromosome 6 open reading frame 59|non-protein coding RNA 241|AGPAT4 intronic transcript 1 (non-protein coding)""			2003-04-29	2011-08-11	2015-02-25	2016-10-04	79992	ENSG00000279355	OTTHUMG00000152859	uc003qtu.5	AK026765	NR_024277		Q9H0P7																							URS000075D301
HGNC:20886	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5	protein-coding gene	gene with protein product	Approved	8p23.1	08p23.1	""FLJ11210|LPAAT-e|LPAAT-epsilon""	lysophosphatidic acid acyltransferase, epsilon		1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	1-acylglycerol-3-phosphate O-acyltransferases	46	2004-12-03		2013-02-05	2013-02-05	55326	ENSG00000155189	OTTHUMG00000163656	uc003wqo.4	AF375789	NM_018361	CCDS34796	Q9NUQ2		MGI:1196345	RGD:1306405		AGPAT5	614796															2.3.1.51		
HGNC:37709	AGPAT5P1	1-acylglycerol-3-phosphate O-acyltransferase 5 pseudogene 1	pseudogene	pseudogene	Approved	Yp11.2	Yp11.2							2010-02-03			2014-11-19	646231	ENSG00000234652	OTTHUMG00000036179			NG_028688														PGOHUM00000233891											
HGNC:327	AGPS	alkylglycerone phosphate synthase	protein-coding gene	gene with protein product	Approved	2q31.2	02q31.2	""ADHAPS|ADAS|ALDHPSY|ADPS|ADAP-S""						1998-10-14			2016-10-05	8540	ENSG00000018510	OTTHUMG00000132530	uc002ull.3	Y09443	NM_003659	CCDS2275	O00116	""9187299|9553082""	MGI:2443065	RGD:620364		AGPS	603051					119528										2.5.1.26		
HGNC:328	AGR2	anterior gradient 2, protein disulphide isomerase family member	protein-coding gene	gene with protein product	Approved	7p21.1	07p21.1	""XAG-2|HAG-2|AG2|PDIA17""	protein disulfide isomerase family A, member 17		anterior gradient 2 homolog (Xenopus laevis)	Protein disulfide isomerases	692	2000-03-06		2015-07-02	2016-10-05	10551	ENSG00000106541	OTTHUMG00000023446	uc003str.4	AF038451	NM_006408	CCDS5364	O95994	9790916	MGI:1344405	RGD:1304606		AGR2	606358																	
HGNC:24167	AGR3	anterior gradient 3, protein disulphide isomerase family member	protein-coding gene	gene with protein product	Approved	7p21.1	07p21.1	""HAG3|hAG-3|BCMP11|PDIA18""	""breast cancer membrane protein 11|protein disulfide isomerase family A, member 18""		anterior gradient 3 homolog (Xenopus laevis)	Protein disulfide isomerases	692	2007-02-05		2015-07-02	2015-08-26	155465	ENSG00000173467	OTTHUMG00000128411	uc003sts.4	AY069977	NM_176813	CCDS5365	Q8TD06	""12592373|12477722""	MGI:2685734	RGD:1565406		AGR3	609482																	
HGNC:329	AGRN	agrin	protein-coding gene	gene with protein product	Approved	1p36.33	01p36.33			AGRIN	agrin proteoglycan	Proteoglycans	570	1992-02-14	2007-02-16		2017-07-07	375790	ENSG00000188157	OTTHUMG00000040778	uc001ack.3	XM_372195	NM_198576	CCDS30551	O00468	""1851019|12270958""	MGI:87961	RGD:2067	""Leiden Muscular Dystrophy pages|http://www.dmd.nl/nmdb2/home.php?select_db=AGRN|LRG_198|http://www.lrg-sequence.org/LRG/LRG_198""	AGRN	103320					233062					ligandId:5319							
HGNC:330	AGRP	agouti related neuropeptide	protein-coding gene	gene with protein product	Approved	16q22.1	16q22.1	""Agrt|ART|ASIP2""			""agouti (mouse) related protein|agouti related protein homolog (mouse)""	Endogenous ligands	542	1998-06-22		2014-07-15	2016-10-05	181	ENSG00000159723	OTTHUMG00000137509	uc002etg.1	U88063	NM_001138	CCDS10839	O00253	""9119224|9311920""	MGI:892013	RGD:2068		AGRP	602311										ligandId:1335							
HGNC:333	AGT	angiotensinogen	protein-coding gene	gene with protein product	Approved	1q42.2	01q42.2		alpha-1 antiproteinase, antitrypsin	SERPINA8	serpin peptidase inhibitor, clade A, member 8	""Endogenous ligands|Serpin peptidase inhibitors""	""542|739""	1989-06-30	2001-06-29	2016-01-12	2016-01-12	183	ENSG00000135744	OTTHUMG00000037757	uc001hty.6	K02215	NM_000029	CCDS1585	P01019	""6089875|24172014""	MGI:87963	RGD:2069		AGT	106150					119535			I04.953		ligandId:583							
HGNC:17258	AGTPBP1	ATP/GTP binding protein 1	protein-coding gene	gene with protein product	Approved	9q21.33	09q21.33	""KIAA1035|Nna1|CCP1""	""cytosolic carboxypeptidase 1|tubulinyl-Tyr carboxypeptidase|carboxypeptidase-tubulin|tyrosine carboxypeptidase|soluble carboxypeptidase""			M14 carboxypeptidases	1321	2002-03-27			2014-11-19	23287	ENSG00000135049	OTTHUMG00000020124	uc010mqc.4	AB028958	NM_015239	""CCDS6672|CCDS75854|CCDS69615|CCDS83382""	Q9UPW5	11083920	MGI:2159437	RGD:1306307		AGTPBP1	606830								M14.028									
HGNC:336	AGTR1	angiotensin II receptor type 1	protein-coding gene	gene with protein product	Approved	3q24	03q24	""AT1|AT2R1|AGTR1A|AT2R1A|HAT1R|AG2S|AT2R1B|AT1B""		AGTR1B	angiotensin receptor 1B	Angiotensin receptors	221	1992-08-25		2016-01-12	2017-07-07	185	ENSG00000144891	OTTHUMG00000159503	uc003ewj.4	M87290	NM_000685	""CCDS3137|CCDS82854|CCDS82855""	P30556	1550596	MGI:87965	RGD:2070		AGTR1	106165					138533					objectId:34							
HGNC:338	AGTR2	angiotensin II receptor type 2	protein-coding gene	gene with protein product	Approved	Xq23	Xq23	""AT2|MRX88""			angiotensin receptor 2	""X-linked mental retardation|Angiotensin receptors""	""103|221""	1992-08-25		2016-01-12	2016-10-05	186	ENSG00000180772	OTTHUMG00000022243	uc004eqh.5	AY324607	NM_000686	CCDS14569	P50052	1550596	MGI:87966	RGD:2072	Mental Retardation database|http://grenada.lumc.nl/LOVD2/MR/home.php?select_db=AGTR2	AGTR2	300034					159921					objectId:35							
HGNC:13539	AGTRAP	angiotensin II receptor associated protein	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22	ATRAP						2002-09-12		2016-01-12	2016-01-12	57085	ENSG00000177674	OTTHUMG00000002230	uc001asv.4	AF165187	NM_020350	""CCDS136|CCDS30585|CCDS30586|CCDS41248|CCDS44056""	Q6RW13	11733189	MGI:1339977	RGD:1359346		AGTRAP	608729																	
HGNC:340	AGTRL2	entry withdrawn	withdrawn	withdrawn	Entry Withdrawn												2005-09-06																															
HGNC:341	AGXT	alanine-glyoxylate aminotransferase	protein-coding gene	gene with protein product	Approved	2q37.3	02q37.3	""AGXT1|PH1|AGT|SPT|AGT1""	""oxalosis I|primary hyperoxaluria type 1|L-alanine: glyoxylate aminotransferase 1|serine:pyruvate aminotransferase|glycolicaciduria""	SPAT				1990-11-20		2007-04-13	2015-09-11	189	ENSG00000172482	OTTHUMG00000133354	uc002waa.5	D13368	NM_000030	CCDS2543	P21549	""2039493|2045108""	MGI:1329033	RGD:2073		AGXT	604285					119538										""2.6.1.44|2.6.1.51""		
HGNC:14412	AGXT2	alanine--glyoxylate aminotransferase 2	protein-coding gene	gene with protein product	Approved	5p13.2	05p13.2	AGT2	""beta-alanine-pyruvate aminotransferase|beta-ALAAT II""		alanine-glyoxylate aminotransferase 2			2001-01-22		2010-05-07	2016-10-05	64902	ENSG00000113492	OTTHUMG00000090788	uc003jjf.4	AJ292204	NM_031900	""CCDS3908|CCDS78000""	Q9BYV1	15240345	MGI:2146052	RGD:621767		AGXT2	612471															2.6.1.44		
HGNC:24618	AHCTF1	AT-hook containing transcription factor 1	protein-coding gene	gene with protein product	Approved	1q44	01q44	ELYS	ELYS transcription factor like protein TMBS62		AT hook containing transcription factor 1	Nucleoporins	1051	2005-06-20		2015-11-23	2016-04-25	25909	ENSG00000153207	OTTHUMG00000040706	uc001ibv.3		NM_015446	CCDS1629	Q8WYP5	11952839	MGI:1915033	RGD:1561291		AHCTF1	610853																	
HGNC:24620	AHCTF1P1	AT-hook containing transcription factor 1 pseudogene 1	pseudogene	pseudogene	Approved	2q24.2	02q24.2	ELYS-like		AHCTF1P	""AT hook containing transcription factor 1 pseudogene|AT hook containing transcription factor 1 pseudogene 1""			2005-06-20	2010-01-12	2015-11-23	2015-11-23	285116					NG_002622																									
HGNC:343	AHCY	adenosylhomocysteinase	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	SAHH			S-adenosylhomocysteine hydrolase			1986-01-01		2009-06-12	2015-09-11	191	ENSG00000101444	OTTHUMG00000140098	uc002xai.4	M61832	NM_000687	""CCDS13233|CCDS54457""	P23526	""7079734|6580258""	MGI:87968	RGD:69260		AHCY	180960					119546					objectId:1233					3.3.1.1		
HGNC:344	AHCYL1	adenosylhomocysteinase like 1	protein-coding gene	gene with protein product	Approved	1p13.3	01p13.3	""XPVKONA|IRBIT|PPP1R78""	""inositol 1,4,5-trisphosphate receptor-binding protein|protein phosphatase 1, regulatory subunit 78""		""S-adenosylhomocysteine hydrolase-like 1|adenosylhomocysteinase-like 1""	Protein phosphatase 1 regulatory subunits	694	1999-07-23		2015-11-11	2016-10-05	10768	ENSG00000168710	OTTHUMG00000011652	uc001dyx.4	U82761	NM_001242673	""CCDS818|CCDS55620""	O43865	""11904675|16754674|12525476""	MGI:2385184	RGD:1309768		AHCYL1	607826																	
HGNC:22204	AHCYL2	adenosylhomocysteinase like 2	protein-coding gene	gene with protein product	Approved	7q32.1	07q32.1	KIAA0828			S-adenosylhomocysteine hydrolase-like 2			2008-01-17		2016-01-14	2016-04-25	23382	ENSG00000158467	OTTHUMG00000157677	uc011kov.3	AB020635	NM_001130720	""CCDS47706|CCDS47707|CCDS47708|CCDS5812""	Q96HN2		MGI:1921590	RGD:1564895		AHCYL2	616520																	
HGNC:44993	AHCYP1	adenosylhomocysteinase pseudogene 1	pseudogene	pseudogene	Approved	10q11.22	10q11.22							2013-01-04			2015-08-24	340844					NG_022175														PGOHUM00000290141											
HGNC:44994	AHCYP2	adenosylhomocysteinase pseudogene 2	pseudogene	pseudogene	Approved	9q33.2	09q33.2							2013-01-04			2013-01-04	392387	ENSG00000238181	OTTHUMG00000020571			NG_021677														PGOHUM00000236763											
HGNC:44995	AHCYP3	adenosylhomocysteinase pseudogene 3	pseudogene	pseudogene	Approved	2q12.1	02q12.1							2013-01-04			2013-01-04	402093	ENSG00000233955	OTTHUMG00000153048			NG_021515														PGOHUM00000240232											
HGNC:44996	AHCYP4	adenosylhomocysteinase pseudogene 4	pseudogene	pseudogene	Approved	2q22.1	02q22.1							2013-01-04			2013-01-04	129560	ENSG00000232992	OTTHUMG00000153632			NG_021526														PGOHUM00000240360											
HGNC:44997	AHCYP5	adenosylhomocysteinase pseudogene 5	pseudogene	pseudogene	Approved	2q32.3	02q32.3							2013-01-04			2013-01-04	391470	ENSG00000213107	OTTHUMG00000154377			NG_021544														PGOHUM00000240468											
HGNC:44998	AHCYP6	adenosylhomocysteinase pseudogene 6	pseudogene	pseudogene	Approved	11q14.1	11q14.1							2013-01-04			2013-01-04	100419714					NG_024541														PGOHUM00000242830											
HGNC:44999	AHCYP7	adenosylhomocysteinase pseudogene 7	pseudogene	pseudogene	Approved	15q21.2	15q21.2							2013-01-04			2014-07-15	645486	ENSG00000259465	OTTHUMG00000172446			NG_022129														PGOHUM00000293238											
HGNC:45000	AHCYP8	adenosylhomocysteinase pseudogene 8	pseudogene	pseudogene	Approved	1q44	01q44							2013-01-04			2013-01-04	107063538	ENSG00000242529	OTTHUMG00000040381			NG_046356														PGOHUM00000244547											
HGNC:25230	AHDC1	AT-hook DNA binding motif containing 1	protein-coding gene	gene with protein product	Approved	1p36.11-p35.3	01p36.11-p35.3	""DJ159A19.3|RP1-159A19.1""			AT hook, DNA binding motif, containing 1			2005-07-21		2015-11-23	2017-06-08	27245	ENSG00000126705	OTTHUMG00000003398	uc057dvu.1	AK125431	NM_001029882	CCDS30652	Q5TGY3	""8619474|9110174""	MGI:2444218	RGD:1310031		AHDC1	615790					423013												
HGNC:21575	AHI1	Abelson helper integration site 1	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	""FLJ20069|ORF1|JBTS3""	Jouberin		Abelson helper integration site	WD repeat domain containing	362	2003-08-22		2005-11-29	2016-10-05	54806	ENSG00000135541	OTTHUMG00000015631	uc003qgj.4	AJ459824	NM_017651	""CCDS47483|CCDS47484""	Q8N157	""15060101|16240161""	MGI:87971	RGD:1303040		AHI1	608894					119549												
HGNC:347	AHNAK	AHNAK nucleoprotein	protein-coding gene	gene with protein product	Approved	11q12.3	11q12.3	MGC5395	desmoyokin		AHNAK nucleoprotein (desmoyokin)	PDZ domain containing	1220	1994-12-12		2007-03-30	2016-10-05	79026	ENSG00000124942	OTTHUMG00000167558	uc001ntl.4	M80899	NM_024060	""CCDS31584|CCDS44625""	Q09666	""7987395|12153988""	MGI:1316648	RGD:619779		AHNAK	103390					469934												
HGNC:20125	AHNAK2	AHNAK nucleoprotein 2	protein-coding gene	gene with protein product	Approved	14q32.33	14q32.33			C14orf78	chromosome 14 open reading frame 78	PDZ domain containing	1220	2003-01-13	2007-03-26	2007-03-26	2015-08-28	113146	ENSG00000185567	OTTHUMG00000170765	uc010axc.2	AB095939	NM_138420	CCDS45177	Q8IVF2	15007166	MGI:2144831	RGD:1309696		AHNAK2	608570																	
HGNC:348	AHR	aryl hydrocarbon receptor	protein-coding gene	gene with protein product	Approved	7p21.1	07p21.1	bHLHe76				Basic helix-loop-helix proteins	420	1993-05-18			2016-10-05	196	ENSG00000106546	OTTHUMG00000149967	uc011jxz.2	L19872	NM_001621	CCDS5366	P35869	8125016	MGI:105043	RGD:2074		AHR	600253										objectId:2951							
HGNC:346	AHRR	aryl-hydrocarbon receptor repressor	protein-coding gene	gene with protein product	Approved	5p15.33	05p15.33	""KIAA1234|bHLHe77""		""AHH|AHHR""	aryl hydrocarbon receptor regulator	Basic helix-loop-helix proteins	420	1986-01-01	2003-09-12	2003-09-11	2014-11-18	57491	ENSG00000063438	OTTHUMG00000162171	uc003jav.4	AB033060	NM_020731	""CCDS43297|CCDS56355""	A9YTQ3	""1070014|11423533""	MGI:1333776	RGD:1559857		AHRR	606517																	
HGNC:1189	AHSA1	activator of HSP90 ATPase activity 1	protein-coding gene	gene with protein product	Approved	14q24.3	14q24.3	""p38|Aha1|hAha1""		C14orf3	""chromosome 14 open reading frame 3|AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast)""			1999-07-01	2003-04-11	2016-11-23	2016-11-23	10598	ENSG00000100591	OTTHUMG00000171539	uc001xtw.4	AJ243310	NM_012111	CCDS9863	O95433	26796264	MGI:2387603	RGD:1589285		AHSA1	608466																	
HGNC:20437	AHSA2P	activator of HSP90 ATPase homolog 2, pseudogene	pseudogene	pseudogene	Approved	2p15	02p15	""DKFZp564C236|Hch1|AHA1""		AHSA2	""AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast)|activator of HSP90 ATPase homolog 2""			2003-04-04	2017-11-03	2017-11-03	2017-11-03	130872	ENSG00000173209	OTTHUMG00000129437	uc002sbc.3	AK092817	NM_001321300	CCDS1868	Q719I0	12504007	MGI:1916133	RGD:1307171																				
HGNC:349	AHSG	alpha 2-HS glycoprotein	protein-coding gene	gene with protein product	Approved	3q27.3	03q27.3	""FETUA|A2HS|HSGA""	fetuin A			Cystatins, type 4	968	1986-01-01		2016-05-23	2016-05-23	197	ENSG00000145192	OTTHUMG00000156605	uc003fqk.5	""D67013|M16961""	NM_001622	CCDS3278	P02765	""9322749|7736783""	MGI:107189	RGD:2075		AHSG	138680								LI25-004									
HGNC:18075	AHSP	alpha hemoglobin stabilizing protein	protein-coding gene	gene with protein product	Approved	16p11.2	16p11.2	EDRF	alpha hemoglobin stabilising protein	ERAF	erythroid associated factor			2002-02-13	2009-10-07	2009-10-07	2017-03-24	51327	ENSG00000169877	OTTHUMG00000132461	uc002ecj.4	AF208865	NM_016633	CCDS10716	Q9NZD4	""11231637|12066189""	MGI:2158492	RGD:1306725	LRG_1073|http://www.lrg-sequence.org/LRG/LRG_1073	AHSP	605821																	
HGNC:350	AIC	Aicardi syndrome	phenotype	phenotype only	Approved	Xp22	Xp22							1986-01-01			2006-02-22	192								""6818132|1971852""					304050																	
HGNC:13203	AICDA	activation induced cytidine deaminase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	""HIGM2|CDA2|ARP2|AID""			activation-induced cytidine deaminase	Apolipoprotein B mRNA editing enzyme catalytic subunits	406	2000-09-19		2016-07-04	2017-03-24	57379	ENSG00000111732	OTTHUMG00000168676	uc001qur.3	AB040430	NM_020661	""CCDS41747|CCDS81662""	Q9GZX7		MGI:1342279	RGD:1303222	""AICDA base: Mutation registry for Aid deficiency|http://structure.bmc.lu.se/idbase/AICDAbase/|LRG_17|http://www.lrg-sequence.org/LRG/LRG_17""	AICDA	605257					119554												
HGNC:25761	AIDA	axin interactor, dorsalization associated	protein-coding gene	gene with protein product	Approved	1q41	01q41	FLJ12806	axin interaction partner and dorsalization antagonist	C1orf80	chromosome 1 open reading frame 80	C2 domain containing	823	2005-05-24	2008-05-22	2008-05-22	2014-11-19	64853	ENSG00000186063	OTTHUMG00000037653	uc001hnn.4	BC043142	NM_022831	CCDS1533	Q96BJ3	""8619474|9110174|17681137""	MGI:1919737	RGD:1592746		AIDA	612375																	
HGNC:352	AIF1	allograft inflammatory factor 1	protein-coding gene	gene with protein product	Approved	6p21.33	06p21.33	""IRT-1|AIF-1|Em:AF129756.17|IBA1""	""interferon gamma responsive transcript|ionized calcium-binding adapter molecule 1""			EF-hand domain containing	863	1997-07-01			2016-10-05	199	ENSG00000204472	OTTHUMG00000031246	uc003nuy.4	U19713	NM_001318970	""CCDS4706|CCDS34398""	P55008	8912632	MGI:1343098	RGD:61924		AIF1	601833																	
HGNC:28904	AIF1L	allograft inflammatory factor 1 like	protein-coding gene	gene with protein product	Approved	9q34.12-q34.13	09q34.12-q34.13	""IBA2|FLJ12783""		C9orf58	""chromosome 9 open reading frame 58|allograft inflammatory factor 1-like""	EF-hand domain containing	863	2004-01-06	2008-10-21	2016-03-15	2017-06-08	83543	ENSG00000126878	OTTHUMG00000020817	uc004cad.2	AL136566	NM_031426	""CCDS6939|CCDS55348|CCDS55349""	Q9BQI0	11230166	MGI:1919598	RGD:1305081		AIF1L																		
HGNC:8768	AIFM1	apoptosis inducing factor mitochondria associated 1	protein-coding gene	gene with protein product	Approved	Xq26.1	Xq26.1	""AIF|CMTX4""		""PDCD8|NAMSD""	""programmed cell death 8 (apoptosis-inducing factor)|neuropathy, axonal, motor-sensory with deafness and mental retardation (Cowchock syndrome)|apoptosis-inducing factor, mitochondrion-associated, 1|apoptosis inducing factor, mitochondria associated 1""			1999-05-28	2006-11-16	2017-01-12	2017-01-12	9131	ENSG00000156709	OTTHUMG00000022392	uc004evg.4	AF100928	NM_001130846	""CCDS14618|CCDS14619|CCDS48167|CCDS48166""	O95831	""9989411|23217327""	MGI:1349419	RGD:620817	Mental Retardation database|http://grenada.lumc.nl/LOVD2/MR/home.php?select_db=AIFM1	AIFM1	300169					244686										1.1.1.-		
HGNC:44884	AIFM1P1	apoptosis inducing factor, mitochondria associated 1 pseudogene 1	pseudogene	pseudogene	Approved	10p12.31	10p12.31				apoptosis-inducing factor, mitochondrion-associated, 1 pseudogene 1			2012-12-11		2015-11-19	2015-11-19	645120	ENSG00000225509	OTTHUMG00000017768			NG_021350														PGOHUM00000238680											
HGNC:21411	AIFM2	apoptosis inducing factor, mitochondria associated 2	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	""FLJ14497|PRG3""		AMID	""apoptosis-inducing factor (AIF)-like mitochondrion-associated inducer of death|apoptosis-inducing factor, mitochondrion-associated, 2""			2004-04-20	2006-11-16	2015-11-19	2016-10-05	84883	ENSG00000042286	OTTHUMG00000018398	uc010qjg.3	AK027403	NM_032797	CCDS7297	Q9BRQ8	""12135761|11980907|15958387""	MGI:1918611	RGD:1304964		AIFM2	605159																	
HGNC:26398	AIFM3	apoptosis inducing factor, mitochondria associated 3	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	""AIFL|FLJ30473""			apoptosis-inducing factor, mitochondrion-associated, 3			2006-11-16		2015-11-19	2015-11-19	150209	ENSG00000183773	OTTHUMG00000150804	uc002ztj.3	AK094844	NM_144704	""CCDS13786|CCDS33605|CCDS54503""	Q96NN9	15764604	MGI:1919418	RGD:1306028		AIFM3	617298																	
HGNC:21607	AIG1	androgen induced 1	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2	""dJ95L4.1|AIG-1|FLJ10485""						2003-06-26		2016-07-01	2016-10-05	51390	ENSG00000146416	OTTHUMG00000015721	uc003qjh.5	AF153605	NM_016108	""CCDS5198|CCDS69216|CCDS69215""	Q9NVV5	11266118	MGI:1913503	RGD:1562920		AIG1	608514																	
HGNC:43926	AIG1P1	androgen induced 1 pseudogene 1	pseudogene	pseudogene	Approved	5p13.1	05p13.1							2012-05-04		2016-07-01	2016-07-01	106479028	ENSG00000249089	OTTHUMG00000162194			NG_044322														PGOHUM00000235567											
HGNC:355	AIH3	amelogenesis imperfecta 3, hypomaturation or hypoplastic type	phenotype	phenotype only	Approved	Xq22-q28	Xq22-q28							1992-02-20			2011-02-24	201								1358807					301201																	
HGNC:357	AIM2	absent in melanoma 2	protein-coding gene	gene with protein product	Approved	1q23.1-q23.2	01q23.1-q23.2	PYHIN4				Pyrin and HIN domain family	995	1999-04-22			2017-06-08	9447	ENSG00000163568	OTTHUMG00000037183	uc001ftj.2	AF024714	NM_004833	CCDS1181	O14862	""9242382|25665578""	MGI:2686159	RGD:1307283		AIM2	604578										objectId:2923							
HGNC:10648	AIMP1	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	protein-coding gene	gene with protein product	Approved	4q24	04q24	""EMAPII|EMAP-2|p43""	""EMAP II|ARS-interacting multifunctional protein 1""	SCYE1	small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating)			2000-04-13	2009-05-20	2016-05-10	2016-05-10	9255	ENSG00000164022	OTTHUMG00000131217	uc011cfg.3	U10117	NM_004757	""CCDS3674|CCDS47121""	Q12904	""7929199|7545917""	MGI:102774	RGD:620466		AIMP1	603605					258625												
HGNC:16543	AIMP1P1	aminoacyl tRNA synthetase complex interacting multifunctional protein 1 pseudogene 1	pseudogene	pseudogene	Approved	20p12.1	20p12.1	bA400P21.1		SCYE1P	small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating) pseudogene			2001-09-17	2012-01-31	2016-05-10	2016-05-10	170547	ENSG00000234187	OTTHUMG00000031913		AL136992	NG_001053														PGOHUM00000247596											
HGNC:43693	AIMP1P2	aminoacyl tRNA synthetase complex interacting multifunctional protein 1 pseudogene 2	pseudogene	pseudogene	Approved	1q24.3	01q24.3							2012-01-31		2016-05-10	2016-05-10	100873064	ENSG00000227177	OTTHUMG00000034833			NG_032149														PGOHUM00000244338											
HGNC:20609	AIMP2	aminoacyl tRNA synthetase complex interacting multifunctional protein 2	protein-coding gene	gene with protein product	Approved	7p22.1	07p22.1	""p38|PRO0992|JTV-1|JTV1""						2009-05-20		2016-05-10	2016-05-10	7965	ENSG00000106305	OTTHUMG00000122077	uc003spo.4	U24169	NM_006303	CCDS5344	Q13155	""8666379|18695251""	MGI:2385237	RGD:1560787		AIMP2	600859																	
HGNC:358	AIP	aryl hydrocarbon receptor interacting protein	protein-coding gene	gene with protein product	Approved	11q13.2	11q13.2	""XAP2|ARA9|FKBP16""			aryl hydrocarbon receptor-interacting protein	FKBP prolyl isomerases	910	1999-01-22		2001-11-29	2017-03-24	9049	ENSG00000110711	OTTHUMG00000167674	uc001olv.4	U31913	NM_001302959	CCDS8168	O00170	""8972861|9111057""	MGI:109622	RGD:628619	LRG_460|http://www.lrg-sequence.org/LRG/LRG_460	AIP	605555					200951												
HGNC:359	AIPL1	aryl hydrocarbon receptor interacting protein like 1	protein-coding gene	gene with protein product	Approved	17p13.2	17p13.2			LCA4	""aryl hydrocarbon receptor-interacting protein-like 1|aryl hydrocarbon receptor interacting protein-like 1""	FKBP prolyl isomerases	910	1999-03-18		2016-03-22	2016-10-05	23746	ENSG00000129221	OTTHUMG00000102043	uc002gcp.5	AF148864	NM_014336	""CCDS11075|CCDS32539|CCDS32540|CCDS67130|CCDS67131|CCDS67132|CCDS67133""	Q9NZN9	""10615133|14555765|15365173""	MGI:2148800	RGD:70906	Mutations of the Aryl Hydrocarbon Receptor-interacting Protein-like 1|http://www.retina-international.org/files/sci-news/aipl1mut.htm	AIPL1	604392					119559												
HGNC:360	AIRE	autoimmune regulator	protein-coding gene	gene with protein product	Approved	21q22.3	21q22.3	""PGA1|APS1""	autoimmune polyendocrinopathy candidiasis ectodermal dystrophy	APECED	autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal dystrophy)	PHD finger proteins	88	1997-09-05		2007-06-20	2017-03-24	326	ENSG00000160224	OTTHUMG00000086921	uc002zei.4	AB006684	NM_000383	CCDS13706	O43918	9398840	MGI:1338803	RGD:1311139	""AIREbase: Mutation registry for APECED|http://structure.bmc.lu.se/idbase/AIREbase/|LRG_18|http://www.lrg-sequence.org/LRG/LRG_18""	AIRE	607358					119562												
HGNC:34515	AIRN	antisense of IGF2R non-protein coding RNA	non-coding RNA	RNA, long non-coding	Approved	6q25.3	06q25.3	""AIR|NCRNA00088|IGF2RAS|IGF2R-AS1""	""non-protein coding RNA 88|IGF2R antisense RNA 1 (non-protein coding)""		antisense of IGF2R RNA (non-protein coding)	Long non-coding RNAs (published)	788	2008-11-25		2012-08-16	2014-10-22	100271873	ENSG00000268257	OTTHUMG00000183173	uc031sqx.1		NR_047511			""18789384|19008856""	MGI:1353471				604893														Air			URS000041E62F
HGNC:16304	AIS1	autoimmune susceptibility 1	phenotype	phenotype only	Approved	1p33-p31	01p33-p31							2003-08-26			2014-02-12	373071								""11912181|12707860|16098053""																						
HGNC:23054	AIS2	autoimmune susceptibility 2	phenotype	phenotype only	Approved	7q11.22	07q11.22							2003-09-11			2004-05-17	378426								14691733					608391																	
HGNC:23083	AIS3	autoimmune susceptibility 3 (vitiligo specific)	phenotype	phenotype only	Approved	8	08							2003-09-11			2004-05-17	378427								14691733					608392																	
HGNC:30801	AJAP1	adherens junctions associated protein 1	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	""SHREW1|SHREW-1|MOT8""	transmembrane protein SHREW1					2005-07-11		2008-01-08	2014-11-19	55966	ENSG00000196581	OTTHUMG00000000645	uc001alo.5	AF175409	NM_018836	CCDS54	Q9UKB5	14595118	MGI:2685419	RGD:1590138		AJAP1	610972																	
HGNC:37284	AJM1	apical junction component 1 homolog	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3	ajm-1		C9orf172	chromosome 9 open reading frame 172			2009-09-11	2017-10-06	2017-10-06	2017-10-06	389813	ENSG00000232434	OTTHUMG00000187258	uc011meh.3		NM_001080482	CCDS48059	C9J069		MGI:2685842	RGD:1560470																				
HGNC:20250	AJUBA	ajuba LIM protein	protein-coding gene	gene with protein product	Approved	14q11.2	14q11.2	MGC15563		JUB	jub, ajuba homolog (Xenopus laevis)	Ajuba family	1403	2003-01-14	2011-11-10	2011-11-10	2014-11-19	84962	ENSG00000129474	OTTHUMG00000028711	uc001whz.4	AK025567	NM_001289097	""CCDS9581|CCDS9582""	Q96IF1	10330178	MGI:1341886	RGD:620407			609066																	
HGNC:361	AK1	adenylate kinase 1	protein-coding gene	gene with protein product	Approved	9q34.11	09q34.11					Adenylate kinases	356	1986-01-01			2016-10-05	203	ENSG00000106992	OTTHUMG00000020722	uc004bsm.4	J04809	NM_000476	""CCDS6881|CCDS83419""	P00568		MGI:87977	RGD:2076		AK1	103000					119567										2.7.4.3		
HGNC:362	AK2	adenylate kinase 2	protein-coding gene	gene with protein product	Approved	1p35.1	01p35.1					Adenylate kinases	356	1986-01-01			2017-03-24	204	ENSG00000004455	OTTHUMG00000004131	uc001bwp.3	U84371	NM_001625	""CCDS373|CCDS374|CCDS81294|CCDS81295|CCDS81296""	P54819	""8843353|6961883""	MGI:87978	RGD:2077	LRG_133|http://www.lrg-sequence.org/LRG/LRG_133	AK2	103020					173523										2.7.4.3		
HGNC:24037	AK2P1	adenylate kinase 2 pseudogene 1	pseudogene	pseudogene	Approved	1p32.1	01p32.1	AK2B						2007-07-25			2007-07-25	266920				AF056332	NG_002393			10092943																						
HGNC:33542	AK2P2	adenylate kinase 2 pseudogene 2	pseudogene	pseudogene	Approved	2p22.3	02p22.3							2007-07-25			2016-10-05	339736	ENSG00000242272	OTTHUMG00000152054			NG_009660														PGOHUM00000240008											
HGNC:17376	AK3	adenylate kinase 3	protein-coding gene	gene with protein product	Approved	9p24.1	09p24.1	AKL3L1		""AK6|AK3L1""	""adenylate kinase 6|adenylate kinase 3 like 1""	Adenylate kinases	356	2002-12-17	2005-04-07	2004-06-11	2014-11-19	50808	ENSG00000147853	OTTHUMG00000019472	uc003ziq.4	BC013771	NM_016282	""CCDS6455|CCDS56561|CCDS56562""	Q9UIJ7	""8288|182062""	MGI:1860835	RGD:619885		AK3	609290																	
HGNC:31099	AK3P2	adenylate kinase 3 pseudogene 2	pseudogene	pseudogene	Approved	8q24.3	08q24.3	HsT26053						2005-10-06			2014-11-19	100419074	ENSG00000250115	OTTHUMG00000160500			NG_026075														PGOHUM00000249519											
HGNC:39062	AK3P3	adenylate kinase 3 pseudogene 3	pseudogene	pseudogene	Approved	7p15.3	07p15.3							2010-09-29			2014-11-19	100419075	ENSG00000230042	OTTHUMG00000152600			NG_026542														PGOHUM00000233148											
HGNC:39063	AK3P4	adenylate kinase 3 pseudogene 4	pseudogene	pseudogene	Approved	5q22.3	05q22.3							2010-09-29			2014-11-19	100129959	ENSG00000248722	OTTHUMG00000162914			NG_028719														PGOHUM00000235732											
HGNC:39064	AK3P5	adenylate kinase 3 pseudogene 5	pseudogene	pseudogene	Approved	10p11.22	10p11.22							2010-09-30			2014-11-19	100288319	ENSG00000228816	OTTHUMG00000017931			NG_022166														PGOHUM00000238717											
HGNC:39065	AK3P6	adenylate kinase 3 pseudogene 6	pseudogene	pseudogene	Approved	12q24.33	12q24.33							2010-09-30			2014-11-18	100873789					NG_032224														PGOHUM00000239611											
HGNC:363	AK4	adenylate kinase 4	protein-coding gene	gene with protein product	Approved	1p31.3	01p31.3			""AK3|AK3L1""	""adenylate kinase 3|adenylate kinase 3-like 1""	Adenylate kinases	356	2001-06-22	2010-06-15	2010-06-15	2014-11-19	205	ENSG00000162433	OTTHUMG00000009033	uc001dby.3	AK025926	NM_013410	""CCDS629|CCDS81340""	P27144	11485571	MGI:87979	RGD:2078		AK4	103030															2.7.4.3		
HGNC:364	AK4P1	adenylate kinase 4 pseudogene 1	pseudogene	pseudogene	Approved	17q11.2	17q11.2			AK3P1	adenylate kinase 3 pseudogene 1			1992-06-24	2010-09-30	2010-09-30	2017-10-25	206	ENSG00000263535	OTTHUMG00000179256		X60674	NG_001070			1639383																						
HGNC:39066	AK4P2	adenylate kinase 4 pseudogene 2	pseudogene	pseudogene	Approved	5q11.2	05q11.2							2010-09-30			2014-11-19	100132104	ENSG00000249410	OTTHUMG00000162238			NG_021849														PGOHUM00000235224											
HGNC:21596	AK4P3	adenylate kinase 4 pseudogene 3	pseudogene	pseudogene	Approved	12p11.21	12p11.21	AK3L2P		AK3L2	""adenylate kinase 3-like 2|adenylate kinase 3-like 2 (pseudogene)""			2004-03-11	2010-09-30	2010-09-30	2016-11-01	645619	ENSG00000233381	OTTHUMG00000169084			NG_007564																									
HGNC:39067	AK4P4	adenylate kinase 4 pseudogene 4	pseudogene	pseudogene	Approved	9p24.1	09p24.1							2010-09-30			2010-09-30	100128705	ENSG00000223621	OTTHUMG00000019509			NG_021605														PGOHUM00000235956											
HGNC:39068	AK4P5	adenylate kinase 4 pseudogene 5	pseudogene	pseudogene	Approved	6q14.1	06q14.1							2010-09-30			2014-11-19	100526416	ENSG00000217377	OTTHUMG00000015090			NG_027847														PGOHUM00000261423											
HGNC:39069	AK4P6	adenylate kinase 4 pseudogene 6	pseudogene	pseudogene	Approved	4q31.3	04q31.3							2010-09-30			2010-09-30	649288	ENSG00000235606	OTTHUMG00000161449			NG_022085														PGOHUM00000246100											
HGNC:365	AK5	adenylate kinase 5	protein-coding gene	gene with protein product	Approved	1p31.1	01p31.1					Adenylate kinases	356	1999-11-19			2016-10-05	26289	ENSG00000154027	OTTHUMG00000009796	uc001dhn.4	AF062595	NM_174858	""CCDS675|CCDS676""	Q9Y6K8	10215863	MGI:2677491	RGD:1590818		AK5	608009																	
HGNC:49151	AK6	adenylate kinase 6	protein-coding gene	gene with protein product	Approved	5q13.2	05q13.2	CINAP	coilin interacting nuclear ATPase protein			Adenylate kinases	356	2013-09-19			2015-08-27	102157402	ENSG00000085231	OTTHUMG00000187252			NM_016283		Q9Y3D8	16079131	MGI:5510732	RGD:7387335																		2.7.4.3		
HGNC:51678	AK6P1	adenylate kinase 6 pseudogene 1	pseudogene	pseudogene	Approved	12p11.1	12p11.1							2015-05-06			2015-05-06	100132086	ENSG00000256614	OTTHUMG00000169291																	PGOHUM00000291621											
HGNC:51679	AK6P2	adenylate kinase 6 pseudogene 2	pseudogene	pseudogene	Approved	12q12	12q12							2015-05-06			2015-05-06	100128817	ENSG00000257173	OTTHUMG00000169296																	PGOHUM00000291295											
HGNC:20091	AK7	adenylate kinase 7	protein-coding gene	gene with protein product	Approved	14q32.2	14q32.2	FLJ32864				Adenylate kinases	356	2002-12-17			2016-10-05	122481	ENSG00000140057	OTTHUMG00000171421	uc001yfn.3	AK057426	NM_152327	CCDS9945	Q96M32		MGI:1926051	RGD:1309600		AK7	615364																	
HGNC:26526	AK8	adenylate kinase 8	protein-coding gene	gene with protein product	Approved	9q34.13	09q34.13	FLJ32704		C9orf98	chromosome 9 open reading frame 98	Adenylate kinases	356	2004-03-11	2010-12-07	2010-12-07	2014-11-19	158067	ENSG00000165695	OTTHUMG00000021009	uc004cbu.2	AK093446	NM_152572	CCDS6954	Q96MA6	21080915	MGI:1916120	RGD:1303144		AK8	615365															2.7.4.3		
HGNC:33814	AK9	adenylate kinase 9	protein-coding gene	gene with protein product	Approved	6q21	06q21	""FLJ42177|FLJ25791|dJ70A9.1|MGC26954""		""C6orf224|AKD2|C6orf199|AKD1""	""chromosome 6 open reading frame 224|adenylate kinase domain containing 2|chromosome 6 open reading frame 199|adenylate kinase domain containing 1""	Adenylate kinases	356	2009-03-13	2013-04-29	2013-04-29	2015-10-15	221264	ENSG00000155085	OTTHUMG00000157658		""AK131244|BC146443|BC087860""	NM_001145128	""CCDS5077|CCDS55048""	Q5TCS8	23416111	MGI:2685080	RGD:1559879			615358															2.7.4.3		
HGNC:28285	AKAIN1	A-kinase anchor inhibitor 1	protein-coding gene	gene with protein product	Approved	18p11.31	18p11.31			C18orf42	""chromosome 18 open reading frame 42|A kinase (PRKA) anchor inhibitor 1""			2011-05-06	2016-04-19	2016-09-26	2016-09-26	642597	ENSG00000231824	OTTHUMG00000178457	uc010wzc.2		NM_001145194	""CCDS54179|CCDS82235""	P0CW23	25653177	MGI:2444600	RGD:2324352			616427																	
HGNC:367	AKAP1	A-kinase anchoring protein 1	protein-coding gene	gene with protein product	Approved	17q22	17q22	""AKAP121|AKAP149|SAKAP84|S-AKAP84|AKAP84|D-AKAP1|PPP1R43|TDRD17""	""protein kinase anchoring protein 1|dual specificity A-kinase-anchoring protein 1|protein phosphatase 1, regulatory subunit 43|tudor domain containing 17""	PRKA1	A kinase (PRKA) anchor protein 1	""A-kinase anchoring proteins|Protein phosphatase 1 regulatory subunits|Tudor domain containing""	""396|694|780""	1999-09-16		2015-11-17	2015-11-17	8165	ENSG00000121057	OTTHUMG00000140369	uc002iux.4	X97335	NM_001242902	CCDS11594	Q92667	""8769136|7499250""	MGI:104729	RGD:620826		AKAP1	602449																	
HGNC:372	AKAP2	A-kinase anchoring protein 2	protein-coding gene	gene with protein product	Approved	9q31.3	09q31.3	""AKAP-KL|KIAA0920|DKFZp564L0716|MISP2""	protein kinase A2	PRKA2	A kinase (PRKA) anchor protein 2	A-kinase anchoring proteins	396	1999-09-16		2015-11-17	2016-07-08	11217	ENSG00000241978	OTTHUMG00000156811	uc004bem.4	AB023137	NM_001004065	""CCDS43861|CCDS48003|CCDS56581""	Q9Y2D5	10231032	MGI:1306795	RGD:1305135		AKAP2	604582																	
HGNC:373	AKAP3	A-kinase anchoring protein 3	protein-coding gene	gene with protein product	Approved	12p13.32	12p13.32	""FSP95|SOB1|AKAP110|CT82""	""Fibrous Sheath Protein of 95 kDa|cancer/testis antigen 82""		A kinase (PRKA) anchor protein 3	A-kinase anchoring proteins	396	1999-09-16		2015-11-17	2015-11-17	10566	ENSG00000111254	OTTHUMG00000168226	uc031qfv.2	U85715	NM_006422	CCDS8531	O75969	""10334916|10319321""	MGI:1341149	RGD:1359735		AKAP3	604689																	
HGNC:374	AKAP4	A-kinase anchoring protein 4	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	""p82|hAKAP82|AKAP82|Fsc1|HI|CT99""	""A-kinase anchor protein 82 kDa|testis-specific gene HI|protein kinase A anchoring protein 4|cancer/testis antigen 99""		A kinase (PRKA) anchor protein 4	A-kinase anchoring proteins	396	1999-09-16		2015-11-17	2016-10-05	8852	ENSG00000147081	OTTHUMG00000021517	uc004dow.1	AF072756	NM_003886	""CCDS14329|CCDS14330""	Q5JQC9	""9822690|9514854""	MGI:102794	RGD:620828	Mental Retardation database|http://grenada.lumc.nl/LOVD2/MR/home.php?select_db=AKAP4	AKAP4	300185																	
HGNC:375	AKAP5	A-kinase anchoring protein 5	protein-coding gene	gene with protein product	Approved	14q23.3	14q23.3	""AKAP75|AKAP79""			A kinase (PRKA) anchor protein 5	A-kinase anchoring proteins	396	1999-09-16		2015-11-17	2015-11-17	9495	ENSG00000179841	OTTHUMG00000029634	uc001xhd.4	M90359	NM_004857	CCDS9764	P24588	""1512224|1618839""	MGI:2685104	RGD:620829		AKAP5	604688																	
HGNC:376	AKAP6	A-kinase anchoring protein 6	protein-coding gene	gene with protein product	Approved	14q12	14q12	""KIAA0311|mAKAP|AKAP100|PRKA6|ADAP6""	protein kinase A anchoring protein 6		A kinase (PRKA) anchor protein 6	A-kinase anchoring proteins	396	1999-09-16		2015-11-17	2015-11-17	9472	ENSG00000151320	OTTHUMG00000140207	uc001wrq.4	AB002309	NM_004274	CCDS9644	Q13023	""7721854|9205841""	MGI:3050566	RGD:69412		AKAP6	604691																	
HGNC:377	AKAP7	A-kinase anchoring protein 7	protein-coding gene	gene with protein product	Approved	6q23.2	06q23.2	""AKAP18|AKAP15""			A kinase (PRKA) anchor protein 7	A-kinase anchoring proteins	396	1999-09-16		2015-11-17	2016-04-25	9465	ENSG00000118507	OTTHUMG00000015563	uc003qck.5	AF047715	NM_004842	""CCDS5142|CCDS5143|CCDS5144""	""O43687|Q9P0M2""	9545239	MGI:1859150	RGD:1303071		AKAP7	604693																	
HGNC:378	AKAP8	A-kinase anchoring protein 8	protein-coding gene	gene with protein product	Approved	19p13.12	19p13.12	""AKAP95|DKFZp586B1222""	A-kinase anchor protein, 95kDa		A kinase (PRKA) anchor protein 8	A-kinase anchoring proteins	396	1999-09-16		2015-11-17	2015-11-17	10270	ENSG00000105127	OTTHUMG00000182444	uc002nav.4	Y11997	NM_005858	CCDS12329	O43823	9473338	MGI:1928488	RGD:620832		AKAP8	604692																	
HGNC:29857	AKAP8L	A-kinase anchoring protein 8 like	protein-coding gene	gene with protein product	Approved	19p13.12	19p13.12	""NAKAP95|HAP95""	neighbor of A kinase anchoring protein 95		A kinase (PRKA) anchor protein 8-like			2004-02-18		2015-11-17	2015-11-17	26993	ENSG00000011243	OTTHUMG00000182446	uc002naw.2	BC000713	NM_014371	""CCDS46005|CCDS77249""	Q9ULX6	""10748171|10761695""	MGI:1860606	RGD:1359200		AKAP8L	609475																	
HGNC:49758	AKAP8P1	A-kinase anchoring protein 8 pseudogene 1	pseudogene	pseudogene	Approved	9p23	09p23				A kinase (PRKA) anchor protein 8 pseudogene 1			2014-02-14		2015-11-17	2015-11-17	646114	ENSG00000234146	OTTHUMG00000019553			NG_021607														PGOHUM00000235963											
HGNC:379	AKAP9	A-kinase anchoring protein 9	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2	""KIAA0803|AKAP350|AKAP450|CG-NAP|YOTIAO|HYPERION|PRKA9|MU-RMS-40.16A|PPP1R45|LQT11""	""A-kinase anchoring protein 450|AKAP9-BRAF fusion protein|AKAP120-like protein|centrosome- and golgi-localized protein kinase N-associated protein|protein kinase A anchoring protein 9|A-kinase anchor protein, 350kDa|protein phosphatase 1, regulatory subunit 45|yotiao""		A kinase (PRKA) anchor protein 9	""A-kinase anchoring proteins|Protein phosphatase 1 regulatory subunits""	""396|694""	1999-09-16		2015-11-17	2017-03-24	10142	ENSG00000127914	OTTHUMG00000131127	uc003ulg.4	AF091711	NM_005751	CCDS5622	Q99996	""9482789|10390370|24475373""	MGI:2178217	RGD:620833	""AKAP9 database at LOVD-China|http://genomed.org/LOVD/LQTs/home.php?select_db=AKAP9|LRG_331|http://www.lrg-sequence.org/LRG/LRG_331""	AKAP9	604001					160008												
HGNC:368	AKAP10	A-kinase anchoring protein 10	protein-coding gene	gene with protein product	Approved	17p11.2	17p11.2	""D-AKAP2|PRKA10|MGC9414""	""dual-specificity A-kinase anchoring protein 2|protein kinase A anchoring protein 10|mitochondrial A kinase PPKA anchor protein 10""		A kinase (PRKA) anchor protein 10	A-kinase anchoring proteins	396	1999-09-16		2015-11-17	2016-10-05	11216	ENSG00000108599	OTTHUMG00000059515	uc002gwo.5	AF037439	NM_007202	""CCDS11214|CCDS82091""	O43572	9326583	MGI:1890218	RGD:1308869		AKAP10	604694																	
HGNC:369	AKAP11	A-kinase anchoring protein 11	protein-coding gene	gene with protein product	Approved	13q14.11	13q14.11	""KIAA0629|AKAP220|PRKA11|FLJ11304|DKFZp781I12161|PPP1R44""	""AKAP 220|A-kinase anchoring protein, 220kDa|protein kinase A anchoring protein 11|protein phosphatase 1, regulatory subunit 44""		A kinase (PRKA) anchor protein 11	""A-kinase anchoring proteins|Protein phosphatase 1 regulatory subunits""	""396|694""	1999-09-16		2015-11-17	2016-10-05	11215	ENSG00000023516	OTTHUMG00000016805	uc001uys.2	AB014529	NM_016248	CCDS9383	Q9UKA4	""9734811|8621616""	MGI:2684060	RGD:2079		AKAP11	604696																	
HGNC:39939	AKAP11-IT1	entry withdrawn	withdrawn	withdrawn	Entry Withdrawn												2014-11-19																															
HGNC:370	AKAP12	A-kinase anchoring protein 12	protein-coding gene	gene with protein product	Approved	6q25.1	06q25.1	""AKAP250|SSeCKS""	""gravin|Src-Suppressed C Kinase Substrate""		""A kinase (PRKA) anchor protein (gravin) 12|A kinase (PRKA) anchor protein 12""	A-kinase anchoring proteins	396	1999-09-16		2015-11-17	2016-10-05	9590	ENSG00000131016	OTTHUMG00000015833	uc011eep.4	U81607	NM_005100	""CCDS5229|CCDS5230""	Q02952	9000000	MGI:1932576	RGD:70988		AKAP12	604698																	
HGNC:371	AKAP13	A-kinase anchoring protein 13	protein-coding gene	gene with protein product	Approved	15q25.3	15q25.3	""Ht31|BRX|AKAP-Lbc|c-lbc|PROTO-LB|HA-3|ARHGEF13""		LBC	""lymphoid blast crisis oncogene|A kinase (PRKA) anchor protein 13""	""A-kinase anchoring proteins|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|Minor histocompatibility antigens""	""396|682|722|870""	1999-09-16		2015-11-17	2016-01-14	11214	ENSG00000170776	OTTHUMG00000172205	uc002blu.3	M90360	NM_007200	""CCDS32319|CCDS32320|CCDS73778""	Q12802	""9627117|1860836""	MGI:2676556	RGD:727893		AKAP13	604686																	
HGNC:24061	AKAP14	A-kinase anchoring protein 14	protein-coding gene	gene with protein product	Approved	Xq24	Xq24	AKAP28			A kinase (PRKA) anchor protein 14	A-kinase anchoring proteins	396	2004-09-09		2015-11-17	2015-11-17	158798	ENSG00000186471	OTTHUMG00000022285	uc004ese.4	AF514780	NM_178813	""CCDS14591|CCDS35376|CCDS35377""	Q86UN6	12475942	MGI:3618288	RGD:708510	Mental Retardation database|http://grenada.lumc.nl/LOVD2/MR/home.php?select_db=AKAP14	AKAP14	300462																	
HGNC:18783	AKAP17A	A-kinase anchoring protein 17A	protein-coding gene	gene with protein product	Approved	Xp22.33 and Yp11.32	Xp22.33 and Yp11.32	""XE7|XE7Y|DXYS155E|MGC39904|721P|CCDC133""		""CXYorf3|SFRS17A""	""chromosome X and Y open reading frame 3|splicing factor, arginine/serine-rich 17A|A kinase (PRKA) anchor protein 17A""	""A-kinase anchoring proteins|Pseudoautosomal region 1""	""396|715""	2006-09-22	2010-09-08	2015-11-17	2015-11-17	8227	ENSG00000197976	OTTHUMG00000021063	uc004fpn.4	L03426	NM_005088	CCDS14116	Q02040	""9736779|1438229|19840947""		RGD:1564640	Mental Retardation database|http://grenada.lumc.nl/LOVD2/MR/home.php?select_db=SFRS17A	AKAP17A	""312095|465000""																	
HGNC:38514	AKAP17BP	A-kinase anchoring protein 17B, pseudogene	pseudogene	pseudogene	Approved	Xq24	Xq24			""AKAP16B|AKAP16BP""	""A kinase (PRKA) anchor protein 16B, pseudogene|A kinase (PRKA) anchor protein 17B, pseudogene""	A-kinase anchoring proteins	396	2010-09-08	2013-10-16	2015-11-17	2015-11-17	139516	ENSG00000214992	OTTHUMG00000022267			NG_022632			17302988	MGI:2443758										PGOHUM00000241516											
HGNC:1170	AKIP1	A-kinase interacting protein 1	protein-coding gene	gene with protein product	Approved	11p15.4	11p15.4	BCA3		C11orf17	""chromosome 11 open reading frame 17|A kinase (PRKA) interacting protein 1""			2000-07-31	2011-04-18	2015-11-24	2016-10-05	56672	ENSG00000166452	OTTHUMG00000165653	uc001mgx.4	AF512007	NM_020642	""CCDS7793|CCDS55743|CCDS55744""	Q9NQ31	""20562110|18178962|15630084""	MGI:3041226	RGD:1306959		AKIP1	609191																	
HGNC:25744	AKIRIN1	akirin 1	protein-coding gene	gene with protein product	Approved	1p34.3	01p34.3	FLJ12666		C1orf108	chromosome 1 open reading frame 108			2005-06-03	2008-06-23	2008-06-23	2014-11-18	79647	ENSG00000174574	OTTHUMG00000007496	uc001ccw.4	AK022728	NM_024595	""CCDS433|CCDS44113""	Q9H9L7	19200367	MGI:1915300	RGD:1585989		AKIRIN1	615164																	
HGNC:50794	AKIRIN1P1	akirin 1 pseudogene 1	pseudogene	pseudogene	Approved	12q21.31	12q21.31							2014-06-18			2014-06-18	100418731	ENSG00000257786	OTTHUMG00000170163			NG_024033														PGOHUM00000239529											
HGNC:50797	AKIRIN1P2	akirin 1 pseudogene 2	pseudogene	pseudogene	Approved	Xq12	Xq12							2014-06-18		2014-06-18	2017-03-10	106480306	ENSG00000228125	OTTHUMG00000021742			NG_008960														PGOHUM00000241824											
HGNC:21407	AKIRIN2	akirin 2	protein-coding gene	gene with protein product	Approved	6q15	06q15	""FLJ10342|dJ486L4.2""		C6orf166	chromosome 6 open reading frame 166			2003-06-12	2008-06-23	2008-06-23	2014-11-19	55122	ENSG00000135334	OTTHUMG00000015180	uc003pmk.4	BC000764	NM_018064	CCDS5013	Q53H80		MGI:1889364	RGD:1307791		AKIRIN2	615165																	
HGNC:28822	AKIRIN2-AS1	entry withdrawn	withdrawn	withdrawn	Entry Withdrawn												2014-11-19																															
HGNC:50796	AKIRIN2P1	akirin 2 pseudogene 1	pseudogene	pseudogene	Approved	4q31.23	04q31.23							2014-06-18			2014-06-18	100216487	ENSG00000251482	OTTHUMG00000161391			NG_009119														PGOHUM00000246099											
HGNC:24108	AKNA	AT-hook transcription factor	protein-coding gene	gene with protein product	Approved	9q32	09q32	KIAA1968						2004-05-27			2015-08-24	80709	ENSG00000106948	OTTHUMG00000020538	uc004bis.5	AK024431	NM_030767	CCDS6805	Q7Z591	""11268217|11853319""	MGI:2140340	RGD:1308202		AKNA	605729																	
HGNC:28398	AKNAD1	AKNA domain containing 1	protein-coding gene	gene with protein product	Approved	1p13.3	01p13.3	MGC26989		C1orf62	chromosome 1 open reading frame 62			2005-05-13	2009-10-29	2009-10-29	2015-08-24	254268	ENSG00000162641	OTTHUMG00000011231	uc001dwa.5	AK095517	NM_152763	CCDS791	Q5T1N1		MGI:3584453	RGD:1583957		AKNAD1																		
HGNC:380	AKR1A1	aldo-keto reductase family 1 member A1	protein-coding gene	gene with protein product	Approved	1p34.1	01p34.1	""ALR|DD3""	""dihydrodiol dehydrogenase 3|aldehyde reductase""		aldo-keto reductase family 1, member A1 (aldehyde reductase)	Aldo-keto reductases	399	1998-09-29		2016-06-03	2016-10-05	10327	ENSG00000117448	OTTHUMG00000007740	uc001cod.4	J04794	NM_006066	CCDS523	P14550	""2498333|10393438""	MGI:1929955	RGD:68346		AKR1A1	103830															1.1.1.2		
HGNC:381	AKR1B1	aldo-keto reductase family 1 member B	protein-coding gene	gene with protein product	Approved	7q33	07q33	AR	aldose reductase	ALDR1	aldo-keto reductase family 1, member B1 (aldose reductase)	Aldo-keto reductases	399	1991-08-07		2016-06-03	2016-10-05	231	ENSG00000085662	OTTHUMG00000155322	uc003vrp.2	J04795	NM_001628	CCDS5831	P15121	1901827	MGI:1353494	RGD:2092		AKR1B1	103880										objectId:2768					1.1.1.21		
HGNC:420	AKR1B1P1	aldehyde reductase family 1 member B1 pseudogene 1	pseudogene	pseudogene	Approved	1q42.12	01q42.12			ALDRL1	aldehyde reductase (aldose reductase)-like 1			1992-03-25	2007-07-31	2016-06-03	2016-06-03	401982	ENSG00000229991	OTTHUMG00000037720			NG_006432			8244370											PGOHUM00000245220											
HGNC:425	AKR1B1P2	aldo-keto reductase family 1 member B1 pseudogene 2	pseudogene	pseudogene	Approved	3p12.3	03p12.3			ALDRP	aldehyde reductase (aldose reductase) pseudogene			1991-11-25	2007-07-31	2016-06-03	2016-06-03	236	ENSG00000213452	OTTHUMG00000158811		M84454	NG_001071			""1612607|8244370""											PGOHUM00000238068											
HGNC:422	AKR1B1P3	aldo-keto reductase family 1 member B1 pseudogene 3	pseudogene	pseudogene	Approved	11p15.2	11p15.2			ALDRL3	aldehyde reductase (aldose reductase)-like 3			1992-03-25	2007-07-31	2016-06-03	2017-02-22	729347	ENSG00000213785	OTTHUMG00000165909			NG_007132			8244370											PGOHUM00000290404											
HGNC:423	AKR1B1P4	aldo-keto reductase family 1 member B1 pseudogene 4	pseudogene	pseudogene	Approved	13q14.13	13q14.13			ALDRL4	aldehyde reductase (aldose reductase)-like 4			1992-03-25	2007-07-31	2016-06-03	2016-10-05	390402	ENSG00000237876	OTTHUMG00000016860			NG_006989			8244370											PGOHUM00000248391											
HGNC:20002	AKR1B1P5	aldo-keto reductase family 1 member B1 pseudogene 5	pseudogene	pseudogene	Approved	14q23.1	14q23.1			AKR1B1P	aldo-keto reductase family 1, member B1 pseudogene			2003-10-03	2007-07-31	2016-06-03	2016-06-03	390482					NG_007013														PGOHUM00000247814											
HGNC:33498	AKR1B1P6	aldo-keto reductase family 1 member B1 pseudogene 6	pseudogene	pseudogene	Approved	18p11.22	18p11.22							2007-07-31		2016-06-03	2016-06-03	100129769		OTTHUMG00000178948			NG_017129																									
HGNC:33497	AKR1B1P7	aldo-keto reductase family 1 member B1 pseudogene 7	pseudogene	pseudogene	Approved	19q13.11	19q13.11							2007-07-31		2016-06-03	2016-07-25	126242	ENSG00000266899	OTTHUMG00000182176			NG_009664														PGOHUM00000294975											
HGNC:33496	AKR1B1P8	aldo-keto reductase family 1 member B1 pseudogene 8	pseudogene	pseudogene	Approved	Xq23	Xq23							2007-07-31		2016-06-03	2016-06-03	392525	ENSG00000231371	OTTHUMG00000022241			NG_009682							AKR1B1P8							PGOHUM00000241963											
HGNC:382	AKR1B10	aldo-keto reductase family 1 member B10	protein-coding gene	gene with protein product	Approved	7q33	07q33	""AKR1B12|ARL-1|HIS|ARL1|HSI|ALDRLn""	""aldose reductase-like 1|aldo-keto reductase family 1, member B11 (aldose reductase-like)|aldose reductase-like peptide|aldose reductase-related protein|small intestine reductase""	AKR1B11	aldo-keto reductase family 1, member B10 (aldose reductase)	Aldo-keto reductases	399	2000-08-24		2016-06-03	2016-06-03	57016	ENSG00000198074	OTTHUMG00000155356	uc003vrr.4	AF052577	NM_020299	CCDS5832	O60218	""9765596|9565553""	""MGI:101918|MGI:107673|MGI:1915111""	RGD:1308277		AKR1B10	604707																	
HGNC:45062	AKR1B10P1	aldo-keto reductase family 1 member B10 pseudogene 1	pseudogene	pseudogene	Approved	10q21.3	10q21.3							2013-02-07		2016-06-03	2016-06-03	340888	ENSG00000213606	OTTHUMG00000018335			NG_022180														PGOHUM00000238821											
HGNC:45063	AKR1B10P2	aldo-keto reductase family 1 member B10 pseudogene 2	pseudogene	pseudogene	Approved	18q22.1	18q22.1							2013-02-07		2016-06-03	2016-06-03	643582	ENSG00000263355	OTTHUMG00000178549			NG_022495														PGOHUM00000235092											
HGNC:37281	AKR1B15	aldo-keto reductase family 1 member B15	protein-coding gene	gene with protein product	Approved	7q33	07q33					Aldo-keto reductases	399	2009-09-09		2016-06-03	2016-06-03	441282	ENSG00000227471	OTTHUMG00000155376	uc011kpr.3		NM_001080538	CCDS47715	C9JRZ8		""MGI:101918|MGI:107673|MGI:1915111""			AKR1B15	616336																	
HGNC:384	AKR1C1	aldo-keto reductase family 1 member C1	protein-coding gene	gene with protein product	Approved	10p15.1	10p15.1	""DDH|MBAB|DD1|HAKRC""	dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase	DDH1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	Aldo-keto reductases	399	1994-09-14		2016-06-03	2016-10-05	1645	ENSG00000187134	OTTHUMG00000017580	uc001ihq.4	D26124	NM_001353	CCDS7061	Q04828	8011662	MGI:1924587			AKR1C1	600449															""1.3.1.20|1.1.1.149|1.1.1.112""		
HGNC:385	AKR1C2	aldo-keto reductase family 1 member C2	protein-coding gene	gene with protein product	Approved	10p15.1	10p15.1	""DD|BABP|DD2|HAKRD|MCDR2""	dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III	""DDH2|TDD""	""aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)|testicular 17,20-desmolase deficiency""	Aldo-keto reductases	399	1994-09-14		2016-06-03	2016-10-05	1646	ENSG00000151632	OTTHUMG00000017584	uc057rik.1	L32592	NM_001354	""CCDS7062|CCDS44350|CCDS81438""	P52895	""9716498|21802064""	MGI:1924587	RGD:1311841		AKR1C2	600450					292247										""1.3.1.20|1.1.1.213""		
HGNC:386	AKR1C3	aldo-keto reductase family 1 member C3	protein-coding gene	gene with protein product	Approved	10p15.1	10p15.1	""KIAA0119|DDX|HAKRB|PGFS""	""dihydrodiol dehydrogenase X|prostaglandin F synthase|3-alpha hydroxysteroid dehydrogenase, type II""	HSD17B5	""hydroxysteroid (17-beta) dehydrogenase 5|aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)""	Aldo-keto reductases	399	1998-09-29		2016-06-03	2016-10-05	8644	ENSG00000196139	OTTHUMG00000017585	uc001ihu.4	L43839	NM_003739	""CCDS7063|CCDS73062""	P42330	""7650035|9792917""	MGI:2145420	RGD:708428		AKR1C3	603966										objectId:1382					""1.1.1.213|1.1.1.188""		
HGNC:387	AKR1C4	aldo-keto reductase family 1 member C4	protein-coding gene	gene with protein product	Approved	10p15.1	10p15.1	""DD4|HAKRA|C11|3-alpha-HSD|CDR|MGC22581""	chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4	CHDR	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	Aldo-keto reductases	399	1993-08-26		2016-06-03	2016-06-03	1109	ENSG00000198610	OTTHUMG00000017591	uc057rjf.1	M33375	NM_001818	CCDS7064	P17516	7789999	MGI:1933427	RGD:1306847		AKR1C4	600451					292259										1.1.1.225		
HGNC:44679	AKR1C5P	aldo-keto reductase family 1 member C5, pseudogene	pseudogene	pseudogene	Approved	10p15.1	10p15.1				aldo-keto reductase family 1, member C5, pseudogene			2012-12-04		2016-06-03	2016-06-03	100996684	ENSG00000225418	OTTHUMG00000017583																	PGOHUM00000262838											
HGNC:44680	AKR1C6P	aldo-keto reductase family 1 member C6, pseudogene	pseudogene	pseudogene	Approved	10p15.1	10p15.1	TAKR	truncated aldo-keto reductase					2012-12-04		2016-06-03	2016-06-03	389932	ENSG00000151631	OTTHUMG00000017578			NR_026743														PGOHUM00000258456											
HGNC:44681	AKR1C7P	aldo-keto reductase family 1 member C7, pseudogene	pseudogene	pseudogene	Approved	10p15.1	10p15.1							2012-12-04		2016-06-03	2016-06-03	648947	ENSG00000215267	OTTHUMG00000017588			NG_023403														PGOHUM00000238338											
HGNC:23469	AKR1C8P	aldo-keto reductase family 1 member C8, pseudogene	pseudogene	pseudogene	Approved	10p15.1	10p15.1			AKR1CL1	aldo-keto reductase family 1, member C-like 1			2004-05-28	2014-09-30	2016-06-03	2016-06-03	340811	ENSG00000264006	OTTHUMG00000184213			NR_027916		Q5T2L2	15164054		RGD:1307514									PGOHUM00000289729											
HGNC:388	AKR1D1	aldo-keto reductase family 1 member D1	protein-coding gene	gene with protein product	Approved	7q33	07q33		delta 4-3-ketosteroid-5-beta-reductase	SRD5B1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	Aldo-keto reductases	399	1995-11-02		2016-06-03	2016-10-05	6718	ENSG00000122787	OTTHUMG00000155787	uc064ijt.1	Z28339	NM_005989	""CCDS5846|CCDS55169|CCDS55170""	P51857	""7508385|10343119""	MGI:2384785	RGD:620752		AKR1D1	604741					139142										1.3.99.6		
HGNC:11288	AKR1D1P1	aldo-keto reductase family 1 member D1 pseudogene 1	pseudogene	pseudogene	Approved	1q24.2	01q24.2			""SRD5BP1|AKR1D1P""	""steroid-5-beta-reductase, beta polypeptide pseudogene 1|aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) pseudogene""			1999-01-07	2010-01-19	2016-06-03	2016-06-03	80701	ENSG00000227776	OTTHUMG00000034681		AF283650	NG_002683			10343119											PGOHUM00000245070											
HGNC:23437	AKR1E2	aldo-keto reductase family 1 member E2	protein-coding gene	gene with protein product	Approved	10p15.1	10p15.1	MGC10612		""AKRDC1|AKR1CL2""	aldo-keto reductase family 1, member C-like 2	Aldo-keto reductases	399	2003-11-18	2009-09-09	2016-06-03	2016-10-05	83592	ENSG00000165568	OTTHUMG00000017577	uc001ihi.5	AB040820	NM_031436	""CCDS31134|CCDS59210|CCDS59209""	Q96JD6		MGI:1914758	RGD:1309599		AKR1E2	617451																	
HGNC:389	AKR7A2	aldo-keto reductase family 7 member A2	protein-coding gene	gene with protein product	Approved	1p36.13	01p36.13	AFAR	aflatoxin aldehyde reductase			Aldo-keto reductases	399	1998-11-17		2016-06-03	2016-06-03	8574	ENSG00000053371	OTTHUMG00000002522	uc001bbw.4	AF026947	NM_003689	CCDS194	O43488	9576847	MGI:107796	RGD:620311		AKR7A2	603418																	
HGNC:24062	AKR7A2P1	aldo-keto reductase family 7 member A2 pseudogene 1	pseudogene	pseudogene	Approved	1p13.2	01p13.2	AFARP1						2010-09-30		2016-06-03	2016-06-03	246182	ENSG00000229020	OTTHUMG00000012135		AJ277796	NR_002796			12879023											PGOHUM00000244853											
HGNC:390	AKR7A3	aldo-keto reductase family 7 member A3	protein-coding gene	gene with protein product	Approved	1p36.13	01p36.13		aflatoxin aldehyde reductase		aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)	Aldo-keto reductases	399	1999-10-05		2016-06-03	2016-06-03	22977	ENSG00000162482	OTTHUMG00000002523	uc001bbv.2	AF040639	NM_012067	CCDS193	O95154	10383892	MGI:107796	RGD:628635		AKR7A3	608477																	
HGNC:24056	AKR7L	aldo-keto reductase family 7 like (gene/pseudogene)	protein-coding gene	gene with protein product	Approved	1p36.13	01p36.13	AFAR3			aldo-keto reductase family 7-like			2008-12-09		2016-06-03	2017-02-09	246181	ENSG00000211454	OTTHUMG00000002520	uc057cwi.1		NM_201252		Q8NHP1	12879023				AKR7L	608478																	
HGNC:391	AKT1	AKT serine/threonine kinase 1	protein-coding gene	gene with protein product	Approved	14q32.33	14q32.33	""RAC|PKB|PRKBA|AKT""			v-akt murine thymoma viral oncogene homolog 1	Pleckstrin homology domain containing	682	1986-01-01		2016-05-04	2017-03-24	207	ENSG00000142208	OTTHUMG00000170795	uc001ypm.4	M63167	NM_005163	CCDS9994	P31749		MGI:87986	RGD:2081	LRG_721|http://www.lrg-sequence.org/LRG/LRG_721	AKT1	164730					281472					objectId:1479					2.7.11.1		
HGNC:28426	AKT1S1	AKT1 substrate 1	protein-coding gene	gene with protein product	Approved	19q13.33	19q13.33	""PRAS40|MGC2865|Lobe""	proline-rich Akt substrate, 40 kDa		AKT1 substrate 1 (proline-rich)	MTOR complex 1	1332	2004-03-04		2016-04-26	2016-04-26	84335	ENSG00000204673	OTTHUMG00000150246	uc031rmg.1	BC022241	NM_032375	""CCDS12784|CCDS59410""	Q96B36	12524439	MGI:1914855	RGD:1312049		AKT1S1	610221																	
HGNC:392	AKT2	AKT serine/threonine kinase 2	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2				v-akt murine thymoma viral oncogene homolog 2	Pleckstrin homology domain containing	682	1992-11-05		2016-05-04	2016-10-05	208	ENSG00000105221	OTTHUMG00000137375	uc002onf.3	M77198	NM_001626	""CCDS12552|CCDS82350""	P31751	1409633	MGI:104874	RGD:2082		AKT2	164731					201112					objectId:1480					2.7.11.1		
HGNC:393	AKT3	AKT serine/threonine kinase 3	protein-coding gene	gene with protein product	Approved	1q43-q44	01q43-q44	""PKBG|RAC-gamma|PRKBG""	protein kinase B, gamma		v-akt murine thymoma viral oncogene homolog 3	Pleckstrin homology domain containing	682	1999-11-16		2016-05-04	2017-06-08	10000	ENSG00000117020	OTTHUMG00000039994	uc057qvr.1	AF124141	NM_181690	""CCDS31076|CCDS31077""	Q9Y243	""10092583|10208883""	MGI:1345147	RGD:62390		AKT3	611223					299660					objectId:2286					2.7.11.1		
HGNC:41304	AKT3-IT1	AKT3 intronic transcript 1	non-coding RNA	RNA, long non-coding	Approved	1q44	01q44				AKT3 intronic transcript 1 (non-protein coding)			2011-05-20		2015-02-25	2015-02-25	100874263	ENSG00000228939	OTTHUMG00000039993	uc057qwa.1																											URS00002C213E
HGNC:16710	AKTIP	AKT interacting protein	protein-coding gene	gene with protein product	Approved	16q12.2	16q12.2	FLJ13258		FTS	""fused toes (mouse) homolog|fused toes homolog (mouse)""	Ubiquitin conjugating enzymes E2	102	2001-10-02	2007-01-16	2007-01-16	2014-11-18	64400	ENSG00000166971	OTTHUMG00000133199	uc002ehl.4	AK023320	NM_022476	""CCDS10749|CCDS76866""	Q9H8T0	""7818539|8626685""	MGI:3693832	RGD:1311170		AKTIP	608483																	
HGNC:395	ALAD	aminolevulinate dehydratase	protein-coding gene	gene with protein product	Approved	9q32	09q32	""ALADH|PBGS""	porphobilinogen synthase		aminolevulinate, delta-, dehydratase			1986-01-01		2010-04-29	2014-11-19	210	ENSG00000148218	OTTHUMG00000020522	uc011lxf.3	M13928	NM_001003945	CCDS6794	P13716	""6839527|6378062""	MGI:96853	RGD:2083	ALSOD, the Amyotrophic Lateral Sclerosis Online Genetic Database|http://alsod.iop.kcl.ac.uk/	ALAD	125270					119569										4.2.1.24		
HGNC:396	ALAS1	5-aminolevulinate synthase 1"	protein-coding gene	gene with protein product	Approved
NA	cenani-lenz syndactyly syndrome	NA	NA	LRP4	604270	212780	biallelic	confirmed	loss of function	Skeleton	6696	LDL receptor related protein 4	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2	MEGF7|CLSS|LRP-4|SOST2			low density lipoprotein receptor-related protein 4	Low density lipoprotein receptors
NA	branchiootic syndrome type 3	NA	NA	SIX1	601205	608389	monoallelic	confirmed	all missense/in frame	Kidney Renal Tract;Ear	10887	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	schinzel-giedion midface retraction syndrome	NA	NA	SETBP1	611060	269150	monoallelic	confirmed	activating	Face;Skeleton;Brain/Cognition	15573	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	noonan syndrome type 3	NA	NA	KRAS	190070	609942	monoallelic	confirmed	activating	Skin;Face;Brain/Cognition	6407	KRAS proto-oncogene, GTPase	protein-coding gene	gene with protein product	Approved	12p12.1	12p12.1	KRAS1		KRAS2	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog|v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma viral oncogene homolog	RAS type GTPase family
NA	neutral lipid storage disease with myopathy	NA	NA	PNPLA2	609059	610717	biallelic	probable	loss of function	Musculature;Endocrine/Metabolic	30802	patatin like phospholipase domain containing 2	protein-coding gene	gene with protein product	Approved	11p15.5	11p15.5	desnutrin|TTS-2.2|ATGL|FP17548|iPLA2zeta			patatin-like phospholipase domain containing 2	Lipases|Patatin like phospholipase domain containing
NA	short-rib polydactyly syndrome type iii	NA	NA	WDR34	No gene mim	No disease mim	biallelic	confirmed	all missense/in frame	Skeleton	28296	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebral palsy spastic quadriplegic type 5	NA	NA	AP4B1	607245	614066	biallelic	probable	loss of function	Brain/Cognition	572	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pontocerebellar hypoplasia, type 10	NA	NA	CLP1	No gene mim	615803	biallelic	probable	all missense/in frame	Brain/Cognition	16999	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	facial paresis, hereditary congenital, 3	NA	NA	HOXB1	142968	614744	biallelic	probable	all missense/in frame	Face	5111	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	early onset epileptic encephalopathy	NA	NA	MAGI2	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	18957	membrane associated guanylate kinase, WW and PDZ domain containing 2	protein-coding gene	gene with protein product	Approved	7q21.11	07q21.11	AIP1|ARIP1|KIAA0705|ACVRIP1|MAGI-2				Membrane associated guanylate kinases|PDZ domain containing
NA	glutaric aciduria type 2a	NA	NA	ETFA	608053	231680	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	3481	electron transfer flavoprotein alpha subunit	protein-coding gene	gene with protein product	Approved	15q24.2-q24.3	15q24.2-q24.3	GA2|EMA|MADD	glutaric aciduria II		electron-transfer-flavoprotein, alpha polypeptide	
NA	pontocerebellar hypoplasia and microcephaly	NA	NA	CHMP1A	164010	614961	biallelic	probable	loss of function	Brain/Cognition	8740	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	COQ5	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	28722	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cleft lip/palate-ectodermal dysplasia syndrome	NA	NA	NECTIN1	No gene mim	225060	biallelic	possible	loss of function	Skin;Face	9706	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	left ventricular outflow tract obstruction	NA	NA	NOTCH1	190198	109730	monoallelic	probable	loss of function	Heart/Cardiovasculature/Lymphatic	7881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cystathionine beta-synthase deficiency	NA	NA	CBS	613381	236200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Heart/Cardiovasculature/Lymphatic	1550	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital ichthyosis	NA	NA	PNPLA1	612121	No disease mim	biallelic	probable	all missense/in frame	Skin	21246	patatin like phospholipase domain containing 1	protein-coding gene	gene with protein product	Approved	6p21.31	06p21.31	FLJ38755|dJ50J22.1			patatin-like phospholipase domain containing 1	Patatin like phospholipase domain containing
NA	peroxisome biogenesis disorder complementation group 3	NA	NA	PEX12	601758	601758	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8854	peroxisomal biogenesis factor 12	protein-coding gene	gene with protein product	Approved	17q12	17q12					Peroxins
NA	multiple synostoses syndrome type 2	NA	NA	GDF5	601146	610017	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
NA	multiple congenital anomalies-hypotonia-seizures syndrome 2	NA	NA	PIGA	No gene mim	300868	hemizygous	confirmed	loss of function	Brain/Cognition	8957	phosphatidylinositol glycan anchor biosynthesis class A	protein-coding gene	gene with protein product	Approved	Xp22.2	Xp22.2	GPI3	paroxysmal nocturnal hemoglobinuria|phosphatidylinositol N-acetylglucosaminyltransferase		phosphatidylinositol glycan, class A (paroxysmal nocturnal hemoglobinuria)	Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis
NA	cornelia de lange syndrome type 1	NA	NA	NIPBL	608667	122470	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Face;Skeleton;Brain/Cognition;GI tract;Genitalia;Ear;Heart/Cardiovasculature/Lymphatic	28862	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	jervell and lange-nielsen syndrome type 1	NA	NA	KCNQ1	No gene mim	220400	biallelic	confirmed	loss of function	Ear;Heart/Cardiovasculature/Lymphatic	6294	potassium voltage-gated channel subfamily Q member 1	protein-coding gene	gene with protein product	Approved	11p15.5-p15.4	11p15.5-p15.4	Kv7.1|KCNA8|KVLQT1|JLNS1|LQT1	Jervell and Lange-Nielsen syndrome 1	LQT|KCNA9	potassium voltage-gated channel, KQT-like subfamily, member 1|potassium channel, voltage gated KQT-like subfamily Q, member 1	Potassium voltage-gated channels
NA	ellis-van creveld syndrome	NA	NA	EVC	604831	225500	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Heart/Cardiovasculature/Lymphatic	3497	EvC ciliary complex subunit 1	protein-coding gene	gene with protein product	Approved	4p16.2	04p16.2	DWF-1			Ellis van Creveld syndrome|Ellis van Creveld protein	
HP:0000028	cardiofaciocutaneous syndrome	Cryptorchidism	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000126	cardiofaciocutaneous syndrome	Hydronephrosis	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000176	cardiofaciocutaneous syndrome	Submucous cleft hard palate	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	cardiofaciocutaneous syndrome	High palate	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	cardiofaciocutaneous syndrome	Hydrocephalus	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	cardiofaciocutaneous syndrome	Macrocephaly	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	cardiofaciocutaneous syndrome	Long face	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	cardiofaciocutaneous syndrome	Coarse facial features	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	cardiofaciocutaneous syndrome	Epicanthus	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000293	cardiofaciocutaneous syndrome	Full cheeks	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	cardiofaciocutaneous syndrome	Hypertelorism	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	cardiofaciocutaneous syndrome	Long philtrum	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	cardiofaciocutaneous syndrome	High forehead	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	cardiofaciocutaneous syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000391	cardiofaciocutaneous syndrome	Thickened helices	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	cardiofaciocutaneous syndrome	Macrotia	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	cardiofaciocutaneous syndrome	Anteverted nares	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000465	cardiofaciocutaneous syndrome	Webbed neck	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	cardiofaciocutaneous syndrome	Short neck	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000478	cardiofaciocutaneous syndrome	Abnormality of the eye	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	cardiofaciocutaneous syndrome	Strabismus	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	cardiofaciocutaneous syndrome	Downslanted palpebral fissures	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000499	cardiofaciocutaneous syndrome	Abnormality of the eyelashes	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	cardiofaciocutaneous syndrome	Abnormality of vision	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	cardiofaciocutaneous syndrome	Ptosis	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	cardiofaciocutaneous syndrome	Myopia	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000637	cardiofaciocutaneous syndrome	Long palpebral fissure	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	cardiofaciocutaneous syndrome	Nystagmus	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	cardiofaciocutaneous syndrome	Optic atrophy	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	cardiofaciocutaneous syndrome	Pectus excavatum	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000958	cardiofaciocutaneous syndrome	Dry skin	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000962	cardiofaciocutaneous syndrome	Hyperkeratosis	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000974	cardiofaciocutaneous syndrome	Hyperextensible skin	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000982	cardiofaciocutaneous syndrome	Palmoplantar keratoderma	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001003	cardiofaciocutaneous syndrome	Multiple lentigines	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001004	cardiofaciocutaneous syndrome	Lymphedema	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001048	cardiofaciocutaneous syndrome	Cavernous hemangioma	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	cardiofaciocutaneous syndrome	Intellectual disability	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	cardiofaciocutaneous syndrome	Muscular hypotonia	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001260	cardiofaciocutaneous syndrome	Dysarthria	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	cardiofaciocutaneous syndrome	Global developmental delay	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001531	cardiofaciocutaneous syndrome	Failure to thrive in infancy	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	cardiofaciocutaneous syndrome	Redundant skin	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001622	cardiofaciocutaneous syndrome	Premature birth	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001631	cardiofaciocutaneous syndrome	Atrial septal defect	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	cardiofaciocutaneous syndrome	Hypertrophic cardiomyopathy	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001642	cardiofaciocutaneous syndrome	Pulmonic stenosis	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001654	cardiofaciocutaneous syndrome	Abnormality of the heart valves	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	cardiofaciocutaneous syndrome	Frontal bossing	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002120	cardiofaciocutaneous syndrome	Cerebral cortical atrophy	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002162	cardiofaciocutaneous syndrome	Low posterior hairline	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	cardiofaciocutaneous syndrome	Neurological speech impairment	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002213	cardiofaciocutaneous syndrome	Fine hair	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002217	cardiofaciocutaneous syndrome	Slow-growing hair	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002299	cardiofaciocutaneous syndrome	Brittle hair	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	cardiofaciocutaneous syndrome	EEG abnormality	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	cardiofaciocutaneous syndrome	Malformation of the heart and great vessels	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	cardiofaciocutaneous syndrome	Scoliosis	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	cardiofaciocutaneous syndrome	Genu valgum	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002967	cardiofaciocutaneous syndrome	Cubitus valgus	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002997	cardiofaciocutaneous syndrome	Abnormality of the ulna	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	cardiofaciocutaneous syndrome	Short nose	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	cardiofaciocutaneous syndrome	Short stature	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004422	cardiofaciocutaneous syndrome	Biparietal narrowing	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	cardiofaciocutaneous syndrome	Depressed nasal bridge	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006191	cardiofaciocutaneous syndrome	Deep palmar crease	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007392	cardiofaciocutaneous syndrome	Excessive wrinkled skin	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007440	cardiofaciocutaneous syndrome	Generalized hyperpigmentation	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007565	cardiofaciocutaneous syndrome	Multiple cafe-au-lait spots	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008064	cardiofaciocutaneous syndrome	Ichthyosis	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008070	cardiofaciocutaneous syndrome	Sparse hair	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008391	cardiofaciocutaneous syndrome	Dystrophic fingernails	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	cardiofaciocutaneous syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009891	cardiofaciocutaneous syndrome	Underdeveloped supraorbital ridges	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010669	cardiofaciocutaneous syndrome	Cheekbone underdevelopment	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011024	cardiofaciocutaneous syndrome	Abnormality of the gastrointestinal tract	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012719	cardiofaciocutaneous syndrome	Functional abnormality of the gastrointestinal tract	Occasional (29-5%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100840	cardiofaciocutaneous syndrome	Aplasia/Hypoplasia of the eyebrow	Very frequent (99-80%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200102	cardiofaciocutaneous syndrome	Sparse or absent eyelashes	Frequent (79-30%)	BRAF	164757	115150	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1097	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	retinitis pigmentosa 54	NA	NA	C2orf71	No gene mim	613428	biallelic	confirmed	loss of function	Eye	34383	chromosome 2 open reading frame 71	protein-coding gene	gene with protein product	Approved	2p23.2	02p23.2	FLJ34931|RP54				
NA	birk-barel syndrome	NA	NA	KCNK9	No gene mim	612292	imprinted	possible	dominant negative	Face;Brain/Cognition	6283	potassium two pore domain channel subfamily K member 9	protein-coding gene	gene with protein product	Approved	8q24.3	08q24.3	K2p9.1|TASK3|TASK-3			potassium channel, subfamily K, member 9|potassium channel, two pore domain subfamily K, member 9	Potassium two pore domain channel subfamily K 
HP:0000023	osteogenesis imperfecta	Inguinal hernia	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	osteogenesis imperfecta	Abnormality of the teeth	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000239	osteogenesis imperfecta	Large fontanelles	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	osteogenesis imperfecta	Brachycephaly	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	osteogenesis imperfecta	Macrocephaly	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000269	osteogenesis imperfecta	Prominent occiput	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000325	osteogenesis imperfecta	Triangular face	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	osteogenesis imperfecta	Micrognathia	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	osteogenesis imperfecta	Hearing impairment	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000444	osteogenesis imperfecta	Convex nasal ridge	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	osteogenesis imperfecta	Glaucoma	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	osteogenesis imperfecta	Visual impairment	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000592	osteogenesis imperfecta	Blue sclerae	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	osteogenesis imperfecta	Carious teeth	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	osteogenesis imperfecta	Abnormality of dental enamel	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000703	osteogenesis imperfecta	Dentinogenesis imperfecta	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	osteogenesis imperfecta	Pectus excavatum	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	osteogenesis imperfecta	Pectus carinatum	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	osteogenesis imperfecta	Abnormality of the ribs	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	osteogenesis imperfecta	Narrow chest	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000883	osteogenesis imperfecta	Thin ribs	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000938	osteogenesis imperfecta	Osteopenia	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000939	osteogenesis imperfecta	Osteoporosis	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	osteogenesis imperfecta	Abnormality of the metaphyses	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000975	osteogenesis imperfecta	Hyperhidrosis	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	osteogenesis imperfecta	Gait disturbance	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	osteogenesis imperfecta	Intrauterine growth retardation	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	osteogenesis imperfecta	Umbilical hernia	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	osteogenesis imperfecta	Thrombocytopenia	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	osteogenesis imperfecta	Malformation of the heart and great vessels	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002645	osteogenesis imperfecta	Wormian bones	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	osteogenesis imperfecta	Scoliosis	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	osteogenesis imperfecta	Recurrent fractures	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	osteogenesis imperfecta	Kyphosis	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002823	osteogenesis imperfecta	Abnormality of the femur	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	osteogenesis imperfecta	Genu valgum	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002980	osteogenesis imperfecta	Femoral bowing	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	osteogenesis imperfecta	Micromelia	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002992	osteogenesis imperfecta	Abnormality of the tibia	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003100	osteogenesis imperfecta	Slender long bone	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003103	osteogenesis imperfecta	Abnormal cortical bone morphology	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003179	osteogenesis imperfecta	Protrusio acetabuli	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003272	osteogenesis imperfecta	Abnormality of the hip bone	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	osteogenesis imperfecta	Abnormal form of the vertebral bodies	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004306	osteogenesis imperfecta	Abnormality of the endocardium	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	osteogenesis imperfecta	Short stature	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004331	osteogenesis imperfecta	Decreased skull ossification	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004586	osteogenesis imperfecta	Biconcave vertebral bodies	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005019	osteogenesis imperfecta	Diaphyseal thickening	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	osteogenesis imperfecta	Joint hyperflexibility	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	osteogenesis imperfecta	Bowing of the long bones	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007957	osteogenesis imperfecta	Corneal opacity	Frequent (79-30%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011073	osteogenesis imperfecta	Abnormality of dental color	Very frequent (99-80%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100761	osteogenesis imperfecta	Visceral angiomatosis	Occasional (29-5%)	WNT1	164820	No disease mim	biallelic	confirmed	loss of function	Skeleton	12774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neonatal epilepsy spectrum	NA	NA	SIK1	No gene mim	No disease mim	monoallelic	confirmed	activating	Brain/Cognition	11142	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebellar ataxia mental retardation and dysequilibrium syndrome type 3	NA	NA	CA8	114815	613227	biallelic	confirmed	loss of function	Brain/Cognition	1382	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infantile hypertrophic cardiomyopathy, lactic acidosis, and isolated complex i deficiency	NA	NA	ELAC2	No gene mim	252010	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	14198	elaC ribonuclease Z 2	protein-coding gene	gene with protein product	Approved	17p12	17p12	FLJ10530|HPC2	tRNase Z (long form)		elaC (E. coli) homolog 2|elaC homolog 2 (E. coli)	
NA	muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type b5	NA	NA	FKRP	606596	606612	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	17997	fukutin related protein	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	LGMD2I|MDC1C				
NA	leopard syndrome type 1	NA	NA	PTPN11	176876	151100	monoallelic	confirmed	all missense/in frame	Skeleton;Ear;Heart/Cardiovasculature/Lymphatic	9644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	saethre-chotzen syndrome	Cryptorchidism	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	saethre-chotzen syndrome	Cleft palate	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000189	saethre-chotzen syndrome	Narrow palate	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	saethre-chotzen syndrome	Brachycephaly	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000270	saethre-chotzen syndrome	Delayed cranial suture closure	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	saethre-chotzen syndrome	Epicanthus	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000294	saethre-chotzen syndrome	Low anterior hairline	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	saethre-chotzen syndrome	Hypertelorism	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000324	saethre-chotzen syndrome	Facial asymmetry	Very frequent (99-80%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	saethre-chotzen syndrome	Hypoplasia of the maxilla	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	saethre-chotzen syndrome	Hearing impairment	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	saethre-chotzen syndrome	Low-set ears	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000405	saethre-chotzen syndrome	Conductive hearing impairment	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	saethre-chotzen syndrome	Prominent nasal bridge	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	saethre-chotzen syndrome	Strabismus	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000601	saethre-chotzen syndrome	Hypotelorism	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000929	saethre-chotzen syndrome	Abnormality of the skull	Very frequent (99-80%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001357	saethre-chotzen syndrome	Plagiocephaly	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	saethre-chotzen syndrome	Craniosynostosis	Very frequent (99-80%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001822	saethre-chotzen syndrome	Hallux valgus	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002516	saethre-chotzen syndrome	Increased intracranial pressure	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	saethre-chotzen syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	saethre-chotzen syndrome	Abnormal form of the vertebral bodies	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	saethre-chotzen syndrome	Clinodactyly of the 5th finger	Very frequent (99-80%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	saethre-chotzen syndrome	Short stature	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008551	saethre-chotzen syndrome	Microtia	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010535	saethre-chotzen syndrome	Sleep apnea	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010807	saethre-chotzen syndrome	Open bite	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011386	saethre-chotzen syndrome	Narrow internal auditory canal	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	saethre-chotzen syndrome	High forehead	Very frequent (99-80%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	saethre-chotzen syndrome	Sensorineural hearing impairment	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000444	saethre-chotzen syndrome	Convex nasal ridge	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	saethre-chotzen syndrome	Ptosis	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000643	saethre-chotzen syndrome	Blepharospasm	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000646	saethre-chotzen syndrome	Amblyopia	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	saethre-chotzen syndrome	Optic atrophy	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	saethre-chotzen syndrome	Brachydactyly syndrome	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001199	saethre-chotzen syndrome	Triphalangeal thumb	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	saethre-chotzen syndrome	Seizures	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002076	saethre-chotzen syndrome	Migraine	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002342	saethre-chotzen syndrome	Intellectual disability, moderate	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	saethre-chotzen syndrome	Scoliosis	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003307	saethre-chotzen syndrome	Hyperlordosis	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005037	saethre-chotzen syndrome	Proximal radio-ulnar synostosis	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	saethre-chotzen syndrome	Depressed nasal bridge	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	saethre-chotzen syndrome	Finger syndactyly	Very frequent (99-80%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007598	saethre-chotzen syndrome	Bilateral single transverse palmar creases	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008572	saethre-chotzen syndrome	External ear malformation	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009738	saethre-chotzen syndrome	Abnormality of the antihelix	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009899	saethre-chotzen syndrome	Prominent crus of helix	Frequent (79-30%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010720	saethre-chotzen syndrome	Abnormal hair pattern	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011304	saethre-chotzen syndrome	Broad thumb	Occasional (29-5%)	TWIST1	601622	101400	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	waardenburg syndrome type 2e	NA	NA	SOX10	602229	611584	monoallelic	confirmed	loss of function	Skin;Face;Spinal cord/Peripheral nerves;Ear	11190	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	adams oliver syndrome	NA	NA	EOGT	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skin;Skeleton	28526	EGF domain specific O-linked N-acetylglucosamine transferase	protein-coding gene	gene with protein product	Approved	3p14.1	03p14.1	AER61|FLJ33770	AER61 glycosyltransferase	C3orf64	chromosome 3 open reading frame 64|EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase	O-linked N-acetylglucosaminyltransferases
NA	spinocerebellar ataxia, autosomal recessive 8	NA	NA	SYNE1	No gene mim	610743	biallelic	both DD and IF	loss of function	Brain/Cognition	17089	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	anterior segment mesenchymal dysgenesis	NA	NA	FOXE3	601094	107250	monoallelic	confirmed	loss of function	Eye	3808	forkhead box E3	protein-coding gene	gene with protein product	Approved	1p33	01p33	FREAC8		FKHL12		Forkhead boxes
NA	meconium ileus	NA	NA	GUCY2C	601330	No disease mim	biallelic	confirmed	loss of function	GI tract	4688	guanylate cyclase 2C	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3	STAR	STA receptor|heat stable enterotoxin receptor	GUC2C	guanylate cyclase 2C (heat stable enterotoxin receptor)	Guanylate cyclase receptors
NA	3-m syndrome 2	NA	NA	OBSL1	610991	612921	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	29092	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nicolaides-baraitser syndrome	NA	NA	SMARCA2	600014	601358	monoallelic	confirmed	all missense/in frame	Skin;Skeleton;Brain/Cognition	11098	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fg syndrome type 2	NA	NA	FLNA	300017	300321	hemizygous	confirmed	uncertain	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
NA	microphthalmia and diaphragmatic hernia	NA	NA	RARB	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition;Eye;Respiratory tract	9865	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia and diaphragmatic hernia	NA	NA	RARB	No gene mim	No disease mim	monoallelic	confirmed	dominant negative	Brain/Cognition;Eye;Respiratory tract	9865	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	methylmalonic aciduria type cblb	NA	NA	MMAB	607568	251110	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	19331	methylmalonic aciduria (cobalamin deficiency) cblB type	protein-coding gene	gene with protein product	Approved	12q24.11	12q24.11	cblB|CFAP23	ATP:cob(I)alamin adenosyltransferase|cilia and flagella associated protein 23		methylmalonic aciduria (cobalamin deficiency) type B	Cilia and flagella associated
NA	mental retardation x-linked type 72 (mrx72) +/- parkinsons	NA	NA	RAB39B	300774	300271	hemizygous	confirmed	loss of function	Brain/Cognition	16499	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	caudal duplication anomaly	NA	NA	AXIN1	No gene mim	607864	imprinted	possible	cis-regulatory or promotor mutation	Skeleton	903	axin 1	protein-coding gene	gene with protein product	Approved	16p13.3	16p13.3	PPP1R49	protein phosphatase 1, regulatory subunit 49			Protein phosphatase 1 regulatory subunits
NA	methylenetetrahydrofolate reductase deficiency	NA	NA	MTHFR	No gene mim	236250	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7436	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	perrault syndrome	NA	NA	LARS2	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Ear;Genitalia	17095	leucyl-tRNA synthetase 2, mitochondrial	protein-coding gene	gene with protein product	Approved	3p21.31	03p21.31	KIAA0028|LEURS|MGC26121|mtLeuRS	leucine tRNA ligase 2, mitochondrial			Aminoacyl tRNA synthetases, Class I
NA	3-hydroxy-3-methylglutaryl-coenzyme a lyase deficiency	NA	NA	HMGCL	613898	246450	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	agammaglobulinemia 7, autosomal recessive	NA	NA	PIK3R1	No gene mim	615214	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Eye	8979	phosphoinositide-3-kinase regulatory subunit 1	protein-coding gene	gene with protein product	Approved	5q13.1	05q13.1	GRB1|p85-ALPHA|p85	phosphoinositide-3-kinase regulatory subunit alpha		phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	SH2 domain containing
NA	cerebro-oculo-facio-skeletal syndrome type 1	NA	NA	ERCC6	609413	214150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	3438	ERCC excision repair 6, chromatin remodeling factor	protein-coding gene	gene with protein product	Approved	10q11.23	10q11.23	CSB|RAD26|ARMD5	Cockayne syndrome B protein	CKN2	excision repair cross-complementing rodent repair deficiency, complementation group 6|excision repair cross-complementation group 6	ERCC excision repair associated
NA	glycogen storage disease xii	NA	NA	ALDOA	103850	611881	biallelic	confirmed	all missense/in frame	Musculature;Endocrine/Metabolic	414	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mucopolysaccharidosis type 3b	NA	NA	NAGLU	609701	252920	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	7632	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	galloway-mowat syndrome: microcephaly and steroid-resistant nephrotic syndrome	NA	NA	WDR73	No gene mim	No disease mim	biallelic	probable	loss of function	Kidney Renal Tract;Brain/Cognition	25928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lacticacidemia due to pdx1 deficiency	NA	NA	PDHX	608769	245349	biallelic	confirmed	loss of function	Endocrine/Metabolic	21350	pyruvate dehydrogenase complex component X	protein-coding gene	gene with protein product	Approved	11p13	11p13	E3BP|proX|PDX1|OPDX|DLDBP				Pyruvate dehydrogenase complex
NA	anterior segment mesenchymal dysgenesis	NA	NA	PITX3	602669	107250	monoallelic	confirmed	loss of function	Eye	9006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	crouzon syndrome with acanthosis nigricans	NA	NA	FGFR3	134934	612247	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	hajdu-cheney syndrome	NA	NA	NOTCH2	600275	102500	monoallelic	confirmed	activating	Kidney Renal Tract;Skeleton	7882	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	immunodeficiency, common variable, 2	NA	NA	TNFRSF13B	No gene mim	240500	biallelic	probable	loss of function	Bone Marrow/Immune	18153	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peters anomaly	NA	NA	PAX6	607108	604229	monoallelic	confirmed	uncertain	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	adrenoleukodystrophy neonatal	NA	NA	PEX10	602859	202370	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001204	brachydactyly type a1	Distal symphalangism (hands)	Occasional (29-5%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0001230	brachydactyly type a1	Broad metacarpals	Occasional (29-5%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0001762	brachydactyly type a1	Talipes equinovarus	Occasional (29-5%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0001773	brachydactyly type a1	Short foot	Very frequent (99-80%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0002650	brachydactyly type a1	Scoliosis	Occasional (29-5%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0003022	brachydactyly type a1	Hypoplasia of the ulna	Occasional (29-5%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0004209	brachydactyly type a1	Clinodactyly of the 5th finger	Occasional (29-5%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0004322	brachydactyly type a1	Short stature	Very frequent (99-80%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0005819	brachydactyly type a1	Short middle phalanx of finger	Very frequent (99-80%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0009778	brachydactyly type a1	Short thumb	Very frequent (99-80%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0010109	brachydactyly type a1	Short hallux	Very frequent (99-80%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0010579	brachydactyly type a1	Cone-shaped epiphysis	Frequent (79-30%)	GDF5	601146	112500	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
NA	craniosynostosis, type 1	NA	NA	TWIST1	601622	123100	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000158	mucopolysaccharidosis type 6	Macroglossia	Occasional (29-5%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0000179	mucopolysaccharidosis type 6	Thick lower lip vermilion	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0000246	mucopolysaccharidosis type 6	Sinusitis	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0000280	mucopolysaccharidosis type 6	Coarse facial features	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0000365	mucopolysaccharidosis type 6	Hearing impairment	Frequent (79-30%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0000389	mucopolysaccharidosis type 6	Chronic otitis media	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0000470	mucopolysaccharidosis type 6	Short neck	Frequent (79-30%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0000505	mucopolysaccharidosis type 6	Visual impairment	Occasional (29-5%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0000885	mucopolysaccharidosis type 6	Broad ribs	Frequent (79-30%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0000944	mucopolysaccharidosis type 6	Abnormality of the metaphyses	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0001387	mucopolysaccharidosis type 6	Joint stiffness	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0001508	mucopolysaccharidosis type 6	Failure to thrive	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0001654	mucopolysaccharidosis type 6	Abnormality of the heart valves	Occasional (29-5%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0001744	mucopolysaccharidosis type 6	Splenomegaly	Frequent (79-30%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0002564	mucopolysaccharidosis type 6	Malformation of the heart and great vessels	Occasional (29-5%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0002656	mucopolysaccharidosis type 6	Epiphyseal dysplasia	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0002788	mucopolysaccharidosis type 6	Recurrent upper respiratory tract infections	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0002808	mucopolysaccharidosis type 6	Kyphosis	Frequent (79-30%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0002857	mucopolysaccharidosis type 6	Genu valgum	Frequent (79-30%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0003300	mucopolysaccharidosis type 6	Ovoid vertebral bodies	Frequent (79-30%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0003521	mucopolysaccharidosis type 6	Disproportionate short-trunk short stature	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0007759	mucopolysaccharidosis type 6	Opacification of the corneal stroma	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0008155	mucopolysaccharidosis type 6	Mucopolysacchariduria	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0009928	mucopolysaccharidosis type 6	Thick nasal alae	Very frequent (99-80%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0100543	mucopolysaccharidosis type 6	Cognitive impairment	Occasional (29-5%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
HP:0100790	mucopolysaccharidosis type 6	Hernia	Frequent (79-30%)	ARSB	611542	253200	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	714	arylsulfatase B	protein-coding gene	gene with protein product	Approved	5q14.1	05q14.1					Sulfatases
NA	intellectual dusbility	NA	NA	PCGF2	No gene mim	No disease mim	monoallelic	probable	activating	Brain/Cognition	12929	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect	NA	NA	RMND1	No gene mim	614922	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	21176	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	limb-girdle muscular dystrophy type 2l	NA	NA	ANO5	No gene mim	611307	biallelic	possible	loss of function	Musculature;Skeleton	27337	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hemimegalencephaly pik3ca	NA	NA	PIK3CA	171834	No disease mim	mosaic	confirmed	activating	Skeleton;Endocrine/Metabolic	8975	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	protein-coding gene	gene with protein product	Approved	3q26.32	03q26.32	PI3K			phosphoinositide-3-kinase, catalytic, alpha polypeptide|phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	Phosphatidylinositol 3-kinase subunits
HP:0000164	nance-horan syndrome	Abnormality of the teeth	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	nance-horan syndrome	Long face	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	nance-horan syndrome	Mandibular prognathia	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000411	nance-horan syndrome	Protruding ear	Frequent (79-30%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	nance-horan syndrome	Prominent nasal bridge	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000448	nance-horan syndrome	Prominent nose	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000482	nance-horan syndrome	Microcornea	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	nance-horan syndrome	Strabismus	Frequent (79-30%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	nance-horan syndrome	Glaucoma	Occasional (29-5%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	nance-horan syndrome	Visual impairment	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	nance-horan syndrome	Cataract	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000541	nance-horan syndrome	Retinal detachment	Occasional (29-5%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	nance-horan syndrome	Microphthalmia	Occasional (29-5%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000572	nance-horan syndrome	Visual loss	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	nance-horan syndrome	Nystagmus	Very frequent (99-80%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	nance-horan syndrome	Behavioral abnormality	Occasional (29-5%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	nance-horan syndrome	Intellectual disability	Frequent (79-30%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010049	nance-horan syndrome	Short metacarpal	Frequent (79-30%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011069	nance-horan syndrome	Increased number of teeth	Frequent (79-30%)	NHS	300457	302350	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	generalized epilepsy with febrile seizures plus, type 3	NA	NA	GABRG2	No gene mim	611277	monoallelic	probable	loss of function		4087	gamma-aminobutyric acid type A receptor gamma2 subunit	protein-coding gene	gene with protein product	Approved	5q34	05q34		GABA(A) receptor, gamma 2		gamma-aminobutyric acid (GABA) A receptor, gamma 2	Gamma-aminobutyric acid type A receptor subunits
NA	robinow syndrome, autosomal dominant	NA	NA	ROR2	602337	180700	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Genitalia	10257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia with linear skin lesions	NA	NA	COX7B	300885	300887	x-linked dominant	confirmed	loss of function	Skin;Eye	2291	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	idiopathic hypogonadotropic hypogonadism	NA	NA	FGFR1	136350	146110	monoallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000294	prolidase deficiency	Low anterior hairline	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000316	prolidase deficiency	Hypertelorism	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000347	prolidase deficiency	Micrognathia	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000365	prolidase deficiency	Hearing impairment	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000370	prolidase deficiency	Abnormality of the middle ear	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000457	prolidase deficiency	Depressed nasal ridge	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000505	prolidase deficiency	Visual impairment	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000520	prolidase deficiency	Proptosis	Occasional (29-5%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000670	prolidase deficiency	Carious teeth	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000958	prolidase deficiency	Dry skin	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000962	prolidase deficiency	Hyperkeratosis	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000963	prolidase deficiency	Thin skin	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000982	prolidase deficiency	Palmoplantar keratoderma	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000989	prolidase deficiency	Pruritus	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0000992	prolidase deficiency	Cutaneous photosensitivity	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0001007	prolidase deficiency	Hirsutism	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0001166	prolidase deficiency	Arachnodactyly	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0001231	prolidase deficiency	Abnormality of the fingernails	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0001249	prolidase deficiency	Intellectual disability	Occasional (29-5%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0001744	prolidase deficiency	Splenomegaly	Occasional (29-5%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0001999	prolidase deficiency	Abnormal facial shape	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0002205	prolidase deficiency	Recurrent respiratory infections	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0002211	prolidase deficiency	White forelock	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0002230	prolidase deficiency	Generalized hirsutism	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0002240	prolidase deficiency	Hepatomegaly	Occasional (29-5%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0002715	prolidase deficiency	Abnormality of the immune system	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0002857	prolidase deficiency	Genu valgum	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0003272	prolidase deficiency	Abnormality of the hip bone	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0004349	prolidase deficiency	Reduced bone mineral density	Occasional (29-5%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0005280	prolidase deficiency	Depressed nasal bridge	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0007473	prolidase deficiency	Crusting erythematous dermatitis	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0007598	prolidase deficiency	Bilateral single transverse palmar creases	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0007703	prolidase deficiency	Abnormality of retinal pigmentation	Frequent (79-30%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0008065	prolidase deficiency	Aplasia/Hypoplasia of the skin	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0010669	prolidase deficiency	Cheekbone underdevelopment	Occasional (29-5%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0010783	prolidase deficiency	Erythema	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0012786	prolidase deficiency	Recurrent cystitis	Occasional (29-5%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0200034	prolidase deficiency	Papule	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
HP:0200042	prolidase deficiency	Skin ulcer	Very frequent (99-80%)	PEPD	613230	170100	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	8840	peptidase D	protein-coding gene	gene with protein product	Approved	19q13.11	19q13.11		prolidase			
NA	short rib-polydactyly syndrome, type v	NA	NA	WDR35	613602	614091	biallelic	confirmed	loss of function	Skeleton	29250	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atelosteogenesis type 2	NA	NA	SLC26A2	606718	256050	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cardiomyopathy familial hypertrophic type 14	NA	NA	MYH6	No gene mim	613251	monoallelic	both DD and IF	uncertain	Heart/Cardiovasculature/Lymphatic	7576	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital disorder of deglycosylation	NA	NA	NGLY1	No gene mim	615273	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	17646	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000085	lathosterolosis	Horseshoe kidney	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000212	lathosterolosis	Gingival overgrowth	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	lathosterolosis	High palate	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	lathosterolosis	Microcephaly	Very frequent (99-80%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	lathosterolosis	Epicanthus	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000293	lathosterolosis	Full cheeks	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000340	lathosterolosis	Sloping forehead	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000341	lathosterolosis	Narrow forehead	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	lathosterolosis	Long philtrum	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	lathosterolosis	Micrognathia	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	lathosterolosis	Hearing impairment	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000414	lathosterolosis	Bulbous nose	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	lathosterolosis	Anteverted nares	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000482	lathosterolosis	Microcornea	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	lathosterolosis	Downslanted palpebral fissures	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	lathosterolosis	Ptosis	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	lathosterolosis	Cataract	Very frequent (99-80%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001162	lathosterolosis	Postaxial hand polydactyly	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	lathosterolosis	Seizures	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	lathosterolosis	Muscular hypotonia	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	lathosterolosis	Global developmental delay	Very frequent (99-80%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	lathosterolosis	Specific learning disability	Very frequent (99-80%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001336	lathosterolosis	Myoclonus	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001399	lathosterolosis	Hepatic failure	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001406	lathosterolosis	Intrahepatic cholestasis	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	lathosterolosis	Failure to thrive	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	lathosterolosis	Intrauterine growth retardation	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001770	lathosterolosis	Toe syndactyly	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001830	lathosterolosis	Postaxial foot polydactyly	Very frequent (99-80%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	lathosterolosis	Thrombocytopenia	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001883	lathosterolosis	Talipes	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	lathosterolosis	Hepatomegaly	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002308	lathosterolosis	Arnold-Chiari malformation	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002435	lathosterolosis	Meningocele	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002514	lathosterolosis	Cerebral calcification	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002714	lathosterolosis	Downturned corners of mouth	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	lathosterolosis	Short nose	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004422	lathosterolosis	Biparietal narrowing	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004823	lathosterolosis	Anisopoikilocytosis	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005487	lathosterolosis	Prominent metopic ridge	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007759	lathosterolosis	Opacification of the corneal stroma	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008278	lathosterolosis	Cerebellar cortical atrophy	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	lathosterolosis	Hypoplasia of penis	Very frequent (99-80%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011875	lathosterolosis	Abnormal platelet morphology	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100711	lathosterolosis	Abnormality of the thoracic spine	Frequent (79-30%)	SC5D	No gene mim	607330	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	10547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness autosomal dominant type 13	NA	NA	COL11A2	120290	601868	monoallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	distal arthrogryposis type 5d	NA	NA	ECEL1	605896	615065	biallelic	confirmed	loss of function	Skeleton	3147	endothelin converting enzyme like 1	protein-coding gene	gene with protein product	Approved	2q37.1	02q37.1	XCE|DINE	damage induced neuronal endopeptidase			M13 metallopeptidases
NA	alstrom syndrome	NA	NA	ALMS1	606844	203800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;Heart/Cardiovasculature/Lymphatic	428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nonspecific severe id	NA	NA	GATAD2B	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	30778	GATA zinc finger domain containing 2B	protein-coding gene	gene with protein product	Approved	1q21.3	01q21.3	P66beta	transcription repressor p66 beta component of the MeCP1 complex			GATA zinc finger domain containing
NA	ciliary dyskinesia, primary, 23	NA	NA	ARMC4	No gene mim	615451	biallelic	confirmed	loss of function	Respiratory tract	25583	armadillo repeat containing 4	protein-coding gene	gene with protein product	Approved	10p12.1	10p12.1	FLJ10817|FLJ10376|DKFZP434P1735|CILD23				Armadillo repeat containing
NA	minicore myopathy with external ophthalmoplegia	NA	NA	RYR1	No gene mim	255320	biallelic	confirmed	loss of function	Musculature	10483	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX10	602859	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
HP:0000112	rothmund-thomson syndrome	Nephropathy	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	rothmund-thomson syndrome	Hypogonadism	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	rothmund-thomson syndrome	Abnormality of the teeth	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000202	rothmund-thomson syndrome	Oral cleft	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	rothmund-thomson syndrome	Microcephaly	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000271	rothmund-thomson syndrome	Abnormality of the face	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	rothmund-thomson syndrome	Epicanthus	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000322	rothmund-thomson syndrome	Short philtrum	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	rothmund-thomson syndrome	Hearing impairment	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	rothmund-thomson syndrome	Sensorineural hearing impairment	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	rothmund-thomson syndrome	Deeply set eye	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	rothmund-thomson syndrome	Glaucoma	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	rothmund-thomson syndrome	Ptosis	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000535	rothmund-thomson syndrome	Sparse eyebrow	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000653	rothmund-thomson syndrome	Sparse eyelashes	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000822	rothmund-thomson syndrome	Hypertension	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000834	rothmund-thomson syndrome	Abnormality of the adrenal glands	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000924	rothmund-thomson syndrome	Abnormality of the skeletal system	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000938	rothmund-thomson syndrome	Osteopenia	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000958	rothmund-thomson syndrome	Dry skin	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000972	rothmund-thomson syndrome	Palmoplantar hyperkeratosis	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000992	rothmund-thomson syndrome	Cutaneous photosensitivity	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001029	rothmund-thomson syndrome	Poikiloderma	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001053	rothmund-thomson syndrome	Hypopigmented skin patches	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001118	rothmund-thomson syndrome	Juvenile cataract	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	rothmund-thomson syndrome	Abnormality of the metacarpal bones	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001231	rothmund-thomson syndrome	Abnormality of the fingernails	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	rothmund-thomson syndrome	Intellectual disability	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	rothmund-thomson syndrome	Global developmental delay	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	rothmund-thomson syndrome	Craniosynostosis	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001371	rothmund-thomson syndrome	Flexion contracture	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001373	rothmund-thomson syndrome	Joint dislocation	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001374	rothmund-thomson syndrome	Congenital hip dislocation	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001376	rothmund-thomson syndrome	Limitation of joint mobility	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	rothmund-thomson syndrome	Growth delay	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001595	rothmund-thomson syndrome	Abnormality of the hair	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001875	rothmund-thomson syndrome	Neutropenia	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	rothmund-thomson syndrome	Frontal bossing	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002017	rothmund-thomson syndrome	Nausea and vomiting	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002021	rothmund-thomson syndrome	Pyloric stenosis	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	rothmund-thomson syndrome	Malabsorption	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	rothmund-thomson syndrome	Hypertelorism	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	rothmund-thomson syndrome	Micrognathia	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000563	rothmund-thomson syndrome	Keratoconus	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	rothmund-thomson syndrome	Carious teeth	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000962	rothmund-thomson syndrome	Hyperkeratosis	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000965	rothmund-thomson syndrome	Cutis marmorata	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001120	rothmund-thomson syndrome	Abnormality of corneal size	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	rothmund-thomson syndrome	Anemia	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002110	rothmund-thomson syndrome	Bronchiectasis	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002216	rothmund-thomson syndrome	Premature graying of hair	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002648	rothmund-thomson syndrome	Abnormality of calvarial morphology	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	rothmund-thomson syndrome	Scoliosis	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002664	rothmund-thomson syndrome	Neoplasm	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002665	rothmund-thomson syndrome	Lymphoma	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002669	rothmund-thomson syndrome	Osteosarcoma	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002671	rothmund-thomson syndrome	Basal cell carcinoma	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002804	rothmund-thomson syndrome	Arthrogryposis multiplex congenita	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002860	rothmund-thomson syndrome	Squamous cell carcinoma	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002863	rothmund-thomson syndrome	Myelodysplasia	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002997	rothmund-thomson syndrome	Abnormality of the ulna	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003065	rothmund-thomson syndrome	Patellar hypoplasia	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	rothmund-thomson syndrome	Short stature	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004334	rothmund-thomson syndrome	Dermal atrophy	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005107	rothmund-thomson syndrome	Abnormality of the sacrum	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	rothmund-thomson syndrome	Joint hyperflexibility	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006368	rothmund-thomson syndrome	Forearm reduction defects	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006501	rothmund-thomson syndrome	Aplasia/Hypoplasia of the radius	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006753	rothmund-thomson syndrome	Neoplasm of the stomach	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007400	rothmund-thomson syndrome	Irregular hyperpigmentation	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007759	rothmund-thomson syndrome	Opacification of the corneal stroma	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008066	rothmund-thomson syndrome	Abnormal blistering of the skin	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008070	rothmund-thomson syndrome	Sparse hair	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008572	rothmund-thomson syndrome	External ear malformation	Frequent (79-30%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009601	rothmund-thomson syndrome	Aplasia/Hypoplasia of the thumb	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	rothmund-thomson syndrome	Reduced number of teeth	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010701	rothmund-thomson syndrome	Abnormal immunoglobulin level	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010783	rothmund-thomson syndrome	Erythema	Very frequent (99-80%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200042	rothmund-thomson syndrome	Skin ulcer	Occasional (29-5%)	RECQL4	603780	268400	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nonsyndromic deafness dfnb48	NA	NA	CIB2	605564	609439	biallelic	confirmed	all missense/in frame	Eye;Ear	24579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ladd syndrome	NA	NA	FGF10	602115	149730	monoallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Eye	3666	fibroblast growth factor 10	protein-coding gene	gene with protein product	Approved	5p12	05p12					
NA	malignant migrating partial seizures of infancy	NA	NA	KCNT1	608167	No disease mim	monoallelic	confirmed	activating	Brain/Cognition	18865	potassium sodium-activated channel subfamily T member 1	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3	KCa4.1|KIAA1422|SLACK|Slo2.2	Sequence like a calcium-activated K+ channel		potassium channel, subfamily T, member 1|potassium channel, sodium activated subfamily T, member 1	Potassium sodium-activated channel subfamily T 
NA	chanarin-dorfman syndrome	NA	NA	ABHD5	604780	275630	biallelic	confirmed	loss of function	Bone Marrow/Immune;Musculature;Skin;Eye	21396	abhydrolase domain containing 5	protein-coding gene	gene with protein product	Approved	3p21.33	03p21.33	CGI-58|NCIE2				Abhydrolase domain containing
NA	epileptic encephalopathies	NA	NA	GABRB3	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame	Brain/Cognition	4083	gamma-aminobutyric acid type A receptor beta3 subunit	protein-coding gene	gene with protein product	Approved	15q12	15q12		GABA(A) receptor, beta 3		gamma-aminobutyric acid (GABA) A receptor, beta 3	Gamma-aminobutyric acid type A receptor subunits
HP:0001288	multiple epiphyseal dysplasia type 5	Gait disturbance	Frequent (79-30%)	MATN3	602109	607078	monoallelic	confirmed	all missense/in frame	Skeleton	6909	matrilin 3	protein-coding gene	gene with protein product	Approved	2p24.1	02p24.1	EDM5|HOA				
HP:0001376	multiple epiphyseal dysplasia type 5	Limitation of joint mobility	Frequent (79-30%)	MATN3	602109	607078	monoallelic	confirmed	all missense/in frame	Skeleton	6909	matrilin 3	protein-coding gene	gene with protein product	Approved	2p24.1	02p24.1	EDM5|HOA				
HP:0001385	multiple epiphyseal dysplasia type 5	Hip dysplasia	Frequent (79-30%)	MATN3	602109	607078	monoallelic	confirmed	all missense/in frame	Skeleton	6909	matrilin 3	protein-coding gene	gene with protein product	Approved	2p24.1	02p24.1	EDM5|HOA				
HP:0001387	multiple epiphyseal dysplasia type 5	Joint stiffness	Frequent (79-30%)	MATN3	602109	607078	monoallelic	confirmed	all missense/in frame	Skeleton	6909	matrilin 3	protein-coding gene	gene with protein product	Approved	2p24.1	02p24.1	EDM5|HOA				
HP:0002656	multiple epiphyseal dysplasia type 5	Epiphyseal dysplasia	Very frequent (99-80%)	MATN3	602109	607078	monoallelic	confirmed	all missense/in frame	Skeleton	6909	matrilin 3	protein-coding gene	gene with protein product	Approved	2p24.1	02p24.1	EDM5|HOA				
HP:0002758	multiple epiphyseal dysplasia type 5	Osteoarthritis	Very frequent (99-80%)	MATN3	602109	607078	monoallelic	confirmed	all missense/in frame	Skeleton	6909	matrilin 3	protein-coding gene	gene with protein product	Approved	2p24.1	02p24.1	EDM5|HOA				
HP:0002829	multiple epiphyseal dysplasia type 5	Arthralgia	Frequent (79-30%)	MATN3	602109	607078	monoallelic	confirmed	all missense/in frame	Skeleton	6909	matrilin 3	protein-coding gene	gene with protein product	Approved	2p24.1	02p24.1	EDM5|HOA				
HP:0002857	multiple epiphyseal dysplasia type 5	Genu valgum	Occasional (29-5%)	MATN3	602109	607078	monoallelic	confirmed	all missense/in frame	Skeleton	6909	matrilin 3	protein-coding gene	gene with protein product	Approved	2p24.1	02p24.1	EDM5|HOA				
HP:0002970	multiple epiphyseal dysplasia type 5	Genu varum	Occasional (29-5%)	MATN3	602109	607078	monoallelic	confirmed	all missense/in frame	Skeleton	6909	matrilin 3	protein-coding gene	gene with protein product	Approved	2p24.1	02p24.1	EDM5|HOA				
NA	mental retardation syndromic x-linked lubs type	NA	NA	MECP2	300005	300260	hemizygous	confirmed	loss of function	Brain/Cognition;GI tract	6990	methyl-CpG binding protein 2	protein-coding gene	gene with protein product	Approved	Xq28	Xq28			RTT|MRX16|MRX79	mental retardation, X-linked 16|mental retardation, X-linked 79|Rett syndrome|methyl CpG binding protein 2 (Rett syndrome)|methyl CpG binding protein 2	X-linked mental retardation|Methyl-CpG binding domain containing
NA	severe intellectual disability, epilepsy, and cataracts	NA	NA	FAR1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	26222	fatty acyl-CoA reductase 1	protein-coding gene	gene with protein product	Approved	11p15.3	11p15.3	FLJ22728|SDR10E1	short chain dehydrogenase/reductase family 10E, member 1	MLSTD2	male sterility domain containing 2	Short chain dehydrogenase/reductase superfamily
NA	mitochondrial respiratory chain complex i deficiency	NA	NA	NDUFS7	601825	252010	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7714	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cystinosis late-onset juvenile or adolescent nephropathic type	NA	NA	CTNS	606272	219900	biallelic	confirmed	loss of function	Kidney Renal Tract	2518	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14	NA	NA	GMPPB	No gene mim	615350	biallelic	confirmed	all missense/in frame	Musculature	22932	GDP-mannose pyrophosphorylase B	protein-coding gene	gene with protein product	Approved	3p21.31	03p21.31	KIAA1851	mannose-1-phosphate guanyltransferase beta			
NA	mitochondrial complex iii deficiency, nuclear type 6	NA	NA	CYC1	No gene mim	615453	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	2579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000262	cole-carpenter syndrome	Turricephaly	Frequent (79-30%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	cole-carpenter syndrome	Micrognathia	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	cole-carpenter syndrome	Downslanted palpebral fissures	Occasional (29-5%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	cole-carpenter syndrome	Proptosis	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000592	cole-carpenter syndrome	Blue sclerae	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	cole-carpenter syndrome	Abnormality of dental enamel	Frequent (79-30%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	cole-carpenter syndrome	Delayed eruption of teeth	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	cole-carpenter syndrome	Abnormality of the ribs	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	cole-carpenter syndrome	Abnormality of the metaphyses	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	cole-carpenter syndrome	Muscular hypotonia	Frequent (79-30%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	cole-carpenter syndrome	Global developmental delay	Occasional (29-5%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001334	cole-carpenter syndrome	Communicating hydrocephalus	Frequent (79-30%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	cole-carpenter syndrome	Intrauterine growth retardation	Frequent (79-30%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001608	cole-carpenter syndrome	Abnormality of the voice	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	cole-carpenter syndrome	Frontal bossing	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002645	cole-carpenter syndrome	Wormian bones	Frequent (79-30%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	cole-carpenter syndrome	Scoliosis	Frequent (79-30%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	cole-carpenter syndrome	Skeletal dysplasia	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	cole-carpenter syndrome	Recurrent fractures	Frequent (79-30%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	cole-carpenter syndrome	Kyphosis	Frequent (79-30%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	cole-carpenter syndrome	Abnormal form of the vertebral bodies	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	cole-carpenter syndrome	Short stature	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	cole-carpenter syndrome	Joint hyperflexibility	Occasional (29-5%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006367	cole-carpenter syndrome	Crumpled long bones	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	cole-carpenter syndrome	Bowing of the long bones	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	cole-carpenter syndrome	Midface retrusion	Very frequent (99-80%)	P4HB	No gene mim	112240	monoallelic	probable	all missense/in frame	Face;Skeleton;Brain/Cognition;Eye	8548	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	craniometaphyseal dysplasia jackson type	NA	NA	ANKH	605145	123000	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear	15492	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peroxisome biogenesis disorder complementation group 4	NA	NA	PEX6	601498	601498	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	8859	peroxisomal biogenesis factor 6	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	PXAAA1|PAF-2				AAA ATPases|Peroxins
NA	autosomal recessive mental retardation	NA	NA	WDR45B	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	25072	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	limb-girdle muscular dystrophy type 2h	NA	NA	TRIM32	602290	254110	biallelic	confirmed	loss of function	Musculature;Kidney Renal Tract;Brain/Cognition;Eye	16380	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infantile cerebellar-retinal degeneration	NA	NA	ACO2	100850	614559	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	118	aconitase 2	protein-coding gene	gene with protein product	Approved	22q13.2	22q13.2	ACONM	aconitate hydratase, mitochondrial|mitochondrial aconitase		aconitase 2, mitochondrial	
NA	mucolipidosis type iii complementation group c	NA	NA	GNPTG	607838	252605	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	23026	N-acetylglucosamine-1-phosphate transferase gamma subunit	protein-coding gene	gene with protein product	Approved	16p13.3	16p13.3	CAB56184|c316G12.3	GlcNAc-phosphotransferase gamma-subunit	GNPTAG|C16orf27	N-acetylglucosamine-1-phosphotransferase, gamma subunit|chromosome 16 open reading frame 27	MRH domain containing 
NA	mental retardation syndromic x-linked type 13	NA	NA	MECP2	300005	300055	hemizygous	confirmed	loss of function	Brain/Cognition;GI tract	6990	methyl-CpG binding protein 2	protein-coding gene	gene with protein product	Approved	Xq28	Xq28			RTT|MRX16|MRX79	mental retardation, X-linked 16|mental retardation, X-linked 79|Rett syndrome|methyl CpG binding protein 2 (Rett syndrome)|methyl CpG binding protein 2	X-linked mental retardation|Methyl-CpG binding domain containing
NA	intestinal atresia, multiple	NA	NA	TTC7A	No gene mim	243150	biallelic	confirmed	loss of function	Bone Marrow/Immune;GI tract	19750	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	RGS7	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	10003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	phosphoglycerate kinase 1 deficiency	NA	NA	PGK1	311800	300653	hemizygous	confirmed	loss of function	Bone Marrow/Immune;Musculature;Endocrine/Metabolic;Brain/Cognition	8896	phosphoglycerate kinase 1	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1					
NA	schindler disease	NA	NA	NAGA	104170	609241	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7631	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bartter syndrome type 4b	NA	NA	CLCNKA	No gene mim	613090	biallelic	possible	loss of function	Kidney Renal Tract;Endocrine/Metabolic	2026	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanconi anemia, complementation group a	NA	NA	FANCA	607139	227650	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	3582	Fanconi anemia complementation group A	protein-coding gene	gene with protein product	Approved	16q24.3	16q24.3	FAA|FA-H|FAH		FACA|FANCH		Fanconi anemia complementation groups
NA	heterotaxy syndrome	NA	NA	LEFTY2	No gene mim	207574	monoallelic	possible	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	3122	left-right determination factor 2	protein-coding gene	gene with protein product	Approved	1q42.12	01q42.12	LEFTA|LEFTYA	transforming growth factor, beta-4 (endometrial bleeding-associated factor; LEFTY A)	TGFB4|EBAF	endometrial bleeding associated factor (left-right determination, factor A; transforming growth factor beta superfamily)	
NA	amelogenesis imperfecta and gingival fibromatosis syndrome	NA	NA	FAM20A	No gene mim	614253	biallelic	confirmed	loss of function	Teeth & Dentitian	23015	FAM20A, golgi associated secretory pathway pseudokinase	protein-coding gene	gene with protein product	Approved	17q24.2	17q24.2	DKFZp434F2322			family with sequence similarity 20, member A	
NA	aminoacylase-1 deficiency	NA	NA	ACY1	104620	609924	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	177	aminoacylase 1	protein-coding gene	gene with protein product	Approved	3p21.2	03p21.2					
NA	tricho-rhino-phalangeal syndrome type 2	NA	NA	EXT1	608177	150230	monoallelic	confirmed	loss of function	Skin;Face;Skeleton	3512	exostosin glycosyltransferase 1	protein-coding gene	gene with protein product	Approved	8q24.11	08q24.11	ttv	Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N- acetylglucosaminyltransferase|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase	LGCR|LGS	Langer-Giedion syndrome chromosome region|exostoses (multiple) 1|exostosin 1	Exostosin glycosyltransferase family
NA	stapes ankylosis with broad thumb and toes	NA	NA	NOG	602991	184460	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	prop1-related combined pituitary hormone deficiency	NA	NA	PROP1	601538	262600	biallelic	confirmed	loss of function	Endocrine/Metabolic	9455	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy	NA	NA	GTPBP3	No gene mim	No disease mim	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	14880	GTP binding protein 3, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11	MSS1|THDF1|GTPBG3|MTGP1|FLJ14700				
NA	autism/id	NA	NA	PTCHD1	No gene mim	300830	hemizygous	confirmed	loss of function	Brain/Cognition	26392	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	alport syndrome with mental retardation midface hypoplasia and elliptocytosis	NA	NA	ACSL4	300157	300194	hemizygous	probable	loss of function	Face;Brain/Cognition	3571	acyl-CoA synthetase long chain family member 4	protein-coding gene	gene with protein product	Approved	Xq23	Xq23	ACS4|LACS4	lignoceroyl-CoA synthase| long-chain fatty-acid-Coenzyme A ligase 4	FACL4|MRX63|MRX68	fatty-acid-Coenzyme A ligase, long-chain 4|mental retardation, X-linked 63|mental retardation, X-linked 68	Acyl-CoA synthetase family|X-linked mental retardation
NA	lujan-fryns syndrome	NA	NA	MED12	300188	309520	hemizygous	confirmed	uncertain	Skeleton;Brain/Cognition;GI tract;Genitalia	11957	mediator complex subunit 12	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	CAGH45|HOPA|OPA1|TRAP230|KIAA0192|OKS		TNRC11|FGS1	trinucleotide repeat containing 11 (THR-associated protein, 230kDa subunit)|mediator of RNA polymerase II transcription, subunit 12 homolog (S. cerevisiae)|FG syndrome 1	Trinucleotide repeat containing|Mediator complex
NA	interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	NA	NA	ITGA3	605025	614748	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Respiratory tract	6139	integrin subunit alpha 3	protein-coding gene	gene with protein product	Approved	17q21.33	17q21.33	CD49c|VLA3a|VCA-2|GAP-B3	alpha 3 subunit of VLA-3 receptor|antigen CD49C	MSK18	antigen identified by monoclonal antibody J143|integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)	CD molecules|Integrin alpha subunits
HP:0000252	dpagt1-cdg	Microcephaly	Very frequent (99-80%)	DPAGT1	191350	300129	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	2995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	dpagt1-cdg	Micrognathia	Very frequent (99-80%)	DPAGT1	191350	300129	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	2995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	dpagt1-cdg	Intellectual disability	Very frequent (99-80%)	DPAGT1	191350	300129	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	2995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	dpagt1-cdg	Seizures	Very frequent (99-80%)	DPAGT1	191350	300129	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	2995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	dpagt1-cdg	Muscular hypotonia	Very frequent (99-80%)	DPAGT1	191350	300129	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	2995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	dpagt1-cdg	Global developmental delay	Very frequent (99-80%)	DPAGT1	191350	300129	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	2995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	dpagt1-cdg	Clinodactyly of the 5th finger	Very frequent (99-80%)	DPAGT1	191350	300129	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	2995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	x-linked mental retardation 88	NA	NA	AGTR2	300034	290909	hemizygous	possible	loss of function	Brain/Cognition	338	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	coach syndrome	NA	NA	CC2D2A	612013	216360	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;GI tract	29253	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondyloepimetaphyseal dysplasia short limb-hand type	NA	NA	DDR2	191311	271665	biallelic	confirmed	uncertain	Skeleton	2731	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type a6	NA	NA	LARGE1	No gene mim	613154	biallelic	confirmed	loss of function	Musculature;Brain/Cognition	6511	LARGE xylosyl- and glucuronyltransferase 1	protein-coding gene	gene with protein product	Approved	22q12.3	22q12.3	KIAA0609	like-acetylglucosaminyltransferase	LARGE	like-glycosyltransferase	Glycosyltransferase family 8
NA	microvillus inclusion disease	NA	NA	MYO5B	606540	251850	biallelic	confirmed	loss of function	GI tract	7603	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	ZBTB40	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	29045	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mct8 (slc16a2)-specific thyroid hormone cell transporter deficiency	NA	NA	SLC16A2	300095	300523	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10923	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mesoaxial synostotic syndactyly with phalangeal reduction, malik-percin type	NA	NA	BHLHA9	No gene mim	69432	biallelic	confirmed	dominant negative	Skeleton	35126	basic helix-loop-helix family member a9	protein-coding gene	gene with protein product	Approved	17p13.3	17p13.3	bHLHa9|BHLHF42	Fingerin		basic helix-loop-helix family, member a9	Basic helix-loop-helix proteins
NA	d-bifunctional protein deficiency	NA	NA	HSD17B4	601860	261515	biallelic	confirmed	loss of function	Brain/Cognition;Ear;Genitalia	5213	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gout hprt-related	NA	NA	HPRT1	308000	300323	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary ciliary dyskinesia-22	NA	NA	ZMYND10	No gene mim	615444	biallelic	probable	loss of function	Respiratory tract	19412	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	postaxial polydactyly type a	NA	NA	GLI3	165240	149847	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
NA	infantile epileptic encephalopathy	NA	NA	KCNH5	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	6254	potassium voltage-gated channel subfamily H member 5	protein-coding gene	gene with protein product	Approved	14q23.2	14q23.2	Kv10.2|H-EAG2|eag2			potassium voltage-gated channel, subfamily H (eag-related), member 5	Potassium voltage-gated channels
NA	bainbridge-ropers syndrome	NA	NA	ASXL3	No gene mim	615485	monoallelic	probable	loss of function	Face;Brain/Cognition	29357	additional sex combs like 3, transcriptional regulator	protein-coding gene	gene with protein product	Approved	18q12.1	18q12.1			KIAA1713	KIAA1713|additional sex combs like 3 (Drosophila)	
HP:0000478	neuronal ceroid lipofuscinosis	Abnormality of the eye	Frequent (79-30%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0000504	neuronal ceroid lipofuscinosis	Abnormality of vision	Frequent (79-30%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0000505	neuronal ceroid lipofuscinosis	Visual impairment	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0000512	neuronal ceroid lipofuscinosis	Abnormal electroretinogram	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0000572	neuronal ceroid lipofuscinosis	Visual loss	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0000648	neuronal ceroid lipofuscinosis	Optic atrophy	Frequent (79-30%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0000708	neuronal ceroid lipofuscinosis	Behavioral abnormality	Occasional (29-5%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0001107	neuronal ceroid lipofuscinosis	Ocular albinism	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0001249	neuronal ceroid lipofuscinosis	Intellectual disability	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0001250	neuronal ceroid lipofuscinosis	Seizures	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0001251	neuronal ceroid lipofuscinosis	Ataxia	Occasional (29-5%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0001252	neuronal ceroid lipofuscinosis	Muscular hypotonia	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0001268	neuronal ceroid lipofuscinosis	Mental deterioration	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0001939	neuronal ceroid lipofuscinosis	Abnormality of metabolism/homeostasis	Frequent (79-30%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0002167	neuronal ceroid lipofuscinosis	Neurological speech impairment	Frequent (79-30%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0002353	neuronal ceroid lipofuscinosis	EEG abnormality	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0002376	neuronal ceroid lipofuscinosis	Developmental regression	Frequent (79-30%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0008046	neuronal ceroid lipofuscinosis	Abnormality of the retinal vasculature	Very frequent (99-80%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
HP:0100022	neuronal ceroid lipofuscinosis	Abnormality of movement	Frequent (79-30%)	KCTD7	611725	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
NA	muscular dystrophy-dystroglycanopathy limb-girdle type c7	NA	NA	DAG1	128239	613818	biallelic	confirmed	all missense/in frame	Musculature;Brain/Cognition	2666	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness autosomal recessive type 53	NA	NA	COL11A2	120290	609706	biallelic	confirmed	all missense/in frame	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe autosomal dominant nocturnal frontal lobe epilepsy	NA	NA	KCNT1	608167	614959	monoallelic	confirmed	all missense/in frame	Brain/Cognition	18865	potassium sodium-activated channel subfamily T member 1	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3	KCa4.1|KIAA1422|SLACK|Slo2.2	Sequence like a calcium-activated K+ channel		potassium channel, subfamily T, member 1|potassium channel, sodium activated subfamily T, member 1	Potassium sodium-activated channel subfamily T 
NA	epileptic encephalopathy	NA	NA	ALG13	No gene mim	No disease mim	hemizygous	probable	all missense/in frame	Brain/Cognition	30881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	anemia, sideroblastic, with ataxia	NA	NA	ABCB7	No gene mim	301310	hemizygous	confirmed	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	48	ATP binding cassette subfamily B member 7	protein-coding gene	gene with protein product	Approved	Xq13.3	Xq13.3	EST140535|Atm1p|ASAT		ABC7	ATP-binding cassette, sub-family B (MDR/TAP), member 7	ATP binding cassette subfamily B
NA	jansen metaphyseal chondrodysplasia	NA	NA	PTH1R	168468	156400	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic	9608	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebroretinal microangiopathy with calcifications and cysts	NA	NA	CTC1	613129	612199	biallelic	confirmed	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	26169	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	long qt syndrome-5	NA	NA	KCNE1	No gene mim	613695	monoallelic	child IF	all missense/in frame	Ear;Heart/Cardiovasculature/Lymphatic	6240	potassium voltage-gated channel subfamily E regulatory subunit 1	protein-coding gene	gene with protein product	Approved	21q22.12	21q22.12	minK|ISK|JLNS2|LQT5			potassium voltage-gated channel, Isk-related family, member 1|potassium channel, voltage gated subfamily E regulatory beta subunit 1	Potassium voltage-gated channel regulatory subunits
NA	klippel-feil syndrome type 3	NA	NA	GDF3	No gene mim	613702	monoallelic	possible	all missense/in frame	Skeleton;Eye	4218	growth differentiation factor 3	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31					Endogenous ligands
NA	familial scaphocephaly syndrome	NA	NA	FGFR2	176943	609579	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004322	congenital short bowel syndrome	Short stature	Frequent (79-30%)	CLMP	No gene mim	615237	biallelic	probable	loss of function	GI tract	24039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005245	congenital short bowel syndrome	Intestinal hypoplasia	Very frequent (99-80%)	CLMP	No gene mim	615237	biallelic	probable	loss of function	GI tract	24039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	congenital short bowel syndrome	Cognitive impairment	Frequent (79-30%)	CLMP	No gene mim	615237	biallelic	probable	loss of function	GI tract	24039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100578	congenital short bowel syndrome	Lipoatrophy	Frequent (79-30%)	CLMP	No gene mim	615237	biallelic	probable	loss of function	GI tract	24039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100627	congenital short bowel syndrome	Displacement of the external urethral meatus	Occasional (29-5%)	CLMP	No gene mim	615237	biallelic	probable	loss of function	GI tract	24039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001006	congenital short bowel syndrome	Hypotrichosis	Frequent (79-30%)	CLMP	No gene mim	615237	biallelic	probable	loss of function	GI tract	24039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002566	congenital short bowel syndrome	Intestinal malrotation	Frequent (79-30%)	CLMP	No gene mim	615237	biallelic	probable	loss of function	GI tract	24039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001402	tyrosinemia type 1	Hepatocellular carcinoma	Occasional (29-5%)	FAH	613871	276700	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	3579	fumarylacetoacetate hydrolase	protein-coding gene	gene with protein product	Approved	15q25.1	15q25.1		fumarylacetoacetase			
HP:0001744	tyrosinemia type 1	Splenomegaly	Occasional (29-5%)	FAH	613871	276700	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	3579	fumarylacetoacetate hydrolase	protein-coding gene	gene with protein product	Approved	15q25.1	15q25.1		fumarylacetoacetase			
HP:0002240	tyrosinemia type 1	Hepatomegaly	Occasional (29-5%)	FAH	613871	276700	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	3579	fumarylacetoacetate hydrolase	protein-coding gene	gene with protein product	Approved	15q25.1	15q25.1		fumarylacetoacetase			
HP:0002909	tyrosinemia type 1	Generalized aminoaciduria	Very frequent (99-80%)	FAH	613871	276700	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	3579	fumarylacetoacetate hydrolase	protein-coding gene	gene with protein product	Approved	15q25.1	15q25.1		fumarylacetoacetase			
HP:0006463	tyrosinemia type 1	Rickets of the lower limbs	Occasional (29-5%)	FAH	613871	276700	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	3579	fumarylacetoacetate hydrolase	protein-coding gene	gene with protein product	Approved	15q25.1	15q25.1		fumarylacetoacetase			
HP:0006554	tyrosinemia type 1	Acute hepatic failure	Occasional (29-5%)	FAH	613871	276700	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;GI tract	3579	fumarylacetoacetate hydrolase	protein-coding gene	gene with protein product	Approved	15q25.1	15q25.1		fumarylacetoacetase			
NA	joubert syndrome type 5	NA	NA	CEP290	610142	610188	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition	29021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cornelia de lange syndrome type 2	NA	NA	SMC1A	300040	300590	x-linked dominant	confirmed	uncertain	Skeleton;Brain/Cognition;GI tract;Genitalia	11111	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	seckel syndrome type 4	NA	NA	CENPJ	609279	613676	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	17272	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	are the cause of pseudoachondroplasia	NA	NA	COMP	600310	177170	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness x-linked type 1	NA	NA	PRPS1	311850	304500	hemizygous	confirmed	uncertain	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehlers-danlos syndrome musculocontractural type	NA	NA	CHST14	No gene mim	601776	biallelic	confirmed	loss of function	Skin;Eye	24464	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract, congenital nuclear, autosomal recessive 2	NA	NA	CRYBB3	123630	609741	biallelic	confirmed	uncertain	Eye	2400	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	brachydactyly, type a1	NA	NA	IHH	600726	112500	monoallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
NA	holoprosencephaly 11	NA	NA	CDON	608707	614226	monoallelic	confirmed	all missense/in frame	Brain/Cognition	17104	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	short rib-polydactyly syndrome type 3	NA	NA	DYNC2H1	603297	263510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract	2962	dynein cytoplasmic 2 heavy chain 1	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	hdhc11|DHC2|DHC1b|DYH1B		DNCH2	dynein, cytoplasmic, heavy polypeptide 2	Dyneins, cytoplasmic
HP:0000238	achondroplasia	Hydrocephalus	Occasional (29-5%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000256	achondroplasia	Macrocephaly	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000389	achondroplasia	Chronic otitis media	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000405	achondroplasia	Conductive hearing impairment	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000463	achondroplasia	Anteverted nares	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000678	achondroplasia	Dental crowding	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000689	achondroplasia	Dental malocclusion	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000772	achondroplasia	Abnormality of the ribs	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000774	achondroplasia	Narrow chest	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000944	achondroplasia	Abnormality of the metaphyses	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000956	achondroplasia	Acanthosis nigricans	Occasional (29-5%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000975	achondroplasia	Hyperhidrosis	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001252	achondroplasia	Muscular hypotonia	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001260	achondroplasia	Dysarthria	Occasional (29-5%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001387	achondroplasia	Joint stiffness	Occasional (29-5%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001511	achondroplasia	Intrauterine growth retardation	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001513	achondroplasia	Obesity	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001522	achondroplasia	Death in infancy	Occasional (29-5%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001645	achondroplasia	Sudden cardiac death	Occasional (29-5%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002007	achondroplasia	Frontal bossing	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002104	achondroplasia	Apnea	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002119	achondroplasia	Ventriculomegaly	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002167	achondroplasia	Neurological speech impairment	Occasional (29-5%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002645	achondroplasia	Wormian bones	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002808	achondroplasia	Kyphosis	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002867	achondroplasia	Abnormality of the ilium	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002870	achondroplasia	Obstructive sleep apnea	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002970	achondroplasia	Genu varum	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003042	achondroplasia	Elbow dislocation	Occasional (29-5%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003307	achondroplasia	Hyperlordosis	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003312	achondroplasia	Abnormal form of the vertebral bodies	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003416	achondroplasia	Spinal canal stenosis	Occasional (29-5%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005019	achondroplasia	Diaphyseal thickening	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005280	achondroplasia	Depressed nasal bridge	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005692	achondroplasia	Joint hyperflexibility	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0006487	achondroplasia	Bowing of the long bones	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0008803	achondroplasia	Narrow sacroiliac notch	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0008873	achondroplasia	Disproportionate short-limb short stature	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0008905	achondroplasia	Rhizomelia	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0008921	achondroplasia	Neonatal short-limb short stature	Very frequent (99-80%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0009811	achondroplasia	Abnormality of the elbow	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0011800	achondroplasia	Midface retrusion	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0100818	achondroplasia	Long thorax	Frequent (79-30%)	FGFR3	134934	100800	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	autosomal recessive mental retardation	NA	NA	LAMA1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	6481	laminin subunit alpha 1	protein-coding gene	gene with protein product	Approved	18p11.31	18p11.31			LAMA	laminin, alpha 1	Laminin subunits
NA	gaucher disease perinatal lethal	NA	NA	GBA	No gene mim	608013	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000164	fucosidosis	Abnormality of the teeth	Occasional (29-5%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0000248	fucosidosis	Brachycephaly	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0000280	fucosidosis	Coarse facial features	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0000365	fucosidosis	Hearing impairment	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0000821	fucosidosis	Hypothyroidism	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0000943	fucosidosis	Dysostosis multiplex	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0000975	fucosidosis	Hyperhidrosis	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001063	fucosidosis	Acrocyanosis	Occasional (29-5%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001250	fucosidosis	Seizures	Frequent (79-30%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001252	fucosidosis	Muscular hypotonia	Frequent (79-30%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001257	fucosidosis	Spasticity	Frequent (79-30%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001263	fucosidosis	Global developmental delay	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001508	fucosidosis	Failure to thrive	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001597	fucosidosis	Abnormality of the nail	Occasional (29-5%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001626	fucosidosis	Abnormality of the cardiovascular system	Frequent (79-30%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001640	fucosidosis	Cardiomegaly	Occasional (29-5%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0001999	fucosidosis	Abnormal facial shape	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0002240	fucosidosis	Hepatomegaly	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0002510	fucosidosis	Spastic tetraplegia	Frequent (79-30%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0002808	fucosidosis	Kyphosis	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0003199	fucosidosis	Decreased muscle mass	Frequent (79-30%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0005264	fucosidosis	Abnormality of the gallbladder	Frequent (79-30%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0005595	fucosidosis	Generalized hyperkeratosis	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0007256	fucosidosis	Abnormal pyramidal signs	Occasional (29-5%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0007957	fucosidosis	Corneal opacity	Frequent (79-30%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0008155	fucosidosis	Mucopolysacchariduria	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0008430	fucosidosis	Anterior beaking of lumbar vertebrae	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0010864	fucosidosis	Intellectual disability, severe	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0011220	fucosidosis	Prominent forehead	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0011276	fucosidosis	Vascular skin abnormality	Frequent (79-30%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
HP:0100578	fucosidosis	Lipoatrophy	Very frequent (99-80%)	FUCA1	612280	230000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	4006	alpha-L-fucosidase 1	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11		-L-fucosidase 1|tissue fucosidase|a-L-fucosidase 1		fucosidase, alpha-L- 1, tissue	
NA	timothy syndrome	NA	NA	CACNA1C	No gene mim	601005	monoallelic	confirmed	activating	Skeleton;Heart/Cardiovasculature/Lymphatic	1390	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	supravalvar aortic stenosis	NA	NA	ELN	130160	185500	monoallelic	confirmed	loss of function	Skin;Heart/Cardiovasculature/Lymphatic	3327	elastin	protein-coding gene	gene with protein product	Approved	7q11.23	07q11.23	WBS|WS|SVAS	tropoelastin|supravalvular aortic stenosis|Williams-Beuren syndrome			
HP:0000256	achondrogenesis type 1a	Macrocephaly	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	achondrogenesis type 1a	Long philtrum	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	achondrogenesis type 1a	Micrognathia	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	achondrogenesis type 1a	Anteverted nares	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	achondrogenesis type 1a	Short neck	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000474	achondrogenesis type 1a	Thickened nuchal skin fold	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000476	achondrogenesis type 1a	Cystic hygroma	Occasional (29-5%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	achondrogenesis type 1a	Narrow chest	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	achondrogenesis type 1a	Umbilical hernia	Frequent (79-30%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	achondrogenesis type 1a	Polyhydramnios	Frequent (79-30%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001773	achondrogenesis type 1a	Short foot	Frequent (79-30%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001789	achondrogenesis type 1a	Hydrops fetalis	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	achondrogenesis type 1a	Frontal bossing	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	achondrogenesis type 1a	Malformation of the heart and great vessels	Occasional (29-5%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	achondrogenesis type 1a	Recurrent fractures	Frequent (79-30%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	achondrogenesis type 1a	Micromelia	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	achondrogenesis type 1a	Short nose	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003270	achondrogenesis type 1a	Abdominal distention	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003336	achondrogenesis type 1a	Abnormal enchondral ossification	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003510	achondrogenesis type 1a	Severe short stature	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004279	achondrogenesis type 1a	Short palm	Frequent (79-30%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005716	achondrogenesis type 1a	Lethal skeletal dysplasia	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006640	achondrogenesis type 1a	Multiple rib fractures	Frequent (79-30%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006703	achondrogenesis type 1a	Aplasia/Hypoplasia of the lungs	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010306	achondrogenesis type 1a	Short thorax	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012368	achondrogenesis type 1a	Flat face	Very frequent (99-80%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100541	achondrogenesis type 1a	Femoral hernia	Frequent (79-30%)	TRIP11	604505	200600	biallelic	confirmed	loss of function	Skeleton	12305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	brachydactyly-syndactyly syndrome	NA	NA	HOXD13	142989	610713	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	alport syndrome autosomal recessive	NA	NA	COL4A3	120070	203780	biallelic	confirmed	loss of function	Kidney Renal Tract;Eye;Ear	2204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	mucopolysaccharidosis type 2	Inguinal hernia	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000158	mucopolysaccharidosis type 2	Macroglossia	Occasional (29-5%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000179	mucopolysaccharidosis type 2	Thick lower lip vermilion	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	mucopolysaccharidosis type 2	Macrocephaly	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000268	mucopolysaccharidosis type 2	Dolichocephaly	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	mucopolysaccharidosis type 2	Coarse facial features	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	mucopolysaccharidosis type 2	Mandibular prognathia	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	mucopolysaccharidosis type 2	Hearing impairment	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000403	mucopolysaccharidosis type 2	Recurrent otitis media	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	mucopolysaccharidosis type 2	Depressed nasal ridge	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	mucopolysaccharidosis type 2	Short neck	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	mucopolysaccharidosis type 2	Ptosis	Occasional (29-5%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	mucopolysaccharidosis type 2	Optic atrophy	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000687	mucopolysaccharidosis type 2	Widely spaced teeth	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	mucopolysaccharidosis type 2	Behavioral abnormality	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	mucopolysaccharidosis type 2	Pectus excavatum	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001072	mucopolysaccharidosis type 2	Thickened skin	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001085	mucopolysaccharidosis type 2	Papilledema	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	mucopolysaccharidosis type 2	Seizures	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	mucopolysaccharidosis type 2	Joint stiffness	Occasional (29-5%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	mucopolysaccharidosis type 2	Umbilical hernia	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001601	mucopolysaccharidosis type 2	Laryngomalacia	Occasional (29-5%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001626	mucopolysaccharidosis type 2	Abnormality of the cardiovascular system	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	mucopolysaccharidosis type 2	Splenomegaly	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	mucopolysaccharidosis type 2	Malabsorption	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002187	mucopolysaccharidosis type 2	Intellectual disability, profound	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002230	mucopolysaccharidosis type 2	Generalized hirsutism	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002777	mucopolysaccharidosis type 2	Tracheal stenosis	Occasional (29-5%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	mucopolysaccharidosis type 2	Kyphosis	Occasional (29-5%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003272	mucopolysaccharidosis type 2	Abnormality of the hip bone	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003510	mucopolysaccharidosis type 2	Severe short stature	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	mucopolysaccharidosis type 2	Depressed nasal bridge	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	mucopolysaccharidosis type 2	Abnormality of retinal pigmentation	Frequent (79-30%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008155	mucopolysaccharidosis type 2	Mucopolysacchariduria	Very frequent (99-80%)	IDS	300823	309900	hemizygous	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5389	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	legius syndrome	NA	NA	SPRED1	609291	611431	monoallelic	confirmed	loss of function	Skin	20249	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	holoprosencephaly	Cryptorchidism	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000079	holoprosencephaly	Abnormality of the urinary system	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000093	holoprosencephaly	Proteinuria	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000161	holoprosencephaly	Median cleft lip	Very frequent (99-80%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	holoprosencephaly	Hydrocephalus	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	holoprosencephaly	Microcephaly	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	holoprosencephaly	Macrocephaly	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	holoprosencephaly	Epicanthus	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000289	holoprosencephaly	Broad philtrum	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	holoprosencephaly	Hypertelorism	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	holoprosencephaly	Macrotia	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000437	holoprosencephaly	Depressed nasal tip	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000453	holoprosencephaly	Choanal atresia	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	holoprosencephaly	Depressed nasal ridge	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000458	holoprosencephaly	Anosmia	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	holoprosencephaly	Anteverted nares	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	holoprosencephaly	Short neck	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000488	holoprosencephaly	Retinopathy	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	holoprosencephaly	Deeply set eye	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	holoprosencephaly	Ptosis	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000528	holoprosencephaly	Anophthalmia	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000567	holoprosencephaly	Chorioretinal coloboma	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	holoprosencephaly	Microphthalmia	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000574	holoprosencephaly	Thick eyebrow	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000581	holoprosencephaly	Blepharophimosis	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000582	holoprosencephaly	Upslanted palpebral fissure	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000601	holoprosencephaly	Hypotelorism	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	holoprosencephaly	Iris coloboma	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	holoprosencephaly	Optic atrophy	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000664	holoprosencephaly	Synophrys	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000776	holoprosencephaly	Congenital diaphragmatic hernia	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000819	holoprosencephaly	Diabetes mellitus	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000830	holoprosencephaly	Anterior hypopituitarism	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000871	holoprosencephaly	Panhypopituitarism	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000873	holoprosencephaly	Diabetes insipidus	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000929	holoprosencephaly	Abnormality of the skull	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	holoprosencephaly	Brachydactyly syndrome	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	holoprosencephaly	Hand polydactyly	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	holoprosencephaly	Seizures	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	holoprosencephaly	Muscular hypotonia	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	holoprosencephaly	Spasticity	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	holoprosencephaly	Global developmental delay	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001305	holoprosencephaly	Dandy-Walker malformation	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	holoprosencephaly	Muscle weakness	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001332	holoprosencephaly	Dystonia	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001360	holoprosencephaly	Holoprosencephaly	Very frequent (99-80%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001531	holoprosencephaly	Failure to thrive in infancy	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001539	holoprosencephaly	Omphalocele	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	holoprosencephaly	Ventricular septal defect	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	holoprosencephaly	Tetralogy of Fallot	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001641	holoprosencephaly	Abnormality of the pulmonary valve	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001679	holoprosencephaly	Abnormality of the aorta	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001743	holoprosencephaly	Abnormality of the spleen	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001883	holoprosencephaly	Talipes	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	holoprosencephaly	Hypoglycemia	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001999	holoprosencephaly	Abnormal facial shape	Very frequent (99-80%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002002	holoprosencephaly	Deep philtrum	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	holoprosencephaly	Frontal bossing	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	holoprosencephaly	Constipation	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	holoprosencephaly	Gastroesophageal reflux	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002072	holoprosencephaly	Chorea	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002084	holoprosencephaly	Encephalocele	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	holoprosencephaly	Respiratory insufficiency	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	holoprosencephaly	Abnormality of neuronal migration	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002553	holoprosencephaly	Highly arched eyebrow	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	holoprosencephaly	Scoliosis	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002902	holoprosencephaly	Hyponatremia	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	holoprosencephaly	Abnormal form of the vertebral bodies	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004409	holoprosencephaly	Hyposmia	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005469	holoprosencephaly	Flat occiput	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	holoprosencephaly	Joint hyperflexibility	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006315	holoprosencephaly	Single median maxillary incisor	Very frequent (99-80%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006703	holoprosencephaly	Aplasia/Hypoplasia of the lungs	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	holoprosencephaly	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	holoprosencephaly	Aplasia/Hypoplasia of the corpus callosum	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008501	holoprosencephaly	Median cleft lip and palate	Very frequent (99-80%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008572	holoprosencephaly	External ear malformation	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	holoprosencephaly	Hypoplasia of penis	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	holoprosencephaly	Feeding difficulties in infancy	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009738	holoprosencephaly	Abnormality of the antihelix	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009794	holoprosencephaly	Branchial anomaly	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	holoprosencephaly	Reduced number of teeth	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009914	holoprosencephaly	Cyclopia	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009924	holoprosencephaly	Aplasia/Hypoplasia involving the nose	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010301	holoprosencephaly	Spinal dysraphism	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010302	holoprosencephaly	Spinal cord tumor	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010669	holoprosencephaly	Cheekbone underdevelopment	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011100	holoprosencephaly	Intestinal atresia	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	holoprosencephaly	Arrhythmia	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012639	holoprosencephaly	Abnormality of nervous system morphology	Very frequent (99-80%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100336	holoprosencephaly	Bilateral cleft lip	Very frequent (99-80%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	holoprosencephaly	Cognitive impairment	Frequent (79-30%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100596	holoprosencephaly	Absent nares	Occasional (29-5%)	TGIF1	602630	609637	monoallelic	confirmed	loss of function	Brain/Cognition	11776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	gracile syndrome	Hearing impairment	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0001394	gracile syndrome	Cirrhosis	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0001396	gracile syndrome	Cholestasis	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0001397	gracile syndrome	Hepatic steatosis	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0001511	gracile syndrome	Intrauterine growth retardation	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0001994	gracile syndrome	Renal Fanconi syndrome	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0003128	gracile syndrome	Lactic acidosis	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0003281	gracile syndrome	Increased serum ferritin	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0012464	gracile syndrome	Decreased transferrin saturation	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0012465	gracile syndrome	Elevated hepatic iron concentration	Very frequent (99-80%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
HP:0100613	gracile syndrome	Death in early adulthood	Frequent (79-30%)	BCS1L	603647	603358	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;GI tract	1020	BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	protein-coding gene	gene with protein product	Approved	2q35	02q35	Hs.6719|BCS|h-BCS|BJS	GRACILE syndrome|Bjornstad syndrome		BCS1 (yeast homolog)-like|BCS1-like (yeast)|BCS1-like (S. cerevisiae)|BC1 (ubiquinol-cytochrome c reductase) synthesis-like	AAA ATPases|Mitochondrial respiratory chain complex assembly factors
NA	leber congenital amaurosis 4	NA	NA	AIPL1	604392	604393	biallelic	confirmed	loss of function	Eye	359	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000271	infantile refsum disease	Abnormality of the face	Occasional (29-5%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000365	infantile refsum disease	Hearing impairment	Frequent (79-30%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000407	infantile refsum disease	Sensorineural hearing impairment	Frequent (79-30%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000505	infantile refsum disease	Visual impairment	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000510	infantile refsum disease	Rod-cone dystrophy	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000518	infantile refsum disease	Cataract	Occasional (29-5%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000639	infantile refsum disease	Nystagmus	Frequent (79-30%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000648	infantile refsum disease	Optic atrophy	Occasional (29-5%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000662	infantile refsum disease	Nyctalopia	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000708	infantile refsum disease	Behavioral abnormality	Frequent (79-30%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001250	infantile refsum disease	Seizures	Occasional (29-5%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001251	infantile refsum disease	Ataxia	Frequent (79-30%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001252	infantile refsum disease	Muscular hypotonia	Frequent (79-30%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001257	infantile refsum disease	Spasticity	Frequent (79-30%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001263	infantile refsum disease	Global developmental delay	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001508	infantile refsum disease	Failure to thrive	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001638	infantile refsum disease	Cardiomyopathy	Occasional (29-5%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0002240	infantile refsum disease	Hepatomegaly	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0003323	infantile refsum disease	Progressive muscle weakness	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0004322	infantile refsum disease	Short stature	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0005930	infantile refsum disease	Abnormality of epiphysis morphology	Occasional (29-5%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0007981	infantile refsum disease	Concentric narrowing of visual fields	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0008064	infantile refsum disease	Ichthyosis	Occasional (29-5%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0008167	infantile refsum disease	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0010571	infantile refsum disease	Elevated levels of phytanic acid	Very frequent (99-80%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0010628	infantile refsum disease	Facial palsy	Occasional (29-5%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0011675	infantile refsum disease	Arrhythmia	Occasional (29-5%)	PEX5	600414	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
NA	boerjeson-forssman-lehmann syndrome	NA	NA	PHF6	300414	301900	hemizygous	confirmed	loss of function	Face;Brain/Cognition	18145	PHD finger protein 6	protein-coding gene	gene with protein product	Approved	Xq26.2	Xq26.2	KIAA1823|MGC14797|CENP-31	centromere protein 31	BFLS|BORJ	Borjeson-Forssman-Lehmann syndrome	PHD finger proteins
HP:0002205	primary ciliary dyskinesia	Recurrent respiratory infections	Very frequent (99-80%)	CCDC114	615038	No disease mim	biallelic	confirmed	loss of function	Respiratory tract	26560	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, autosomal dominant 9	NA	NA	KIF1A	601255	614255	monoallelic	confirmed	all missense/in frame	Peripheral nerves;Brain/Cognition	888	kinesin family member 1A	protein-coding gene	gene with protein product	Approved	2q37.3	02q37.3	UNC104		ATSV|C2orf20|SPG30	axonal transport of synaptic vesicles|chromosome 2 open reading frame 20|spastic paraplegia 30 (autosomal recessive)	Kinesins|Pleckstrin homology domain containing
NA	raine syndrome	NA	NA	FAM20C	611061	259775	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	22140	FAM20C, golgi associated secretory pathway kinase	protein-coding gene	gene with protein product	Approved	7p22.3	07p22.3	IMAGE:4942737|DKFZp547D065|DMP4|G-CK	dentin matrix protein 4|golgi casein kinase		family with sequence similarity 20, member C	
NA	night blindness, congenital stationary, type 1b	NA	NA	GRM6	604096	257270	biallelic	confirmed	loss of function	Eye	4598	glutamate metabotropic receptor 6	protein-coding gene	gene with protein product	Approved	5q35.3	05q35.3	GPRC1F|mGlu6|MGLUR6|CSNB1B			glutamate receptor, metabotropic 6	Glutamate metabotropic receptors
NA	autosomal-dominant hypotrichosis simplex	NA	NA	SNRPE	128260	615059	monoallelic	probable	all missense/in frame	Hair/Nails	11161	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	noonan syndrome 5	NA	NA	RAF1	164760	611553	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Ear	9829	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neuropathy, hereditary sensory, type iic	NA	NA	KIF1A	601255	614213	biallelic	confirmed	loss of function	Peripheral nerves	888	kinesin family member 1A	protein-coding gene	gene with protein product	Approved	2q37.3	02q37.3	UNC104		ATSV|C2orf20|SPG30	axonal transport of synaptic vesicles|chromosome 2 open reading frame 20|spastic paraplegia 30 (autosomal recessive)	Kinesins|Pleckstrin homology domain containing
NA	neuropathy, hereditary sensory, type iic	NA	NA	KIF1A	601255	614213	biallelic	confirmed	loss of function	Peripheral nerves	888	kinesin family member 1A	protein-coding gene	gene with protein product	Approved	2q37.3	02q37.3	UNC104		ATSV|C2orf20|SPG30	axonal transport of synaptic vesicles|chromosome 2 open reading frame 20|spastic paraplegia 30 (autosomal recessive)	Kinesins|Pleckstrin homology domain containing
NA	congenital disorders of glycosylation	NA	NA	SRD5A3	611715	612379	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	25812	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	insulin-like growth factor i, resistance to	NA	NA	IGF1R	No gene mim	270450	biallelic	confirmed	loss of function	Endocrine/Metabolic	5465	insulin like growth factor 1 receptor	protein-coding gene	gene with protein product	Approved	15q26.3	15q26.3	JTK13|CD221|IGFIR|MGC18216|IGFR			insulin-like growth factor 1 receptor	Receptor Tyrosine Kinases|CD molecules|Fibronectin type III domain containing
NA	insulin-like growth factor i, resistance to	NA	NA	IGF1R	No gene mim	270450	monoallelic	confirmed	loss of function	Endocrine/Metabolic	5465	insulin like growth factor 1 receptor	protein-coding gene	gene with protein product	Approved	15q26.3	15q26.3	JTK13|CD221|IGFIR|MGC18216|IGFR			insulin-like growth factor 1 receptor	Receptor Tyrosine Kinases|CD molecules|Fibronectin type III domain containing
NA	cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	NA	NA	IARS2	No gene mim	616007	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	29685	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	CAPN10	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	1477	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	retinitis pigmentosa 28	NA	NA	FAM161A	No gene mim	606068	biallelic	both DD and IF	loss of function	Eye	25808	family with sequence similarity 161 member A	protein-coding gene	gene with protein product	Approved	2p15	02p15	FLJ13305		RP28	retinitis pigmentosa 28 (autosomal recessive)|family with sequence similarity 161, member A	
NA	opitz g/bbb syndrome, x-linked	NA	NA	MID1	300552	300000	hemizygous	confirmed	loss of function	Face;Brain/Cognition	7095	midline 1	protein-coding gene	gene with protein product	Approved	Xp22	Xp22	OS|FXY|TRIM18|RNF59	Opitz/BBB syndrome			Ring finger proteins|Tripartite motif containing|Fibronectin type III domain containing
NA	respiratory chain disorder	NA	NA	PNPT1	610316	614932	biallelic	confirmed	loss of function	Ear	23166	polyribonucleotide nucleotidyltransferase 1	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	PNPase|OLD35|old-35	polynucleotide phosphorylase|3'-5' RNA exonuclease	DFNB70	deafness, autosomal recessive 70	Deafness associated genes
NA	pitt hopkins 2	NA	NA	NRXN1	600565	No disease mim	biallelic	probable	loss of function	Brain/Cognition	8008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephrotic syndrome, type 3	NA	NA	PLCE1	608414	610725	biallelic	confirmed	loss of function	Kidney Renal Tract	17175	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebellar ataxia mental retardation and dysequilibrium syndrome type 1	NA	NA	VLDLR	192977	224050	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	12698	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation-stereotypic movements-epilepsy and/or cerebral malformations	NA	NA	MEF2C	600662	613443	monoallelic	confirmed	loss of function	Face;Brain/Cognition	6996	myocyte enhancer factor 2C	protein-coding gene	gene with protein product	Approved	5q14.3	05q14.3					Myocyte enhancer factor 2 proteins|MADS box family
NA	mental retardation-anterior maxillary protrusion-strabismus	NA	NA	SOBP	No gene mim	613671	biallelic	possible	loss of function	Face;Brain/Cognition;Eye	29256	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	enlarged parietal foramina/cranium bifidum	NA	NA	MSX2	123101	168550	monoallelic	confirmed	loss of function	Skeleton	7392	msh homeobox 2	protein-coding gene	gene with protein product	Approved	5q35.2	05q35.2	CRS2|FPP|HOX8|MSH|PFM	craniosynostosis, type 2	PFM1	msh (Drosophila) homeo box homolog 2|parietal foramina 1|msh homeobox homolog 2 (Drosophila)	NKL subclass homeoboxes and pseudogenes
NA	not in omim	NA	NA	ZNF599	No gene mim	No disease mim	monoallelic	possible	uncertain	Brain/Cognition	26408	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	susceptibility to autism x-linked type 2	NA	NA	NLGN4X	No gene mim	300495	hemizygous	possible	loss of function	Brain/Cognition	14287	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	pyridoxine-dependent epilepsy	Strabismus	Occasional (29-5%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	pyridoxine-dependent epilepsy	Intellectual disability	Very frequent (99-80%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	pyridoxine-dependent epilepsy	Seizures	Very frequent (99-80%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	pyridoxine-dependent epilepsy	Muscular hypotonia	Frequent (79-30%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	pyridoxine-dependent epilepsy	Global developmental delay	Very frequent (99-80%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001939	pyridoxine-dependent epilepsy	Abnormality of metabolism/homeostasis	Very frequent (99-80%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	pyridoxine-dependent epilepsy	Ventriculomegaly	Occasional (29-5%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002120	pyridoxine-dependent epilepsy	Cerebral cortical atrophy	Occasional (29-5%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002133	pyridoxine-dependent epilepsy	Status epilepticus	Very frequent (99-80%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	pyridoxine-dependent epilepsy	Neurological speech impairment	Very frequent (99-80%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	pyridoxine-dependent epilepsy	Hepatomegaly	Occasional (29-5%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	pyridoxine-dependent epilepsy	EEG abnormality	Very frequent (99-80%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	pyridoxine-dependent epilepsy	Abnormality of movement	Very frequent (99-80%)	ALDH7A1	107323	266100	biallelic	confirmed	loss of function	Brain/Cognition	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	frasier syndrome frasier syndrome frasier syndrome	NA	NA	WT1	607102	136680	monoallelic	confirmed	dominant negative	Kidney Renal Tract;Genitalia;Heart/Cardiovasculature/Lymphatic	12796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	leber congenital amaurosis	Hearing impairment	Occasional (29-5%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000512	leber congenital amaurosis	Abnormal electroretinogram	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	leber congenital amaurosis	Cataract	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000563	leber congenital amaurosis	Keratoconus	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leber congenital amaurosis	Nystagmus	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001141	leber congenital amaurosis	Severe visual impairment	Very frequent (99-80%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	leber congenital amaurosis	Intellectual disability	Occasional (29-5%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leber congenital amaurosis	Seizures	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leber congenital amaurosis	Muscular hypotonia	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	leber congenital amaurosis	Global developmental delay	Occasional (29-5%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002084	leber congenital amaurosis	Encephalocele	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	leber congenital amaurosis	Abnormality of neuronal migration	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leber congenital amaurosis	Hemiplegia/hemiparesis	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006817	leber congenital amaurosis	Aplasia/Hypoplasia of the cerebellar vermis	Frequent (79-30%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	leber congenital amaurosis	Abnormality of retinal pigmentation	Very frequent (99-80%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012795	leber congenital amaurosis	Abnormality of the optic disc	Very frequent (99-80%)	NMNAT1	608700	608553	biallelic	confirmed	loss of function	Eye	17877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hypomyelination with atrophy of the basal ganglia and cerebellum	NA	NA	TUBB4A	No gene mim	No disease mim	monoallelic	confirmed	activating	Brain/Cognition	20774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy limb-girdle type c2	NA	NA	POMT2	607439	613158	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	19743	protein O-mannosyltransferase 2	protein-coding gene	gene with protein product	Approved	14q24.3	14q24.3	LGMD2N	Dolichyl-phosphate-mannose--protein mannosyltransferase			Dolichyl D-mannosyl phosphate dependent mannosyltransferases
HP:0000365	reticular dysgenesis	Hearing impairment	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000389	reticular dysgenesis	Chronic otitis media	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000988	reticular dysgenesis	Skin rash	Occasional (29-5%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	reticular dysgenesis	Failure to thrive	Frequent (79-30%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001824	reticular dysgenesis	Weight loss	Frequent (79-30%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001874	reticular dysgenesis	Abnormality of neutrophils	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001882	reticular dysgenesis	Leukopenia	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	reticular dysgenesis	Anemia	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001944	reticular dysgenesis	Dehydration	Occasional (29-5%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001945	reticular dysgenesis	Fever	Frequent (79-30%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002014	reticular dysgenesis	Diarrhea	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	reticular dysgenesis	Malabsorption	Frequent (79-30%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	reticular dysgenesis	Recurrent respiratory infections	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003287	reticular dysgenesis	Abnormality of mitochondrial metabolism	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004313	reticular dysgenesis	Decreased antibody level in blood	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004430	reticular dysgenesis	Severe combined immunodeficiency	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005374	reticular dysgenesis	Cellular immunodeficiency	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010515	reticular dysgenesis	Aplasia/Hypoplasia of the thymus	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100806	reticular dysgenesis	Sepsis	Very frequent (99-80%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200042	reticular dysgenesis	Skin ulcer	Occasional (29-5%)	AK2	103020	267500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Ear	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bile acid synthesis defect, congenital, 1	NA	NA	HSD3B7	No gene mim	607765	biallelic	confirmed	loss of function	Endocrine/Metabolic;GI tract	18324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neuropathy, congenital hypomyelinating, 1	NA	NA	EGR2	No gene mim	605253	biallelic	confirmed	loss of function	Spinal cord/Peripheral nerves	3239	early growth response 2	protein-coding gene	gene with protein product	Approved	10q21.3	10q21.3		Krox-20 homolog, Drosophila	KROX20	early growth response 2 (Krox-20 homolog, Drosophila)	Zinc fingers C2H2-type
NA	intellectual disability	NA	NA	ZMYM6	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	13050	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	noonan syndrome 1	NA	NA	PTPN11	176876	163950	monoallelic	confirmed	activating	Skeleton;Ear;Heart/Cardiovasculature/Lymphatic	9644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia, isolated, with cataract 2	NA	NA	SIX6	No gene mim	212550	monoallelic	possible	uncertain	Eye	10892	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	joubert syndrome 9	NA	NA	CC2D2A	612013	612285	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;GI tract	29253	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	asphyxiating thoracic dystrophy 5	NA	NA	WDR19	608151	614376	biallelic	confirmed	uncertain	Kidney Renal Tract;Skeleton	18340	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	central hypothyroidism and testicular enlargement	NA	NA	IGSF1	300137	300888	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Genitalia	5948	immunoglobulin superfamily member 1	protein-coding gene	gene with protein product	Approved	Xq25	Xq25	KIAA0364|IGDC1|IGCD1|INHBP|MGC75490|PGSF2			immunoglobulin superfamily, member 1	Immunoglobulin like domain containing
NA	kallmann syndrome with deafness	NA	NA	SOX10	602229	No disease mim	monoallelic	confirmed	loss of function	Skin;Face;Spinal cord/Peripheral nerves;Ear	11190	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bone marrow failure syndrome 2	NA	NA	ERCC6L2	No gene mim	615715	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	26922	ERCC excision repair 6 like 2	protein-coding gene	gene with protein product	Approved	9q22.32	09q22.32	FLJ37706|RAD26L		C9orf102	chromosome 9 open reading frame 102|excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2|excision repair cross-complementation group 6 like 2	
NA	mosaic variegated aneuploidy syndrome 2	NA	NA	CEP57	607951	614114	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	30794	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	urofacial syndrome	NA	NA	HPSE2	613469	236730	biallelic	confirmed	loss of function	Kidney Renal Tract;Face	18374	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000083	jeune syndrome	Renal insufficiency	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0000090	jeune syndrome	Nephronophthisis	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0000112	jeune syndrome	Nephropathy	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0000766	jeune syndrome	Abnormality of the sternum	Frequent (79-30%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0000772	jeune syndrome	Abnormality of the ribs	Very frequent (99-80%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0000774	jeune syndrome	Narrow chest	Very frequent (99-80%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0000889	jeune syndrome	Abnormality of the clavicle	Frequent (79-30%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0000944	jeune syndrome	Abnormality of the metaphyses	Frequent (79-30%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0001156	jeune syndrome	Brachydactyly syndrome	Frequent (79-30%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0001162	jeune syndrome	Postaxial hand polydactyly	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0001392	jeune syndrome	Abnormality of the liver	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0001770	jeune syndrome	Toe syndactyly	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0001773	jeune syndrome	Short foot	Frequent (79-30%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0001830	jeune syndrome	Postaxial foot polydactyly	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0002093	jeune syndrome	Respiratory insufficiency	Frequent (79-30%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0002644	jeune syndrome	Abnormality of pelvic girdle bone morphology	Very frequent (99-80%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0002652	jeune syndrome	Skeletal dysplasia	Very frequent (99-80%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0002983	jeune syndrome	Micromelia	Very frequent (99-80%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0004322	jeune syndrome	Short stature	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0006703	jeune syndrome	Aplasia/Hypoplasia of the lungs	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0007703	jeune syndrome	Abnormality of retinal pigmentation	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0008872	jeune syndrome	Feeding difficulties in infancy	Occasional (29-5%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0010306	jeune syndrome	Short thorax	Very frequent (99-80%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
HP:0010579	jeune syndrome	Cone-shaped epiphysis	Frequent (79-30%)	IFT172	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	30391	intraflagellar transport 172	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SLB|wim|osm-1|NPHP17|BBS20	wimple homolog		intraflagellar transport 172 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins|Bardet-Biedl syndrome associated
NA	autism spectrum disorders	NA	NA	NLGN3	300336	198890	hemizygous	probable	loss of function	Brain/Cognition	14289	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hypertelorism, severe, with midface prominence, myopia, mental retardation, and bone fragility	NA	NA	IRX5	No gene mim	611174	biallelic	probable	all missense/in frame	Bone Marrow/Immune;Face;Skeleton;Brain/Cognition	14361	iroquois homeobox 5	protein-coding gene	gene with protein product	Approved	16q12.2	16q12.2	IRX-2a				TALE class homeoboxes and pseudogenes
HP:0000023	acrocallosal syndrome	Inguinal hernia	Occasional (29-5%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000028	acrocallosal syndrome	Cryptorchidism	Occasional (29-5%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000047	acrocallosal syndrome	Hypospadias	Occasional (29-5%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000098	acrocallosal syndrome	Tall stature	Occasional (29-5%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000256	acrocallosal syndrome	Macrocephaly	Very frequent (99-80%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000260	acrocallosal syndrome	Wide anterior fontanel	Occasional (29-5%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000269	acrocallosal syndrome	Prominent occiput	Frequent (79-30%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000316	acrocallosal syndrome	Hypertelorism	Very frequent (99-80%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000340	acrocallosal syndrome	Sloping forehead	Frequent (79-30%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000407	acrocallosal syndrome	Sensorineural hearing impairment	Occasional (29-5%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000776	acrocallosal syndrome	Congenital diaphragmatic hernia	Occasional (29-5%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0000889	acrocallosal syndrome	Abnormality of the clavicle	Occasional (29-5%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0001162	acrocallosal syndrome	Postaxial hand polydactyly	Very frequent (99-80%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0001199	acrocallosal syndrome	Triphalangeal thumb	Frequent (79-30%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0001305	acrocallosal syndrome	Dandy-Walker malformation	Frequent (79-30%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0007360	acrocallosal syndrome	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0007370	acrocallosal syndrome	Aplasia/Hypoplasia of the corpus callosum	Very frequent (99-80%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
HP:0010864	acrocallosal syndrome	Intellectual disability, severe	Very frequent (99-80%)	KIF7	611254	200990	biallelic	confirmed	loss of function	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
NA	methylmalonic aciduria and homocystinuria type cblf	NA	NA	LMBRD1	612625	277380	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Heart/Cardiovasculature/Lymphatic	23038	LMBR1 domain containing 1	protein-coding gene	gene with protein product	Approved	6q13	06q13	FLJ11240|bA810I22.1|cblF		C6orf209	chromosome 6 open reading frame 209	
HP:0000174	cartilage-hair hypoplasia	Abnormality of the palate	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000212	cartilage-hair hypoplasia	Gingival overgrowth	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	cartilage-hair hypoplasia	Brachycephaly	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	cartilage-hair hypoplasia	Epicanthus	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	cartilage-hair hypoplasia	Low-set, posteriorly rotated ears	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	cartilage-hair hypoplasia	Macrotia	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	cartilage-hair hypoplasia	Wide nasal bridge	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000444	cartilage-hair hypoplasia	Convex nasal ridge	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	cartilage-hair hypoplasia	Depressed nasal ridge	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	cartilage-hair hypoplasia	Anteverted nares	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	cartilage-hair hypoplasia	Short neck	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	cartilage-hair hypoplasia	Strabismus	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	cartilage-hair hypoplasia	Visual impairment	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000535	cartilage-hair hypoplasia	Sparse eyebrow	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	cartilage-hair hypoplasia	Myopia	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000592	cartilage-hair hypoplasia	Blue sclerae	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	cartilage-hair hypoplasia	Pectus carinatum	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	cartilage-hair hypoplasia	Abnormality of the ribs	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	cartilage-hair hypoplasia	Narrow chest	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000940	cartilage-hair hypoplasia	Abnormal diaphysis morphology	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	cartilage-hair hypoplasia	Abnormality of the metaphyses	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000960	cartilage-hair hypoplasia	Sacral dimple	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	cartilage-hair hypoplasia	Muscular hypotonia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001315	cartilage-hair hypoplasia	Reduced tendon reflexes	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001377	cartilage-hair hypoplasia	Limited elbow extension	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	cartilage-hair hypoplasia	Failure to thrive	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001638	cartilage-hair hypoplasia	Cardiomyopathy	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001671	cartilage-hair hypoplasia	Abnormality of the cardiac septa	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001732	cartilage-hair hypoplasia	Abnormality of the pancreas	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001875	cartilage-hair hypoplasia	Neutropenia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	cartilage-hair hypoplasia	Anemia	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	cartilage-hair hypoplasia	Malabsorption	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	cartilage-hair hypoplasia	Respiratory insufficiency	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	cartilage-hair hypoplasia	Hepatomegaly	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002251	cartilage-hair hypoplasia	Aganglionic megacolon	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	cartilage-hair hypoplasia	EEG abnormality	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002644	cartilage-hair hypoplasia	Abnormality of pelvic girdle bone morphology	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	cartilage-hair hypoplasia	Scoliosis	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	cartilage-hair hypoplasia	Skeletal dysplasia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	cartilage-hair hypoplasia	Delayed skeletal maturation	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002777	cartilage-hair hypoplasia	Tracheal stenosis	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002901	cartilage-hair hypoplasia	Hypocalcemia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002982	cartilage-hair hypoplasia	Tibial bowing	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	cartilage-hair hypoplasia	Micromelia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003027	cartilage-hair hypoplasia	Mesomelia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003220	cartilage-hair hypoplasia	Abnormality of chromosome stability	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003272	cartilage-hair hypoplasia	Abnormality of the hip bone	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003307	cartilage-hair hypoplasia	Hyperlordosis	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	cartilage-hair hypoplasia	Abnormal form of the vertebral bodies	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004279	cartilage-hair hypoplasia	Short palm	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004313	cartilage-hair hypoplasia	Decreased antibody level in blood	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004625	cartilage-hair hypoplasia	Biconvex vertebral bodies	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005019	cartilage-hair hypoplasia	Diaphyseal thickening	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	cartilage-hair hypoplasia	Depressed nasal bridge	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005616	cartilage-hair hypoplasia	Accelerated skeletal maturation	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	cartilage-hair hypoplasia	Joint hyperflexibility	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005871	cartilage-hair hypoplasia	Metaphyseal chondrodysplasia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	cartilage-hair hypoplasia	Abnormality of epiphysis morphology	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	cartilage-hair hypoplasia	Bowing of the long bones	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006589	cartilage-hair hypoplasia	Flaring of lower rib cage	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	cartilage-hair hypoplasia	Abnormality of retinal pigmentation	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008056	cartilage-hair hypoplasia	Aplasia/Hypoplasia affecting the eye	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008070	cartilage-hair hypoplasia	Sparse hair	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008155	cartilage-hair hypoplasia	Mucopolysacchariduria	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008499	cartilage-hair hypoplasia	High-grade hypermetropia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008873	cartilage-hair hypoplasia	Disproportionate short-limb short stature	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008905	cartilage-hair hypoplasia	Rhizomelia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009832	cartilage-hair hypoplasia	Abnormality of the distal phalanx of finger	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010301	cartilage-hair hypoplasia	Spinal dysraphism	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010306	cartilage-hair hypoplasia	Short thorax	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010318	cartilage-hair hypoplasia	Aplasia/Hypoplasia of the abdominal wall musculature	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011220	cartilage-hair hypoplasia	Prominent forehead	Frequent (79-30%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011849	cartilage-hair hypoplasia	Abnormal bone ossification	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012722	cartilage-hair hypoplasia	Heart block	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100255	cartilage-hair hypoplasia	Metaphyseal dysplasia	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	cartilage-hair hypoplasia	Cognitive impairment	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100569	cartilage-hair hypoplasia	Abnormal vertebral ossification	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100729	cartilage-hair hypoplasia	Large face	Very frequent (99-80%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200055	cartilage-hair hypoplasia	Small hand	Occasional (29-5%)	RMRP	No gene mim	250250	biallelic	confirmed	loss of function	Skeleton	10031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	danon disease	NA	NA	LAMP2	309060	300257	hemizygous	confirmed	loss of function	Musculature;Heart/Cardiovasculature/Lymphatic	6501	lysosomal associated membrane protein 2	protein-coding gene	gene with protein product	Approved	Xq24	Xq24	CD107b			lysosomal-associated membrane protein 2	CD molecules
NA	cerebral palsy spastic quadriplegic type 1	NA	NA	GAD1	No gene mim	603513	biallelic	possible	all missense/in frame	Brain/Cognition	4092	glutamate decarboxylase 1	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1			GAD	glutamate decarboxylase 1 (brain, 67kD)|glutamate decarboxylase 1 (brain, 67kDa)	
NA	hnf4a-related maturity-onset diabetes of the young type 1	NA	NA	HNF4A	No gene mim	125850	monoallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic	5024	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microspherophakia	NA	NA	LTBP2	602091	251750	biallelic	confirmed	loss of function	Eye	6715	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	col1a1/2-related osteogenesis imperfecta	NA	NA	COL1A1	120150	166210	monoallelic	confirmed	dominant negative	Skeleton	2197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ectodermal dysplasia rapp-hodgkin type	NA	NA	TP63	603273	129400	monoallelic	confirmed	uncertain	Skin;Face;Skeleton	15979	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy lennox-gastaut type	NA	NA	MAPK10	No gene mim	606369	monoallelic	possible	loss of function	Brain/Cognition	6872	mitogen-activated protein kinase 10	protein-coding gene	gene with protein product	Approved	4q21.3	04q21.3	JNK3|p493F12|p54bSAPK		PRKM10		Mitogen-activated protein kinases
HP:0000175	multiple epiphyseal dysplasia type 4	Cleft palate	Frequent (79-30%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001762	multiple epiphyseal dysplasia type 4	Talipes equinovarus	Frequent (79-30%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	multiple epiphyseal dysplasia type 4	Scoliosis	Frequent (79-30%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002656	multiple epiphyseal dysplasia type 4	Epiphyseal dysplasia	Very frequent (99-80%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002758	multiple epiphyseal dysplasia type 4	Osteoarthritis	Very frequent (99-80%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002815	multiple epiphyseal dysplasia type 4	Abnormality of the knee	Frequent (79-30%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002829	multiple epiphyseal dysplasia type 4	Arthralgia	Frequent (79-30%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003045	multiple epiphyseal dysplasia type 4	Abnormality of the patella	Frequent (79-30%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	multiple epiphyseal dysplasia type 4	Clinodactyly of the 5th finger	Frequent (79-30%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	multiple epiphyseal dysplasia type 4	Short stature	Occasional (29-5%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200055	multiple epiphyseal dysplasia type 4	Small hand	Frequent (79-30%)	SLC26A2	606718	226900	biallelic	confirmed	all missense/in frame	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia syndromic type 5	NA	NA	OTX2	600037	610125	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	8522	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial respiratory chain complex iii deficiency, uqcrq related	NA	NA	UQCRQ	612080	319211	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	29594	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000174	jackson-weiss syndrome	Abnormality of the palate	Frequent (79-30%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000262	jackson-weiss syndrome	Turricephaly	Very frequent (99-80%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000303	jackson-weiss syndrome	Mandibular prognathia	Frequent (79-30%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000316	jackson-weiss syndrome	Hypertelorism	Very frequent (99-80%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000327	jackson-weiss syndrome	Hypoplasia of the maxilla	Frequent (79-30%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000444	jackson-weiss syndrome	Convex nasal ridge	Frequent (79-30%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000486	jackson-weiss syndrome	Strabismus	Frequent (79-30%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000508	jackson-weiss syndrome	Ptosis	Frequent (79-30%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000520	jackson-weiss syndrome	Proptosis	Frequent (79-30%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001770	jackson-weiss syndrome	Toe syndactyly	Very frequent (99-80%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001783	jackson-weiss syndrome	Broad metatarsal	Very frequent (99-80%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001839	jackson-weiss syndrome	Split foot	Occasional (29-5%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001841	jackson-weiss syndrome	Preaxial foot polydactyly	Occasional (29-5%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002007	jackson-weiss syndrome	Frontal bossing	Frequent (79-30%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002991	jackson-weiss syndrome	Abnormality of the fibula	Occasional (29-5%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004691	jackson-weiss syndrome	2-3 toe syndactyly	Occasional (29-5%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0009773	jackson-weiss syndrome	Symphalangism affecting the phalanges of the hand	Occasional (29-5%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0009891	jackson-weiss syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010059	jackson-weiss syndrome	Broad hallux phalanx	Very frequent (99-80%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010743	jackson-weiss syndrome	Short metatarsal	Very frequent (99-80%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0011800	jackson-weiss syndrome	Midface retrusion	Very frequent (99-80%)	FGFR2	176943	123150	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	congenital hemidysplasia with ichthyosiform erythroderma and limb defects	NA	NA	NSDHL	300275	308050	x-linked dominant	confirmed	loss of function	Skin;Skeleton	13398	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness, autosomal recessive	NA	NA	GJB3	No gene mim	No disease mim	biallelic	both DD and IF	loss of function	Skin;Ear	4285	gap junction protein beta 3	protein-coding gene	gene with protein product	Approved	1p34.3	01p34.3	CX31	connexin 31	DFNA2|EKV	gap junction protein, beta 3, 31kD (connexin 31)|gap junction protein, beta 3, 31kDa (connexin 31)|erythrokeratodermia variabilis|gap junction protein, beta 3, 31kDa	Gap junction proteins|Deafness associated genes
NA	uv-sensitive syndrome	NA	NA	ERCC6	609413	609413	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	3438	ERCC excision repair 6, chromatin remodeling factor	protein-coding gene	gene with protein product	Approved	10q11.23	10q11.23	CSB|RAD26|ARMD5	Cockayne syndrome B protein	CKN2	excision repair cross-complementing rodent repair deficiency, complementation group 6|excision repair cross-complementation group 6	ERCC excision repair associated
NA	mental retardation, fra12a type	NA	NA	DIP2B	No gene mim	136630	monoallelic	possible	cis-regulatory or promotor mutation	Brain/Cognition	29284	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	KIF7	611254	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	30497	kinesin family member 7	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	JBTS12				Kinesins
NA	emberger syndrome	NA	NA	GATA2	137295	614038	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Heart/Cardiovasculature/Lymphatic	4171	GATA binding protein 2	protein-coding gene	gene with protein product	Approved	3q21.3	03q21.3	NFE1B			GATA-binding protein 2	GATA zinc finger domain containing
NA	mitochondrial complex ii deficiency	NA	NA	SDHAF1	612848	252011	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	33867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	marfan syndrome	Pectus carinatum	Very frequent (99-80%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001065	marfan syndrome	Striae distensae	Very frequent (99-80%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001166	marfan syndrome	Arachnodactyly	Very frequent (99-80%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001519	marfan syndrome	Disproportionate tall stature	Very frequent (99-80%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001533	marfan syndrome	Slender build	Very frequent (99-80%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001763	marfan syndrome	Pes planus	Very frequent (99-80%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002108	marfan syndrome	Spontaneous pneumothorax	Very frequent (99-80%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0005111	marfan syndrome	Dilatation of the ascending aorta	Very frequent (99-80%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0012432	marfan syndrome	Chronic fatigue	Very frequent (99-80%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000275	marfan syndrome	Narrow face	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000505	marfan syndrome	Visual impairment	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000545	marfan syndrome	Myopia	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000678	marfan syndrome	Dental crowding	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000767	marfan syndrome	Pectus excavatum	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001083	marfan syndrome	Ectopia lentis	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001132	marfan syndrome	Lens subluxation	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001382	marfan syndrome	Joint hypermobility	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001634	marfan syndrome	Mitral valve prolapse	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002360	marfan syndrome	Sleep disturbance	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002650	marfan syndrome	Scoliosis	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002705	marfan syndrome	High, narrow palate	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0003179	marfan syndrome	Protrusio acetabuli	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0005059	marfan syndrome	Arthralgia/arthritis	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0007800	marfan syndrome	Increased axial globe length	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0012019	marfan syndrome	Lens luxation	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0012369	marfan syndrome	Malar anomaly	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0100775	marfan syndrome	Dural ectasia	Frequent (79-30%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000023	marfan syndrome	Inguinal hernia	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000175	marfan syndrome	Cleft palate	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000268	marfan syndrome	Dolichocephaly	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000278	marfan syndrome	Retrognathia	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000347	marfan syndrome	Micrognathia	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000494	marfan syndrome	Downslanted palpebral fissures	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000501	marfan syndrome	Glaucoma	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000541	marfan syndrome	Retinal detachment	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000938	marfan syndrome	Osteopenia	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000939	marfan syndrome	Osteoporosis	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001252	marfan syndrome	Muscular hypotonia	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001635	marfan syndrome	Congestive heart failure	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002097	marfan syndrome	Emphysema	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002105	marfan syndrome	Hemoptysis	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002435	marfan syndrome	Meningocele	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002636	marfan syndrome	Aneurysm of an abdominal artery	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002808	marfan syndrome	Kyphosis	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002996	marfan syndrome	Limited elbow movement	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0003202	marfan syndrome	Skeletal muscle atrophy	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0003302	marfan syndrome	Spondylolisthesis	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0003326	marfan syndrome	Myalgia	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0004326	marfan syndrome	Cachexia	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0004382	marfan syndrome	Mitral valve calcification	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0004927	marfan syndrome	Pulmonary artery dilatation	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0004933	marfan syndrome	Ascending aortic dissection	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0005294	marfan syndrome	Arterial dissection	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0006687	marfan syndrome	Aortic tortuosity	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0007018	marfan syndrome	Attention deficit hyperactivity disorder	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0007676	marfan syndrome	Hypoplasia of the iris	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0007720	marfan syndrome	Flat cornea	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0010807	marfan syndrome	Open bite	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0012499	marfan syndrome	Descending aortic dissection	Occasional (29-5%)	FBN1	134797	154700	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000768	marfan syndrome	Pectus carinatum	Very frequent (99-80%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001065	marfan syndrome	Striae distensae	Very frequent (99-80%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001166	marfan syndrome	Arachnodactyly	Very frequent (99-80%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001519	marfan syndrome	Disproportionate tall stature	Very frequent (99-80%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001533	marfan syndrome	Slender build	Very frequent (99-80%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001763	marfan syndrome	Pes planus	Very frequent (99-80%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002108	marfan syndrome	Spontaneous pneumothorax	Very frequent (99-80%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0005111	marfan syndrome	Dilatation of the ascending aorta	Very frequent (99-80%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0012432	marfan syndrome	Chronic fatigue	Very frequent (99-80%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000275	marfan syndrome	Narrow face	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000505	marfan syndrome	Visual impairment	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000545	marfan syndrome	Myopia	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000678	marfan syndrome	Dental crowding	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000767	marfan syndrome	Pectus excavatum	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001083	marfan syndrome	Ectopia lentis	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001132	marfan syndrome	Lens subluxation	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001382	marfan syndrome	Joint hypermobility	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001634	marfan syndrome	Mitral valve prolapse	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002360	marfan syndrome	Sleep disturbance	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002650	marfan syndrome	Scoliosis	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002705	marfan syndrome	High, narrow palate	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0003179	marfan syndrome	Protrusio acetabuli	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0005059	marfan syndrome	Arthralgia/arthritis	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0007800	marfan syndrome	Increased axial globe length	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0012019	marfan syndrome	Lens luxation	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0012369	marfan syndrome	Malar anomaly	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0100775	marfan syndrome	Dural ectasia	Frequent (79-30%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000023	marfan syndrome	Inguinal hernia	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000175	marfan syndrome	Cleft palate	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000268	marfan syndrome	Dolichocephaly	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000278	marfan syndrome	Retrognathia	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000347	marfan syndrome	Micrognathia	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000494	marfan syndrome	Downslanted palpebral fissures	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000501	marfan syndrome	Glaucoma	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000541	marfan syndrome	Retinal detachment	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000938	marfan syndrome	Osteopenia	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000939	marfan syndrome	Osteoporosis	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001252	marfan syndrome	Muscular hypotonia	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001635	marfan syndrome	Congestive heart failure	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002097	marfan syndrome	Emphysema	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002105	marfan syndrome	Hemoptysis	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002435	marfan syndrome	Meningocele	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002636	marfan syndrome	Aneurysm of an abdominal artery	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002808	marfan syndrome	Kyphosis	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0002996	marfan syndrome	Limited elbow movement	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0003202	marfan syndrome	Skeletal muscle atrophy	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0003302	marfan syndrome	Spondylolisthesis	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0003326	marfan syndrome	Myalgia	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0004326	marfan syndrome	Cachexia	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0004382	marfan syndrome	Mitral valve calcification	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0004927	marfan syndrome	Pulmonary artery dilatation	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0004933	marfan syndrome	Ascending aortic dissection	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0005294	marfan syndrome	Arterial dissection	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0006687	marfan syndrome	Aortic tortuosity	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0007018	marfan syndrome	Attention deficit hyperactivity disorder	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0007676	marfan syndrome	Hypoplasia of the iris	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0007720	marfan syndrome	Flat cornea	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0010807	marfan syndrome	Open bite	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0012499	marfan syndrome	Descending aortic dissection	Occasional (29-5%)	FBN1	134797	154700	biallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
NA	atp8b1-related intrahepatic cholestasis	NA	NA	ATP8B1	602397	211600	biallelic	confirmed	loss of function	Endocrine/Metabolic;GI tract	3706	ATPase phospholipid transporting 8B1	protein-coding gene	gene with protein product	Approved	18q21.31	18q21.31	ATPIC|PFIC		FIC1|BRIC|PFIC1	ATPase, Class I, type 8B, member 1|ATPase, class I, type 8B, member 1|ATPase, aminophospholipid transporter, class I, type 8B, member 1	ATPase phospholipid transporting
NA	charcot-marie-tooth disease, type 4j	NA	NA	FIG4	609390	611228	biallelic	probable	loss of function	Skeleton;Spinal cord/Peripheral nerves;Brain/Cognition	16873	FIG4 phosphoinositide 5-phosphatase	protein-coding gene	gene with protein product	Approved	6q21	06q21	SAC3|hSac3|dJ249I4.1|ALS11|CMT4J		KIAA0274	KIAA0274|FIG4 homolog (S. cerevisiae)|FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae)	Phosphoinositide phosphatases
NA	thyroid hormone metabolism, abnormal	NA	NA	SECISBP2	607693	609698	biallelic	probable	loss of function	Endocrine	30972	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	centronuclear myopathy, autosomal, modifier of	NA	NA	MTMR14	No gene mim	160150	digenic	possible	all missense/in frame	Musculature	26190	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lysosomal alpha-mannosidosis	NA	NA	MAN2B1	609458	248500	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	6826	mannosidase alpha class 2B member 1	protein-coding gene	gene with protein product	Approved	19p13.13	19p13.13	LAMAN		MANB	mannosidase, alpha, class 2B, member 1	Mannosidases alpha class 2
NA	fanconi anemia, complementation group 0	NA	NA	RAD51C	602774	613390	biallelic	probable	all missense/in frame	Bone Marrow/Immune;Skeleton;Brain/Cognition	9820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital variant of rett syndrome	NA	NA	FOXG1	164874	613454	monoallelic	confirmed	loss of function	Brain/Cognition	3811	forkhead box G1	protein-coding gene	gene with protein product	Approved	14q12	14q12	HFK2|QIN|BF1|HFK1|HFK3|HBF-3		FKHL2|FOXG1B|FKHL4|FKH2|FKHL1|FOXG1C|FKHL3|FOXG1A	forkhead box G1B|forkhead box G1C|forkhead box G1A	Forkhead boxes
NA	autosomal recessive mental retardation	NA	NA	CCNA2	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	1578	cyclin A2	protein-coding gene	gene with protein product	Approved	4q27	04q27			CCNA|CCN1		Cyclins
NA	setleis syndrome	NA	NA	TWIST2	607556	227260	biallelic	probable	loss of function	Skin	20670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, autosomal dominant, 28	NA	NA	ADNP	No gene mim	615873	monoallelic	confirmed	loss of function	Brain/Cognition	15766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000271	infantile refsum disease	Abnormality of the face	Occasional (29-5%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000365	infantile refsum disease	Hearing impairment	Frequent (79-30%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000407	infantile refsum disease	Sensorineural hearing impairment	Frequent (79-30%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000505	infantile refsum disease	Visual impairment	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000510	infantile refsum disease	Rod-cone dystrophy	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000518	infantile refsum disease	Cataract	Occasional (29-5%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000639	infantile refsum disease	Nystagmus	Frequent (79-30%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000648	infantile refsum disease	Optic atrophy	Occasional (29-5%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000662	infantile refsum disease	Nyctalopia	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000708	infantile refsum disease	Behavioral abnormality	Frequent (79-30%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001250	infantile refsum disease	Seizures	Occasional (29-5%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001251	infantile refsum disease	Ataxia	Frequent (79-30%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001252	infantile refsum disease	Muscular hypotonia	Frequent (79-30%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001257	infantile refsum disease	Spasticity	Frequent (79-30%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001263	infantile refsum disease	Global developmental delay	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001508	infantile refsum disease	Failure to thrive	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0001638	infantile refsum disease	Cardiomyopathy	Occasional (29-5%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0002240	infantile refsum disease	Hepatomegaly	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0003323	infantile refsum disease	Progressive muscle weakness	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0004322	infantile refsum disease	Short stature	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0005930	infantile refsum disease	Abnormality of epiphysis morphology	Occasional (29-5%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0007981	infantile refsum disease	Concentric narrowing of visual fields	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0008064	infantile refsum disease	Ichthyosis	Occasional (29-5%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0008167	infantile refsum disease	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0010571	infantile refsum disease	Elevated levels of phytanic acid	Very frequent (99-80%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0010628	infantile refsum disease	Facial palsy	Occasional (29-5%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0011675	infantile refsum disease	Arrhythmia	Occasional (29-5%)	PEX2	170993	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000486	leigh syndrome	Strabismus	Very frequent (99-80%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leigh syndrome	Nystagmus	Very frequent (99-80%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	leigh syndrome	Optic atrophy	Frequent (79-30%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leigh syndrome	Seizures	Frequent (79-30%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	leigh syndrome	Ataxia	Very frequent (99-80%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leigh syndrome	Muscular hypotonia	Very frequent (99-80%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	leigh syndrome	Respiratory insufficiency	Very frequent (99-80%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leigh syndrome	Hemiplegia/hemiparesis	Frequent (79-30%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007020	leigh syndrome	Progressive spastic paraplegia	Frequent (79-30%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007650	leigh syndrome	Progressive ophthalmoplegia	Frequent (79-30%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008972	leigh syndrome	Decreased activity of mitochondrial respiratory chain	Very frequent (99-80%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	leigh syndrome	Abnormality of movement	Very frequent (99-80%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	leigh syndrome	Cognitive impairment	Very frequent (99-80%)	NDUFAF2	609653	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	chromosome xq28 duplication syndrome	NA	NA	MECP2	300005	300815	hemizygous	confirmed	increased gene dosage	Brain/Cognition;GI tract	6990	methyl-CpG binding protein 2	protein-coding gene	gene with protein product	Approved	Xq28	Xq28			RTT|MRX16|MRX79	mental retardation, X-linked 16|mental retardation, X-linked 79|Rett syndrome|methyl CpG binding protein 2 (Rett syndrome)|methyl CpG binding protein 2	X-linked mental retardation|Methyl-CpG binding domain containing
NA	cone-rod dystrophy 13	NA	NA	RPGRIP1	605446	608194	biallelic	confirmed	all missense/in frame	Eye	13436	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	agenesis of the corpus callosum with mental retardation-ocular coloboma-micrognathia	NA	NA	IGBP1	No gene mim	300472	hemizygous	possible	uncertain	Face;Brain/Cognition;Eye	5461	immunoglobulin binding protein 1	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1		alpha 4	IBP1	immunoglobulin (CD79A) binding protein 1	Protein phosphatase 2 modulatory subunits
NA	gtp cyclohydrolase 1 deficiency	NA	NA	GCH1	600225	233910	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition	4193	GTP cyclohydrolase 1	protein-coding gene	gene with protein product	Approved	14q22.2	14q22.2	GTPCH1|DYT5a	dopa-responsive dystonia	GCH|DYT5|DYT14	dystonia 14	
HP:0000926	spondylometaphyseal dysplasia, kozlowski type	Platyspondyly	Very frequent (99-80%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	spondylometaphyseal dysplasia, kozlowski type	Gait disturbance	Very frequent (99-80%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002657	spondylometaphyseal dysplasia, kozlowski type	Spondylometaphyseal dysplasia	Very frequent (99-80%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002812	spondylometaphyseal dysplasia, kozlowski type	Coxa vara	Very frequent (99-80%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003015	spondylometaphyseal dysplasia, kozlowski type	Flared metaphysis	Very frequent (99-80%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	spondylometaphyseal dysplasia, kozlowski type	Short stature	Very frequent (99-80%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010306	spondylometaphyseal dysplasia, kozlowski type	Short thorax	Very frequent (99-80%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	spondylometaphyseal dysplasia, kozlowski type	High forehead	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	spondylometaphyseal dysplasia, kozlowski type	Short neck	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	spondylometaphyseal dysplasia, kozlowski type	Pectus carinatum	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	spondylometaphyseal dysplasia, kozlowski type	Brachydactyly syndrome	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001376	spondylometaphyseal dysplasia, kozlowski type	Limitation of joint mobility	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	spondylometaphyseal dysplasia, kozlowski type	Scoliosis	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	spondylometaphyseal dysplasia, kozlowski type	Delayed skeletal maturation	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	spondylometaphyseal dysplasia, kozlowski type	Kyphosis	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	spondylometaphyseal dysplasia, kozlowski type	Genu valgum	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003037	spondylometaphyseal dysplasia, kozlowski type	Enlarged joints	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	spondylometaphyseal dysplasia, kozlowski type	Depressed nasal bridge	Frequent (79-30%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	spondylometaphyseal dysplasia, kozlowski type	Narrow chest	Occasional (29-5%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003311	spondylometaphyseal dysplasia, kozlowski type	Hypoplasia of the odontoid process	Occasional (29-5%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	spondylometaphyseal dysplasia, kozlowski type	Abnormality of epiphysis morphology	Occasional (29-5%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006660	spondylometaphyseal dysplasia, kozlowski type	Aplastic clavicles	Occasional (29-5%)	TRPV4	605427	184252	monoallelic	confirmed	activating	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	lig4 syndrome	Cryptorchidism	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000233	lig4 syndrome	Thin vermilion border	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000248	lig4 syndrome	Brachycephaly	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000252	lig4 syndrome	Microcephaly	Very frequent (99-80%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000286	lig4 syndrome	Epicanthus	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000294	lig4 syndrome	Low anterior hairline	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000320	lig4 syndrome	Bird-like facies	Very frequent (99-80%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000347	lig4 syndrome	Micrognathia	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000431	lig4 syndrome	Wide nasal bridge	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000506	lig4 syndrome	Telecanthus	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000582	lig4 syndrome	Upslanted palpebral fissure	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000821	lig4 syndrome	Hypothyroidism	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000924	lig4 syndrome	Abnormality of the skeletal system	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000992	lig4 syndrome	Cutaneous photosensitivity	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0001249	lig4 syndrome	Intellectual disability	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0001263	lig4 syndrome	Global developmental delay	Very frequent (99-80%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0001510	lig4 syndrome	Growth delay	Very frequent (99-80%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0001876	lig4 syndrome	Pancytopenia	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0001974	lig4 syndrome	Leukocytosis	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0002024	lig4 syndrome	Malabsorption	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0002240	lig4 syndrome	Hepatomegaly	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0002488	lig4 syndrome	Acute leukemia	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0002665	lig4 syndrome	Lymphoma	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0002716	lig4 syndrome	Lymphadenopathy	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0002721	lig4 syndrome	Immunodeficiency	Very frequent (99-80%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0003220	lig4 syndrome	Abnormality of chromosome stability	Very frequent (99-80%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0003683	lig4 syndrome	Large beaked nose	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0004209	lig4 syndrome	Clinodactyly of the 5th finger	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0004422	lig4 syndrome	Biparietal narrowing	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0004430	lig4 syndrome	Severe combined immunodeficiency	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0005561	lig4 syndrome	Abnormality of bone marrow cell morphology	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0005978	lig4 syndrome	Type II diabetes mellitus	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0008736	lig4 syndrome	Hypoplasia of penis	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0010783	lig4 syndrome	Erythema	Frequent (79-30%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0100585	lig4 syndrome	Telangiectasia of the skin	Occasional (29-5%)	LIG4	601837	606593	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
NA	epstein syndrome	NA	NA	MYH9	No gene mim	153650	monoallelic	confirmed	uncertain	Bone Marrow/Immune	7579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial complex iv deficiency	NA	NA	COA5	No gene mim	220110	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	33848	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fechtner syndrome	NA	NA	MYH9	No gene mim	153640	monoallelic	confirmed	uncertain	Bone Marrow/Immune	7579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fibrosis of extraocular muscles, congenital, 5	NA	NA	COL25A1	No gene mim	616219	biallelic	probable	loss of function	Spinal cord/Peripheral nerves;Eye	18603	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	treacher collins syndrome type 3	NA	NA	POLR1C	610060	248390	biallelic	confirmed	loss of function	Face;Ear	20194	RNA polymerase I subunit C	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	RPA40|RPA39|RPA5|RPAC1			polymerase (RNA) I polypeptide C, 30kDa	RNA polymerase subunits
NA	temple barraister syndrome	NA	NA	KCNH1	No gene mim	611816	monoallelic	probable	activating	Skeleton;Brain/Cognition	6250	potassium voltage-gated channel subfamily H member 1	protein-coding gene	gene with protein product	Approved	1q32.2	01q32.2	Kv10.1|eag|h-eag|eag1			potassium voltage-gated channel, subfamily H (eag-related), member 1	Potassium voltage-gated channels
NA	albright hereditary osteodystrophy	NA	NA	GNAS	139320	103580	monoallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
NA	mental retardation, autosomal dominant 12	NA	NA	ARID1B	614556	614562	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	18040	AT-rich interaction domain 1B	protein-coding gene	gene with protein product	Approved	6q25.3	06q25.3	KIAA1235|ELD/OSA1|p250R|BAF250b|DAN15|6A3-5			AT rich interactive domain 1B (SWI1-like)	AT-rich interaction domain containing
NA	aicardi-goutieres syndrome 7	NA	NA	IFIH1	No gene mim	615846	monoallelic	confirmed	all missense/in frame	Bone Marrow/Immune;Teeth & Dentitian;Skin;Skeleton;Brain/Cognition;Eye	18873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	holoprosencephaly	Cryptorchidism	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000079	holoprosencephaly	Abnormality of the urinary system	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000093	holoprosencephaly	Proteinuria	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000161	holoprosencephaly	Median cleft lip	Very frequent (99-80%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	holoprosencephaly	Hydrocephalus	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	holoprosencephaly	Microcephaly	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	holoprosencephaly	Macrocephaly	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	holoprosencephaly	Epicanthus	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000289	holoprosencephaly	Broad philtrum	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	holoprosencephaly	Hypertelorism	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	holoprosencephaly	Macrotia	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000437	holoprosencephaly	Depressed nasal tip	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000453	holoprosencephaly	Choanal atresia	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	holoprosencephaly	Depressed nasal ridge	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000458	holoprosencephaly	Anosmia	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	holoprosencephaly	Anteverted nares	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	holoprosencephaly	Short neck	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000488	holoprosencephaly	Retinopathy	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	holoprosencephaly	Deeply set eye	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	holoprosencephaly	Ptosis	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000528	holoprosencephaly	Anophthalmia	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000567	holoprosencephaly	Chorioretinal coloboma	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	holoprosencephaly	Microphthalmia	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000574	holoprosencephaly	Thick eyebrow	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000581	holoprosencephaly	Blepharophimosis	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000582	holoprosencephaly	Upslanted palpebral fissure	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000601	holoprosencephaly	Hypotelorism	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	holoprosencephaly	Iris coloboma	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	holoprosencephaly	Optic atrophy	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000664	holoprosencephaly	Synophrys	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000776	holoprosencephaly	Congenital diaphragmatic hernia	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000819	holoprosencephaly	Diabetes mellitus	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000830	holoprosencephaly	Anterior hypopituitarism	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000871	holoprosencephaly	Panhypopituitarism	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000873	holoprosencephaly	Diabetes insipidus	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000929	holoprosencephaly	Abnormality of the skull	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	holoprosencephaly	Brachydactyly syndrome	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	holoprosencephaly	Hand polydactyly	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	holoprosencephaly	Seizures	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	holoprosencephaly	Muscular hypotonia	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	holoprosencephaly	Spasticity	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	holoprosencephaly	Global developmental delay	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001305	holoprosencephaly	Dandy-Walker malformation	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	holoprosencephaly	Muscle weakness	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001332	holoprosencephaly	Dystonia	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001360	holoprosencephaly	Holoprosencephaly	Very frequent (99-80%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001531	holoprosencephaly	Failure to thrive in infancy	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001539	holoprosencephaly	Omphalocele	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	holoprosencephaly	Ventricular septal defect	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	holoprosencephaly	Tetralogy of Fallot	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001641	holoprosencephaly	Abnormality of the pulmonary valve	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001679	holoprosencephaly	Abnormality of the aorta	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001743	holoprosencephaly	Abnormality of the spleen	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001883	holoprosencephaly	Talipes	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	holoprosencephaly	Hypoglycemia	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001999	holoprosencephaly	Abnormal facial shape	Very frequent (99-80%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002002	holoprosencephaly	Deep philtrum	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	holoprosencephaly	Frontal bossing	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	holoprosencephaly	Constipation	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	holoprosencephaly	Gastroesophageal reflux	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002072	holoprosencephaly	Chorea	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002084	holoprosencephaly	Encephalocele	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	holoprosencephaly	Respiratory insufficiency	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	holoprosencephaly	Abnormality of neuronal migration	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002553	holoprosencephaly	Highly arched eyebrow	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	holoprosencephaly	Scoliosis	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002902	holoprosencephaly	Hyponatremia	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	holoprosencephaly	Abnormal form of the vertebral bodies	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004409	holoprosencephaly	Hyposmia	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005469	holoprosencephaly	Flat occiput	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	holoprosencephaly	Joint hyperflexibility	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006315	holoprosencephaly	Single median maxillary incisor	Very frequent (99-80%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006703	holoprosencephaly	Aplasia/Hypoplasia of the lungs	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	holoprosencephaly	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	holoprosencephaly	Aplasia/Hypoplasia of the corpus callosum	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008501	holoprosencephaly	Median cleft lip and palate	Very frequent (99-80%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008572	holoprosencephaly	External ear malformation	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	holoprosencephaly	Hypoplasia of penis	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	holoprosencephaly	Feeding difficulties in infancy	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009738	holoprosencephaly	Abnormality of the antihelix	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009794	holoprosencephaly	Branchial anomaly	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	holoprosencephaly	Reduced number of teeth	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009914	holoprosencephaly	Cyclopia	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009924	holoprosencephaly	Aplasia/Hypoplasia involving the nose	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010301	holoprosencephaly	Spinal dysraphism	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010302	holoprosencephaly	Spinal cord tumor	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010669	holoprosencephaly	Cheekbone underdevelopment	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011100	holoprosencephaly	Intestinal atresia	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	holoprosencephaly	Arrhythmia	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012639	holoprosencephaly	Abnormality of nervous system morphology	Very frequent (99-80%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100336	holoprosencephaly	Bilateral cleft lip	Very frequent (99-80%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	holoprosencephaly	Cognitive impairment	Frequent (79-30%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100596	holoprosencephaly	Absent nares	Occasional (29-5%)	SIX3	603714	609637	monoallelic	confirmed	loss of function	Brain/Cognition	10889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nocturnal frontal lobe epilepsy type 1	NA	NA	CHRNA4	No gene mim	600513	monoallelic	confirmed	activating	Brain/Cognition	1958	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy early infantile type 9	NA	NA	PCDH19	300460	300088	x-linked over-dominance	confirmed	loss of function	Brain/Cognition	14270	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	small patella syndrome	NA	NA	TBX4	601719	147891	monoallelic	confirmed	loss of function	Skeleton	11603	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	craniosynostosis, type 2	NA	NA	MSX2	123101	604757	monoallelic	confirmed	all missense/in frame	Skeleton	7392	msh homeobox 2	protein-coding gene	gene with protein product	Approved	5q35.2	05q35.2	CRS2|FPP|HOX8|MSH|PFM	craniosynostosis, type 2	PFM1	msh (Drosophila) homeo box homolog 2|parietal foramina 1|msh homeobox homolog 2 (Drosophila)	NKL subclass homeoboxes and pseudogenes
NA	primary congenital glaucoma type 3d	NA	NA	LTBP2	602091	613086	biallelic	confirmed	loss of function	Eye	6715	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bardet-biedl syndrome type 13	NA	NA	MKS1	609883	209900	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye	7121	Meckel syndrome, type 1	protein-coding gene	gene with protein product	Approved	17q22	17q22	FLJ20345|POC12|BBS13	POC12 centriolar protein homolog (Chlamydomonas)	MKS		Bardet-Biedl syndrome associated|B9 domain containing|MKS complex
NA	spastic paraplegia x-linked type 2	NA	NA	PLP1	300401	312920	hemizygous	confirmed	uncertain	Brain/Cognition	9086	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mucolipidosis type iii complementation group a	NA	NA	GNPTAB	607840	252600	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	29670	N-acetylglucosamine-1-phosphate transferase alpha and beta subunits	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	KIAA1208|MGC4170		GNPTA	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits	EF-hand domain containing
NA	gm2-gangliosidosis type 1	NA	NA	HEXA	606869	272800	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4878	hexosaminidase subunit alpha	protein-coding gene	gene with protein product	Approved	15q23	15q23		Tay Sachs disease|GM2 gangliosidosis|beta-hexosaminidase subunit alpha		hexosaminidase A (alpha polypeptide)	
NA	distal renal tubular acidosis with deafness	NA	NA	ATP6V1B1	192132	267300	biallelic	confirmed	loss of function	Kidney Renal Tract;Ear	853	ATPase H+ transporting V1 subunit B1	protein-coding gene	gene with protein product	Approved	2p13.3	02p13.3	VATB|RTA1B|Vma2	Renal tubular acidosis with deafness	VPP3|ATP6B1	vacuolar proton pump 3|ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	V-type ATPases
NA	primary ciliary dyskinesia with central-complex and radial-spoke defects	NA	NA	RSPH1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Respiratory tract	12371	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	myhre syndrome	Narrow mouth	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000233	myhre syndrome	Thin vermilion border	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	myhre syndrome	Mandibular prognathia	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	myhre syndrome	Hypoplasia of the maxilla	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	myhre syndrome	Hearing impairment	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	myhre syndrome	Abnormality of the ribs	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000926	myhre syndrome	Platyspondyly	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	myhre syndrome	Brachydactyly syndrome	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	myhre syndrome	Intellectual disability	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	myhre syndrome	Global developmental delay	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	myhre syndrome	Specific learning disability	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	myhre syndrome	Joint stiffness	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	myhre syndrome	Intrauterine growth retardation	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003172	myhre syndrome	Abnormality of the pubic bone	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003510	myhre syndrome	Severe short stature	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003712	myhre syndrome	Skeletal muscle hypertrophy	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004279	myhre syndrome	Short palm	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004493	myhre syndrome	Craniofacial hyperostosis	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008818	myhre syndrome	Large iliac wings	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	myhre syndrome	Midface retrusion	Very frequent (99-80%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	myhre syndrome	Cryptorchidism	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000159	myhre syndrome	Abnormality of the lip	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	myhre syndrome	Ptosis	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000581	myhre syndrome	Blepharophimosis	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000822	myhre syndrome	Hypertension	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	myhre syndrome	Abnormality of the metaphyses	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001072	myhre syndrome	Thickened skin	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001671	myhre syndrome	Abnormality of the cardiac septa	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003457	myhre syndrome	EMG abnormality	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	myhre syndrome	Abnormality of epiphysis morphology	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008499	myhre syndrome	High-grade hypermetropia	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012745	myhre syndrome	Short palpebral fissure	Frequent (79-30%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	myhre syndrome	Inguinal hernia	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000036	myhre syndrome	Abnormality of the penis	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000039	myhre syndrome	Epispadias	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	myhre syndrome	Hypospadias	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	myhre syndrome	Hypogonadism	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	myhre syndrome	Cleft palate	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000176	myhre syndrome	Submucous cleft hard palate	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000193	myhre syndrome	Bifid uvula	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	myhre syndrome	Cataract	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	myhre syndrome	Behavioral abnormality	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000826	myhre syndrome	Precocious puberty	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003241	myhre syndrome	External genital hypoplasia	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030690	myhre syndrome	Gingival cleft	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100333	myhre syndrome	Unilateral cleft lip	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100541	myhre syndrome	Femoral hernia	Occasional (29-5%)	SMAD4	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000202	joubert syndrome	Oral cleft	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	joubert syndrome	Hydrocephalus	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	joubert syndrome	Long face	Frequent (79-30%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	joubert syndrome	Low-set ears	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	joubert syndrome	Prominent nasal bridge	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	joubert syndrome	Anteverted nares	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	joubert syndrome	Strabismus	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	joubert syndrome	Ptosis	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	joubert syndrome	Iris coloboma	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	joubert syndrome	Nystagmus	Frequent (79-30%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000657	joubert syndrome	Oculomotor apraxia	Very frequent (99-80%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000864	joubert syndrome	Abnormality of the hypothalamus-pituitary axis	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	joubert syndrome	Hand polydactyly	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	joubert syndrome	Intellectual disability	Very frequent (99-80%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	joubert syndrome	Seizures	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	joubert syndrome	Ataxia	Very frequent (99-80%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	joubert syndrome	Muscular hypotonia	Very frequent (99-80%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	joubert syndrome	Global developmental delay	Very frequent (99-80%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	joubert syndrome	Gait disturbance	Frequent (79-30%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001320	joubert syndrome	Cerebellar vermis hypoplasia	Very frequent (99-80%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001337	joubert syndrome	Tremor	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001696	joubert syndrome	Situs inversus totalis	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001829	joubert syndrome	Foot polydactyly	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002084	joubert syndrome	Encephalocele	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002104	joubert syndrome	Apnea	Very frequent (99-80%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002126	joubert syndrome	Polymicrogyria	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002251	joubert syndrome	Aganglionic megacolon	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	joubert syndrome	Abnormality of neuronal migration	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002553	joubert syndrome	Highly arched eyebrow	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	joubert syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	joubert syndrome	Scoliosis	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002793	joubert syndrome	Abnormal pattern of respiration	Very frequent (99-80%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002876	joubert syndrome	Episodic tachypnea	Very frequent (99-80%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	joubert syndrome	Abnormal form of the vertebral bodies	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004422	joubert syndrome	Biparietal narrowing	Frequent (79-30%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	joubert syndrome	Aplasia/Hypoplasia of the corpus callosum	Occasional (29-5%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	joubert syndrome	Feeding difficulties in infancy	Frequent (79-30%)	C5orf42	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	25801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	frontonasal dysplasia 2	NA	NA	ALX4	605420	605420	biallelic	confirmed	loss of function	Face;Skeleton	450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fatal infantile cardioencephalomyopathy due to cytochrome c oxidase deficiency	NA	NA	SCO2	604272	604377	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy congenital with mental retardation type b6	NA	NA	LARGE1	No gene mim	608840	biallelic	confirmed	loss of function	Musculature;Brain/Cognition	6511	LARGE xylosyl- and glucuronyltransferase 1	protein-coding gene	gene with protein product	Approved	22q12.3	22q12.3	KIAA0609	like-acetylglucosaminyltransferase	LARGE	like-glycosyltransferase	Glycosyltransferase family 8
NA	cataract, deafness, intellectual disability, seizures, and a down syndrome-like facies	NA	NA	MAF	177075	No disease mim	monoallelic	confirmed	all missense/in frame	Face;Brain/Cognition;Eye	6776	MAF bZIP transcription factor	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2	c-MAF			v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog	Basic leucine zipper proteins
NA	ciliary dyskinesia, primary, 29	NA	NA	CCNO	No gene mim	615872	biallelic	confirmed	loss of function	Respiratory tract	18576	cyclin O	protein-coding gene	gene with protein product	Approved	5q11.2	05q11.2	UDG2|FLJ22422|UNG2		CCNU	cyclin U	Cyclins
NA	xeroderma pigmentosum complementation group d	NA	NA	ERCC2	126340	278730	biallelic	confirmed	loss of function	Skin;Skeleton;Spinal cord/Peripheral nerves;Brain/Cognition	3434	ERCC excision repair 2, TFIIH core complex helicase subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	MAG|EM9|MGC102762|MGC126218|MGC126219|TFIIH	excision repair cross-complementing rodent repair deficiency, complementation group 2 protein|TFIIH basal transcription factor complex helicase XPB subunit	XPD	xeroderma pigmentosum complementary group D|excision repair cross-complementing rodent repair deficiency, complementation group 2|excision repair cross-complementation group 2	General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated
HP:0000028	fetal akinesia deformation sequence	Cryptorchidism	Frequent (79-30%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	fetal akinesia deformation sequence	Cleft palate	Frequent (79-30%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	fetal akinesia deformation sequence	Hypertelorism	Frequent (79-30%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	fetal akinesia deformation sequence	Micrognathia	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000358	fetal akinesia deformation sequence	Posteriorly rotated ears	Frequent (79-30%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000476	fetal akinesia deformation sequence	Cystic hygroma	Frequent (79-30%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001059	fetal akinesia deformation sequence	Pterygium	Occasional (29-5%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001262	fetal akinesia deformation sequence	Excessive daytime somnolence	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001305	fetal akinesia deformation sequence	Dandy-Walker malformation	Occasional (29-5%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	fetal akinesia deformation sequence	Intrauterine growth retardation	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	fetal akinesia deformation sequence	Polyhydramnios	Frequent (79-30%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001989	fetal akinesia deformation sequence	Fetal akinesia sequence	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002089	fetal akinesia deformation sequence	Pulmonary hypoplasia	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	fetal akinesia deformation sequence	Respiratory insufficiency	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002304	fetal akinesia deformation sequence	Akinesia	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002375	fetal akinesia deformation sequence	Hypokinesia	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	fetal akinesia deformation sequence	Scoliosis	Frequent (79-30%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002804	fetal akinesia deformation sequence	Arthrogryposis multiplex congenita	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002828	fetal akinesia deformation sequence	Multiple joint contractures	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003700	fetal akinesia deformation sequence	Generalized amyotrophy	Frequent (79-30%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005245	fetal akinesia deformation sequence	Intestinal hypoplasia	Occasional (29-5%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	fetal akinesia deformation sequence	Depressed nasal bridge	Frequent (79-30%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010489	fetal akinesia deformation sequence	Absent palmar crease	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	fetal akinesia deformation sequence	Camptodactyly of finger	Very frequent (99-80%)	RAPSN	No gene mim	208150	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition	9863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe hypotonia, speech impairment, and cognitive delay	NA	NA	NALCN	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	19082	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bardet-biedl syndrome type 15	NA	NA	WDPCP	613580	209900	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye	28027	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	frontonasal dysplasia type 1	NA	NA	ALX3	606014	136760	biallelic	confirmed	loss of function	Face	449	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cacnb4-related juvenile myoclonic epilepsy	NA	NA	CACNB4	No gene mim	311100		possible		Brain/Cognition	1404	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	manitoba oculotrichoanal syndrome	NA	NA	FREM1	608944	248450	biallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;GI tract	23399	FRAS1 related extracellular matrix 1	protein-coding gene	gene with protein product	Approved	9p22.3	09p22.3	FLJ25461|C9orf145|C9orf143|DKFZp686M16108|TILRR		C9orf154	chromosome 9 open reading frame 154	C-type lectin domain containing
NA	filippi syndrome. syndactyly, type i, with microcephaly and mental retardation	NA	NA	CKAP2L	No gene mim	272440	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	26877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	alternating hemiplegia of childhood	NA	NA	ATP1A3	No gene mim	104290	monoallelic	both DD and IF	all missense/in frame	Brain/Cognition	801	ATPase Na+/K+ transporting subunit alpha 3	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2		sodium/potassium-transporting ATPase subunit alpha-3|sodium pump subunit alpha-3|sodium-potassium ATPase catalytic subunit alpha-3	DYT12	dystonia 12|ATPase, Na+/K+ transporting, alpha 3 polypeptide	ATPase Na+/K+ transporting subunits
NA	peroxisome biogenesis disorder complementation group k	NA	NA	PEX14	601791	601791	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	8856	peroxisomal biogenesis factor 14	protein-coding gene	gene with protein product	Approved	1p36.22	01p36.22					Peroxins
NA	waardenburg syndrome type 2a	NA	NA	MITF	156845	193510	monoallelic	confirmed	loss of function	Skin;Ear	7105	melanogenesis associated transcription factor	protein-coding gene	gene with protein product	Approved	3p13	03p13	MI|bHLHe32	homolog of mouse microphthalmia	WS2A|WS2	Waardenburg syndrome, type 2A|microphthalmia-associated transcription factor	Basic helix-loop-helix proteins
HP:0000023	angelman syndrome	Inguinal hernia	Occasional (29-5%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	angelman syndrome	Wide mouth	Frequent (79-30%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000158	angelman syndrome	Macroglossia	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	angelman syndrome	Brachycephaly	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	angelman syndrome	Microcephaly	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000271	angelman syndrome	Abnormality of the face	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	angelman syndrome	Mandibular prognathia	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	angelman syndrome	Hypoplasia of the maxilla	Frequent (79-30%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	angelman syndrome	Strabismus	Occasional (29-5%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000635	angelman syndrome	Blue irides	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000687	angelman syndrome	Widely spaced teeth	Frequent (79-30%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	angelman syndrome	Behavioral abnormality	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	angelman syndrome	Seizures	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	angelman syndrome	Ataxia	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	angelman syndrome	Muscular hypotonia	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001344	angelman syndrome	Absent speech	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001347	angelman syndrome	Hyperreflexia	Frequent (79-30%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002120	angelman syndrome	Cerebral cortical atrophy	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	angelman syndrome	Neurological speech impairment	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	angelman syndrome	EEG abnormality	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006887	angelman syndrome	Intellectual disability, progressive	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010864	angelman syndrome	Intellectual disability, severe	Very frequent (99-80%)	UBE3A	601623	105830	imprinted	confirmed	loss of function	Face;Brain/Cognition	12496	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	NA	NA	POLR3B	614366	607694	biallelic	confirmed	loss of function	Teeth & Dentitian;Endocrine/Metabolic;Brain/Cognition	30348	RNA polymerase III subunit B	protein-coding gene	gene with protein product	Approved	12q23.3	12q23.3	RPC2|FLJ10388			polymerase (RNA) III (DNA directed) polypeptide B	RNA polymerase subunits
HP:0000154	craniolenticulosutural dysplasia	Wide mouth	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	craniolenticulosutural dysplasia	High palate	Occasional (29-5%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000233	craniolenticulosutural dysplasia	Thin vermilion border	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000239	craniolenticulosutural dysplasia	Large fontanelles	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	craniolenticulosutural dysplasia	Hypertelorism	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000319	craniolenticulosutural dysplasia	Smooth philtrum	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	craniolenticulosutural dysplasia	Hypoplasia of the maxilla	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000336	craniolenticulosutural dysplasia	Prominent supraorbital ridges	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	craniolenticulosutural dysplasia	Long philtrum	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	craniolenticulosutural dysplasia	Prominent nasal bridge	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000445	craniolenticulosutural dysplasia	Wide nose	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	craniolenticulosutural dysplasia	Carious teeth	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	craniolenticulosutural dysplasia	Delayed eruption of teeth	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000685	craniolenticulosutural dysplasia	Hypoplasia of teeth	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000691	craniolenticulosutural dysplasia	Microdontia	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000750	craniolenticulosutural dysplasia	Delayed speech and language development	Occasional (29-5%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	craniolenticulosutural dysplasia	Narrow chest	Frequent (79-30%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000953	craniolenticulosutural dysplasia	Hyperpigmentation of the skin	Frequent (79-30%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001000	craniolenticulosutural dysplasia	Abnormality of skin pigmentation	Frequent (79-30%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	craniolenticulosutural dysplasia	Pes planus	Frequent (79-30%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	craniolenticulosutural dysplasia	Frontal bossing	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002208	craniolenticulosutural dysplasia	Coarse hair	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002299	craniolenticulosutural dysplasia	Brittle hair	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	craniolenticulosutural dysplasia	Scoliosis	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	craniolenticulosutural dysplasia	Skeletal dysplasia	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	craniolenticulosutural dysplasia	Short stature	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004331	craniolenticulosutural dysplasia	Decreased skull ossification	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005306	craniolenticulosutural dysplasia	Capillary hemangiomas	Frequent (79-30%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	craniolenticulosutural dysplasia	Joint hyperflexibility	Occasional (29-5%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006480	craniolenticulosutural dysplasia	Premature loss of teeth	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008031	craniolenticulosutural dysplasia	Posterior Y-sutural cataract	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008070	craniolenticulosutural dysplasia	Sparse hair	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008444	craniolenticulosutural dysplasia	Posterior wedging of vertebral bodies	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008808	craniolenticulosutural dysplasia	High iliac wings	Very frequent (99-80%)	SEC23A	No gene mim	607812	biallelic	possible	all missense/in frame	Skeleton;Eye	10701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	wnt5a-related robinow syndrome, autosomal dominant	NA	NA	WNT5A	164975	180700	monoallelic	confirmed	all missense/in frame	Face;Skeleton	12784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	x-linked hypospadias type 2	NA	NA	MAMLD1	300120	300758	hemizygous	probable	loss of function	Genitalia	2568	mastermind like domain containing 1	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	CG1|F18		CXorf6	chromosome X open reading frame 6	
NA	watson syndrome	NA	NA	NF1	613113	193520	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type a2	NA	NA	POMT2	607439	613150	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	19743	protein O-mannosyltransferase 2	protein-coding gene	gene with protein product	Approved	14q24.3	14q24.3	LGMD2N	Dolichyl-phosphate-mannose--protein mannosyltransferase			Dolichyl D-mannosyl phosphate dependent mannosyltransferases
NA	congenital disorder of glycosylation, type iw	NA	NA	STT3A	No gene mim	615596	biallelic	possible	all missense/in frame	Brain/Cognition	6172	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	blepharophimosis-mental retardation	NA	NA	UBE3B	608047	615057	biallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition;GI tract	13478	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000158	lhermitte-duclos disease	Macroglossia	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	lhermitte-duclos disease	Hydrocephalus	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	lhermitte-duclos disease	Macrocephaly	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	lhermitte-duclos disease	Hand polydactyly	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	lhermitte-duclos disease	Seizures	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	lhermitte-duclos disease	Ataxia	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002017	lhermitte-duclos disease	Nausea and vomiting	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002126	lhermitte-duclos disease	Polymicrogyria	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002315	lhermitte-duclos disease	Headache	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002516	lhermitte-duclos disease	Increased intracranial pressure	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006824	lhermitte-duclos disease	Cranial nerve paralysis	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012081	lhermitte-duclos disease	Enlarged cerebellum	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200034	lhermitte-duclos disease	Papule	Very frequent (99-80%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010619	lhermitte-duclos disease	Fibroma of the breast	Frequent (79-30%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012844	lhermitte-duclos disease	Trichilemmoma	Frequent (79-30%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100031	lhermitte-duclos disease	Neoplasm of the thyroid gland	Frequent (79-30%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100615	lhermitte-duclos disease	Ovarian neoplasm	Frequent (79-30%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200016	lhermitte-duclos disease	Acrokeratosis	Frequent (79-30%)	PTEN	601728	158350	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe combined immune deficiency, autosomal recessive, t cell-negative, b cell -positive, nk cell-negative, jak3-related	NA	NA	JAK3	600173	600802	biallelic	confirmed	loss of function	Bone Marrow/Immune	6193	Janus kinase 3	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11	L-JAK|JAKL|LJAK|JAK3_HUMAN|JAK-3	tyrosine-protein kinase JAK3|leukocyte Janus kinase			Jak family tyrosine kinases
NA	cerebral palsy spastic quadriplegic type 6	NA	NA	AP4S1	No gene mim	614067	biallelic	probable	loss of function	Brain/Cognition	575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	leigh syndrome	Strabismus	Very frequent (99-80%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leigh syndrome	Nystagmus	Very frequent (99-80%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	leigh syndrome	Optic atrophy	Frequent (79-30%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leigh syndrome	Seizures	Frequent (79-30%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	leigh syndrome	Ataxia	Very frequent (99-80%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leigh syndrome	Muscular hypotonia	Very frequent (99-80%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	leigh syndrome	Respiratory insufficiency	Very frequent (99-80%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leigh syndrome	Hemiplegia/hemiparesis	Frequent (79-30%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007020	leigh syndrome	Progressive spastic paraplegia	Frequent (79-30%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007650	leigh syndrome	Progressive ophthalmoplegia	Frequent (79-30%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008972	leigh syndrome	Decreased activity of mitochondrial respiratory chain	Very frequent (99-80%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	leigh syndrome	Abnormality of movement	Very frequent (99-80%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	leigh syndrome	Cognitive impairment	Very frequent (99-80%)	COX10	602125	256000	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peroxisome biogenesis disorder complementation group 5	NA	NA	PEX2	170993	170993	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9717	peroxisomal biogenesis factor 2	protein-coding gene	gene with protein product	Approved	8q21.13	08q21.13	PMP35|PAF-1|RNF72|ZWS3	Zellweger syndrome|peroxin 2	PXMP3	peroxisomal membrane protein 3 (35kD, Zellweger syndrome)|peroxisomal membrane protein 3, 35kDa	Ring finger proteins|Peroxins
HP:0000252	alg3-cdg	Microcephaly	Very frequent (99-80%)	ALG3	608750	237128	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23056	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000478	alg3-cdg	Abnormality of the eye	Very frequent (99-80%)	ALG3	608750	237128	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23056	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	alg3-cdg	Abnormality of vision	Very frequent (99-80%)	ALG3	608750	237128	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23056	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	alg3-cdg	Seizures	Very frequent (99-80%)	ALG3	608750	237128	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23056	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	alg3-cdg	Muscular hypotonia	Very frequent (99-80%)	ALG3	608750	237128	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23056	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	alg3-cdg	Global developmental delay	Very frequent (99-80%)	ALG3	608750	237128	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23056	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infantile sialic acid storage disorder	NA	NA	SLC17A5	604322	269920	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	10933	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	malformations of cortical development and microcephaly.	NA	NA	KIF2A	No gene mim	No disease mim	monoallelic	probable	dominant negative	Brain/Cognition	6318	kinesin family member 2A	protein-coding gene	gene with protein product	Approved	5q12.1	05q12.1	HK2		KIF2	kinesin heavy chain member 2	Kinesins
NA	lissencephaly 4	NA	NA	NDE1	609449	614019	biallelic	confirmed	loss of function	Brain/Cognition	17619	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	chromosome 17q21.31 microdeletion syndrome	NA	NA	KANSL1	612452	610443	monoallelic	confirmed	loss of function	Brain/Cognition	24565	KAT8 regulatory NSL complex subunit 1	protein-coding gene	gene with protein product	Approved	17q21.31	17q21.31	DKFZP727C091|MSL1v1|CENP-36|NSL1	centromere protein 36	KIAA1267	KIAA1267	NSL histone acetyltransferase complex
HP:0000162	stickler syndrome type 3	Glossoptosis	Frequent (79-30%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	stickler syndrome type 3	Cleft palate	Very frequent (99-80%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	stickler syndrome type 3	Malar flattening	Very frequent (99-80%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	stickler syndrome type 3	Long philtrum	Very frequent (99-80%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	stickler syndrome type 3	Micrognathia	Frequent (79-30%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	stickler syndrome type 3	Sensorineural hearing impairment	Very frequent (99-80%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	stickler syndrome type 3	Pectus excavatum	Occasional (29-5%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	stickler syndrome type 3	Pectus carinatum	Occasional (29-5%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002758	stickler syndrome type 3	Osteoarthritis	Frequent (79-30%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002829	stickler syndrome type 3	Arthralgia	Very frequent (99-80%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005916	stickler syndrome type 3	Abnormal metacarpal morphology	Occasional (29-5%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100777	stickler syndrome type 3	Exostoses	Occasional (29-5%)	COL11A2	120290	184840	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000008	kallmann syndrome	Abnormality of female internal genitalia	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	kallmann syndrome	Cryptorchidism	Frequent (79-30%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000044	kallmann syndrome	Hypogonadotrophic hypogonadism	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000054	kallmann syndrome	Micropenis	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000104	kallmann syndrome	Renal agenesis	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000144	kallmann syndrome	Decreased fertility	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	kallmann syndrome	Cleft palate	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	kallmann syndrome	Sensorineural hearing impairment	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000458	kallmann syndrome	Anosmia	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	kallmann syndrome	Visual impairment	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	kallmann syndrome	Ptosis	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000551	kallmann syndrome	Abnormality of color vision	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	kallmann syndrome	Nystagmus	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000771	kallmann syndrome	Gynecomastia	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000786	kallmann syndrome	Primary amenorrhea	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	kallmann syndrome	Delayed puberty	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000830	kallmann syndrome	Anterior hypopituitarism	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	kallmann syndrome	Seizures	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	kallmann syndrome	Ataxia	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	kallmann syndrome	Muscular hypotonia	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001260	kallmann syndrome	Dysarthria	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	kallmann syndrome	Gait disturbance	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	kallmann syndrome	Muscle weakness	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001335	kallmann syndrome	Bimanual synkinesia	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001337	kallmann syndrome	Tremor	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001513	kallmann syndrome	Obesity	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001608	kallmann syndrome	Abnormality of the voice	Frequent (79-30%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001761	kallmann syndrome	Pes cavus	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	kallmann syndrome	Pes planus	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	kallmann syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	kallmann syndrome	Skeletal dysplasia	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	kallmann syndrome	Delayed skeletal maturation	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	kallmann syndrome	Recurrent fractures	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003164	kallmann syndrome	Hypothalamic gonadotropin-releasing hormone (GNRH) deficiency	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003187	kallmann syndrome	Breast hypoplasia	Frequent (79-30%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004349	kallmann syndrome	Reduced bone mineral density	Frequent (79-30%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004409	kallmann syndrome	Hyposmia	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008064	kallmann syndrome	Ichthyosis	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008734	kallmann syndrome	Decreased testicular size	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	kallmann syndrome	Hypoplasia of penis	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	kallmann syndrome	Reduced number of teeth	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010550	kallmann syndrome	Paraplegia	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030016	kallmann syndrome	Dyspareunia	Occasional (29-5%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100639	kallmann syndrome	Erectile abnormalities	Very frequent (99-80%)	WDR11	606417	No disease mim	monoallelic	confirmed	all missense/in frame	Endocrine;Genitalia	13831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	anophthalmia/microphthalmia	NA	NA	ALDH1A3	600463	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition;Eye	409	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dystonia 6, torsion	NA	NA	THAP1	No gene mim	602629	monoallelic	both DD and IF	loss of function	Brain/Cognition	20856	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	noonan syndrome 4	NA	NA	SOS1	182530	610733	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neutropenia, severe congenital 3, autosomal recessive	NA	NA	HAX1	605998	610738	biallelic	confirmed	loss of function	Bone Marrow/Immune	16915	HCLS1 associated protein X-1	protein-coding gene	gene with protein product	Approved	1q21.3	01q21.3	HS1BP1|HCLSBP1	HCLS1 (and PKD2) associated protein			
NA	mitochondrial complex iv deficiency	NA	NA	COX14	No gene mim	220110	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	28216	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital muscular dystrophy	NA	NA	ITGA7	600536	607855	biallelic	confirmed	loss of function	Musculature	6143	integrin subunit alpha 7	protein-coding gene	gene with protein product	Approved	12q13.2	12q13.2				integrin, alpha 7	Integrin alpha subunits
NA	mental retardation x-linked type 58	NA	NA	TSPAN7	300096	300210	hemizygous	confirmed	loss of function	Brain/Cognition	11854	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	idiopathic hypogonadotropic hypogonadism	NA	NA	CHD7	608892	146110	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary congenital glaucoma type 3a	NA	NA	MYOC	No gene mim	231300	monoallelic	possible	loss of function	Eye	7610	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	CASP2	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	1503	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehmt1-like intellectual disability	NA	NA	MBD5	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	20444	methyl-CpG binding domain protein 5	protein-coding gene	gene with protein product	Approved	2q23.2	02q23.2	FLJ11113|KIAA1461				Methyl-CpG binding domain containing|PWWP domain containing
NA	dystonia type 5	NA	NA	GCH1	600225	128230	monoallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition	4193	GTP cyclohydrolase 1	protein-coding gene	gene with protein product	Approved	14q22.2	14q22.2	GTPCH1|DYT5a	dopa-responsive dystonia	GCH|DYT5|DYT14	dystonia 14	
HP:0000365	leber congenital amaurosis	Hearing impairment	Occasional (29-5%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000512	leber congenital amaurosis	Abnormal electroretinogram	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	leber congenital amaurosis	Cataract	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000563	leber congenital amaurosis	Keratoconus	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leber congenital amaurosis	Nystagmus	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001141	leber congenital amaurosis	Severe visual impairment	Very frequent (99-80%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	leber congenital amaurosis	Intellectual disability	Occasional (29-5%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leber congenital amaurosis	Seizures	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leber congenital amaurosis	Muscular hypotonia	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	leber congenital amaurosis	Global developmental delay	Occasional (29-5%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002084	leber congenital amaurosis	Encephalocele	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	leber congenital amaurosis	Abnormality of neuronal migration	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leber congenital amaurosis	Hemiplegia/hemiparesis	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006817	leber congenital amaurosis	Aplasia/Hypoplasia of the cerebellar vermis	Frequent (79-30%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	leber congenital amaurosis	Abnormality of retinal pigmentation	Very frequent (99-80%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012795	leber congenital amaurosis	Abnormality of the optic disc	Very frequent (99-80%)	RPE65	No gene mim	608553	biallelic	confirmed	loss of function	Eye	10294	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation syndromic x-linked cabezas type	NA	NA	CUL4B	300304	300354	hemizygous	confirmed	loss of function	Brain/Cognition;Genitalia	2555	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	capillary malformation-arteriovenous malformation	NA	NA	RASA1	139150	608354	monoallelic	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	9871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	NA	NA	TMCO1	No gene mim	213980	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	18188	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	antley-bixler syndrome	Narrow mouth	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000175	antley-bixler syndrome	Cleft palate	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000248	antley-bixler syndrome	Brachycephaly	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000262	antley-bixler syndrome	Turricephaly	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000270	antley-bixler syndrome	Delayed cranial suture closure	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000316	antley-bixler syndrome	Hypertelorism	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000343	antley-bixler syndrome	Long philtrum	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000368	antley-bixler syndrome	Low-set, posteriorly rotated ears	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000453	antley-bixler syndrome	Choanal atresia	Frequent (79-30%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000463	antley-bixler syndrome	Anteverted nares	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000486	antley-bixler syndrome	Strabismus	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000494	antley-bixler syndrome	Downslanted palpebral fissures	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000520	antley-bixler syndrome	Proptosis	Frequent (79-30%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000772	antley-bixler syndrome	Abnormality of the ribs	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000774	antley-bixler syndrome	Narrow chest	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001166	antley-bixler syndrome	Arachnodactyly	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001363	antley-bixler syndrome	Craniosynostosis	Frequent (79-30%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001387	antley-bixler syndrome	Joint stiffness	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001883	antley-bixler syndrome	Talipes	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002007	antley-bixler syndrome	Frontal bossing	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002564	antley-bixler syndrome	Malformation of the heart and great vessels	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002757	antley-bixler syndrome	Recurrent fractures	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002980	antley-bixler syndrome	Femoral bowing	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003070	antley-bixler syndrome	Elbow ankylosis	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003196	antley-bixler syndrome	Short nose	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003275	antley-bixler syndrome	Narrow pelvis bone	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0009891	antley-bixler syndrome	Underdeveloped supraorbital ridges	Occasional (29-5%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010669	antley-bixler syndrome	Cheekbone underdevelopment	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0012210	antley-bixler syndrome	Abnormal renal morphology	Frequent (79-30%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0100490	antley-bixler syndrome	Camptodactyly of finger	Very frequent (99-80%)	FGFR2	176943	207410	monoallelic	confirmed	uncertain	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	multiple synostoses syndrome type 1	NA	NA	NOG	602991	186500	monoallelic	confirmed	loss of function	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hemimegalencephaly akt3	NA	NA	AKT3	611223	603387	mosaic	probable	all missense/in frame	Brain/Cognition	393	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peroxisome biogenesis disorder complementation group 14	NA	NA	PEX19	600279	600279	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	9713	peroxisomal biogenesis factor 19	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	HK33|D1S2223E|PMP1|PMPI|PXMP1	housekeeping gene, 33kD	PXF	peroxisomal farnesylated protein	Peroxins
NA	neurodegeneration due to cerebral folate transport deficiency	NA	NA	FOLR1	136430	613068	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	3791	folate receptor 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4		folate receptor alpha	FOLR	folate receptor 1 (adult)	
NA	spondyloepimetaphyseal dysplasia pakistani type	NA	NA	PAPSS2	603005	612847	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	8604	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spinal muscular atrophy associated with progressive myoclonic epilepsy	NA	NA	ASAH1	613468	159950	biallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	735	N-acylsphingosine amidohydrolase 1	protein-coding gene	gene with protein product	Approved	8p22	08p22	AC|PHP32|FLJ21558|ACDase	acylsphingosine deacylase|acid ceramidase	ASAH	N-acylsphingosine amidohydrolase (acid ceramidase)	
NA	intellectual disability	NA	NA	TRIO	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Brain/Cognition	12303	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	ASH1L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	19088	ASH1 like histone lysine methyltransferase	protein-coding gene	gene with protein product	Approved	1q22	01q22	huASH1|ASH1|ASH1L1|KMT2H			ash1 (absent, small, or homeotic)-like (Drosophila)	PHD finger proteins|Lysine methyltransferases|SET domain containing
HP:0000486	leigh syndrome	Strabismus	Very frequent (99-80%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leigh syndrome	Nystagmus	Very frequent (99-80%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	leigh syndrome	Optic atrophy	Frequent (79-30%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leigh syndrome	Seizures	Frequent (79-30%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	leigh syndrome	Ataxia	Very frequent (99-80%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leigh syndrome	Muscular hypotonia	Very frequent (99-80%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	leigh syndrome	Respiratory insufficiency	Very frequent (99-80%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leigh syndrome	Hemiplegia/hemiparesis	Frequent (79-30%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007020	leigh syndrome	Progressive spastic paraplegia	Frequent (79-30%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007650	leigh syndrome	Progressive ophthalmoplegia	Frequent (79-30%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008972	leigh syndrome	Decreased activity of mitochondrial respiratory chain	Very frequent (99-80%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	leigh syndrome	Abnormality of movement	Very frequent (99-80%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	leigh syndrome	Cognitive impairment	Very frequent (99-80%)	SDHA	600857	256000	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10680	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000093	gaucher disease type 3	Proteinuria	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000486	gaucher disease type 3	Strabismus	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000602	gaucher disease type 3	Ophthalmoplegia	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000726	gaucher disease type 3	Dementia	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000790	gaucher disease type 3	Hematuria	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000823	gaucher disease type 3	Delayed puberty	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001251	gaucher disease type 3	Ataxia	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001288	gaucher disease type 3	Gait disturbance	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001298	gaucher disease type 3	Encephalopathy	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001510	gaucher disease type 3	Growth delay	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001637	gaucher disease type 3	Abnormality of the myocardium	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001654	gaucher disease type 3	Abnormality of the heart valves	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001698	gaucher disease type 3	Pericardial effusion	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001744	gaucher disease type 3	Splenomegaly	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001789	gaucher disease type 3	Hydrops fetalis	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001873	gaucher disease type 3	Thrombocytopenia	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001876	gaucher disease type 3	Pancytopenia	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001903	gaucher disease type 3	Anemia	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002092	gaucher disease type 3	Pulmonary arterial hypertension	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002123	gaucher disease type 3	Generalized myoclonic seizures	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002205	gaucher disease type 3	Recurrent respiratory infections	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002240	gaucher disease type 3	Hepatomegaly	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002653	gaucher disease type 3	Bone pain	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002659	gaucher disease type 3	Increased susceptibility to fractures	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002750	gaucher disease type 3	Delayed skeletal maturation	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002797	gaucher disease type 3	Osteolysis	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0004380	gaucher disease type 3	Aortic valve calcification	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0004382	gaucher disease type 3	Mitral valve calcification	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0006530	gaucher disease type 3	Interstitial pulmonary disease	Occasional (29-5%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0010702	gaucher disease type 3	Increased antibody level in blood	Frequent (79-30%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0010885	gaucher disease type 3	Aseptic necrosis	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0011001	gaucher disease type 3	Increased bone mineral density	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0012378	gaucher disease type 3	Fatigue	Very frequent (99-80%)	GBA	No gene mim	231000	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
NA	hypothyroidism, congenital, nongoitrous, 1	NA	NA	TSHR	603372	275200	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic	12373	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple epiphyseal dysplasia type 3	NA	NA	COL9A3	120270	600969	monoallelic	confirmed	dominant negative	Musculature;Skeleton	2219	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000077	thanatophoric dysplasia type 2	Abnormality of the kidney	Occasional (29-5%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000238	thanatophoric dysplasia type 2	Hydrocephalus	Occasional (29-5%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000256	thanatophoric dysplasia type 2	Macrocephaly	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000365	thanatophoric dysplasia type 2	Hearing impairment	Frequent (79-30%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000520	thanatophoric dysplasia type 2	Proptosis	Frequent (79-30%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000774	thanatophoric dysplasia type 2	Narrow chest	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000926	thanatophoric dysplasia type 2	Platyspondyly	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000944	thanatophoric dysplasia type 2	Abnormality of the metaphyses	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000956	thanatophoric dysplasia type 2	Acanthosis nigricans	Occasional (29-5%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001156	thanatophoric dysplasia type 2	Brachydactyly syndrome	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001250	thanatophoric dysplasia type 2	Seizures	Frequent (79-30%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001252	thanatophoric dysplasia type 2	Muscular hypotonia	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001360	thanatophoric dysplasia type 2	Holoprosencephaly	Occasional (29-5%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001376	thanatophoric dysplasia type 2	Limitation of joint mobility	Occasional (29-5%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001561	thanatophoric dysplasia type 2	Polyhydramnios	Frequent (79-30%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001582	thanatophoric dysplasia type 2	Redundant skin	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001631	thanatophoric dysplasia type 2	Atrial septal defect	Occasional (29-5%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001643	thanatophoric dysplasia type 2	Patent ductus arteriosus	Occasional (29-5%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002007	thanatophoric dysplasia type 2	Frontal bossing	Frequent (79-30%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002084	thanatophoric dysplasia type 2	Encephalocele	Occasional (29-5%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002093	thanatophoric dysplasia type 2	Respiratory insufficiency	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002119	thanatophoric dysplasia type 2	Ventriculomegaly	Frequent (79-30%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002269	thanatophoric dysplasia type 2	Abnormality of neuronal migration	Occasional (29-5%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002652	thanatophoric dysplasia type 2	Skeletal dysplasia	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002676	thanatophoric dysplasia type 2	Cloverleaf skull	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002808	thanatophoric dysplasia type 2	Kyphosis	Frequent (79-30%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002983	thanatophoric dysplasia type 2	Micromelia	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004322	thanatophoric dysplasia type 2	Short stature	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005280	thanatophoric dysplasia type 2	Depressed nasal bridge	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005692	thanatophoric dysplasia type 2	Joint hyperflexibility	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0006703	thanatophoric dysplasia type 2	Aplasia/Hypoplasia of the lungs	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010306	thanatophoric dysplasia type 2	Short thorax	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010880	thanatophoric dysplasia type 2	Increased nuchal translucency	Frequent (79-30%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0012368	thanatophoric dysplasia type 2	Flat face	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0100543	thanatophoric dysplasia type 2	Cognitive impairment	Very frequent (99-80%)	FGFR3	134934	187601	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	mental retardation x-linked type 94	NA	NA	GRIA3	305915	300699	hemizygous	confirmed	loss of function	Brain/Cognition	4573	glutamate ionotropic receptor AMPA type subunit 3	protein-coding gene	gene with protein product	Approved	Xq25	Xq25	GluA3|GLURC|MRX94		GLUR3	glutamate receptor, ionotrophic, AMPA 3	X-linked mental retardation|Glutamate ionotropic receptor AMPA type subunits
NA	intellectual disability	NA	NA	PHIP	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	15673	pleckstrin homology domain interacting protein	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1	ndrp|FLJ20705|DCAF14|BRWD2	DDB1 and CUL4 associated factor 14	WDR11		WD repeat domain containing|DDB1 and CUL4 associated factors
NA	xeroderma pigmentosum complementation group g	NA	NA	ERCC5	133530	278780	biallelic	confirmed	loss of function	Skin;Skeleton;Spinal cord/Peripheral nerves;Brain/Cognition;Eye;Ear	3437	ERCC excision repair 5, endonuclease	protein-coding gene	gene with protein product	Approved	13q33.1	13q33.1		Cockayne syndrome	ERCM2|XPGC	xeroderma pigmentosum, complementation group G|excision repair cross-complementing rodent repair deficiency, complementation group 5|excision repair cross-complementation group 5	Xeroderma pigmentosum complementation groups|ERCC excision repair associated
HP:0000008	lymphangioleiomyomatosis	Abnormality of female internal genitalia	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	lymphangioleiomyomatosis	Hydrocephalus	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	lymphangioleiomyomatosis	Optic atrophy	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000790	lymphangioleiomyomatosis	Hematuria	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001000	lymphangioleiomyomatosis	Abnormality of skin pigmentation	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001004	lymphangioleiomyomatosis	Lymphedema	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	lymphangioleiomyomatosis	Seizures	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001541	lymphangioleiomyomatosis	Ascites	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001945	lymphangioleiomyomatosis	Fever	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002027	lymphangioleiomyomatosis	Abdominal pain	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002091	lymphangioleiomyomatosis	Restrictive lung disease	Very frequent (99-80%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002094	lymphangioleiomyomatosis	Dyspnea	Very frequent (99-80%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002097	lymphangioleiomyomatosis	Emphysema	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002105	lymphangioleiomyomatosis	Hemoptysis	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002107	lymphangioleiomyomatosis	Pneumothorax	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002113	lymphangioleiomyomatosis	Pulmonary infiltrates	Very frequent (99-80%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	lymphangioleiomyomatosis	Recurrent respiratory infections	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002239	lymphangioleiomyomatosis	Gastrointestinal hemorrhage	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002716	lymphangioleiomyomatosis	Lymphadenopathy	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005562	lymphangioleiomyomatosis	Multiple renal cysts	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006772	lymphangioleiomyomatosis	Renal angiomyolipoma	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009594	lymphangioleiomyomatosis	Retinal hamartoma	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009721	lymphangioleiomyomatosis	Shagreen patch	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009726	lymphangioleiomyomatosis	Renal neoplasm	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010310	lymphangioleiomyomatosis	Chylothorax	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011852	lymphangioleiomyomatosis	Chylopericardium	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012086	lymphangioleiomyomatosis	Abnormal urinary color	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012378	lymphangioleiomyomatosis	Fatigue	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012733	lymphangioleiomyomatosis	Macule	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012735	lymphangioleiomyomatosis	Cough	Very frequent (99-80%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012798	lymphangioleiomyomatosis	Pulmonary lymphangiomyomatosis	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	lymphangioleiomyomatosis	Cognitive impairment	Occasional (29-5%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100749	lymphangioleiomyomatosis	Chest pain	Very frequent (99-80%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100750	lymphangioleiomyomatosis	Atelectasis	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100763	lymphangioleiomyomatosis	Abnormality of the lymphatic system	Very frequent (99-80%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100804	lymphangioleiomyomatosis	Ungual fibroma	Frequent (79-30%)	TSC2	191092	606690	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	eiken skeletal dysplasia	NA	NA	PTH1R	168468	600002	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9608	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	senior-loken syndrome type 1	NA	NA	NPHP1	607100	266900	biallelic	confirmed	loss of function	Kidney Renal Tract;Eye	7905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation syndromic x-linked type 10	NA	NA	HSD17B10	300256	300220	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rickets vitamin d-dependent type 2a	NA	NA	VDR	601769	277440	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	12679	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia isolated type 6	NA	NA	PRSS56	613858	613517	biallelic	confirmed	loss of function	Eye	39433	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	combined oxidative phosphorylation deficiency 4	NA	NA	TUFM	602389	610678	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	12420	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy	NA	NA	GRIN1	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame	Brain/Cognition	4584	glutamate ionotropic receptor NMDA type subunit 1	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3	GluN1		NMDAR1	N-methyl-D-aspartate receptor subunit NR1|glutamate receptor, ionotropic, N-methyl D-aspartate 1	Glutamate ionotropic receptor NMDA type subunits
NA	familial spinal neurofibromatosis	NA	NA	NF1	613113	162210	monoallelic	confirmed	loss of function	Skin;Spinal cord/Peripheral nerves;Brain/Cognition	7765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple congenital anomalies-hypotonia-seizures syndrome 3	NA	NA	PIGT	No gene mim	615398	biallelic	confirmed	all missense/in frame	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye	14938	phosphatidylinositol glycan anchor biosynthesis class T	protein-coding gene	gene with protein product	Approved	20q13.12	20q13.12		GPI transamidase subunit		phosphatidylinositol glycan, class T	Phosphatidylinositol glycan anchor biosynthesis
NA	keratoconus with cataract; edict syndrome	NA	NA	MIR184	No gene mim	614303	monoallelic	possible	uncertain	Eye	31555	microRNA 184	non-coding RNA	RNA, micro	Approved	15q25.1	15q25.1	hsa-mir-184		MIRN184		MicroRNAs
NA	muscular dystrophy congenital lmna-related	NA	NA	LMNA	No gene mim	613205	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
NA	spastic paraplegia-11	NA	NA	SPG11	610844	604360	biallelic	confirmed	loss of function	Brain/Cognition	11226	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	loeys-dietz syndrome type 1a	NA	NA	TGFBR1	190181	609192	monoallelic	confirmed	uncertain	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11772	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000083	lesch-nyhan syndrome	Renal insufficiency	Frequent (79-30%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	lesch-nyhan syndrome	Behavioral abnormality	Very frequent (99-80%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000790	lesch-nyhan syndrome	Hematuria	Frequent (79-30%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001256	lesch-nyhan syndrome	Intellectual disability, mild	Very frequent (99-80%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	lesch-nyhan syndrome	Spasticity	Very frequent (99-80%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	lesch-nyhan syndrome	Anemia	Frequent (79-30%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001997	lesch-nyhan syndrome	Gout	Very frequent (99-80%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002149	lesch-nyhan syndrome	Hyperuricemia	Very frequent (99-80%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002342	lesch-nyhan syndrome	Intellectual disability, moderate	Very frequent (99-80%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	lesch-nyhan syndrome	Hemiplegia/hemiparesis	Very frequent (99-80%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	lesch-nyhan syndrome	Abnormality of movement	Very frequent (99-80%)	HPRT1	308000	300322	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	5157	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	oculocutaneous albinism type 3	Strabismus	Frequent (79-30%)	TYRP1	115501	203290	biallelic	confirmed	loss of function	Skin;Eye	12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	oculocutaneous albinism type 3	Nystagmus	Very frequent (99-80%)	TYRP1	115501	203290	biallelic	confirmed	loss of function	Skin;Eye	12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000992	oculocutaneous albinism type 3	Cutaneous photosensitivity	Occasional (29-5%)	TYRP1	115501	203290	biallelic	confirmed	loss of function	Skin;Eye	12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001010	oculocutaneous albinism type 3	Hypopigmentation of the skin	Very frequent (99-80%)	TYRP1	115501	203290	biallelic	confirmed	loss of function	Skin;Eye	12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001022	oculocutaneous albinism type 3	Albinism	Very frequent (99-80%)	TYRP1	115501	203290	biallelic	confirmed	loss of function	Skin;Eye	12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001480	oculocutaneous albinism type 3	Freckling	Frequent (79-30%)	TYRP1	115501	203290	biallelic	confirmed	loss of function	Skin;Eye	12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002297	oculocutaneous albinism type 3	Red hair	Frequent (79-30%)	TYRP1	115501	203290	biallelic	confirmed	loss of function	Skin;Eye	12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005599	oculocutaneous albinism type 3	Hypopigmentation of hair	Frequent (79-30%)	TYRP1	115501	203290	biallelic	confirmed	loss of function	Skin;Eye	12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007730	oculocutaneous albinism type 3	Iris hypopigmentation	Very frequent (99-80%)	TYRP1	115501	203290	biallelic	confirmed	loss of function	Skin;Eye	12450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	NA	NA	SMAD4	No gene mim	175050	monoallelic	both DD and IF	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	agenesis of the corpus callosum	NA	NA	PAK3	300142	No disease mim	hemizygous	confirmed	activating	Brain/Cognition	8592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	shprintzen-goldberg craniosynostosis syndrome	NA	NA	FBN1	134797	182212	monoallelic	confirmed	dominant negative	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
NA	joubert syndrome with or without jeune asphyxiating thoracic dystrophy	NA	NA	CSPP1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	26193	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	familial schizencephaly, emx2-related	NA	NA	EMX2	No gene mim	269160	monoallelic	possible	loss of function	Brain/Cognition	3341	empty spiracles homeobox 2	protein-coding gene	gene with protein product	Approved	10q26.11	10q26.11				empty spiracles homolog 2 (Drosophila)	NKL subclass homeoboxes and pseudogenes
NA	severe combined immunodeficiency autosomal recessive t-cell-negative/b-cell-negative/nk-cell-positive with sensitivity to ionizing radiation	NA	NA	LIG4	601837	602450	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition	6601	DNA ligase 4	protein-coding gene	gene with protein product	Approved	13q33.3	13q33.3		polydeoxyribonucleotide synthase [ATP] 4|polynucleotide ligase|sealase|DNA repair enzyme|DNA joinase		ligase IV, DNA, ATP-dependent	DNA ligases
HP:0000518	alg2-cdg	Cataract	Very frequent (99-80%)	ALG2	607905	237149	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	23159	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	alg2-cdg	Iris coloboma	Very frequent (99-80%)	ALG2	607905	237149	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	23159	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	alg2-cdg	Nystagmus	Very frequent (99-80%)	ALG2	607905	237149	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	23159	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	alg2-cdg	Seizures	Very frequent (99-80%)	ALG2	607905	237149	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	23159	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	alg2-cdg	Cognitive impairment	Very frequent (99-80%)	ALG2	607905	237149	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	23159	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	foveal hypoplasia	NA	NA	PAX6	607108	136520	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leigh syndrome due to mitochondrial complex iv deficiency	NA	NA	TACO1	612958	256000	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	24316	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atelosteogenesis type 1	NA	NA	FLNB	603381	108720	monoallelic	confirmed	activating	Skeleton	3755	filamin B	protein-coding gene	gene with protein product	Approved	3p14.3	03p14.3	TAP|TABP|ABP-278|FH1	actin binding protein 278|beta filamin	FLN1L|LRS1	filamin B, beta (actin binding protein 278)|Larsen syndrome 1 (autosomal dominant)|filamin B, beta	
NA	cortical dysplasia, complex, with other brain malformations 1	NA	NA	TUBB3	No gene mim	614039	monoallelic	probable	all missense/in frame	Brain/Cognition	20772	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome	NA	NA	CCND2	No gene mim	603387	monoallelic	confirmed	activating	Skeleton;Brain/Cognition	1583	cyclin D2	protein-coding gene	gene with protein product	Approved	12p13.32	12p13.32		G1/S-specific cyclin D2			Cyclins
NA	trichohepatoenteric syndrome	NA	NA	TTC37	614589	222470	biallelic	confirmed	loss of function	Skin;GI tract	23639	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	osteogenesis imperfecta, type viii	NA	NA	P3H1	No gene mim	610915	biallelic	confirmed	loss of function	Skeleton	19316	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia syndromic type 3	NA	NA	SOX2	184429	206900	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	11195	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bilateral optic nerve hypoplasia	NA	NA	PAX6	607108	165550	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	auriculocondylar syndrome	NA	NA	GNAI3	139370	602483	monoallelic	confirmed	all missense/in frame	Face;Ear	4387	G protein subunit alpha i3	protein-coding gene	gene with protein product	Approved	1p13.3	01p13.3	87U6			guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3	G protein subunits alpha, group i
NA	epileptic encephalopathy early infantile type 4	NA	NA	STXBP1	602926	612164	monoallelic	confirmed	loss of function	Brain/Cognition	11444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperprolinemia type 2	NA	NA	ALDH4A1	606811	239510	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	406	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nocturnal frontal lobe epilepsy, autosomal dominant	NA	NA	CHRNA2	No gene mim	117426		possible		Brain/Cognition	1956	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia isolated with cataract type 4	NA	NA	CRYBA4	123631	610426	monoallelic	possible	dominant negative	Eye	2396	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract coppock-like	NA	NA	CRYGC	123680	604307	monoallelic	possible	loss of function	Eye	2410	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	adams oliver syndrome	NA	NA	RBPJ	147183	No disease mim	monoallelic	probable	all missense/in frame	Skin;Skeleton	5724	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal-recessive complete congenital stationary night blindness	NA	NA	GPR179	614515	615058	biallelic	confirmed	loss of function	Eye	31371	G protein-coupled receptor 179	protein-coding gene	gene with protein product	Approved	17q12	17q12	CSNB1E		GPR158L1	GPR158-like 1|GPR179	G protein-coupled receptors, Class C orphans
NA	hypoparathyroidism-retardation-dysmorphism syndrome	NA	NA	TBCE	604934	241410	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Brain/Cognition	11582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	myotubular myopathy, x-linked	NA	NA	MTM1	300415	310400	hemizygous	confirmed	loss of function	Musculature	7448	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ataxia, spastic, 5, autosomal recessive	NA	NA	AFG3L2	No gene mim	614487	biallelic	child IF	all missense/in frame	Brain/Cognition	315	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lethal congenital contracture syndrome type 2	NA	NA	ERBB3	No gene mim	607598	biallelic	possible	uncertain	Skeleton;Spinal cord/Peripheral nerves	3431	erb-b2 receptor tyrosine kinase 3	protein-coding gene	gene with protein product	Approved	12q13.2	12q13.2	HER3	human epidermal growth factor receptor 3	LCCS2	lethal congenital contracture syndrome 2|v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3	Erb-b2 receptor tyrosine kinases
NA	congenital cataracts facial dysmorphism and neuropathy syndrome	NA	NA	CTDP1	604927	604168	biallelic	confirmed	loss of function	Musculature;Spinal cord/Peripheral nerves;Brain/Cognition;Eye	2498	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondylocostal dysostosis type 3	NA	NA	LFNG	602576	609813	biallelic	confirmed	uncertain	Skeleton	6560	LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase	protein-coding gene	gene with protein product	Approved	7p22.3	07p22.3	SCDO3			lunatic fringe (Drosophila) homolog|lunatic fringe homolog (Drosophila)	Beta 3-glycosyltransferases
NA	ellis-van creveld syndrome	NA	NA	EVC2	607261	225500	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Heart/Cardiovasculature/Lymphatic	19747	EvC ciliary complex subunit 2	protein-coding gene	gene with protein product	Approved	4p16.2	04p16.2	LBN	limbin		Ellis van Creveld syndrome 2	
NA	hyperammonemia due to carbonic anhydrase va deficiency	NA	NA	CA5A	No gene mim	615751	biallelic	probable	loss of function	Endocrine/Metabolic	1377	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	MAN1B1	No gene mim	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	6823	mannosidase alpha class 1B member 1	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3	MANA-ER|MRT15|ERManI	endoplasmic reticulum alpha-mannosidase 1|alpha 1,2-mannosidase|endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase 1|ER alpha 1,2-mannosidase|Man9GlcNAc2-specific processing alpha-mannosidase|endoplasmic Reticulum Class I alpha-mannosidase		mannosidase, alpha, class 1B, member 1	Mannosidases alpha class 1
HP:0000072	codas syndrome	Hydroureter	Occasional (29-5%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000286	codas syndrome	Epicanthus	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000396	codas syndrome	Overfolded helix	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000407	codas syndrome	Sensorineural hearing impairment	Frequent (79-30%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000463	codas syndrome	Anteverted nares	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000486	codas syndrome	Strabismus	Occasional (29-5%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000508	codas syndrome	Ptosis	Frequent (79-30%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000518	codas syndrome	Cataract	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000639	codas syndrome	Nystagmus	Occasional (29-5%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000682	codas syndrome	Abnormality of dental enamel	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0000684	codas syndrome	Delayed eruption of teeth	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0001156	codas syndrome	Brachydactyly syndrome	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0001252	codas syndrome	Muscular hypotonia	Frequent (79-30%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0001263	codas syndrome	Global developmental delay	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0001374	codas syndrome	Congenital hip dislocation	Frequent (79-30%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0001600	codas syndrome	Abnormality of the larynx	Occasional (29-5%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0001629	codas syndrome	Ventricular septal defect	Occasional (29-5%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0002644	codas syndrome	Abnormality of pelvic girdle bone morphology	Frequent (79-30%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0002650	codas syndrome	Scoliosis	Frequent (79-30%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0002750	codas syndrome	Delayed skeletal maturation	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0003196	codas syndrome	Short nose	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0003312	codas syndrome	Abnormal form of the vertebral bodies	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0003417	codas syndrome	Coronal cleft vertebrae	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0004122	codas syndrome	Midline defect of the nose	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0004322	codas syndrome	Short stature	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0005242	codas syndrome	Extrahepatic biliary duct atresia	Occasional (29-5%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0005280	codas syndrome	Depressed nasal bridge	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0005692	codas syndrome	Joint hyperflexibility	Frequent (79-30%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0005930	codas syndrome	Abnormality of epiphysis morphology	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0006482	codas syndrome	Abnormality of dental morphology	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0009901	codas syndrome	Crumpled ear	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0010049	codas syndrome	Short metacarpal	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
HP:0012368	codas syndrome	Flat face	Very frequent (99-80%)	LONP1	No gene mim	600373	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition;GI tract;Ear;Genitalia;Heart/Cardiovasculature/Lymphatic	9479	lon peptidase 1, mitochondrial	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	LonHS|hLON|PIM1		PRSS15	protease, serine, 15	AAA ATPases|Proteases, serine
NA	megalencephaly-capillary malformation-polymicrogyria syndrome, somatic 3	NA	NA	PIK3CA	171834	602501	mosaic	confirmed	activating	Skeleton;Endocrine/Metabolic	8975	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	protein-coding gene	gene with protein product	Approved	3q26.32	03q26.32	PI3K			phosphoinositide-3-kinase, catalytic, alpha polypeptide|phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	Phosphatidylinositol 3-kinase subunits
NA	distinct dna breakage syndrome	NA	NA	NSMCE3	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Respiratory tract	7677	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	heterotaxy syndrome	NA	NA	CRELD1	607170	207574	monoallelic	probable	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	14630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hearing loss	NA	NA	PNPT1	610316	No disease mim	biallelic	confirmed	all missense/in frame	Ear	23166	polyribonucleotide nucleotidyltransferase 1	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	PNPase|OLD35|old-35	polynucleotide phosphorylase|3'-5' RNA exonuclease	DFNB70	deafness, autosomal recessive 70	Deafness associated genes
NA	acyl-coa dehydrogenase family member type 9 deficiency	NA	NA	ACAD9	611103	611126	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	21497	acyl-CoA dehydrogenase family member 9	protein-coding gene	gene with protein product	Approved	3q21.3	03q21.3	NPD002|MGC14452			acyl-Coenzyme A dehydrogenase family, member 9|acyl-CoA dehydrogenase family, member 9	Acyl-CoA dehydrogenase family|Mitochondrial complex I assembly complex
HP:0000338	dopa-responsive dystonia due to sepiapterin reductase deficiency	Hypomimic face	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000366	dopa-responsive dystonia due to sepiapterin reductase deficiency	Abnormality of the nose	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	dopa-responsive dystonia due to sepiapterin reductase deficiency	Ptosis	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	dopa-responsive dystonia due to sepiapterin reductase deficiency	Behavioral abnormality	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000750	dopa-responsive dystonia due to sepiapterin reductase deficiency	Delayed speech and language development	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000975	dopa-responsive dystonia due to sepiapterin reductase deficiency	Hyperhidrosis	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	dopa-responsive dystonia due to sepiapterin reductase deficiency	Intellectual disability	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001270	dopa-responsive dystonia due to sepiapterin reductase deficiency	Motor delay	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	dopa-responsive dystonia due to sepiapterin reductase deficiency	Muscle weakness	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001332	dopa-responsive dystonia due to sepiapterin reductase deficiency	Dystonia	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001337	dopa-responsive dystonia due to sepiapterin reductase deficiency	Tremor	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001347	dopa-responsive dystonia due to sepiapterin reductase deficiency	Hyperreflexia	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002063	dopa-responsive dystonia due to sepiapterin reductase deficiency	Rigidity	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002067	dopa-responsive dystonia due to sepiapterin reductase deficiency	Bradykinesia	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002329	dopa-responsive dystonia due to sepiapterin reductase deficiency	Drowsiness	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002360	dopa-responsive dystonia due to sepiapterin reductase deficiency	Sleep disturbance	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002509	dopa-responsive dystonia due to sepiapterin reductase deficiency	Limb hypertonia	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005968	dopa-responsive dystonia due to sepiapterin reductase deficiency	Temperature instability	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008936	dopa-responsive dystonia due to sepiapterin reductase deficiency	Muscular hypotonia of the trunk	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010553	dopa-responsive dystonia due to sepiapterin reductase deficiency	Oculogyric crisis	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	dopa-responsive dystonia due to sepiapterin reductase deficiency	Cognitive impairment	Frequent (79-30%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	dopa-responsive dystonia due to sepiapterin reductase deficiency	Microcephaly	Occasional (29-5%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	dopa-responsive dystonia due to sepiapterin reductase deficiency	Seizures	Occasional (29-5%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	dopa-responsive dystonia due to sepiapterin reductase deficiency	Growth delay	Occasional (29-5%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001518	dopa-responsive dystonia due to sepiapterin reductase deficiency	Small for gestational age	Occasional (29-5%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100021	dopa-responsive dystonia due to sepiapterin reductase deficiency	Cerebral palsy	Occasional (29-5%)	SPR	No gene mim	612716	biallelic	confirmed	loss of function	Brain/Cognition	11257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy	NA	NA	GABBR2	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	4507	gamma-aminobutyric acid type B receptor subunit 2	protein-coding gene	gene with protein product	Approved	9q22.33	09q22.33	HG20|GABABR2|GPRC3B		GPR51	G protein-coupled receptor 51|gamma-aminobutyric acid (GABA) B receptor, 2	Gamma-aminobutyric acid type B receptor subunits
NA	muscular dystrophy-dystroglycanopathy congenital with mental retardation type b1	NA	NA	POMT1	607423	613155	biallelic	confirmed	loss of function	Musculature;Brain/Cognition	9202	protein O-mannosyltransferase 1	protein-coding gene	gene with protein product	Approved	9q34.13	09q34.13	LGMD2K	dolichyl-phosphate-mannose-protein mannosyltransferase			Dolichyl D-mannosyl phosphate dependent mannosyltransferases
NA	dentin dysplasia, type i, with microdontia and misshapen teeth	NA	NA	SMOC2	607223	125400	biallelic	probable	loss of function	Teeth & Dentitian	20323	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	methylmalonyl-coa epimerase deficiency	NA	NA	MCEE	608419	251120	biallelic	confirmed	loss of function	Multisystem	16732	methylmalonyl-CoA epimerase	protein-coding gene	gene with protein product	Approved	2p13.3	02p13.3	GLOD2	glyoxalase domain containing 2			
NA	intellectual disability with epilepsy	NA	NA	CNKSR2	No gene mim	No disease mim	hemizygous	probable	loss of function	Brain/Cognition	19701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	auriculocondylar syndrome	NA	NA	EDN1	No gene mim	602483	monoallelic	probable	loss of function	Face;Ear	3176	endothelin 1	protein-coding gene	gene with protein product	Approved	6p24.1	06p24.1	ET1				Endogenous ligands
NA	auriculocondylar syndrome	NA	NA	EDN1	No gene mim	602483	biallelic	probable	all missense/in frame	Face;Ear	3176	endothelin 1	protein-coding gene	gene with protein product	Approved	6p24.1	06p24.1	ET1				Endogenous ligands
NA	aica-ribosuria	NA	NA	ATIC	601731	608688	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	794	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	protein-coding gene	gene with protein product	Approved	2q35	02q35	PURH|AICARFT|IMPCHASE	phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase			
NA	cerebral palsy spastic quadriplegic type 4	NA	NA	AP4E1	No gene mim	613744	biallelic	confirmed	loss of function	Brain/Cognition	573	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	roberts syndrome	Cryptorchidism	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000040	roberts syndrome	Long penis	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000057	roberts syndrome	Clitoromegaly	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000113	roberts syndrome	Polycystic kidney dysplasia	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	roberts syndrome	Cleft palate	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000204	roberts syndrome	Cleft upper lip	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	roberts syndrome	High palate	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	roberts syndrome	Brachycephaly	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	roberts syndrome	Microcephaly	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	roberts syndrome	Malar flattening	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	roberts syndrome	Hypertelorism	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	roberts syndrome	Micrognathia	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000387	roberts syndrome	Absent earlobe	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000430	roberts syndrome	Underdeveloped nasal alae	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	roberts syndrome	Short neck	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	roberts syndrome	Glaucoma	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	roberts syndrome	Cataract	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	roberts syndrome	Proptosis	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	roberts syndrome	Microphthalmia	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000592	roberts syndrome	Blue sclerae	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	roberts syndrome	Nystagmus	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	roberts syndrome	Brachydactyly syndrome	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001239	roberts syndrome	Wrist flexion contracture	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	roberts syndrome	Intellectual disability	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	roberts syndrome	Global developmental delay	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	roberts syndrome	Craniosynostosis	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	roberts syndrome	Polyhydramnios	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001622	roberts syndrome	Premature birth	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001852	roberts syndrome	Sandal gap	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	roberts syndrome	Thrombocytopenia	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	roberts syndrome	Malformation of the heart and great vessels	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002817	roberts syndrome	Abnormality of the upper limb	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002974	roberts syndrome	Radioulnar synostosis	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002984	roberts syndrome	Hypoplasia of the radius	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	roberts syndrome	Clinodactyly of the 5th finger	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005011	roberts syndrome	Mesomelic arm shortening	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005048	roberts syndrome	Synostosis of carpal bones	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005876	roberts syndrome	Progressive flexion contractures	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	roberts syndrome	Finger syndactyly	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006380	roberts syndrome	Knee flexion contracture	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006443	roberts syndrome	Patellar aplasia	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	roberts syndrome	Bowing of the long bones	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007452	roberts syndrome	Midface capillary hemangioma	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007598	roberts syndrome	Bilateral single transverse palmar creases	Occasional (29-5%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008070	roberts syndrome	Sparse hair	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008572	roberts syndrome	External ear malformation	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008846	roberts syndrome	Severe intrauterine growth retardation	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008897	roberts syndrome	Postnatal growth retardation	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009466	roberts syndrome	Radial deviation of finger	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009601	roberts syndrome	Aplasia/Hypoplasia of the thumb	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009623	roberts syndrome	Proximal placement of thumb	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009829	roberts syndrome	Phocomelia	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009891	roberts syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009943	roberts syndrome	Complete duplication of thumb phalanx	Very frequent (99-80%)	ESCO2	609353	268300	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	27230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	mandibuloacral dysplasia with type a lipodystrophy	Abnormality of the teeth	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000218	mandibuloacral dysplasia with type a lipodystrophy	High palate	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000239	mandibuloacral dysplasia with type a lipodystrophy	Large fontanelles	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000365	mandibuloacral dysplasia with type a lipodystrophy	Hearing impairment	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000518	mandibuloacral dysplasia with type a lipodystrophy	Cataract	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000520	mandibuloacral dysplasia with type a lipodystrophy	Proptosis	Frequent (79-30%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000534	mandibuloacral dysplasia with type a lipodystrophy	Abnormality of the eyebrow	Frequent (79-30%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000561	mandibuloacral dysplasia with type a lipodystrophy	Absent eyelashes	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000855	mandibuloacral dysplasia with type a lipodystrophy	Insulin resistance	Frequent (79-30%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000953	mandibuloacral dysplasia with type a lipodystrophy	Hyperpigmentation of the skin	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000963	mandibuloacral dysplasia with type a lipodystrophy	Thin skin	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001252	mandibuloacral dysplasia with type a lipodystrophy	Muscular hypotonia	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001371	mandibuloacral dysplasia with type a lipodystrophy	Flexion contracture	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001376	mandibuloacral dysplasia with type a lipodystrophy	Limitation of joint mobility	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001596	mandibuloacral dysplasia with type a lipodystrophy	Alopecia	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0001870	mandibuloacral dysplasia with type a lipodystrophy	Acroosteolysis of distal phalanges (feet)	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002645	mandibuloacral dysplasia with type a lipodystrophy	Wormian bones	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002797	mandibuloacral dysplasia with type a lipodystrophy	Osteolysis	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0002829	mandibuloacral dysplasia with type a lipodystrophy	Arthralgia	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0003011	mandibuloacral dysplasia with type a lipodystrophy	Abnormality of the musculature	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0003077	mandibuloacral dysplasia with type a lipodystrophy	Hyperlipidemia	Frequent (79-30%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0004322	mandibuloacral dysplasia with type a lipodystrophy	Short stature	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0004334	mandibuloacral dysplasia with type a lipodystrophy	Dermal atrophy	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0005328	mandibuloacral dysplasia with type a lipodystrophy	Progeroid facial appearance	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0006710	mandibuloacral dysplasia with type a lipodystrophy	Aplasia/Hypoplasia of the clavicles	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0007495	mandibuloacral dysplasia with type a lipodystrophy	Prematurely aged appearance	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0009839	mandibuloacral dysplasia with type a lipodystrophy	Osteolytic defects of the distal phalanges of the hand	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0009882	mandibuloacral dysplasia with type a lipodystrophy	Short distal phalanx of finger	Very frequent (99-80%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0100679	mandibuloacral dysplasia with type a lipodystrophy	Lack of skin elasticity	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0100783	mandibuloacral dysplasia with type a lipodystrophy	Breast aplasia	Occasional (29-5%)	LMNA	No gene mim	248370	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000486	leigh syndrome	Strabismus	Very frequent (99-80%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leigh syndrome	Nystagmus	Very frequent (99-80%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	leigh syndrome	Optic atrophy	Frequent (79-30%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leigh syndrome	Seizures	Frequent (79-30%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	leigh syndrome	Ataxia	Very frequent (99-80%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leigh syndrome	Muscular hypotonia	Very frequent (99-80%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	leigh syndrome	Respiratory insufficiency	Very frequent (99-80%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leigh syndrome	Hemiplegia/hemiparesis	Frequent (79-30%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007020	leigh syndrome	Progressive spastic paraplegia	Frequent (79-30%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007650	leigh syndrome	Progressive ophthalmoplegia	Frequent (79-30%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008972	leigh syndrome	Decreased activity of mitochondrial respiratory chain	Very frequent (99-80%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	leigh syndrome	Abnormality of movement	Very frequent (99-80%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	leigh syndrome	Cognitive impairment	Very frequent (99-80%)	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	periventricular heterotopia	NA	NA	ERMARD	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	21056	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	macrocephaly, neurodevelopmental delay, and seizures	NA	NA	KPTN	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	6404	kaptin, actin binding protein	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	2E4			kaptin (actin-binding protein)	KICSTOR complex
NA	carbamoyl phosphate synthetase 1 deficiency	NA	NA	CPS1	608307	237300	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2323	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nocturnal frontal lobe epilepsy, autosomal dominant	NA	NA	CHRNB2	No gene mim	117426	monoallelic	probable	activating	Brain/Cognition	1962	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000239	opsismodysplasia	Large fontanelles	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0000256	opsismodysplasia	Macrocephaly	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0000592	opsismodysplasia	Blue sclerae	Occasional (29-5%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0000767	opsismodysplasia	Pectus excavatum	Occasional (29-5%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0000774	opsismodysplasia	Narrow chest	Occasional (29-5%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0000944	opsismodysplasia	Abnormality of the metaphyses	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0001156	opsismodysplasia	Brachydactyly syndrome	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0001182	opsismodysplasia	Tapered finger	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0001252	opsismodysplasia	Muscular hypotonia	Frequent (79-30%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0001387	opsismodysplasia	Joint stiffness	Occasional (29-5%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0001744	opsismodysplasia	Splenomegaly	Occasional (29-5%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0002007	opsismodysplasia	Frontal bossing	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0002093	opsismodysplasia	Respiratory insufficiency	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0002205	opsismodysplasia	Recurrent respiratory infections	Frequent (79-30%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0002240	opsismodysplasia	Hepatomegaly	Occasional (29-5%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0002750	opsismodysplasia	Delayed skeletal maturation	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0003173	opsismodysplasia	Hypoplastic pubic bone	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0003175	opsismodysplasia	Hypoplastic ischia	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0003177	opsismodysplasia	Squared iliac bones	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0003196	opsismodysplasia	Short nose	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0003510	opsismodysplasia	Severe short stature	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0005280	opsismodysplasia	Depressed nasal bridge	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0005469	opsismodysplasia	Flat occiput	Frequent (79-30%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0005930	opsismodysplasia	Abnormality of epiphysis morphology	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0008479	opsismodysplasia	Hypoplastic vertebral bodies	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0011304	opsismodysplasia	Broad thumb	Occasional (29-5%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
HP:0100569	opsismodysplasia	Abnormal vertebral ossification	Very frequent (99-80%)	INPPL1	600829	258480	biallelic	confirmed	loss of function	Skeleton	6080	inositol polyphosphate phosphatase like 1	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4	SHIP2	51C protein|SH2 domain-containing inositol 5'-phosphatase 2|phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2			SH2 domain containing|Sterile alpha motif domain containing|Phosphoinositide phosphatases
NA	glucocorticoid deficiency 1	NA	NA	MC2R	607397	202200	biallelic	confirmed	loss of function	Endocrine/Metabolic	6930	melanocortin 2 receptor	protein-coding gene	gene with protein product	Approved	18p11.2	18p11.2	ACTHR	adrenocorticotropic hormone receptor		melanocortin 2 receptor (adrenocorticotropic hormone)	Melanocortin receptors
NA	gm1-gangliosidosis type 3	NA	NA	GLB1	611458	230650	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4298	galactosidase beta 1	protein-coding gene	gene with protein product	Approved	3p22.3	03p22.3	EBP		ELNR1	elastin receptor 1, 67kDa|elastin receptor 1 (67kD)|galactosidase, beta 1	
NA	mental retardation autosomal dominant type 7	NA	NA	DYRK1A	600855	614104	monoallelic	confirmed	loss of function	Face;Brain/Cognition	3091	dual specificity tyrosine phosphorylation regulated kinase 1A	protein-coding gene	gene with protein product	Approved	21q22.13	21q22.13			DYRK1|DYRK|MNBH	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A|dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1A	
NA	nemaline myopathy 3	NA	NA	ACTA1	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Musculature	129	actin, alpha 1, skeletal muscle	protein-coding gene	gene with protein product	Approved	1q42.13	01q42.13	NEM3	nemaline myopathy type 3	ACTA		Actins
HP:0000268	hypotonia-cystinuria syndrome	Dolichocephaly	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0000278	hypotonia-cystinuria syndrome	Retrognathia	Frequent (79-30%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0000286	hypotonia-cystinuria syndrome	Epicanthus	Frequent (79-30%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0000508	hypotonia-cystinuria syndrome	Ptosis	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0000787	hypotonia-cystinuria syndrome	Nephrolithiasis	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0001252	hypotonia-cystinuria syndrome	Muscular hypotonia	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0001508	hypotonia-cystinuria syndrome	Failure to thrive	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0001510	hypotonia-cystinuria syndrome	Growth delay	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0001558	hypotonia-cystinuria syndrome	Decreased fetal movement	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0001611	hypotonia-cystinuria syndrome	Nasal speech	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0002007	hypotonia-cystinuria syndrome	Frontal bossing	Frequent (79-30%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0002591	hypotonia-cystinuria syndrome	Polyphagia	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0003131	hypotonia-cystinuria syndrome	Cystinuria	Very frequent (99-80%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
HP:0012378	hypotonia-cystinuria syndrome	Fatigue	Frequent (79-30%)	PREPL	No gene mim	606407	biallelic	probable	loss of function	Kidney Renal Tract;Endocrine/Metabolic;Brain/Cognition	30228	prolyl endopeptidase-like	protein-coding gene	gene with protein product	Approved	2p21	02p21	KIAA0436				
NA	singleton-merten syndrome	NA	NA	DDX58	No gene mim	182250	monoallelic	possible	all missense/in frame	Teeth & Dentitian;Skin;Skeleton;Eye	19102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	2,4-dienoyl-coa reductase deficiency	NA	NA	DECR1	No gene mim	222745	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	2753	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	walker warberg syndrome	NA	NA	POMGNT2	No gene mim	614830	biallelic	confirmed	loss of function	Brain/Cognition;Eye	25902	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	protein-coding gene	gene with protein product	Approved	3p22.1	03p22.1	FLJ14566|AGO61		C3orf39|GTDC2	chromosome 3 open reading frame 39|glycosyltransferase-like domain containing 2	O-linked N-acetylglucosaminyltransferases
NA	specific language impairment 5	NA	NA	TM4SF20	No gene mim	615432	monoallelic	possible	loss of function	Brain/Cognition	26230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	COL4A3BP	No gene mim	No disease mim	monoallelic	confirmed	activating	Brain/Cognition	2205	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gnas hyperfunction	NA	NA	GNAS	139320	139320	monoallelic	confirmed	activating	Skeleton;Endocrine/Metabolic;Brain/Cognition	4392	GNAS complex locus	protein-coding gene	gene with protein product	Approved	20q13.32	20q13.32	NESP55|NESP|GNASXL|GPSA|SCG6|SgVI	secretogranin VI|G protein subunit alpha S	GNAS1	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	Granins|G protein subunits alpha, group s
HP:0000040	proteus syndrome	Long penis	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	proteus syndrome	Macrocephaly	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000268	proteus syndrome	Dolichocephaly	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	proteus syndrome	Long face	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000311	proteus syndrome	Round face	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000324	proteus syndrome	Facial asymmetry	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	proteus syndrome	Proptosis	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000567	proteus syndrome	Chorioretinal coloboma	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000873	proteus syndrome	Diabetes insipidus	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000995	proteus syndrome	Melanocytic nevus	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001000	proteus syndrome	Abnormality of skin pigmentation	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001072	proteus syndrome	Thickened skin	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	proteus syndrome	Abnormality of the metacarpal bones	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	proteus syndrome	Intellectual disability	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	proteus syndrome	Seizures	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	proteus syndrome	Craniosynostosis	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001482	proteus syndrome	Subcutaneous nodule	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	proteus syndrome	Splenomegaly	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002230	proteus syndrome	Generalized hirsutism	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	proteus syndrome	Scoliosis	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	proteus syndrome	Skeletal dysplasia	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002664	proteus syndrome	Neoplasm	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002858	proteus syndrome	Meningioma	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003199	proteus syndrome	Decreased muscle mass	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	proteus syndrome	Abnormal form of the vertebral bodies	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003715	proteus syndrome	Myofibrillar myopathy	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004099	proteus syndrome	Macrodactyly	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004326	proteus syndrome	Cachexia	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004418	proteus syndrome	Thrombophlebitis	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004490	proteus syndrome	Calvarial hyperostosis	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005306	proteus syndrome	Capillary hemangiomas	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005595	proteus syndrome	Generalized hyperkeratosis	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007440	proteus syndrome	Generalized hyperpigmentation	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	proteus syndrome	Abnormality of retinal pigmentation	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010508	proteus syndrome	Metatarsus valgus	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010516	proteus syndrome	Thymus hyperplasia	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011276	proteus syndrome	Vascular skin abnormality	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012032	proteus syndrome	Lipoma	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100006	proteus syndrome	Neoplasm of the central nervous system	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100026	proteus syndrome	Arteriovenous malformation	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100521	proteus syndrome	Neoplasm of the thymus	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100526	proteus syndrome	Neoplasm of the lung	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100555	proteus syndrome	Asymmetric growth	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100559	proteus syndrome	Lower limb asymmetry	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100560	proteus syndrome	Upper limb asymmetry	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100615	proteus syndrome	Ovarian neoplasm	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100730	proteus syndrome	Bronchogenic cyst	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100761	proteus syndrome	Visceral angiomatosis	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100764	proteus syndrome	Lymphangioma	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100774	proteus syndrome	Hyperostosis	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000053	proteus syndrome	Macroorchidism	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000107	proteus syndrome	Renal cyst	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	proteus syndrome	Hypertelorism	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	proteus syndrome	Low-set ears	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	proteus syndrome	Macrotia	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	proteus syndrome	Anteverted nares	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000464	proteus syndrome	Abnormality of the neck	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	proteus syndrome	Strabismus	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	proteus syndrome	Downslanted palpebral fissures	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	proteus syndrome	Glaucoma	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	proteus syndrome	Ptosis	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	proteus syndrome	Cataract	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	proteus syndrome	Myopia	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000557	proteus syndrome	Buphthalmos	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	proteus syndrome	Carious teeth	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	proteus syndrome	Abnormality of dental enamel	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001004	proteus syndrome	Lymphedema	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001167	proteus syndrome	Abnormality of finger	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	proteus syndrome	Joint stiffness	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001519	proteus syndrome	Disproportionate tall stature	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001555	proteus syndrome	Asymmetry of the thorax	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001597	proteus syndrome	Abnormality of the nail	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001645	proteus syndrome	Sudden cardiac death	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001822	proteus syndrome	Hallux valgus	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002204	proteus syndrome	Pulmonary embolism	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002282	proteus syndrome	Heterotopia	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	proteus syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002719	proteus syndrome	Recurrent infections	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	proteus syndrome	Kyphosis	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002827	proteus syndrome	Hip dislocation	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003019	proteus syndrome	Abnormality of the wrist	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	proteus syndrome	Clinodactyly of the 5th finger	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004420	proteus syndrome	Arterial thrombosis	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	proteus syndrome	Depressed nasal bridge	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	proteus syndrome	Finger syndactyly	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006525	proteus syndrome	Lung segmentation defects	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007400	proteus syndrome	Irregular hyperpigmentation	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007552	proteus syndrome	Abnormal subcutaneous fat tissue distribution	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007565	proteus syndrome	Multiple cafe-au-lait spots	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007818	proteus syndrome	Central heterochromia	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007899	proteus syndrome	Retinal nonattachment	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008675	proteus syndrome	Enlarged polycystic ovaries	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009594	proteus syndrome	Retinal hamartoma	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	proteus syndrome	Reduced number of teeth	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009928	proteus syndrome	Thick nasal alae	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010497	proteus syndrome	Sirenomelia	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010566	proteus syndrome	Hamartoma	Frequent (79-30%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010788	proteus syndrome	Testicular neoplasm	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010816	proteus syndrome	Epidermal nevus	Very frequent (99-80%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011386	proteus syndrome	Narrow internal auditory canal	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100777	proteus syndrome	Exostoses	Occasional (29-5%)	AKT1	164730	176920	mosaic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	homeotic arm-to-leg transformation associated with genomic rearrangements at the pitx1 locus	NA	NA	PITX1	602149	No disease mim	monoallelic	probable	cis-regulatory or promotor mutation	Skeleton	9004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondyloperipheral dysplasia	NA	NA	COL2A1	120140	271700	monoallelic	confirmed	loss of function	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peters anomaly	NA	NA	PITX2	601542	604229	monoallelic	confirmed	loss of function	Teeth & Dentitian;Eye;GI tract	9005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cobblestone brain malformation without muscular or ocular abnormalities	NA	NA	LAMB1	No gene mim	615191	biallelic	probable	loss of function	Brain/Cognition	6486	laminin subunit beta 1	protein-coding gene	gene with protein product	Approved	7q31.1	07q31.1			CLM	cutis laxa with marfanoid phenotype|laminin, beta 1	Laminin subunits
NA	pancreatic agenesis	NA	NA	PTF1A	607194	No disease mim	biallelic	confirmed	cis-regulatory or promotor mutation	Endocrine/Metabolic;Brain/Cognition	23734	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000600	maple syrup urine disease	Abnormality of the pharynx	Very frequent (99-80%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0001249	maple syrup urine disease	Intellectual disability	Very frequent (99-80%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0001250	maple syrup urine disease	Seizures	Very frequent (99-80%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0001251	maple syrup urine disease	Ataxia	Frequent (79-30%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0001252	maple syrup urine disease	Muscular hypotonia	Very frequent (99-80%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0001263	maple syrup urine disease	Global developmental delay	Very frequent (99-80%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0001315	maple syrup urine disease	Reduced tendon reflexes	Very frequent (99-80%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0001608	maple syrup urine disease	Abnormality of the voice	Very frequent (99-80%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0002093	maple syrup urine disease	Respiratory insufficiency	Very frequent (99-80%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0004374	maple syrup urine disease	Hemiplegia/hemiparesis	Frequent (79-30%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0008344	maple syrup urine disease	Elevated plasma branched chain amino acids	Very frequent (99-80%)	BCKDHB	248611	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	987	branched chain keto acid dehydrogenase E1 subunit beta	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1		maple syrup urine disease|2-oxoisovalerate dehydrogenase subunit beta, mitochondrial		branched chain keto acid dehydrogenase E1, beta polypeptide	
HP:0001644	barth syndrome	Dilated cardiomyopathy	Very frequent (99-80%)	TAZ	No gene mim	302060	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11577	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001706	barth syndrome	Endocardial fibroelastosis	Frequent (79-30%)	TAZ	No gene mim	302060	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11577	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001874	barth syndrome	Abnormality of neutrophils	Frequent (79-30%)	TAZ	No gene mim	302060	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11577	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008322	barth syndrome	Abnormal mitochondrial morphology	Frequent (79-30%)	TAZ	No gene mim	302060	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11577	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	parietal foramina 2	NA	NA	ALX4	605420	221704	monoallelic	confirmed	loss of function	Face;Skeleton	450	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	methylcobalamin deficiency type g	NA	NA	MTR	156570	250940	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	7468	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mendelian susceptibility to mycobacterial disease	NA	NA	STAT1	600555	209950	biallelic	confirmed	loss of function	Bone Marrow/Immune	11362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	feingold syndrome type 1	NA	NA	MYCN	164840	164280	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;GI tract;Ear	7559	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondyloenchondrodysplasia with immune dysregulation	NA	NA	ACP5	171640	607944	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	124	acid phosphatase 5, tartrate resistant	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	TRAP|HPAP	tartrate-resistant acid phosphatase|human purple acid phosphatase			Acid phosphatases
NA	mental retardation x-linked type 44	NA	NA	FTSJ1	300499	309549	hemizygous	confirmed	loss of function	Brain/Cognition	13254	FtsJ RNA methyltransferase homolog 1	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	JM23|CDLIV|SPB1|TRM7|TRMT7	tRNA methyltransferase 7 homolog (S. cerevisiae)	MRX9|MRX44	mental retardation, X-linked 9|mental retardation, X-linked 44|FtsJ RNA methyltransferase homolog 1 (E. coli)	X-linked mental retardation|Seven-beta-strand methyltransferase motif containing
NA	autosomal-recessive cerebellar ataxia with spasticity.	NA	NA	GBA2	609471	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	18986	glucosylceramidase beta 2	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3	KIAA1605|AD035|DKFZp762K054	bile acid beta-glucosidase|non-lysosomal glucosylceramidase	SPG46	spastic paraplegia 46 (autosomal recessive)|glucosidase, beta (bile acid) 2	
NA	mental retardation x-linked type 21	NA	NA	IL1RAPL1	300206	300143	hemizygous	confirmed	loss of function	Brain/Cognition	5996	interleukin 1 receptor accessory protein like 1	protein-coding gene	gene with protein product	Approved	Xp21.3-p21.2	Xp21.3-p21.2	OPHN4|TIGIRR-2|IL1R8		IL1RAPL|MRX34|MRX21|MRX10	mental retardation, X-linked 34|mental retardation, X-linked 21|mental retardation, X-linked 10	X-linked mental retardation|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing
NA	amish infantile epilepsy syndrome	NA	NA	ST3GAL5	604402	319543	biallelic	probable	loss of function	Brain/Cognition	10872	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000077	thrombocytopenia-absent radius syndrome	Abnormality of the kidney	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000085	thrombocytopenia-absent radius syndrome	Horseshoe kidney	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000119	thrombocytopenia-absent radius syndrome	Abnormality of the genitourinary system	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000151	thrombocytopenia-absent radius syndrome	Aplasia of the uterus	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	thrombocytopenia-absent radius syndrome	Cleft palate	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	thrombocytopenia-absent radius syndrome	Broad forehead	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	thrombocytopenia-absent radius syndrome	Micrognathia	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	thrombocytopenia-absent radius syndrome	High forehead	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	thrombocytopenia-absent radius syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	thrombocytopenia-absent radius syndrome	Sensorineural hearing impairment	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000891	thrombocytopenia-absent radius syndrome	Cervical ribs	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001181	thrombocytopenia-absent radius syndrome	Adducted thumb	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	thrombocytopenia-absent radius syndrome	Tetralogy of Fallot	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001671	thrombocytopenia-absent radius syndrome	Abnormality of the cardiac septa	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	thrombocytopenia-absent radius syndrome	Thrombocytopenia	Very frequent (99-80%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001928	thrombocytopenia-absent radius syndrome	Abnormality of coagulation	Very frequent (99-80%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	thrombocytopenia-absent radius syndrome	Scoliosis	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002673	thrombocytopenia-absent radius syndrome	Coxa valga	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002827	thrombocytopenia-absent radius syndrome	Hip dislocation	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002949	thrombocytopenia-absent radius syndrome	Fused cervical vertebrae	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002970	thrombocytopenia-absent radius syndrome	Genu varum	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002990	thrombocytopenia-absent radius syndrome	Fibular aplasia	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002999	thrombocytopenia-absent radius syndrome	Patellar dislocation	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003974	thrombocytopenia-absent radius syndrome	Absent radius	Very frequent (99-80%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	thrombocytopenia-absent radius syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004717	thrombocytopenia-absent radius syndrome	Axial malrotation of the kidney	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	thrombocytopenia-absent radius syndrome	Finger syndactyly	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006495	thrombocytopenia-absent radius syndrome	Aplasia/Hypoplasia of the ulna	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006498	thrombocytopenia-absent radius syndrome	Aplasia/Hypoplasia of the patella	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006507	thrombocytopenia-absent radius syndrome	Aplasia/hypoplasia of the humerus	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007413	thrombocytopenia-absent radius syndrome	Nevus flammeus of the forehead	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009829	thrombocytopenia-absent radius syndrome	Phocomelia	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011304	thrombocytopenia-absent radius syndrome	Broad thumb	Occasional (29-5%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100694	thrombocytopenia-absent radius syndrome	Tibial torsion	Frequent (79-30%)	RBM8A	605313	274000	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	9905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	slit-robo rho gtpase-activating protein 3	NA	NA	SRGAP3	No gene mim	606525	monoallelic	possible	loss of function	Brain/Cognition	19744	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	seizures-sensorineural deafness-ataxia-mental retardation-electrolyte imbalance	NA	NA	KCNJ10	602208	612780	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Ear	6256	potassium voltage-gated channel subfamily J member 10	protein-coding gene	gene with protein product	Approved	1q23.2	01q23.2	Kir4.1|Kir1.2			potassium inwardly-rectifying channel, subfamily J, member 10	Potassium voltage-gated channel subfamily J
NA	microphthalmia isolated with coloboma type 5	NA	NA	SHH	600725	611638	monoallelic	confirmed	uncertain	Teeth & Dentitian;Face;Brain/Cognition;Eye	10848	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bruck syndrome type 2	NA	NA	PLOD2	No gene mim	609220	biallelic	confirmed	loss of function	Skeleton	9082	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000010	fanconi anemia	Recurrent urinary tract infections	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000027	fanconi anemia	Azoospermia	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000028	fanconi anemia	Cryptorchidism	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000035	fanconi anemia	Abnormality of the testis	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000047	fanconi anemia	Hypospadias	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000072	fanconi anemia	Hydroureter	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000079	fanconi anemia	Abnormality of the urinary system	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000130	fanconi anemia	Abnormality of the uterus	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000135	fanconi anemia	Hypogonadism	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000175	fanconi anemia	Cleft palate	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000218	fanconi anemia	High palate	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000238	fanconi anemia	Hydrocephalus	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000268	fanconi anemia	Dolichocephaly	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000316	fanconi anemia	Hypertelorism	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000324	fanconi anemia	Facial asymmetry	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000340	fanconi anemia	Sloping forehead	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000347	fanconi anemia	Micrognathia	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000364	fanconi anemia	Hearing abnormality	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000365	fanconi anemia	Hearing impairment	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000453	fanconi anemia	Choanal atresia	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000478	fanconi anemia	Abnormality of the eye	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000483	fanconi anemia	Astigmatism	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000486	fanconi anemia	Strabismus	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000492	fanconi anemia	Abnormality of the eyelid	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000083	fanconi anemia	Renal insufficiency	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000252	fanconi anemia	Microcephaly	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000286	fanconi anemia	Epicanthus	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000504	fanconi anemia	Abnormality of vision	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000505	fanconi anemia	Visual impairment	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000508	fanconi anemia	Ptosis	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000518	fanconi anemia	Cataract	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000520	fanconi anemia	Proptosis	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000568	fanconi anemia	Microphthalmia	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000582	fanconi anemia	Upslanted palpebral fissure	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000639	fanconi anemia	Nystagmus	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000813	fanconi anemia	Bicornuate uterus	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0000864	fanconi anemia	Abnormality of the hypothalamus-pituitary axis	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001000	fanconi anemia	Abnormality of skin pigmentation	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001053	fanconi anemia	Hypopigmented skin patches	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001172	fanconi anemia	Abnormality of the thumb	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001199	fanconi anemia	Triphalangeal thumb	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001249	fanconi anemia	Intellectual disability	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001263	fanconi anemia	Global developmental delay	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001347	fanconi anemia	Hyperreflexia	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001392	fanconi anemia	Abnormality of the liver	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001510	fanconi anemia	Growth delay	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001511	fanconi anemia	Intrauterine growth retardation	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001537	fanconi anemia	Umbilical hernia	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001562	fanconi anemia	Oligohydramnios	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001631	fanconi anemia	Atrial septal defect	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001636	fanconi anemia	Tetralogy of Fallot	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001639	fanconi anemia	Hypertrophic cardiomyopathy	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001643	fanconi anemia	Patent ductus arteriosus	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001646	fanconi anemia	Abnormality of the aortic valve	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001671	fanconi anemia	Abnormality of the cardiac septa	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001679	fanconi anemia	Abnormality of the aorta	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001760	fanconi anemia	Abnormality of the foot	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001763	fanconi anemia	Pes planus	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001770	fanconi anemia	Toe syndactyly	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001824	fanconi anemia	Weight loss	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001871	fanconi anemia	Abnormality of blood and blood-forming tissues	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001873	fanconi anemia	Thrombocytopenia	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001882	fanconi anemia	Leukopenia	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0001903	fanconi anemia	Anemia	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002007	fanconi anemia	Frontal bossing	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002023	fanconi anemia	Anal atresia	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002119	fanconi anemia	Ventriculomegaly	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002245	fanconi anemia	Meckel diverticulum	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002251	fanconi anemia	Aganglionic megacolon	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002414	fanconi anemia	Spina bifida	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002575	fanconi anemia	Tracheoesophageal fistula	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002650	fanconi anemia	Scoliosis	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002664	fanconi anemia	Neoplasm	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002817	fanconi anemia	Abnormality of the upper limb	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002823	fanconi anemia	Abnormality of the femur	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002827	fanconi anemia	Hip dislocation	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002863	fanconi anemia	Myelodysplasia	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0002997	fanconi anemia	Abnormality of the ulna	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0003022	fanconi anemia	Hypoplasia of the ulna	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0003220	fanconi anemia	Abnormality of chromosome stability	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0004209	fanconi anemia	Clinodactyly of the 5th finger	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0004322	fanconi anemia	Short stature	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0004349	fanconi anemia	Reduced bone mineral density	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0005344	fanconi anemia	Abnormality of the carotid arteries	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0005522	fanconi anemia	Pyridoxine-responsive sideroblastic anemia	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0006101	fanconi anemia	Finger syndactyly	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0006265	fanconi anemia	Aplasia/Hypoplasia of fingers	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0006501	fanconi anemia	Aplasia/Hypoplasia of the radius	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0006824	fanconi anemia	Cranial nerve paralysis	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0007400	fanconi anemia	Irregular hyperpigmentation	Very frequent (99-80%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0007565	fanconi anemia	Multiple cafe-au-lait spots	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0007874	fanconi anemia	Almond-shaped palpebral fissure	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0008053	fanconi anemia	Aplasia/Hypoplasia of the iris	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0008572	fanconi anemia	External ear malformation	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0008678	fanconi anemia	Renal hypoplasia/aplasia	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0010293	fanconi anemia	Aplasia/Hypoplasia of the uvula	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0010469	fanconi anemia	Absent testis	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0012041	fanconi anemia	Decreased fertility in males	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0012210	fanconi anemia	Abnormal renal morphology	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0012639	fanconi anemia	Abnormality of nervous system morphology	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0012745	fanconi anemia	Short palpebral fissure	Frequent (79-30%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0100026	fanconi anemia	Arteriovenous malformation	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0100542	fanconi anemia	Abnormal localization of kidney	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0100587	fanconi anemia	Abnormality of the preputium	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0100760	fanconi anemia	Clubbing of toes	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
HP:0100867	fanconi anemia	Duodenal stenosis	Occasional (29-5%)	FANCM	609644	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
NA	knobloch syndrome type i	NA	NA	COL18A1	120328	315926	biallelic	confirmed	loss of function	Skin;Skeleton;Eye	2195	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cog4-cdg	NA	NA	COG4	606976	319493	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	18620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	oculocutaneous albinism type 1	NA	NA	TYR	606933	203100	biallelic	confirmed	loss of function	Skin;Eye	12442	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	conotruncal heart malformations	Tetralogy of Fallot	Very frequent (99-80%)	GDF1	No gene mim	217095	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0001643	conotruncal heart malformations	Patent ductus arteriosus	Frequent (79-30%)	GDF1	No gene mim	217095	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0001669	conotruncal heart malformations	Transposition of the great arteries	Very frequent (99-80%)	GDF1	No gene mim	217095	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0001679	conotruncal heart malformations	Abnormality of the aorta	Frequent (79-30%)	GDF1	No gene mim	217095	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0004414	conotruncal heart malformations	Abnormality of the pulmonary artery	Frequent (79-30%)	GDF1	No gene mim	217095	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0004935	conotruncal heart malformations	Pulmonary artery atresia	Frequent (79-30%)	GDF1	No gene mim	217095	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
HP:0012303	conotruncal heart malformations	Abnormality of the aortic arch	Frequent (79-30%)	GDF1	No gene mim	217095	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	4214	growth differentiation factor 1	protein-coding gene	gene with protein product	Approved	19p13.11	19p13.11					Endogenous ligands
NA	endosteal hyperostosis worth type	NA	NA	LRP5	603506	144750	monoallelic	confirmed	activating	Skeleton;Eye	6697	LDL receptor related protein 5	protein-coding gene	gene with protein product	Approved	11q13.2	11q13.2	LR3|BMND1|HBM|OPS|OPTA1|VBCH2|EVR4		LRP7|OPPG|EVR1	osteoporosis pseudoglioma syndrome|exudative vitreoretinopathy 1|low density lipoprotein receptor-related protein 5	Low density lipoprotein receptors
NA	spinal muscular atrophy with respiratory distress 1	NA	NA	IGHMBP2	600502	604320	biallelic	confirmed	loss of function	Musculature;Respiratory tract	5542	immunoglobulin mu binding protein 2	protein-coding gene	gene with protein product	Approved	11q13.3	11q13.3	ZFAND7|SMUBP2|CATF1|SMARD1|HCSA|HMN6|CMT2S	cardiac transcription factor 1|zinc finger, AN1-type domain 7			Zinc fingers AN1-type|UPF1 like RNA helicases
NA	lissencephaly type 3	NA	NA	TUBA1A	602529	611603	monoallelic	confirmed	all missense/in frame	Brain/Cognition	20766	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	anemia, dyserythropoietic congenital, type iv	NA	NA	KLF1	600599	613673	monoallelic	confirmed	dominant negative	Bone Marrow/Immune	6345	Kruppel like factor 1	protein-coding gene	gene with protein product	Approved	19p13.13	19p13.13	EKLF	erythroid Kruppel-like factor		Kruppel-like factor 1 (erythroid)	Zinc fingers C2H2-type|Kruppel like factors
NA	leukoencephalopathy megalencephalic with subcortical cysts	NA	NA	MLC1	605908	604004	biallelic	confirmed	loss of function	Brain/Cognition	17082	megalencephalic leukoencephalopathy with subcortical cysts 1	protein-coding gene	gene with protein product	Approved	22q13.33	22q13.33	MLC|KIAA0027|LVM|VL				
NA	leber congenital amaurosis 8	NA	NA	CRB1	604210	613835	biallelic	confirmed	loss of function	Eye	2343	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	loeys-dietz syndrome, type 4	NA	NA	TGFB2	No gene mim	614816	monoallelic	both DD and IF	loss of function	Heart/Cardiovasculature/Lymphatic	11768	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ciliary dyskinesia, primary, 18	NA	NA	DNAAF5	No gene mim	614874	biallelic	probable	all missense/in frame	Respiratory tract	26013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nop10-related dyskeratosis congenita	NA	NA	NOP10	No gene mim	318811		possible		Bone Marrow/Immune;Skin	14378	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003028	tarsal-carpal coalition syndrome	Abnormality of the ankles	Very frequent (99-80%)	NOG	602991	186570	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	tarsal-carpal coalition syndrome	Short stature	Very frequent (99-80%)	NOG	602991	186570	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008368	tarsal-carpal coalition syndrome	Tarsal synostosis	Very frequent (99-80%)	NOG	602991	186570	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy	NA	NA	RYR3	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	10485	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked type 63	NA	NA	ACSL4	300157	300387	hemizygous	probable	loss of function	Face;Brain/Cognition	3571	acyl-CoA synthetase long chain family member 4	protein-coding gene	gene with protein product	Approved	Xq23	Xq23	ACS4|LACS4	lignoceroyl-CoA synthase| long-chain fatty-acid-Coenzyme A ligase 4	FACL4|MRX63|MRX68	fatty-acid-Coenzyme A ligase, long-chain 4|mental retardation, X-linked 63|mental retardation, X-linked 68	Acyl-CoA synthetase family|X-linked mental retardation
NA	aortic aneurysm familial thoracic type 5	NA	NA	TGFBR1	190181	608967	monoallelic	confirmed	uncertain	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11772	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy, limb-girdle, type 2s	NA	NA	TRAPPC11	No gene mim	615356	biallelic	probable	loss of function	Musculature;Brain/Cognition	25751	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000040	proteus syndrome	Long penis	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	proteus syndrome	Macrocephaly	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000268	proteus syndrome	Dolichocephaly	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	proteus syndrome	Long face	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000311	proteus syndrome	Round face	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000324	proteus syndrome	Facial asymmetry	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	proteus syndrome	Proptosis	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000567	proteus syndrome	Chorioretinal coloboma	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000873	proteus syndrome	Diabetes insipidus	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000995	proteus syndrome	Melanocytic nevus	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001000	proteus syndrome	Abnormality of skin pigmentation	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001072	proteus syndrome	Thickened skin	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	proteus syndrome	Abnormality of the metacarpal bones	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	proteus syndrome	Intellectual disability	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	proteus syndrome	Seizures	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	proteus syndrome	Craniosynostosis	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001482	proteus syndrome	Subcutaneous nodule	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	proteus syndrome	Splenomegaly	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002230	proteus syndrome	Generalized hirsutism	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	proteus syndrome	Scoliosis	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	proteus syndrome	Skeletal dysplasia	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002664	proteus syndrome	Neoplasm	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002858	proteus syndrome	Meningioma	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003199	proteus syndrome	Decreased muscle mass	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	proteus syndrome	Abnormal form of the vertebral bodies	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003715	proteus syndrome	Myofibrillar myopathy	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004099	proteus syndrome	Macrodactyly	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004326	proteus syndrome	Cachexia	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004418	proteus syndrome	Thrombophlebitis	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004490	proteus syndrome	Calvarial hyperostosis	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005306	proteus syndrome	Capillary hemangiomas	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005595	proteus syndrome	Generalized hyperkeratosis	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007440	proteus syndrome	Generalized hyperpigmentation	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	proteus syndrome	Abnormality of retinal pigmentation	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010508	proteus syndrome	Metatarsus valgus	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010516	proteus syndrome	Thymus hyperplasia	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011276	proteus syndrome	Vascular skin abnormality	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012032	proteus syndrome	Lipoma	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100006	proteus syndrome	Neoplasm of the central nervous system	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100026	proteus syndrome	Arteriovenous malformation	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100521	proteus syndrome	Neoplasm of the thymus	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100526	proteus syndrome	Neoplasm of the lung	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100555	proteus syndrome	Asymmetric growth	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100559	proteus syndrome	Lower limb asymmetry	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100560	proteus syndrome	Upper limb asymmetry	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100615	proteus syndrome	Ovarian neoplasm	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100730	proteus syndrome	Bronchogenic cyst	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100761	proteus syndrome	Visceral angiomatosis	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100764	proteus syndrome	Lymphangioma	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100774	proteus syndrome	Hyperostosis	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000053	proteus syndrome	Macroorchidism	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000107	proteus syndrome	Renal cyst	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	proteus syndrome	Hypertelorism	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	proteus syndrome	Low-set ears	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	proteus syndrome	Macrotia	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	proteus syndrome	Anteverted nares	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000464	proteus syndrome	Abnormality of the neck	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	proteus syndrome	Strabismus	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	proteus syndrome	Downslanted palpebral fissures	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	proteus syndrome	Glaucoma	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	proteus syndrome	Ptosis	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	proteus syndrome	Cataract	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	proteus syndrome	Myopia	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000557	proteus syndrome	Buphthalmos	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000670	proteus syndrome	Carious teeth	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	proteus syndrome	Abnormality of dental enamel	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001004	proteus syndrome	Lymphedema	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001167	proteus syndrome	Abnormality of finger	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	proteus syndrome	Joint stiffness	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001519	proteus syndrome	Disproportionate tall stature	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001555	proteus syndrome	Asymmetry of the thorax	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001597	proteus syndrome	Abnormality of the nail	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001645	proteus syndrome	Sudden cardiac death	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001822	proteus syndrome	Hallux valgus	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002204	proteus syndrome	Pulmonary embolism	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002282	proteus syndrome	Heterotopia	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	proteus syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002719	proteus syndrome	Recurrent infections	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	proteus syndrome	Kyphosis	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002827	proteus syndrome	Hip dislocation	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003019	proteus syndrome	Abnormality of the wrist	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	proteus syndrome	Clinodactyly of the 5th finger	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004420	proteus syndrome	Arterial thrombosis	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	proteus syndrome	Depressed nasal bridge	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	proteus syndrome	Finger syndactyly	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006525	proteus syndrome	Lung segmentation defects	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007400	proteus syndrome	Irregular hyperpigmentation	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007552	proteus syndrome	Abnormal subcutaneous fat tissue distribution	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007565	proteus syndrome	Multiple cafe-au-lait spots	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007818	proteus syndrome	Central heterochromia	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007899	proteus syndrome	Retinal nonattachment	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008675	proteus syndrome	Enlarged polycystic ovaries	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009594	proteus syndrome	Retinal hamartoma	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	proteus syndrome	Reduced number of teeth	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009928	proteus syndrome	Thick nasal alae	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010497	proteus syndrome	Sirenomelia	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010566	proteus syndrome	Hamartoma	Frequent (79-30%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010788	proteus syndrome	Testicular neoplasm	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010816	proteus syndrome	Epidermal nevus	Very frequent (99-80%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011386	proteus syndrome	Narrow internal auditory canal	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100777	proteus syndrome	Exostoses	Occasional (29-5%)	PTEN	601728	176920	mosaic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	camptodactyly tall stature and hearing loss syndrome	NA	NA	FGFR3	134934	610474	monoallelic	confirmed	uncertain	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	centronuclear myopathy with dilated cardiomyopathy	NA	NA	SPEG	No gene mim	615959	biallelic	confirmed	loss of function	Musculature;Heart/Cardiovasculature/Lymphatic	16901	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hibch deficiency	NA	NA	HIBCH	610690	250620	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4908	3-hydroxyisobutyryl-CoA hydrolase	protein-coding gene	gene with protein product	Approved	2q32.2	02q32.2				3-hydroxyisobutyryl-Coenzyme A hydrolase	
NA	mitochondrial complex iv deficiency	NA	NA	SCO1	603644	220110	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	10603	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pituitary hormone deficiency combined type 3	NA	NA	LHX3	600577	221750	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Ear	6595	LIM homeobox 3	protein-coding gene	gene with protein product	Approved	9q34.3	09q34.3					LIM class homeoboxes
NA	dyskeratosis congenita, autosomal recessive 2	NA	NA	NHP2	No gene mim	613987	biallelic	probable	all missense/in frame	Skin;Endocrine/Metabolic	14377	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	episodic ataxia type 5	NA	NA	CACNB4	No gene mim	318989		possible		Brain/Cognition	1404	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000495	congenital erythropoietic porphyria	Recurrent corneal erosions	Occasional (29-5%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000498	congenital erythropoietic porphyria	Blepharitis	Occasional (29-5%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000656	congenital erythropoietic porphyria	Ectropion	Occasional (29-5%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000938	congenital erythropoietic porphyria	Osteopenia	Frequent (79-30%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000987	congenital erythropoietic porphyria	Atypical scarring of skin	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000992	congenital erythropoietic porphyria	Cutaneous photosensitivity	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000998	congenital erythropoietic porphyria	Hypertrichosis	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001000	congenital erythropoietic porphyria	Abnormality of skin pigmentation	Occasional (29-5%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001072	congenital erythropoietic porphyria	Thickened skin	Occasional (29-5%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001096	congenital erythropoietic porphyria	Keratoconjunctivitis	Occasional (29-5%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001155	congenital erythropoietic porphyria	Abnormality of the hand	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001581	congenital erythropoietic porphyria	Recurrent skin infections	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	congenital erythropoietic porphyria	Splenomegaly	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001760	congenital erythropoietic porphyria	Abnormality of the foot	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001790	congenital erythropoietic porphyria	Nonimmune hydrops fetalis	Occasional (29-5%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	congenital erythropoietic porphyria	Thrombocytopenia	Occasional (29-5%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001878	congenital erythropoietic porphyria	Hemolytic anemia	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002721	congenital erythropoietic porphyria	Immunodeficiency	Frequent (79-30%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	congenital erythropoietic porphyria	Recurrent fractures	Frequent (79-30%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008066	congenital erythropoietic porphyria	Abnormal blistering of the skin	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010472	congenital erythropoietic porphyria	Abnormality of the heme biosynthetic pathway	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012086	congenital erythropoietic porphyria	Abnormal urinary color	Very frequent (99-80%)	UROS	606938	263700	biallelic	confirmed	loss of function	Skin	12592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dyssegmental dysplasia silverman-handmaker type	NA	NA	HSPG2	142461	224410	biallelic	confirmed	loss of function	Musculature;Skeleton	5273	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	susceptibility to autism type 17	NA	NA	SHANK2	No gene mim	613436	monoallelic	probable	loss of function	Brain/Cognition	14295	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mucopolysaccharidosis type 1h	NA	NA	IDUA	252800	607014	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	5391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive typical nemaline myopathy	NA	NA	NEB	No gene mim	256030	biallelic	possible	loss of function	Musculature;Spinal cord/Peripheral nerves	7720	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	l-2-hydroxyglutaric aciduria	Macrocephaly	Frequent (79-30%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0000708	l-2-hydroxyglutaric aciduria	Behavioral abnormality	Frequent (79-30%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0001250	l-2-hydroxyglutaric aciduria	Seizures	Very frequent (99-80%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0001252	l-2-hydroxyglutaric aciduria	Muscular hypotonia	Frequent (79-30%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0001285	l-2-hydroxyglutaric aciduria	Spastic tetraparesis	Frequent (79-30%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0002071	l-2-hydroxyglutaric aciduria	Abnormality of extrapyramidal motor function	Frequent (79-30%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0002357	l-2-hydroxyglutaric aciduria	Dysphasia	Occasional (29-5%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0002383	l-2-hydroxyglutaric aciduria	Encephalitis	Very frequent (99-80%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0004375	l-2-hydroxyglutaric aciduria	Neoplasm of the nervous system	Frequent (79-30%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0006887	l-2-hydroxyglutaric aciduria	Intellectual disability, progressive	Very frequent (99-80%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0007360	l-2-hydroxyglutaric aciduria	Aplasia/Hypoplasia of the cerebellum	Frequent (79-30%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
HP:0010864	l-2-hydroxyglutaric aciduria	Intellectual disability, severe	Very frequent (99-80%)	L2HGDH	609584	236792	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20499	L-2-hydroxyglutarate dehydrogenase	protein-coding gene	gene with protein product	Approved	14q21.3	14q21.3	FLJ12618	2-hydroxyglutarate dehydrogenase	C14orf160	chromosome 14 open reading frame 160	
NA	developmental and expressive language delay	NA	NA	SETBP1	611060	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	15573	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	niemann-pick disease type b	NA	NA	SMPD1	607608	607616	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract	11120	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple synostoses syndrome type 3	NA	NA	FGF9	600921	612961	monoallelic	probable	loss of function	Skeleton;Ear	3687	fibroblast growth factor 9	protein-coding gene	gene with protein product	Approved	13q12.11	13q12.11		glia-activating factor		fibroblast growth factor 9 (glia-activating factor)	Endogenous ligands
NA	fancm-related fanconi anemia	NA	NA	FANCM	609644	287713	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	23168	Fanconi anemia complementation group M	protein-coding gene	gene with protein product	Approved	14q21.2	14q21.2	FAAP250		KIAA1596	KIAA1596	Fanconi anemia complementation groups|RNA helicases
NA	martsolf syndrome	NA	NA	RAB3GAP2	609275	212720	biallelic	confirmed	loss of function	Brain/Cognition;Eye;Genitalia	17168	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000162	catel-manzke syndrome	Glossoptosis	Very frequent (99-80%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	catel-manzke syndrome	Cleft palate	Very frequent (99-80%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	catel-manzke syndrome	Malar flattening	Very frequent (99-80%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000293	catel-manzke syndrome	Full cheeks	Frequent (79-30%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	catel-manzke syndrome	Hypertelorism	Occasional (29-5%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	catel-manzke syndrome	Micrognathia	Very frequent (99-80%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	catel-manzke syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000389	catel-manzke syndrome	Chronic otitis media	Frequent (79-30%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000767	catel-manzke syndrome	Pectus excavatum	Occasional (29-5%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	catel-manzke syndrome	Joint stiffness	Frequent (79-30%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	catel-manzke syndrome	Failure to thrive	Very frequent (99-80%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	catel-manzke syndrome	Ventricular septal defect	Frequent (79-30%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001631	catel-manzke syndrome	Atrial septal defect	Occasional (29-5%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	catel-manzke syndrome	Ventriculomegaly	Occasional (29-5%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002553	catel-manzke syndrome	Highly arched eyebrow	Frequent (79-30%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	catel-manzke syndrome	Malformation of the heart and great vessels	Frequent (79-30%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	catel-manzke syndrome	Scoliosis	Frequent (79-30%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	catel-manzke syndrome	Clinodactyly of the 5th finger	Very frequent (99-80%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	catel-manzke syndrome	Short stature	Frequent (79-30%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	catel-manzke syndrome	Joint hyperflexibility	Occasional (29-5%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	catel-manzke syndrome	Abnormality of epiphysis morphology	Very frequent (99-80%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009467	catel-manzke syndrome	Radial deviation of the 2nd finger	Occasional (29-5%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010285	catel-manzke syndrome	Oral synechia	Occasional (29-5%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010508	catel-manzke syndrome	Metatarsus valgus	Occasional (29-5%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	catel-manzke syndrome	Camptodactyly of finger	Occasional (29-5%)	TGDS	No gene mim	616145	biallelic	confirmed	loss of function	Face;Skeleton	20324	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hydrops-ectopic calcification-moth-eaten skeletal dysplasia	NA	NA	LBR	600024	215140	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Brain/Cognition	6518	lamin B receptor	protein-coding gene	gene with protein product	Approved	1q42.12	01q42.12	DHCR14B|TDRD18	tudor domain containing 18			Tudor domain containing
NA	anemia, dyserythropoietic congenital, type ii	NA	NA	SEC23B	610512	224100	biallelic	confirmed	loss of function	Bone Marrow/Immune	10702	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	smith-kingsmore syndrome	NA	NA	MTOR	No gene mim	No disease mim	monoallelic,mosaic	confirmed	all missense/in frame	Face;Brain/Cognition	3942	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	waardenburg syndrome type 4c	NA	NA	SOX10	602229	613266	monoallelic	confirmed	loss of function	Skin;Face;Spinal cord/Peripheral nerves;Ear	11190	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000010	hand-foot-genital syndrome	Recurrent urinary tract infections	Frequent (79-30%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	hand-foot-genital syndrome	Hypospadias	Frequent (79-30%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000074	hand-foot-genital syndrome	Ureteropelvic junction obstruction	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	hand-foot-genital syndrome	Vesicoureteral reflux	Frequent (79-30%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000130	hand-foot-genital syndrome	Abnormality of the uterus	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	hand-foot-genital syndrome	Strabismus	Occasional (29-5%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000795	hand-foot-genital syndrome	Abnormality of the urethra	Frequent (79-30%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000813	hand-foot-genital syndrome	Bicornuate uterus	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000960	hand-foot-genital syndrome	Sacral dimple	Occasional (29-5%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001162	hand-foot-genital syndrome	Postaxial hand polydactyly	Occasional (29-5%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	hand-foot-genital syndrome	Ventricular septal defect	Occasional (29-5%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	hand-foot-genital syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005048	hand-foot-genital syndrome	Synostosis of carpal bones	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005268	hand-foot-genital syndrome	Spontaneous abortion	Occasional (29-5%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006110	hand-foot-genital syndrome	Shortening of all middle phalanges of the fingers	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007477	hand-foot-genital syndrome	Abnormal dermatoglyphics	Frequent (79-30%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008080	hand-foot-genital syndrome	Hallux varus	Frequent (79-30%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008551	hand-foot-genital syndrome	Microtia	Occasional (29-5%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009623	hand-foot-genital syndrome	Proximal placement of thumb	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009778	hand-foot-genital syndrome	Short thumb	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009882	hand-foot-genital syndrome	Short distal phalanx of finger	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010034	hand-foot-genital syndrome	Short 1st metacarpal	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010105	hand-foot-genital syndrome	Short first metatarsal	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010109	hand-foot-genital syndrome	Short hallux	Very frequent (99-80%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011937	hand-foot-genital syndrome	Hypoplastic fifth toenail	Frequent (79-30%)	HOXA13	No gene mim	140000	monoallelic	confirmed	loss of function	Skeleton;Genitalia	5102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked with isolated growth hormone deficiency	NA	NA	SOX3	313430	300123	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11199	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ichthyosis prematurity syndrome	NA	NA	SLC27A4	No gene mim	608649	biallelic	confirmed	loss of function	Skin;Respiratory tract	10998	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	sjoegren-larsson syndrome	NA	NA	ALDH3A2	609523	270200	biallelic	confirmed	loss of function	Brain/Cognition	403	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	craniofacial-deafness-hand syndrome	Narrow mouth	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000275	craniofacial-deafness-hand syndrome	Narrow face	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	craniofacial-deafness-hand syndrome	Hypertelorism	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	craniofacial-deafness-hand syndrome	Hypoplasia of the maxilla	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	craniofacial-deafness-hand syndrome	Sensorineural hearing impairment	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	craniofacial-deafness-hand syndrome	Depressed nasal ridge	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	craniofacial-deafness-hand syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000564	craniofacial-deafness-hand syndrome	Lacrimal duct atresia	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000581	craniofacial-deafness-hand syndrome	Blepharophimosis	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003019	craniofacial-deafness-hand syndrome	Abnormality of the wrist	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003049	craniofacial-deafness-hand syndrome	Ulnar deviation of the wrist	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	craniofacial-deafness-hand syndrome	Short nose	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	craniofacial-deafness-hand syndrome	Depressed nasal bridge	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009465	craniofacial-deafness-hand syndrome	Ulnar deviation of finger	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009924	craniofacial-deafness-hand syndrome	Aplasia/Hypoplasia involving the nose	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012368	craniofacial-deafness-hand syndrome	Flat face	Very frequent (99-80%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	craniofacial-deafness-hand syndrome	Camptodactyly of finger	Frequent (79-30%)	PAX3	606597	122880	monoallelic	confirmed	loss of function	Face;GI tract;Ear	8617	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cleft palate, x-linked	NA	NA	TBX22	300307	304011	hemizygous	confirmed	loss of function	Face	11600	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	hermansky-pudlak syndrome	Nystagmus	Very frequent (99-80%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001010	hermansky-pudlak syndrome	Hypopigmentation of the skin	Very frequent (99-80%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001875	hermansky-pudlak syndrome	Neutropenia	Very frequent (99-80%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001892	hermansky-pudlak syndrome	Abnormal bleeding	Very frequent (99-80%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002721	hermansky-pudlak syndrome	Immunodeficiency	Very frequent (99-80%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007443	hermansky-pudlak syndrome	Partial albinism	Very frequent (99-80%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007730	hermansky-pudlak syndrome	Iris hypopigmentation	Very frequent (99-80%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000083	hermansky-pudlak syndrome	Renal insufficiency	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000421	hermansky-pudlak syndrome	Epistaxis	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000483	hermansky-pudlak syndrome	Astigmatism	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	hermansky-pudlak syndrome	Strabismus	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	hermansky-pudlak syndrome	Cataract	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	hermansky-pudlak syndrome	Myopia	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000587	hermansky-pudlak syndrome	Abnormality of the optic nerve	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000613	hermansky-pudlak syndrome	Photophobia	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000646	hermansky-pudlak syndrome	Amblyopia	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000649	hermansky-pudlak syndrome	Abnormality of visual evoked potentials	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000978	hermansky-pudlak syndrome	Bruising susceptibility	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001107	hermansky-pudlak syndrome	Ocular albinism	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002206	hermansky-pudlak syndrome	Pulmonary fibrosis	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005599	hermansky-pudlak syndrome	Hypopigmentation of hair	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0400008	hermansky-pudlak syndrome	Menometrorrhagia	Frequent (79-30%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	hermansky-pudlak syndrome	Visual impairment	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000527	hermansky-pudlak syndrome	Long eyelashes	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	hermansky-pudlak syndrome	Abnormality of dental enamel	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000962	hermansky-pudlak syndrome	Hyperkeratosis	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000995	hermansky-pudlak syndrome	Melanocytic nevus	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001072	hermansky-pudlak syndrome	Thickened skin	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001638	hermansky-pudlak syndrome	Cardiomyopathy	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001824	hermansky-pudlak syndrome	Weight loss	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001872	hermansky-pudlak syndrome	Abnormality of thrombocytes	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	hermansky-pudlak syndrome	Malabsorption	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002027	hermansky-pudlak syndrome	Abdominal pain	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002039	hermansky-pudlak syndrome	Anorexia	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002094	hermansky-pudlak syndrome	Dyspnea	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002239	hermansky-pudlak syndrome	Gastrointestinal hemorrhage	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002671	hermansky-pudlak syndrome	Basal cell carcinoma	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006739	hermansky-pudlak syndrome	Squamous cell carcinoma of the skin	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012378	hermansky-pudlak syndrome	Fatigue	Occasional (29-5%)	HPS1	604982	203300	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin	5163	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glycerol kinase deficiency	NA	NA	GK	No gene mim	307030	hemizygous	confirmed	loss of function	Endocrine/Metabolic	4289	glycerol kinase	protein-coding gene	gene with protein product	Approved	Xp21.2	Xp21.2	GK1|GKD				Glycerol kinases
NA	polymicrogyria asymmetric	NA	NA	TUBB2B	612850	610031	monoallelic	confirmed	dominant negative	Brain/Cognition	30829	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	meckel syndrome type 5	NA	NA	RPGRIP1L	610937	611561	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;GI tract	29168	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	primary ciliary dyskinesia	Recurrent respiratory infections	Very frequent (99-80%)	CCDC103	614677	No disease mim	biallelic	confirmed	loss of function	Lungs;GI tract;Heart/Cardiovasculature/Lymphatic	32700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atrichia with papular lesions	NA	NA	HR	602302	209500	biallelic	confirmed	loss of function	Skin;Hair/Nails	5172	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital disorder of glycosylation, type ix	NA	NA	STT3B	No gene mim	615597	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition	30611	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	3-methylglutaconic aciduria, type vii, with cataracts, neurologic involvement and neutropenia	NA	NA	CLPB	No gene mim	616271	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	30664	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	vitreoretinopathy exudative type 4	NA	NA	LRP5	603506	601813	monoallelic	confirmed	loss of function	Skeleton;Eye	6697	LDL receptor related protein 5	protein-coding gene	gene with protein product	Approved	11q13.2	11q13.2	LR3|BMND1|HBM|OPS|OPTA1|VBCH2|EVR4		LRP7|OPPG|EVR1	osteoporosis pseudoglioma syndrome|exudative vitreoretinopathy 1|low density lipoprotein receptor-related protein 5	Low density lipoprotein receptors
HP:0002355	becker muscular dystrophy	Difficulty walking	Very frequent (99-80%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002913	becker muscular dystrophy	Myoglobinuria	Very frequent (99-80%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003236	becker muscular dystrophy	Elevated serum creatine phosphokinase	Very frequent (99-80%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003326	becker muscular dystrophy	Myalgia	Very frequent (99-80%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003546	becker muscular dystrophy	Exercise intolerance	Very frequent (99-80%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003551	becker muscular dystrophy	Difficulty climbing stairs	Very frequent (99-80%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012086	becker muscular dystrophy	Abnormal urinary color	Very frequent (99-80%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	becker muscular dystrophy	Muscle weakness	Frequent (79-30%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002527	becker muscular dystrophy	Falls	Frequent (79-30%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002814	becker muscular dystrophy	Abnormality of the lower limb	Frequent (79-30%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002910	becker muscular dystrophy	Elevated hepatic transaminases	Frequent (79-30%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003394	becker muscular dystrophy	Muscle cramps	Frequent (79-30%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012378	becker muscular dystrophy	Fatigue	Frequent (79-30%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001763	becker muscular dystrophy	Pes planus	Occasional (29-5%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	becker muscular dystrophy	Skeletal muscle atrophy	Occasional (29-5%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0040083	becker muscular dystrophy	Toe walking	Occasional (29-5%)	DMD	300377	300376	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	tarp syndrome	NA	NA	RBM10	300080	311900	hemizygous	probable	loss of function	Face;Brain/Cognition	9896	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mandibulofacial dysostosis with microcephaly	NA	NA	EFTUD2	603892	610536	monoallelic	confirmed	loss of function	Face;Brain/Cognition;Genitalia	30858	elongation factor Tu GTP binding domain containing 2	protein-coding gene	gene with protein product	Approved	17q21.31	17q21.31	U5-116KD|Snrp116|Snu114|SNRNP116	U5 snRNP specific protein, 116 kD			U5 small nucleolar ribonucleoprotein|Spliceosomal Bact complex|Spliceosomal C complex|Spliceosomal P complex
HP:0001773	brachydactyly type b2	Short foot	Very frequent (99-80%)	NOG	602991	611377	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001817	brachydactyly type b2	Absent fingernail	Very frequent (99-80%)	NOG	602991	611377	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001831	brachydactyly type b2	Short toe	Very frequent (99-80%)	NOG	602991	611377	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001857	brachydactyly type b2	Short distal phalanx of toe	Very frequent (99-80%)	NOG	602991	611377	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005048	brachydactyly type b2	Synostosis of carpal bones	Frequent (79-30%)	NOG	602991	611377	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005831	brachydactyly type b2	Type B brachydactyly	Very frequent (99-80%)	NOG	602991	611377	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	brachydactyly type b2	Finger syndactyly	Frequent (79-30%)	NOG	602991	611377	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009773	brachydactyly type b2	Symphalangism affecting the phalanges of the hand	Frequent (79-30%)	NOG	602991	611377	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009882	brachydactyly type b2	Short distal phalanx of finger	Very frequent (99-80%)	NOG	602991	611377	monoallelic	confirmed	uncertain	Skeleton	7866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	FASN	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	3594	fatty acid synthase	protein-coding gene	gene with protein product	Approved	17q25.3	17q25.3	FAS|SDR27X1	short chain dehydrogenase/reductase family 27X, member 1			Short chain dehydrogenase/reductase superfamily|Seven-beta-strand methyltransferase motif containing
NA	cataract autosomal dominant	NA	NA	PITX3	602669	604219	monoallelic	confirmed	uncertain	Eye	9006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	metaphyseal anadysplasia type 1	NA	NA	MMP13	600108	602111	biallelic	confirmed	all missense/in frame	Skeleton	7159	matrix metallopeptidase 13	protein-coding gene	gene with protein product	Approved	11q22.2	11q22.2	CLG3	collagenase 3		matrix metalloproteinase 13 (collagenase 3)	Endogenous ligands|M10 matrix metallopeptidases
NA	autosomal recessive mental retardation	NA	NA	POLR3B	614366	No disease mim	biallelic	confirmed	all missense/in frame	Teeth & Dentitian;Endocrine/Metabolic;Brain/Cognition	30348	RNA polymerase III subunit B	protein-coding gene	gene with protein product	Approved	12q23.3	12q23.3	RPC2|FLJ10388			polymerase (RNA) III (DNA directed) polypeptide B	RNA polymerase subunits
NA	ataxia with oculomotor apraxia 1	NA	NA	APTX	606350	208920	biallelic	confirmed	loss of function	Spinal cord/Peripheral nerves;Brain/Cognition;Eye	15984	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	3-methylcrotonyl-coa carboxylase deficiency	Muscular hypotonia	Very frequent (99-80%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0001257	3-methylcrotonyl-coa carboxylase deficiency	Spasticity	Occasional (29-5%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0001531	3-methylcrotonyl-coa carboxylase deficiency	Failure to thrive in infancy	Frequent (79-30%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0001943	3-methylcrotonyl-coa carboxylase deficiency	Hypoglycemia	Very frequent (99-80%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0001987	3-methylcrotonyl-coa carboxylase deficiency	Hyperammonemia	Frequent (79-30%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0001992	3-methylcrotonyl-coa carboxylase deficiency	Organic aciduria	Very frequent (99-80%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0002093	3-methylcrotonyl-coa carboxylase deficiency	Respiratory insufficiency	Occasional (29-5%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0004357	3-methylcrotonyl-coa carboxylase deficiency	Abnormality of leucine metabolism	Very frequent (99-80%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0100022	3-methylcrotonyl-coa carboxylase deficiency	Abnormality of movement	Frequent (79-30%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0100659	3-methylcrotonyl-coa carboxylase deficiency	Abnormality of the cerebral vasculature	Occasional (29-5%)	MCCC1	No gene mim	210200	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6936	methylcrotonoyl-CoA carboxylase 1	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	MCCA	methylcrotonoyl-CoA carboxylase alpha		methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)	
HP:0000028	schneckenbecken dysplasia	Cryptorchidism	Frequent (79-30%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	schneckenbecken dysplasia	Cleft palate	Occasional (29-5%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	schneckenbecken dysplasia	Macrocephaly	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000268	schneckenbecken dysplasia	Dolichocephaly	Frequent (79-30%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	schneckenbecken dysplasia	Malar flattening	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	schneckenbecken dysplasia	Short neck	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000773	schneckenbecken dysplasia	Short ribs	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	schneckenbecken dysplasia	Narrow chest	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000882	schneckenbecken dysplasia	Hypoplastic scapulae	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000895	schneckenbecken dysplasia	Lateral clavicle hook	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	schneckenbecken dysplasia	Abnormality of the metaphyses	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000946	schneckenbecken dysplasia	Hypoplastic ilia	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000947	schneckenbecken dysplasia	Dumbbell-shaped long bone	Occasional (29-5%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001004	schneckenbecken dysplasia	Lymphedema	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001231	schneckenbecken dysplasia	Abnormality of the fingernails	Frequent (79-30%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	schneckenbecken dysplasia	Polyhydramnios	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001800	schneckenbecken dysplasia	Hypoplastic toenails	Frequent (79-30%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	schneckenbecken dysplasia	Micromelia	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003038	schneckenbecken dysplasia	Fibular hypoplasia	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	schneckenbecken dysplasia	Abnormal form of the vertebral bodies	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005019	schneckenbecken dysplasia	Diaphyseal thickening	Occasional (29-5%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005616	schneckenbecken dysplasia	Accelerated skeletal maturation	Occasional (29-5%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008108	schneckenbecken dysplasia	Advanced tarsal ossification	Occasional (29-5%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008479	schneckenbecken dysplasia	Hypoplastic vertebral bodies	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008873	schneckenbecken dysplasia	Disproportionate short-limb short stature	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012107	schneckenbecken dysplasia	Increased fibular diameter	Very frequent (99-80%)	SLC35D1	610804	269250	biallelic	confirmed	loss of function	Skeleton	20800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	diastrophic dysplasia	NA	NA	SLC26A2	606718	222600	biallelic	confirmed	loss of function	Skeleton	10994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephronophthisis type 1	NA	NA	NPHP1	607100	256100	biallelic	confirmed	loss of function	Kidney Renal Tract;Eye	7905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mismatch repair cancer syndrome	NA	NA	PMS2	No gene mim	276300	biallelic	confirmed	loss of function	GI tract	9122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital heart disease, nonsyndromic, 2	NA	NA	TAB2	No gene mim	612863	monoallelic	confirmed	all missense/in frame	Heart/Cardiovasculature/Lymphatic	17075	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX16	603360	214100	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye;Ear	8857	peroxisomal biogenesis factor 16	protein-coding gene	gene with protein product	Approved	11p11.2	11p11.2					Peroxins
NA	platyspondyly with amelogenesis imperfecta	NA	NA	LTBP3	No gene mim	601216	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton	6716	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	phosphoglycerate dehydrogenase deficiency	NA	NA	PHGDH	606879	601815	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8923	phosphoglycerate dehydrogenase	protein-coding gene	gene with protein product	Approved	1p12	01p12	SERA|PGDH|PDG				
NA	autosomal recessive mental retardation	NA	NA	ZCCHC8	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	25265	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	KDM6B	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	29012	lysine demethylase 6B	protein-coding gene	gene with protein product	Approved	17p13.1	17p13.1	KIAA0346		JMJD3	jumonji domain containing 3|jumonji domain containing 3, histone lysine demethylase|lysine (K)-specific demethylase 6B	Lysine demethylases
NA	weissenbacher-zweymueller syndrome	NA	NA	COL11A2	120290	277610	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000482	cataract-microcornea syndrome	Microcornea	Very frequent (99-80%)	GJA8	600897	116150	monoallelic	confirmed	uncertain	Eye	4281	gap junction protein alpha 8	protein-coding gene	gene with protein product	Approved	1q21.2	01q21.2	CX50	connexin 50	CAE1|CZP1|CAE	gap junction protein, alpha 8, 50kD (connexin 50)|gap junction protein, alpha 8, 50kDa (connexin 50)|gap junction protein, alpha 8, 50kDa	Gap junction proteins
HP:0000518	cataract-microcornea syndrome	Cataract	Very frequent (99-80%)	GJA8	600897	116150	monoallelic	confirmed	uncertain	Eye	4281	gap junction protein alpha 8	protein-coding gene	gene with protein product	Approved	1q21.2	01q21.2	CX50	connexin 50	CAE1|CZP1|CAE	gap junction protein, alpha 8, 50kD (connexin 50)|gap junction protein, alpha 8, 50kDa (connexin 50)|gap junction protein, alpha 8, 50kDa	Gap junction proteins
HP:0000545	cataract-microcornea syndrome	Myopia	Frequent (79-30%)	GJA8	600897	116150	monoallelic	confirmed	uncertain	Eye	4281	gap junction protein alpha 8	protein-coding gene	gene with protein product	Approved	1q21.2	01q21.2	CX50	connexin 50	CAE1|CZP1|CAE	gap junction protein, alpha 8, 50kD (connexin 50)|gap junction protein, alpha 8, 50kDa (connexin 50)|gap junction protein, alpha 8, 50kDa	Gap junction proteins
HP:0000612	cataract-microcornea syndrome	Iris coloboma	Occasional (29-5%)	GJA8	600897	116150	monoallelic	confirmed	uncertain	Eye	4281	gap junction protein alpha 8	protein-coding gene	gene with protein product	Approved	1q21.2	01q21.2	CX50	connexin 50	CAE1|CZP1|CAE	gap junction protein, alpha 8, 50kD (connexin 50)|gap junction protein, alpha 8, 50kDa (connexin 50)|gap junction protein, alpha 8, 50kDa	Gap junction proteins
HP:0000639	cataract-microcornea syndrome	Nystagmus	Occasional (29-5%)	GJA8	600897	116150	monoallelic	confirmed	uncertain	Eye	4281	gap junction protein alpha 8	protein-coding gene	gene with protein product	Approved	1q21.2	01q21.2	CX50	connexin 50	CAE1|CZP1|CAE	gap junction protein, alpha 8, 50kD (connexin 50)|gap junction protein, alpha 8, 50kDa (connexin 50)|gap junction protein, alpha 8, 50kDa	Gap junction proteins
HP:0001131	cataract-microcornea syndrome	Corneal dystrophy	Occasional (29-5%)	GJA8	600897	116150	monoallelic	confirmed	uncertain	Eye	4281	gap junction protein alpha 8	protein-coding gene	gene with protein product	Approved	1q21.2	01q21.2	CX50	connexin 50	CAE1|CZP1|CAE	gap junction protein, alpha 8, 50kD (connexin 50)|gap junction protein, alpha 8, 50kDa (connexin 50)|gap junction protein, alpha 8, 50kDa	Gap junction proteins
HP:0007957	cataract-microcornea syndrome	Corneal opacity	Occasional (29-5%)	GJA8	600897	116150	monoallelic	confirmed	uncertain	Eye	4281	gap junction protein alpha 8	protein-coding gene	gene with protein product	Approved	1q21.2	01q21.2	CX50	connexin 50	CAE1|CZP1|CAE	gap junction protein, alpha 8, 50kD (connexin 50)|gap junction protein, alpha 8, 50kDa (connexin 50)|gap junction protein, alpha 8, 50kDa	Gap junction proteins
NA	asphyxiating thoracic dystrophy 2	NA	NA	IFT80	611177	611263	biallelic	confirmed	all missense/in frame	Skeleton	29262	intraflagellar transport 80	protein-coding gene	gene with protein product	Approved	3q25.33	03q25.33	KIAA1374		WDR56	WD repeat domain 56|intraflagellar transport 80 homolog (Chlamydomonas)	WD repeat domain containing|Intraflagellar transport proteins
NA	ehlers-danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss	NA	NA	FKBP14	614505	No disease mim	biallelic	confirmed	loss of function	Musculature;Skin;Skeleton;Ear	18625	FK506 binding protein 14	protein-coding gene	gene with protein product	Approved	7p14.3	07p14.3	FLJ20731|FKBP22			FK506 binding protein 14 (22 kDa)|FK506 binding protein 14, 22 kDa	EF-hand domain containing|FKBP prolyl isomerases
HP:0000010	lymphedema-distichiasis syndrome	Recurrent urinary tract infections	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000075	lymphedema-distichiasis syndrome	Renal duplication	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000093	lymphedema-distichiasis syndrome	Proteinuria	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000175	lymphedema-distichiasis syndrome	Cleft palate	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000204	lymphedema-distichiasis syndrome	Cleft upper lip	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000465	lymphedema-distichiasis syndrome	Webbed neck	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000508	lymphedema-distichiasis syndrome	Ptosis	Frequent (79-30%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000509	lymphedema-distichiasis syndrome	Conjunctivitis	Very frequent (99-80%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000518	lymphedema-distichiasis syndrome	Cataract	Frequent (79-30%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000613	lymphedema-distichiasis syndrome	Photophobia	Very frequent (99-80%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000656	lymphedema-distichiasis syndrome	Ectropion	Frequent (79-30%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0000819	lymphedema-distichiasis syndrome	Diabetes mellitus	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0001324	lymphedema-distichiasis syndrome	Muscle weakness	Frequent (79-30%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0001581	lymphedema-distichiasis syndrome	Recurrent skin infections	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0001643	lymphedema-distichiasis syndrome	Patent ductus arteriosus	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0001970	lymphedema-distichiasis syndrome	Tubulointerstitial nephritis	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0002564	lymphedema-distichiasis syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0002619	lymphedema-distichiasis syndrome	Varicose veins	Frequent (79-30%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0003550	lymphedema-distichiasis syndrome	Predominantly lower limb lymphedema	Very frequent (99-80%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0004930	lymphedema-distichiasis syndrome	Abnormality of the pulmonary vasculature	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0009743	lymphedema-distichiasis syndrome	Distichiasis	Very frequent (99-80%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0009745	lymphedema-distichiasis syndrome	Spinalarachnoid cyst	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0011675	lymphedema-distichiasis syndrome	Arrhythmia	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0100244	lymphedema-distichiasis syndrome	Fibrosarcoma	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0100820	lymphedema-distichiasis syndrome	Glomerulopathy	Occasional (29-5%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
HP:0200020	lymphedema-distichiasis syndrome	Corneal erosion	Very frequent (99-80%)	FOXC2	602402	153400	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
NA	autosomal recessive mental retardation	NA	NA	LINS1	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	30922	lines homolog 1	protein-coding gene	gene with protein product	Approved	15q26.3	15q26.3	WINS1		LINS	lines homolog 1 (Drosophila)|lines homolog (Drosophila)	
NA	dihydrolipoamide dehydrogenase (e3) deficiency	NA	NA	DLD	238331	248600	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	hypochondroplasia	Macrocephaly	Occasional (29-5%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000944	hypochondroplasia	Abnormality of the metaphyses	Frequent (79-30%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001156	hypochondroplasia	Brachydactyly syndrome	Very frequent (99-80%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001249	hypochondroplasia	Intellectual disability	Occasional (29-5%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001831	hypochondroplasia	Short toe	Very frequent (99-80%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002644	hypochondroplasia	Abnormality of pelvic girdle bone morphology	Frequent (79-30%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002650	hypochondroplasia	Scoliosis	Occasional (29-5%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002652	hypochondroplasia	Skeletal dysplasia	Very frequent (99-80%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002758	hypochondroplasia	Osteoarthritis	Occasional (29-5%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002823	hypochondroplasia	Abnormality of the femur	Frequent (79-30%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002970	hypochondroplasia	Genu varum	Frequent (79-30%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002983	hypochondroplasia	Micromelia	Very frequent (99-80%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003307	hypochondroplasia	Hyperlordosis	Occasional (29-5%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003312	hypochondroplasia	Abnormal form of the vertebral bodies	Very frequent (99-80%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003416	hypochondroplasia	Spinal canal stenosis	Occasional (29-5%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005692	hypochondroplasia	Joint hyperflexibility	Frequent (79-30%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0006487	hypochondroplasia	Bowing of the long bones	Occasional (29-5%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0009811	hypochondroplasia	Abnormality of the elbow	Frequent (79-30%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010535	hypochondroplasia	Sleep apnea	Occasional (29-5%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0011405	hypochondroplasia	Childhood onset short-limb short stature	Very frequent (99-80%)	FGFR3	134934	146000	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	cataract congenital cerulean type 3	NA	NA	CRYGD	123690	608983	monoallelic	confirmed	uncertain	Eye	2411	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital hypothyroidism non-goitrous type 2	NA	NA	PAX8	167415	218700	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8622	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neu-laxova	NA	NA	PSPH	172480	256520	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	9577	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hypophosphatemic rickets, autosomal recessive, 2	NA	NA	ENPP1	173335	613312	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	3356	ectonucleotide pyrophosphatase/phosphodiesterase 1	protein-coding gene	gene with protein product	Approved	6q23.2	06q23.2	PC-1|PCA1		NPPS|M6S1|PDNP1		
HP:0000028	acrodysostosis	Cryptorchidism	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000055	acrodysostosis	Abnormality of female external genitalia	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	acrodysostosis	Hypogonadism	Occasional (29-5%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000194	acrodysostosis	Open mouth	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	acrodysostosis	Brachycephaly	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	acrodysostosis	Epicanthus	Occasional (29-5%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	acrodysostosis	Mandibular prognathia	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	acrodysostosis	Hypertelorism	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000327	acrodysostosis	Hypoplasia of the maxilla	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	acrodysostosis	Hearing impairment	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	acrodysostosis	Wide nasal bridge	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	acrodysostosis	Depressed nasal ridge	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	acrodysostosis	Anteverted nares	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	acrodysostosis	Delayed eruption of teeth	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000858	acrodysostosis	Menstrual irregularities	Occasional (29-5%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000995	acrodysostosis	Melanocytic nevus	Occasional (29-5%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	acrodysostosis	Brachydactyly syndrome	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	acrodysostosis	Abnormality of the metacarpal bones	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	acrodysostosis	Intellectual disability	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001597	acrodysostosis	Abnormality of the nail	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001831	acrodysostosis	Short toe	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002818	acrodysostosis	Abnormality of the radius	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	acrodysostosis	Micromelia	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002984	acrodysostosis	Hypoplasia of the radius	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002997	acrodysostosis	Abnormality of the ulna	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003022	acrodysostosis	Hypoplasia of the ulna	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	acrodysostosis	Short nose	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	acrodysostosis	Abnormal form of the vertebral bodies	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003416	acrodysostosis	Spinal canal stenosis	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	acrodysostosis	Short stature	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	acrodysostosis	Depressed nasal bridge	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005616	acrodysostosis	Accelerated skeletal maturation	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009830	acrodysostosis	Peripheral neuropathy	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010049	acrodysostosis	Short metacarpal	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010579	acrodysostosis	Cone-shaped epiphysis	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010655	acrodysostosis	Epiphyseal stippling	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010743	acrodysostosis	Short metatarsal	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010807	acrodysostosis	Open bite	Occasional (29-5%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	acrodysostosis	Abnormality of immune system physiology	Frequent (79-30%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	acrodysostosis	Midface retrusion	Very frequent (99-80%)	PDE4D	600129	101800	monoallelic	confirmed	activating	Skeleton	8783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acrofacial dysostosis weyers type	NA	NA	EVC2	607261	193530	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Heart/Cardiovasculature/Lymphatic	19747	EvC ciliary complex subunit 2	protein-coding gene	gene with protein product	Approved	4p16.2	04p16.2	LBN	limbin		Ellis van Creveld syndrome 2	
NA	macrocephaly/autism syndrome	NA	NA	PTEN	601728	605309	monoallelic	confirmed	uncertain	Skin;Skeleton;Brain/Cognition	9588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation autosomal recessive type 13	NA	NA	TRAPPC9	611966	613192	biallelic	confirmed	loss of function	Brain/Cognition	30832	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, autosomal dominant 19	NA	NA	CTNNB1	No gene mim	615075	monoallelic	confirmed	loss of function	Brain/Cognition	2514	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autism	NA	NA	ZNF713	No gene mim	209850	monoallelic	possible	5_prime or 3_prime UTR mutation	Brain/Cognition	22043	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation syndromic x-linked jarid1c-related	NA	NA	KDM5C	314690	300534	hemizygous	confirmed	loss of function	Face;Brain/Cognition	11114	lysine demethylase 5C	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	DXS1272E|XE169		SMCX|JARID1C|MRX13	Jumonji, AT rich interactive domain 1C (RBP2-like)|Smcy homolog, X-linked (mouse)|jumonji, AT rich interactive domain 1C|mental retardation, X-linked 13|lysine (K)-specific demethylase 5C	PHD finger proteins|X-linked mental retardation|AT-rich interaction domain containing|Lysine demethylases
NA	milroy disease	NA	NA	FLT4	136352	153100	monoallelic	confirmed	all missense/in frame	Heart/Cardiovasculature/Lymphatic	3767	fms related tyrosine kinase 4	protein-coding gene	gene with protein product	Approved	5q35.3	05q35.3	VEGFR3|PCL			fms-related tyrosine kinase 4	Receptor Tyrosine Kinases|I-set domain containing|Immunoglobulin like domain containing
NA	congenital heart disease	NA	NA	SMAD2	No gene mim	No disease mim	monoallelic	possible	loss of function	Heart/Cardiovasculature/Lymphatic	6768	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	CACNA1G	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	1394	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	adrenoleukodystrophy neonatal	NA	NA	PEX1	602136	202370	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
NA	mitochondrial dna depletion syndrome 6	NA	NA	MPV17	137960	256810	biallelic	confirmed	loss of function	Endocrine/Metabolic;GI tract	7224	MPV17, mitochondrial inner membrane protein	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	SYM1	glomerulosclerosis		MpV17 transgene, murine homolog, glomerulosclerosis	
NA	tuberous sclerosis type 1	NA	NA	TSC1	605284	191100	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy, early infantile, 10	NA	NA	PNKP	605610	613402	biallelic	confirmed	loss of function	Brain/Cognition	9154	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital disorder of glycosylation, type is	NA	NA	ALG13	No gene mim	300884	hemizygous	probable	all missense/in frame	Brain/Cognition	30881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	syndromic osteogenesis imperfecta	NA	NA	SEC24D	No gene mim	No disease mim	biallelic	probable	loss of function	Face;Skeleton	10706	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	beare-stevenson cutis gyrata syndrome	NA	NA	FGFR2	176943	123790	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	epilepsy, x-linked, with variable learning disabilities and behavior disorders	NA	NA	SYN1	313440	290927	hemizygous	probable	loss of function	Brain/Cognition	11494	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spastic paraplegia x-linked type 1	NA	NA	L1CAM	308840	303350	hemizygous	confirmed	loss of function	Brain/Cognition	6470	L1 cell adhesion molecule	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	CD171	neural cell adhesion molecule L1	HSAS1|SPG1|HSAS|MASA|MIC5|S10	antigen identified by monoclonal antibody R1	CD molecules|Fibronectin type III domain containing|I-set domain containing|Ig-like cell adhesion molecule family
NA	bardet-biedl syndrome type 6	NA	NA	MKKS	604896	209900	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition;Eye;Genitalia	7108	McKusick-Kaufman syndrome	protein-coding gene	gene with protein product	Approved	20p12.2	20p12.2			BBS6		Chaperonins|Bardet-Biedl syndrome associated
NA	syndromic x-linked intellectual disability	NA	NA	CCDC22	No gene mim	No disease mim	hemizygous	probable	all missense/in frame	Brain/Cognition	28909	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	shprintzen-goldberg craniosynostosis syndrome	NA	NA	SKI	164780	182212	monoallelic	confirmed	all missense/in frame	Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10896	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital diarrheal disorders	NA	NA	DGAT1	No gene mim	No disease mim	biallelic	possible	loss of function	GI tract	2843	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leri-weill dyschondrosteosis	NA	NA	SHOX	312865	127300	monoallelic	confirmed	loss of function	Skeleton	10853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	usher syndrome type 1d	NA	NA	CDH23	605516	601067	biallelic	confirmed	loss of function	Eye;Ear	13733	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	periventricular neuronal heterotopia	NA	NA	DCHS1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	13681	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	treacher collins syndrome type 2	NA	NA	POLR1D	613715	613717	monoallelic	confirmed	loss of function	Face;Ear	20422	RNA polymerase I subunit D	protein-coding gene	gene with protein product	Approved	13q12.2	13q12.2	RPAC2|RPA16|RPO1-3|RPA9|MGC9850			polymerase (RNA) I polypeptide D, 16kDa	RNA polymerase subunits
NA	microphthalmia isolated type 4	NA	NA	GDF6	601147	613094	monoallelic	confirmed	uncertain	Skeleton;Eye	4221	growth differentiation factor 6	protein-coding gene	gene with protein product	Approved	8q22.1	08q22.1	BMP13|KFS|KFS1		SGM1	segmentation syndrome 1	
NA	complex iv deficiency	NA	NA	SURF1	185620	220110	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	familial cold autoinflammatory syndrome 3	NA	NA	PLCG2	No gene mim	614468	monoallelic	possible	loss of function	Bone Marrow/Immune;Skin	9066	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	fibrodysplasia ossificans progressiva	Hearing impairment	Frequent (79-30%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0000501	fibrodysplasia ossificans progressiva	Glaucoma	Occasional (29-5%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0001249	fibrodysplasia ossificans progressiva	Intellectual disability	Occasional (29-5%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0001250	fibrodysplasia ossificans progressiva	Seizures	Occasional (29-5%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0001376	fibrodysplasia ossificans progressiva	Limitation of joint mobility	Very frequent (99-80%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0001482	fibrodysplasia ossificans progressiva	Subcutaneous nodule	Very frequent (99-80%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0001508	fibrodysplasia ossificans progressiva	Failure to thrive	Occasional (29-5%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0001596	fibrodysplasia ossificans progressiva	Alopecia	Frequent (79-30%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0001822	fibrodysplasia ossificans progressiva	Hallux valgus	Occasional (29-5%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0001903	fibrodysplasia ossificans progressiva	Anemia	Occasional (29-5%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0002093	fibrodysplasia ossificans progressiva	Respiratory insufficiency	Frequent (79-30%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0003306	fibrodysplasia ossificans progressiva	Spinal rigidity	Very frequent (99-80%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0003468	fibrodysplasia ossificans progressiva	Abnormality of the vertebrae	Very frequent (99-80%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0004209	fibrodysplasia ossificans progressiva	Clinodactyly of the 5th finger	Frequent (79-30%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0010054	fibrodysplasia ossificans progressiva	Abnormality of the first metatarsal bone	Very frequent (99-80%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0010058	fibrodysplasia ossificans progressiva	Aplasia/Hypoplasia of the phalanges of the hallux	Frequent (79-30%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0010109	fibrodysplasia ossificans progressiva	Short hallux	Very frequent (99-80%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0011987	fibrodysplasia ossificans progressiva	Ectopic ossification in muscle tissue	Very frequent (99-80%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0011989	fibrodysplasia ossificans progressiva	Ectopic ossification in ligament tissue	Very frequent (99-80%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0100240	fibrodysplasia ossificans progressiva	Synostosis of joints	Occasional (29-5%)	ACVR1	102576	135100	monoallelic	probable	activating	Musculature;Skeleton	171	activin A receptor type 1	protein-coding gene	gene with protein product	Approved	2q24.1	02q24.1	SKR1|ALK2|ACVR1A		ACVRLK2	activin A receptor, type I	Type 1 receptor serine/threonine kinases
HP:0000271	infantile refsum disease	Abnormality of the face	Occasional (29-5%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0000365	infantile refsum disease	Hearing impairment	Frequent (79-30%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0000407	infantile refsum disease	Sensorineural hearing impairment	Frequent (79-30%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0000505	infantile refsum disease	Visual impairment	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0000510	infantile refsum disease	Rod-cone dystrophy	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0000518	infantile refsum disease	Cataract	Occasional (29-5%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0000639	infantile refsum disease	Nystagmus	Frequent (79-30%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0000648	infantile refsum disease	Optic atrophy	Occasional (29-5%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0000662	infantile refsum disease	Nyctalopia	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0000708	infantile refsum disease	Behavioral abnormality	Frequent (79-30%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0001250	infantile refsum disease	Seizures	Occasional (29-5%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0001251	infantile refsum disease	Ataxia	Frequent (79-30%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0001252	infantile refsum disease	Muscular hypotonia	Frequent (79-30%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0001257	infantile refsum disease	Spasticity	Frequent (79-30%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0001263	infantile refsum disease	Global developmental delay	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0001508	infantile refsum disease	Failure to thrive	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0001638	infantile refsum disease	Cardiomyopathy	Occasional (29-5%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0002240	infantile refsum disease	Hepatomegaly	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0003323	infantile refsum disease	Progressive muscle weakness	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0004322	infantile refsum disease	Short stature	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0005930	infantile refsum disease	Abnormality of epiphysis morphology	Occasional (29-5%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0007981	infantile refsum disease	Concentric narrowing of visual fields	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0008064	infantile refsum disease	Ichthyosis	Occasional (29-5%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0008167	infantile refsum disease	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0010571	infantile refsum disease	Elevated levels of phytanic acid	Very frequent (99-80%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0010628	infantile refsum disease	Facial palsy	Occasional (29-5%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
HP:0011675	infantile refsum disease	Arrhythmia	Occasional (29-5%)	PEX1	602136	266510	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8850	peroxisomal biogenesis factor 1	protein-coding gene	gene with protein product	Approved	7q21.2	07q21.2			ZWS1|ZWS	peroxisome biogenesis factor 1|Zellweger syndrome 1|Zellweger syndrome	AAA ATPases|Peroxins
NA	central hypoventilation syndrome, congenital, with or without hirschsprung disease	NA	NA	PHOX2B	603851	209880	monoallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	9143	paired like homeobox 2b	protein-coding gene	gene with protein product	Approved	4p13	04p13	Phox2b|NBPhox		PMX2B	paired mesoderm homeobox 2b	PRD class homeoboxes and pseudogenes
NA	ichthyosis autosomal recessive with hypotrichosis	NA	NA	ST14	606797	610765	biallelic	probable	all missense/in frame	Skin	11344	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neurodegeneration with brain iron accumulation 2b	NA	NA	PLA2G6	No gene mim	610217	biallelic	both DD and IF	loss of function	Brain/Cognition	9039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked type 93	NA	NA	BRWD3	300553	300659	hemizygous	confirmed	loss of function	Brain/Cognition	17342	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microcephaly cortical malformations and mental retardation	NA	NA	WDR62	613583	604317	biallelic	confirmed	loss of function	Brain/Cognition	24502	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	MYT1L	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	7623	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peroxisome biogenesis disorder complementation group 7	NA	NA	PEX10	602859	602859	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8851	peroxisomal biogenesis factor 10	protein-coding gene	gene with protein product	Approved	1p36.32	01p36.32	RNF69			peroxisome biogenesis factor 10	Ring finger proteins|Peroxins
NA	intellectual disability	NA	NA	PPP2R5D	No gene mim	No disease mim	monoallelic	confirmed	dominant negative	Brain/Cognition	9312	"protein phosphatase 2 regulatory subunit Bdelta	protein-coding gene	gene with protein product	Approved	6p21.1	06p21.1	""B56D|B56delta""			protein phosphatase 2, regulatory subunit B (B56), delta isoform	Protein phosphatase 2 regulatory subunits	696	1996-05-08		2016-05-13	2017-04-05	5528	ENSG00000112640	OTTHUMG00000014716	uc003oth.5	L76702	NM_006245	""CCDS4878|CCDS43464|CCDS55002""	Q14738	7592815	MGI:2388481	RGD:1306666		PPP2R5D	601646					460676												
HGNC:9313	PPP2R5E	protein phosphatase 2 regulatory subunit Bepsilon"	protein-coding gene	gene with protein product	Approved	14q23.2	14q23.2	B56E|B56epsilon			protein phosphatase 2, regulatory subunit B (B56), epsilon isoform	Protein phosphatase 2 regulatory subunits
NA	meckel syndrome 9	NA	NA	B9D1	No gene mim	614209	biallelic	probable	loss of function	Skeleton;Brain/Cognition	24123	B9 domain containing 1	protein-coding gene	gene with protein product	Approved	17p11.2	17p11.2	B9|EPPB9|MKS9	endothelial precursor protein B9		B9 protein domain 1	B9 domain containing|MKS complex
NA	cockayne syndrome type a	NA	NA	ERCC8	609412	216400	biallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	3439	ERCC excision repair 8, CSA ubiquitin ligase complex subunit	protein-coding gene	gene with protein product	Approved	5q12.1	05q12.1	CSA		CKN1	Cockayne syndrome 1 (classical)|excision repair cross-complementing rodent repair deficiency, complementation group 8|excision repair cross-complementation group 8	WD repeat domain containing|ERCC excision repair associated
NA	porencephaly 2	NA	NA	COL4A2	No gene mim	614483	monoallelic	both DD and IF	dominant negative	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2203	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dkc1-related dyskeratosis congenita	NA	NA	DKC1	300126	314912	hemizygous	confirmed	loss of function	Bone Marrow/Immune;Skin;Endocrine/Metabolic	2890	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	niemann-pick disease, type c1	NA	NA	NPC1	607623	257220	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7897	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract zonular pulverulent cataract type 3	NA	NA	GJA3	121015	601885	monoallelic	confirmed	uncertain	Eye	4277	gap junction protein alpha 3	protein-coding gene	gene with protein product	Approved	13q12.11	13q12.11	CX46	connexin 46	CZP3	gap junction protein, alpha 3, 46kD (connexin 46)|gap junction protein, alpha 3, 46kDa (connexin 46)|gap junction protein, alpha 3, 46kDa	Gap junction proteins
NA	periventricular nodular heterotopia type 1	NA	NA	FLNA	300017	300049	x-linked dominant	confirmed	loss of function	Face;Skeleton;Brain/Cognition	3754	filamin A	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	ABP-280	actin binding protein 280|alpha filamin	FLN1|FLN|OPD2|OPD1	filamin A, alpha (actin binding protein 280)|filamin A, alpha	
NA	congenital disorders of glycosylation	NA	NA	DPM1	603503	612379	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	3005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked type 90	NA	NA	DLG3	300189	300189	hemizygous	confirmed	loss of function	Brain/Cognition	2902	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cholesterol desmolase-deficient congenital adrenal hyperplasia	NA	NA	STAR	600617	201710	biallelic	confirmed	loss of function	Genitalia	11359	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epimerase-deficiency galactosemia	NA	NA	GALE	606953	230350	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract;Ear	4116	UDP-galactose-4-epimerase	protein-coding gene	gene with protein product	Approved	1p36.11	01p36.11	SDR1E1	short chain dehydrogenase/reductase family 1E, member 1|UDP-glucose 4-epimerase		galactose-4-epimerase, UDP-	Short chain dehydrogenase/reductase superfamily
NA	pallister-hall syndrome	NA	NA	GLI3	165240	146510	monoallelic	confirmed	loss of function	Endocrine;Skeleton;Brain/Cognition	4319	GLI family zinc finger 3	protein-coding gene	gene with protein product	Approved	7p14.1	07p14.1	PAP-A|PAPA|PAPA1|PAPB|ACLS|PPDIV	zinc finger protein GLI3|oncogene GLI3|DNA-binding protein	GCPS|PHS	Greig cephalopolysyndactyly syndrome|GLI-Kruppel family member GLI3|glioma-associated oncogene family zinc finger 3	Zinc fingers C2H2-type
NA	methylmalonic aciduria and homocystinuria, cblc type	NA	NA	MMACHC	609831	277400	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	24525	methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria	protein-coding gene	gene with protein product	Approved	1p34.1	01p34.1	DKFZP564I122|cblC				
NA	cataract, autosomal recessive congenital 2	NA	NA	FYCO1	607182	610019	biallelic	confirmed	loss of function	Eye	14673	FYVE and coiled-coil domain containing 1	protein-coding gene	gene with protein product	Approved	3p21.31	03p21.31	FLJ13335|ZFYVE7				Zinc fingers FYVE-type|GOLD domain containing
NA	bardet-biedl syndrome type 2	NA	NA	BBS2	606151	209900	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	967	Bardet-Biedl syndrome 2	protein-coding gene	gene with protein product	Approved	16q13	16q13			BBS		Bardet-Biedl syndrome associated|BBSome
NA	mitochondrial complex iv deficiency	NA	NA	APOPT1	No gene mim	220110	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20492	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fatal encephalopathy, lactic acidosis, and severe mtdna depletion in muscle	NA	NA	FBXL4	No gene mim	No disease mim	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	13601	F-box and leucine rich repeat protein 4	protein-coding gene	gene with protein product	Approved	6q16.1-q16.2	06q16.1-q16.2	FBL4|FBL5				F-box and leucine rich repeat proteins
NA	fructose 1,6 bisphosphatase deficiency	NA	NA	FBP1	611570	229700	biallelic	confirmed	loss of function	Endocrine/Metabolic	3606	fructose-bisphosphatase 1	protein-coding gene	gene with protein product	Approved	9q22.32	09q22.32			FBP	fructose-1,6-bisphosphatase 1	Fructose-1,6-bisphosphatases
NA	hyperoxaluria, primary, type 1	NA	NA	AGXT	No gene mim	259900	biallelic	both DD and IF	loss of function	Kidney Renal Tract;Endocrine/Metabolic	341	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	primary ciliary dyskinesia	Recurrent respiratory infections	Very frequent (99-80%)	C21orf59	No gene mim	No disease mim	biallelic	probable	loss of function	Respiratory tract	1301	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation autosomal recessive type 7	NA	NA	TUSC3	601385	611093	biallelic	confirmed	loss of function	Brain/Cognition	30242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pontocerebellar hypoplasia type 2 and type 4	NA	NA	TSEN2	608753	316970	biallelic	probable	all missense/in frame	Brain/Cognition	28422	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	urofacial syndrome	NA	NA	LRIG2	608869	236730	biallelic	probable	loss of function	Kidney Renal Tract;Face	20889	leucine rich repeats and immunoglobulin like domains 2	protein-coding gene	gene with protein product	Approved	1p13.2	01p13.2	KIAA0806				I-set domain containing
NA	symptomatic epilepsy and skull dysplasia	NA	NA	SNIP1	No gene mim	614501	biallelic	possible	all missense/in frame	Skeleton;Brain/Cognition	30587	Smad nuclear interacting protein 1	protein-coding gene	gene with protein product	Approved	1p34.3	01p34.3	PML1	PML1 homolog (yeast)			Spliceosomal P complex
NA	microphthalmia isolated with coloboma type 6	NA	NA	GDF3	No gene mim	613703	monoallelic	possible	all missense/in frame	Skeleton;Eye	4218	growth differentiation factor 3	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31					Endogenous ligands
NA	spondylometaphyseal dysplasia with cone-rod dystrophy	NA	NA	PCYT1A	No gene mim	608940	biallelic	confirmed	loss of function	Skeleton;Eye	8754	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acromelic frontonasal dysostosis	NA	NA	ZSWIM6	No gene mim	603671	monoallelic	probable	activating	Face;Skeleton	29316	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	joubert syndrome type 4	NA	NA	NPHP1	607100	609583	biallelic	confirmed	loss of function	Kidney Renal Tract;Eye	7905	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	cardiofaciocutaneous syndrome	Cryptorchidism	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000126	cardiofaciocutaneous syndrome	Hydronephrosis	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000176	cardiofaciocutaneous syndrome	Submucous cleft hard palate	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000218	cardiofaciocutaneous syndrome	High palate	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000238	cardiofaciocutaneous syndrome	Hydrocephalus	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000256	cardiofaciocutaneous syndrome	Macrocephaly	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000276	cardiofaciocutaneous syndrome	Long face	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000280	cardiofaciocutaneous syndrome	Coarse facial features	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000286	cardiofaciocutaneous syndrome	Epicanthus	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000293	cardiofaciocutaneous syndrome	Full cheeks	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000316	cardiofaciocutaneous syndrome	Hypertelorism	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000343	cardiofaciocutaneous syndrome	Long philtrum	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000348	cardiofaciocutaneous syndrome	High forehead	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000368	cardiofaciocutaneous syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000391	cardiofaciocutaneous syndrome	Thickened helices	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000400	cardiofaciocutaneous syndrome	Macrotia	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000463	cardiofaciocutaneous syndrome	Anteverted nares	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000465	cardiofaciocutaneous syndrome	Webbed neck	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000470	cardiofaciocutaneous syndrome	Short neck	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000478	cardiofaciocutaneous syndrome	Abnormality of the eye	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000486	cardiofaciocutaneous syndrome	Strabismus	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000494	cardiofaciocutaneous syndrome	Downslanted palpebral fissures	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000499	cardiofaciocutaneous syndrome	Abnormality of the eyelashes	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000504	cardiofaciocutaneous syndrome	Abnormality of vision	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000508	cardiofaciocutaneous syndrome	Ptosis	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000545	cardiofaciocutaneous syndrome	Myopia	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000637	cardiofaciocutaneous syndrome	Long palpebral fissure	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000639	cardiofaciocutaneous syndrome	Nystagmus	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000648	cardiofaciocutaneous syndrome	Optic atrophy	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000767	cardiofaciocutaneous syndrome	Pectus excavatum	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000958	cardiofaciocutaneous syndrome	Dry skin	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000962	cardiofaciocutaneous syndrome	Hyperkeratosis	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000974	cardiofaciocutaneous syndrome	Hyperextensible skin	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0000982	cardiofaciocutaneous syndrome	Palmoplantar keratoderma	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001003	cardiofaciocutaneous syndrome	Multiple lentigines	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001004	cardiofaciocutaneous syndrome	Lymphedema	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001048	cardiofaciocutaneous syndrome	Cavernous hemangioma	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001249	cardiofaciocutaneous syndrome	Intellectual disability	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001252	cardiofaciocutaneous syndrome	Muscular hypotonia	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001260	cardiofaciocutaneous syndrome	Dysarthria	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001263	cardiofaciocutaneous syndrome	Global developmental delay	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001531	cardiofaciocutaneous syndrome	Failure to thrive in infancy	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001582	cardiofaciocutaneous syndrome	Redundant skin	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001622	cardiofaciocutaneous syndrome	Premature birth	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001631	cardiofaciocutaneous syndrome	Atrial septal defect	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001639	cardiofaciocutaneous syndrome	Hypertrophic cardiomyopathy	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001642	cardiofaciocutaneous syndrome	Pulmonic stenosis	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0001654	cardiofaciocutaneous syndrome	Abnormality of the heart valves	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002007	cardiofaciocutaneous syndrome	Frontal bossing	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002120	cardiofaciocutaneous syndrome	Cerebral cortical atrophy	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002162	cardiofaciocutaneous syndrome	Low posterior hairline	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002167	cardiofaciocutaneous syndrome	Neurological speech impairment	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002213	cardiofaciocutaneous syndrome	Fine hair	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002217	cardiofaciocutaneous syndrome	Slow-growing hair	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002299	cardiofaciocutaneous syndrome	Brittle hair	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002353	cardiofaciocutaneous syndrome	EEG abnormality	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002564	cardiofaciocutaneous syndrome	Malformation of the heart and great vessels	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002650	cardiofaciocutaneous syndrome	Scoliosis	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002857	cardiofaciocutaneous syndrome	Genu valgum	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002967	cardiofaciocutaneous syndrome	Cubitus valgus	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0002997	cardiofaciocutaneous syndrome	Abnormality of the ulna	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0003196	cardiofaciocutaneous syndrome	Short nose	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0004322	cardiofaciocutaneous syndrome	Short stature	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0004422	cardiofaciocutaneous syndrome	Biparietal narrowing	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0005280	cardiofaciocutaneous syndrome	Depressed nasal bridge	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0006191	cardiofaciocutaneous syndrome	Deep palmar crease	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0007392	cardiofaciocutaneous syndrome	Excessive wrinkled skin	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0007440	cardiofaciocutaneous syndrome	Generalized hyperpigmentation	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0007565	cardiofaciocutaneous syndrome	Multiple cafe-au-lait spots	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0008064	cardiofaciocutaneous syndrome	Ichthyosis	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0008070	cardiofaciocutaneous syndrome	Sparse hair	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0008391	cardiofaciocutaneous syndrome	Dystrophic fingernails	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0008872	cardiofaciocutaneous syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0009891	cardiofaciocutaneous syndrome	Underdeveloped supraorbital ridges	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0010669	cardiofaciocutaneous syndrome	Cheekbone underdevelopment	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0011024	cardiofaciocutaneous syndrome	Abnormality of the gastrointestinal tract	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0012719	cardiofaciocutaneous syndrome	Functional abnormality of the gastrointestinal tract	Occasional (29-5%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0100840	cardiofaciocutaneous syndrome	Aplasia/Hypoplasia of the eyebrow	Very frequent (99-80%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
HP:0200102	cardiofaciocutaneous syndrome	Sparse or absent eyelashes	Frequent (79-30%)	MAP2K2	601263	115150	monoallelic	confirmed	activating	Skin;Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	6842	mitogen-activated protein kinase kinase 2	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	MEK2		PRKMK2		Mitogen-activated protein kinase kinases
NA	autism or intellectual disability	NA	NA	CAPRIN1	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	6743	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	winchester syndrome	NA	NA	MMP14	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Skeleton	7160	matrix metallopeptidase 14	protein-coding gene	gene with protein product	Approved	14q11.2	14q11.2	MT1-MMP	membrane type 1 metalloprotease		matrix metalloproteinase 14 (membrane-inserted)|matrix metallopeptidase 14 (membrane-inserted)	M10 matrix metallopeptidases
HP:0000407	phosphoribosylpyrophosphate synthetase superactivity	Sensorineural hearing impairment	Very frequent (99-80%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	phosphoribosylpyrophosphate synthetase superactivity	Ataxia	Very frequent (99-80%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002149	phosphoribosylpyrophosphate synthetase superactivity	Hyperuricemia	Very frequent (99-80%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000083	phosphoribosylpyrophosphate synthetase superactivity	Renal insufficiency	Frequent (79-30%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	phosphoribosylpyrophosphate synthetase superactivity	Intellectual disability	Frequent (79-30%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	phosphoribosylpyrophosphate synthetase superactivity	Muscular hypotonia	Frequent (79-30%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001679	phosphoribosylpyrophosphate synthetase superactivity	Abnormality of the aorta	Frequent (79-30%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	phosphoribosylpyrophosphate synthetase superactivity	Neurological speech impairment	Frequent (79-30%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	phosphoribosylpyrophosphate synthetase superactivity	Strabismus	Occasional (29-5%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000496	phosphoribosylpyrophosphate synthetase superactivity	Abnormality of eye movement	Occasional (29-5%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000822	phosphoribosylpyrophosphate synthetase superactivity	Hypertension	Occasional (29-5%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001638	phosphoribosylpyrophosphate synthetase superactivity	Cardiomyopathy	Occasional (29-5%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	phosphoribosylpyrophosphate synthetase superactivity	Arrhythmia	Occasional (29-5%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0040290	phosphoribosylpyrophosphate synthetase superactivity	Abnormality of skeletal muscles	Occasional (29-5%)	PRPS1	311850	300661	hemizygous	confirmed	activating	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	TAF2	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	11536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	symphalangism proximal syndrome	NA	NA	GDF5	601146	185800	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0000077	thanatophoric dysplasia type 1	Abnormality of the kidney	Occasional (29-5%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000238	thanatophoric dysplasia type 1	Hydrocephalus	Occasional (29-5%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000256	thanatophoric dysplasia type 1	Macrocephaly	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000260	thanatophoric dysplasia type 1	Wide anterior fontanel	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000365	thanatophoric dysplasia type 1	Hearing impairment	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000520	thanatophoric dysplasia type 1	Proptosis	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000774	thanatophoric dysplasia type 1	Narrow chest	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000926	thanatophoric dysplasia type 1	Platyspondyly	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000944	thanatophoric dysplasia type 1	Abnormality of the metaphyses	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000946	thanatophoric dysplasia type 1	Hypoplastic ilia	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000956	thanatophoric dysplasia type 1	Acanthosis nigricans	Occasional (29-5%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001156	thanatophoric dysplasia type 1	Brachydactyly syndrome	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001171	thanatophoric dysplasia type 1	Split hand	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001250	thanatophoric dysplasia type 1	Seizures	Occasional (29-5%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001252	thanatophoric dysplasia type 1	Muscular hypotonia	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001387	thanatophoric dysplasia type 1	Joint stiffness	Occasional (29-5%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001561	thanatophoric dysplasia type 1	Polyhydramnios	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001582	thanatophoric dysplasia type 1	Redundant skin	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001631	thanatophoric dysplasia type 1	Atrial septal defect	Occasional (29-5%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001643	thanatophoric dysplasia type 1	Patent ductus arteriosus	Occasional (29-5%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002007	thanatophoric dysplasia type 1	Frontal bossing	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002093	thanatophoric dysplasia type 1	Respiratory insufficiency	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002119	thanatophoric dysplasia type 1	Ventriculomegaly	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002187	thanatophoric dysplasia type 1	Intellectual disability, profound	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002282	thanatophoric dysplasia type 1	Heterotopia	Occasional (29-5%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002652	thanatophoric dysplasia type 1	Skeletal dysplasia	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002676	thanatophoric dysplasia type 1	Cloverleaf skull	Occasional (29-5%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002808	thanatophoric dysplasia type 1	Kyphosis	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002980	thanatophoric dysplasia type 1	Femoral bowing	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002983	thanatophoric dysplasia type 1	Micromelia	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003097	thanatophoric dysplasia type 1	Short femur	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003185	thanatophoric dysplasia type 1	Short sacroiliac notch	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005280	thanatophoric dysplasia type 1	Depressed nasal bridge	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0006487	thanatophoric dysplasia type 1	Bowing of the long bones	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0006703	thanatophoric dysplasia type 1	Aplasia/Hypoplasia of the lungs	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0007392	thanatophoric dysplasia type 1	Excessive wrinkled skin	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0008909	thanatophoric dysplasia type 1	Lethal short-limbed short stature	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010880	thanatophoric dysplasia type 1	Increased nuchal translucency	Frequent (79-30%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0012368	thanatophoric dysplasia type 1	Flat face	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0100781	thanatophoric dysplasia type 1	Abnormality of the sacroiliac joint	Very frequent (99-80%)	FGFR3	134934	187600	monoallelic	confirmed	activating	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	3690	fibroblast growth factor receptor 3	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	CEK2|JTK4|CD333		ACH	achondroplasia, thanatophoric dwarfism	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	acrocephalopolysyndactyly type 2	NA	NA	RAB23	606144	201000	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	14263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	iron-refractory iron deficiency anemia	NA	NA	TMPRSS6	609862	206200	biallelic	confirmed	loss of function	Bone Marrow/Immune	16517	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atrial septal defect 9	NA	NA	GATA6	601656	614475	monoallelic	confirmed	all missense/in frame	Heart/Cardiovasculature/Lymphatic	4174	GATA binding protein 6	protein-coding gene	gene with protein product	Approved	18q11.2	18q11.2				GATA-binding protein 6	GATA zinc finger domain containing
NA	3-hydroxy-3-methylglutaryl-coa synthase 2 deficiency	NA	NA	HMGCS2	600234	605911	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic	5008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	citrullinemia type i	NA	NA	ASS1	603470	615700	biallelic	confirmed	loss of function	Endocrine/Metabolic	758	argininosuccinate synthase 1	protein-coding gene	gene with protein product	Approved	9q34.11	09q34.11	CTLN1		ASS	argininosuccinate synthetase	
NA	mitochondrial dna depletion syndrome 4a	NA	NA	POLG	No gene mim	607459	biallelic	confirmed	all missense/in frame	Brain/Cognition	9179	DNA polymerase gamma, catalytic subunit	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	POLG1|POLGA			polymerase (DNA directed), gamma|polymerase (DNA) gamma, catalytic subunit	DNA polymerases
NA	arthrogryposis, renal dysfunction, and cholestasis 1	NA	NA	VPS33B	608552	319164	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;GI tract	12712	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	renal-hepatic ciliopathy	NA	NA	DCDC2	No gene mim	616217	biallelic	probable	loss of function	Kidney Renal Tract;GI tract	18141	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leukoencephalopathy, cystic, without megalencephaly	NA	NA	RNASET2	612944	612951	biallelic	confirmed	loss of function	Brain/Cognition	21686	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	keutel syndrome	Long face	Very frequent (99-80%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0000340	keutel syndrome	Sloping forehead	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0000365	keutel syndrome	Hearing impairment	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0000403	keutel syndrome	Recurrent otitis media	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0000430	keutel syndrome	Underdeveloped nasal alae	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0000445	keutel syndrome	Wide nose	Very frequent (99-80%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0000648	keutel syndrome	Optic atrophy	Occasional (29-5%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0001027	keutel syndrome	Soft, doughy skin	Occasional (29-5%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0001250	keutel syndrome	Seizures	Occasional (29-5%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0001256	keutel syndrome	Intellectual disability, mild	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0001263	keutel syndrome	Global developmental delay	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0001596	keutel syndrome	Alopecia	Occasional (29-5%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0001629	keutel syndrome	Ventricular septal defect	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0002092	keutel syndrome	Pulmonary arterial hypertension	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0002205	keutel syndrome	Recurrent respiratory infections	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0004322	keutel syndrome	Short stature	Occasional (29-5%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0004334	keutel syndrome	Dermal atrophy	Occasional (29-5%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0004415	keutel syndrome	Pulmonary artery stenosis	Very frequent (99-80%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0005280	keutel syndrome	Depressed nasal bridge	Very frequent (99-80%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0009882	keutel syndrome	Short distal phalanx of finger	Very frequent (99-80%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0011108	keutel syndrome	Recurrent sinusitis	Frequent (79-30%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0011800	keutel syndrome	Midface retrusion	Very frequent (99-80%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0100593	keutel syndrome	Calcification of cartilage	Very frequent (99-80%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
HP:0100682	keutel syndrome	Tracheal atresia	Very frequent (99-80%)	MGP	154870	245150	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	7060	matrix Gla protein	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3					Gla domain containing
NA	congenital clubfoot	NA	NA	PITX1	602149	119800	monoallelic	probable	loss of function	Skeleton	9004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infantile neuroaxonal dystrophy 1	NA	NA	PLA2G6	No gene mim	256600	biallelic	both DD and IF	loss of function	Brain/Cognition	9039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	treacher collins syndrome type 1	NA	NA	TCOF1	606847	154500	monoallelic	confirmed	loss of function	Face;Ear	11654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	trichothiodystrophy photosensitive	NA	NA	ERCC2	126340	601675	biallelic	confirmed	loss of function	Skin;Skeleton;Spinal cord/Peripheral nerves;Brain/Cognition	3434	ERCC excision repair 2, TFIIH core complex helicase subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	MAG|EM9|MGC102762|MGC126218|MGC126219|TFIIH	excision repair cross-complementing rodent repair deficiency, complementation group 2 protein|TFIIH basal transcription factor complex helicase XPB subunit	XPD	xeroderma pigmentosum complementary group D|excision repair cross-complementing rodent repair deficiency, complementation group 2|excision repair cross-complementation group 2	General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated
NA	epileptic encephalopathy, early infantile, 23	NA	NA	DOCK7	No gene mim	615859	biallelic	probable	loss of function	Brain/Cognition	19190	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leukodystrophy, hypomyelinating, 3	NA	NA	AIMP1	603605	260600	biallelic	probable	loss of function	Brain/Cognition	10648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	tooth agenesis selective x-linked type 1	NA	NA	EDA	300451	313500	hemizygous	confirmed	all missense/in frame	Teeth & Dentitian;Skin	3157	ectodysplasin A	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	EDA1|XLHED|HED|XHED|ED1-A1|ED1-A2|EDA-A1|EDA-A2		ED1|EDA2|ODT1	ectodermal dysplasia 1, anhidrotic|oligodontia 1	Tumor necrosis factor superfamily
NA	brachydactyly-mental retardation syndrome	NA	NA	HDAC4	605314	600430	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	14063	histone deacetylase 4	protein-coding gene	gene with protein product	Approved	2q37.3	02q37.3	KIAA0288|HDAC-A|HDACA|HD4|HA6116|HDAC-4		BDMR	brachydactyly-mental retardation syndrome	Histone deacetylases, class IIA
NA	mental retardation autosomal recessive type 2a	NA	NA	CRBN	No gene mim	607417	biallelic	possible	loss of function	Brain/Cognition	30185	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	premature ovarian failure syndrome type 1	NA	NA	FMR1	No gene mim	311360	x-linked dominant	both DD and IF	uncertain	Brain/Cognition	3775	fragile X mental retardation 1	protein-coding gene	gene with protein product	Approved	Xq27.3	Xq27.3	FMRP|FRAXA|MGC87458		POF1|POF	premature ovarian failure 1	
NA	peroxisome biogenesis disorder complementation group 8	NA	NA	PEX26	608666	608666	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	22965	peroxisomal biogenesis factor 26	protein-coding gene	gene with protein product	Approved	22q11.21	22q11.21	FLJ20695			peroxisome biogenesis factor 26	Peroxins
NA	distal arthrogryposis type 2a	NA	NA	MYH3	160720	193700	monoallelic	confirmed	uncertain	Musculature;Skeleton	7573	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	brachydactyly type d	NA	NA	HOXD13	142989	113200	monoallelic	confirmed	uncertain	Skeleton	5136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	emery-dreifuss muscular dystrophy type 2	NA	NA	LMNA	No gene mim	181350	monoallelic	both DD and IF	loss of function	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
NA	primary avascular necrosis of femoral head	NA	NA	COL2A1	120140	608805	monoallelic	possible	all missense/in frame	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation autosomal dominant type 5	NA	NA	SYNGAP1	603384	612621	monoallelic	confirmed	loss of function	Brain/Cognition	11497	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	kohlschtter-tnz syndrome	NA	NA	ROGDI	614574	226750	biallelic	confirmed	loss of function	Teeth & Dentitian;Brain/Cognition	29478	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	trichothiodystrophy photosensitive	NA	NA	ERCC3	133510	601675	biallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition;Eye;Ear	3435	ERCC excision repair 3, TFIIH core complex helicase subunit	protein-coding gene	gene with protein product	Approved	2q14.3	02q14.3	XPB|BTF2|RAD25|TFIIH|GTF2H	xeroderma pigmentosum group B complementing		excision repair cross-complementing rodent repair deficiency, complementation group 3|excision repair cross-complementation group 3	General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated
NA	ichthyosis hystrix-like with deafness syndrome	NA	NA	GJB2	121011	602540	monoallelic	confirmed	all missense/in frame	Skin;Ear	4284	gap junction protein beta 2	protein-coding gene	gene with protein product	Approved	13q12.11	13q12.11	CX26|NSRD1	connexin 26	DFNB1|DFNA3	gap junction protein, beta 2, 26kD (connexin 26)|gap junction protein, beta 2, 26kDa (connexin 26)|gap junction protein, beta 2, 26kDa	Gap junction proteins|Deafness associated genes
NA	noonan syndrome type 6	NA	NA	NRAS	164790	613224	monoallelic	confirmed	activating	Skin;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	7989	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	nijmegen breakage syndrome	Cleft palate	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	nijmegen breakage syndrome	Microcephaly	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000271	nijmegen breakage syndrome	Abnormality of the face	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000278	nijmegen breakage syndrome	Retrognathia	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000294	nijmegen breakage syndrome	Low anterior hairline	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000340	nijmegen breakage syndrome	Sloping forehead	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000364	nijmegen breakage syndrome	Hearing abnormality	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	nijmegen breakage syndrome	Macrotia	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	nijmegen breakage syndrome	Prominent nasal bridge	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000444	nijmegen breakage syndrome	Convex nasal ridge	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000448	nijmegen breakage syndrome	Prominent nose	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	nijmegen breakage syndrome	Short neck	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000492	nijmegen breakage syndrome	Abnormality of the eyelid	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000582	nijmegen breakage syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000992	nijmegen breakage syndrome	Cutaneous photosensitivity	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001268	nijmegen breakage syndrome	Mental deterioration	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	nijmegen breakage syndrome	Muscle weakness	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001480	nijmegen breakage syndrome	Freckling	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001595	nijmegen breakage syndrome	Abnormality of the hair	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	nijmegen breakage syndrome	Thrombocytopenia	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001878	nijmegen breakage syndrome	Hemolytic anemia	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001890	nijmegen breakage syndrome	Autoimmune hemolytic anemia	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002002	nijmegen breakage syndrome	Deep philtrum	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002023	nijmegen breakage syndrome	Anal atresia	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002025	nijmegen breakage syndrome	Anal stenosis	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002028	nijmegen breakage syndrome	Chronic diarrhea	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	nijmegen breakage syndrome	Recurrent respiratory infections	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	nijmegen breakage syndrome	Abnormality of neuronal migration	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002488	nijmegen breakage syndrome	Acute leukemia	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002664	nijmegen breakage syndrome	Neoplasm	Frequent (79-30%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002665	nijmegen breakage syndrome	Lymphoma	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002859	nijmegen breakage syndrome	Rhabdomyosarcoma	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002878	nijmegen breakage syndrome	Respiratory failure	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003011	nijmegen breakage syndrome	Abnormality of the musculature	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	nijmegen breakage syndrome	Skeletal muscle atrophy	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003220	nijmegen breakage syndrome	Abnormality of chromosome stability	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	nijmegen breakage syndrome	Short stature	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004326	nijmegen breakage syndrome	Cachexia	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	nijmegen breakage syndrome	Depressed nasal bridge	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005425	nijmegen breakage syndrome	Recurrent sinopulmonary infections	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006532	nijmegen breakage syndrome	Recurrent pneumonia	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007018	nijmegen breakage syndrome	Attention deficit hyperactivity disorder	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009733	nijmegen breakage syndrome	Glioma	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011362	nijmegen breakage syndrome	Abnormal hair quantity	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012190	nijmegen breakage syndrome	T-cell lymphoma	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012191	nijmegen breakage syndrome	B-cell lymphoma	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012732	nijmegen breakage syndrome	Anorectal anomaly	Very frequent (99-80%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100335	nijmegen breakage syndrome	Non-midline cleft lip	Occasional (29-5%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100515	nijmegen breakage syndrome	Pollakisuria	Frequent (79-30%)	NBN	602667	251260	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	7652	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000083	nail-patella syndrome	Renal insufficiency	Occasional (29-5%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0000093	nail-patella syndrome	Proteinuria	Frequent (79-30%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0000100	nail-patella syndrome	Nephrotic syndrome	Frequent (79-30%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0000112	nail-patella syndrome	Nephropathy	Occasional (29-5%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0000365	nail-patella syndrome	Hearing impairment	Occasional (29-5%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0000501	nail-patella syndrome	Glaucoma	Occasional (29-5%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0000518	nail-patella syndrome	Cataract	Occasional (29-5%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0000790	nail-patella syndrome	Hematuria	Occasional (29-5%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0000822	nail-patella syndrome	Hypertension	Occasional (29-5%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0001231	nail-patella syndrome	Abnormality of the fingernails	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0001373	nail-patella syndrome	Joint dislocation	Frequent (79-30%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0001386	nail-patella syndrome	Joint swelling	Frequent (79-30%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0001387	nail-patella syndrome	Joint stiffness	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0001598	nail-patella syndrome	Concave nail	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0001800	nail-patella syndrome	Hypoplastic toenails	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0001807	nail-patella syndrome	Ridged nail	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0002633	nail-patella syndrome	Vasculitis	Occasional (29-5%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0002652	nail-patella syndrome	Skeletal dysplasia	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0002758	nail-patella syndrome	Osteoarthritis	Frequent (79-30%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0002814	nail-patella syndrome	Abnormality of the lower limb	Frequent (79-30%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0002817	nail-patella syndrome	Abnormality of the upper limb	Frequent (79-30%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0002967	nail-patella syndrome	Cubitus valgus	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0002999	nail-patella syndrome	Patellar dislocation	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0005692	nail-patella syndrome	Joint hyperflexibility	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0006498	nail-patella syndrome	Aplasia/Hypoplasia of the patella	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0006650	nail-patella syndrome	Thickening of the lateral border of the scapula	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0008388	nail-patella syndrome	Abnormality of the toenails	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0009780	nail-patella syndrome	Iliac horns	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0009811	nail-patella syndrome	Abnormality of the elbow	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0010624	nail-patella syndrome	Aplastic/hypoplastic toenail	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0100777	nail-patella syndrome	Exostoses	Very frequent (99-80%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
HP:0100820	nail-patella syndrome	Glomerulopathy	Occasional (29-5%)	LMX1B	602575	161200	monoallelic	confirmed	loss of function	Skin;Skeleton	6654	LIM homeobox transcription factor 1 beta	protein-coding gene	gene with protein product	Approved	9q33.3	09q33.3			NPS1	LIM homeobox transcription factor 1, beta	LIM class homeoboxes
NA	muscular dystrophy-dystroglycanopathy limb-girdle type c1	NA	NA	POMT1	607423	609308	biallelic	confirmed	loss of function	Musculature;Brain/Cognition	9202	protein O-mannosyltransferase 1	protein-coding gene	gene with protein product	Approved	9q34.13	09q34.13	LGMD2K	dolichyl-phosphate-mannose-protein mannosyltransferase			Dolichyl D-mannosyl phosphate dependent mannosyltransferases
NA	limb-girdle muscular dystrophy type 1b	NA	NA	LMNA	No gene mim	159001	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
NA	spondyloepimetaphyseal dysplasia strudwick type	NA	NA	COL2A1	120140	184250	monoallelic	confirmed	all missense/in frame	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000093	gaucher disease	Proteinuria	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000225	gaucher disease	Gingival bleeding	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000238	gaucher disease	Hydrocephalus	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000365	gaucher disease	Hearing impairment	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000486	gaucher disease	Strabismus	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000488	gaucher disease	Retinopathy	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000657	gaucher disease	Oculomotor apraxia	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000716	gaucher disease	Depression	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000790	gaucher disease	Hematuria	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000823	gaucher disease	Delayed puberty	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000924	gaucher disease	Abnormality of the skeletal system	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000938	gaucher disease	Osteopenia	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001000	gaucher disease	Abnormality of skin pigmentation	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001103	gaucher disease	Abnormality of the macula	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001251	gaucher disease	Ataxia	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001252	gaucher disease	Muscular hypotonia	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001337	gaucher disease	Tremor	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001373	gaucher disease	Joint dislocation	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001387	gaucher disease	Joint stiffness	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001394	gaucher disease	Cirrhosis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001522	gaucher disease	Death in infancy	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001637	gaucher disease	Abnormality of the myocardium	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001654	gaucher disease	Abnormality of the heart valves	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001697	gaucher disease	Abnormality of the pericardium	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001744	gaucher disease	Splenomegaly	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001789	gaucher disease	Hydrops fetalis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001873	gaucher disease	Thrombocytopenia	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001876	gaucher disease	Pancytopenia	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001892	gaucher disease	Abnormal bleeding	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001903	gaucher disease	Anemia	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0001945	gaucher disease	Fever	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002015	gaucher disease	Dysphagia	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002027	gaucher disease	Abdominal pain	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002069	gaucher disease	Generalized tonic-clonic seizures	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002071	gaucher disease	Abnormality of extrapyramidal motor function	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002092	gaucher disease	Pulmonary arterial hypertension	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002093	gaucher disease	Respiratory insufficiency	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002119	gaucher disease	Ventriculomegaly	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002123	gaucher disease	Generalized myoclonic seizures	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002206	gaucher disease	Pulmonary fibrosis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002240	gaucher disease	Hepatomegaly	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002376	gaucher disease	Developmental regression	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002653	gaucher disease	Bone pain	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002750	gaucher disease	Delayed skeletal maturation	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002754	gaucher disease	Osteomyelitis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002757	gaucher disease	Recurrent fractures	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002758	gaucher disease	Osteoarthritis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002797	gaucher disease	Osteolysis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002804	gaucher disease	Arthrogryposis multiplex congenita	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0002829	gaucher disease	Arthralgia	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0003330	gaucher disease	Abnormal bone structure	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0004322	gaucher disease	Short stature	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0004374	gaucher disease	Hemiplegia/hemiparesis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0004380	gaucher disease	Aortic valve calcification	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0004382	gaucher disease	Mitral valve calcification	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0006530	gaucher disease	Interstitial pulmonary disease	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0006824	gaucher disease	Cranial nerve paralysis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0007957	gaucher disease	Corneal opacity	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0008064	gaucher disease	Ichthyosis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0008872	gaucher disease	Feeding difficulties in infancy	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0010702	gaucher disease	Increased antibody level in blood	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0010729	gaucher disease	Cherry red spot of the macula	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0010885	gaucher disease	Aseptic necrosis	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0011001	gaucher disease	Increased bone mineral density	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0011227	gaucher disease	Elevated C-reactive protein level	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0012115	gaucher disease	Hepatitis	Occasional (29-5%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0012378	gaucher disease	Fatigue	Very frequent (99-80%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0100022	gaucher disease	Abnormality of movement	Frequent (79-30%)	GBA	No gene mim	230800	biallelic	both DD and IF	loss of function	Bone Marrow/Immune;Skeleton;Endocrine/Metabolic	4177	glucosylceramidase beta	protein-coding gene	gene with protein product	Approved	1q22	01q22	GBA1		GLUC	glucosylceramidase|glucosidase, beta; acid (includes glucosylceramidase)|glucosidase, beta, acid	
HP:0000486	leigh syndrome	Strabismus	Very frequent (99-80%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leigh syndrome	Nystagmus	Very frequent (99-80%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	leigh syndrome	Optic atrophy	Frequent (79-30%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leigh syndrome	Seizures	Frequent (79-30%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	leigh syndrome	Ataxia	Very frequent (99-80%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leigh syndrome	Muscular hypotonia	Very frequent (99-80%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	leigh syndrome	Respiratory insufficiency	Very frequent (99-80%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leigh syndrome	Hemiplegia/hemiparesis	Frequent (79-30%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007020	leigh syndrome	Progressive spastic paraplegia	Frequent (79-30%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007650	leigh syndrome	Progressive ophthalmoplegia	Frequent (79-30%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008972	leigh syndrome	Decreased activity of mitochondrial respiratory chain	Very frequent (99-80%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	leigh syndrome	Abnormality of movement	Very frequent (99-80%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	leigh syndrome	Cognitive impairment	Very frequent (99-80%)	DLD	238331	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	alpha-methylacetoacetic aciduria	NA	NA	ACAT1	607809	203750	biallelic	confirmed	loss of function	Endocrine/Metabolic	93	acetyl-CoA acetyltransferase 1	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	THIL	acetoacetyl Coenzyme A thiolase	ACAT	acetyl-Coenzyme A acetyltransferase 1	
NA	hypothryoidism, congenital, nongoitrous 4	NA	NA	TSHB	No gene mim	275100	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	12372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	vohwinkel syndrome	NA	NA	GJB2	121011	124500	monoallelic	confirmed	all missense/in frame	Skin;Ear	4284	gap junction protein beta 2	protein-coding gene	gene with protein product	Approved	13q12.11	13q12.11	CX26|NSRD1	connexin 26	DFNB1|DFNA3	gap junction protein, beta 2, 26kD (connexin 26)|gap junction protein, beta 2, 26kDa (connexin 26)|gap junction protein, beta 2, 26kDa	Gap junction proteins|Deafness associated genes
HP:0000486	leigh syndrome	Strabismus	Very frequent (99-80%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leigh syndrome	Nystagmus	Very frequent (99-80%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	leigh syndrome	Optic atrophy	Frequent (79-30%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leigh syndrome	Seizures	Frequent (79-30%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	leigh syndrome	Ataxia	Very frequent (99-80%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leigh syndrome	Muscular hypotonia	Very frequent (99-80%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	leigh syndrome	Respiratory insufficiency	Very frequent (99-80%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leigh syndrome	Hemiplegia/hemiparesis	Frequent (79-30%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007020	leigh syndrome	Progressive spastic paraplegia	Frequent (79-30%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007650	leigh syndrome	Progressive ophthalmoplegia	Frequent (79-30%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008972	leigh syndrome	Decreased activity of mitochondrial respiratory chain	Very frequent (99-80%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	leigh syndrome	Abnormality of movement	Very frequent (99-80%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	leigh syndrome	Cognitive impairment	Very frequent (99-80%)	COX15	603646	256000	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;GI tract;Heart/Cardiovasculature/Lymphatic	2263	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	meckel syndrome type 7	NA	NA	NPHP3	608002	267010	biallelic	confirmed	loss of function	Kidney Renal Tract;GI tract	7907	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	KDM5A	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	9886	lysine demethylase 5A	protein-coding gene	gene with protein product	Approved	12p13.33	12p13.33			RBBP2|JARID1A	retinoblastoma-binding protein 2|Jumonji, AT rich interactive domain 1A (RBBP2-like)|jumonji, AT rich interactive domain 1A|lysine (K)-specific demethylase 5A	PHD finger proteins|AT-rich interaction domain containing|Lysine demethylases|EMSY complex
HP:0007750	achromatopsia	Hypoplasia of the fovea	Occasional (29-5%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007793	achromatopsia	Granular macular appearance	Occasional (29-5%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007843	achromatopsia	Attenuation of retinal blood vessels	Occasional (29-5%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007939	achromatopsia	Blue cone monochromacy	Very rare (<4-1%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	achromatopsia	Visual impairment	Very frequent (99-80%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000512	achromatopsia	Abnormal electroretinogram	Very frequent (99-80%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000577	achromatopsia	Exotropia	Very frequent (99-80%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000613	achromatopsia	Photophobia	Very frequent (99-80%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007641	achromatopsia	Dyschromatopsia	Very frequent (99-80%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007803	achromatopsia	Monochromacy	Very frequent (99-80%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012043	achromatopsia	Pendular nystagmus	Very frequent (99-80%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000540	achromatopsia	Hypermetropia	Frequent (79-30%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000603	achromatopsia	Central scotoma	Occasional (29-5%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007722	achromatopsia	Loss of retinal pigment epithelium	Occasional (29-5%)	PDE6H	601190	No disease mim	biallelic	probable	loss of function	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000098	perlman syndrome	Tall stature	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000177	perlman syndrome	Abnormality of upper lip	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000194	perlman syndrome	Open mouth	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	perlman syndrome	Macrocephaly	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000278	perlman syndrome	Retrognathia	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000311	perlman syndrome	Round face	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000319	perlman syndrome	Smooth philtrum	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	perlman syndrome	Micrognathia	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	perlman syndrome	High forehead	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	perlman syndrome	Wide nasal bridge	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000490	perlman syndrome	Deeply set eye	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	perlman syndrome	Intellectual disability	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	perlman syndrome	Muscular hypotonia	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	perlman syndrome	Global developmental delay	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	perlman syndrome	Specific learning disability	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	perlman syndrome	Hepatomegaly	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	perlman syndrome	Short nose	Very frequent (99-80%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	perlman syndrome	Cryptorchidism	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000187	perlman syndrome	Broad alveolar ridges	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	perlman syndrome	Epicanthus	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000358	perlman syndrome	Posteriorly rotated ears	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	perlman syndrome	Low-set ears	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000391	perlman syndrome	Thickened helices	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	perlman syndrome	Anteverted nares	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000842	perlman syndrome	Hyperinsulinemia	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002667	perlman syndrome	Nephroblastoma	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002705	perlman syndrome	High, narrow palate	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	perlman syndrome	Hypoplasia of penis	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012090	perlman syndrome	Abnormality of pancreas morphology	Frequent (79-30%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	perlman syndrome	Inguinal hernia	Occasional (29-5%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000268	perlman syndrome	Dolichocephaly	Occasional (29-5%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	perlman syndrome	Ptosis	Occasional (29-5%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	perlman syndrome	Seizures	Occasional (29-5%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002133	perlman syndrome	Status epilepticus	Occasional (29-5%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005306	perlman syndrome	Capillary hemangiomas	Occasional (29-5%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007598	perlman syndrome	Bilateral single transverse palmar creases	Occasional (29-5%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010733	perlman syndrome	Naevus flammeus of the eyelid	Occasional (29-5%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100541	perlman syndrome	Femoral hernia	Occasional (29-5%)	DIS3L2	614184	267000	biallelic	confirmed	loss of function	Cancer predisposition	28648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	trichothiodystrophy photosensitive	NA	NA	GTF2H5	608780	601675	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	21157	general transcription factor IIH subunit 5	protein-coding gene	gene with protein product	Approved	6q25.3	06q25.3	FLJ30544|bA120J8.2|TTD-A|TFB5|TFIIH|TTDA	DNA repair syndrome trichothiodystrophy group A	C6orf175|TTD	chromosome 6 open reading frame 175|trichothiodystrophy|general transcription factor IIH, polypeptide 5	General transcription factors|Nucleotide excision repair
NA	multiple epiphyseal dysplasia type 2	NA	NA	COL9A2	120260	600204	monoallelic	confirmed	dominant negative	Face;Skeleton;Eye;Ear	2218	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mucopolysaccharidosis type 9	NA	NA	HYAL1	607071	601492	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	5320	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, x-linked 3	NA	NA	HCFC1	300019	309541	hemizygous	confirmed	5_prime or 3_prime UTR mutation	Brain/Cognition	4839	host cell factor C1	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	HCF-1|HCF1|CFF|VCAF|MGC70925|PPP1R89	VP16-accessory protein|protein phosphatase 1, regulatory subunit 89	HFC1|MRX3	mental retardation, X-linked 3|host cell factor C1 (VP16-accessory protein)	X-linked mental retardation|Protein phosphatase 1 regulatory subunits|ATAC complex|NSL histone acetyltransferase complex
HP:0000256	acrocapitofemoral dysplasia	Macrocephaly	Occasional (29-5%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0000767	acrocapitofemoral dysplasia	Pectus excavatum	Occasional (29-5%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0000768	acrocapitofemoral dysplasia	Pectus carinatum	Occasional (29-5%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0000774	acrocapitofemoral dysplasia	Narrow chest	Occasional (29-5%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0001792	acrocapitofemoral dysplasia	Small nail	Frequent (79-30%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0001821	acrocapitofemoral dysplasia	Broad nail	Frequent (79-30%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0002650	acrocapitofemoral dysplasia	Scoliosis	Occasional (29-5%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0002652	acrocapitofemoral dysplasia	Skeletal dysplasia	Very frequent (99-80%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0002750	acrocapitofemoral dysplasia	Delayed skeletal maturation	Very frequent (99-80%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0002812	acrocapitofemoral dysplasia	Coxa vara	Very frequent (99-80%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0002869	acrocapitofemoral dysplasia	Flared iliac wings	Frequent (79-30%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0002970	acrocapitofemoral dysplasia	Genu varum	Frequent (79-30%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0002983	acrocapitofemoral dysplasia	Micromelia	Very frequent (99-80%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0003300	acrocapitofemoral dysplasia	Ovoid vertebral bodies	Frequent (79-30%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0003307	acrocapitofemoral dysplasia	Hyperlordosis	Frequent (79-30%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0003367	acrocapitofemoral dysplasia	Abnormality of the femoral neck	Very frequent (99-80%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0004279	acrocapitofemoral dysplasia	Short palm	Very frequent (99-80%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0004322	acrocapitofemoral dysplasia	Short stature	Very frequent (99-80%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0006059	acrocapitofemoral dysplasia	Cone-shaped metacarpal epiphyses	Frequent (79-30%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0010306	acrocapitofemoral dysplasia	Short thorax	Occasional (29-5%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
HP:0010579	acrocapitofemoral dysplasia	Cone-shaped epiphysis	Very frequent (99-80%)	IHH	600726	607778	biallelic	confirmed	all missense/in frame	Skeleton	5956	indian hedgehog	protein-coding gene	gene with protein product	Approved	2q35	02q35	HHG2|BDA1			Indian hedgehog (Drosophila) homolog|Indian hedgehog homolog (Drosophila)	
NA	congenital hypothyroidism non-goitrous type 5	NA	NA	NKX2-5	600584	225250	monoallelic	confirmed	uncertain	Heart/Cardiovasculature/Lymphatic	2488	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	riddle syndrome	NA	NA	RNF168	No gene mim	611943	biallelic	possible	loss of function	Bone Marrow/Immune;Face;Brain/Cognition	26661	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infantile nephronophthisis and intellectual disability	NA	NA	CEP83	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition	17966	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	solitary median maxillary central incisor	NA	NA	SHH	600725	147250	monoallelic	confirmed	loss of function	Teeth & Dentitian;Face;Brain/Cognition;Eye	10848	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spinocerebellar ataxia type15	NA	NA	ITPR1	No gene mim	606658	monoallelic	probable	loss of function	Brain/Cognition	6180	inositol 1,4,5-trisphosphate receptor type 1	protein-coding gene	gene with protein product	Approved	3p26.1	03p26.1	Insp3r1|IP3R1|ACV|PPP1R94	protein phosphatase 1, regulatory subunit 94	SCA15|SCA16|SCA29	spinocerebellar ataxia 15|spinocerebellar ataxia 16|spinocerebellar ataxia 29|inositol 1,4,5-trisphosphate receptor, type 1	Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits
NA	intellectual disability	NA	NA	WAC	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	17327	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autism	NA	NA	CHD8	610528	209850	monoallelic	probable	loss of function	Brain/Cognition	20153	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary congenital glaucoma type 3a	NA	NA	CYP1B1	601771	231300	biallelic	confirmed	uncertain	Eye	2597	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acrofacial dysostosis 1, nager type	NA	NA	SF3B4	605593	154400	monoallelic	confirmed	loss of function	Face	10771	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy	NA	NA	HNRNPU	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	5048	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	NA	NA	ATP8A2	No gene mim	615268	biallelic	possible	all missense/in frame	Brain/Cognition	13533	ATPase phospholipid transporting 8A2	protein-coding gene	gene with protein product	Approved	13q12.13	13q12.13	ATPIB|ML-1			ATPase, aminophospholipid transporter-like, Class I, type 8A, member 2|ATPase, aminophospholipid transporter-like, class I, type 8A, member 2|ATPase, aminophospholipid transporter, class I, type 8A, member 2	ATPase phospholipid transporting
HP:0001252	biotinidase deficiency	Muscular hypotonia	Very frequent (99-80%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002123	biotinidase deficiency	Generalized myoclonic seizures	Very frequent (99-80%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005979	biotinidase deficiency	Metabolic ketoacidosis	Very frequent (99-80%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	biotinidase deficiency	Hearing impairment	Frequent (79-30%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	biotinidase deficiency	Optic atrophy	Frequent (79-30%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001096	biotinidase deficiency	Keratoconjunctivitis	Frequent (79-30%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	biotinidase deficiency	Ataxia	Frequent (79-30%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	biotinidase deficiency	Global developmental delay	Frequent (79-30%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001596	biotinidase deficiency	Alopecia	Frequent (79-30%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007549	biotinidase deficiency	Desquamation of skin soon after birth	Frequent (79-30%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011127	biotinidase deficiency	Perioral eczema	Frequent (79-30%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	biotinidase deficiency	Myopia	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001123	biotinidase deficiency	Visual field defect	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001254	biotinidase deficiency	Lethargy	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001259	biotinidase deficiency	Coma	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001276	biotinidase deficiency	Hypertonia	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001317	biotinidase deficiency	Abnormality of the cerebellum	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001324	biotinidase deficiency	Muscle weakness	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	biotinidase deficiency	Growth delay	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002104	biotinidase deficiency	Apnea	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002841	biotinidase deficiency	Recurrent fungal infections	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002883	biotinidase deficiency	Hyperventilation	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006511	biotinidase deficiency	Laryngeal stridor	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007730	biotinidase deficiency	Iris hypopigmentation	Occasional (29-5%)	BTD	609019	253260	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition;Ear	1122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked syp-related	NA	NA	SYP	313475	300802	hemizygous	confirmed	loss of function	Brain/Cognition	11506	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	urocanase deficiency	NA	NA	UROC1	613012	276880	biallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition	26444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	retinal arterial macroaneurysm with supravalvular pulmonic stenosis	NA	NA	IGFBP7	602867	614224	biallelic	probable	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	5476	insulin like growth factor binding protein 7	protein-coding gene	gene with protein product	Approved	4q12	04q12	MAC25|IGFBP-7|PSF|FSTL2			insulin-like growth factor binding protein 7	I-set domain containing
HP:0001250	isovaleric acidemia	Seizures	Frequent (79-30%)	IVD	607036	243500	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6186	isovaleryl-CoA dehydrogenase	protein-coding gene	gene with protein product	Approved	15q15.1	15q15.1	ACAD2			isovaleryl Coenzyme A dehydrogenase|isovaleryl CoA dehydrogenase	Acyl-CoA dehydrogenase family
HP:0001263	isovaleric acidemia	Global developmental delay	Very frequent (99-80%)	IVD	607036	243500	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6186	isovaleryl-CoA dehydrogenase	protein-coding gene	gene with protein product	Approved	15q15.1	15q15.1	ACAD2			isovaleryl Coenzyme A dehydrogenase|isovaleryl CoA dehydrogenase	Acyl-CoA dehydrogenase family
HP:0001942	isovaleric acidemia	Metabolic acidosis	Very frequent (99-80%)	IVD	607036	243500	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	6186	isovaleryl-CoA dehydrogenase	protein-coding gene	gene with protein product	Approved	15q15.1	15q15.1	ACAD2			isovaleryl Coenzyme A dehydrogenase|isovaleryl CoA dehydrogenase	Acyl-CoA dehydrogenase family
NA	autosomal-recessive complete congenital stationary night blindness	NA	NA	LRIT3	615004	615058	biallelic	probable	loss of function	Eye	24783	leucine rich repeat, Ig-like and transmembrane domains 3	protein-coding gene	gene with protein product	Approved	4q25	04q25	FLJ44691|FIGLER4|CSNB1F	fibronectin type III, immunoglobulin and leucine rich repeat domains 4			I-set domain containing
NA	marinesco-sjoegren syndrome	NA	NA	SIL1	608005	248800	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;Eye	24624	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	deafness, autosomal recessive 89	NA	NA	KARS	No gene mim	613916	biallelic	both DD and IF	all missense/in frame	Spinal cord/Peripheral nerves;Ear	6215	lysyl-tRNA synthetase	protein-coding gene	gene with protein product	Approved	16q23.1	16q23.1	KARS2|KARS1	lysine tRNA ligase	DFNB89	deafness, autosomal recessive 89	Aminoacyl tRNA synthetases, Class II|Deafness associated genes
NA	12p12.5 intragenic deletions associated with intellectual disability	NA	NA	SOX5	No gene mim	No disease mim	monoallelic	probable	loss of function	Brain/Cognition	11201	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000935	gnathodiaphyseal dysplasia	Thickened cortex of long bones	Very frequent (99-80%)	ANO5	No gene mim	166260	monoallelic	both DD and IF	activating	Musculature;Skeleton	27337	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000938	gnathodiaphyseal dysplasia	Osteopenia	Frequent (79-30%)	ANO5	No gene mim	166260	monoallelic	both DD and IF	activating	Musculature;Skeleton	27337	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	gnathodiaphyseal dysplasia	Scoliosis	Occasional (29-5%)	ANO5	No gene mim	166260	monoallelic	both DD and IF	activating	Musculature;Skeleton	27337	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	gnathodiaphyseal dysplasia	Recurrent fractures	Occasional (29-5%)	ANO5	No gene mim	166260	monoallelic	both DD and IF	activating	Musculature;Skeleton	27337	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	gnathodiaphyseal dysplasia	Bowing of the long bones	Very frequent (99-80%)	ANO5	No gene mim	166260	monoallelic	both DD and IF	activating	Musculature;Skeleton	27337	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007626	gnathodiaphyseal dysplasia	Mandibular osteomyelitis	Frequent (79-30%)	ANO5	No gene mim	166260	monoallelic	both DD and IF	activating	Musculature;Skeleton	27337	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012802	gnathodiaphyseal dysplasia	Broad jaw	Very frequent (99-80%)	ANO5	No gene mim	166260	monoallelic	both DD and IF	activating	Musculature;Skeleton	27337	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	focal dermal hypoplasia	Multicystic kidney dysplasia	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000023	focal dermal hypoplasia	Inguinal hernia	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000085	focal dermal hypoplasia	Horseshoe kidney	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000126	focal dermal hypoplasia	Hydronephrosis	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000164	focal dermal hypoplasia	Abnormality of the teeth	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000307	focal dermal hypoplasia	Pointed chin	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000324	focal dermal hypoplasia	Facial asymmetry	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000365	focal dermal hypoplasia	Hearing impairment	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000369	focal dermal hypoplasia	Low-set ears	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000370	focal dermal hypoplasia	Abnormality of the middle ear	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000446	focal dermal hypoplasia	Narrow nasal bridge	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000486	focal dermal hypoplasia	Strabismus	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000567	focal dermal hypoplasia	Chorioretinal coloboma	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000568	focal dermal hypoplasia	Microphthalmia	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000612	focal dermal hypoplasia	Iris coloboma	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000682	focal dermal hypoplasia	Abnormality of dental enamel	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000773	focal dermal hypoplasia	Short ribs	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000776	focal dermal hypoplasia	Congenital diaphragmatic hernia	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000894	focal dermal hypoplasia	Short clavicles	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0000963	focal dermal hypoplasia	Thin skin	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001000	focal dermal hypoplasia	Abnormality of skin pigmentation	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001018	focal dermal hypoplasia	Abnormal palmar dermatoglyphics	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001083	focal dermal hypoplasia	Ectopia lentis	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001161	focal dermal hypoplasia	Hand polydactyly	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001171	focal dermal hypoplasia	Split hand	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001482	focal dermal hypoplasia	Subcutaneous nodule	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001537	focal dermal hypoplasia	Umbilical hernia	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001539	focal dermal hypoplasia	Omphalocele	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001540	focal dermal hypoplasia	Diastasis recti	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001596	focal dermal hypoplasia	Alopecia	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001597	focal dermal hypoplasia	Abnormality of the nail	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001629	focal dermal hypoplasia	Ventricular septal defect	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001643	focal dermal hypoplasia	Patent ductus arteriosus	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001671	focal dermal hypoplasia	Abnormality of the cardiac septa	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001770	focal dermal hypoplasia	Toe syndactyly	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0001839	focal dermal hypoplasia	Split foot	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0002020	focal dermal hypoplasia	Gastroesophageal reflux	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0002027	focal dermal hypoplasia	Abdominal pain	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0002247	focal dermal hypoplasia	Duodenal atresia	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0002414	focal dermal hypoplasia	Spina bifida	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0002650	focal dermal hypoplasia	Scoliosis	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0004334	focal dermal hypoplasia	Dermal atrophy	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0004930	focal dermal hypoplasia	Abnormality of the pulmonary vasculature	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0005930	focal dermal hypoplasia	Abnormality of epiphysis morphology	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0006101	focal dermal hypoplasia	Finger syndactyly	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0006482	focal dermal hypoplasia	Abnormality of dental morphology	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0006554	focal dermal hypoplasia	Acute hepatic failure	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0006703	focal dermal hypoplasia	Aplasia/Hypoplasia of the lungs	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0007676	focal dermal hypoplasia	Hypoplasia of the iris	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0007957	focal dermal hypoplasia	Corneal opacity	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0008065	focal dermal hypoplasia	Aplasia/Hypoplasia of the skin	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0008678	focal dermal hypoplasia	Renal hypoplasia/aplasia	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0008839	focal dermal hypoplasia	Hypoplastic pelvis	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0009124	focal dermal hypoplasia	Abnormality of adipose tissue	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0009804	focal dermal hypoplasia	Reduced number of teeth	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0010783	focal dermal hypoplasia	Erythema	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0010807	focal dermal hypoplasia	Open bite	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0011847	focal dermal hypoplasia	Giant cell tumor of bone	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0012733	focal dermal hypoplasia	Macule	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0012740	focal dermal hypoplasia	Papilloma	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0045026	focal dermal hypoplasia	Abnormality of the mediastinum	Occasional (29-5%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0100490	focal dermal hypoplasia	Camptodactyly of finger	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0100543	focal dermal hypoplasia	Cognitive impairment	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0100559	focal dermal hypoplasia	Lower limb asymmetry	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0100560	focal dermal hypoplasia	Upper limb asymmetry	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0100585	focal dermal hypoplasia	Telangiectasia of the skin	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0100670	focal dermal hypoplasia	Rough bone trabeculation	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0100790	focal dermal hypoplasia	Hernia	Very frequent (99-80%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
HP:0200036	focal dermal hypoplasia	Skin nodule	Frequent (79-30%)	PORCN	300651	305600	x-linked dominant	confirmed	loss of function	Skin;Skeleton	17652	porcupine O-acyltransferase	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	MG61|PORC|PPN|por		DHOF	dermal hypoplasia, focal|porcupine homolog (Drosophila)	Membrane bound O-acyltransferases
NA	tgfbr2-related loeys-dietz syndrome	NA	NA	TGFBR2	190182	249163	monoallelic	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	11773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy limb-girdle type c4	NA	NA	FKTN	607440	611588	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	3622	fukutin	protein-coding gene	gene with protein product	Approved	9q31.2	09q31.2	LGMD2M		FCMD	Fukuyama type congenital muscular dystrophy (fukutin)	
NA	congenital heart disease and neurodevelopmental disorder	NA	NA	NAA15	No gene mim	No disease mim	monoallelic	probable	loss of function	Heart/Cardiovasculature/Lymphatic	30782	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bardet-biedl syndrome type 7	NA	NA	BBS7	607590	209900	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	18758	Bardet-Biedl syndrome 7	protein-coding gene	gene with protein product	Approved	4q27	04q27	FLJ10715|BBS2L1				Bardet-Biedl syndrome associated|BBSome
HP:0000112	familial isolated hypoparathyroidism	Nephropathy	Very frequent (99-80%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	familial isolated hypoparathyroidism	Cataract	Frequent (79-30%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	familial isolated hypoparathyroidism	Abnormality of dental enamel	Frequent (79-30%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	familial isolated hypoparathyroidism	Delayed eruption of teeth	Frequent (79-30%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000829	familial isolated hypoparathyroidism	Hypoparathyroidism	Very frequent (99-80%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	familial isolated hypoparathyroidism	Seizures	Very frequent (99-80%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002514	familial isolated hypoparathyroidism	Cerebral calcification	Frequent (79-30%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002901	familial isolated hypoparathyroidism	Hypocalcemia	Very frequent (99-80%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003198	familial isolated hypoparathyroidism	Myopathy	Very frequent (99-80%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	familial isolated hypoparathyroidism	Short stature	Very frequent (99-80%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	familial isolated hypoparathyroidism	Arrhythmia	Frequent (79-30%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100530	familial isolated hypoparathyroidism	Abnormality of calcium-phosphate metabolism	Very frequent (99-80%)	PTH	168450	146200	biallelic	probable	loss of function	Skeleton	9606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ethylmalonic encephalopathy	NA	NA	ETHE1	608451	602473	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	23287	ETHE1, persulfide dioxygenase	protein-coding gene	gene with protein product	Approved	19q13.31	19q13.31	YF13H12|HSCO			ethylmalonic encephalopathy 1	
HP:0000164	pycnodysostosis	Abnormality of the teeth	Frequent (79-30%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000189	pycnodysostosis	Narrow palate	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	pycnodysostosis	Hydrocephalus	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	pycnodysostosis	Brachycephaly	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000271	pycnodysostosis	Abnormality of the face	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000272	pycnodysostosis	Malar flattening	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	pycnodysostosis	High forehead	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	pycnodysostosis	Proptosis	Frequent (79-30%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000592	pycnodysostosis	Blue sclerae	Frequent (79-30%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	pycnodysostosis	Delayed eruption of teeth	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	pycnodysostosis	Narrow chest	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000889	pycnodysostosis	Abnormality of the clavicle	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000924	pycnodysostosis	Abnormality of the skeletal system	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000925	pycnodysostosis	Abnormality of the vertebral column	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000951	pycnodysostosis	Abnormality of the skin	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	pycnodysostosis	Brachydactyly syndrome	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001231	pycnodysostosis	Abnormality of the fingernails	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001597	pycnodysostosis	Abnormality of the nail	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	pycnodysostosis	Splenomegaly	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001807	pycnodysostosis	Ridged nail	Frequent (79-30%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001831	pycnodysostosis	Short toe	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	pycnodysostosis	Anemia	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	pycnodysostosis	Frontal bossing	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	pycnodysostosis	Hepatomegaly	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002644	pycnodysostosis	Abnormality of pelvic girdle bone morphology	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002645	pycnodysostosis	Wormian bones	Frequent (79-30%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	pycnodysostosis	Skeletal dysplasia	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002653	pycnodysostosis	Bone pain	Frequent (79-30%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002754	pycnodysostosis	Osteomyelitis	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	pycnodysostosis	Recurrent fractures	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002793	pycnodysostosis	Abnormal pattern of respiration	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002797	pycnodysostosis	Osteolysis	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	pycnodysostosis	Kyphosis	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003307	pycnodysostosis	Hyperlordosis	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003468	pycnodysostosis	Abnormality of the vertebrae	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	pycnodysostosis	Short stature	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004474	pycnodysostosis	Persistent open anterior fontanelle	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	pycnodysostosis	Abnormality of epiphysis morphology	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006482	pycnodysostosis	Abnormality of dental morphology	Frequent (79-30%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009106	pycnodysostosis	Abnormal pelvis bone ossification	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009882	pycnodysostosis	Short distal phalanx of finger	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	pycnodysostosis	Midface retrusion	Very frequent (99-80%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	pycnodysostosis	Cognitive impairment	Occasional (29-5%)	CTSK	601105	265800	biallelic	confirmed	loss of function	Skeleton	2536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehlers-danlos syndrome type 4	NA	NA	COL3A1	120180	130050	monoallelic	child IF	dominant negative	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	2201	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	three m syndrome 3	NA	NA	CCDC8	614145	614205	biallelic	probable	loss of function	Skeleton;Brain/Cognition	25367	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ichthyosis, lamellar, 4	NA	NA	LIPN	613924	613943	biallelic	probable	loss of function	Skin	23452	lipase family member N	protein-coding gene	gene with protein product	Approved	10q23.31	10q23.31	bA186O14.3		LIPL4	lipase-like, ab-hydrolase domain containing 4	Lipases
NA	night blindness, congenital stationary, type 1d	NA	NA	SLC24A1	No gene mim	613830	biallelic	possible	loss of function	Eye	10975	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000035	ataxia-telangiectasia	Abnormality of the testis	Occasional (29-5%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0000147	ataxia-telangiectasia	Polycystic ovaries	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0000486	ataxia-telangiectasia	Strabismus	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0000496	ataxia-telangiectasia	Abnormality of eye movement	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0000639	ataxia-telangiectasia	Nystagmus	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0000819	ataxia-telangiectasia	Diabetes mellitus	Frequent (79-30%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0000823	ataxia-telangiectasia	Delayed puberty	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0001250	ataxia-telangiectasia	Seizures	Frequent (79-30%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0001251	ataxia-telangiectasia	Ataxia	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0001257	ataxia-telangiectasia	Spasticity	Frequent (79-30%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0001260	ataxia-telangiectasia	Dysarthria	Frequent (79-30%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0001288	ataxia-telangiectasia	Gait disturbance	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0001337	ataxia-telangiectasia	Tremor	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0001508	ataxia-telangiectasia	Failure to thrive	Occasional (29-5%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0001888	ataxia-telangiectasia	Lymphopenia	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0002167	ataxia-telangiectasia	Neurological speech impairment	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0002205	ataxia-telangiectasia	Recurrent respiratory infections	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0002216	ataxia-telangiectasia	Premature graying of hair	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0002664	ataxia-telangiectasia	Neoplasm	Frequent (79-30%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0002715	ataxia-telangiectasia	Abnormality of the immune system	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0002721	ataxia-telangiectasia	Immunodeficiency	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0002910	ataxia-telangiectasia	Elevated hepatic transaminases	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0003202	ataxia-telangiectasia	Skeletal muscle atrophy	Frequent (79-30%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0003220	ataxia-telangiectasia	Abnormality of chromosome stability	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0004313	ataxia-telangiectasia	Decreased antibody level in blood	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0004322	ataxia-telangiectasia	Short stature	Frequent (79-30%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0005374	ataxia-telangiectasia	Cellular immunodeficiency	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0005599	ataxia-telangiectasia	Hypopigmentation of hair	Frequent (79-30%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0005978	ataxia-telangiectasia	Type II diabetes mellitus	Occasional (29-5%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0007495	ataxia-telangiectasia	Prematurely aged appearance	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0007565	ataxia-telangiectasia	Multiple cafe-au-lait spots	Occasional (29-5%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0008065	ataxia-telangiectasia	Aplasia/Hypoplasia of the skin	Occasional (29-5%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0010515	ataxia-telangiectasia	Aplasia/Hypoplasia of the thymus	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0100022	ataxia-telangiectasia	Abnormality of movement	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0100543	ataxia-telangiectasia	Cognitive impairment	Occasional (29-5%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0100579	ataxia-telangiectasia	Mucosal telangiectasiae	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
HP:0100585	ataxia-telangiectasia	Telangiectasia of the skin	Very frequent (99-80%)	ATM	607585	208900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	795	ATM serine/threonine kinase	protein-coding gene	gene with protein product	Approved	11q22.3	11q22.3	TEL1|TELO1	TEL1, telomere maintenance 1, homolog (S. cerevisiae)	ATA|ATDC|ATC|ATD	ataxia telangiectasia mutated (includes complementation groups A, C and D)|ataxia telangiectasia mutated	
NA	arts syndrome	NA	NA	PRPS1	311850	301835	hemizygous	confirmed	loss of function	Spinal cord/Peripheral nerves;Endocrine/Metabolic	9462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	xfe progeroid syndrome	NA	NA	ERCC4	133520	610965	biallelic	probable	loss of function	Skin;Skeleton	3436	ERCC excision repair 4, endonuclease catalytic subunit	protein-coding gene	gene with protein product	Approved	16p13.12	16p13.12	RAD1|FANCQ	xeroderma pigmentosum, complementation group F	XPF	excision repair cross-complementing rodent repair deficiency, complementation group 4|excision repair cross-complementation group 4	Fanconi anemia complementation groups|Xeroderma pigmentosum complementation groups|ERCC excision repair associated
NA	mitochondrial complex v (atp synthase) deficiency, nuclear type 2	NA	NA	TMEM70	612418	614052	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	26050	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	encephalopathy neonatal severe due to mecp2 mutations	NA	NA	MECP2	300005	300673	hemizygous	confirmed	loss of function	Brain/Cognition;GI tract	6990	methyl-CpG binding protein 2	protein-coding gene	gene with protein product	Approved	Xq28	Xq28			RTT|MRX16|MRX79	mental retardation, X-linked 16|mental retardation, X-linked 79|Rett syndrome|methyl CpG binding protein 2 (Rett syndrome)|methyl CpG binding protein 2	X-linked mental retardation|Methyl-CpG binding domain containing
NA	neuroblastoma with hirschsprung disease	NA	NA	PHOX2B	603851	613013	monoallelic	confirmed	uncertain	Endocrine/Metabolic;Brain/Cognition;GI tract	9143	paired like homeobox 2b	protein-coding gene	gene with protein product	Approved	4p13	04p13	Phox2b|NBPhox		PMX2B	paired mesoderm homeobox 2b	PRD class homeoboxes and pseudogenes
NA	familial candidiasis type 7	NA	NA	STAT1	600555	614162	monoallelic	confirmed	all missense/in frame	Bone Marrow/Immune	11362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital disorder of glycosylation, type it	NA	NA	PGM1	No gene mim	614921	biallelic	confirmed	loss of function	Face;Endocrine/Metabolic	8905	phosphoglucomutase 1	protein-coding gene	gene with protein product	Approved	1p31.3	01p31.3					
NA	short rib-polydactyly syndorme, type ii	NA	NA	NEK1	604588	263520	biallelic	confirmed	loss of function	Skeleton	7744	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	short rib-polydactyly syndorme, type ii	NA	NA	NEK1	604588	263520	digenic	confirmed	loss of function	Skeleton	7744	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	progressive myoclonic epilepsy type 3	NA	NA	KCTD7	611725	611726	biallelic	confirmed	loss of function	Brain/Cognition	21957	potassium channel tetramerization domain containing 7	protein-coding gene	gene with protein product	Approved	7q11.21	07q11.21	FLJ32069|EPM3|CLN14			potassium channel tetramerisation domain containing 7	
NA	mental retardation with language impairment and autistic features	NA	NA	FOXP1	605515	613670	monoallelic	confirmed	loss of function	Brain/Cognition	3823	forkhead box P1	protein-coding gene	gene with protein product	Approved	3p13	03p13	QRF1|12CC4|HSPC215|hFKH1B	fork head-related protein like B|glutamine-rich factor 1|PAX5/FOXP1 fusion protein			Forkhead boxes
NA	schimke immunoosseous dysplasia	NA	NA	SMARCAL1	606622	242900	biallelic	confirmed	loss of function	Skeleton	11102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	charge syndrome	Cryptorchidism	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000044	charge syndrome	Hypogonadotrophic hypogonadism	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000054	charge syndrome	Micropenis	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000359	charge syndrome	Abnormality of the inner ear	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	charge syndrome	Hearing impairment	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000396	charge syndrome	Overfolded helix	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000458	charge syndrome	Anosmia	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	charge syndrome	Iris coloboma	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000823	charge syndrome	Delayed puberty	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	charge syndrome	Global developmental delay	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001291	charge syndrome	Abnormality of the cranial nerves	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008572	charge syndrome	External ear malformation	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	charge syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009906	charge syndrome	Aplasia/Hypoplasia of the earlobes	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011382	charge syndrome	Hypoplasia of the semicircular canal	Very frequent (99-80%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000008	charge syndrome	Abnormality of female internal genitalia	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000048	charge syndrome	Bifid scrotum	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000066	charge syndrome	Labial hypoplasia	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	charge syndrome	Narrow mouth	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	charge syndrome	Cleft palate	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000204	charge syndrome	Cleft upper lip	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000275	charge syndrome	Narrow face	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000324	charge syndrome	Facial asymmetry	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	charge syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000453	charge syndrome	Choanal atresia	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	charge syndrome	Strabismus	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	charge syndrome	Ptosis	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000528	charge syndrome	Anophthalmia	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000567	charge syndrome	Chorioretinal coloboma	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	charge syndrome	Microphthalmia	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	charge syndrome	Nystagmus	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	charge syndrome	Optic atrophy	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000684	charge syndrome	Delayed eruption of teeth	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000717	charge syndrome	Autism	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000722	charge syndrome	Obsessive-compulsive behavior	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000830	charge syndrome	Anterior hypopituitarism	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	charge syndrome	Intellectual disability	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	charge syndrome	Muscular hypotonia	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	charge syndrome	Polyhydramnios	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	charge syndrome	Tetralogy of Fallot	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	charge syndrome	Patent ductus arteriosus	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001646	charge syndrome	Abnormality of the aortic valve	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001671	charge syndrome	Abnormality of the cardiac septa	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	charge syndrome	Gastroesophageal reflux	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	charge syndrome	Malformation of the heart and great vessels	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	charge syndrome	Short stature	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005113	charge syndrome	Dilatation of the aortic arch	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	charge syndrome	Depressed nasal bridge	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007018	charge syndrome	Attention deficit hyperactivity disorder	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008897	charge syndrome	Postnatal growth retardation	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010628	charge syndrome	Facial palsy	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010751	charge syndrome	Chin dimple	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011611	charge syndrome	Interrupted aortic arch	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100736	charge syndrome	Abnormality of the soft palate	Frequent (79-30%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	charge syndrome	Vesicoureteral reflux	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000085	charge syndrome	Horseshoe kidney	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000126	charge syndrome	Hydronephrosis	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	charge syndrome	Microcephaly	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	charge syndrome	Epicanthus	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	charge syndrome	Hypertelorism	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000384	charge syndrome	Preauricular skin tag	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000478	charge syndrome	Abnormality of the eye	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	charge syndrome	Abnormality of vision	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000625	charge syndrome	Cleft eyelid	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000632	charge syndrome	Lacrimation abnormality	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	charge syndrome	Abnormality of the ribs	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000834	charge syndrome	Abnormality of the adrenal glands	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	charge syndrome	Brachydactyly syndrome	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001305	charge syndrome	Dandy-Walker malformation	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001360	charge syndrome	Holoprosencephaly	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	charge syndrome	Intrauterine growth retardation	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001601	charge syndrome	Laryngomalacia	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001883	charge syndrome	Talipes	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	charge syndrome	Respiratory insufficiency	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002410	charge syndrome	Aqueductal stenosis	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002553	charge syndrome	Highly arched eyebrow	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002575	charge syndrome	Tracheoesophageal fistula	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	charge syndrome	Scoliosis	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002937	charge syndrome	Hemivertebrae	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002992	charge syndrome	Abnormality of the tibia	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	charge syndrome	Clinodactyly of the 5th finger	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004348	charge syndrome	Abnormality of bone mineral density	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006824	charge syndrome	Cranial nerve paralysis	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	charge syndrome	Aplasia/Hypoplasia of the cerebellum	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008551	charge syndrome	Microtia	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010443	charge syndrome	Bifid femur	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010669	charge syndrome	Cheekbone underdevelopment	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	charge syndrome	Abnormality of immune system physiology	Occasional (29-5%)	CHD7	608892	214800	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye;Ear;Heart/Cardiovasculature/Lymphatic	20626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	facial clefting, oblique, 1	NA	NA	SPECC1L	No gene mim	600251	monoallelic	probable	all missense/in frame	Face	29022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	smith-lemli-opitz syndrome	Multicystic kidney dysplasia	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	smith-lemli-opitz syndrome	Cryptorchidism	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	smith-lemli-opitz syndrome	Hypospadias	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000057	smith-lemli-opitz syndrome	Clitoromegaly	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000062	smith-lemli-opitz syndrome	Ambiguous genitalia	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000074	smith-lemli-opitz syndrome	Ureteropelvic junction obstruction	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000126	smith-lemli-opitz syndrome	Hydronephrosis	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	smith-lemli-opitz syndrome	Wide mouth	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000171	smith-lemli-opitz syndrome	Microglossia	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	smith-lemli-opitz syndrome	Cleft palate	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000212	smith-lemli-opitz syndrome	Gingival overgrowth	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	smith-lemli-opitz syndrome	Microcephaly	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	smith-lemli-opitz syndrome	Epicanthus	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	smith-lemli-opitz syndrome	Hypertelorism	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000343	smith-lemli-opitz syndrome	Long philtrum	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	smith-lemli-opitz syndrome	Micrognathia	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	smith-lemli-opitz syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	smith-lemli-opitz syndrome	Sensorineural hearing impairment	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	smith-lemli-opitz syndrome	Wide nasal bridge	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000453	smith-lemli-opitz syndrome	Choanal atresia	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	smith-lemli-opitz syndrome	Anteverted nares	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	smith-lemli-opitz syndrome	Short neck	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	smith-lemli-opitz syndrome	Strabismus	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	smith-lemli-opitz syndrome	Downslanted palpebral fissures	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000499	smith-lemli-opitz syndrome	Abnormality of the eyelashes	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	smith-lemli-opitz syndrome	Glaucoma	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	smith-lemli-opitz syndrome	Ptosis	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	smith-lemli-opitz syndrome	Cataract	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	smith-lemli-opitz syndrome	Proptosis	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000582	smith-lemli-opitz syndrome	Upslanted palpebral fissure	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	smith-lemli-opitz syndrome	Iris coloboma	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	smith-lemli-opitz syndrome	Nystagmus	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000647	smith-lemli-opitz syndrome	Sclerocornea	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	smith-lemli-opitz syndrome	Optic atrophy	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	smith-lemli-opitz syndrome	Abnormality of dental enamel	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000717	smith-lemli-opitz syndrome	Autism	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	smith-lemli-opitz syndrome	Abnormality of the ribs	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000776	smith-lemli-opitz syndrome	Congenital diaphragmatic hernia	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000965	smith-lemli-opitz syndrome	Cutis marmorata	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000992	smith-lemli-opitz syndrome	Cutaneous photosensitivity	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000996	smith-lemli-opitz syndrome	Facial capillary hemangioma	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	smith-lemli-opitz syndrome	Brachydactyly syndrome	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001162	smith-lemli-opitz syndrome	Postaxial hand polydactyly	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	smith-lemli-opitz syndrome	Abnormality of the metacarpal bones	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001171	smith-lemli-opitz syndrome	Split hand	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	smith-lemli-opitz syndrome	Intellectual disability	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	smith-lemli-opitz syndrome	Seizures	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	smith-lemli-opitz syndrome	Muscular hypotonia	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001262	smith-lemli-opitz syndrome	Excessive daytime somnolence	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	smith-lemli-opitz syndrome	Global developmental delay	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001276	smith-lemli-opitz syndrome	Hypertonia	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001360	smith-lemli-opitz syndrome	Holoprosencephaly	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	smith-lemli-opitz syndrome	Growth delay	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	smith-lemli-opitz syndrome	Intrauterine growth retardation	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001543	smith-lemli-opitz syndrome	Gastroschisis	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	smith-lemli-opitz syndrome	Polyhydramnios	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001600	smith-lemli-opitz syndrome	Abnormality of the larynx	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001629	smith-lemli-opitz syndrome	Ventricular septal defect	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001631	smith-lemli-opitz syndrome	Atrial septal defect	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	smith-lemli-opitz syndrome	Patent ductus arteriosus	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001830	smith-lemli-opitz syndrome	Postaxial foot polydactyly	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001884	smith-lemli-opitz syndrome	Talipes calcaneovalgus	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002020	smith-lemli-opitz syndrome	Gastroesophageal reflux	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002021	smith-lemli-opitz syndrome	Pyloric stenosis	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002089	smith-lemli-opitz syndrome	Pulmonary hypoplasia	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002101	smith-lemli-opitz syndrome	Abnormal lung lobation	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	smith-lemli-opitz syndrome	Ventriculomegaly	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002251	smith-lemli-opitz syndrome	Aganglionic megacolon	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002360	smith-lemli-opitz syndrome	Sleep disturbance	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	smith-lemli-opitz syndrome	Malformation of the heart and great vessels	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	smith-lemli-opitz syndrome	Scoliosis	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002719	smith-lemli-opitz syndrome	Recurrent infections	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002777	smith-lemli-opitz syndrome	Tracheal stenosis	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	smith-lemli-opitz syndrome	Kyphosis	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002827	smith-lemli-opitz syndrome	Hip dislocation	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003027	smith-lemli-opitz syndrome	Mesomelia	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	smith-lemli-opitz syndrome	Abnormal form of the vertebral bodies	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	smith-lemli-opitz syndrome	Short stature	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004422	smith-lemli-opitz syndrome	Biparietal narrowing	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004691	smith-lemli-opitz syndrome	2-3 toe syndactyly	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005264	smith-lemli-opitz syndrome	Abnormality of the gallbladder	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005599	smith-lemli-opitz syndrome	Hypopigmentation of hair	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	smith-lemli-opitz syndrome	Finger syndactyly	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006288	smith-lemli-opitz syndrome	Advanced eruption of teeth	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006482	smith-lemli-opitz syndrome	Abnormality of dental morphology	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006501	smith-lemli-opitz syndrome	Aplasia/Hypoplasia of the radius	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006610	smith-lemli-opitz syndrome	Wide intermamillary distance	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006695	smith-lemli-opitz syndrome	Atrioventricular canal defect	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007018	smith-lemli-opitz syndrome	Attention deficit hyperactivity disorder	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	smith-lemli-opitz syndrome	Aplasia/Hypoplasia of the cerebellum	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	smith-lemli-opitz syndrome	Aplasia/Hypoplasia of the corpus callosum	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007477	smith-lemli-opitz syndrome	Abnormal dermatoglyphics	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008056	smith-lemli-opitz syndrome	Aplasia/Hypoplasia affecting the eye	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008678	smith-lemli-opitz syndrome	Renal hypoplasia/aplasia	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008736	smith-lemli-opitz syndrome	Hypoplasia of penis	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	smith-lemli-opitz syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008905	smith-lemli-opitz syndrome	Rhizomelia	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009465	smith-lemli-opitz syndrome	Ulnar deviation of finger	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009623	smith-lemli-opitz syndrome	Proximal placement of thumb	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009804	smith-lemli-opitz syndrome	Reduced number of teeth	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010297	smith-lemli-opitz syndrome	Bifid tongue	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010569	smith-lemli-opitz syndrome	Elevated 7-dehydrocholesterol	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010880	smith-lemli-opitz syndrome	Increased nuchal translucency	Very frequent (99-80%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011069	smith-lemli-opitz syndrome	Increased number of teeth	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100542	smith-lemli-opitz syndrome	Abnormal localization of kidney	Occasional (29-5%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100716	smith-lemli-opitz syndrome	Self-injurious behavior	Frequent (79-30%)	DHCR7	602858	270400	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;Genitalia	2860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ataxia-oculomotor apraxia 4	NA	NA	PNKP	605610	616267	biallelic	confirmed	loss of function	Brain/Cognition	9154	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary ciliary dyskinesia with central-complex defects	NA	NA	RSPH3	No gene mim	No disease mim	biallelic	confirmed	loss of function		21054	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spinocerebellar ataxia 29, congenital nonprogressive	NA	NA	ITPR1	No gene mim	117360	monoallelic	probable	all missense/in frame	Brain/Cognition	6180	inositol 1,4,5-trisphosphate receptor type 1	protein-coding gene	gene with protein product	Approved	3p26.1	03p26.1	Insp3r1|IP3R1|ACV|PPP1R94	protein phosphatase 1, regulatory subunit 94	SCA15|SCA16|SCA29	spinocerebellar ataxia 15|spinocerebellar ataxia 16|spinocerebellar ataxia 29|inositol 1,4,5-trisphosphate receptor, type 1	Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits
NA	alazami syndrome	NA	NA	LARP7	No gene mim	615071	biallelic	confirmed	loss of function	Teeth & Dentitian;Skin;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	24912	La ribonucleoprotein domain family member 7	protein-coding gene	gene with protein product	Approved	4q25	04q25	HDCMA18P|PIP7S|DKFZP564K112	P-TEFb-interaction protein for 7SK stability		La ribonucleoprotein domain family, member 7	La ribonucleoprotein domain containing|RNA binding motif containing
NA	wiedemann-steiner syndrome	NA	NA	KMT2A	No gene mim	605130	monoallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	7132	lysine methyltransferase 2A	protein-coding gene	gene with protein product	Approved	11q23.3	11q23.3	TRX1|HRX|ALL-1|HTRX1|CXXC7|MLL1A		MLL	myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog)|myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)|lysine (K)-specific methyltransferase 2A	PHD finger proteins|Zinc fingers CXXC-type|Lysine methyltransferases|SET domain containing
NA	methemoglobinemia due to deficiency of methemoglobin reductase	NA	NA	CYB5R3	No gene mim	319395	biallelic	probable	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	2873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	diabetes mellitus, kcnj11-related transient neonatal	NA	NA	KCNJ11	No gene mim	261090	monoallelic	confirmed	activating	Endocrine/Metabolic;Brain/Cognition	6257	potassium voltage-gated channel subfamily J member 11	protein-coding gene	gene with protein product	Approved	11p15.1	11p15.1	Kir6.2|BIR			potassium inwardly-rectifying channel, subfamily J, member 11	Potassium voltage-gated channel subfamily J
NA	diabetes mellitus, kcnj11-related transient neonatal	NA	NA	KCNJ11	No gene mim	261090	monoallelic	confirmed	activating	Endocrine/Metabolic;Brain/Cognition	6257	potassium voltage-gated channel subfamily J member 11	protein-coding gene	gene with protein product	Approved	11p15.1	11p15.1	Kir6.2|BIR			potassium inwardly-rectifying channel, subfamily J, member 11	Potassium voltage-gated channel subfamily J
NA	mental retardation, non-syndromic	NA	NA	CRADD	No gene mim	614499	biallelic	possible	all missense/in frame	Brain/Cognition	2340	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation syndromic x-linked siderius type	NA	NA	PHF8	300560	300263	hemizygous	confirmed	loss of function	Brain/Cognition	20672	PHD finger protein 8	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZNF422|KIAA1111|JHDM1F|KDM7B	jumonji C domain-containing histone demethylase 1F			PHD finger proteins|Lysine demethylases
NA	chondrodysplasia punctata 1, x-linked	NA	NA	ARSE	300180	302950	hemizygous	confirmed	loss of function	Skeleton;Brain/Cognition	719	arylsulfatase E (chondrodysplasia punctata 1)	protein-coding gene	gene with protein product	Approved	Xp22.33	Xp22.33			CDPX|CDPX1		Sulfatases
NA	congenital cerebellar ataxia	NA	NA	GRM1	604473	614831	biallelic	probable	loss of function	Brain/Cognition	4593	glutamate metabotropic receptor 1	protein-coding gene	gene with protein product	Approved	6q24.3	06q24.3	GPRC1A|mGlu1|MGLUR1|PPP1R85	protein phosphatase 1, regulatory subunit 85		glutamate receptor, metabotropic 1	Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits
NA	microcephaly primary type 7	NA	NA	STIL	181590	612703	biallelic	probable	loss of function	Brain/Cognition	10879	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acro-dermato-ungual-lacrimal-tooth syndrome	NA	NA	TP63	603273	103285	monoallelic	confirmed	uncertain	Skin;Face;Skeleton	15979	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple congenital anomalies-hypotonia-seizures syndrome	NA	NA	PIGN	No gene mim	614080	biallelic	probable	all missense/in frame	Brain/Cognition	8967	phosphatidylinositol glycan anchor biosynthesis class N	protein-coding gene	gene with protein product	Approved	18q21.33	18q21.33	MDC4|PIG-N			phosphatidylinositol glycan, class N	Phosphatidylinositol glycan anchor biosynthesis
NA	cataract pulverulent juvenile-onset maf-related	NA	NA	MAF	177075	610202	monoallelic	confirmed	uncertain	Eye	6776	MAF bZIP transcription factor	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2	c-MAF			v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog	Basic leucine zipper proteins
NA	centronuclear myopathy 2	NA	NA	BIN1	601248	255200	biallelic	confirmed	loss of function	Musculature	1052	bridging integrator 1	protein-coding gene	gene with protein product	Approved	2q14.3	02q14.3	SH3P9|AMPH2	amphiphysin II	AMPHL		N-BAR domain containing
NA	hypomyelination with brain stem and spinal cord involvement and leg spasticity.	NA	NA	DARS	603084	615281	biallelic	confirmed	all missense/in frame	Brain/Cognition	2678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bilateral perisylvian polymicrogyria	NA	NA	SRPX2	300642	300388	hemizygous	probable	uncertain	Brain/Cognition	30668	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	renal-hepatic-pancreatic dysplasia	NA	NA	NPHP3	608002	208540	biallelic	confirmed	loss of function	Kidney Renal Tract;GI tract	7907	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cardiomyopathy dilated type 1x	NA	NA	FKTN	607440	611615	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	3622	fukutin	protein-coding gene	gene with protein product	Approved	9q31.2	09q31.2	LGMD2M		FCMD	Fukuyama type congenital muscular dystrophy (fukutin)	
HP:0001540	beckwith-wiedemann syndrome	Diastasis recti	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	beckwith-wiedemann syndrome	Hypertrophic cardiomyopathy	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001640	beckwith-wiedemann syndrome	Cardiomegaly	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	beckwith-wiedemann syndrome	Splenomegaly	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001901	beckwith-wiedemann syndrome	Polycythemia	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	beckwith-wiedemann syndrome	Neurological speech impairment	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	beckwith-wiedemann syndrome	Hepatomegaly	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	beckwith-wiedemann syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002667	beckwith-wiedemann syndrome	Nephroblastoma	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002859	beckwith-wiedemann syndrome	Rhabdomyosarcoma	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002884	beckwith-wiedemann syndrome	Hepatoblastoma	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003006	beckwith-wiedemann syndrome	Neuroblastoma	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005487	beckwith-wiedemann syndrome	Prominent metopic ridge	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005562	beckwith-wiedemann syndrome	Multiple renal cysts	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006254	beckwith-wiedemann syndrome	Elevated alpha-fetoprotein	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006744	beckwith-wiedemann syndrome	Adrenocortical carcinoma	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008186	beckwith-wiedemann syndrome	Adrenocortical cytomegaly	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008676	beckwith-wiedemann syndrome	Congenital megaureter	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	beckwith-wiedemann syndrome	Feeding difficulties in infancy	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010535	beckwith-wiedemann syndrome	Sleep apnea	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012090	beckwith-wiedemann syndrome	Abnormality of pancreas morphology	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012758	beckwith-wiedemann syndrome	Neurodevelopmental delay	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030255	beckwith-wiedemann syndrome	Large intestinal polyposis	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100243	beckwith-wiedemann syndrome	Leiomyosarcoma	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100589	beckwith-wiedemann syndrome	Urogenital fistula	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000852	beckwith-wiedemann syndrome	Pseudohypoparathyroidism	Very rare (<4-1%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002308	beckwith-wiedemann syndrome	Arnold-Chiari malformation	Very rare (<4-1%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000098	beckwith-wiedemann syndrome	Tall stature	Very frequent (99-80%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001520	beckwith-wiedemann syndrome	Large for gestational age	Very frequent (99-80%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002664	beckwith-wiedemann syndrome	Neoplasm	Very frequent (99-80%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000105	beckwith-wiedemann syndrome	Enlarged kidney	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000112	beckwith-wiedemann syndrome	Nephropathy	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000154	beckwith-wiedemann syndrome	Wide mouth	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000158	beckwith-wiedemann syndrome	Macroglossia	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000269	beckwith-wiedemann syndrome	Prominent occiput	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	beckwith-wiedemann syndrome	Coarse facial features	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	beckwith-wiedemann syndrome	Mandibular prognathia	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000363	beckwith-wiedemann syndrome	Abnormality of earlobe	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	beckwith-wiedemann syndrome	Proptosis	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000776	beckwith-wiedemann syndrome	Congenital diaphragmatic hernia	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000995	beckwith-wiedemann syndrome	Melanocytic nevus	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001052	beckwith-wiedemann syndrome	Nevus flammeus	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001139	beckwith-wiedemann syndrome	Choroideremia	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001513	beckwith-wiedemann syndrome	Obesity	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001528	beckwith-wiedemann syndrome	Hemihypertrophy	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	beckwith-wiedemann syndrome	Umbilical hernia	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001539	beckwith-wiedemann syndrome	Omphalocele	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	beckwith-wiedemann syndrome	Polyhydramnios	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001582	beckwith-wiedemann syndrome	Redundant skin	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001622	beckwith-wiedemann syndrome	Premature birth	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001738	beckwith-wiedemann syndrome	Exocrine pancreatic insufficiency	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	beckwith-wiedemann syndrome	Hypoglycemia	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001998	beckwith-wiedemann syndrome	Neonatal hypoglycemia	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002150	beckwith-wiedemann syndrome	Hypercalciuria	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003271	beckwith-wiedemann syndrome	Visceromegaly	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005616	beckwith-wiedemann syndrome	Accelerated skeletal maturation	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006267	beckwith-wiedemann syndrome	Large placenta	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008523	beckwith-wiedemann syndrome	Posterior helix pit	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009796	beckwith-wiedemann syndrome	Branchial cyst	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009908	beckwith-wiedemann syndrome	Anterior creases of earlobe	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	beckwith-wiedemann syndrome	Midface retrusion	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030720	beckwith-wiedemann syndrome	Subchorionic septal cyst	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100555	beckwith-wiedemann syndrome	Asymmetric growth	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100876	beckwith-wiedemann syndrome	Infra-orbital crease	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0430026	beckwith-wiedemann syndrome	Abnormality of the shape of the midface	Frequent (79-30%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	beckwith-wiedemann syndrome	Inguinal hernia	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	beckwith-wiedemann syndrome	Cryptorchidism	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000073	beckwith-wiedemann syndrome	Ureteral duplication	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	beckwith-wiedemann syndrome	Vesicoureteral reflux	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000150	beckwith-wiedemann syndrome	Gonadoblastoma	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	beckwith-wiedemann syndrome	Cleft palate	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000239	beckwith-wiedemann syndrome	Large fontanelles	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000260	beckwith-wiedemann syndrome	Wide anterior fontanel	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000329	beckwith-wiedemann syndrome	Facial hemangioma	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000362	beckwith-wiedemann syndrome	Otosclerosis	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000787	beckwith-wiedemann syndrome	Nephrolithiasis	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000821	beckwith-wiedemann syndrome	Hypothyroidism	Occasional (29-5%)	CDKN1C	600856	130650	imprinted	confirmed	loss of function	Endocrine/Metabolic;Cancer predisposition	1786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hypotrichosis, congenital, with juvenile macular dystrophy	NA	NA	CDH3	114021	601553	biallelic	confirmed	loss of function	Skin;Eye	1762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy	NA	NA	CHD2	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	1917	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000478	choroideremia	Abnormality of the eye	Very frequent (99-80%)	CHM	300390	303100	hemizygous	confirmed	loss of function	Eye	1940	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000504	choroideremia	Abnormality of vision	Very frequent (99-80%)	CHM	300390	303100	hemizygous	confirmed	loss of function	Eye	1940	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	choroideremia	Visual impairment	Very frequent (99-80%)	CHM	300390	303100	hemizygous	confirmed	loss of function	Eye	1940	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000512	choroideremia	Abnormal electroretinogram	Very frequent (99-80%)	CHM	300390	303100	hemizygous	confirmed	loss of function	Eye	1940	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000529	choroideremia	Progressive visual loss	Frequent (79-30%)	CHM	300390	303100	hemizygous	confirmed	loss of function	Eye	1940	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	choroideremia	Myopia	Very frequent (99-80%)	CHM	300390	303100	hemizygous	confirmed	loss of function	Eye	1940	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000662	choroideremia	Nyctalopia	Very frequent (99-80%)	CHM	300390	303100	hemizygous	confirmed	loss of function	Eye	1940	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	choroideremia	Abnormality of retinal pigmentation	Very frequent (99-80%)	CHM	300390	303100	hemizygous	confirmed	loss of function	Eye	1940	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ectodermal dysplasia anhidrotic with immunodeficiency x-linked	NA	NA	IKBKG	300248	300291	hemizygous	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
NA	hyperthyroidism, familial gestational	NA	NA	TSHR	603372	603373	monoallelic	confirmed	activating	Endocrine/Metabolic	12373	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	holoprosencephaly-7	NA	NA	PTCH1	601309	610828	monoallelic	confirmed	uncertain	Skin;Brain/Cognition	9585	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000010	fanconi anemia	Recurrent urinary tract infections	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000027	fanconi anemia	Azoospermia	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000028	fanconi anemia	Cryptorchidism	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000035	fanconi anemia	Abnormality of the testis	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000047	fanconi anemia	Hypospadias	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000072	fanconi anemia	Hydroureter	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000079	fanconi anemia	Abnormality of the urinary system	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000130	fanconi anemia	Abnormality of the uterus	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000135	fanconi anemia	Hypogonadism	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000175	fanconi anemia	Cleft palate	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000218	fanconi anemia	High palate	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000238	fanconi anemia	Hydrocephalus	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000268	fanconi anemia	Dolichocephaly	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000316	fanconi anemia	Hypertelorism	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000324	fanconi anemia	Facial asymmetry	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000340	fanconi anemia	Sloping forehead	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000347	fanconi anemia	Micrognathia	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000364	fanconi anemia	Hearing abnormality	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000365	fanconi anemia	Hearing impairment	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000453	fanconi anemia	Choanal atresia	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000478	fanconi anemia	Abnormality of the eye	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000483	fanconi anemia	Astigmatism	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000486	fanconi anemia	Strabismus	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000492	fanconi anemia	Abnormality of the eyelid	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000083	fanconi anemia	Renal insufficiency	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000252	fanconi anemia	Microcephaly	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000286	fanconi anemia	Epicanthus	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000504	fanconi anemia	Abnormality of vision	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000505	fanconi anemia	Visual impairment	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000508	fanconi anemia	Ptosis	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000518	fanconi anemia	Cataract	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000520	fanconi anemia	Proptosis	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000568	fanconi anemia	Microphthalmia	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000582	fanconi anemia	Upslanted palpebral fissure	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000639	fanconi anemia	Nystagmus	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000813	fanconi anemia	Bicornuate uterus	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0000864	fanconi anemia	Abnormality of the hypothalamus-pituitary axis	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001000	fanconi anemia	Abnormality of skin pigmentation	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001053	fanconi anemia	Hypopigmented skin patches	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001172	fanconi anemia	Abnormality of the thumb	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001199	fanconi anemia	Triphalangeal thumb	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001249	fanconi anemia	Intellectual disability	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001263	fanconi anemia	Global developmental delay	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001347	fanconi anemia	Hyperreflexia	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001392	fanconi anemia	Abnormality of the liver	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001510	fanconi anemia	Growth delay	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001511	fanconi anemia	Intrauterine growth retardation	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001537	fanconi anemia	Umbilical hernia	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001562	fanconi anemia	Oligohydramnios	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001631	fanconi anemia	Atrial septal defect	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001636	fanconi anemia	Tetralogy of Fallot	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001639	fanconi anemia	Hypertrophic cardiomyopathy	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001643	fanconi anemia	Patent ductus arteriosus	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001646	fanconi anemia	Abnormality of the aortic valve	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001671	fanconi anemia	Abnormality of the cardiac septa	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001679	fanconi anemia	Abnormality of the aorta	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001760	fanconi anemia	Abnormality of the foot	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001763	fanconi anemia	Pes planus	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001770	fanconi anemia	Toe syndactyly	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001824	fanconi anemia	Weight loss	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001871	fanconi anemia	Abnormality of blood and blood-forming tissues	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001873	fanconi anemia	Thrombocytopenia	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001882	fanconi anemia	Leukopenia	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0001903	fanconi anemia	Anemia	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002007	fanconi anemia	Frontal bossing	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002023	fanconi anemia	Anal atresia	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002119	fanconi anemia	Ventriculomegaly	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002245	fanconi anemia	Meckel diverticulum	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002251	fanconi anemia	Aganglionic megacolon	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002414	fanconi anemia	Spina bifida	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002575	fanconi anemia	Tracheoesophageal fistula	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002650	fanconi anemia	Scoliosis	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002664	fanconi anemia	Neoplasm	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002817	fanconi anemia	Abnormality of the upper limb	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002823	fanconi anemia	Abnormality of the femur	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002827	fanconi anemia	Hip dislocation	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002863	fanconi anemia	Myelodysplasia	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0002997	fanconi anemia	Abnormality of the ulna	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0003022	fanconi anemia	Hypoplasia of the ulna	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0003220	fanconi anemia	Abnormality of chromosome stability	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0004209	fanconi anemia	Clinodactyly of the 5th finger	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0004322	fanconi anemia	Short stature	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0004349	fanconi anemia	Reduced bone mineral density	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0005344	fanconi anemia	Abnormality of the carotid arteries	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0005522	fanconi anemia	Pyridoxine-responsive sideroblastic anemia	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0006101	fanconi anemia	Finger syndactyly	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0006265	fanconi anemia	Aplasia/Hypoplasia of fingers	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0006501	fanconi anemia	Aplasia/Hypoplasia of the radius	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0006824	fanconi anemia	Cranial nerve paralysis	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0007400	fanconi anemia	Irregular hyperpigmentation	Very frequent (99-80%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0007565	fanconi anemia	Multiple cafe-au-lait spots	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0007874	fanconi anemia	Almond-shaped palpebral fissure	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0008053	fanconi anemia	Aplasia/Hypoplasia of the iris	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0008572	fanconi anemia	External ear malformation	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0008678	fanconi anemia	Renal hypoplasia/aplasia	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0010293	fanconi anemia	Aplasia/Hypoplasia of the uvula	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0010469	fanconi anemia	Absent testis	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0012041	fanconi anemia	Decreased fertility in males	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0012210	fanconi anemia	Abnormal renal morphology	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0012639	fanconi anemia	Abnormality of nervous system morphology	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0012745	fanconi anemia	Short palpebral fissure	Frequent (79-30%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0100026	fanconi anemia	Arteriovenous malformation	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0100542	fanconi anemia	Abnormal localization of kidney	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0100587	fanconi anemia	Abnormality of the preputium	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0100760	fanconi anemia	Clubbing of toes	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
HP:0100867	fanconi anemia	Duodenal stenosis	Occasional (29-5%)	ERCC1	126380	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
NA	short stature, onychodysplasia, facial dysmorphism, and hypotrichosis syndrome	NA	NA	POC1A	614783	614813	biallelic	confirmed	loss of function	Skeleton	24488	POC1 centriolar protein A	protein-coding gene	gene with protein product	Approved	3p21.2	03p21.2	DKFZP434C245		WDR51A	WD repeat domain 51A|POC1 centriolar protein homolog A (Chlamydomonas)	WD repeat domain containing
HP:0001773	brachydactyly type a2	Short foot	Frequent (79-30%)	BMPR1B	603248	112600	biallelic	confirmed	loss of function	Skeleton	1077	bone morphogenetic protein receptor type 1B	protein-coding gene	gene with protein product	Approved	4q22.3	04q22.3	ALK6|CDw293			bone morphogenetic protein receptor, type IB	Type 1 receptor serine/threonine kinases|CD molecules
HP:0004209	brachydactyly type a2	Clinodactyly of the 5th finger	Frequent (79-30%)	BMPR1B	603248	112600	biallelic	confirmed	loss of function	Skeleton	1077	bone morphogenetic protein receptor type 1B	protein-coding gene	gene with protein product	Approved	4q22.3	04q22.3	ALK6|CDw293			bone morphogenetic protein receptor, type IB	Type 1 receptor serine/threonine kinases|CD molecules
HP:0004220	brachydactyly type a2	Short middle phalanx of the 5th finger	Occasional (29-5%)	BMPR1B	603248	112600	biallelic	confirmed	loss of function	Skeleton	1077	bone morphogenetic protein receptor type 1B	protein-coding gene	gene with protein product	Approved	4q22.3	04q22.3	ALK6|CDw293			bone morphogenetic protein receptor, type IB	Type 1 receptor serine/threonine kinases|CD molecules
HP:0005819	brachydactyly type a2	Short middle phalanx of finger	Occasional (29-5%)	BMPR1B	603248	112600	biallelic	confirmed	loss of function	Skeleton	1077	bone morphogenetic protein receptor type 1B	protein-coding gene	gene with protein product	Approved	4q22.3	04q22.3	ALK6|CDw293			bone morphogenetic protein receptor, type IB	Type 1 receptor serine/threonine kinases|CD molecules
HP:0009372	brachydactyly type a2	Type A2 brachydactyly	Very frequent (99-80%)	BMPR1B	603248	112600	biallelic	confirmed	loss of function	Skeleton	1077	bone morphogenetic protein receptor type 1B	protein-coding gene	gene with protein product	Approved	4q22.3	04q22.3	ALK6|CDw293			bone morphogenetic protein receptor, type IB	Type 1 receptor serine/threonine kinases|CD molecules
HP:0009568	brachydactyly type a2	Aplasia/Hypoplasia of the middle phalanx of the 2nd finger	Occasional (29-5%)	BMPR1B	603248	112600	biallelic	confirmed	loss of function	Skeleton	1077	bone morphogenetic protein receptor type 1B	protein-coding gene	gene with protein product	Approved	4q22.3	04q22.3	ALK6|CDw293			bone morphogenetic protein receptor, type IB	Type 1 receptor serine/threonine kinases|CD molecules
HP:0010038	brachydactyly type a2	Short 2nd metacarpal	Occasional (29-5%)	BMPR1B	603248	112600	biallelic	confirmed	loss of function	Skeleton	1077	bone morphogenetic protein receptor type 1B	protein-coding gene	gene with protein product	Approved	4q22.3	04q22.3	ALK6|CDw293			bone morphogenetic protein receptor, type IB	Type 1 receptor serine/threonine kinases|CD molecules
HP:0000003	zellweger syndrome	Multicystic kidney dysplasia	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000028	zellweger syndrome	Cryptorchidism	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000047	zellweger syndrome	Hypospadias	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000057	zellweger syndrome	Clitoromegaly	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000126	zellweger syndrome	Hydronephrosis	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000157	zellweger syndrome	Abnormality of the tongue	Occasional (29-5%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000218	zellweger syndrome	High palate	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000252	zellweger syndrome	Microcephaly	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000256	zellweger syndrome	Macrocephaly	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000260	zellweger syndrome	Wide anterior fontanel	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000286	zellweger syndrome	Epicanthus	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000347	zellweger syndrome	Micrognathia	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000348	zellweger syndrome	High forehead	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000407	zellweger syndrome	Sensorineural hearing impairment	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000431	zellweger syndrome	Wide nasal bridge	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000474	zellweger syndrome	Thickened nuchal skin fold	Occasional (29-5%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000501	zellweger syndrome	Glaucoma	Occasional (29-5%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000505	zellweger syndrome	Visual impairment	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000518	zellweger syndrome	Cataract	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000532	zellweger syndrome	Chorioretinal abnormality	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000582	zellweger syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000627	zellweger syndrome	Posterior embryotoxon	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000639	zellweger syndrome	Nystagmus	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000648	zellweger syndrome	Optic atrophy	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0000952	zellweger syndrome	Jaundice	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001088	zellweger syndrome	Brushfield spots	Occasional (29-5%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001250	zellweger syndrome	Seizures	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001315	zellweger syndrome	Reduced tendon reflexes	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001399	zellweger syndrome	Hepatic failure	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001508	zellweger syndrome	Failure to thrive	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001522	zellweger syndrome	Death in infancy	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001622	zellweger syndrome	Premature birth	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001629	zellweger syndrome	Ventricular septal defect	Occasional (29-5%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0001928	zellweger syndrome	Abnormality of coagulation	Occasional (29-5%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0002021	zellweger syndrome	Pyloric stenosis	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0002024	zellweger syndrome	Malabsorption	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0002093	zellweger syndrome	Respiratory insufficiency	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0002126	zellweger syndrome	Polymicrogyria	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0002240	zellweger syndrome	Hepatomegaly	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0002353	zellweger syndrome	EEG abnormality	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0002652	zellweger syndrome	Skeletal dysplasia	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0004322	zellweger syndrome	Short stature	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0005280	zellweger syndrome	Depressed nasal bridge	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0005469	zellweger syndrome	Flat occiput	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0006829	zellweger syndrome	Severe muscular hypotonia	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0007957	zellweger syndrome	Corneal opacity	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0008167	zellweger syndrome	Very long chain fatty acid accumulation	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0008207	zellweger syndrome	Primary adrenal insufficiency	Occasional (29-5%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0008572	zellweger syndrome	External ear malformation	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0008872	zellweger syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0009891	zellweger syndrome	Underdeveloped supraorbital ridges	Frequent (79-30%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0010655	zellweger syndrome	Epiphyseal stippling	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0012368	zellweger syndrome	Flat face	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0012736	zellweger syndrome	Profound global developmental delay	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
HP:0100543	zellweger syndrome	Cognitive impairment	Very frequent (99-80%)	PEX5	600414	214100	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	9719	peroxisomal biogenesis factor 5	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	PTS1R	peroxisomal targeting signal 1 receptor|peroxisomal import receptor 5	PXR1	peroxisome receptor 1	Tetratricopeptide repeat domain containing|Peroxins
NA	cataract congenital cerulean type 4	NA	NA	MAF	177075	610202	monoallelic	confirmed	uncertain	Eye	6776	MAF bZIP transcription factor	protein-coding gene	gene with protein product	Approved	16q23.2	16q23.2	c-MAF			v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog	Basic leucine zipper proteins
NA	methylmalonic aciduria type mut	NA	NA	MUT	609058	251000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7526	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	phosphoserine aminotransferase deficiency	NA	NA	PSAT1	610936	610992	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	retinal cone dystrophy 3 pde6h	NA	NA	PDE6H	601190	610024	biallelic	probable	5_prime or 3_prime UTR mutation	Eye	8790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephronophthisis type 11	NA	NA	TMEM67	609884	613550	biallelic	confirmed	uncertain	Kidney Renal Tract;Skeleton;Brain/Cognition;GI tract	28396	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	aural atresia, congenital	NA	NA	TSHZ1	No gene mim	607842	monoallelic	possible	loss of function	Ear	10669	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	landau-kleffner syndrome	NA	NA	GRIN2A	138253	245570	monoallelic	confirmed	loss of function	Brain/Cognition	4585	glutamate ionotropic receptor NMDA type subunit 2A	protein-coding gene	gene with protein product	Approved	16p13.2	16p13.2	GluN2A		NMDAR2A	glutamate receptor, ionotropic, N-methyl D-aspartate 2A	Glutamate ionotropic receptor NMDA type subunits
NA	intellectual disability	NA	NA	PACS1	607492	No disease mim	monoallelic	probable	activating	Brain/Cognition	30032	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanci-related fanconi anemia	NA	NA	FANCI	611360	234476	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
NA	holoprosencephaly type 3	NA	NA	SHH	600725	236100	monoallelic	confirmed	loss of function	Teeth & Dentitian;Face;Brain/Cognition;Eye	10848	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	xl intellectual disability	NA	NA	GSPT2	No gene mim	No disease mim	hemizygous	probable	loss of function	Brain/Cognition	4622	G1 to S phase transition 2	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	eRF3b|FLJ10441				
NA	diabetes mellitus neonatal with congenital hypothyroidism	NA	NA	GLIS3	610192	610199	biallelic	confirmed	loss of function	Kidney Renal Tract;Endocrine/Metabolic	28510	GLIS family zinc finger 3	protein-coding gene	gene with protein product	Approved	9p24.2	09p24.2	MGC33662		ZNF515	zinc finger protein 515	Zinc fingers C2H2-type
NA	x-linked trichothiodystrophy	NA	NA	RNF113A	No gene mim	No disease mim	hemizygous	possible	loss of function	Skin;Skeleton;Brain/Cognition	12974	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	PPP2R1A	No gene mim	No disease mim	monoallelic	confirmed	dominant negative	Brain/Cognition	9302	protein phosphatase 2 scaffold subunit Aalpha	protein-coding gene	gene with protein product	Approved	19q13.41	19q13.41	PR65A|PP2A-Aalpha|PP2AA	protein phosphatase 2A, regulatory subunit A, alpha isoform|protein phosphatase 2, 65kDa regulatory subunit A|protein phosphatase 2A structural subunit A, alpha isoform		protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform	Protein phosphatase 2 scaffold subunits|STRIPAK complex
NA	aicardi-goutieres syndrome associated with a type i interferon signature	NA	NA	ADAR	146920	615010	biallelic	confirmed	loss of function	Brain/Cognition	225	adenosine deaminase, RNA specific	protein-coding gene	gene with protein product	Approved	1q21.3	01q21.3	ADAR1		IFI4|G1P1	interferon-induced protein 4	Adenosine deaminases acting on RNA
NA	aicardi-goutieres syndrome associated with a type i interferon signature	NA	NA	ADAR	146920	615010	monoallelic	confirmed	loss of function	Brain/Cognition	225	adenosine deaminase, RNA specific	protein-coding gene	gene with protein product	Approved	1q21.3	01q21.3	ADAR1		IFI4|G1P1	interferon-induced protein 4	Adenosine deaminases acting on RNA
NA	intellectual disability	NA	NA	KIF4A	No gene mim	No disease mim	hemizygous	possible	loss of function	Brain/Cognition	13339	kinesin family member 4A	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	KIF4-G1|KIF4|HSA271784|FLJ12530|FLJ12655|FLJ14204|FLJ20631|MRX100	chromokinesin			X-linked mental retardation|Kinesins
NA	brunner syndrome	NA	NA	MAOA	No gene mim	300615	hemizygous	probable	loss of function	Brain/Cognition	6833	monoamine oxidase A	protein-coding gene	gene with protein product	Approved	Xp11.3	Xp11.3					
HP:0002751	carpenter syndrome	Kyphoscoliosis	Occasional (29-5%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001156	carpenter syndrome	Brachydactyly syndrome	Obligate (100%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001770	carpenter syndrome	Toe syndactyly	Obligate (100%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0006101	carpenter syndrome	Finger syndactyly	Obligate (100%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0000028	carpenter syndrome	Cryptorchidism	Very frequent (99-80%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0000263	carpenter syndrome	Oxycephaly	Very frequent (99-80%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0000929	carpenter syndrome	Abnormality of the skull	Very frequent (99-80%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001159	carpenter syndrome	Syndactyly	Very frequent (99-80%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001249	carpenter syndrome	Intellectual disability	Very frequent (99-80%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001363	carpenter syndrome	Craniosynostosis	Very frequent (99-80%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001513	carpenter syndrome	Obesity	Very frequent (99-80%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0003241	carpenter syndrome	External genital hypoplasia	Very frequent (99-80%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0010442	carpenter syndrome	Polydactyly	Very frequent (99-80%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0000262	carpenter syndrome	Turricephaly	Frequent (79-30%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0000481	carpenter syndrome	Abnormality of the cornea	Frequent (79-30%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001162	carpenter syndrome	Postaxial hand polydactyly	Frequent (79-30%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001841	carpenter syndrome	Preaxial foot polydactyly	Frequent (79-30%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0002676	carpenter syndrome	Cloverleaf skull	Frequent (79-30%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0002857	carpenter syndrome	Genu valgum	Frequent (79-30%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0011304	carpenter syndrome	Broad thumb	Frequent (79-30%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0012243	carpenter syndrome	Abnormal genital system morphology	Frequent (79-30%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0030680	carpenter syndrome	Abnormality of cardiovascular system morphology	Frequent (79-30%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001537	carpenter syndrome	Umbilical hernia	Occasional (29-5%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001643	carpenter syndrome	Patent ductus arteriosus	Occasional (29-5%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001748	carpenter syndrome	Polysplenia	Occasional (29-5%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
HP:0001762	carpenter syndrome	Talipes equinovarus	Occasional (29-5%)	MEGF8	604267	201000	biallelic	confirmed	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	3233	multiple EGF like domains 8	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	SBP1|FLJ22365	HBV pre s2 binding protein 1	EGFL4|C19orf49	EGF-like-domain, multiple 4|chromosome 19 open reading frame 49|multiple EGF-like-domains 8	
NA	trichohepatoenteric syndrome 2	NA	NA	SKIV2L	600478	615602	biallelic	confirmed	loss of function	Skin;GI tract	10898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bardet-biedl syndrome type 12	NA	NA	BBS12	610683	209900	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	26648	Bardet-Biedl syndrome 12	protein-coding gene	gene with protein product	Approved	4q27	04q27	FLJ35630|FLJ41559		C4orf24	chromosome 4 open reading frame 24	Chaperonins|Bardet-Biedl syndrome associated
NA	epileptic encephalopathy	NA	NA	GABRA1	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Brain/Cognition	4075	gamma-aminobutyric acid type A receptor alpha1 subunit	protein-coding gene	gene with protein product	Approved	5q34	05q34	EJM5	GABA(A) receptor, alpha 1		gamma-aminobutyric acid (GABA) A receptor, alpha 1	Gamma-aminobutyric acid type A receptor subunits
NA	amyelogenesis	NA	NA	C4orf26	614829	614832	biallelic	confirmed	loss of function	Teeth & Dentitian	26300	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rhabdoid tumor predisposition syndrome 2	NA	NA	SMARCA4	603254	613325	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Cancer predisposition	11100	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cornelia de lange-like syndrome	NA	NA	AFF4	No gene mim	No disease mim	monoallelic	confirmed	activating	Brain/Cognition	17869	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	osteogenesis imperfecta type v	NA	NA	IFITM5	614757	610967	monoallelic	confirmed	5_prime or 3_prime UTR mutation	Skeleton	16644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	niemann-pick disease, type c2	NA	NA	NPC2	601015	607625	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	14537	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	susceptibility to autism type 16	NA	NA	SLC9A9	No gene mim	613410	monoallelic	possible	loss of function	Brain/Cognition	20653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial respiratory chain complex i deficiency	NA	NA	NDUFS1	157655	252010	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	7707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	capicua, drosophila, homolog of	NA	NA	CIC	No gene mim	612082	monoallelic	possible	uncertain	Brain/Cognition	14214	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	richieri-costa-pereira syndrome	NA	NA	EIF4A3	No gene mim	No disease mim	biallelic	confirmed	5_prime or 3_prime UTR mutation	Face;Skeleton	18683	eukaryotic translation initiation factor 4A3	protein-coding gene	gene with protein product	Approved	17q25.3	17q25.3	KIAA0111|EIF4AIII|Fal1		DDX48	DEAD (Asp-Glu-Ala-Asp) box polypeptide 48|eukaryotic translation initiation factor 4A, isoform 3	DEAD-box helicases|Exon junction complex|Spliceosomal Bact complex|Spliceosomal P complex
NA	cataract autosomal dominant	NA	NA	CRYGD	123690	604219	monoallelic	confirmed	uncertain	Eye	2411	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epilepsy, childhood absence, susceptibility to, 6	NA	NA	CACNA1H	No gene mim	611942	monoallelic	possible	all missense/in frame	Brain/Cognition	1395	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, autosomal recessive 12	NA	NA	ST3GAL3	606494	611090	biallelic	probable	all missense/in frame	Brain/Cognition	10866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy early infantile type 7	NA	NA	KCNQ2	602235	613720	monoallelic	confirmed	loss of function	Musculature;Brain/Cognition	6296	potassium voltage-gated channel subfamily Q member 2	protein-coding gene	gene with protein product	Approved	20q13.33	20q13.33	Kv7.2|ENB1|BFNC|KCNA11|HNSPC		EBN|EBN1	potassium voltage-gated channel, KQT-like subfamily, member 2|potassium channel, voltage gated KQT-like subfamily Q, member 2	Potassium voltage-gated channels
NA	infantile epileptic encephalopathy and/or intellectual disability	NA	NA	CLCN4	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	2022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia, syndromic 14	NA	NA	MAB21L2	No gene mim	615877	monoallelic	confirmed	activating	Skeleton;Brain/Cognition;Eye	6758	mab-21 like 2	protein-coding gene	gene with protein product	Approved	4q31.3	04q31.3				mab-21 (C. elegans)-like 2|mab-21-like 2 (C. elegans)	
NA	microphthalmia, syndromic 14	NA	NA	MAB21L2	No gene mim	615877	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Eye	6758	mab-21 like 2	protein-coding gene	gene with protein product	Approved	4q31.3	04q31.3				mab-21 (C. elegans)-like 2|mab-21-like 2 (C. elegans)	
NA	mental retardation x-linked with epilepsy	NA	NA	ATP6AP2	No gene mim	300423	hemizygous	possible	uncertain	Brain/Cognition	18305	ATPase H+ transporting accessory protein 2	protein-coding gene	gene with protein product	Approved	Xp11.4	Xp11.4	M8-9|APT6M8-9|ATP6M8-9|PRR|RENR	prorenin receptor|renin receptor	ATP6IP2	ATPase, H+ transporting, lysosomal interacting protein 2|ATPase, H+ transporting, lysosomal accessory protein 2	
NA	seckel syndrome type 5	NA	NA	CEP152	613529	613823	biallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	29298	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	juvenile polyposis syndrome	NA	NA	SMAD4	No gene mim	174900	monoallelic	both DD and IF	loss of function	Skeleton;GI tract;Heart/Cardiovasculature/Lymphatic	6770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal-recessive disorder with congenital cataracts, hearing loss, and low serum copper and ceruloplasmin	NA	NA	SLC33A1	603690	No disease mim	biallelic	confirmed	loss of function	Endocrine/Metabolic;Eye;Ear	95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000023	aarskog-scott syndrome	Inguinal hernia	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000028	aarskog-scott syndrome	Cryptorchidism	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000049	aarskog-scott syndrome	Shawl scrotum	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000164	aarskog-scott syndrome	Abnormality of the teeth	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000175	aarskog-scott syndrome	Cleft palate	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000202	aarskog-scott syndrome	Oral cleft	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000204	aarskog-scott syndrome	Cleft upper lip	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000232	aarskog-scott syndrome	Everted lower lip vermilion	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000286	aarskog-scott syndrome	Epicanthus	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000311	aarskog-scott syndrome	Round face	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000316	aarskog-scott syndrome	Hypertelorism	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000327	aarskog-scott syndrome	Hypoplasia of the maxilla	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000337	aarskog-scott syndrome	Broad forehead	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000343	aarskog-scott syndrome	Long philtrum	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000368	aarskog-scott syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000431	aarskog-scott syndrome	Wide nasal bridge	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000463	aarskog-scott syndrome	Anteverted nares	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000470	aarskog-scott syndrome	Short neck	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000485	aarskog-scott syndrome	Megalocornea	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000486	aarskog-scott syndrome	Strabismus	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000494	aarskog-scott syndrome	Downslanted palpebral fissures	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000508	aarskog-scott syndrome	Ptosis	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000684	aarskog-scott syndrome	Delayed eruption of teeth	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000708	aarskog-scott syndrome	Behavioral abnormality	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000767	aarskog-scott syndrome	Pectus excavatum	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000954	aarskog-scott syndrome	Single transverse palmar crease	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0000974	aarskog-scott syndrome	Hyperextensible skin	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0001169	aarskog-scott syndrome	Broad palm	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0001537	aarskog-scott syndrome	Umbilical hernia	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0001635	aarskog-scott syndrome	Congestive heart failure	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0001763	aarskog-scott syndrome	Pes planus	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0001769	aarskog-scott syndrome	Broad foot	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0001773	aarskog-scott syndrome	Short foot	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0001883	aarskog-scott syndrome	Talipes	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0002564	aarskog-scott syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0002816	aarskog-scott syndrome	Genu recurvatum	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0003319	aarskog-scott syndrome	Abnormality of the cervical spine	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0004209	aarskog-scott syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0004279	aarskog-scott syndrome	Short palm	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0004322	aarskog-scott syndrome	Short stature	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0005640	aarskog-scott syndrome	Abnormal vertebral segmentation and fusion	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0005692	aarskog-scott syndrome	Joint hyperflexibility	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0006101	aarskog-scott syndrome	Finger syndactyly	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0007018	aarskog-scott syndrome	Attention deficit hyperactivity disorder	Occasional (29-5%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0008572	aarskog-scott syndrome	External ear malformation	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0009890	aarskog-scott syndrome	High anterior hairline	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0100490	aarskog-scott syndrome	Camptodactyly of finger	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0100543	aarskog-scott syndrome	Cognitive impairment	Frequent (79-30%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
HP:0200055	aarskog-scott syndrome	Small hand	Very frequent (99-80%)	FGD1	300546	305400	hemizygous	confirmed	loss of function	Face;Skeleton;Genitalia	3663	FYVE, RhoGEF and PH domain containing 1	protein-coding gene	gene with protein product	Approved	Xp11.22	Xp11.22	ZFYVE3		FGDY	faciogenital dysplasia (Aarskog-Scott syndrome)	Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors
NA	autosomal recessive mental retardation	NA	NA	PRMT9	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	25099	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cranioosteoarthropathy	NA	NA	HPGD	No gene mim	259100	biallelic	confirmed	loss of function	Skeleton	5154	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rhegmatogenous retinal detachment autosomal dominant	NA	NA	COL2A1	120140	609508	monoallelic	confirmed	loss of function	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peroxisome biogenesis disorder complementation group 11	NA	NA	PEX7	601757	601757	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000518	coenzyme q10 deficiency	Cataract	Very frequent (99-80%)	COQ8A	No gene mim	607426	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition	16812	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000974	coenzyme q10 deficiency	Hyperextensible skin	Very frequent (99-80%)	COQ8A	No gene mim	607426	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition	16812	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	coenzyme q10 deficiency	Intellectual disability	Very frequent (99-80%)	COQ8A	No gene mim	607426	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition	16812	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005692	coenzyme q10 deficiency	Joint hyperflexibility	Very frequent (99-80%)	COQ8A	No gene mim	607426	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition	16812	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	xeroderma pigmentosum, group a	NA	NA	XPA	611153	278700	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton	12814	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract congenital autosomal recessive type 4	NA	NA	TDRD7	No gene mim	613887	biallelic	possible	uncertain	Eye	30831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	TTI2	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Brain/Cognition	26262	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	heterotaxy syndrome	NA	NA	NODAL	601265	207574	monoallelic	confirmed	loss of function	GI tract;Heart/Cardiovasculature/Lymphatic	7865	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cleidocranial dysplasia with micrognathia, absent thumbs, and distal aphalangia yunis-varon syndrome	NA	NA	FIG4	609390	216340	biallelic	probable	loss of function	Skeleton;Spinal cord/Peripheral nerves;Brain/Cognition	16873	FIG4 phosphoinositide 5-phosphatase	protein-coding gene	gene with protein product	Approved	6q21	06q21	SAC3|hSac3|dJ249I4.1|ALS11|CMT4J		KIAA0274	KIAA0274|FIG4 homolog (S. cerevisiae)|FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae)	Phosphoinositide phosphatases
HP:0000027	bloom syndrome	Azoospermia	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000246	bloom syndrome	Sinusitis	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000252	bloom syndrome	Microcephaly	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000268	bloom syndrome	Dolichocephaly	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000271	bloom syndrome	Abnormality of the face	Frequent (79-30%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000272	bloom syndrome	Malar flattening	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000275	bloom syndrome	Narrow face	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000366	bloom syndrome	Abnormality of the nose	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000411	bloom syndrome	Protruding ear	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000868	bloom syndrome	Decreased fertility in females	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000951	bloom syndrome	Abnormality of the skin	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000960	bloom syndrome	Sacral dimple	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000975	bloom syndrome	Hyperhidrosis	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0000992	bloom syndrome	Cutaneous photosensitivity	Frequent (79-30%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0001053	bloom syndrome	Hypopigmented skin patches	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0001161	bloom syndrome	Hand polydactyly	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0001256	bloom syndrome	Intellectual disability, mild	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0001511	bloom syndrome	Intrauterine growth retardation	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0001620	bloom syndrome	High pitched voice	Frequent (79-30%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0002014	bloom syndrome	Diarrhea	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0002205	bloom syndrome	Recurrent respiratory infections	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0002488	bloom syndrome	Acute leukemia	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0002664	bloom syndrome	Neoplasm	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0002665	bloom syndrome	Lymphoma	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0002720	bloom syndrome	IgA deficiency	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0002750	bloom syndrome	Delayed skeletal maturation	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0002850	bloom syndrome	IgM deficiency	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0002860	bloom syndrome	Squamous cell carcinoma	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0003196	bloom syndrome	Short nose	Frequent (79-30%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0003220	bloom syndrome	Abnormality of chromosome stability	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0004313	bloom syndrome	Decreased antibody level in blood	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0004315	bloom syndrome	IgG deficiency	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0004322	bloom syndrome	Short stature	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0005585	bloom syndrome	Spotty hyperpigmentation	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0005598	bloom syndrome	Facial telangiectasia in butterfly midface distribution	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0006101	bloom syndrome	Finger syndactyly	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0007378	bloom syndrome	Neoplasm of the gastrointestinal tract	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0008064	bloom syndrome	Ichthyosis	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0008897	bloom syndrome	Postnatal growth retardation	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0009804	bloom syndrome	Reduced number of teeth	Occasional (29-5%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0010669	bloom syndrome	Cheekbone underdevelopment	Frequent (79-30%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0010783	bloom syndrome	Erythema	Very frequent (99-80%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
HP:0100585	bloom syndrome	Telangiectasia of the skin	Frequent (79-30%)	BLM	604610	210900	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	1058	Bloom syndrome RecQ like helicase	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	BS|RECQL3|RECQ2			Bloom syndrome	RecQ like helicases
NA	autosomal recessive mental retardation	NA	NA	TMEM135	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	26167	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epilepsy, generalized, with febrile seizures plus, type 3	NA	NA	GABRG2	No gene mim	611277	monoallelic	probable	loss of function		4087	gamma-aminobutyric acid type A receptor gamma2 subunit	protein-coding gene	gene with protein product	Approved	5q34	05q34		GABA(A) receptor, gamma 2		gamma-aminobutyric acid (GABA) A receptor, gamma 2	Gamma-aminobutyric acid type A receptor subunits
NA	klippel-feil anomaly	NA	NA	MEOX1	600147	118100	biallelic	probable	loss of function	Skeleton	7013	mesenchyme homeobox 1	protein-coding gene	gene with protein product	Approved	17q21.31	17q21.31	MOX1			mesenchyme homeo box 1	HOXL subclass homeoboxes
NA	deafness autosomal dominant type 23	NA	NA	SIX1	601205	605192	monoallelic	confirmed	all missense/in frame	Kidney Renal Tract;Ear	10887	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	choreoathetosis, hypothyroidism, and neonatal respiratory distress	NA	NA	NKX2-1	No gene mim	610978	monoallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Respiratory tract	11825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	craniosynostosis and dental anomalies	NA	NA	IL11	No gene mim	614188	biallelic	possible	all missense/in frame	Teeth & Dentitian;Skeleton	5966	interleukin 11	protein-coding gene	gene with protein product	Approved	19q13.42	19q13.42	IL-11|AGIF	adipogenesis inhibitory factor|oprelvekin			Endogenous ligands|Interleukins|Interleukin 6 type cytokine family
HP:0001250	glycine encephalopathy	Seizures	Very frequent (99-80%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002079	glycine encephalopathy	Hypoplasia of the corpus callosum	Very frequent (99-80%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002154	glycine encephalopathy	Hyperglycinemia	Very frequent (99-80%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	glycine encephalopathy	EEG abnormality	Very frequent (99-80%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010851	glycine encephalopathy	EEG with burst suppression	Very frequent (99-80%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011398	glycine encephalopathy	Central hypotonia	Very frequent (99-80%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012705	glycine encephalopathy	Abnormal metabolic brain imaging by MRS	Very frequent (99-80%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100247	glycine encephalopathy	Recurrent singultus	Very frequent (99-80%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001254	glycine encephalopathy	Lethargy	Frequent (79-30%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002033	glycine encephalopathy	Poor suck	Frequent (79-30%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002123	glycine encephalopathy	Generalized myoclonic seizures	Frequent (79-30%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005957	glycine encephalopathy	Breathing dysregulation	Frequent (79-30%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005972	glycine encephalopathy	Respiratory acidosis	Frequent (79-30%)	AMT	238310	605899	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephronophthisis-like nephropathy type 1	NA	NA	XPNPEP3	No gene mim	613159	biallelic	possible	loss of function	Kidney Renal Tract	28052	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	3-m syndrome 1	NA	NA	CUL7	609577	273750	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	21024	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neuronal ceroid lipofuscinosis type 10	NA	NA	CTSD	116840	610127	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2529	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	joubert syndrome type 7	NA	NA	RPGRIP1L	610937	611560	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition;Eye;GI tract	29168	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	brugada syndrome 5	NA	NA	SCN1B	No gene mim	612838	monoallelic	confirmed	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10586	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	warburg micro syndrome type 1	NA	NA	RAB3GAP1	602536	600118	biallelic	confirmed	loss of function	Brain/Cognition;Eye;Genitalia	17063	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	abcd syndrome	NA	NA	EDNRB	131244	600501	monoallelic	confirmed	loss of function	Multisystem	3180	endothelin receptor type B	protein-coding gene	gene with protein product	Approved	13q22.3	13q22.3	ETB		HSCR2|HSCR		Endothelin receptors
NA	glut1 deficiency syndrome type 2	NA	NA	SLC2A1	138140	612126	monoallelic	confirmed	loss of function	Brain/Cognition	11005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	multiple epiphyseal dysplasia type 1	Gait disturbance	Frequent (79-30%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001373	multiple epiphyseal dysplasia type 1	Joint dislocation	Frequent (79-30%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001376	multiple epiphyseal dysplasia type 1	Limitation of joint mobility	Frequent (79-30%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001385	multiple epiphyseal dysplasia type 1	Hip dysplasia	Frequent (79-30%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002656	multiple epiphyseal dysplasia type 1	Epiphyseal dysplasia	Very frequent (99-80%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002758	multiple epiphyseal dysplasia type 1	Osteoarthritis	Very frequent (99-80%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002829	multiple epiphyseal dysplasia type 1	Arthralgia	Frequent (79-30%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	multiple epiphyseal dysplasia type 1	Genu valgum	Occasional (29-5%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002970	multiple epiphyseal dysplasia type 1	Genu varum	Occasional (29-5%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	multiple epiphyseal dysplasia type 1	Micromelia	Frequent (79-30%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003502	multiple epiphyseal dysplasia type 1	Mild short stature	Frequent (79-30%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004279	multiple epiphyseal dysplasia type 1	Short palm	Frequent (79-30%)	COMP	600310	132400	monoallelic	confirmed	dominant negative	Skeleton	2227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	senior-loken syndrome 7	NA	NA	SDCCAG8	613524	613615	biallelic	confirmed	loss of function	Kidney Renal Tract;Eye	10671	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephronophthisis type 3	NA	NA	NPHP3	608002	604387	biallelic	confirmed	loss of function	Kidney Renal Tract;GI tract	7907	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	marshall-smith syndrome	NA	NA	NFIX	164005	602535	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Respiratory tract	7788	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	basal cell nevus syndrome	NA	NA	PTCH1	601309	109400	monoallelic	confirmed	loss of function	Skin;Brain/Cognition	9585	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondyloepimetaphyseal dysplasia aggrecan type	NA	NA	ACAN	No gene mim	612813	biallelic	confirmed	all missense/in frame	Skeleton	319	aggrecan	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	CSPGCP	aggrecan proteoglycan	MSK16|CSPG1|AGC1	chondroitin sulfate proteoglycan 1|aggrecan 1	Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing
NA	zimmermann-laband syndrome	NA	NA	ATP6V1B2	No gene mim	No disease mim	monoallelic	probable	dominant negative	Teeth & Dentitian;Skin;Brain/Cognition	854	ATPase H+ transporting V1 subunit B2	protein-coding gene	gene with protein product	Approved	8p21.3	08p21.3	VATB|Vma2|HO57		VPP3|ATP6B2	ATPase, H+ transporting, lysosomal (vacuolar proton pump), beta polypeptide, 56/58kD, isoform 2|ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B, isoform 2|ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	V-type ATPases
NA	renpenning s(yndrome 1	NA	NA	PQBP1	300463	309500	hemizygous	confirmed	loss of function	Brain/Cognition;Eye;Genitalia	9330	polyglutamine binding protein 1	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23			RENS1|MRXS8|SHS|MRX55|MRX2|MRXS3	Sutherland-Haan X-linked mental retardation syndrome|mental retardation, X-linked 55|mental retardation, X-linked 2 (non-dysmorphic)	X-linked mental retardation|Spliceosomal B complex
NA	microcephaly primary type 1	NA	NA	MCPH1	607117	251200	biallelic	confirmed	loss of function	Brain/Cognition	6954	microcephalin 1	protein-coding gene	gene with protein product	Approved	8p23.1	08p23.1	FLJ12847|BRIT1	BRCT-repeat inhibitor of TERT expression 1		microcephaly, primary autosomal recessive 1	
NA	kiaa2022	NA	NA	NEXMIF	No gene mim	300912	hemizygous	probable	uncertain	Brain/Cognition	29433	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lethal tight skin contracture syndrome	NA	NA	LMNA	No gene mim	275210	monoallelic	both DD and IF	activating	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
NA	primary ciliary dyskinesia associated with defective outer and inner dynein arms.	NA	NA	SPAG1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Respiratory tract	11212	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	arthrogryposis, lethal, with anterior horn cell disease	NA	NA	GLE1	603371	611890	biallelic	confirmed	all missense/in frame	Skeleton;Spinal cord/Peripheral nerves	4315	GLE1, RNA export mediator	protein-coding gene	gene with protein product	Approved	9q34.11	09q34.11	hGLE1		GLE1L|LCCS1	GLE1 (yeast homolog)-like, RNA export mediator|GLE1 RNA export mediator-like (yeast)|GLE1 RNA export mediator (yeast)|lethal congenital contracture syndrome 1|GLE1 RNA export mediator homolog (yeast)	Nucleoporins
NA	heart-hand syndrome slovenian type	NA	NA	LMNA	No gene mim	610140	monoallelic	both DD and IF	uncertain	Musculature;Heart/Cardiovasculature/Lymphatic	6636	lamin A/C	protein-coding gene	gene with protein product	Approved	1q22	01q22	HGPS|MADA	mandibuloacral dysplasia type A	LMN1|CMD1A|LGMD1B|PRO1|LMNL1	cardiomyopathy, dilated 1A (autosomal dominant)|limb girdle muscular dystrophy 1B (autosomal dominant)|progeria 1 (Hutchinson-Gilford type)|lamin A/C-like 1	Lamins
HP:0000028	tetralogy of fallot	Cryptorchidism	Frequent (79-30%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000233	tetralogy of fallot	Thin vermilion border	Frequent (79-30%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000268	tetralogy of fallot	Dolichocephaly	Frequent (79-30%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	tetralogy of fallot	Broad forehead	Very frequent (99-80%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	tetralogy of fallot	Proptosis	Frequent (79-30%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001156	tetralogy of fallot	Brachydactyly syndrome	Very frequent (99-80%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	tetralogy of fallot	Intrauterine growth retardation	Very frequent (99-80%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001636	tetralogy of fallot	Tetralogy of Fallot	Frequent (79-30%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	tetralogy of fallot	Clinodactyly of the 5th finger	Very frequent (99-80%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004467	tetralogy of fallot	Preauricular pit	Frequent (79-30%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005105	tetralogy of fallot	Abnormal nasal morphology	Very frequent (99-80%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009891	tetralogy of fallot	Underdeveloped supraorbital ridges	Frequent (79-30%)	ZFPM2	No gene mim	187500	monoallelic	possible	all missense/in frame	GI tract;Heart/Cardiovasculature/Lymphatic	16700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ciliary dyskinesia, primary, 14	NA	NA	CCDC39	613798	613807	biallelic	confirmed	loss of function	Multisystem	25244	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial complex i deficiency	NA	NA	NUBPL	613621	252010	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	20278	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract congenital x-linked	NA	NA	NHS	300457	302200	hemizygous	confirmed	loss of function	Teeth & Dentitian;Eye	7820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	macrothrombocytopenia with progressive sensorineural deafness	NA	NA	MYH9	No gene mim	600208	monoallelic	confirmed	loss of function	Bone Marrow/Immune	7579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epidermolysis bullosa with pyloric atresia	NA	NA	ITGA6	No gene mim	226730	monoallelic	possible	loss of function	Skin;GI tract	6142	integrin subunit alpha 6	protein-coding gene	gene with protein product	Approved	2q31.1	02q31.1	CD49f			integrin, alpha 6	CD molecules|Integrin alpha subunits
NA	omodysplasia type 1 (omod1) [	NA	NA	GPC6	604404	258315	biallelic	probable	loss of function	Skeleton	4454	glypican 6	protein-coding gene	gene with protein product	Approved	13q31.3-q32.1	13q31.3-q32.1		glypican proteoglycan 6			Glypicans
NA	keratosis linearis with ichthyosis congenita and sclerosing keratoderma	NA	NA	POMP	No gene mim	601952	biallelic	possible	cis-regulatory or promotor mutation	Skin	20330	proteasome maturation protein	protein-coding gene	gene with protein product	Approved	13q12.3	13q12.3	HSPC014|UMP1	proteassemblin	C13orf12	chromosome 13 open reading frame 12	
NA	griscelli syndrome type 3	NA	NA	MYO5A	160777	609227	biallelic	confirmed	loss of function	Skin	7602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	weaver syndrome 2	NA	NA	EZH2	601573	614421	monoallelic	confirmed	all missense/in frame	Skeleton;Brain/Cognition	3527	enhancer of zeste 2 polycomb repressive complex 2 subunit	protein-coding gene	gene with protein product	Approved	7q36.1	07q36.1	EZH1|ENX-1|KMT6|KMT6A			enhancer of zeste (Drosophila) homolog 2|enhancer of zeste homolog 2 (Drosophila)	Lysine methyltransferases|Myb/SANT domain containing|Polycomb repressive complex 2|SET domain containing
NA	chondrodysplasia blomstrand type	NA	NA	PTH1R	168468	215045	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic	9608	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glomuvenous malformations	NA	NA	GLMN	601749	138000	monoallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	14373	glomulin, FKBP associated protein	protein-coding gene	gene with protein product	Approved	1p22.1	01p22.1	FAP48|GLML|GVM|FKBPAP		VMGLOM	venous malformation with glomus cells	
NA	hereditary lymphedema ii	NA	NA	FOXC2	602402	241432	monoallelic	confirmed	loss of function	Eye;Heart/Cardiovasculature/Lymphatic	3801	forkhead box C2	protein-coding gene	gene with protein product	Approved	16q24.1	16q24.1	MFH-1	mesenchyme forkhead 1	FKHL14	forkhead box C2 (MFH-1, mesenchyme forkhead 1)	Forkhead boxes
NA	alport syndrome autosomal recessive	NA	NA	COL4A4	120131	203780	biallelic	confirmed	loss of function	Kidney Renal Tract;Eye;Ear	2206	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial dna depletion syndrome, myopathic form	NA	NA	TK2	188250	258276	biallelic	confirmed	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	11831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glutaric aciduria type 2b	NA	NA	ETFB	130410	231680	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	3482	electron transfer flavoprotein beta subunit	protein-coding gene	gene with protein product	Approved	19q13.41	19q13.41				electron-transfer-flavoprotein, beta polypeptide	
HP:0001831	syndactyly type 3	Short toe	Occasional (29-5%)	GJA1	121014	186100	monoallelic	possible	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0006101	syndactyly type 3	Finger syndactyly	Very frequent (99-80%)	GJA1	121014	186100	monoallelic	possible	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
HP:0100490	syndactyly type 3	Camptodactyly of finger	Frequent (79-30%)	GJA1	121014	186100	monoallelic	possible	all missense/in frame	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
NA	truncus arteriosis	NA	NA	PLXND1	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Spinal cord/Peripheral nerves;Eye;Heart/Cardiovasculature/Lymphatic	9107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	north american indian childhood cirrhosis	NA	NA	UTP4	No gene mim	205306	biallelic	possible	all missense/in frame	GI tract	1983	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive oculodentodigital dysplasia	NA	NA	GJA1	121014	257850	biallelic	confirmed	loss of function	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
NA	burn mckeown syndrome	NA	NA	TXNL4A	No gene mim	608572	biallelic	confirmed	loss of function	Face;Heart/Cardiovasculature/Lymphatic	30551	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	xeroderma pigmentosum, group f	NA	NA	ERCC4	133520	278760	biallelic	confirmed	loss of function	Skin;Skeleton	3436	ERCC excision repair 4, endonuclease catalytic subunit	protein-coding gene	gene with protein product	Approved	16p13.12	16p13.12	RAD1|FANCQ	xeroderma pigmentosum, complementation group F	XPF	excision repair cross-complementing rodent repair deficiency, complementation group 4|excision repair cross-complementation group 4	Fanconi anemia complementation groups|Xeroderma pigmentosum complementation groups|ERCC excision repair associated
HP:0000175	spondyloepiphyseal dysplasia congenita	Cleft palate	Frequent (79-30%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	spondyloepiphyseal dysplasia congenita	Short neck	Very frequent (99-80%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	spondyloepiphyseal dysplasia congenita	Glaucoma	Occasional (29-5%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000545	spondyloepiphyseal dysplasia congenita	Myopia	Occasional (29-5%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	spondyloepiphyseal dysplasia congenita	Nystagmus	Occasional (29-5%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	spondyloepiphyseal dysplasia congenita	Narrow chest	Very frequent (99-80%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001376	spondyloepiphyseal dysplasia congenita	Limitation of joint mobility	Frequent (79-30%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	spondyloepiphyseal dysplasia congenita	Scoliosis	Occasional (29-5%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	spondyloepiphyseal dysplasia congenita	Kyphosis	Occasional (29-5%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002812	spondyloepiphyseal dysplasia congenita	Coxa vara	Frequent (79-30%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	spondyloepiphyseal dysplasia congenita	Micromelia	Very frequent (99-80%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003307	spondyloepiphyseal dysplasia congenita	Hyperlordosis	Frequent (79-30%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	spondyloepiphyseal dysplasia congenita	Short stature	Very frequent (99-80%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005930	spondyloepiphyseal dysplasia congenita	Abnormality of epiphysis morphology	Very frequent (99-80%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010306	spondyloepiphyseal dysplasia congenita	Short thorax	Very frequent (99-80%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	spondyloepiphyseal dysplasia congenita	Hypertelorism	Frequent (79-30%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	spondyloepiphyseal dysplasia congenita	Broad forehead	Frequent (79-30%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	spondyloepiphyseal dysplasia congenita	Hearing impairment	Occasional (29-5%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	spondyloepiphyseal dysplasia congenita	Cataract	Occasional (29-5%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000541	spondyloepiphyseal dysplasia congenita	Retinal detachment	Occasional (29-5%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000926	spondyloepiphyseal dysplasia congenita	Platyspondyly	Very frequent (99-80%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001762	spondyloepiphyseal dysplasia congenita	Talipes equinovarus	Frequent (79-30%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	spondyloepiphyseal dysplasia congenita	Skeletal dysplasia	Very frequent (99-80%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002758	spondyloepiphyseal dysplasia congenita	Osteoarthritis	Frequent (79-30%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012368	spondyloepiphyseal dysplasia congenita	Flat face	Frequent (79-30%)	COL2A1	120140	183900	monoallelic	confirmed	uncertain	Face;Skeleton	2200	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	singleton-merten syndrome	NA	NA	IFIH1	No gene mim	182250	monoallelic	probable	activating	Bone Marrow/Immune;Teeth & Dentitian;Skin;Skeleton;Brain/Cognition;Eye	18873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	renal hypodysplasia/aplasia 1	NA	NA	ITGA8	No gene mim	191830	biallelic	probable	loss of function	Kidney Renal Tract	6144	integrin subunit alpha 8	protein-coding gene	gene with protein product	Approved	10p13	10p13				integrin, alpha 8	Integrin alpha subunits
NA	meier-gorlin syndrome 3	NA	NA	ORC6	607213	613803	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear	17151	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pou1f1-related combined pituitary hormone deficiency	NA	NA	POU1F1	173110	613038	biallelic	confirmed	loss of function	Endocrine/Metabolic	9210	POU class 1 homeobox 1	protein-coding gene	gene with protein product	Approved	3p11.2	03p11.2	GHF-1|POU1F1a	growth hormone factor 1	PIT1	POU domain class 1, transcription factor 1	POU class homeoboxes and pseudogenes
NA	iridogoniodysgenesis anomaly	NA	NA	FOXC1	601090	601631	monoallelic	confirmed	loss of function	Eye	3800	forkhead box C1	protein-coding gene	gene with protein product	Approved	6p25.3	06p25.3	FREAC3|ARA|IGDA|IHG1		FKHL7|IRID1		Forkhead boxes
NA	intellectual disabiltiy	NA	NA	PDHA1	300502	312170	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8806	pyruvate dehydrogenase E1 alpha 1 subunit	protein-coding gene	gene with protein product	Approved	Xp22.12	Xp22.12		pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	PDHA	pyruvate dehydrogenase (lipoamide) alpha 1|pyruvate dehydrogenase alpha 1	Pyruvate dehydrogenase complex
NA	stickler syndrome, type ii	NA	NA	COL11A1	120280	604841	monoallelic	confirmed	dominant negative	Skeleton;Eye;Ear	2186	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	ENTPD1	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	3363	ectonucleoside triphosphate diphosphohydrolase 1	protein-coding gene	gene with protein product	Approved	10q24.1	10q24.1	NTPDase-1|ATPDase|SPG64		CD39		CD molecules
NA	cerebrooculofacioskeletal syndrome 4	NA	NA	ERCC1	126380	298956	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition;Eye	3433	ERCC excision repair 1, endonuclease non-catalytic subunit	protein-coding gene	gene with protein product	Approved	19q13.32	19q13.32	RAD10			excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)|excision repair cross-complementation group 1	ERCC excision repair associated
NA	craniofrontonasal syndrome	NA	NA	EFNB1	300035	304110	x-linked over-dominance	confirmed	loss of function	Face;Skeleton	3226	ephrin B1	protein-coding gene	gene with protein product	Approved	Xq13.1	Xq13.1	LERK2|Elk-L		EPLG2|CFNS	craniofrontonasal syndrome (craniofrontonasal dysplasia)|ephrin-B1	Ephrins
NA	mental retardation autosomal recessive type 3	NA	NA	CC2D1A	610055	608443	biallelic	confirmed	loss of function	Brain/Cognition	30237	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	UBR7	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	20344	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type a4	NA	NA	FKTN	607440	253800	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye	3622	fukutin	protein-coding gene	gene with protein product	Approved	9q31.2	09q31.2	LGMD2M		FCMD	Fukuyama type congenital muscular dystrophy (fukutin)	
NA	orofaciodigital syndrome	NA	NA	DDX59	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Face;Skeleton;GI tract	25360	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000528	microphthalmia with linear skin defects syndrome	Anophthalmia	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	microphthalmia with linear skin defects syndrome	Microphthalmia	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000647	microphthalmia with linear skin defects syndrome	Sclerocornea	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000776	microphthalmia with linear skin defects syndrome	Congenital diaphragmatic hernia	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000953	microphthalmia with linear skin defects syndrome	Hyperpigmentation of the skin	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001000	microphthalmia with linear skin defects syndrome	Abnormality of skin pigmentation	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004334	microphthalmia with linear skin defects syndrome	Dermal atrophy	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007957	microphthalmia with linear skin defects syndrome	Corneal opacity	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008065	microphthalmia with linear skin defects syndrome	Aplasia/Hypoplasia of the skin	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010783	microphthalmia with linear skin defects syndrome	Erythema	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011800	microphthalmia with linear skin defects syndrome	Midface retrusion	Very frequent (99-80%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000278	microphthalmia with linear skin defects syndrome	Retrognathia	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	microphthalmia with linear skin defects syndrome	Micrognathia	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	microphthalmia with linear skin defects syndrome	Wide nasal bridge	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000445	microphthalmia with linear skin defects syndrome	Wide nose	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000492	microphthalmia with linear skin defects syndrome	Abnormality of the eyelid	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000499	microphthalmia with linear skin defects syndrome	Abnormality of the eyelashes	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000598	microphthalmia with linear skin defects syndrome	Abnormality of the ear	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000614	microphthalmia with linear skin defects syndrome	Abnormality of the nasolacrimal system	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001053	microphthalmia with linear skin defects syndrome	Hypopigmented skin patches	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001639	microphthalmia with linear skin defects syndrome	Hypertrophic cardiomyopathy	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001644	microphthalmia with linear skin defects syndrome	Dilated cardiomyopathy	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001671	microphthalmia with linear skin defects syndrome	Abnormality of the cardiac septa	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001999	microphthalmia with linear skin defects syndrome	Abnormal facial shape	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003510	microphthalmia with linear skin defects syndrome	Severe short stature	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004327	microphthalmia with linear skin defects syndrome	Abnormality of the vitreous humor	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007703	microphthalmia with linear skin defects syndrome	Abnormality of retinal pigmentation	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009939	microphthalmia with linear skin defects syndrome	Mandibular aplasia	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011531	microphthalmia with linear skin defects syndrome	Vitritis	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	microphthalmia with linear skin defects syndrome	Arrhythmia	Frequent (79-30%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000035	microphthalmia with linear skin defects syndrome	Abnormality of the testis	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000036	microphthalmia with linear skin defects syndrome	Abnormality of the penis	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000037	microphthalmia with linear skin defects syndrome	Male pseudohermaphroditism	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000039	microphthalmia with linear skin defects syndrome	Epispadias	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	microphthalmia with linear skin defects syndrome	Hypospadias	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000062	microphthalmia with linear skin defects syndrome	Ambiguous genitalia	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	microphthalmia with linear skin defects syndrome	Hydrocephalus	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	microphthalmia with linear skin defects syndrome	Microcephaly	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000363	microphthalmia with linear skin defects syndrome	Abnormality of earlobe	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	microphthalmia with linear skin defects syndrome	Hearing impairment	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	microphthalmia with linear skin defects syndrome	Glaucoma	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000556	microphthalmia with linear skin defects syndrome	Retinal dystrophy	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000572	microphthalmia with linear skin defects syndrome	Visual loss	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000618	microphthalmia with linear skin defects syndrome	Blindness	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000627	microphthalmia with linear skin defects syndrome	Posterior embryotoxon	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000646	microphthalmia with linear skin defects syndrome	Amblyopia	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000682	microphthalmia with linear skin defects syndrome	Abnormality of dental enamel	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000960	microphthalmia with linear skin defects syndrome	Sacral dimple	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	microphthalmia with linear skin defects syndrome	Intellectual disability	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	microphthalmia with linear skin defects syndrome	Seizures	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	microphthalmia with linear skin defects syndrome	Global developmental delay	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001274	microphthalmia with linear skin defects syndrome	Agenesis of corpus callosum	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	microphthalmia with linear skin defects syndrome	Specific learning disability	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001331	microphthalmia with linear skin defects syndrome	Absent septum pellucidum	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	microphthalmia with linear skin defects syndrome	Failure to thrive	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	microphthalmia with linear skin defects syndrome	Growth delay	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001597	microphthalmia with linear skin defects syndrome	Abnormality of the nail	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001634	microphthalmia with linear skin defects syndrome	Mitral valve prolapse	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001653	microphthalmia with linear skin defects syndrome	Mitral regurgitation	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001704	microphthalmia with linear skin defects syndrome	Tricuspid valve prolapse	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002034	microphthalmia with linear skin defects syndrome	Abnormality of the rectum	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002094	microphthalmia with linear skin defects syndrome	Dyspnea	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002098	microphthalmia with linear skin defects syndrome	Respiratory distress	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002133	microphthalmia with linear skin defects syndrome	Status epilepticus	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002300	microphthalmia with linear skin defects syndrome	Mutism	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002357	microphthalmia with linear skin defects syndrome	Dysphasia	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002381	microphthalmia with linear skin defects syndrome	Aphasia	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002878	microphthalmia with linear skin defects syndrome	Respiratory failure	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004302	microphthalmia with linear skin defects syndrome	Functional motor problems	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004378	microphthalmia with linear skin defects syndrome	Abnormality of the anus	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005180	microphthalmia with linear skin defects syndrome	Tricuspid regurgitation	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007731	microphthalmia with linear skin defects syndrome	Chorioretinal dysplasia	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007973	microphthalmia with linear skin defects syndrome	Retinal dysplasia	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008665	microphthalmia with linear skin defects syndrome	Clitoral hypertrophy	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010529	microphthalmia with linear skin defects syndrome	Echolalia	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011027	microphthalmia with linear skin defects syndrome	Abnormality of the fallopian tube	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011265	microphthalmia with linear skin defects syndrome	Cleft earlobe	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011968	microphthalmia with linear skin defects syndrome	Feeding difficulties	Occasional (29-5%)	NDUFB11	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Endocrine/Metabolic;Eye	20372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	distal arthrogryposis type	NA	NA	MYH8	No gene mim	158300	monoallelic	both DD and IF	loss of function	Skin;Skeleton;Cancer predisposition	7578	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gm2-gangliosidosis type ab	NA	NA	GM2A	613109	272750	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4367	GM2 ganglioside activator	protein-coding gene	gene with protein product	Approved	5q33.1	05q33.1	SAP-3	cerebroside sulfate activator protein|sphingolipid activator protein 3		GM2 ganglioside activator protein	
NA	mucolipidosis iv	NA	NA	MCOLN1	605248	252650	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye;GI tract	13356	mucolipin 1	protein-coding gene	gene with protein product	Approved	19p13.2	19p13.2	TRPML1|ML4|MLIV|MST080|MSTP080|TRPM-L1				Transient receptor potential cation channels
NA	complex craniosynostosis	NA	NA	ERF	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Skeleton	3444	ETS2 repressor factor	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	PE-2|PE2			Ets2 repressor factor	ETS transcription factor family
NA	mandibulofacial dysostosis with alopecia	NA	NA	EDNRA	No gene mim	No disease mim	monoallelic	confirmed	activating	Face;Hair/Nails	3179	endothelin receptor type A	protein-coding gene	gene with protein product	Approved	4q31.22-q31.23	04q31.22-q31.23					Endothelin receptors
NA	rhizomelic chondrodysplasia punctata type 1	NA	NA	PEX7	601757	215100	biallelic	confirmed	loss of function	Face;Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	8860	peroxisomal biogenesis factor 7	protein-coding gene	gene with protein product	Approved	6q23.3	06q23.3	PTS2R|RD	Refsum disease			WD repeat domain containing|Peroxins
HP:0000272	isolated ectopia lentis	Malar flattening	Frequent (79-30%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000303	isolated ectopia lentis	Mandibular prognathia	Frequent (79-30%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000505	isolated ectopia lentis	Visual impairment	Occasional (29-5%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000518	isolated ectopia lentis	Cataract	Occasional (29-5%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000639	isolated ectopia lentis	Nystagmus	Occasional (29-5%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000646	isolated ectopia lentis	Amblyopia	Occasional (29-5%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0000822	isolated ectopia lentis	Hypertension	Occasional (29-5%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001083	isolated ectopia lentis	Ectopia lentis	Very frequent (99-80%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0001387	isolated ectopia lentis	Joint stiffness	Very frequent (99-80%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0009918	isolated ectopia lentis	Ectopia pupillae	Occasional (29-5%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
HP:0100543	isolated ectopia lentis	Cognitive impairment	Frequent (79-30%)	FBN1	134797	129600	monoallelic	possible	all missense/in frame	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
NA	dyggve-melchior-clausen syndrome	NA	NA	DYM	607461	223800	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	21317	dymeclin	protein-coding gene	gene with protein product	Approved	18q21.1	18q21.1	FLJ20071|DMC|SMC				
HP:0000256	mulibrey nanism	Macrocephaly	Very frequent (99-80%)	TRIM37	605073	213300	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye;GI tract	7523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000431	mulibrey nanism	Wide nasal bridge	Frequent (79-30%)	TRIM37	605073	213300	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye;GI tract	7523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001315	mulibrey nanism	Reduced tendon reflexes	Very frequent (99-80%)	TRIM37	605073	213300	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye;GI tract	7523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	mulibrey nanism	Intrauterine growth retardation	Very frequent (99-80%)	TRIM37	605073	213300	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye;GI tract	7523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001620	mulibrey nanism	High pitched voice	Very frequent (99-80%)	TRIM37	605073	213300	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye;GI tract	7523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	mulibrey nanism	Hepatomegaly	Frequent (79-30%)	TRIM37	605073	213300	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye;GI tract	7523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002680	mulibrey nanism	J-shaped sella turcica	Very frequent (99-80%)	TRIM37	605073	213300	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye;GI tract	7523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	mulibrey nanism	Short stature	Very frequent (99-80%)	TRIM37	605073	213300	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye;GI tract	7523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004326	mulibrey nanism	Cachexia	Very frequent (99-80%)	TRIM37	605073	213300	biallelic	confirmed	loss of function	Musculature;Brain/Cognition;Eye;GI tract	7523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bile acid synthesis defect, congenital, 2	NA	NA	AKR1D1	No gene mim	235555	biallelic	confirmed	loss of function	Endocrine/Metabolic;GI tract	388	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cardiomyopathy dilated x-linked type 3b	NA	NA	DMD	300377	302045	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acute necrotizing encephalopathy 1, susceptibility to	NA	NA	RANBP2	No gene mim	285648	monoallelic	possible	all missense/in frame	Brain/Cognition	9848	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	8q24.3 deletion-like	NA	NA	SCRIB	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition;Eye	30377	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperphosphatasia with mental retardation syndrome 4	NA	NA	PGAP3	No gene mim	615716	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	23719	post-GPI attachment to proteins 3	protein-coding gene	gene with protein product	Approved	17q21.2	17q21.2	MGC9753|CAB2|PP1498|PER1	post-GPI attachment to proteins 3	PERLD1	per1-like domain containing 1	
NA	neuropathy, hereditary sensory and autonomic, type ic	NA	NA	SPTLC2	No gene mim	613640	monoallelic	both DD and IF	all missense/in frame	Peripheral nerves	11278	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	HIST1H4B	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	4789	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	very long chain acyl-coenzyme a dehydrogenase deficiency	NA	NA	ACADVL	609575	201475	biallelic	confirmed	loss of function	Endocrine/Metabolic	92	acyl-CoA dehydrogenase very long chain	protein-coding gene	gene with protein product	Approved	17p13.1	17p13.1	VLCAD|LCACD|ACAD6			acyl-Coenzyme A dehydrogenase, very long chain	Acyl-CoA dehydrogenase family
HP:0001249	propionic acidemia	Intellectual disability	Frequent (79-30%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	propionic acidemia	Global developmental delay	Frequent (79-30%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001638	propionic acidemia	Cardiomyopathy	Occasional (29-5%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	propionic acidemia	Hypoglycemia	Very frequent (99-80%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001987	propionic acidemia	Hyperammonemia	Very frequent (99-80%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001992	propionic acidemia	Organic aciduria	Very frequent (99-80%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002019	propionic acidemia	Constipation	Very frequent (99-80%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	propionic acidemia	Hepatomegaly	Frequent (79-30%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003353	propionic acidemia	Propionyl-CoA carboxylase deficiency	Very frequent (99-80%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	propionic acidemia	Abnormality of immune system physiology	Frequent (79-30%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011675	propionic acidemia	Arrhythmia	Frequent (79-30%)	PCCB	232050	606054	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	8654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ipex syndrome	NA	NA	FOXP3	300292	304790	hemizygous	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic;Brain/Cognition	6106	forkhead box P3	protein-coding gene	gene with protein product	Approved	Xp11.23	Xp11.23	JM2|XPID|AIID|PIDX|DIETER|SCURFIN		IPEX	immune dysregulation, polyendocrinopathy, enteropathy, X-linked	Forkhead boxes
NA	cataract zonular hsf4-related	NA	NA	HSF4	602438	116800	monoallelic	confirmed	uncertain	Eye	5227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000077	infantile myofibromatosis	Abnormality of the kidney	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000169	infantile myofibromatosis	Gingival fibromatosis	Frequent (79-30%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000271	infantile myofibromatosis	Abnormality of the face	Frequent (79-30%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000478	infantile myofibromatosis	Abnormality of the eye	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000765	infantile myofibromatosis	Abnormality of the thorax	Frequent (79-30%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000929	infantile myofibromatosis	Abnormality of the skull	Frequent (79-30%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000934	infantile myofibromatosis	Chondrocalcinosis	Frequent (79-30%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	infantile myofibromatosis	Abnormality of the metaphyses	Very frequent (99-80%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001376	infantile myofibromatosis	Limitation of joint mobility	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001482	infantile myofibromatosis	Subcutaneous nodule	Very frequent (99-80%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001595	infantile myofibromatosis	Abnormality of the hair	Frequent (79-30%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002242	infantile myofibromatosis	Abnormality of the intestine	Frequent (79-30%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002575	infantile myofibromatosis	Tracheoesophageal fistula	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002797	infantile myofibromatosis	Osteolysis	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002894	infantile myofibromatosis	Neoplasm of the pancreas	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003011	infantile myofibromatosis	Abnormality of the musculature	Very frequent (99-80%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003072	infantile myofibromatosis	Hypercalcemia	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	infantile myofibromatosis	Hemiplegia/hemiparesis	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005107	infantile myofibromatosis	Abnormality of the sacrum	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005214	infantile myofibromatosis	Intestinal obstruction	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007400	infantile myofibromatosis	Irregular hyperpigmentation	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008069	infantile myofibromatosis	Neoplasm of the skin	Very frequent (99-80%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010614	infantile myofibromatosis	Fibroma	Very frequent (99-80%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012062	infantile myofibromatosis	Bone cyst	Very frequent (99-80%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100242	infantile myofibromatosis	Sarcoma	Very frequent (99-80%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100526	infantile myofibromatosis	Neoplasm of the lung	Frequent (79-30%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100835	infantile myofibromatosis	Benign neoplasm of the central nervous system	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200042	infantile myofibromatosis	Skin ulcer	Occasional (29-5%)	NOTCH3	No gene mim	615293	monoallelic	possible	activating	Skin;GI tract	7883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	limb-mammary syndrome	NA	NA	TP63	603273	603543	monoallelic	confirmed	uncertain	Skin;Face;Skeleton	15979	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bartter syndrome type 4a	NA	NA	BSND	606412	602522	biallelic	confirmed	loss of function	Kidney Renal Tract;Ear	16512	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial complex iv deficiency	NA	NA	COX6B1	124089	220110	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2280	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	8q24.3 deletion-like	NA	NA	PUF60	No gene mim	No disease mim	monoallelic	possible	loss of function	Kidney Renal Tract;Skeleton;Eye;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	17042	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	?coffin-siris syndrome	NA	NA	SMARCB1	601607	135900	monoallelic	confirmed	loss of function	Musculature;Skeleton;Brain/Cognition;Cancer predisposition	11103	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanconi anemia, complementation group n	NA	NA	PALB2	610355	610832	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	26144	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000037	campomelic dysplasia	Male pseudohermaphroditism	Frequent (79-30%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000062	campomelic dysplasia	Ambiguous genitalia	Frequent (79-30%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000126	campomelic dysplasia	Hydronephrosis	Occasional (29-5%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	campomelic dysplasia	Cleft palate	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	campomelic dysplasia	Macrocephaly	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	campomelic dysplasia	Hypertelorism	Frequent (79-30%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	campomelic dysplasia	Micrognathia	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	campomelic dysplasia	Hearing impairment	Occasional (29-5%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	campomelic dysplasia	Low-set ears	Frequent (79-30%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000470	campomelic dysplasia	Short neck	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	campomelic dysplasia	Proptosis	Frequent (79-30%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	campomelic dysplasia	Narrow chest	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000878	campomelic dysplasia	11 pairs of ribs	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001601	campomelic dysplasia	Laryngomalacia	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001762	campomelic dysplasia	Talipes equinovarus	Frequent (79-30%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	campomelic dysplasia	Respiratory insufficiency	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	campomelic dysplasia	Ventriculomegaly	Occasional (29-5%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	campomelic dysplasia	Malformation of the heart and great vessels	Occasional (29-5%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	campomelic dysplasia	Scoliosis	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002757	campomelic dysplasia	Recurrent fractures	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002779	campomelic dysplasia	Tracheomalacia	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002786	campomelic dysplasia	Tracheobronchomalacia	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	campomelic dysplasia	Kyphosis	Occasional (29-5%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002827	campomelic dysplasia	Hip dislocation	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002980	campomelic dysplasia	Femoral bowing	Frequent (79-30%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002982	campomelic dysplasia	Tibial bowing	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003026	campomelic dysplasia	Short long bone	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003038	campomelic dysplasia	Fibular hypoplasia	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	campomelic dysplasia	Short stature	Frequent (79-30%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004408	campomelic dysplasia	Abnormality of the sense of smell	Occasional (29-5%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	campomelic dysplasia	Depressed nasal bridge	Occasional (29-5%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	campomelic dysplasia	Bowing of the long bones	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006584	campomelic dysplasia	Small abnormally formed scapulae	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007036	campomelic dysplasia	Hypoplasia of olfactory tract	Occasional (29-5%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008477	campomelic dysplasia	Poorly ossified cervical vertebrae	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008821	campomelic dysplasia	Hypoplastic inferior ilia	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010781	campomelic dysplasia	Skin dimples	Frequent (79-30%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012368	campomelic dysplasia	Flat face	Very frequent (99-80%)	SOX9	608160	114290	monoallelic	confirmed	loss of function	Face;Skeleton;Genitalia	11204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	doors syndrome	NA	NA	TBC1D24	613577	220500	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear	29203	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehlers-danlos syndrome type 3	NA	NA	COL3A1	120180	130020	monoallelic	child IF	dominant negative	Skin;Skeleton;Heart/Cardiovasculature/Lymphatic	2201	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe asphyxiating thoracic dysplasia	NA	NA	WDR34	No gene mim	No disease mim	biallelic	confirmed	all missense/in frame	Skeleton	28296	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	asperger	NA	NA	VIP	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	12693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	immunodeficiency 23	NA	NA	PGM3	No gene mim	615816	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton	8907	phosphoglucomutase 3	protein-coding gene	gene with protein product	Approved	6q14.1	06q14.1	AGM1|DKFZP434B187|PAGM	acetylglucosamine phosphomutase			
NA	susceptibility to x-linked familial atypical micobacteriosis type 1	NA	NA	IKBKG	300248	300636	hemizygous	confirmed	loss of function	Bone Marrow/Immune;Skin;Heart/Cardiovasculature/Lymphatic	5961	inhibitor of nuclear factor kappa B kinase subunit gamma	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	IKK-gamma|NEMO|Fip3p|FIP-3|FIP3|ZC2HC9		IP2|IP1	incontinentia pigmenti|inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma	Zinc fingers C2HC-type
NA	fatal infantile lactic acidosis	NA	NA	SUCLG1	611224	308078	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11449	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	osteoporosis-pseudoglioma syndrome	NA	NA	LRP5	603506	259770	biallelic	confirmed	loss of function	Skeleton;Eye	6697	LDL receptor related protein 5	protein-coding gene	gene with protein product	Approved	11q13.2	11q13.2	LR3|BMND1|HBM|OPS|OPTA1|VBCH2|EVR4		LRP7|OPPG|EVR1	osteoporosis pseudoglioma syndrome|exudative vitreoretinopathy 1|low density lipoprotein receptor-related protein 5	Low density lipoprotein receptors
HP:0000078	aniridia	Abnormality of the genital system	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	aniridia	Abnormality of the teeth	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000407	aniridia	Sensorineural hearing impairment	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000482	aniridia	Microcornea	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	aniridia	Strabismus	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000491	aniridia	Keratitis	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000501	aniridia	Glaucoma	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	aniridia	Visual impairment	Very frequent (99-80%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	aniridia	Ptosis	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000563	aniridia	Keratoconus	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000588	aniridia	Optic nerve coloboma	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000609	aniridia	Optic nerve hypoplasia	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000613	aniridia	Photophobia	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	aniridia	Nystagmus	Very frequent (99-80%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	aniridia	Behavioral abnormality	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000864	aniridia	Abnormality of the hypothalamus-pituitary axis	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001083	aniridia	Ectopia lentis	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001097	aniridia	Keratoconjunctivitis sicca	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001104	aniridia	Macular hypoplasia	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	aniridia	Intellectual disability	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	aniridia	Global developmental delay	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001537	aniridia	Umbilical hernia	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004408	aniridia	Abnormality of the sense of smell	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	aniridia	Aplasia/Hypoplasia of the corpus callosum	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007730	aniridia	Iris hypopigmentation	Occasional (29-5%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007759	aniridia	Opacification of the corneal stroma	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007988	aniridia	Macular hypopigmentation	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008053	aniridia	Aplasia/Hypoplasia of the iris	Very frequent (99-80%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011496	aniridia	Corneal neovascularization	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012745	aniridia	Short palpebral fissure	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0200020	aniridia	Corneal erosion	Frequent (79-30%)	PAX6	607108	106210	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	INPP4A	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	6074	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation x-linked type 30	NA	NA	PAK3	300142	300558	hemizygous	confirmed	loss of function	Brain/Cognition	8592	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal recessive mental retardation	NA	NA	SLC31A1	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	11016	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000010	fanconi anemia	Recurrent urinary tract infections	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000027	fanconi anemia	Azoospermia	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000028	fanconi anemia	Cryptorchidism	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000035	fanconi anemia	Abnormality of the testis	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000047	fanconi anemia	Hypospadias	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000072	fanconi anemia	Hydroureter	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000079	fanconi anemia	Abnormality of the urinary system	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000130	fanconi anemia	Abnormality of the uterus	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000135	fanconi anemia	Hypogonadism	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000175	fanconi anemia	Cleft palate	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000218	fanconi anemia	High palate	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000238	fanconi anemia	Hydrocephalus	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000268	fanconi anemia	Dolichocephaly	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000316	fanconi anemia	Hypertelorism	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000324	fanconi anemia	Facial asymmetry	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000340	fanconi anemia	Sloping forehead	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000347	fanconi anemia	Micrognathia	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000364	fanconi anemia	Hearing abnormality	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000365	fanconi anemia	Hearing impairment	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000453	fanconi anemia	Choanal atresia	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000478	fanconi anemia	Abnormality of the eye	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000483	fanconi anemia	Astigmatism	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000486	fanconi anemia	Strabismus	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000492	fanconi anemia	Abnormality of the eyelid	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000083	fanconi anemia	Renal insufficiency	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000252	fanconi anemia	Microcephaly	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000286	fanconi anemia	Epicanthus	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000504	fanconi anemia	Abnormality of vision	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000505	fanconi anemia	Visual impairment	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000508	fanconi anemia	Ptosis	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000518	fanconi anemia	Cataract	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000520	fanconi anemia	Proptosis	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000568	fanconi anemia	Microphthalmia	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000582	fanconi anemia	Upslanted palpebral fissure	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000639	fanconi anemia	Nystagmus	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000813	fanconi anemia	Bicornuate uterus	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0000864	fanconi anemia	Abnormality of the hypothalamus-pituitary axis	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001000	fanconi anemia	Abnormality of skin pigmentation	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001053	fanconi anemia	Hypopigmented skin patches	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001172	fanconi anemia	Abnormality of the thumb	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001199	fanconi anemia	Triphalangeal thumb	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001249	fanconi anemia	Intellectual disability	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001263	fanconi anemia	Global developmental delay	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001347	fanconi anemia	Hyperreflexia	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001392	fanconi anemia	Abnormality of the liver	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001510	fanconi anemia	Growth delay	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001511	fanconi anemia	Intrauterine growth retardation	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001537	fanconi anemia	Umbilical hernia	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001562	fanconi anemia	Oligohydramnios	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001631	fanconi anemia	Atrial septal defect	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001636	fanconi anemia	Tetralogy of Fallot	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001639	fanconi anemia	Hypertrophic cardiomyopathy	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001643	fanconi anemia	Patent ductus arteriosus	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001646	fanconi anemia	Abnormality of the aortic valve	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001671	fanconi anemia	Abnormality of the cardiac septa	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001679	fanconi anemia	Abnormality of the aorta	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001760	fanconi anemia	Abnormality of the foot	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001763	fanconi anemia	Pes planus	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001770	fanconi anemia	Toe syndactyly	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001824	fanconi anemia	Weight loss	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001871	fanconi anemia	Abnormality of blood and blood-forming tissues	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001873	fanconi anemia	Thrombocytopenia	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001882	fanconi anemia	Leukopenia	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001903	fanconi anemia	Anemia	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002007	fanconi anemia	Frontal bossing	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002023	fanconi anemia	Anal atresia	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002119	fanconi anemia	Ventriculomegaly	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002245	fanconi anemia	Meckel diverticulum	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002251	fanconi anemia	Aganglionic megacolon	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002414	fanconi anemia	Spina bifida	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002575	fanconi anemia	Tracheoesophageal fistula	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002650	fanconi anemia	Scoliosis	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002664	fanconi anemia	Neoplasm	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002817	fanconi anemia	Abnormality of the upper limb	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002823	fanconi anemia	Abnormality of the femur	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002827	fanconi anemia	Hip dislocation	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002863	fanconi anemia	Myelodysplasia	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0002997	fanconi anemia	Abnormality of the ulna	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0003022	fanconi anemia	Hypoplasia of the ulna	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0003220	fanconi anemia	Abnormality of chromosome stability	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0004209	fanconi anemia	Clinodactyly of the 5th finger	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0004322	fanconi anemia	Short stature	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0004349	fanconi anemia	Reduced bone mineral density	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0005344	fanconi anemia	Abnormality of the carotid arteries	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0005522	fanconi anemia	Pyridoxine-responsive sideroblastic anemia	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0006101	fanconi anemia	Finger syndactyly	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0006265	fanconi anemia	Aplasia/Hypoplasia of fingers	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0006501	fanconi anemia	Aplasia/Hypoplasia of the radius	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0006824	fanconi anemia	Cranial nerve paralysis	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0007400	fanconi anemia	Irregular hyperpigmentation	Very frequent (99-80%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0007565	fanconi anemia	Multiple cafe-au-lait spots	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0007874	fanconi anemia	Almond-shaped palpebral fissure	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0008053	fanconi anemia	Aplasia/Hypoplasia of the iris	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0008572	fanconi anemia	External ear malformation	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0008678	fanconi anemia	Renal hypoplasia/aplasia	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0010293	fanconi anemia	Aplasia/Hypoplasia of the uvula	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0010469	fanconi anemia	Absent testis	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0012041	fanconi anemia	Decreased fertility in males	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0012210	fanconi anemia	Abnormal renal morphology	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0012639	fanconi anemia	Abnormality of nervous system morphology	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0012745	fanconi anemia	Short palpebral fissure	Frequent (79-30%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0100026	fanconi anemia	Arteriovenous malformation	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0100542	fanconi anemia	Abnormal localization of kidney	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0100587	fanconi anemia	Abnormality of the preputium	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0100760	fanconi anemia	Clubbing of toes	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0100867	fanconi anemia	Duodenal stenosis	Occasional (29-5%)	FANCI	611360	229154	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	25568	Fanconi anemia complementation group I	protein-coding gene	gene with protein product	Approved	15q26.1	15q26.1	FLJ10719		KIAA1794	KIAA1794	Fanconi anemia complementation groups
HP:0001336	unverricht-lundborg disease	Myoclonus	Very frequent (99-80%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002070	unverricht-lundborg disease	Limb ataxia	Very frequent (99-80%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002392	unverricht-lundborg disease	EEG with polyspike wave complexes	Very frequent (99-80%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007000	unverricht-lundborg disease	Morning myoclonic jerks	Very frequent (99-80%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	unverricht-lundborg disease	Ataxia	Frequent (79-30%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001260	unverricht-lundborg disease	Dysarthria	Frequent (79-30%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002080	unverricht-lundborg disease	Intention tremor	Frequent (79-30%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000726	unverricht-lundborg disease	Dementia	Occasional (29-5%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000992	unverricht-lundborg disease	Cutaneous photosensitivity	Occasional (29-5%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	unverricht-lundborg disease	Intellectual disability	Occasional (29-5%)	CSTB	601145	254800	biallelic	confirmed	loss of function	Brain/Cognition	2482	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dentinogenesis imperfecta, shields type ii	NA	NA	DSPP	125485	125490	monoallelic	confirmed	loss of function	Teeth & Dentitian;Ear	3054	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001257	dopa-responsive dystonia	Spasticity	Very frequent (99-80%)	TH	191290	605407	biallelic	confirmed	loss of function	Brain/Cognition	11782	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	dopa-responsive dystonia	Gait disturbance	Very frequent (99-80%)	TH	191290	605407	biallelic	confirmed	loss of function	Brain/Cognition	11782	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	dopa-responsive dystonia	Abnormality of movement	Very frequent (99-80%)	TH	191290	605407	biallelic	confirmed	loss of function	Brain/Cognition	11782	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	weill-marchesani syndrome autosomal dominant	NA	NA	FBN1	134797	608328	monoallelic	possible	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
NA	mental retardation x-linked type 95	NA	NA	MAGT1	300715	300716	hemizygous	possible	loss of function	Brain/Cognition	28880	magnesium transporter 1	protein-coding gene	gene with protein product	Approved	Xq21.1	Xq21.1	DKFZp564K142|IAP|OST3B|MRX95	oligosaccharyltransferase 3 homolog B (S. cerevisiae)			X-linked mental retardation|Oligosaccharyltransferase complex subunits
HP:0002205	primary ciliary dyskinesia	Recurrent respiratory infections	Very frequent (99-80%)	CCDC65	No gene mim	No disease mim	biallelic	confirmed	loss of function	Respiratory tract	29937	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy-dystroglycanopathy limb-girdle type c3	NA	NA	POMGNT1	606822	613157	biallelic	confirmed	uncertain	Musculature;Brain/Cognition;Eye	19139	protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)	protein-coding gene	gene with protein product	Approved	1p34.1	01p34.1	FLJ20277|MGAT1.2|LGMD2O	protein O-mannose beta-1,2-N-acetylglucosaminyltransferase	MEB	muscle-eye-brain disease|protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase	O-linked N-acetylglucosaminyltransferases
NA	primary cilary dyskineasia	NA	NA	DRC1	No gene mim	244400	biallelic	probable	loss of function	Respiratory tract	24245	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nijmegen breakage syndrome-like disorder	NA	NA	RAD50	No gene mim	613078	biallelic	possible	loss of function	Bone Marrow/Immune;Brain/Cognition	9816	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mass syndrome/overlap connective tissue disease	NA	NA	FBN1	134797	604308	monoallelic	confirmed	loss of function	Skeleton;Eye;Heart/Cardiovasculature/Lymphatic	3603	fibrillin 1	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	MASS|OCTD|SGS	Marfan syndrome|asprosin	FBN|MFS1|WMS	fibrillin 1 (Marfan syndrome)	
NA	aicardi-goutieres syndrome 3	NA	NA	RNASEH2C	610330	610329	biallelic	confirmed	loss of function	Skin;Brain/Cognition	24116	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mullerian aplasia and hyperandrogenism	NA	NA	WNT4	No gene mim	158330	monoallelic	probable	all missense/in frame	Brain/Cognition;Genitalia	12783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ciliary dyskinesia, primary, 15	NA	NA	CCDC40	613799	613808	biallelic	confirmed	loss of function		26090	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	familial diarrhea diarrhea 6	NA	NA	GUCY2C	601330	614616	monoallelic	confirmed	activating	GI tract	4688	guanylate cyclase 2C	protein-coding gene	gene with protein product	Approved	12p12.3	12p12.3	STAR	STA receptor|heat stable enterotoxin receptor	GUC2C	guanylate cyclase 2C (heat stable enterotoxin receptor)	Guanylate cyclase receptors
NA	postnatal microcephaly, hypomyelination, and reduced cerebral white-matter volume	NA	NA	PYCR2	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Brain/Cognition	30262	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial complex iv deficiency	NA	NA	COX10	602125	220110	biallelic	confirmed	uncertain	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	alport syndrome autosomal dominant	NA	NA	COL4A3	120070	104200	monoallelic	confirmed	loss of function	Kidney Renal Tract;Eye;Ear	2204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	acromesomelic chondrodysplasia hunter-thompson type	NA	NA	GDF5	601146	201250	biallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0000010	fanconi anemia	Recurrent urinary tract infections	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000027	fanconi anemia	Azoospermia	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000028	fanconi anemia	Cryptorchidism	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000035	fanconi anemia	Abnormality of the testis	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000047	fanconi anemia	Hypospadias	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000072	fanconi anemia	Hydroureter	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000079	fanconi anemia	Abnormality of the urinary system	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000130	fanconi anemia	Abnormality of the uterus	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000135	fanconi anemia	Hypogonadism	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000175	fanconi anemia	Cleft palate	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000218	fanconi anemia	High palate	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000238	fanconi anemia	Hydrocephalus	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000268	fanconi anemia	Dolichocephaly	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000316	fanconi anemia	Hypertelorism	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000324	fanconi anemia	Facial asymmetry	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000340	fanconi anemia	Sloping forehead	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000347	fanconi anemia	Micrognathia	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000364	fanconi anemia	Hearing abnormality	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000365	fanconi anemia	Hearing impairment	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000453	fanconi anemia	Choanal atresia	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000478	fanconi anemia	Abnormality of the eye	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000483	fanconi anemia	Astigmatism	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000486	fanconi anemia	Strabismus	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000492	fanconi anemia	Abnormality of the eyelid	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000083	fanconi anemia	Renal insufficiency	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000252	fanconi anemia	Microcephaly	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000286	fanconi anemia	Epicanthus	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000504	fanconi anemia	Abnormality of vision	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000505	fanconi anemia	Visual impairment	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000508	fanconi anemia	Ptosis	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000518	fanconi anemia	Cataract	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000520	fanconi anemia	Proptosis	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000568	fanconi anemia	Microphthalmia	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000582	fanconi anemia	Upslanted palpebral fissure	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000639	fanconi anemia	Nystagmus	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000813	fanconi anemia	Bicornuate uterus	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000864	fanconi anemia	Abnormality of the hypothalamus-pituitary axis	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001000	fanconi anemia	Abnormality of skin pigmentation	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001053	fanconi anemia	Hypopigmented skin patches	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001172	fanconi anemia	Abnormality of the thumb	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001199	fanconi anemia	Triphalangeal thumb	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001249	fanconi anemia	Intellectual disability	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001263	fanconi anemia	Global developmental delay	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001347	fanconi anemia	Hyperreflexia	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001392	fanconi anemia	Abnormality of the liver	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001510	fanconi anemia	Growth delay	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001511	fanconi anemia	Intrauterine growth retardation	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001537	fanconi anemia	Umbilical hernia	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001562	fanconi anemia	Oligohydramnios	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001631	fanconi anemia	Atrial septal defect	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001636	fanconi anemia	Tetralogy of Fallot	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001639	fanconi anemia	Hypertrophic cardiomyopathy	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001643	fanconi anemia	Patent ductus arteriosus	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001646	fanconi anemia	Abnormality of the aortic valve	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001671	fanconi anemia	Abnormality of the cardiac septa	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001679	fanconi anemia	Abnormality of the aorta	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001760	fanconi anemia	Abnormality of the foot	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001763	fanconi anemia	Pes planus	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001770	fanconi anemia	Toe syndactyly	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001824	fanconi anemia	Weight loss	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001871	fanconi anemia	Abnormality of blood and blood-forming tissues	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001873	fanconi anemia	Thrombocytopenia	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001882	fanconi anemia	Leukopenia	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0001903	fanconi anemia	Anemia	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002007	fanconi anemia	Frontal bossing	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002023	fanconi anemia	Anal atresia	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002119	fanconi anemia	Ventriculomegaly	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002245	fanconi anemia	Meckel diverticulum	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002251	fanconi anemia	Aganglionic megacolon	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002414	fanconi anemia	Spina bifida	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002575	fanconi anemia	Tracheoesophageal fistula	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002650	fanconi anemia	Scoliosis	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002664	fanconi anemia	Neoplasm	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002817	fanconi anemia	Abnormality of the upper limb	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002823	fanconi anemia	Abnormality of the femur	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002827	fanconi anemia	Hip dislocation	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002863	fanconi anemia	Myelodysplasia	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0002997	fanconi anemia	Abnormality of the ulna	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0003022	fanconi anemia	Hypoplasia of the ulna	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0003220	fanconi anemia	Abnormality of chromosome stability	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0004209	fanconi anemia	Clinodactyly of the 5th finger	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0004322	fanconi anemia	Short stature	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0004349	fanconi anemia	Reduced bone mineral density	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0005344	fanconi anemia	Abnormality of the carotid arteries	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0005522	fanconi anemia	Pyridoxine-responsive sideroblastic anemia	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0006101	fanconi anemia	Finger syndactyly	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0006265	fanconi anemia	Aplasia/Hypoplasia of fingers	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0006501	fanconi anemia	Aplasia/Hypoplasia of the radius	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0006824	fanconi anemia	Cranial nerve paralysis	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0007400	fanconi anemia	Irregular hyperpigmentation	Very frequent (99-80%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0007565	fanconi anemia	Multiple cafe-au-lait spots	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0007874	fanconi anemia	Almond-shaped palpebral fissure	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0008053	fanconi anemia	Aplasia/Hypoplasia of the iris	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0008572	fanconi anemia	External ear malformation	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0008678	fanconi anemia	Renal hypoplasia/aplasia	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0010293	fanconi anemia	Aplasia/Hypoplasia of the uvula	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0010469	fanconi anemia	Absent testis	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0012041	fanconi anemia	Decreased fertility in males	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0012210	fanconi anemia	Abnormal renal morphology	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0012639	fanconi anemia	Abnormality of nervous system morphology	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0012745	fanconi anemia	Short palpebral fissure	Frequent (79-30%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0100026	fanconi anemia	Arteriovenous malformation	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0100542	fanconi anemia	Abnormal localization of kidney	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0100587	fanconi anemia	Abnormality of the preputium	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0100760	fanconi anemia	Clubbing of toes	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0100867	fanconi anemia	Duodenal stenosis	Occasional (29-5%)	FANCL	608111	229154	biallelic	probable	loss of function	Bone Marrow/Immune;Skeleton;Cancer predisposition	20748	Fanconi anemia complementation group L	protein-coding gene	gene with protein product	Approved	2p16.1	02p16.1	FLJ10335|FAAP43|Pog		PHF9	PHD finger protein 9	PHD finger proteins|Fanconi anemia complementation groups
HP:0000670	shwachman-diamond syndrome	Carious teeth	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000691	shwachman-diamond syndrome	Microdontia	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000768	shwachman-diamond syndrome	Pectus carinatum	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000938	shwachman-diamond syndrome	Osteopenia	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	shwachman-diamond syndrome	Abnormality of the metaphyses	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000964	shwachman-diamond syndrome	Eczema	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	shwachman-diamond syndrome	Intellectual disability	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	shwachman-diamond syndrome	Global developmental delay	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	shwachman-diamond syndrome	Gait disturbance	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001290	shwachman-diamond syndrome	Generalized hypotonia	Very frequent (99-80%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001508	shwachman-diamond syndrome	Failure to thrive	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	shwachman-diamond syndrome	Growth delay	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001738	shwachman-diamond syndrome	Exocrine pancreatic insufficiency	Very frequent (99-80%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	shwachman-diamond syndrome	Thrombocytopenia	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001875	shwachman-diamond syndrome	Neutropenia	Very frequent (99-80%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001903	shwachman-diamond syndrome	Anemia	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001909	shwachman-diamond syndrome	Leukemia	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001915	shwachman-diamond syndrome	Aplastic anemia	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	shwachman-diamond syndrome	Malabsorption	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002240	shwachman-diamond syndrome	Hepatomegaly	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	shwachman-diamond syndrome	Scoliosis	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002719	shwachman-diamond syndrome	Recurrent infections	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	shwachman-diamond syndrome	Delayed skeletal maturation	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002863	shwachman-diamond syndrome	Myelodysplasia	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	shwachman-diamond syndrome	Short stature	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004808	shwachman-diamond syndrome	Acute myeloid leukemia	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005528	shwachman-diamond syndrome	Bone marrow hypocellularity	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008064	shwachman-diamond syndrome	Ichthyosis	Frequent (79-30%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010306	shwachman-diamond syndrome	Short thorax	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011107	shwachman-diamond syndrome	Recurrent aphthous stomatitis	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100651	shwachman-diamond syndrome	Type I diabetes mellitus	Occasional (29-5%)	SBDS	607444	607444	biallelic	confirmed	loss of function	Bone Marrow/Immune;Endocrine/Metabolic	19440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	bilateral diffuse polymicrogyria	NA	NA	RTTN	610436	614833	biallelic	probable	all missense/in frame	Brain/Cognition	18654	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	insulin-like growth factor i deficiency	NA	NA	IGF1	147440	608747	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear	5464	insulin like growth factor 1	protein-coding gene	gene with protein product	Approved	12q23.2	12q23.2	IGF1A|IGFI|IGF-I	somatomedin C		insulin-like growth factor 1 (somatomedin C)	Endogenous ligands
HP:0000175	metatropic dysplasia	Cleft palate	Occasional (29-5%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	metatropic dysplasia	Hydrocephalus	Occasional (29-5%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	metatropic dysplasia	High forehead	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	metatropic dysplasia	Low-set, posteriorly rotated ears	Occasional (29-5%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	metatropic dysplasia	Cataract	Occasional (29-5%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000772	metatropic dysplasia	Abnormality of the ribs	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000774	metatropic dysplasia	Narrow chest	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	metatropic dysplasia	Abnormality of the metaphyses	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001387	metatropic dysplasia	Joint stiffness	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	metatropic dysplasia	Scoliosis	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002652	metatropic dysplasia	Skeletal dysplasia	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002808	metatropic dysplasia	Kyphosis	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002826	metatropic dysplasia	Halberd-shaped pelvis	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	metatropic dysplasia	Micromelia	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003103	metatropic dysplasia	Abnormal cortical bone morphology	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	metatropic dysplasia	Abnormal form of the vertebral bodies	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003336	metatropic dysplasia	Abnormal enchondral ossification	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003510	metatropic dysplasia	Severe short stature	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004209	metatropic dysplasia	Clinodactyly of the 5th finger	Occasional (29-5%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005108	metatropic dysplasia	Abnormality of the intervertebral disk	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005280	metatropic dysplasia	Depressed nasal bridge	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006703	metatropic dysplasia	Aplasia/Hypoplasia of the lungs	Occasional (29-5%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008434	metatropic dysplasia	Hypoplastic cervical vertebrae	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100490	metatropic dysplasia	Camptodactyly of finger	Occasional (29-5%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100670	metatropic dysplasia	Rough bone trabeculation	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100818	metatropic dysplasia	Long thorax	Very frequent (99-80%)	TRPV4	605427	156530	monoallelic	confirmed	all missense/in frame	Skeleton	18083	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	fraser syndrome	Multicystic kidney dysplasia	Very frequent (99-80%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000028	fraser syndrome	Cryptorchidism	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000046	fraser syndrome	Scrotal hypoplasia	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000047	fraser syndrome	Hypospadias	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000062	fraser syndrome	Ambiguous genitalia	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000068	fraser syndrome	Urethral atresia	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000089	fraser syndrome	Renal hypoplasia	Very frequent (99-80%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000142	fraser syndrome	Abnormality of the vagina	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000148	fraser syndrome	Vaginal atresia	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000202	fraser syndrome	Oral cleft	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000204	fraser syndrome	Cleft upper lip	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000218	fraser syndrome	High palate	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000252	fraser syndrome	Microcephaly	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000316	fraser syndrome	Hypertelorism	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000368	fraser syndrome	Low-set, posteriorly rotated ears	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000370	fraser syndrome	Abnormality of the middle ear	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000405	fraser syndrome	Conductive hearing impairment	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000413	fraser syndrome	Atresia of the external auditory canal	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000430	fraser syndrome	Underdeveloped nasal alae	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000431	fraser syndrome	Wide nasal bridge	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000528	fraser syndrome	Anophthalmia	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000568	fraser syndrome	Microphthalmia	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000618	fraser syndrome	Blindness	Very frequent (99-80%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000678	fraser syndrome	Dental crowding	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000689	fraser syndrome	Dental malocclusion	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0000813	fraser syndrome	Bicornuate uterus	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0001126	fraser syndrome	Cryptophthalmos	Very frequent (99-80%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0001249	fraser syndrome	Intellectual disability	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0001362	fraser syndrome	Skull defect	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0001522	fraser syndrome	Death in infancy	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0001537	fraser syndrome	Umbilical hernia	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0001539	fraser syndrome	Omphalocele	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0001602	fraser syndrome	Laryngeal stenosis	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0001607	fraser syndrome	Subglottic stenosis	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0001770	fraser syndrome	Toe syndactyly	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0002023	fraser syndrome	Anal atresia	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0002025	fraser syndrome	Anal stenosis	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0002084	fraser syndrome	Encephalocele	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0002089	fraser syndrome	Pulmonary hypoplasia	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0002101	fraser syndrome	Abnormal lung lobation	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0002475	fraser syndrome	Myelomeningocele	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0002564	fraser syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0002777	fraser syndrome	Tracheal stenosis	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0003183	fraser syndrome	Wide pubic symphysis	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0003191	fraser syndrome	Cleft ala nasi	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0003422	fraser syndrome	Vertebral segmentation defect	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0004112	fraser syndrome	Midline nasal groove	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0004397	fraser syndrome	Ectopic anus	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0005280	fraser syndrome	Depressed nasal bridge	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0006101	fraser syndrome	Finger syndactyly	Very frequent (99-80%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0006610	fraser syndrome	Wide intermamillary distance	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0007925	fraser syndrome	Lacrimal duct aplasia	Very frequent (99-80%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0007993	fraser syndrome	Malformed lacrimal ducts	Very frequent (99-80%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0008572	fraser syndrome	External ear malformation	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0008736	fraser syndrome	Hypoplasia of penis	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0010297	fraser syndrome	Bifid tongue	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0010458	fraser syndrome	Female pseudohermaphroditism	Frequent (79-30%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
HP:0010720	fraser syndrome	Abnormal hair pattern	Occasional (29-5%)	FRAS1	607830	219000	biallelic	confirmed	loss of function	Skin;Eye;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19185	Fraser extracellular matrix complex subunit 1	protein-coding gene	gene with protein product	Approved	4q21.21	04q21.21	FLJ22031|FLJ14927|KIAA1500			Fraser syndrome 1	
NA	id, macrocephaly and cerebellar hypoplasia	NA	NA	SNX14	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	14977	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	familial infantile myofibromatosis	NA	NA	PDGFRB	173410	228550	monoallelic	confirmed	activating	Musculature;Skin;Skeleton	8804	platelet derived growth factor receptor beta	protein-coding gene	gene with protein product	Approved	5q32	05q32	JTK12|CD140b|PDGFR1		PDGFR	platelet-derived growth factor receptor, beta polypeptide	Receptor Tyrosine Kinases|CD molecules|I-set domain containing|Immunoglobulin like domain containing
HP:0000098	sotos syndrome	Tall stature	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	sotos syndrome	High palate	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000256	sotos syndrome	Macrocephaly	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000303	sotos syndrome	Mandibular prognathia	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	sotos syndrome	Hypertelorism	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000348	sotos syndrome	High forehead	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	sotos syndrome	Macrotia	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	sotos syndrome	Depressed nasal ridge	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	sotos syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	sotos syndrome	Intellectual disability	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	sotos syndrome	Muscular hypotonia	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	sotos syndrome	Global developmental delay	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	sotos syndrome	Frontal bossing	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005616	sotos syndrome	Accelerated skeletal maturation	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	sotos syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011220	sotos syndrome	Prominent forehead	Very frequent (99-80%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000268	sotos syndrome	Dolichocephaly	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000405	sotos syndrome	Conductive hearing impairment	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	sotos syndrome	Anteverted nares	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000826	sotos syndrome	Precocious puberty	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001513	sotos syndrome	Obesity	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001943	sotos syndrome	Hypoglycemia	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	sotos syndrome	Ventriculomegaly	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006288	sotos syndrome	Advanced eruption of teeth	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	sotos syndrome	Aplasia/Hypoplasia of the corpus callosum	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010978	sotos syndrome	Abnormality of immune system physiology	Frequent (79-30%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	sotos syndrome	Cryptorchidism	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000047	sotos syndrome	Hypospadias	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000069	sotos syndrome	Abnormality of the ureter	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000075	sotos syndrome	Renal duplication	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	sotos syndrome	Vesicoureteral reflux	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000280	sotos syndrome	Coarse facial features	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	sotos syndrome	Micrognathia	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	sotos syndrome	Strabismus	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000708	sotos syndrome	Behavioral abnormality	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001231	sotos syndrome	Abnormality of the fingernails	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	sotos syndrome	Seizures	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001347	sotos syndrome	Hyperreflexia	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	sotos syndrome	Craniosynostosis	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001374	sotos syndrome	Congenital hip dislocation	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001643	sotos syndrome	Patent ductus arteriosus	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001671	sotos syndrome	Abnormality of the cardiac septa	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002353	sotos syndrome	EEG abnormality	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	sotos syndrome	Scoliosis	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002664	sotos syndrome	Neoplasm	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002857	sotos syndrome	Genu valgum	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002970	sotos syndrome	Genu varum	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004375	sotos syndrome	Neoplasm of the nervous system	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005562	sotos syndrome	Multiple renal cysts	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030736	sotos syndrome	Sacrococcygeal teratoma	Occasional (29-5%)	NSD1	606681	117550	monoallelic	confirmed	loss of function	Face;Skeleton;Brain/Cognition	14234	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	progeroid syndrome	NA	NA	SPRTN	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Bone Marrow/Immune;Cancer predisposition	25356	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	duane-radial ray syndrome	NA	NA	SALL4	607343	173212	monoallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Eye	15924	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	f-box only protein 25	NA	NA	FBXO25	No gene mim	609098	monoallelic	possible	uncertain	Brain/Cognition	13596	F-box protein 25	protein-coding gene	gene with protein product	Approved	8p23.3	08p23.3	FBX25			F-box only protein 25	F-boxes other
NA	acrocephalosyndactyly type v	NA	NA	FGFR2	176943	101600	monoallelic	confirmed	activating	Face;Skeleton	3689	fibroblast growth factor receptor 2	protein-coding gene	gene with protein product	Approved	10q26.13	10q26.13	CEK3|TK14|TK25|ECT1|K-SAM|CD332	Crouzon syndrome|Pfeiffer syndrome	KGFR|BEK|CFD1|JWS	bacteria-expressed kinase|keratinocyte growth factor receptor|craniofacial dysostosis 1|Jackson-Weiss syndrome	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	arginine:glycine amidinotransferase deficiency	NA	NA	GATM	602360	612718	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	4175	glycine amidinotransferase	protein-coding gene	gene with protein product	Approved	15q21.1	15q21.1	AGAT	L-arginine:glycine amidinotransferase			
NA	xia-gibbs syndrome	NA	NA	AHDC1	No gene mim	615829	monoallelic	confirmed	loss of function	Brain/Cognition	25230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital disorder of glycosylation, type ir	NA	NA	DDOST	602202	614507	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2728	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	arterial calcification, generalized, of infancy, 1	NA	NA	ENPP1	173335	208000	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	3356	ectonucleotide pyrophosphatase/phosphodiesterase 1	protein-coding gene	gene with protein product	Approved	6q23.2	06q23.2	PC-1|PCA1		NPPS|M6S1|PDNP1		
NA	warburg micro syndrome type 3	NA	NA	RAB18	602207	614222	biallelic	confirmed	loss of function	Brain/Cognition;Eye;Genitalia	14244	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atypical dominant fanconi syndrome with mody	NA	NA	HNF4A	No gene mim	315353	monoallelic	confirmed	uncertain	Kidney Renal Tract;Endocrine/Metabolic	5024	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leigh syndrome dup	NA	NA	NDUFS4	602694	256000	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	multiple pterygium syndrome lethal type	NA	NA	CHRNA1	No gene mim	253290	biallelic	probable	loss of function	Musculature;Spinal cord/Peripheral nerves	1955	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	aniridia cerebellar ataxia and mental deficiency	NA	NA	PAX6	607108	206700	monoallelic	confirmed	loss of function	Brain/Cognition;Eye	8620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microphthalmia isolated type 5	NA	NA	MFRP	606227	611040	biallelic	confirmed	loss of function	Eye	18121	membrane frizzled-related protein	protein-coding gene	gene with protein product	Approved	11q23.3	11q23.3	FLJ30570|rd6|NNO2|C1QTNF5	membrane-type frizzled-related protein|C1q and TNF related 5			
NA	chondrocalcinosis 2	NA	NA	ANKH	605145	118600	monoallelic	confirmed	all missense/in frame	Skeleton;Brain/Cognition;Ear	15492	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy early infantile type 2	NA	NA	CDKL5	300203	300672	x-linked dominant	confirmed	loss of function	Brain/Cognition	11411	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy, early infantile, 26	NA	NA	KCNB1	No gene mim	616056	monoallelic	confirmed	all missense/in frame	Brain/Cognition	6231	potassium voltage-gated channel subfamily B member 1	protein-coding gene	gene with protein product	Approved	20q13.13	20q13.13	Kv2.1			potassium voltage-gated channel, Shab-related subfamily, member 1	Potassium voltage-gated channels
NA	atypical krabbe disease	NA	NA	PSAP	176801	611722	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	9498	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glycosylation disorder characterized by intellectual disability and autonomic dysfunction	NA	NA	GMPPA	No gene mim	No disease mim	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	22923	GDP-mannose pyrophosphorylase A	protein-coding gene	gene with protein product	Approved	2q35	02q35					
NA	infantile epileptic encephalopathy	NA	NA	EEF1A2	No gene mim	No disease mim	monoallelic	probable	activating	Brain/Cognition	3192	eukaryotic translation elongation factor 1 alpha 2	protein-coding gene	gene with protein product	Approved	20q13.33	20q13.33	EEF1AL|HS1		STNL|STN	statin-like|statin	
NA	neuronal ceroid lipofuscinosis type 2	NA	NA	TPP1	607998	204500	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2073	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal dominant oculodentodigital dysplasia	NA	NA	GJA1	121014	164200	monoallelic	confirmed	uncertain	Teeth & Dentitian;Skeleton;Eye	4274	gap junction protein alpha 1	protein-coding gene	gene with protein product	Approved	6q22.31	06q22.31	CX43|ODD|ODOD|SDTY3	oculodentodigital dysplasia (syndactyly type III)|connexin 43	ODDD|GJAL	gap junction protein, alpha-like|gap junction protein, alpha 1, 43kDa (connexin 43)|gap junction protein, alpha 1, 43kDa	Gap junction proteins
NA	arthrogryposis, distal, type 3	NA	NA	PIEZO2	No gene mim	114300	monoallelic	confirmed	loss of function	Musculature;Eye;Respiratory tract	26270	piezo type mechanosensitive ion channel component 2	protein-coding gene	gene with protein product	Approved	18p11.22-p11.21	18p11.22-p11.21	FLJ23403|FLJ23144|HsT748|HsT771|FLJ34907		FAM38B2|C18orf30|C18orf58|FAM38B	chromosome 18 open reading frame 30|chromosome 18 open reading frame 58|family with sequence similarity 38, member B|piezo-type mechanosensitive ion channel component 2	
NA	primrose syndrome	NA	NA	ZBTB20	No gene mim	259050	monoallelic	confirmed	dominant negative	Brain/Cognition	13503	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mrx with/without nystagmus	NA	NA	CASK	300172	300749	hemizygous	confirmed	all missense/in frame	Face;Brain/Cognition;GI tract	1497	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	meckel syndrome type 4	NA	NA	CEP290	610142	611134	biallelic	confirmed	loss of function	Kidney Renal Tract;Brain/Cognition	29021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	polymicrogyria and corpus callosum agenesis	NA	NA	EOMES	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	3372	eomesodermin	protein-coding gene	gene with protein product	Approved	3p24.1	03p24.1	TBR2	T-box brain2		eomesodermin (Xenopus laevis) homolog	T-boxes
NA	arthrogryposis, renal dysfunction, and cholestasis 2	NA	NA	VIPAS39	613401	613404	biallelic	confirmed	loss of function	Kidney Renal Tract;Skeleton;Spinal cord/Peripheral nerves;GI tract	20347	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	wolfram syndrome type 2	NA	NA	CISD2	No gene mim	604928	biallelic	both DD and IF	loss of function	Endocrine/Metabolic;Brain/Cognition;GI tract;Ear	24212	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spermatogenic failure 8	NA	NA	NR5A1	No gene mim	613957	monoallelic	both DD and IF	all missense/in frame	Genitalia	7983	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy, early infantile, 13	NA	NA	SCN8A	600702	614558	monoallelic	confirmed	dominant negative	Brain/Cognition	10596	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	warsaw breakage syndrome	NA	NA	DDX11	601150	613398	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Brain/Cognition	2736	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pontocerebellar hypoplasia type 2 and type 4	NA	NA	TSEN54	608755	316970	biallelic	confirmed	loss of function	Brain/Cognition	27561	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000003	genitopatellar syndrome	Multicystic kidney dysplasia	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000028	genitopatellar syndrome	Cryptorchidism	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000046	genitopatellar syndrome	Scrotal hypoplasia	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000126	genitopatellar syndrome	Hydronephrosis	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000252	genitopatellar syndrome	Microcephaly	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000280	genitopatellar syndrome	Coarse facial features	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000316	genitopatellar syndrome	Hypertelorism	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000343	genitopatellar syndrome	Long philtrum	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000347	genitopatellar syndrome	Micrognathia	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000365	genitopatellar syndrome	Hearing impairment	Occasional (29-5%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000369	genitopatellar syndrome	Low-set ears	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000426	genitopatellar syndrome	Prominent nasal bridge	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000445	genitopatellar syndrome	Wide nose	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000448	genitopatellar syndrome	Prominent nose	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000684	genitopatellar syndrome	Delayed eruption of teeth	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000750	genitopatellar syndrome	Delayed speech and language development	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0000946	genitopatellar syndrome	Hypoplastic ilia	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0001249	genitopatellar syndrome	Intellectual disability	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0001250	genitopatellar syndrome	Seizures	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0001263	genitopatellar syndrome	Global developmental delay	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0001274	genitopatellar syndrome	Agenesis of corpus callosum	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0001631	genitopatellar syndrome	Atrial septal defect	Occasional (29-5%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0001762	genitopatellar syndrome	Talipes equinovarus	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0002020	genitopatellar syndrome	Gastroesophageal reflux	Occasional (29-5%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0002089	genitopatellar syndrome	Pulmonary hypoplasia	Occasional (29-5%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0002104	genitopatellar syndrome	Apnea	Occasional (29-5%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0002209	genitopatellar syndrome	Sparse scalp hair	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0002213	genitopatellar syndrome	Fine hair	Frequent (79-30%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0002804	genitopatellar syndrome	Arthrogryposis multiplex congenita	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0002974	genitopatellar syndrome	Radioulnar synostosis	Occasional (29-5%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0003175	genitopatellar syndrome	Hypoplastic ischia	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0003273	genitopatellar syndrome	Hip contracture	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0004279	genitopatellar syndrome	Short palm	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0004322	genitopatellar syndrome	Short stature	Occasional (29-5%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0006380	genitopatellar syndrome	Knee flexion contracture	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0006443	genitopatellar syndrome	Patellar aplasia	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0008665	genitopatellar syndrome	Clitoral hypertrophy	Very frequent (99-80%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
HP:0011968	genitopatellar syndrome	Feeding difficulties	Occasional (29-5%)	KAT6B	605880	606170	monoallelic	confirmed	dominant negative	Skeleton;Brain/Cognition;Genitalia	17582	lysine acetyltransferase 6B	protein-coding gene	gene with protein product	Approved	10q22.2	10q22.2	querkopf|qkf|Morf|MOZ2|ZC2HC6B	MOZ-related factor	MYST4	MYST histone acetyltransferase (monocytic leukemia) 4|K(lysine) acetyltransferase 6B	Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases
NA	mitochondrial complex i deficiency	NA	NA	FOXRED1	613622	252010	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	26927	FAD dependent oxidoreductase domain containing 1	protein-coding gene	gene with protein product	Approved	11q24.2	11q24.2	H17				Mitochondrial respiratory chain complex assembly factors
NA	bart-pumphrey syndrome	NA	NA	GJB2	121011	149200	monoallelic	confirmed	all missense/in frame	Skin;Ear	4284	gap junction protein beta 2	protein-coding gene	gene with protein product	Approved	13q12.11	13q12.11	CX26|NSRD1	connexin 26	DFNB1|DFNA3	gap junction protein, beta 2, 26kD (connexin 26)|gap junction protein, beta 2, 26kDa (connexin 26)|gap junction protein, beta 2, 26kDa	Gap junction proteins|Deafness associated genes
NA	acrofacial dysostosis, cincinnati type	NA	NA	POLR1A	No gene mim	No disease mim	monoallelic	probable	loss of function	Face;Skeleton	17264	RNA polymerase I subunit A	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	DKFZP586M0122|FLJ21915|RPO1-4|RPA1			polymerase (RNA) I polypeptide A, 194kDa	RNA polymerase subunits
NA	mucopolysaccharidosis type 4a	NA	NA	GALNS	No gene mim	253000	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition	4122	galactosamine (N-acetyl)-6-sulfatase	protein-coding gene	gene with protein product	Approved	16q24.3	16q24.3	GAS|GALNAC6S	Morquio syndrome|mucopolysaccharidosis type IVA		galactosamine (N-acetyl)-6-sulfate sulfatase	Sulfatases
NA	cobalamin disorder	NA	NA	HCFC1	300019	No disease mim	hemizygous	confirmed	loss of function	Brain/Cognition	4839	host cell factor C1	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	HCF-1|HCF1|CFF|VCAF|MGC70925|PPP1R89	VP16-accessory protein|protein phosphatase 1, regulatory subunit 89	HFC1|MRX3	mental retardation, X-linked 3|host cell factor C1 (VP16-accessory protein)	X-linked mental retardation|Protein phosphatase 1 regulatory subunits|ATAC complex|NSL histone acetyltransferase complex
NA	cog8-cdg	NA	NA	COG8	606979	300204	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	18623	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cataract, congenital, cerulean type, 2	NA	NA	CRYBB2	123620	601547	monoallelic	confirmed	uncertain	Eye	2398	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehlers-danlos syndrome, kyphoscoliotic form	NA	NA	PLOD1	153454	225400	biallelic	confirmed	loss of function	Skin;Skeleton	9081	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primordial dwarfism	NA	NA	POC1A	614783	615272	biallelic	confirmed	loss of function	Skeleton	24488	POC1 centriolar protein A	protein-coding gene	gene with protein product	Approved	3p21.2	03p21.2	DKFZP434C245		WDR51A	WD repeat domain 51A|POC1 centriolar protein homolog A (Chlamydomonas)	WD repeat domain containing
NA	mitochondrial respiratory chain complex iii deficiency, uqcrb-related	NA	NA	UQCRB	191330	257827	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	12582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neuronal ceroid lipofuscinosis type 8 northern epilepsy variant	NA	NA	CLN8	607837	610003	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	2079	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autism	NA	NA	SHANK1	No gene mim	209850	monoallelic	probable	loss of function	Brain/Cognition	15474	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000750	duchenne muscular dystrophy	Delayed speech and language development	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	duchenne muscular dystrophy	Global developmental delay	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001270	duchenne muscular dystrophy	Motor delay	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001328	duchenne muscular dystrophy	Specific learning disability	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001371	duchenne muscular dystrophy	Flexion contracture	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001638	duchenne muscular dystrophy	Cardiomyopathy	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	duchenne muscular dystrophy	Respiratory insufficiency	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002515	duchenne muscular dystrophy	Waddling gait	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	duchenne muscular dystrophy	Scoliosis	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	duchenne muscular dystrophy	Skeletal muscle atrophy	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003236	duchenne muscular dystrophy	Elevated serum creatine phosphokinase	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003323	duchenne muscular dystrophy	Progressive muscle weakness	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003701	duchenne muscular dystrophy	Proximal muscle weakness	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008981	duchenne muscular dystrophy	Calf muscle hypertrophy	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	duchenne muscular dystrophy	Cognitive impairment	Very frequent (99-80%)	DMD	300377	310200	hemizygous	confirmed	loss of function	Musculature;Brain/Cognition	2928	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ciliary dyskinesia, primary, 5	NA	NA	HYDIN	610812	608647	biallelic	confirmed	loss of function	GI tract;Respiratory tract;Heart/Cardiovasculature/Lymphatic	19368	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mohr-tranebjaerg syndrome	NA	NA	TIMM8A	No gene mim	304700	hemizygous	both DD and IF	loss of function	Musculature;Brain/Cognition;Ear	11817	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mohr-majewski syndrome	NA	NA	TCTN3	613847	258860	biallelic	confirmed	loss of function	Skeleton	24519	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	spondyloepimetaphyseal dysplasia with joint laxity, type 2	NA	NA	KIF22	603213	603546	monoallelic	confirmed	activating	Skeleton	6391	kinesin family member 22	protein-coding gene	gene with protein product	Approved	16p11.2	16p11.2	Kid|OBP-1|OBP-2		KNSL4	kinesin-like 4	Kinesins
NA	mitochondrial respiratory chain complex i deficiency	NA	NA	NDUFA1	300078	252010	hemizygous	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	7683	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	nephronophthisis 7	NA	NA	GLIS2	608539	611498	biallelic	probable	loss of function	Kidney Renal Tract	29450	GLIS family zinc finger 2	protein-coding gene	gene with protein product	Approved	16p13.3	16p13.3	NPHP7	nephrocystin-7			Zinc fingers C2H2-type
HP:0000023	bohring-opitz syndrome	Inguinal hernia	Occasional (29-5%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000077	bohring-opitz syndrome	Abnormality of the kidney	Occasional (29-5%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000175	bohring-opitz syndrome	Cleft palate	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000191	bohring-opitz syndrome	Accessory oral frenulum	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000204	bohring-opitz syndrome	Cleft upper lip	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000243	bohring-opitz syndrome	Trigonocephaly	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000252	bohring-opitz syndrome	Microcephaly	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000278	bohring-opitz syndrome	Retrognathia	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000293	bohring-opitz syndrome	Full cheeks	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000294	bohring-opitz syndrome	Low anterior hairline	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000316	bohring-opitz syndrome	Hypertelorism	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000365	bohring-opitz syndrome	Hearing impairment	Occasional (29-5%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000369	bohring-opitz syndrome	Low-set ears	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000431	bohring-opitz syndrome	Wide nasal bridge	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000444	bohring-opitz syndrome	Convex nasal ridge	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000486	bohring-opitz syndrome	Strabismus	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000488	bohring-opitz syndrome	Retinopathy	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000520	bohring-opitz syndrome	Proptosis	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000545	bohring-opitz syndrome	Myopia	Occasional (29-5%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000582	bohring-opitz syndrome	Upslanted palpebral fissure	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000593	bohring-opitz syndrome	Abnormality of the anterior chamber	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000664	bohring-opitz syndrome	Synophrys	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000774	bohring-opitz syndrome	Narrow chest	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000926	bohring-opitz syndrome	Platyspondyly	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0000998	bohring-opitz syndrome	Hypertrichosis	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001250	bohring-opitz syndrome	Seizures	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001263	bohring-opitz syndrome	Global developmental delay	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001305	bohring-opitz syndrome	Dandy-Walker malformation	Occasional (29-5%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001376	bohring-opitz syndrome	Limitation of joint mobility	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001508	bohring-opitz syndrome	Failure to thrive	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001511	bohring-opitz syndrome	Intrauterine growth retardation	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001522	bohring-opitz syndrome	Death in infancy	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001561	bohring-opitz syndrome	Polyhydramnios	Occasional (29-5%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001732	bohring-opitz syndrome	Abnormality of the pancreas	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001773	bohring-opitz syndrome	Short foot	Occasional (29-5%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0001883	bohring-opitz syndrome	Talipes	Occasional (29-5%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0002020	bohring-opitz syndrome	Gastroesophageal reflux	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0002079	bohring-opitz syndrome	Hypoplasia of the corpus callosum	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0002119	bohring-opitz syndrome	Ventriculomegaly	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0002120	bohring-opitz syndrome	Cerebral cortical atrophy	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0002558	bohring-opitz syndrome	Supernumerary nipple	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0002564	bohring-opitz syndrome	Malformation of the heart and great vessels	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0002566	bohring-opitz syndrome	Intestinal malrotation	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0003042	bohring-opitz syndrome	Elbow dislocation	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0004422	bohring-opitz syndrome	Biparietal narrowing	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0005487	bohring-opitz syndrome	Prominent metopic ridge	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0006610	bohring-opitz syndrome	Wide intermamillary distance	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0007413	bohring-opitz syndrome	Nevus flammeus of the forehead	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0009465	bohring-opitz syndrome	Ulnar deviation of finger	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0009891	bohring-opitz syndrome	Underdeveloped supraorbital ridges	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0010306	bohring-opitz syndrome	Short thorax	Frequent (79-30%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0010864	bohring-opitz syndrome	Intellectual disability, severe	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0011968	bohring-opitz syndrome	Feeding difficulties	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0100490	bohring-opitz syndrome	Camptodactyly of finger	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
HP:0100874	bohring-opitz syndrome	Thick hair	Very frequent (99-80%)	ASXL1	612990	605039	monoallelic	confirmed	loss of function	Face;Brain/Cognition	18318	additional sex combs like 1, transcriptional regulator	protein-coding gene	gene with protein product	Approved	20q11.21	20q11.21	KIAA0978			additional sex combs like 1 (Drosophila)	
NA	autism	NA	NA	TBR1	No gene mim	209850	monoallelic	probable	loss of function	Brain/Cognition	11590	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neuronal ceroid lipofuscinosis type 5	NA	NA	CLN5	608102	256731	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition;Eye	2076	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe id with neuronal migration disorder	NA	NA	DYNC1H1	No gene mim	600112	monoallelic	confirmed	all missense/in frame	Brain/Cognition	2961	dynein cytoplasmic 1 heavy chain 1	protein-coding gene	gene with protein product	Approved	14q32.31	14q32.31	Dnchc1|HL-3|p22|DHC1|CMT2O		DNECL|DNCL|DNCH1	dynein, cytoplasmic, heavy polypeptide 1	Dyneins, cytoplasmic
NA	melorheostosis	NA	NA	LEMD3	607844	155950	monoallelic	confirmed	loss of function	Skeleton	28887	LEM domain containing 3	protein-coding gene	gene with protein product	Approved	12q14.3	12q14.3	MAN1				LEM domain containing
NA	lissencephaly x-linked type 1	NA	NA	DCX	300121	300067	hemizygous	confirmed	loss of function	Brain/Cognition	2714	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	adams oliver syndrome	NA	NA	NOTCH1	190198	No disease mim	monoallelic	probable	loss of function	Heart/Cardiovasculature/Lymphatic	7881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rubinstein-taybi syndrome type 1	NA	NA	CREBBP	600140	180849	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	2348	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	simpson-golabi-behmel syndrome, type 1	NA	NA	GPC3	300037	312870	hemizygous	confirmed	loss of function	Face;Skeleton;Heart/Cardiovasculature/Lymphatic	4451	glypican 3	protein-coding gene	gene with protein product	Approved	Xq26.2	Xq26.2	OCI-5|SGBS|SGBS1|SGB|DGSX	glypican proteoglycan 3	SDYS		Glypicans
NA	noonan-like syndrome with loose anagen hair	NA	NA	SHOC2	602775	607721	monoallelic	confirmed	activating	Skin;Skeleton;Multisystem	15454	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehlers-danlos syndrome-like spondylocheirodysplasia	NA	NA	SLC39A13	608735	612350	biallelic	confirmed	all missense/in frame	Skin;Skeleton	20859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	heterotaxy syndrome	NA	NA	ZIC3	300265	207574	hemizygous	confirmed	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	12874	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	tuberous sclerosis type 2	NA	NA	TSC2	191092	613254	monoallelic	confirmed	loss of function	Skin;Kidney Renal Tract;Brain/Cognition	12363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000124	wolcott-rallison syndrome	Renal tubular dysfunction	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000233	wolcott-rallison syndrome	Thin vermilion border	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000286	wolcott-rallison syndrome	Epicanthus	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000325	wolcott-rallison syndrome	Triangular face	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000348	wolcott-rallison syndrome	High forehead	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000540	wolcott-rallison syndrome	Hypermetropia	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000691	wolcott-rallison syndrome	Microdontia	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000938	wolcott-rallison syndrome	Osteopenia	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000939	wolcott-rallison syndrome	Osteoporosis	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000944	wolcott-rallison syndrome	Abnormality of the metaphyses	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001522	wolcott-rallison syndrome	Death in infancy	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001824	wolcott-rallison syndrome	Weight loss	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001944	wolcott-rallison syndrome	Dehydration	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002149	wolcott-rallison syndrome	Hyperuricemia	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002570	wolcott-rallison syndrome	Steatorrhea	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002654	wolcott-rallison syndrome	Multiple epiphyseal dysplasia	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002656	wolcott-rallison syndrome	Epiphyseal dysplasia	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0003074	wolcott-rallison syndrome	Hyperglycemia	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0003076	wolcott-rallison syndrome	Glycosuria	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0004322	wolcott-rallison syndrome	Short stature	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0005930	wolcott-rallison syndrome	Abnormality of epiphysis morphology	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0008255	wolcott-rallison syndrome	Transient neonatal diabetes mellitus	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0010230	wolcott-rallison syndrome	Cone-shaped epiphyses of the phalanges of the hand	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0012090	wolcott-rallison syndrome	Abnormality of pancreas morphology	Very frequent (99-80%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000926	wolcott-rallison syndrome	Platyspondyly	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001156	wolcott-rallison syndrome	Brachydactyly syndrome	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001249	wolcott-rallison syndrome	Intellectual disability	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001252	wolcott-rallison syndrome	Muscular hypotonia	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001270	wolcott-rallison syndrome	Motor delay	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001288	wolcott-rallison syndrome	Gait disturbance	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001627	wolcott-rallison syndrome	Abnormal heart morphology	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001875	wolcott-rallison syndrome	Neutropenia	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001993	wolcott-rallison syndrome	Ketoacidosis	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002240	wolcott-rallison syndrome	Hepatomegaly	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002673	wolcott-rallison syndrome	Coxa valga	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002750	wolcott-rallison syndrome	Delayed skeletal maturation	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002827	wolcott-rallison syndrome	Hip dislocation	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002857	wolcott-rallison syndrome	Genu valgum	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002868	wolcott-rallison syndrome	Narrow iliac wings	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002910	wolcott-rallison syndrome	Elevated hepatic transaminases	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0006554	wolcott-rallison syndrome	Acute hepatic failure	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0007229	wolcott-rallison syndrome	Intracerebral periventricular calcifications	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0010306	wolcott-rallison syndrome	Short thorax	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0012758	wolcott-rallison syndrome	Neurodevelopmental delay	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0100625	wolcott-rallison syndrome	Enlarged thorax	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0100626	wolcott-rallison syndrome	Chronic hepatic failure	Frequent (79-30%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000083	wolcott-rallison syndrome	Renal insufficiency	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000112	wolcott-rallison syndrome	Nephropathy	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000252	wolcott-rallison syndrome	Microcephaly	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000821	wolcott-rallison syndrome	Hypothyroidism	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0000952	wolcott-rallison syndrome	Jaundice	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001250	wolcott-rallison syndrome	Seizures	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001511	wolcott-rallison syndrome	Intrauterine growth retardation	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001738	wolcott-rallison syndrome	Exocrine pancreatic insufficiency	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001943	wolcott-rallison syndrome	Hypoglycemia	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002269	wolcott-rallison syndrome	Abnormality of neuronal migration	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002594	wolcott-rallison syndrome	Pancreatic hypoplasia	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002757	wolcott-rallison syndrome	Recurrent fractures	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0002808	wolcott-rallison syndrome	Kyphosis	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0003307	wolcott-rallison syndrome	Hyperlordosis	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0006274	wolcott-rallison syndrome	Reduced pancreatic beta cells	Occasional (29-5%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
HP:0001259	wolcott-rallison syndrome	Coma	Very rare (<4-1%)	EIF2AK3	604032	226980	biallelic	confirmed	loss of function	Skeleton;Endocrine/Metabolic;Brain/Cognition;GI tract	3255	eukaryotic translation initiation factor 2 alpha kinase 3	protein-coding gene	gene with protein product	Approved	2p11.2	02p11.2	PEK|PERK				
NA	baraitser-winter syndrome	NA	NA	ACTG1	102560	No disease mim	monoallelic	confirmed	all missense/in frame	Brain/Cognition;Eye	144	actin gamma 1	protein-coding gene	gene with protein product	Approved	17q25.3	17q25.3			ACTG|DFNA20|DFNA26	deafness, autosomal dominant 20|deafness, autosomal dominant 26	Actins|Deafness associated genes
NA	ceroid lipofuscinosis, neuronal, kufs type, adult onset	NA	NA	CLN6	No gene mim	204300	biallelic	both DD and IF	all missense/in frame	Brain/Cognition	2077	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001773	brachydactyly type a2	Short foot	Frequent (79-30%)	GDF5	601146	112600	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0004209	brachydactyly type a2	Clinodactyly of the 5th finger	Frequent (79-30%)	GDF5	601146	112600	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0004220	brachydactyly type a2	Short middle phalanx of the 5th finger	Occasional (29-5%)	GDF5	601146	112600	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0005819	brachydactyly type a2	Short middle phalanx of finger	Occasional (29-5%)	GDF5	601146	112600	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0009372	brachydactyly type a2	Type A2 brachydactyly	Very frequent (99-80%)	GDF5	601146	112600	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0009568	brachydactyly type a2	Aplasia/Hypoplasia of the middle phalanx of the 2nd finger	Occasional (29-5%)	GDF5	601146	112600	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0010038	brachydactyly type a2	Short 2nd metacarpal	Occasional (29-5%)	GDF5	601146	112600	monoallelic	confirmed	uncertain	Skeleton	4220	growth differentiation factor 5	protein-coding gene	gene with protein product	Approved	20q11.22	20q11.22	CDMP1|BMP14	cartilage-derived morphogenetic protein-1			
HP:0000069	baller-gerold syndrome	Abnormality of the ureter	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000076	baller-gerold syndrome	Vesicoureteral reflux	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000126	baller-gerold syndrome	Hydronephrosis	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000160	baller-gerold syndrome	Narrow mouth	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	baller-gerold syndrome	Cleft palate	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000218	baller-gerold syndrome	High palate	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000239	baller-gerold syndrome	Large fontanelles	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000244	baller-gerold syndrome	Brachyturricephaly	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000248	baller-gerold syndrome	Brachycephaly	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000275	baller-gerold syndrome	Narrow face	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000286	baller-gerold syndrome	Epicanthus	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	baller-gerold syndrome	Hypertelorism	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000337	baller-gerold syndrome	Broad forehead	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	baller-gerold syndrome	Micrognathia	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000405	baller-gerold syndrome	Conductive hearing impairment	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	baller-gerold syndrome	Prominent nasal bridge	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000446	baller-gerold syndrome	Narrow nasal bridge	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	baller-gerold syndrome	Proptosis	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000601	baller-gerold syndrome	Hypotelorism	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	baller-gerold syndrome	Nystagmus	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001029	baller-gerold syndrome	Poikiloderma	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001163	baller-gerold syndrome	Abnormality of the metacarpal bones	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001180	baller-gerold syndrome	Oligodactyly (hands)	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001191	baller-gerold syndrome	Abnormality of the carpal bones	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	baller-gerold syndrome	Growth delay	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	baller-gerold syndrome	Intrauterine growth retardation	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001531	baller-gerold syndrome	Failure to thrive in infancy	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001545	baller-gerold syndrome	Anteriorly placed anus	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001671	baller-gerold syndrome	Abnormality of the cardiac septa	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	baller-gerold syndrome	Frontal bossing	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002023	baller-gerold syndrome	Anal atresia	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002024	baller-gerold syndrome	Malabsorption	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	baller-gerold syndrome	Scoliosis	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002665	baller-gerold syndrome	Lymphoma	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002669	baller-gerold syndrome	Osteosarcoma	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	baller-gerold syndrome	Short nose	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	baller-gerold syndrome	Short stature	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006487	baller-gerold syndrome	Bowing of the long bones	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006498	baller-gerold syndrome	Aplasia/Hypoplasia of the patella	Frequent (79-30%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006501	baller-gerold syndrome	Aplasia/Hypoplasia of the radius	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009601	baller-gerold syndrome	Aplasia/Hypoplasia of the thumb	Very frequent (99-80%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100542	baller-gerold syndrome	Abnormal localization of kidney	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100589	baller-gerold syndrome	Urogenital fistula	Occasional (29-5%)	RECQL4	603780	218600	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Eye	9949	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	combined oxidative phosphorylation deficiency 6	NA	NA	AIFM1	300169	319521	hemizygous	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	8768	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	phenylketonuria	Malformation of the heart and great vessels	Occasional (29-5%)	PAH	612349	261600	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	8582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003355	phenylketonuria	Aminoaciduria	Very frequent (99-80%)	PAH	612349	261600	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	8582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0010864	phenylketonuria	Intellectual disability, severe	Frequent (79-30%)	PAH	612349	261600	biallelic	confirmed	loss of function	Skin;Endocrine/Metabolic;Brain/Cognition	8582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000252	neu-laxova syndrome	Microcephaly	Very frequent (99-80%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000340	neu-laxova syndrome	Sloping forehead	Very frequent (99-80%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001511	neu-laxova syndrome	Intrauterine growth retardation	Very frequent (99-80%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008064	neu-laxova syndrome	Ichthyosis	Very frequent (99-80%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012471	neu-laxova syndrome	Thick vermilion border	Very frequent (99-80%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012639	neu-laxova syndrome	Abnormality of nervous system morphology	Very frequent (99-80%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100679	neu-laxova syndrome	Lack of skin elasticity	Very frequent (99-80%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000062	neu-laxova syndrome	Ambiguous genitalia	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000135	neu-laxova syndrome	Hypogonadism	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000153	neu-laxova syndrome	Abnormality of the mouth	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000211	neu-laxova syndrome	Trismus	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000232	neu-laxova syndrome	Everted lower lip vermilion	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000288	neu-laxova syndrome	Abnormality of the philtrum	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	neu-laxova syndrome	Hypertelorism	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000400	neu-laxova syndrome	Macrotia	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000457	neu-laxova syndrome	Depressed nasal ridge	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	neu-laxova syndrome	Proptosis	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000951	neu-laxova syndrome	Abnormality of the skin	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001176	neu-laxova syndrome	Large hands	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001302	neu-laxova syndrome	Pachygyria	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001305	neu-laxova syndrome	Dandy-Walker malformation	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001321	neu-laxova syndrome	Cerebellar hypoplasia	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001331	neu-laxova syndrome	Absent septum pellucidum	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001339	neu-laxova syndrome	Lissencephaly	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001371	neu-laxova syndrome	Flexion contracture	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001460	neu-laxova syndrome	Aplasia/Hypoplasia involving the skeletal musculature	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001558	neu-laxova syndrome	Decreased fetal movement	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001561	neu-laxova syndrome	Polyhydramnios	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001769	neu-laxova syndrome	Broad foot	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002126	neu-laxova syndrome	Polymicrogyria	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002179	neu-laxova syndrome	Opisthotonus	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	neu-laxova syndrome	Abnormality of neuronal migration	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002334	neu-laxova syndrome	Abnormality of the cerebellar vermis	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002536	neu-laxova syndrome	Abnormal cortical gyration	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003202	neu-laxova syndrome	Skeletal muscle atrophy	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003241	neu-laxova syndrome	External genital hypoplasia	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003394	neu-laxova syndrome	Muscle cramps	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003560	neu-laxova syndrome	Muscular dystrophy	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007227	neu-laxova syndrome	Macrogyria	Frequent (79-30%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	neu-laxova syndrome	Cleft palate	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000176	neu-laxova syndrome	Submucous cleft hard palate	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000193	neu-laxova syndrome	Bifid uvula	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000269	neu-laxova syndrome	Prominent occiput	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000278	neu-laxova syndrome	Retrognathia	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000347	neu-laxova syndrome	Micrognathia	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000492	neu-laxova syndrome	Abnormality of the eyelid	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000499	neu-laxova syndrome	Abnormality of the eyelashes	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000518	neu-laxova syndrome	Cataract	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000614	neu-laxova syndrome	Abnormality of the nasolacrimal system	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000938	neu-laxova syndrome	Osteopenia	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000939	neu-laxova syndrome	Osteoporosis	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001059	neu-laxova syndrome	Pterygium	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001595	neu-laxova syndrome	Abnormality of the hair	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002089	neu-laxova syndrome	Pulmonary hypoplasia	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	neu-laxova syndrome	Ventriculomegaly	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002414	neu-laxova syndrome	Spina bifida	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002514	neu-laxova syndrome	Cerebral calcification	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	neu-laxova syndrome	Scoliosis	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002748	neu-laxova syndrome	Rickets	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002749	neu-laxova syndrome	Osteomalacia	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002804	neu-laxova syndrome	Arthrogryposis multiplex congenita	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002983	neu-laxova syndrome	Micromelia	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0030680	neu-laxova syndrome	Abnormality of cardiovascular system morphology	Occasional (29-5%)	PSAT1	610936	256520	biallelic	probable	loss of function	Brain/Cognition	19129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000737	holocarboxylase synthetase deficiency	Irritability	Very frequent (99-80%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001096	holocarboxylase synthetase deficiency	Keratoconjunctivitis	Very frequent (99-80%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	holocarboxylase synthetase deficiency	Seizures	Very frequent (99-80%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	holocarboxylase synthetase deficiency	Muscular hypotonia	Very frequent (99-80%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001510	holocarboxylase synthetase deficiency	Growth delay	Very frequent (99-80%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001824	holocarboxylase synthetase deficiency	Weight loss	Very frequent (99-80%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002017	holocarboxylase synthetase deficiency	Nausea and vomiting	Very frequent (99-80%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002039	holocarboxylase synthetase deficiency	Anorexia	Very frequent (99-80%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011127	holocarboxylase synthetase deficiency	Perioral eczema	Very frequent (99-80%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001987	holocarboxylase synthetase deficiency	Hyperammonemia	Frequent (79-30%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001992	holocarboxylase synthetase deficiency	Organic aciduria	Frequent (79-30%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002098	holocarboxylase synthetase deficiency	Respiratory distress	Frequent (79-30%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002789	holocarboxylase synthetase deficiency	Tachypnea	Frequent (79-30%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000964	holocarboxylase synthetase deficiency	Eczema	Occasional (29-5%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	holocarboxylase synthetase deficiency	Ataxia	Occasional (29-5%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001254	holocarboxylase synthetase deficiency	Lethargy	Occasional (29-5%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001259	holocarboxylase synthetase deficiency	Coma	Occasional (29-5%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001596	holocarboxylase synthetase deficiency	Alopecia	Occasional (29-5%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001873	holocarboxylase synthetase deficiency	Thrombocytopenia	Occasional (29-5%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007549	holocarboxylase synthetase deficiency	Desquamation of skin soon after birth	Occasional (29-5%)	HLCS	609018	609018	biallelic	confirmed	loss of function	Endocrine/Metabolic	4976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	ZMYND11	No gene mim	No disease mim	monoallelic	probable	loss of function	Face;Brain/Cognition	16966	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	poikiloderma with neutropenia	NA	NA	USB1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton	25792	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	viral induced severe multiorgan dysfunction associated with impaired mitochondrial fission	NA	NA	STAT2	No gene mim	No disease mim	biallelic	possible	loss of function	Multisystem;Brain/Cognition	11363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	macrocephaly, alopecia, cutis laxa, and scoliosis tall forehead, sparse hair, skin hyperextensibility, and scoliosis	NA	NA	RIN2	No gene mim	No disease mim	biallelic	probable	loss of function	Skin;Skeleton;Brain/Cognition	18750	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hace1 related disorder	NA	NA	HACE1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	21033	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	protein-coding gene	gene with protein product	Approved	6q16.3	06q16.3	KIAA1320				Ankyrin repeat domain containing
HP:0000202	joubert syndrome	Oral cleft	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000238	joubert syndrome	Hydrocephalus	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000276	joubert syndrome	Long face	Frequent (79-30%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000369	joubert syndrome	Low-set ears	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000426	joubert syndrome	Prominent nasal bridge	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000463	joubert syndrome	Anteverted nares	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000486	joubert syndrome	Strabismus	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000508	joubert syndrome	Ptosis	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000612	joubert syndrome	Iris coloboma	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000639	joubert syndrome	Nystagmus	Frequent (79-30%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000657	joubert syndrome	Oculomotor apraxia	Very frequent (99-80%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0000864	joubert syndrome	Abnormality of the hypothalamus-pituitary axis	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001161	joubert syndrome	Hand polydactyly	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001249	joubert syndrome	Intellectual disability	Very frequent (99-80%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001250	joubert syndrome	Seizures	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001251	joubert syndrome	Ataxia	Very frequent (99-80%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001252	joubert syndrome	Muscular hypotonia	Very frequent (99-80%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001263	joubert syndrome	Global developmental delay	Very frequent (99-80%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001288	joubert syndrome	Gait disturbance	Frequent (79-30%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001320	joubert syndrome	Cerebellar vermis hypoplasia	Very frequent (99-80%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001337	joubert syndrome	Tremor	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001696	joubert syndrome	Situs inversus totalis	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0001829	joubert syndrome	Foot polydactyly	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002084	joubert syndrome	Encephalocele	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002104	joubert syndrome	Apnea	Very frequent (99-80%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002126	joubert syndrome	Polymicrogyria	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002251	joubert syndrome	Aganglionic megacolon	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002269	joubert syndrome	Abnormality of neuronal migration	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002553	joubert syndrome	Highly arched eyebrow	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002564	joubert syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002650	joubert syndrome	Scoliosis	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002793	joubert syndrome	Abnormal pattern of respiration	Very frequent (99-80%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0002876	joubert syndrome	Episodic tachypnea	Very frequent (99-80%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0003312	joubert syndrome	Abnormal form of the vertebral bodies	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0004422	joubert syndrome	Biparietal narrowing	Frequent (79-30%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0007370	joubert syndrome	Aplasia/Hypoplasia of the corpus callosum	Occasional (29-5%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
HP:0008872	joubert syndrome	Feeding difficulties in infancy	Frequent (79-30%)	KIAA0586	No gene mim	614615	biallelic	confirmed	loss of function	Brain/Cognition	19960	KIAA0586	protein-coding gene	gene with protein product	Approved	14q23.1	14q23.1	Talpid3|JBTS23				
NA	mmp21-associated heterotaxy	NA	NA	MMP21	No gene mim	No disease mim	biallelic	confirmed	loss of function	GI tract;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	14357	matrix metallopeptidase 21	protein-coding gene	gene with protein product	Approved	10q26.2	10q26.2				matrix metalloproteinase 21	M10 matrix metallopeptidases
NA	pseudohypoparathyroidism-like disorder	NA	NA	PRMT7	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	25557	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	focal epilepsy	NA	NA	SCN3A	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Brain/Cognition	10590	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000202	joubert syndrome	Oral cleft	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	joubert syndrome	Hydrocephalus	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	joubert syndrome	Long face	Frequent (79-30%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	joubert syndrome	Low-set ears	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	joubert syndrome	Prominent nasal bridge	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	joubert syndrome	Anteverted nares	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	joubert syndrome	Strabismus	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	joubert syndrome	Ptosis	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	joubert syndrome	Iris coloboma	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	joubert syndrome	Nystagmus	Frequent (79-30%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000657	joubert syndrome	Oculomotor apraxia	Very frequent (99-80%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000864	joubert syndrome	Abnormality of the hypothalamus-pituitary axis	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	joubert syndrome	Hand polydactyly	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	joubert syndrome	Intellectual disability	Very frequent (99-80%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	joubert syndrome	Seizures	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	joubert syndrome	Ataxia	Very frequent (99-80%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	joubert syndrome	Muscular hypotonia	Very frequent (99-80%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	joubert syndrome	Global developmental delay	Very frequent (99-80%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	joubert syndrome	Gait disturbance	Frequent (79-30%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001320	joubert syndrome	Cerebellar vermis hypoplasia	Very frequent (99-80%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001337	joubert syndrome	Tremor	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001696	joubert syndrome	Situs inversus totalis	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001829	joubert syndrome	Foot polydactyly	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002084	joubert syndrome	Encephalocele	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002104	joubert syndrome	Apnea	Very frequent (99-80%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002126	joubert syndrome	Polymicrogyria	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002251	joubert syndrome	Aganglionic megacolon	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	joubert syndrome	Abnormality of neuronal migration	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002553	joubert syndrome	Highly arched eyebrow	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	joubert syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	joubert syndrome	Scoliosis	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002793	joubert syndrome	Abnormal pattern of respiration	Very frequent (99-80%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002876	joubert syndrome	Episodic tachypnea	Very frequent (99-80%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	joubert syndrome	Abnormal form of the vertebral bodies	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004422	joubert syndrome	Biparietal narrowing	Frequent (79-30%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	joubert syndrome	Aplasia/Hypoplasia of the corpus callosum	Occasional (29-5%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	joubert syndrome	Feeding difficulties in infancy	Frequent (79-30%)	AHI1	No gene mim	614615	biallelic	confirmed	loss of function		21575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	circumferential skin creases kunze type	NA	NA	TUBB	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame	Skin;Skeleton;Face;Brain/Cognition	20778	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	circumferential skin creases kunze type	NA	NA	MAPRE2	No gene mim	No disease mim	biallelic	confirmed	all missense/in frame	Bone Marrow/Immune;Skin;Skeleton;Face	6891	microtubule associated protein RP/EB family member 2	protein-coding gene	gene with protein product	Approved	18q12.1-q12.2	18q12.1-q12.2	RP1|EB1|EB2	APC-binding protein EB1			
NA	radioulnar synostosis with amegakaryocytic thrombocytopenia	NA	NA	MECOM	No gene mim	No disease mim	monoallelic	probable	activating	Bone Marrow/Immune;Skeleton	3498	MDS1 and EVI1 complex locus	protein-coding gene	gene with protein product	Approved	3q26.2	03q26.2	MDS1-EVI1|PRDM3|KMT8E	PR domain 3	MDS1|EVI1	myelodysplasia syndrome 1|ecotropic viral integration site 1	Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family
NA	radioulnar synostosis with amegakaryocytic thrombocytopenia	NA	NA	HOXA11	No gene mim	No disease mim	monoallelic	possible	loss of function	Bone Marrow/Immune;Skeleton	5101	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	episodes of liver failure, peripheral neuropathy, cerebellar atrophy, and ataxia	NA	NA	SCYL1	No gene mim	No disease mim	biallelic	probable	loss of function	Peripheral nerves;GI tract;Brain/Cognition	14372	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital myasthenic syndrome type 19	NA	NA	COL13A1	No gene mim	No disease mim	biallelic	probable	loss of function	Musculature;Peripheral nerves	2190	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability with cerebellar atrophy	NA	NA	SLC39A8	No gene mim	No disease mim	biallelic	confirmed	all missense/in frame	Brain/Cognition	20862	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal-dominant primordial dwarfism associated with meier-gorlin syndrome	NA	NA	GMNN	No gene mim	No disease mim	monoallelic	probable	activating	Skeleton;Brain/Cognition;Ear	17493	geminin, DNA replication inhibitor	protein-coding gene	gene with protein product	Approved	6p22.3	06p22.3	Gem				
NA	dysmorphic features, intellectual disability, and neurological manifestations	NA	NA	TAF1	No gene mim	No disease mim	hemizygous	confirmed	loss of function	Face;Brain/Cognition	11535	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dyskeratosis congenita, x-linked	NA	NA	DKC1	300126	No disease mim	hemizygous	confirmed	loss of function	Bone Marrow/Immune;Skeleton;Brain/Cognition	2890	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dyskeratosis congenita, autosomal recessive 4	NA	NA	TERT	No gene mim	No disease mim	biallelic	confirmed	all missense/in frame	Bone Marrow/Immune;Skin;Skeleton;Brain/Cognition	11730	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dyskeratosis congenita, autosomal recessive 6	NA	NA	PARN	No gene mim	No disease mim	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;Brain/Cognition	8609	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	exudative retinopathy with bone marrow failure	NA	NA	TINF2	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Skeleton;GI tract;Brain/Cognition	11824	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	arthrogryposis, distal, type 1	NA	NA	TPM2	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Musculature	12011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	transcobalamin ii deficiency	NA	NA	TCN2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	11653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, x-linked, syndromic 32	NA	NA	CLIC2	No gene mim	No disease mim	hemizygous	possible	all missense/in frame	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2063	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dyskeratosis congenita, autosomal dominant 1	NA	NA	TERC	No gene mim	No disease mim	monoallelic	child IF	loss of function	Bone Marrow/Immune	11727	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primordial dwarfism	NA	NA	TRAIP	No gene mim	615272	biallelic	probable	loss of function	Skeleton;Brain/Cognition	30764	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dystonia 27	NA	NA	COL6A3	No gene mim	616411	biallelic	confirmed	loss of function		2213	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ullrich congenital muscular dystrophy 1	NA	NA	COL6A3	No gene mim	254090	biallelic	confirmed	loss of function		2213	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lethal congenital contracture syndrome 9	NA	NA	ADGRG6	No gene mim	616503	biallelic	confirmed	loss of function		13841	adhesion G protein-coupled receptor G6	protein-coding gene	gene with protein product	Approved	6q24.2	06q24.2	FLJ14937		GPR126	G protein-coupled receptor 126	Adhesion G protein-coupled receptors, subfamily G
NA	spondyloocular syndrome	NA	NA	XYLT2	No gene mim	605822	biallelic	probable	loss of function		15517	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	osteogenesis imperfecta, type xvii	NA	NA	SPARC	No gene mim	616507	biallelic	probable	all missense/in frame		11219	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fanconi anemia, complementation group t	NA	NA	UBE2T	No gene mim	616435	biallelic	probable	loss of function		25009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital anomalies of kidney and urinary tract 2	NA	NA	TBX18	No gene mim	143400	monoallelic	probable	loss of function		11595	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mental retardation, x-linked 12	NA	NA	THOC2	No gene mim	300957	hemizygous	probable	all missense/in frame		19073	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	craniosynostosis 6	NA	NA	ZIC1	No gene mim	616602	monoallelic	confirmed	activating		12872	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epilepsy, hearing loss, and mental retardation syndrome	NA	NA	SPATA5	No gene mim	616577	biallelic	confirmed	loss of function		18119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	premature aging syndrome, penttinen type	NA	NA	PDGFRB	173410	601812	monoallelic	confirmed	activating		8804	platelet derived growth factor receptor beta	protein-coding gene	gene with protein product	Approved	5q32	05q32	JTK12|CD140b|PDGFR1		PDGFR	platelet-derived growth factor receptor, beta polypeptide	Receptor Tyrosine Kinases|CD molecules|I-set domain containing|Immunoglobulin like domain containing
NA	adams-oliver syndrome 6	NA	NA	DLL4	No gene mim	616589	monoallelic	confirmed	loss of function		2910	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cutis laxa, autosomal dominant 3	NA	NA	ALDH18A1	138250	616603	monoallelic	confirmed	activating		9722	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	complex lethal osteochondrodysplasia	NA	NA	TAPT1	No gene mim	No disease mim	biallelic	probable	loss of function		26887	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	primary ciliary dyskinesia	Recurrent respiratory infections	Very frequent (99-80%)	GAS8	No gene mim	No disease mim	biallelic	confirmed	loss of function		4166	growth arrest specific 8	protein-coding gene	gene with protein product	Approved	16q24.3	16q24.3	DRC4		GAS11	growth arrest-specific 11	Dynein regulatory complex
NA	early-childhood-onset steroid-resistant nephrotic syndrome	NA	NA	NUP107	No gene mim	No disease mim	biallelic	confirmed	loss of function		29914	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	progressive spondyloepimetaphyseal dysplasia	NA	NA	RSPRY1	No gene mim	No disease mim	biallelic	probable	loss of function		29420	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	arthrogryposis multiplex congenita	Low-set, posteriorly rotated ears	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0000457	arthrogryposis multiplex congenita	Depressed nasal ridge	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0000776	arthrogryposis multiplex congenita	Congenital diaphragmatic hernia	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0001004	arthrogryposis multiplex congenita	Lymphedema	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0001543	arthrogryposis multiplex congenita	Gastroschisis	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0001561	arthrogryposis multiplex congenita	Polyhydramnios	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0001883	arthrogryposis multiplex congenita	Talipes	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0002103	arthrogryposis multiplex congenita	Abnormality of the pleura	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0002650	arthrogryposis multiplex congenita	Scoliosis	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0002804	arthrogryposis multiplex congenita	Arthrogryposis multiplex congenita	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0002827	arthrogryposis multiplex congenita	Hip dislocation	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0003019	arthrogryposis multiplex congenita	Abnormality of the wrist	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0004295	arthrogryposis multiplex congenita	Abnormality of the gastric mucosa	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0006703	arthrogryposis multiplex congenita	Aplasia/Hypoplasia of the lungs	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
HP:0009465	arthrogryposis multiplex congenita	Ulnar deviation of finger	Very frequent (99-80%)	MAGEL2	No gene mim	No disease mim	imprinted	probable	loss of function		6814	MAGE family member L2	protein-coding gene	gene with protein product	Approved	15q11.2	15q11.2	nM15		NDNL1	MAGE-like 2|melanoma antigen family L2	MAGE family
NA	intra-mitochondrial methylation deficiency	NA	NA	SLC25A26	No gene mim	No disease mim	biallelic	confirmed	loss of function		20661	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	early-onset recessive optic neuropathy	NA	NA	RTN4IP1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	18647	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000202	joubert syndrome	Oral cleft	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000238	joubert syndrome	Hydrocephalus	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000276	joubert syndrome	Long face	Frequent (79-30%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000369	joubert syndrome	Low-set ears	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000426	joubert syndrome	Prominent nasal bridge	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	joubert syndrome	Anteverted nares	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	joubert syndrome	Strabismus	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000508	joubert syndrome	Ptosis	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	joubert syndrome	Iris coloboma	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	joubert syndrome	Nystagmus	Frequent (79-30%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000657	joubert syndrome	Oculomotor apraxia	Very frequent (99-80%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000864	joubert syndrome	Abnormality of the hypothalamus-pituitary axis	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001161	joubert syndrome	Hand polydactyly	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	joubert syndrome	Intellectual disability	Very frequent (99-80%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	joubert syndrome	Seizures	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	joubert syndrome	Ataxia	Very frequent (99-80%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	joubert syndrome	Muscular hypotonia	Very frequent (99-80%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001263	joubert syndrome	Global developmental delay	Very frequent (99-80%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	joubert syndrome	Gait disturbance	Frequent (79-30%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001320	joubert syndrome	Cerebellar vermis hypoplasia	Very frequent (99-80%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001337	joubert syndrome	Tremor	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001696	joubert syndrome	Situs inversus totalis	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001829	joubert syndrome	Foot polydactyly	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002084	joubert syndrome	Encephalocele	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002104	joubert syndrome	Apnea	Very frequent (99-80%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002126	joubert syndrome	Polymicrogyria	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002251	joubert syndrome	Aganglionic megacolon	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002269	joubert syndrome	Abnormality of neuronal migration	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002553	joubert syndrome	Highly arched eyebrow	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002564	joubert syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002650	joubert syndrome	Scoliosis	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002793	joubert syndrome	Abnormal pattern of respiration	Very frequent (99-80%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002876	joubert syndrome	Episodic tachypnea	Very frequent (99-80%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003312	joubert syndrome	Abnormal form of the vertebral bodies	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004422	joubert syndrome	Biparietal narrowing	Frequent (79-30%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007370	joubert syndrome	Aplasia/Hypoplasia of the corpus callosum	Occasional (29-5%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	joubert syndrome	Feeding difficulties in infancy	Frequent (79-30%)	CEP104	No gene mim	614615	biallelic	confirmed	loss of function		24866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000365	waardenburg syndrome type 2	Hearing impairment	Very frequent (99-80%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0002216	waardenburg syndrome type 2	Premature graying of hair	Very frequent (99-80%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0005599	waardenburg syndrome type 2	Hypopigmentation of hair	Very frequent (99-80%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0000407	waardenburg syndrome type 2	Sensorineural hearing impairment	Frequent (79-30%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0001053	waardenburg syndrome type 2	Hypopigmented skin patches	Frequent (79-30%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0001100	waardenburg syndrome type 2	Heterochromia iridis	Frequent (79-30%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0002211	waardenburg syndrome type 2	White forelock	Frequent (79-30%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0000077	waardenburg syndrome type 2	Abnormality of the kidney	Occasional (29-5%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0000506	waardenburg syndrome type 2	Telecanthus	Occasional (29-5%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0000508	waardenburg syndrome type 2	Ptosis	Occasional (29-5%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0002251	waardenburg syndrome type 2	Aganglionic megacolon	Occasional (29-5%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
HP:0004414	waardenburg syndrome type 2	Abnormality of the pulmonary artery	Occasional (29-5%)	KITLG	No gene mim	No disease mim	monoallelic	possible	dominant negative		6343	KIT ligand	protein-coding gene	gene with protein product	Approved	12q21.32	12q21.32	SCF|SF|Kitl|KL-1|FPH2|SLF|DFNA69	mast cell growth factor|stem cell factor|steel factor|familial progressive hyperpigmentation 2	MGF		Deafness associated genes
NA	microcephaly 15, primary, autosomal recessive	NA	NA	MFSD2A	No gene mim	616486	biallelic	confirmed	all missense/in frame		25897	major facilitator superfamily domain containing 2A	protein-coding gene	gene with protein product	Approved	1p34.2	01p34.2	FLJ14490		MFSD2	major facilitator superfamily domain containing 2	
NA	hereditary sensory & autonomic neuropathy type viii	NA	NA	PRDM12	No gene mim	616488	biallelic	confirmed	loss of function		13997	PR/SET domain 12	protein-coding gene	gene with protein product	Approved	9q34.12	09q34.12		PR-domain containing protein 12|PR-domain zinc finger protein 12		PR domain containing 12|PR domain 12	Zinc fingers C2H2-type|PR/SET domain family
NA	short stature with microcephaly and distinctive facies	NA	NA	CRIPT	No gene mim	615789	biallelic	possible	loss of function		14312	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	d-2-hydroxyglutaric aciduria 1	NA	NA	D2HGDH	No gene mim	600721	biallelic	possible	loss of function		28358	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lethal congenital contracture syndrome 7	NA	NA	CNTNAP1	No gene mim	616286	biallelic	probable	loss of function		8011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ehlers-danlos syndrome, musculocontractural type 2	NA	NA	DSE	No gene mim	615539	biallelic	possible	all missense/in frame		21144	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	NA	NA	WDR81	No gene mim	610185	biallelic	possible	all missense/in frame		26600	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hydrocephalus, nonsyndromic, autosomal recessive	NA	NA	CCDC88C	No gene mim	236600	biallelic	probable	loss of function		19967	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	leigh syndrome dup	NA	NA	NDUFA10	No gene mim	256000	biallelic	probable	all missense/in frame		7684	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000486	leigh syndrome	Strabismus	Very frequent (99-80%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	leigh syndrome	Nystagmus	Very frequent (99-80%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	leigh syndrome	Optic atrophy	Frequent (79-30%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001250	leigh syndrome	Seizures	Frequent (79-30%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	leigh syndrome	Ataxia	Very frequent (99-80%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001252	leigh syndrome	Muscular hypotonia	Very frequent (99-80%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002093	leigh syndrome	Respiratory insufficiency	Very frequent (99-80%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004374	leigh syndrome	Hemiplegia/hemiparesis	Frequent (79-30%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007020	leigh syndrome	Progressive spastic paraplegia	Frequent (79-30%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007650	leigh syndrome	Progressive ophthalmoplegia	Frequent (79-30%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008972	leigh syndrome	Decreased activity of mitochondrial respiratory chain	Very frequent (99-80%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100022	leigh syndrome	Abnormality of movement	Very frequent (99-80%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0100543	leigh syndrome	Cognitive impairment	Very frequent (99-80%)	NDUFA9	No gene mim	256000	biallelic	possible	all missense/in frame		7693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperphosphatasia with mental retardation syndrome 5	NA	NA	PIGW	No gene mim	616025	biallelic	possible	all missense/in frame		23213	phosphatidylinositol glycan anchor biosynthesis class W	protein-coding gene	gene with protein product	Approved	17q12	17q12	Gwt1|FLJ37433			phosphatidylinositol glycan, class W	Phosphatidylinositol glycan anchor biosynthesis
HP:0000262	spondylometaphyseal dysplasia, sedaghatian type	Turricephaly	Frequent (79-30%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0000772	spondylometaphyseal dysplasia, sedaghatian type	Abnormality of the ribs	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0000774	spondylometaphyseal dysplasia, sedaghatian type	Narrow chest	Frequent (79-30%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0000782	spondylometaphyseal dysplasia, sedaghatian type	Abnormality of the scapula	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0000926	spondylometaphyseal dysplasia, sedaghatian type	Platyspondyly	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0001274	spondylometaphyseal dysplasia, sedaghatian type	Agenesis of corpus callosum	Occasional (29-5%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0001290	spondylometaphyseal dysplasia, sedaghatian type	Generalized hypotonia	Frequent (79-30%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0001302	spondylometaphyseal dysplasia, sedaghatian type	Pachygyria	Occasional (29-5%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0001321	spondylometaphyseal dysplasia, sedaghatian type	Cerebellar hypoplasia	Frequent (79-30%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0001678	spondylometaphyseal dysplasia, sedaghatian type	Atrioventricular block	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0002093	spondylometaphyseal dysplasia, sedaghatian type	Respiratory insufficiency	Frequent (79-30%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0002657	spondylometaphyseal dysplasia, sedaghatian type	Spondylometaphyseal dysplasia	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0002750	spondylometaphyseal dysplasia, sedaghatian type	Delayed skeletal maturation	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0003085	spondylometaphyseal dysplasia, sedaghatian type	Long fibula	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0003498	spondylometaphyseal dysplasia, sedaghatian type	Disproportionate short stature	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0004279	spondylometaphyseal dysplasia, sedaghatian type	Short palm	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0004991	spondylometaphyseal dysplasia, sedaghatian type	Rhizomelic arm shortening	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0005616	spondylometaphyseal dysplasia, sedaghatian type	Accelerated skeletal maturation	Occasional (29-5%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0005871	spondylometaphyseal dysplasia, sedaghatian type	Metaphyseal chondrodysplasia	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0006543	spondylometaphyseal dysplasia, sedaghatian type	Cardiorespiratory arrest	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0008786	spondylometaphyseal dysplasia, sedaghatian type	Iliac crest serration	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0010049	spondylometaphyseal dysplasia, sedaghatian type	Short metacarpal	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0010579	spondylometaphyseal dysplasia, sedaghatian type	Cone-shaped epiphysis	Occasional (29-5%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0011675	spondylometaphyseal dysplasia, sedaghatian type	Arrhythmia	Very frequent (99-80%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
HP:0012819	spondylometaphyseal dysplasia, sedaghatian type	Myocarditis	Occasional (29-5%)	GPX4	No gene mim	250220	biallelic	probable	loss of function		4556	glutathione peroxidase 4	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	PHGPx|MCSP	phospholipid hydroperoxidase		glutathione peroxidase 4 (phospholipid hydroperoxidase)	Selenoproteins
NA	cnot3 syndrome	NA	NA	CNOT3	No gene mim	No disease mim	monoallelic	confirmed	loss of function		7879	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	csnk2a1 syndrome	NA	NA	CSNK2A1	No gene mim	No disease mim	monoallelic	confirmed	activating		2457	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gnai1 syndrome	NA	NA	GNAI1	No gene mim	No disease mim	monoallelic	confirmed	loss of function		4384	G protein subunit alpha i1	protein-coding gene	gene with protein product	Approved	7q21.11	07q21.11		Gi1 protein alpha subunit		guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1	G protein subunits alpha, group i
NA	kcnq3 syndrome	NA	NA	KCNQ3	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame		6297	potassium voltage-gated channel subfamily Q member 3	protein-coding gene	gene with protein product	Approved	8q24.22	08q24.22	Kv7.3		EBN2	potassium voltage-gated channel, KQT-like subfamily, member 3|potassium channel, voltage gated KQT-like subfamily Q, member 3	Potassium voltage-gated channels
NA	kdm5b syndrome	NA	NA	KDM5B	No gene mim	No disease mim	monoallelic	confirmed	loss of function		18039	lysine demethylase 5B	protein-coding gene	gene with protein product	Approved	1q32.1	01q32.1	RBBP2H1A|PLU-1|CT31|PPP1R98	cancer/testis antigen 31|protein phosphatase 1, regulatory subunit 98	JARID1B	Jumonji, AT rich interactive domain 1B (RBP2-like)|jumonji, AT rich interactive domain 1B|lysine (K)-specific demethylase 5B	PHD finger proteins|AT-rich interaction domain containing|Lysine demethylases
NA	msl3 syndrome	NA	NA	MSL3	No gene mim	No disease mim	x-linked dominant	confirmed	loss of function		7370	MSL complex subunit 3	protein-coding gene	gene with protein product	Approved	Xp22.2	Xp22.2			MSL3L1	male-specific lethal-3 (Drosophila)-like 1|male-specific lethal 3-like 1 (Drosophila)|male-specific lethal 3 homolog (Drosophila)	MSL histone acetyltransferase complex
NA	myt1l syndrome	NA	NA	MYT1L	No gene mim	No disease mim	monoallelic	confirmed	loss of function		7623	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ppm1d syndrome	NA	NA	PPM1D	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	9277	protein phosphatase, Mg2+/Mn2+ dependent 1D	protein-coding gene	gene with protein product	Approved	17q23.3	17q23.3	Wip1|PP2C-DELTA	wild-type p53-induced phosphatase 1|protein phosphatase 2C, delta isoform		protein phosphatase 1D magnesium-dependent, delta isoform|protein phosphatase, Mg2+/Mn2+ dependent, 1D	Protein phosphatases, Mg2+/Mn2+ dependent
NA	puf60 syndrome	NA	NA	PUF60	No gene mim	No disease mim	monoallelic	confirmed	loss of function		17042	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	qrich1 syndrome	NA	NA	QRICH1	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Brain/Cognition	24713	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	set syndrome	NA	NA	SET	No gene mim	No disease mim	monoallelic	probable	loss of function	Brain/Cognition	10760	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	kmt5b syndrome	NA	NA	KMT5B	No gene mim	No disease mim	monoallelic	confirmed	loss of function		24283	lysine methyltransferase 5B	protein-coding gene	gene with protein product	Approved	11q13.2	11q13.2	CGI-85		SUV420H1	suppressor of variegation 4-20 homolog 1 (Drosophila)|lysine (K)-specific methyltransferase 5B	Lysine methyltransferases
NA	tcf20 syndrome	NA	NA	TCF20	No gene mim	No disease mim	monoallelic	confirmed	loss of function		11631	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	zbtb18 syndrome	NA	NA	ZBTB18	No gene mim	No disease mim	monoallelic	confirmed	loss of function		13030	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	wac syndrome	NA	NA	WAC	No gene mim	No disease mim	monoallelic	confirmed	loss of function		17327	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infantile epileptic encephalopathy	NA	NA	SCN2A	182390	No disease mim	monoallelic	confirmed	all missense/in frame	Brain/Cognition	10588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	persistent hypotonia, encephalopathy, growth retardation, and severe intellectual disability	NA	NA	UNC80	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	26582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	disorder of golgi homeostasis	NA	NA	CCDC115	No gene mim	No disease mim	biallelic	confirmed	loss of function	Endocrine/Metabolic;GI tract;Brain/Cognition	28178	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	disorder of golgi homeostasis	NA	NA	TMEM199	No gene mim	No disease mim	biallelic	child IF	loss of function		18085	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infancy-onset recurrent metabolic crises with encephalocardiomyopathy	NA	NA	TANGO2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	25439	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	prenatal spinal muscular atrophy and congenital bone fractures	NA	NA	TRIP4	No gene mim	No disease mim	biallelic	probable	loss of function	Spinal cord/Peripheral nerves;Skeleton;Brain/Cognition	12310	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	prenatal spinal muscular atrophy and congenital bone fractures	NA	NA	ASCC1	No gene mim	No disease mim	biallelic	possible	loss of function	Spinal cord/Peripheral nerves;Skeleton;Brain/Cognition	24268	activating signal cointegrator 1 complex subunit 1	protein-coding gene	gene with protein product	Approved	10q22.1	10q22.1	CGI-18|ASC1p50|Em:AC022392.3				
NA	autosomal-dominant robinow syndrome	NA	NA	DVL3	No gene mim	No disease mim	monoallelic	confirmed	dominant negative	Skeleton;Face;Genitalia	3087	dishevelled segment polarity protein 3	protein-coding gene	gene with protein product	Approved	3q27.1	03q27.1	KIAA0208			dishevelled 3 (homologous to Drosophila dsh)|dishevelled, dsh homolog 3 (Drosophila)	Dishevelled segment polarity proteins|PDZ domain containing
NA	global developmental delay, hypotonia, scoliosis, and cerebellar atrophy.	NA	NA	EMC1	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Brain/Cognition	28957	ER membrane protein complex subunit 1	protein-coding gene	gene with protein product	Approved	1p36.13	01p36.13			KIAA0090	KIAA0090	
NA	global developmental delay, hypotonia, scoliosis, and cerebellar atrophy.	NA	NA	EMC1	No gene mim	No disease mim	monoallelic	probable	dominant negative	Skeleton;Brain/Cognition	28957	ER membrane protein complex subunit 1	protein-coding gene	gene with protein product	Approved	1p36.13	01p36.13			KIAA0090	KIAA0090	
HP:0000488	encephalocraniocutaneous lipomatosis	Retinopathy	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000991	encephalocraniocutaneous lipomatosis	Xanthomatosis	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001012	encephalocraniocutaneous lipomatosis	Multiple lipomas	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001249	encephalocraniocutaneous lipomatosis	Intellectual disability	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001250	encephalocraniocutaneous lipomatosis	Seizures	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001263	encephalocraniocutaneous lipomatosis	Global developmental delay	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001482	encephalocraniocutaneous lipomatosis	Subcutaneous nodule	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001596	encephalocraniocutaneous lipomatosis	Alopecia	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0009125	encephalocraniocutaneous lipomatosis	Lipodystrophy	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0012759	encephalocraniocutaneous lipomatosis	Neurodevelopmental abnormality	Very frequent (99-80%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000256	encephalocraniocutaneous lipomatosis	Macrocephaly	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000271	encephalocraniocutaneous lipomatosis	Abnormality of the face	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000492	encephalocraniocutaneous lipomatosis	Abnormality of the eyelid	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000499	encephalocraniocutaneous lipomatosis	Abnormality of the eyelashes	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000612	encephalocraniocutaneous lipomatosis	Iris coloboma	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000614	encephalocraniocutaneous lipomatosis	Abnormality of the nasolacrimal system	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000708	encephalocraniocutaneous lipomatosis	Behavioral abnormality	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000929	encephalocraniocutaneous lipomatosis	Abnormality of the skull	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001052	encephalocraniocutaneous lipomatosis	Nevus flammeus	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001257	encephalocraniocutaneous lipomatosis	Spasticity	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001274	encephalocraniocutaneous lipomatosis	Agenesis of corpus callosum	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001276	encephalocraniocutaneous lipomatosis	Hypertonia	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001331	encephalocraniocutaneous lipomatosis	Absent septum pellucidum	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001704	encephalocraniocutaneous lipomatosis	Tricuspid valve prolapse	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002059	encephalocraniocutaneous lipomatosis	Cerebral atrophy	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002063	encephalocraniocutaneous lipomatosis	Rigidity	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002092	encephalocraniocutaneous lipomatosis	Pulmonary arterial hypertension	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002119	encephalocraniocutaneous lipomatosis	Ventriculomegaly	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002120	encephalocraniocutaneous lipomatosis	Cerebral cortical atrophy	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002167	encephalocraniocutaneous lipomatosis	Neurological speech impairment	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002300	encephalocraniocutaneous lipomatosis	Mutism	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002357	encephalocraniocutaneous lipomatosis	Dysphasia	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002381	encephalocraniocutaneous lipomatosis	Aphasia	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002514	encephalocraniocutaneous lipomatosis	Cerebral calcification	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002797	encephalocraniocutaneous lipomatosis	Osteolysis	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003552	encephalocraniocutaneous lipomatosis	Muscle stiffness	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0004493	encephalocraniocutaneous lipomatosis	Craniofacial hyperostosis	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005306	encephalocraniocutaneous lipomatosis	Capillary hemangiomas	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0007957	encephalocraniocutaneous lipomatosis	Corneal opacity	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010529	encephalocraniocutaneous lipomatosis	Echolalia	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0010622	encephalocraniocutaneous lipomatosis	Neoplasm of the skeletal system	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0012062	encephalocraniocutaneous lipomatosis	Bone cyst	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0012157	encephalocraniocutaneous lipomatosis	Subcortical cerebral atrophy	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0100761	encephalocraniocutaneous lipomatosis	Visceral angiomatosis	Frequent (79-30%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000943	encephalocraniocutaneous lipomatosis	Dysostosis multiplex	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001269	encephalocraniocutaneous lipomatosis	Hemiparesis	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001650	encephalocraniocutaneous lipomatosis	Aortic valve stenosis	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001679	encephalocraniocutaneous lipomatosis	Abnormality of the aorta	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001680	encephalocraniocutaneous lipomatosis	Coarctation of aorta	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002301	encephalocraniocutaneous lipomatosis	Hemiplegia	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002445	encephalocraniocutaneous lipomatosis	Tetraplegia	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002652	encephalocraniocutaneous lipomatosis	Skeletal dysplasia	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002763	encephalocraniocutaneous lipomatosis	Abnormal cartilage morphology	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0003470	encephalocraniocutaneous lipomatosis	Paralysis	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0011611	encephalocraniocutaneous lipomatosis	Interrupted aortic arch	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0040188	encephalocraniocutaneous lipomatosis	Osteochondrosis	Occasional (29-5%)	FGFR1	136350	No disease mim	mosaic	confirmed	activating	Skin;Skeleton;Brain/Cognition	3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
NA	intellectual disability with seizures and hypotonia	NA	NA	PIGG	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	25985	phosphatidylinositol glycan anchor biosynthesis class G	protein-coding gene	gene with protein product	Approved	4p16.3	04p16.3	FLJ20265|GPI7|LAS21			phosphatidylinositol glycan, class G	Phosphatidylinositol glycan anchor biosynthesis
NA	dna repair-proficient trichothiodystrophy	NA	NA	GTF2E2	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Bone Marrow/Immune;Skin;Brain/Cognition	4651	general transcription factor IIE subunit 2	protein-coding gene	gene with protein product	Approved	8p12	08p12	TFIIE-B|FE|TF2E2	TFIIE beta subunit		general transcription factor IIE, polypeptide 2 (beta subunit, 34kD)|general transcription factor IIE, polypeptide 2, beta 34kDa	General transcription factors
NA	smg9 multiple congenital anomaly syndrome	NA	NA	SMG9	No gene mim	No disease mim	biallelic	probable	loss of function	Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	25763	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	childhood-onset chorea with bilateral striatal lesions	NA	NA	PDE10A	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Brain/Cognition	8772	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe infantile syndromic encephalopathy	NA	NA	TBCK	No gene mim	No disease mim	biallelic	confirmed	loss of function	Musculature;Face;Brain/Cognition	28261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital hemangioma	NA	NA	GNAQ	No gene mim	No disease mim	mosaic	probable	activating	Heart/Cardiovasculature/Lymphatic	4390	G protein subunit alpha q	protein-coding gene	gene with protein product	Approved	9q21.2	09q21.2	G-ALPHA-q|GAQ			guanine nucleotide binding protein (G protein), q polypeptide	G protein subunits alpha, group q
NA	congenital hemangioma	NA	NA	GNA11	No gene mim	No disease mim	mosaic	probable	activating	Heart/Cardiovasculature/Lymphatic	4379	G protein subunit alpha 11	protein-coding gene	gene with protein product	Approved	19p13.3	19p13.3	FBH|FBH2|FHH2		HHC2	hypocalciuric hypercalcemia 2|guanine nucleotide binding protein (G protein), alpha 11 (Gq class)	G protein subunits alpha, group q
NA	telo2 syndromic intellectual disability disorder	NA	NA	TELO2	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Skeleton;Face;Eye;Brain/Cognition;Ear;Heart/Cardiovasculature/Lymphatic	29099	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	phenocopy of proximal 1p36 deletions	NA	NA	RERE	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Kidney Renal Tract;Face;Brain/Cognition;Genitalia;Ear;Heart/Cardiovasculature/Lymphatic	9965	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gillespie syndrome	NA	NA	ITPR1	No gene mim	No disease mim	monoallelic	confirmed	dominant negative	Eye;Brain/Cognition	6180	inositol 1,4,5-trisphosphate receptor type 1	protein-coding gene	gene with protein product	Approved	3p26.1	03p26.1	Insp3r1|IP3R1|ACV|PPP1R94	protein phosphatase 1, regulatory subunit 94	SCA15|SCA16|SCA29	spinocerebellar ataxia 15|spinocerebellar ataxia 16|spinocerebellar ataxia 29|inositol 1,4,5-trisphosphate receptor, type 1	Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits
NA	gillespie syndrome	NA	NA	ITPR1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Eye;Brain/Cognition	6180	inositol 1,4,5-trisphosphate receptor type 1	protein-coding gene	gene with protein product	Approved	3p26.1	03p26.1	Insp3r1|IP3R1|ACV|PPP1R94	protein phosphatase 1, regulatory subunit 94	SCA15|SCA16|SCA29	spinocerebellar ataxia 15|spinocerebellar ataxia 16|spinocerebellar ataxia 29|inositol 1,4,5-trisphosphate receptor, type 1	Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits
NA	mitochondrial rna processing and multiple respiratory chain deficiencies	NA	NA	TRMT10C	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition;Ear	26022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe neurodevelopmental disability, hypotonia, and seizures	NA	NA	GNB1	No gene mim	No disease mim	monoallelic	confirmed	activating	Brain/Cognition	4396	G protein subunit beta 1	protein-coding gene	gene with protein product	Approved	1p36.33	01p36.33		transducin beta chain 1|guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1		guanine nucleotide binding protein (G protein), beta polypeptide 1	WD repeat domain containing|G protein subunits beta
NA	gnb3 autosomal-recessive congenital stationary night blindness.	NA	NA	GNB3	No gene mim	No disease mim	biallelic	possible	loss of function	Eye	4400	G protein subunit beta 3	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31		transducin beta chain 3		guanine nucleotide binding protein (G protein), beta polypeptide 3	WD repeat domain containing|G protein subunits beta
NA	isolated nonsyndromic patent ductus arteriosus.	NA	NA	PRDM6	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Heart/Cardiovasculature/Lymphatic	9350	PR/SET domain 6	protein-coding gene	gene with protein product	Approved	5q23.2	05q23.2	PRISM|KMT8C			PR domain containing 6|PR domain 6	Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family
NA	riboflavin-responsive and non-responsive multiple acyl-coa dehydrogenase and combined respiratory-chain deficiency.	NA	NA	FLAD1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Endocrine/Metabolic;Brain/Cognition	24671	flavin adenine dinucleotide synthetase 1	protein-coding gene	gene with protein product	Approved	1q21.3	01q21.3	PP591|FAD1			Fad1, flavin adenine dinucleotide synthetase, homolog (yeast)|FAD1 flavin adenine dinucleotide synthetase homolog (S. cerevisiae)|flavin adenine dinucleotide synthetase	
HP:0000252	ataxia-pancytopenia syndrome	Microcephaly	Occasional (29-5%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000639	ataxia-pancytopenia syndrome	Nystagmus	Frequent (79-30%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001251	ataxia-pancytopenia syndrome	Ataxia	Very frequent (99-80%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001272	ataxia-pancytopenia syndrome	Cerebellar atrophy	Very frequent (99-80%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001288	ataxia-pancytopenia syndrome	Gait disturbance	Very frequent (99-80%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001347	ataxia-pancytopenia syndrome	Hyperreflexia	Frequent (79-30%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001744	ataxia-pancytopenia syndrome	Splenomegaly	Frequent (79-30%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001874	ataxia-pancytopenia syndrome	Abnormality of neutrophils	Frequent (79-30%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001876	ataxia-pancytopenia syndrome	Pancytopenia	Occasional (29-5%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001908	ataxia-pancytopenia syndrome	Hypoplastic anemia	Frequent (79-30%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002167	ataxia-pancytopenia syndrome	Neurological speech impairment	Frequent (79-30%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002205	ataxia-pancytopenia syndrome	Recurrent respiratory infections	Frequent (79-30%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002317	ataxia-pancytopenia syndrome	Unsteady gait	Very frequent (99-80%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004311	ataxia-pancytopenia syndrome	Abnormality of macrophages	Frequent (79-30%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004313	ataxia-pancytopenia syndrome	Decreased antibody level in blood	Occasional (29-5%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004820	ataxia-pancytopenia syndrome	Acute myelomonocytic leukemia	Frequent (79-30%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0007360	ataxia-pancytopenia syndrome	Aplasia/Hypoplasia of the cerebellum	Very frequent (99-80%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011869	ataxia-pancytopenia syndrome	Abnormal platelet function	Occasional (29-5%)	SAMD9L	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Brain/Cognition	1349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	duane syndrome, aberrant extraocular muscle innervation, and inner-ear defects	NA	NA	MAFB	608968	No disease mim	monoallelic	probable	loss of function	Eye;Ear	6408	MAF bZIP transcription factor B	protein-coding gene	gene with protein product	Approved	20q12	20q12			KRML	Kreisler (mouse) maf-related leucine zipper homolog|v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B	Basic leucine zipper proteins
NA	short stature, developmental delay, and congenital heart defects	NA	NA	TKT	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	11834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	x-linked spondyloepimetaphyseal dysplasia	NA	NA	BGN	No gene mim	No disease mim	hemizygous	probable	all missense/in frame	Skeleton	1044	biglycan	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	DSPG1|SLRR1A	biglycan proteoglycan			Small leucine rich repeat proteoglycans
NA	epileptic encephalopathy with continuous spike-and-wave during sleep	NA	NA	FRRS1L	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	1362	ferric chelate reductase 1 like	protein-coding gene	gene with protein product	Approved	9q31.3	09q31.3	CG-6		C9orf4	chromosome 9 open reading frame 4|ferric-chelate reductase 1-like	
HP:0000316	curry-jones syndrome	Hypertelorism	Very frequent (99-80%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000324	curry-jones syndrome	Facial asymmetry	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000568	curry-jones syndrome	Microphthalmia	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000588	curry-jones syndrome	Optic nerve coloboma	Occasional (29-5%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000612	curry-jones syndrome	Iris coloboma	Occasional (29-5%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001053	curry-jones syndrome	Hypopigmented skin patches	Very frequent (99-80%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001177	curry-jones syndrome	Preaxial hand polydactyly	Occasional (29-5%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001249	curry-jones syndrome	Intellectual disability	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001274	curry-jones syndrome	Agenesis of corpus callosum	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001363	curry-jones syndrome	Craniosynostosis	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001770	curry-jones syndrome	Toe syndactyly	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001829	curry-jones syndrome	Foot polydactyly	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002119	curry-jones syndrome	Ventriculomegaly	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002230	curry-jones syndrome	Generalized hirsutism	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002566	curry-jones syndrome	Intestinal malrotation	Occasional (29-5%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006101	curry-jones syndrome	Finger syndactyly	Very frequent (99-80%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008065	curry-jones syndrome	Aplasia/Hypoplasia of the skin	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0009602	curry-jones syndrome	Abnormality of thumb phalanx	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0011304	curry-jones syndrome	Broad thumb	Frequent (79-30%)	SMO	No gene mim	No disease mim	mosaic	confirmed	activating	Skeleton;Face;Brain/Cognition	11119	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	combined immunodeficiency	NA	NA	TFRC	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Bone Marrow/Immune	11763	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal dominant coloboma	NA	NA	FZD5	No gene mim	No disease mim	monoallelic	probable	dominant negative		4043	frizzled class receptor 5	protein-coding gene	gene with protein product	Approved	2q33.3	02q33.3	HFZ5|DKFZP434E2135		C2orf31	frizzled (Drosophila) homolog 5|chromosome 2 open reading frame 31|frizzled homolog 5 (Drosophila)|frizzled 5, seven transmembrane spanning receptor|frizzled family receptor 5	G protein-coupled receptors, Class F frizzled
NA	col6a1 associated myopathy	NA	NA	COL6A1	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame		2211	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	meier-gorlin syndrome and craniosynostosis	NA	NA	CDC45	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition;Ear	1739	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia	NA	NA	SEC61A1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Bone Marrow/Immune;Kidney Renal Tract	18276	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	progressive neurological disorder and regression of developmental milestones	NA	NA	VAC14	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Brain/Cognition	25507	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscle weakness and isolated complex i deficiency	NA	NA	TMEM126B	No gene mim	No disease mim	biallelic	confirmed	loss of function	Musculature;Endocrine/Metabolic	30883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	pontocerebellar hypoplasia and progressive microcephaly	NA	NA	TSEN15	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Brain/Cognition	16791	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cold-induced sweating syndrome type 1 (ciss1-like phenotype associated with early-onset retinitis pigmentosa	NA	NA	KLHL7	No gene mim	No disease mim	biallelic	probable	uncertain	Eye;Brain/Cognition	15646	kelch like family member 7	protein-coding gene	gene with protein product	Approved	7p15.3	07p15.3	KLHL6|SBBI26|RP42	retinitis pigmentosa 42		kelch-like 7 (Drosophila)	Kelch like|BTB domain containing
NA	coats plus	NA	NA	POT1	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Eye;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	17284	protection of telomeres 1	protein-coding gene	gene with protein product	Approved	7q31.33	07q31.33	hPot1|DKFZp586D211			protection of telomeres 1 homolog (S. pombe)	Shelterin complex
NA	peho-like syndrome	NA	NA	CCDC88A	No gene mim	No disease mim		possible		Brain/Cognition	25523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	rasopathy with developmental delay, short stature and sparse slow-growing hair	NA	NA	PPP1CB	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame	Multisystem;Hair/Nails;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	9282	protein phosphatase 1 catalytic subunit beta	protein-coding gene	gene with protein product	Approved	2p23.2	02p23.2	PP1B|PP-1B|PP1beta			protein phosphatase 1, catalytic subunit, beta isoform|protein phosphatase 1, catalytic subunit, beta isozyme	Protein phosphatase catalytic subunits
NA	syndromic intellectual disability	NA	NA	NONO	No gene mim	612100	hemizygous	probable	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	7871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	atad3a disorder -  global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy	NA	NA	ATAD3A	No gene mim	No disease mim	monoallelic	confirmed	dominant negative	Spinal cord/Peripheral nerves;Endocrine/Metabolic;Eye;Brain/Cognition	25567	ATPase family, AAA domain containing 3A	protein-coding gene	gene with protein product	Approved	1p36.33	01p36.33	FLJ10709				AAA ATPases
NA	geroderma osteodysplasticum	NA	NA	GORAB	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skin;Skeleton;Brain/Cognition	25676	golgin, RAB6 interacting	protein-coding gene	gene with protein product	Approved	1q24.2	01q24.2	FLJ11752|NTKL-BP1|GO	gerodermia osteodysplastica|RAB6-interacting golgin	SCYL1BP1	SCY1-like 1 binding protein 1|golgin, RAB6-interacting	
NA	hereditary 1,25-dihydroxyvitamin d-resistant rickets	NA	NA	CYP24A1	No gene mim	No disease mim	biallelic	possible	loss of function	Kidney Renal Tract;Endocrine/Metabolic	2602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe infantile-onset encephalopathy	NA	NA	UBA5	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	23230	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cousin syndrome; craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature	NA	NA	TBX15	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Face	11594	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	syndromic intellectual disability with or without congenital heart disease	NA	NA	CHD4	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1919	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000164	cherubism	Abnormality of the teeth	Frequent (79-30%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000277	cherubism	Abnormality of the mandible	Very frequent (99-80%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000293	cherubism	Full cheeks	Very frequent (99-80%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	cherubism	Visual impairment	Occasional (29-5%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	cherubism	Proptosis	Occasional (29-5%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000529	cherubism	Progressive visual loss	Occasional (29-5%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	cherubism	Optic atrophy	Occasional (29-5%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000677	cherubism	Oligodontia	Frequent (79-30%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0001608	cherubism	Abnormality of the voice	Occasional (29-5%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002781	cherubism	Upper airway obstruction	Occasional (29-5%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002870	cherubism	Obstructive sleep apnea	Occasional (29-5%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0006482	cherubism	Abnormality of dental morphology	Frequent (79-30%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008872	cherubism	Feeding difficulties in infancy	Occasional (29-5%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012062	cherubism	Bone cyst	Very frequent (99-80%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0012802	cherubism	Broad jaw	Very frequent (99-80%)	SH3BP2	No gene mim	No disease mim	monoallelic	possible	activating	Skeleton;Face	10825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	syndromic intellectual disability with or without congenital heart disease	NA	NA	CDK13	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	1733	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	syndromic congenital heart defects	NA	NA	PRKD1	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame	Brain/Cognition;Heart/Cardiovasculature/Lymphatic	9407	protein kinase D1	protein-coding gene	gene with protein product	Approved	14q12	14q12	PKCM|PKD|PKC-mu		PRKCM	protein kinase C, mu	Pleckstrin homology domain containing
NA	crebbp intellectual disability without typical rts features	NA	NA	CREBBP	600140	No disease mim		confirmed		Brain/Cognition	2348	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	gomez-lopez-fernandes syndrome	NA	NA	KPNA7	No gene mim	No disease mim		possible		Brain/Cognition	21839	karyopherin subunit alpha 7	protein-coding gene	gene with protein product	Approved	7q22.1	07q22.1	IPOA8	importin alpha 8		karyopherin alpha 7 (importin alpha 8)|karyopherin alpha 7	Armadillo repeat containing|Importins
NA	tlk2 syndrome	NA	NA	TLK2	No gene mim	No disease mim	monoallelic	possible	loss of function		11842	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	sudden arrhythmic cardiac death after infectious or alcohol trigger	NA	NA	PPA2	No gene mim	No disease mim	biallelic	confirmed	all missense/in frame	Heart/Cardiovasculature/Lymphatic	28883	pyrophosphatase (inorganic) 2	protein-coding gene	gene with protein product	Approved	4q24	04q24	FLJ20459				
NA	x-linked anophthalmia syndrome	NA	NA	NAA10	300013	No disease mim	hemizygous	confirmed	loss of function		18704	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	x-linked anophthalmia syndrome/lenz	NA	NA	NAA10	300013	No disease mim	hemizygous	confirmed	loss of function		18704	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	isolated arhinia/bosma arhinia syndrome	NA	NA	SMCHD1	No gene mim	No disease mim	monoallelic	both DD and IF	all missense/in frame	Face;Eye	29090	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	oavs/goldenhar syndrome	NA	NA	MYT1	No gene mim	No disease mim	monoallelic	possible	loss of function	Skeleton;Face;Eye;Ear	7622	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	laterality defects	NA	NA	PKD1L1	No gene mim	No disease mim	biallelic	confirmed	loss of function	Heart/Cardiovasculature/Lymphatic	18053	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000405	cardiospondylocarpofacial syndrome	Conductive hearing impairment	Very frequent (99-80%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0001156	cardiospondylocarpofacial syndrome	Brachydactyly syndrome	Very frequent (99-80%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0001634	cardiospondylocarpofacial syndrome	Mitral valve prolapse	Very frequent (99-80%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0001653	cardiospondylocarpofacial syndrome	Mitral regurgitation	Very frequent (99-80%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0002705	cardiospondylocarpofacial syndrome	High, narrow palate	Very frequent (99-80%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0003312	cardiospondylocarpofacial syndrome	Abnormal form of the vertebral bodies	Very frequent (99-80%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0003510	cardiospondylocarpofacial syndrome	Severe short stature	Very frequent (99-80%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0004279	cardiospondylocarpofacial syndrome	Short palm	Very frequent (99-80%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0005048	cardiospondylocarpofacial syndrome	Synostosis of carpal bones	Very frequent (99-80%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000692	cardiospondylocarpofacial syndrome	Misalignment of teeth	Frequent (79-30%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0006352	cardiospondylocarpofacial syndrome	Failure of eruption of permanent teeth	Frequent (79-30%)	MAP3K7	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Face;Ear;Heart/Cardiovasculature/Lymphatic	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000071	frontometaphyseal dysplasia	Ureteral stenosis	Occasional (29-5%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000126	frontometaphyseal dysplasia	Hydronephrosis	Occasional (29-5%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000218	frontometaphyseal dysplasia	High palate	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000316	frontometaphyseal dysplasia	Hypertelorism	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000336	frontometaphyseal dysplasia	Prominent supraorbital ridges	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000347	frontometaphyseal dysplasia	Micrognathia	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000405	frontometaphyseal dysplasia	Conductive hearing impairment	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000407	frontometaphyseal dysplasia	Sensorineural hearing impairment	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000494	frontometaphyseal dysplasia	Downslanted palpebral fissures	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000940	frontometaphyseal dysplasia	Abnormal diaphysis morphology	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0000944	frontometaphyseal dysplasia	Abnormality of the metaphyses	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0001363	frontometaphyseal dysplasia	Craniosynostosis	Occasional (29-5%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0001387	frontometaphyseal dysplasia	Joint stiffness	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0001607	frontometaphyseal dysplasia	Subglottic stenosis	Occasional (29-5%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0002650	frontometaphyseal dysplasia	Scoliosis	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0002777	frontometaphyseal dysplasia	Tracheal stenosis	Occasional (29-5%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0002949	frontometaphyseal dysplasia	Fused cervical vertebrae	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0003042	frontometaphyseal dysplasia	Elbow dislocation	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0003312	frontometaphyseal dysplasia	Abnormal form of the vertebral bodies	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0004493	frontometaphyseal dysplasia	Craniofacial hyperostosis	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0005048	frontometaphyseal dysplasia	Synostosis of carpal bones	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0005453	frontometaphyseal dysplasia	Absent/hypoplastic paranasal sinuses	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0005616	frontometaphyseal dysplasia	Accelerated skeletal maturation	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0006160	frontometaphyseal dysplasia	Irregular metacarpals	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0006482	frontometaphyseal dysplasia	Abnormality of dental morphology	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0006487	frontometaphyseal dysplasia	Bowing of the long bones	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0006695	frontometaphyseal dysplasia	Atrioventricular canal defect	Occasional (29-5%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0008451	frontometaphyseal dysplasia	Posterior vertebral hypoplasia	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0008661	frontometaphyseal dysplasia	Urethral stenosis	Occasional (29-5%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0009004	frontometaphyseal dysplasia	Hypoplasia of the musculature	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0009465	frontometaphyseal dysplasia	Ulnar deviation of finger	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0009650	frontometaphyseal dysplasia	Short distal phalanx of the thumb	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0009804	frontometaphyseal dysplasia	Reduced number of teeth	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0010103	frontometaphyseal dysplasia	Short distal phalanx of hallux	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0010493	frontometaphyseal dysplasia	Long metacarpals	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0100490	frontometaphyseal dysplasia	Camptodactyly of finger	Very frequent (99-80%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
HP:0100807	frontometaphyseal dysplasia	Long fingers	Frequent (79-30%)	MAP3K7	No gene mim	305620	monoallelic	probable	all missense/in frame	Skeleton	6859	mitogen-activated protein kinase kinase kinase 7	protein-coding gene	gene with protein product	Approved	6q15	06q15	MEKK7	TGF-beta activated kinase 1	TAK1		Mitogen-activated protein kinase kinase kinases
NA	crouzon-like craniosynostosis	NA	NA	IL11RA	No gene mim	No disease mim	biallelic	probable	loss of function	Teeth & Dentitian;Skeleton;Heart/Cardiovasculature/Lymphatic	5967	interleukin 11 receptor subunit alpha	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3				interleukin 11 receptor, alpha	Immunoglobulin like domain containing|Interleukin receptors
NA	autosomal recessive craniosynostosis	NA	NA	IL11RA	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Face;Ear	5967	interleukin 11 receptor subunit alpha	protein-coding gene	gene with protein product	Approved	9p13.3	09p13.3				interleukin 11 receptor, alpha	Immunoglobulin like domain containing|Interleukin receptors
NA	syndromic id with severe microcephaly	NA	NA	EIF2S3	No gene mim	No disease mim	hemizygous	probable	loss of function	Brain/Cognition	3267	eukaryotic translation initiation factor 2 subunit gamma	protein-coding gene	gene with protein product	Approved	Xp22.11	Xp22.11	EIF2gamma|EIF2	eukaryotic translation initiation factor 2G	EIF2G	eukaryotic translation initiation factor 2, subunit 3 (gamma, 52kD)|eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa	
NA	severe microcephaly, short stature and intellectual disability	NA	NA	PPP1R15B	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	14951	protein phosphatase 1 regulatory subunit 15B	protein-coding gene	gene with protein product	Approved	1q32.1	01q32.1	FLJ14744			protein phosphatase 1, regulatory (inhibitor) subunit 15B|protein phosphatase 1, regulatory subunit 15B	Protein phosphatase 1 regulatory subunits
NA	microcephaly with short stature	NA	NA	NCAPD2	No gene mim	No disease mim		possible		Skeleton;Brain/Cognition	24305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microcephaly with short stature	NA	NA	NCAPD3	No gene mim	No disease mim		possible		Skeleton;Brain/Cognition	28952	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microcephaly	NA	NA	NCAPH	No gene mim	No disease mim	biallelic	possible	loss of function	Brain/Cognition	1112	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microcephalic dwarfism	NA	NA	ARCN1	No gene mim	No disease mim	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	649	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glycosylphosphatidylinositol deficiency	NA	NA	PIGY	No gene mim	No disease mim	biallelic	probable	all missense/in frame		28213	phosphatidylinositol glycan anchor biosynthesis class Y	protein-coding gene	gene with protein product	Approved	4q22.1	04q22.1	MGC14156			phosphatidylinositol glycan, class Y	Phosphatidylinositol glycan anchor biosynthesis
NA	early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria	NA	NA	HTRA2	No gene mim	No disease mim	biallelic	possible	loss of function	Endocrine/Metabolic;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	14348	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital lymphatic dysplasia with hydrops and/or lymphoedema	NA	NA	PIEZO1	No gene mim	No disease mim	biallelic	probable	loss of function	Heart/Cardiovasculature/Lymphatic	28993	piezo type mechanosensitive ion channel component 1	protein-coding gene	gene with protein product	Approved	16q24.3	16q24.3	KIAA0233		FAM38A	family with sequence similarity 38, member A|piezo-type mechanosensitive ion channel component 1	
NA	leukoencephalopathy with cerebral calcification & cysts	NA	NA	SNORD118	No gene mim	No disease mim	biallelic	both DD and IF	loss of function	Brain/Cognition	32952	small nucleolar RNA, C/D box 118	non-coding RNA	RNA, small nucleolar	Approved	17p13.1	17p13.1	U8				Small nucleolar RNAs, C/D box
NA	otulin-related auto inflammatory syndrome	NA	NA	OTULIN	No gene mim	No disease mim	biallelic	confirmed	loss of function	Bone Marrow/Immune;Skin;Multisystem;GI tract	25118	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe pseudo-torch syndrome	NA	NA	USP18	No gene mim	No disease mim	biallelic	probable	loss of function	Lungs;Skeleton;Multisystem;Brain/Cognition	12616	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	severe syndromic form of thoracic aortic aneurysm & dissection	NA	NA	BGN	No gene mim	No disease mim	hemizygous	both DD and IF	loss of function	Skeleton;Face;Heart/Cardiovasculature/Lymphatic	1044	biglycan	protein-coding gene	gene with protein product	Approved	Xq28	Xq28	DSPG1|SLRR1A	biglycan proteoglycan			Small leucine rich repeat proteoglycans
NA	mlid syndrome	NA	NA	NLRP5	No gene mim	No disease mim		probable		Multisystem;Brain/Cognition	21269	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infantile-onset severe developmental delay and skeletal dysplasia	NA	NA	NANS	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Brain/Cognition	19237	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	trna isopentenyltransferase deficiency	NA	NA	TRIT1	No gene mim	No disease mim	biallelic	possible	all missense/in frame	Musculature;Endocrine/Metabolic;Brain/Cognition	20286	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ataxia, dysmetria, contractures & scoliosis with normal cognition but loss of discriminative touch perception	NA	NA	PIEZO2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Musculature;Skeleton	26270	piezo type mechanosensitive ion channel component 2	protein-coding gene	gene with protein product	Approved	18p11.22-p11.21	18p11.22-p11.21	FLJ23403|FLJ23144|HsT748|HsT771|FLJ34907		FAM38B2|C18orf30|C18orf58|FAM38B	chromosome 18 open reading frame 30|chromosome 18 open reading frame 58|family with sequence similarity 38, member B|piezo-type mechanosensitive ion channel component 2	
NA	brpf1 associated syndromic intellectual disability with ptosis	NA	NA	BRPF1	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Brain/Cognition	14255	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hivep2 associated syndromic developmental delay with intellectual disability	NA	NA	HIVEP2	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Brain/Cognition	4921	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	colobomatous macrophthalmia with microcornea syndrome	NA	NA	CRIM1	No gene mim	No disease mim	biallelic	possible	loss of function	Eye	2359	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	colobomatous microphthalmia, microcephaly, intellectual disability, and short stature	NA	NA	HMGB3	No gene mim	No disease mim	hemizygous	possible	loss of function		5004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	complex early-onset dystonia	NA	NA	KMT2B	No gene mim	No disease mim	monoallelic	probable	loss of function	Brain/Cognition	15840	lysine methyltransferase 2B	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12	KIAA0304|MLL2|TRX2|HRX2|WBP7|MLL1B|MLL4|CXXC10	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) 4		lysine (K)-specific methyltransferase 2B	PHD finger proteins|Zinc fingers CXXC-type|Lysine methyltransferases|SET domain containing
NA	intellectual disability	NA	NA	SETD1A	No gene mim	No disease mim	monoallelic	probable	loss of function	Brain/Cognition	29010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	stag1 syndromic intellectual disability	NA	NA	STAG1	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Brain/Cognition	11354	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy	NA	NA	SLC1A2	No gene mim	No disease mim	monoallelic	probable	all missense/in frame		10940	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intraosseous vascular malformation	NA	NA	ELMO2	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Heart/Cardiovasculature/Lymphatic	17233	engulfment and cell motility 2	protein-coding gene	gene with protein product	Approved	20q13.12	20q13.12	CED12|ELMO-2|CED-12|KIAA1834|FLJ11656			engulfment and cell motility 2 (ced-12 homolog, C. elegans)	
NA	growth retardation with prenatal onset, intellectual disability, muscular hypotonia, and infantile hepatopathy	NA	NA	IARS	No gene mim	No disease mim	biallelic	probable	loss of function	Bone Marrow/Immune;Musculature;GI tract	5330	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital vascular tumours	NA	NA	GNA14	No gene mim	No disease mim	mosaic	probable	activating	Heart/Cardiovasculature/Lymphatic	4382	G protein subunit alpha 14	protein-coding gene	gene with protein product	Approved	9q21.2	09q21.2				guanine nucleotide binding protein (G protein), alpha 14	G protein subunits alpha, group q
NA	primary ciliary dyskinesia with left-right body asymmetry randomization	NA	NA	TTC25	No gene mim	No disease mim	biallelic	probable	loss of function	Lungs;GI tract;Heart/Cardiovasculature/Lymphatic	25280	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary ciliary dyskinesia and male infertility	NA	NA	DNAJB13	No gene mim	No disease mim	biallelic	possible	loss of function	Lungs;Genitalia	30718	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	primary microcephaly	NA	NA	CIT	No gene mim	615414	biallelic	probable	all missense/in frame	Brain/Cognition	1985	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	syndromic intellectual disability	NA	NA	SIN3A	No gene mim	612100	monoallelic	probable	loss of function	Face;Brain/Cognition	19353	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	sinus bradycardia and cognitive disability	NA	NA	GNB5	No gene mim	No disease mim	biallelic	probable	loss of function		4401	G protein subunit beta 5	protein-coding gene	gene with protein product	Approved	15q21.2	15q21.2	GB5			guanine nucleotide binding protein (G protein), beta 5	WD repeat domain containing|G protein subunits beta
NA	intellectual disability, congenital malformations, and failure to thrive	NA	NA	SON	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Skeleton;Brain/Cognition	11183	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neurodevelopmental disorder in females	NA	NA	HNRNPH2	No gene mim	No disease mim	x-linked dominant	probable	all missense/in frame	Brain/Cognition	5042	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital myasthenic syndrome with episodic apnea	NA	NA	SLC5A7	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Musculature;Peripheral nerves	14025	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000028	bowen-conradi syndrome	Cryptorchidism	Frequent (79-30%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0000202	bowen-conradi syndrome	Oral cleft	Occasional (29-5%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0000252	bowen-conradi syndrome	Microcephaly	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0000340	bowen-conradi syndrome	Sloping forehead	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0000347	bowen-conradi syndrome	Micrognathia	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0000448	bowen-conradi syndrome	Prominent nose	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0001250	bowen-conradi syndrome	Seizures	Occasional (29-5%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0001387	bowen-conradi syndrome	Joint stiffness	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0001522	bowen-conradi syndrome	Death in infancy	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0001838	bowen-conradi syndrome	Rocker bottom foot	Frequent (79-30%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0002101	bowen-conradi syndrome	Abnormal lung lobation	Occasional (29-5%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0002119	bowen-conradi syndrome	Ventriculomegaly	Occasional (29-5%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0002564	bowen-conradi syndrome	Malformation of the heart and great vessels	Occasional (29-5%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0004209	bowen-conradi syndrome	Clinodactyly of the 5th finger	Frequent (79-30%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0004322	bowen-conradi syndrome	Short stature	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0008846	bowen-conradi syndrome	Severe intrauterine growth retardation	Frequent (79-30%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0008850	bowen-conradi syndrome	Severe postnatal growth retardation	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0008872	bowen-conradi syndrome	Feeding difficulties in infancy	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0011344	bowen-conradi syndrome	Severe global developmental delay	Very frequent (99-80%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
HP:0100490	bowen-conradi syndrome	Camptodactyly of finger	Frequent (79-30%)	EMG1	No gene mim	No disease mim	biallelic	probable	uncertain	Bone Marrow/Immune;Multisystem;Brain/Cognition	16912	EMG1, N1-specific pseudouridine methyltransferase	protein-coding gene	gene with protein product	Approved	12p13.31	12p13.31	C2F|NEP1|Grcc2f			EMG1 nucleolar protein homolog (S. cerevisiae)	SPOUT methyltranferase domain containing
NA	severe epileptic encephalopathy treatable with nmda receptor channel blockers	NA	NA	GRIN2D	No gene mim	No disease mim	monoallelic	probable	activating	Brain/Cognition	4588	glutamate ionotropic receptor NMDA type subunit 2D	protein-coding gene	gene with protein product	Approved	19q13.33	19q13.33	GluN2D|EB11|NR2D	N-methyl-d-aspartate receptor subunit 2D	NMDAR2D	glutamate receptor, ionotropic, N-methyl D-aspartate 2D	Glutamate ionotropic receptor NMDA type subunits
NA	atad3a disorder - global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy	NA	NA	ATAD3A	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	25567	ATPase family, AAA domain containing 3A	protein-coding gene	gene with protein product	Approved	1p36.33	01p36.33	FLJ10709				AAA ATPases
NA	severe early-onset mitochondrial disease and loss of mitochondrial dna copy number	NA	NA	SLC25A4	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Musculature;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	10990	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lethal neurometabolic disorder of early childhood	NA	NA	NAXE	No gene mim	No disease mim	biallelic	probable	loss of function	Skin;Brain/Cognition	18453	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy	NA	NA	FGF12	No gene mim	No disease mim	monoallelic	confirmed	activating	Brain/Cognition	3668	fibroblast growth factor 12	protein-coding gene	gene with protein product	Approved	3q28-q29	03q28-q29	FHF1	fibroblast growth factor 12B|fibroblast growth factor homologous factor 1|myocyte-activating factor|fibroblast growth factor FGF-12b	FGF12B		
NA	intellectual disability, ataxia, and facial dysmorphism	NA	NA	EBF3	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Brain/Cognition	19087	early B-cell factor 3	protein-coding gene	gene with protein product	Approved	10q26.3	10q26.3	COE3|DKFZp667B0210				
NA	spastic paraplegia, intellectual disability, nystagmus, and obesity.	NA	NA	KIDINS220	No gene mim	No disease mim	monoallelic	probable	loss of function	Endocrine/Metabolic;Eye;Brain/Cognition	29508	kinase D interacting substrate 220	protein-coding gene	gene with protein product	Approved	2p25.1	02p25.1	ARMS	ankyrin repeat-rich membrane-spanning protein		kinase D-interacting substrate 220kDa	Ankyrin repeat domain containing
NA	intellectual disability accompanied by epilepsy and autistic features	NA	NA	MBOAT7	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	15505	membrane bound O-acyltransferase domain containing 7	protein-coding gene	gene with protein product	Approved	19q13.42	19q13.42	BB1|hMBOA-7|LPIAT	lysophosphatidylinositol acyltransferase	LENG4	leukocyte receptor cluster (LRC) member 4	Membrane bound O-acyltransferases
NA	lethal arthroogryposis	NA	NA	GLDN	No gene mim	No disease mim	biallelic	probable	loss of function	Spinal cord/Peripheral nerves	29514	gliomedin	protein-coding gene	gene with protein product	Approved	15q21.2	15q21.2	CRG-L2|CLOM|colmedin|UNC-112		COLM	collomin	
NA	early-onset neurodegenerative encephalopathy	NA	NA	TBCD	No gene mim	No disease mim	biallelic	confirmed	loss of function	Brain/Cognition	11581	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	early-onset progressive encephalopathy with distal spinal muscular atrophy	NA	NA	TBCE	604934	No disease mim	biallelic	probable	all missense/in frame	Spinal cord/Peripheral nerves;Brain/Cognition	11582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	developmental delay, macrocephaly, and dysmorphic features	NA	NA	ASXL2	No gene mim	No disease mim	monoallelic	probable	loss of function	Face;Brain/Cognition	23805	additional sex combs like 2, transcriptional regulator	protein-coding gene	gene with protein product	Approved	2p23.3	02p23.3	ASXH2|FLJ10898|KIAA1685			additional sex combs like 2 (Drosophila)	
NA	arid2-coffin-siris like disorder	NA	NA	ARID2	No gene mim	No disease mim	monoallelic	probable	loss of function		18037	AT-rich interaction domain 2	protein-coding gene	gene with protein product	Approved	12q12	12q12	KIAA1557|DKFZp686G052|FLJ30619|BAF200			AT rich interactive domain 2 (ARID, RFX-like)	AT-rich interaction domain containing
NA	epileptic encephalopathy with complex movement disorder and regression	NA	NA	CARS2	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	25695	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	overgrowth intellectual disability	NA	NA	CLTC	No gene mim	No disease mim	monoallelic	possible	loss of function	Brain/Cognition	2092	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cul3 associated autism spectrum disorder	NA	NA	CUL3	No gene mim	No disease mim		possible		Brain/Cognition	2553	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dlg4 related intellectual disability	NA	NA	DLG4	No gene mim	No disease mim		probable		Brain/Cognition	2903	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	fbxo11 related intellectual disability	NA	NA	FBXO11	No gene mim	No disease mim		possible		Brain/Cognition	13590	F-box protein 11	protein-coding gene	gene with protein product	Approved	2p16.3	02p16.3	FBX11|UBR6	ubiquitin protein ligase E3 component n-recognin 6		F-box only protein 11	F-boxes other|Ubiquitin protein ligase E3 component n-recognins
NA	hecw2	NA	NA	HECW2	No gene mim	No disease mim	monoallelic	confirmed	all missense/in frame	Brain/Cognition	29853	HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2	protein-coding gene	gene with protein product	Approved	2q32.3	02q32.3	KIAA1301|NEDL2				C2 domain containing
NA	morc2 - axonal neuropathy	NA	NA	MORC2	No gene mim	No disease mim		probable			23573	MORC family CW-type zinc finger 2	protein-coding gene	gene with protein product	Approved	22q12.2	22q12.2	ZCW3|KIAA0852|AC004542.C22.1		ZCWCC1	zinc finger, CW-type with coiled-coil domain 1|zinc finger, CW type with coiled-coil domain 1	Zinc fingers CW-type
NA	trip12-related intellectual disability with/without autism spectrum disorder	NA	NA	TRIP12	No gene mim	No disease mim	monoallelic	confirmed	loss of function		12306	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	early-onset myopathy with internalized nuclei and myofibrillar disorganization	NA	NA	PYROXD1	No gene mim	No disease mim	biallelic	probable	loss of function	Musculature	26162	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	megalencephaly with variant lissencephaly	NA	NA	CRADD	No gene mim	No disease mim		probable		Brain/Cognition	2340	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	glycine encephalopathy with arthrogryposis	NA	NA	SLC6A9	No gene mim	No disease mim	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	11056	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	cobblestone lissencephaly	NA	NA	TMTC3	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	26899	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	childhood-onset dystonia and optic atrophy	NA	NA	MECR	No gene mim	No disease mim	biallelic	probable	loss of function		19691	mitochondrial trans-2-enoyl-CoA reductase	protein-coding gene	gene with protein product	Approved	1p35.3	01p35.3	CGI-63|NRBF1|FASN2B|ETR1	nuclear receptor binding factor 1|mitochondrial 2-enoyl thioester reductase			
NA	vitamin-b6-dependent epilepsy	NA	NA	PLPBP	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	9457	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	anterior segment dysgenesis	NA	NA	CPAMD8	No gene mim	No disease mim	biallelic	probable	loss of function	Eye	23228	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy	NA	NA	DENND5A	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	19344	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	epileptic encephalopathy with optic atrophy	NA	NA	AP3B2	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	567	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness	NA	NA	MITF	156845	No disease mim	biallelic	probable	loss of function		7105	melanogenesis associated transcription factor	protein-coding gene	gene with protein product	Approved	3p13	03p13	MI|bHLHe32	homolog of mouse microphthalmia	WS2A|WS2	Waardenburg syndrome, type 2A|microphthalmia-associated transcription factor	Basic helix-loop-helix proteins
NA	early-onset severe encephalopathy	NA	NA	MDH2	No gene mim	No disease mim	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	6971	malate dehydrogenase 2	protein-coding gene	gene with protein product	Approved	7q11.23	07q11.23				malate dehydrogenase 2, NAD (mitochondrial)	
NA	x-linked primary ciliary dyskinesia with outer and inner dynein arm defects	NA	NA	PIH1D3	No gene mim	No disease mim	hemizygous	child IF	loss of function		28570	PIH1 domain containing 3	protein-coding gene	gene with protein product	Approved	Xq22.3	Xq22.3	MGC35261|NYSAR97	sarcoma antigen NY-SAR-97	CXorf41	chromosome X open reading frame 41	
NA	childhood-onset, slowly progressive nemaline myopathy	NA	NA	MYPN	No gene mim	No disease mim	biallelic	child IF	loss of function		23246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hyperphenylalaninemia, dystonia, and intellectual disability	NA	NA	DNAJC12	No gene mim	No disease mim	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	28908	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability and epilepsy	NA	NA	NEXMIF	No gene mim	No disease mim	x-linked dominant	probable	loss of function	Skeleton;Brain/Cognition	29433	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	myh10-related multiple congenital anomalies	NA	NA	MYH10	No gene mim	No disease mim	monoallelic	possible	loss of function	Skeleton;Respiratory tract;Brain/Cognition	7568	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	tooth agenesis	NA	NA	LRP6	No gene mim	No disease mim	monoallelic	possible	loss of function	GI tract	6698	LDL receptor related protein 6	protein-coding gene	gene with protein product	Approved	12p13.2	12p13.2	ADCAD2			low density lipoprotein receptor-related protein 6	Low density lipoprotein receptors
NA	peho like condition	NA	NA	PRUNE1	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	13420	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	hist1h4c	NA	NA	HIST1H4C	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Face;Brain/Cognition	4787	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	EPB41L1	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	3378	erythrocyte membrane protein band 4.1 like 1	protein-coding gene	gene with protein product	Approved	20q11.23	20q11.23	KIAA0338|4.1N				Erythrocyte membrane protein band 4.1|FERM domain containing
NA	childhood overgrowth	NA	NA	HIST1H1E	No gene mim	No disease mim	monoallelic	probable	loss of function	Skeleton;Brain/Cognition	4718	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	RAB11B	No gene mim	No disease mim	monoallelic	possible	all missense/in frame	Brain/Cognition	9761	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	global developmental delay, multiple malformations	NA	NA	PSMD12	No gene mim	No disease mim	monoallelic	possible	loss of function	Kidney Renal Tract;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	9557	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	blepharo-cheiro-dontic syndrome	NA	NA	CDH1	No gene mim	No disease mim	monoallelic	both DD and IF	all missense/in frame	Teeth & Dentitian;Face;GI tract;Eye	1748	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	blepharo-cheiro-dontic syndrome	NA	NA	CTNND1	No gene mim	No disease mim	monoallelic	both DD and IF	loss of function	Teeth & Dentitian;Face;GI tract;Eye	2515	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	actb haploinsufficiency syndtome	NA	NA	ACTB	102630	No disease mim	monoallelic	probable	loss of function	Kidney Renal Tract;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	132	actin beta	protein-coding gene	gene with protein product	Approved	7p22.1	07p22.1					Actins
NA	skeletal dysplasia with severe neurological disease	NA	NA	AFF3	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Skeleton;Brain/Cognition	6473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	brain atrophy, dandy walker and contractures	NA	NA	KIAA1109	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Skeleton;Brain/Cognition	26953	KIAA1109	protein-coding gene	gene with protein product	Approved	4q27	04q27	FLJ21404|FSA|KIAA1371|Tweek	fragile site-associated			
NA	short stature, palatal anomalies, congenital heart disease, and skeletal malformations	NA	NA	BMP2	No gene mim	No disease mim		probable			1069	bone morphogenetic protein 2	protein-coding gene	gene with protein product	Approved	20p12.3	20p12.3			BMP2A		Bone morphogenetic proteins|Endogenous ligands
NA	beaulieu-boycott-innes syndrome	NA	NA	THOC6	No gene mim	No disease mim	biallelic	confirmed	loss of function	Kidney Renal Tract;Face;Brain/Cognition	28369	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	ciliary dyskinesia, primary, 3	NA	NA	DNAH5	No gene mim	No disease mim	biallelic	probable	loss of function	Lungs;Liver;Genitalia;Heart/Cardiovasculature/Lymphatic	2950	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	FRMPD4	No gene mim	No disease mim	hemizygous	probable	loss of function	Brain/Cognition	29007	FERM and PDZ domain containing 4	protein-coding gene	gene with protein product	Approved	Xp22.2	Xp22.2	KIAA0316		PDZK10|PDZD10	PDZ domain containing 10	PDZ domain containing|FERM domain containing
NA	intellectual disability	NA	NA	KLHL15	No gene mim	No disease mim	hemizygous	possible	loss of function		29347	kelch like family member 15	protein-coding gene	gene with protein product	Approved	Xp22.11	Xp22.11	KIAA1677			kelch-like 15 (Drosophila)	Kelch like|BTB domain containing
NA	intellectual disability	NA	NA	LAS1L	No gene mim	No disease mim		possible		Brain/Cognition	25726	LAS1 like, ribosome biogenesis factor	protein-coding gene	gene with protein product	Approved	Xq12	Xq12	FLJ12525			LAS1-like (S. cerevisiae)	5FMC ribosome biogenesis complex
NA	intellectual disability	NA	NA	RLIM	No gene mim	No disease mim	hemizygous	probable	all missense/in frame	Brain/Cognition;Genitalia	13429	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	USP27X	No gene mim	No disease mim	hemizygous	probable	loss of function	Brain/Cognition	13486	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability	NA	NA	CDK16	No gene mim	No disease mim	hemizygous	possible	loss of function	Brain/Cognition	8749	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000316	axial spondylometaphyseal dysplasia	Hypertelorism	Occasional (29-5%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000463	axial spondylometaphyseal dysplasia	Anteverted nares	Occasional (29-5%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000483	axial spondylometaphyseal dysplasia	Astigmatism	Occasional (29-5%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000494	axial spondylometaphyseal dysplasia	Downslanted palpebral fissures	Occasional (29-5%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000505	axial spondylometaphyseal dysplasia	Visual impairment	Very frequent (99-80%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000506	axial spondylometaphyseal dysplasia	Telecanthus	Occasional (29-5%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000510	axial spondylometaphyseal dysplasia	Rod-cone dystrophy	Very frequent (99-80%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000520	axial spondylometaphyseal dysplasia	Proptosis	Occasional (29-5%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000613	axial spondylometaphyseal dysplasia	Photophobia	Occasional (29-5%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000648	axial spondylometaphyseal dysplasia	Optic atrophy	Frequent (79-30%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000887	axial spondylometaphyseal dysplasia	Cupped ribs	Very frequent (99-80%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000926	axial spondylometaphyseal dysplasia	Platyspondyly	Very frequent (99-80%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000944	axial spondylometaphyseal dysplasia	Abnormality of the metaphyses	Very frequent (99-80%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002007	axial spondylometaphyseal dysplasia	Frontal bossing	Frequent (79-30%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0002750	axial spondylometaphyseal dysplasia	Delayed skeletal maturation	Very frequent (99-80%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003196	axial spondylometaphyseal dysplasia	Short nose	Occasional (29-5%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003411	axial spondylometaphyseal dysplasia	Proximal femoral metaphyseal irregularity	Frequent (79-30%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0003796	axial spondylometaphyseal dysplasia	Irregular iliac crest	Frequent (79-30%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0004322	axial spondylometaphyseal dysplasia	Short stature	Very frequent (99-80%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0005257	axial spondylometaphyseal dysplasia	Thoracic hypoplasia	Frequent (79-30%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0008905	axial spondylometaphyseal dysplasia	Rhizomelia	Very frequent (99-80%)	C21orf2	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye	1260	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial depletion syndrome	NA	NA	RRM2B	No gene mim	No disease mim	biallelic	both DD and IF	loss of function	Multisystem;Brain/Cognition	17296	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	split hand and foot malformation	NA	NA	BHLHA9	No gene mim	220600	monoallelic	confirmed	increased gene dosage		35126	basic helix-loop-helix family member a9	protein-coding gene	gene with protein product	Approved	17p13.3	17p13.3	bHLHa9|BHLHF42	Fingerin		basic helix-loop-helix family, member a9	Basic helix-loop-helix proteins
NA	craniofacial anomalies, corpus callosum dysgenesis, ptosis, and developmental delay	NA	NA	ZNF462	No gene mim	No disease mim	monoallelic	probable	loss of function	Face;Multisystem;Eye;Brain/Cognition	21684	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability, seizures, abnormal gait, and distinctive facial features	NA	NA	WDR26	No gene mim	No disease mim	monoallelic	confirmed	loss of function	Face;Brain/Cognition	21208	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia	NA	NA	ERF	No gene mim	No disease mim	monoallelic	confirmed	activating	Skeleton;Face;Respiratory tract	3444	ETS2 repressor factor	protein-coding gene	gene with protein product	Approved	19q13.2	19q13.2	PE-2|PE2			Ets2 repressor factor	ETS transcription factor family
NA	leigh syndrome with instability of the small mitoribosomal subunit	NA	NA	MRPS34	No gene mim	No disease mim	biallelic	probable	loss of function	Endocrine/Metabolic;Brain/Cognition	16618	mitochondrial ribosomal protein S34	protein-coding gene	gene with protein product	Approved	16p13.3	16p13.3	MRP-S12|MGC2616				Mitochondrial ribosomal proteins
NA	childhood-onset neurodegeneration	NA	NA	UBTF	No gene mim	No disease mim	monoallelic	probable	activating	Brain/Cognition	12511	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mitochondrial lipoylation defect associated with severe neonatal encephalopathy	NA	NA	LIPT2	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	37216	lipoyl(octanoyl) transferase 2	protein-coding gene	gene with protein product	Approved	11q13.4	11q13.4				lipoyl(octanoyl) transferase 2 (putative)	
NA	progressive childhood encephalopathy and golgi dysfunction	NA	NA	TRAPPC12	No gene mim	No disease mim	digenic	probable	loss of function	Brain/Cognition	24284	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	early-onset epilepsy	NA	NA	YWHAG	No gene mim	No disease mim	monoallelic	probable	activating	Brain/Cognition	12852	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation	NA	NA	LIAS	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	16429	lipoic acid synthetase	protein-coding gene	gene with protein product	Approved	4p14	04p14	LAS				
NA	leigh syndrome with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase.	NA	NA	LIPT1	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Endocrine/Metabolic;Brain/Cognition	29569	lipoyltransferase 1	protein-coding gene	gene with protein product	Approved	2q11.2	02q11.2	MGC12290|MGC13378				
NA	joubert syndrome 30	NA	NA	ARMC9	No gene mim	No disease mim	biallelic	confirmed	loss of function	Eye: Retina;Brain/Cognition	20730	armadillo repeat containing 9	protein-coding gene	gene with protein product	Approved	2q37.1	02q37.1	FLJ12584|KIAA1868|ARM|KU-MEL-1				Armadillo repeat containing
NA	intellectual disability with or without epileptic encephalopathy	NA	NA	KCNQ5	No gene mim	No disease mim	monoallelic	probable	loss of function	Brain/Cognition	6299	potassium voltage-gated channel subfamily Q member 5	protein-coding gene	gene with protein product	Approved	6q13	06q13	Kv7.5			potassium voltage-gated channel, KQT-like subfamily, member 5|potassium channel, voltage gated KQT-like subfamily Q, member 5	Potassium voltage-gated channels
NA	intellectual disability with or without epileptic encephalopathy	NA	NA	KCNQ5	No gene mim	No disease mim	monoallelic	probable	activating	Brain/Cognition	6299	potassium voltage-gated channel subfamily Q member 5	protein-coding gene	gene with protein product	Approved	6q13	06q13	Kv7.5			potassium voltage-gated channel, KQT-like subfamily, member 5|potassium channel, voltage gated KQT-like subfamily Q, member 5	Potassium voltage-gated channels
NA	megacystis microcolon intestinal hypoperistalsis syndrome	NA	NA	MYLK	No gene mim	No disease mim	biallelic	probable	loss of function	Kidney Renal Tract;GI tract	7590	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	progressive spastic ataxia and hypomyelination	NA	NA	NKX6-2	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	19321	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	lethal infantile epileptic encephalopathy	NA	NA	PLAA	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	9043	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	weaver-like overgrowth syndrome	NA	NA	EED	No gene mim	No disease mim	monoallelic	probable	all missense/in frame		3188	embryonic ectoderm development	protein-coding gene	gene with protein product	Approved	11q14.2	11q14.2	WAIT-1|HEED	WD protein associating with integrin cytoplasmic tails 1			WD repeat domain containing|Polycomb repressive complex 2
NA	intellectual disability and epilepsy	NA	NA	SLC45A1	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Brain/Cognition	17939	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	larsen syndrome	NA	NA	GZF1	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Eye	15808	GDNF inducible zinc finger protein 1	protein-coding gene	gene with protein product	Approved	20p11.21	20p11.21	dJ322G13.2|ZBTB23		ZNF336	zinc finger protein 336	Zinc fingers C2H2-type|BTB domain containing
NA	retinitis pigmentosa, skeletal anomalies and intellectual disability	NA	NA	CWC27	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Eye;Brain/Cognition	10664	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000368	arthrogryposis multiplex congenita	Low-set, posteriorly rotated ears	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0000457	arthrogryposis multiplex congenita	Depressed nasal ridge	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0000776	arthrogryposis multiplex congenita	Congenital diaphragmatic hernia	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0001004	arthrogryposis multiplex congenita	Lymphedema	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0001543	arthrogryposis multiplex congenita	Gastroschisis	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0001561	arthrogryposis multiplex congenita	Polyhydramnios	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0001883	arthrogryposis multiplex congenita	Talipes	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0002103	arthrogryposis multiplex congenita	Abnormality of the pleura	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0002650	arthrogryposis multiplex congenita	Scoliosis	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0002804	arthrogryposis multiplex congenita	Arthrogryposis multiplex congenita	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0002827	arthrogryposis multiplex congenita	Hip dislocation	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0003019	arthrogryposis multiplex congenita	Abnormality of the wrist	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0004295	arthrogryposis multiplex congenita	Abnormality of the gastric mucosa	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0006703	arthrogryposis multiplex congenita	Aplasia/Hypoplasia of the lungs	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
HP:0009465	arthrogryposis multiplex congenita	Ulnar deviation of finger	Very frequent (99-80%)	LGI4	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Peripheral nerves	18712	leucine rich repeat LGI family member 4	protein-coding gene	gene with protein product	Approved	19q13.12	19q13.12				leucine-rich repeat LGI family, member 4	
NA	neurodevelopmental, cardiac, and renal syndrome	NA	NA	TMEM260	No gene mim	No disease mim	biallelic	probable	loss of function	Kidney Renal Tract;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	20185	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	intellectual disability syndrome associated with seizures and dysmorphic features	NA	NA	OTUD6B	No gene mim	No disease mim	biallelic	probable	loss of function	Skeleton;Brain/Cognition	24281	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	microcephaly, hearing loss, and dysmorphic features	NA	NA	RPS23	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Face;Brain/Cognition;Ear	10410	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	muscular dystrophy, congenital, with cataracts and intellectual disability	NA	NA	INPP5K	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Musculature;Skeleton;Eye: Lens;Brain/Cognition	33882	inositol polyphosphate-5-phosphatase K	protein-coding gene	gene with protein product	Approved	17p13.3	17p13.3	SKIP	skeletal muscle and kidney enriched inositol phosphatase			Phosphoinositide phosphatases
NA	autosomal-recessive intellectual disability and microcephaly	NA	NA	TAF13	No gene mim	No disease mim	biallelic	probable	all missense/in frame	Brain/Cognition	11546	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	infantile epilepsy, cataracts, and profound developmental delay	NA	NA	NACC1	No gene mim	No disease mim	monoallelic	confirmed	activating	Eye;Brain/Cognition	20967	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	mosaic variegated aneuploidy and wilms tumour	NA	NA	TRIP13	No gene mim	No disease mim	biallelic	probable	loss of function	Kidney Renal Tract;Skeleton;Brain/Cognition	12307	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	midline-bridging neuronal commissure disruption, horizontal gaze palsy, scoliosis, and intellectual disability	NA	NA	DCC	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	2701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	congenital heart defects and skeletal malformations	NA	NA	ABL1	No gene mim	No disease mim	monoallelic	probable	activating	Skeleton;Heart/Cardiovasculature/Lymphatic	76	ABL proto-oncogene 1, non-receptor tyrosine kinase	protein-coding gene	gene with protein product	Approved	9q34.12	09q34.12	JTK7|c-ABL|p150		ABL	v-abl Abelson murine leukemia viral oncogene homolog 1|c-abl oncogene 1, receptor tyrosine kinase|c-abl oncogene 1, non-receptor tyrosine kinase	SH2 domain containing|Abl family tyrosine kinases
NA	pontocerebellar hypoplasia	NA	NA	TOE1	No gene mim	No disease mim	biallelic	probable	loss of function	Brain/Cognition	15954	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	developmental delay and distinctive facial features	NA	NA	KDM1A	No gene mim	No disease mim	monoallelic	probable	uncertain	Face;Brain/Cognition	29079	lysine demethylase 1A	protein-coding gene	gene with protein product	Approved	1p36.12	01p36.12	KIAA0601|BHC110|LSD1		AOF2|KDM1	amine oxidase (flavin containing) domain 2|lysine (K)-specific demethylase 1	Lysine demethylases
NA	3mc	NA	NA	COLEC10	No gene mim	No disease mim	biallelic	probable	loss of function	Kidney Renal Tract;Face;Brain/Cognition;Heart/Cardiovasculature/Lymphatic	2220	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	dhrs3 related craniosynostosis	NA	NA	DHRS3	No gene mim	No disease mim	biallelic	possible	cis-regulatory or promotor mutation	Skeleton;Face;Brain/Cognition	17693	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NA	peroxisome biogenesis disorder 14b	NA	NA	PEX11B	No gene mim	No disease mim	biallelic	confirmed	loss of function	Skeleton;Multisystem;Eye;Brain/Cognition	8853	peroxisomal biogenesis factor 11 beta	protein-coding gene	gene with protein product	Approved	1q21.1	01q21.1				peroxisomal biogenesis factor 11B	Peroxins
NA	posteriorly predominant pachygyria and severe microcephaly	NA	NA	TUBG1	No gene mim	No disease mim	monoallelic	probable	all missense/in frame	Brain/Cognition	12417	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HP:0000175	hartsfield syndrome	Cleft palate	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000316	hartsfield syndrome	Hypertelorism	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000368	hartsfield syndrome	Low-set, posteriorly rotated ears	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000494	hartsfield syndrome	Downslanted palpebral fissures	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000506	hartsfield syndrome	Telecanthus	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000508	hartsfield syndrome	Ptosis	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0000568	hartsfield syndrome	Microphthalmia	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001171	hartsfield syndrome	Split hand	Frequent (79-30%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001363	hartsfield syndrome	Craniosynostosis	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0001511	hartsfield syndrome	Intrauterine growth retardation	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002084	hartsfield syndrome	Encephalocele	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0002093	hartsfield syndrome	Respiratory insufficiency	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0005280	hartsfield syndrome	Depressed nasal bridge	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0006501	hartsfield syndrome	Aplasia/Hypoplasia of the radius	Frequent (79-30%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0006870	hartsfield syndrome	Lobar holoprosencephaly	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0007370	hartsfield syndrome	Aplasia/Hypoplasia of the corpus callosum	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
HP:0100335	hartsfield syndrome	Non-midline cleft lip	Very frequent (99-80%)	FGFR1	136350	No disease mim	monoallelic	confirmed	dominant negative		3688	fibroblast growth factor receptor 1	protein-coding gene	gene with protein product	Approved	8p11.23	08p11.23	H2|H3|H4|H5|CEK|FLG|BFGFR|N-SAM|CD331	Pfeiffer syndrome	FLT2|KAL2	fms-related tyrosine kinase 2	Receptor Tyrosine Kinases|CD molecules|I-set domain containing
